Citrus Sinensis ID: 024336
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 269 | 2.2.26 [Sep-21-2011] | |||||||
| P0C5D6 | 334 | Serine/threonine-protein | yes | no | 1.0 | 0.805 | 0.832 | 1e-133 | |
| A2ZAB5 | 334 | Serine/threonine-protein | N/A | no | 1.0 | 0.805 | 0.832 | 1e-133 | |
| Q0D4J7 | 339 | Serine/threonine-protein | no | no | 0.914 | 0.725 | 0.869 | 1e-128 | |
| A2YNT8 | 339 | Serine/threonine-protein | N/A | no | 0.914 | 0.725 | 0.865 | 1e-128 | |
| Q940H6 | 362 | Serine/threonine-protein | yes | no | 0.914 | 0.679 | 0.845 | 1e-127 | |
| Q75LR7 | 342 | Serine/threonine-protein | no | no | 0.914 | 0.719 | 0.841 | 1e-124 | |
| Q39193 | 361 | Serine/threonine-protein | no | no | 0.910 | 0.678 | 0.832 | 1e-123 | |
| Q9M9E9 | 343 | Serine/threonine-protein | no | no | 0.914 | 0.717 | 0.837 | 1e-123 | |
| Q75V57 | 361 | Serine/threonine-protein | no | no | 0.910 | 0.678 | 0.828 | 1e-123 | |
| Q7XQP4 | 359 | Serine/threonine-protein | no | no | 0.914 | 0.685 | 0.829 | 1e-122 |
| >sp|P0C5D6|SAPK3_ORYSJ Serine/threonine-protein kinase SAPK3 OS=Oryza sativa subsp. japonica GN=SAPK3 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 473 bits (1217), Expect = e-133, Method: Compositional matrix adjust.
Identities = 228/274 (83%), Positives = 248/274 (90%), Gaps = 5/274 (1%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
MEERYE +KELG+GNFGVARLVRDKR+KELVAVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1 MEERYEALKELGAGNFGVARLVRDKRSKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
IIRFKEV LTPTHLAIVMEYAAGGELF +IC+AGRFSEDEAR+FFQQLISGVSYCHS+EI
Sbjct: 61 IIRFKEVCLTPTHLAIVMEYAAGGELFEQICTAGRFSEDEARYFFQQLISGVSYCHSLEI 120
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
CHRDLKLENTLLDGSP PR+KICDFGYSKS LLHS+PKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPTPRVKICDFGYSKSALLHSKPKSTVGTPAYIAPEVLSRKEYDGK 180
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
++DVWSCGVTLYVMLVG+YPFEDP DPRNFRKTI RI VQY +PDYVRVS+DCR LLSQ
Sbjct: 181 VADVWSCGVTLYVMLVGSYPFEDPGDPRNFRKTISRILGVQYSIPDYVRVSSDCRRLLSQ 240
Query: 241 IFVADPSKD---PHSRDQKASL--VPEEFAERDN 269
IFVADPSK P + L +P+E +ER+
Sbjct: 241 IFVADPSKRITIPEIKKHTWFLKNLPKEISEREK 274
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|A2ZAB5|SAPK3_ORYSI Serine/threonine-protein kinase SAPK3 OS=Oryza sativa subsp. indica GN=SAPK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 473 bits (1217), Expect = e-133, Method: Compositional matrix adjust.
Identities = 228/274 (83%), Positives = 248/274 (90%), Gaps = 5/274 (1%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
MEERYE +KELG+GNFGVARLVRDKR+KELVAVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1 MEERYEALKELGAGNFGVARLVRDKRSKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
IIRFKEV LTPTHLAIVMEYAAGGELF +IC+AGRFSEDEAR+FFQQLISGVSYCHS+EI
Sbjct: 61 IIRFKEVCLTPTHLAIVMEYAAGGELFEQICTAGRFSEDEARYFFQQLISGVSYCHSLEI 120
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
CHRDLKLENTLLDGSP PR+KICDFGYSKS LLHS+PKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPTPRVKICDFGYSKSALLHSKPKSTVGTPAYIAPEVLSRKEYDGK 180
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
++DVWSCGVTLYVMLVG+YPFEDP DPRNFRKTI RI VQY +PDYVRVS+DCR LLSQ
Sbjct: 181 VADVWSCGVTLYVMLVGSYPFEDPGDPRNFRKTISRILGVQYSIPDYVRVSSDCRRLLSQ 240
Query: 241 IFVADPSKD---PHSRDQKASL--VPEEFAERDN 269
IFVADPSK P + L +P+E +ER+
Sbjct: 241 IFVADPSKRITIPEIKKHTWFLKNLPKEISEREK 274
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 458 bits (1178), Expect = e-128, Method: Compositional matrix adjust.
Identities = 214/246 (86%), Positives = 234/246 (95%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
ERYE +K++GSGNFGVA+LVRD RTKEL AVK+IERG+KIDENVQREI+NHRSLRHPNI+
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEV+LTPTHLAIVMEYAAGGELF RICSAGRFSEDEARFFFQQLISGVSYCHSM+ICH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGS PRLKICDFGYSKS LLHSQPKSTVGTPAYIAPEVLARKEYDGK++
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGVTLYVMLVGAYPFEDP++PRNFRKTI RI +VQY +PDYVRVS +CRHLLS+IF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIF 241
Query: 243 VADPSK 248
VA+P +
Sbjct: 242 VANPEQ 247
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 457 bits (1175), Expect = e-128, Method: Compositional matrix adjust.
Identities = 213/246 (86%), Positives = 234/246 (95%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
ERYE +K++GSGNFGVA+LVRD RTKEL AVK+IERG+KIDENVQREI+NHRSLRHPNI+
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEV+LTPTHLAIVMEYAAGGELF RICSAGRFSEDEARFFFQQLISGVSYCHSM+ICH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGS PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVLARKEYDGK++
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGVTLYVMLVGAYPFEDP++PRNFRKTI RI +VQY +PDYVRVS +CRHLLS+IF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIF 241
Query: 243 VADPSK 248
VA+P +
Sbjct: 242 VANPEQ 247
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-127, Method: Compositional matrix adjust.
Identities = 208/246 (84%), Positives = 235/246 (95%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
+RYE VK++GSGNFGVARL+RDK++ ELVAVKYIERG+KIDENV+REIINHRSLRHPNI+
Sbjct: 19 DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEV+LTPTHLAIVMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGVSYCH+M++CH
Sbjct: 79 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL +KEYDGK++
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGVTLYVMLVGAYPFEDPE+P+NFRKTI RI NVQY +PDYV +S +CRHL+S+IF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 243 VADPSK 248
VADP+K
Sbjct: 259 VADPAK 264
|
Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75LR7|SAPK1_ORYSJ Serine/threonine-protein kinase SAPK1 OS=Oryza sativa subsp. japonica GN=SAPK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 445 bits (1144), Expect = e-124, Method: Compositional matrix adjust.
Identities = 207/246 (84%), Positives = 230/246 (93%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
ERYE ++++GSGNFGVA+LVRD T L AVK+IERG KIDE+VQREI+NHRSL+HPNII
Sbjct: 2 ERYEVMRDIGSGNFGVAKLVRDVATNHLFAVKFIERGLKIDEHVQREIMNHRSLKHPNII 61
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEV+LTPTHLAIVMEYAAGGELF RIC+AGRFSEDEARFFFQQLISGVSYCHSM++CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 121
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGS PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL+RKEYDGK++
Sbjct: 122 RDLKLENTLLDGSVTPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRKEYDGKVA 181
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGVTLYVMLVGAYPFEDP+DPRNFRKTI RI +VQY +PDYVRVSADCRHLLS+IF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDDPRNFRKTITRILSVQYSIPDYVRVSADCRHLLSRIF 241
Query: 243 VADPSK 248
V +P +
Sbjct: 242 VGNPEQ 247
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1 | Back alignment and function description |
|---|
Score = 442 bits (1136), Expect = e-123, Method: Compositional matrix adjust.
Identities = 204/245 (83%), Positives = 232/245 (94%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
+RY+ VK++GSGNFGVARL+RDK TKELVAVKYIERG KIDENVQREIINHRSLRHPNI+
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 79
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEV+LTPTHLAI+MEYA+GGEL+ RIC+AGRFSEDEARFFFQQL+SGVSYCHSM+ICH
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL R+EYDGKI+
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIA 199
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGVTLYVMLVGAYPFEDPE+PR++RKTI RI +V+Y +PD +R+S +C HL+S+IF
Sbjct: 200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF 259
Query: 243 VADPS 247
VADP+
Sbjct: 260 VADPA 264
|
Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M9E9|SRK2C_ARATH Serine/threonine-protein kinase SRK2C OS=Arabidopsis thaliana GN=SRK2C PE=1 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1133), Expect = e-123, Method: Compositional matrix adjust.
Identities = 206/246 (83%), Positives = 229/246 (93%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
ERYE VK++GSGNFGVA+LVRDK +KEL AVK+IERG+KIDE+VQREI+NHRSL HPNII
Sbjct: 2 ERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNII 61
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEVLLT THLA+VMEYAAGGELF RICSAGRFSEDEARFFFQQLISGV+YCHS++ICH
Sbjct: 62 RFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICH 121
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGS PR+KICDFGYSKSG+LHSQPK+TVGTPAYIAPEVL+ KEYDGKI+
Sbjct: 122 RDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIA 181
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGVTLYVMLVGAYPFEDP DP++FRKTI RI QY +PDYVRVS +CRHLLS+IF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRIF 241
Query: 243 VADPSK 248
VA+P K
Sbjct: 242 VANPEK 247
|
Involved in gene regulation and confers tolerance to drought and osmotic stress. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1133), Expect = e-123, Method: Compositional matrix adjust.
Identities = 203/245 (82%), Positives = 229/245 (93%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
+RYE VKE+GSGNFGVARL+R++ + +LVAVKYI+RG+KIDENVQREIINHRSLRHPNII
Sbjct: 20 DRYELVKEIGSGNFGVARLMRNRASGDLVAVKYIDRGEKIDENVQREIINHRSLRHPNII 79
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEV+LTPTHLAIVMEYA+GGELF RICSAGRFSEDEARFFFQQLISGVSYCHSM++CH
Sbjct: 80 RFKEVILTPTHLAIVMEYASGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQVCH 139
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGS PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL +KEYDGKI+
Sbjct: 140 RDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 199
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGVTLYVMLVGAYPFEDPEDP+NFRKTI +I VQY +PDYV +S +CR L+++IF
Sbjct: 200 DVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIQKILGVQYSIPDYVHISPECRDLITRIF 259
Query: 243 VADPS 247
V +P+
Sbjct: 260 VGNPA 264
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7XQP4|SAPK7_ORYSJ Serine/threonine-protein kinase SAPK7 OS=Oryza sativa subsp. japonica GN=SAPK7 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 439 bits (1128), Expect = e-122, Method: Compositional matrix adjust.
Identities = 204/246 (82%), Positives = 229/246 (93%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
ERYE +K++G+GNFGVARL+R+K TKELVA+KYI RG KIDENV REIINHRSLRHPNII
Sbjct: 2 ERYELLKDIGAGNFGVARLMRNKETKELVAMKYIPRGLKIDENVAREIINHRSLRHPNII 61
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEV++TPTHLAIVMEYAAGGELF RIC+AGRFSEDEAR+FFQQLI GVSYCH M+ICH
Sbjct: 62 RFKEVVVTPTHLAIVMEYAAGGELFDRICNAGRFSEDEARYFFQQLICGVSYCHFMQICH 121
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGSP PRLKICDFGYSKS LLHS+PKSTVGTPAYIAPEVL+R+EYDGK +
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYDGKTA 181
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGVTLYVMLVGAYPFEDP+DP+NFRKTI RI ++QY +P+YV VS DCR LLS+IF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTIGRIMSIQYKIPEYVHVSQDCRQLLSRIF 241
Query: 243 VADPSK 248
VA+P+K
Sbjct: 242 VANPAK 247
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 269 | ||||||
| 224126431 | 338 | predicted protein [Populus trichocarpa] | 0.921 | 0.733 | 0.923 | 1e-135 | |
| 255552916 | 336 | Serine/threonine-protein kinase SAPK3, p | 0.921 | 0.738 | 0.915 | 1e-134 | |
| 356511001 | 336 | PREDICTED: serine/threonine-protein kina | 0.921 | 0.738 | 0.903 | 1e-132 | |
| 356563403 | 336 | PREDICTED: serine/threonine-protein kina | 0.921 | 0.738 | 0.899 | 1e-132 | |
| 219363405 | 333 | SnRK2.3 [Zea mays] gi|194695926|gb|ACF82 | 0.921 | 0.744 | 0.899 | 1e-132 | |
| 225427681 | 340 | PREDICTED: serine/threonine-protein kina | 0.921 | 0.729 | 0.907 | 1e-132 | |
| 255639129 | 336 | unknown [Glycine max] | 0.921 | 0.738 | 0.899 | 1e-132 | |
| 388504366 | 337 | unknown [Lotus japonicus] | 0.921 | 0.735 | 0.895 | 1e-131 | |
| 449459014 | 340 | PREDICTED: serine/threonine-protein kina | 0.921 | 0.729 | 0.895 | 1e-131 | |
| 158513710 | 334 | RecName: Full=Serine/threonine-protein k | 1.0 | 0.805 | 0.832 | 1e-131 |
| >gi|224126431|ref|XP_002329552.1| predicted protein [Populus trichocarpa] gi|222870261|gb|EEF07392.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1250), Expect = e-135, Method: Compositional matrix adjust.
Identities = 229/248 (92%), Positives = 240/248 (96%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
MEERYE +KE+GSGNFGVARLVRDK+T ELVAVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1 MEERYETIKEIGSGNFGVARLVRDKKTMELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
I+RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE RFFFQQLISGVSYCHSMEI
Sbjct: 61 IVRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDETRFFFQQLISGVSYCHSMEI 120
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
CHRDLKLENTLLDGSP PRLKICDFGYSKS LLHSQPKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPAPRLKICDFGYSKSALLHSQPKSTVGTPAYIAPEVLSRKEYDGK 180
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI +VQY +PDYVRVSADC+HLLS+
Sbjct: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIGRIMSVQYSIPDYVRVSADCKHLLSR 240
Query: 241 IFVADPSK 248
IFVA+P+K
Sbjct: 241 IFVANPAK 248
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552916|ref|XP_002517501.1| Serine/threonine-protein kinase SAPK3, putative [Ricinus communis] gi|223543512|gb|EEF45043.1| Serine/threonine-protein kinase SAPK3, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 482 bits (1241), Expect = e-134, Method: Compositional matrix adjust.
Identities = 227/248 (91%), Positives = 240/248 (96%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
MEERYEP+KELGSGNFGVARLVRDK++KELVAVKYIERG KIDENVQREIINHRSLRHPN
Sbjct: 1 MEERYEPIKELGSGNFGVARLVRDKKSKELVAVKYIERGNKIDENVQREIINHRSLRHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
I+RFKEVLL PTHLAIVMEYAAGGELFARIC+AGRFSEDEARFFFQQLISGVSYCHSMEI
Sbjct: 61 IVRFKEVLLAPTHLAIVMEYAAGGELFARICNAGRFSEDEARFFFQQLISGVSYCHSMEI 120
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
CHRDLKLENTLLDGSP PRLKICDFGYSKS LLHSQPKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPTPRLKICDFGYSKSALLHSQPKSTVGTPAYIAPEVLSRKEYDGK 180
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
I+DVWSCGVTLYVMLVGAYPFEDPED RNFRKTI RI +VQY +PDYVRVSADC+HLLS+
Sbjct: 181 IADVWSCGVTLYVMLVGAYPFEDPEDSRNFRKTIGRIMSVQYSIPDYVRVSADCKHLLSR 240
Query: 241 IFVADPSK 248
IFVA+P+K
Sbjct: 241 IFVANPAK 248
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511001|ref|XP_003524220.1| PREDICTED: serine/threonine-protein kinase SAPK3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 476 bits (1225), Expect = e-132, Method: Compositional matrix adjust.
Identities = 224/248 (90%), Positives = 239/248 (96%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
MEERYEP+KELG+GNFGVARL +DK+T ELVAVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1 MEERYEPLKELGAGNFGVARLAKDKKTGELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
IIRFKEVLLTPTHLAIV+EYA+GGELF RIC+AGRFSEDEAR+FFQQLISGVSYCHSMEI
Sbjct: 61 IIRFKEVLLTPTHLAIVLEYASGGELFERICTAGRFSEDEARYFFQQLISGVSYCHSMEI 120
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
CHRDLKLENTLLDG+P PRLKICDFGYSKS LLHSQPKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGNPSPRLKICDFGYSKSALLHSQPKSTVGTPAYIAPEVLSRKEYDGK 180
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI VQY +PDYVRVS+DCR+LLS+
Sbjct: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIGRIIGVQYSIPDYVRVSSDCRNLLSR 240
Query: 241 IFVADPSK 248
IFVADP+K
Sbjct: 241 IFVADPAK 248
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356563403|ref|XP_003549953.1| PREDICTED: serine/threonine-protein kinase SAPK3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 476 bits (1224), Expect = e-132, Method: Compositional matrix adjust.
Identities = 223/248 (89%), Positives = 239/248 (96%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
MEERYEP+KELG+GNFGVARL +DK+T ELVAVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1 MEERYEPLKELGAGNFGVARLAKDKKTGELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
IIRFKEVLLTPTHLAIV+EYA+GGELF RIC+AGRFSEDEAR+FFQQLISGVSYCHSMEI
Sbjct: 61 IIRFKEVLLTPTHLAIVLEYASGGELFERICTAGRFSEDEARYFFQQLISGVSYCHSMEI 120
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
CHRDLKLENTLLDG+P PRLKICDFGYSKS LLHSQPKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGNPSPRLKICDFGYSKSALLHSQPKSTVGTPAYIAPEVLSRKEYDGK 180
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI +QY +PDYVRVS+DCR+LLS+
Sbjct: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIGRIIGIQYSIPDYVRVSSDCRNLLSR 240
Query: 241 IFVADPSK 248
IFVADP+K
Sbjct: 241 IFVADPAK 248
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|219363405|ref|NP_001136496.1| SnRK2.3 [Zea mays] gi|194695926|gb|ACF82047.1| unknown [Zea mays] gi|195549559|gb|ACG50007.1| SnRK2.3 [Zea mays] gi|414867780|tpg|DAA46337.1| TPA: putative snRK/SAPK family protein kinase [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 476 bits (1224), Expect = e-132, Method: Compositional matrix adjust.
Identities = 223/248 (89%), Positives = 238/248 (95%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
MEERYE +KELG+GNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH+SLRHPN
Sbjct: 1 MEERYEALKELGAGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHQSLRHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
I+RFKEV LTPTHLAIVMEYAAGGELF +ICSAGRFSEDE+R+FFQQLISGVSYCHSMEI
Sbjct: 61 IVRFKEVCLTPTHLAIVMEYAAGGELFEKICSAGRFSEDESRYFFQQLISGVSYCHSMEI 120
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
CHRDLKLENTLLDGSP PR+KICDFGYSKS LLHS+PKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPTPRVKICDFGYSKSALLHSKPKSTVGTPAYIAPEVLSRKEYDGK 180
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
++DVWSCGVTLYVMLVG+YPFEDPEDPRNFRKTI RI VQY +PDYVRVS+DCR LLSQ
Sbjct: 181 VADVWSCGVTLYVMLVGSYPFEDPEDPRNFRKTISRILGVQYSIPDYVRVSSDCRRLLSQ 240
Query: 241 IFVADPSK 248
IFVADPSK
Sbjct: 241 IFVADPSK 248
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225427681|ref|XP_002262726.1| PREDICTED: serine/threonine-protein kinase SAPK3 [Vitis vinifera] gi|296083436|emb|CBI23389.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 476 bits (1224), Expect = e-132, Method: Compositional matrix adjust.
Identities = 225/248 (90%), Positives = 238/248 (95%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
MEERY+ +KELGSGNFGVARLVRDK+TKELVAVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1 MEERYDALKELGSGNFGVARLVRDKKTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
I+RFKEVLLTPTHLAIVMEYAAGGELF RIC+AGRFSEDEARFFFQQLISGVSYCHSMEI
Sbjct: 61 IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMEI 120
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
CHRDLKLENTLLDGSP PRLKICDFGYSKS LLHSQPKS VGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPMPRLKICDFGYSKSALLHSQPKSAVGTPAYIAPEVLSRKEYDGK 180
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
I+DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI +VQY +PDYV VSA+CR LLS+
Sbjct: 181 IADVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIGRIMSVQYSIPDYVHVSAECRQLLSR 240
Query: 241 IFVADPSK 248
IFVA+P+K
Sbjct: 241 IFVANPAK 248
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255639129|gb|ACU19864.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 475 bits (1223), Expect = e-132, Method: Compositional matrix adjust.
Identities = 223/248 (89%), Positives = 239/248 (96%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
MEERYEP+KELG+GNFGVARL +DK+T ELVAVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1 MEERYEPLKELGAGNFGVARLAKDKKTGELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
IIRFKEVLLTPTHLAIV+EYA+GGELF RIC+AGRFSEDEAR+FFQQLISGVSYCHSMEI
Sbjct: 61 IIRFKEVLLTPTHLAIVLEYASGGELFERICTAGRFSEDEARYFFQQLISGVSYCHSMEI 120
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
CHRDLKLENTLLDG+P PRLKICDFGYSKS LLHSQPKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGNPSPRLKICDFGYSKSALLHSQPKSTVGTPAYIAPEVLSRKEYDGK 180
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI +QY +PDYVRVS+DCR+LLS+
Sbjct: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIGRIIGIQYSIPDYVRVSSDCRNLLSR 240
Query: 241 IFVADPSK 248
IFVADP+K
Sbjct: 241 IFVADPAK 248
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388504366|gb|AFK40249.1| unknown [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 474 bits (1221), Expect = e-131, Method: Compositional matrix adjust.
Identities = 222/248 (89%), Positives = 238/248 (95%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
MEERYEP+KELGSGNFGVARL RDK T ELVAVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1 MEERYEPLKELGSGNFGVARLARDKNTGELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
IIRFKEVLLTPTHLAIV+EYA+GGELF RICSAGRFSEDEAR+FFQQLISGVSYCHSMEI
Sbjct: 61 IIRFKEVLLTPTHLAIVLEYASGGELFERICSAGRFSEDEARYFFQQLISGVSYCHSMEI 120
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
CHRDLKLENTLLDG+P PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGNPSPRLKICDFGYSKSAILHSQPKSTVGTPAYIAPEVLSRKEYDGK 180
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
++DVWSCG+TLYVMLVGAYPFEDP+DPRNFRKTI RI VQY +PDYVRVSA+CR+LLS+
Sbjct: 181 VADVWSCGMTLYVMLVGAYPFEDPDDPRNFRKTIGRIIGVQYSIPDYVRVSAECRNLLSR 240
Query: 241 IFVADPSK 248
IFVADP+K
Sbjct: 241 IFVADPAK 248
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449459014|ref|XP_004147241.1| PREDICTED: serine/threonine-protein kinase SAPK3-like [Cucumis sativus] gi|449515157|ref|XP_004164616.1| PREDICTED: serine/threonine-protein kinase SAPK3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 474 bits (1219), Expect = e-131, Method: Compositional matrix adjust.
Identities = 222/248 (89%), Positives = 238/248 (95%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
ME+RYEP+K+LGSGNFGVARLV+DK+T ELVAVKYIERGKKIDE VQREIINHRSLRHPN
Sbjct: 1 MEDRYEPLKDLGSGNFGVARLVKDKKTNELVAVKYIERGKKIDEKVQREIINHRSLRHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
IIRFKEV LTPTHLAIVMEYAAGGELF RICSAGRFSEDEARFFFQQLISGVSYCHSM+I
Sbjct: 61 IIRFKEVFLTPTHLAIVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVSYCHSMQI 120
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
CHRDLKLENTLLDGSP P+LKICDFGYSKS LLHSQPKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPTPQLKICDFGYSKSALLHSQPKSTVGTPAYIAPEVLSRKEYDGK 180
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
I+DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI +VQY +PDYVRVS +CR+LLS+
Sbjct: 181 IADVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIARILSVQYSIPDYVRVSVECRNLLSR 240
Query: 241 IFVADPSK 248
IFVA+P+K
Sbjct: 241 IFVANPAK 248
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|158513710|sp|A2ZAB5.2|SAPK3_ORYSI RecName: Full=Serine/threonine-protein kinase SAPK3; AltName: Full=Osmotic stress/abscisic acid-activated protein kinase 3; AltName: Full=Protein kinase REK gi|158517784|sp|P0C5D6.1|SAPK3_ORYSJ RecName: Full=Serine/threonine-protein kinase SAPK3; AltName: Full=Osmotic stress/abscisic acid-activated protein kinase 3; AltName: Full=Protein kinase REK gi|12597887|gb|AAG60195.1|AC084763_15 protein kinase REK [Oryza sativa Japonica Group] gi|31433548|gb|AAP55046.1| Serine/threonine-protein kinase SAPK3, putative, expressed [Oryza sativa Japonica Group] gi|218185026|gb|EEC67453.1| hypothetical protein OsI_34678 [Oryza sativa Indica Group] gi|222613279|gb|EEE51411.1| hypothetical protein OsJ_32488 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1217), Expect = e-131, Method: Compositional matrix adjust.
Identities = 228/274 (83%), Positives = 248/274 (90%), Gaps = 5/274 (1%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
MEERYE +KELG+GNFGVARLVRDKR+KELVAVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1 MEERYEALKELGAGNFGVARLVRDKRSKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
IIRFKEV LTPTHLAIVMEYAAGGELF +IC+AGRFSEDEAR+FFQQLISGVSYCHS+EI
Sbjct: 61 IIRFKEVCLTPTHLAIVMEYAAGGELFEQICTAGRFSEDEARYFFQQLISGVSYCHSLEI 120
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
CHRDLKLENTLLDGSP PR+KICDFGYSKS LLHS+PKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPTPRVKICDFGYSKSALLHSKPKSTVGTPAYIAPEVLSRKEYDGK 180
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
++DVWSCGVTLYVMLVG+YPFEDP DPRNFRKTI RI VQY +PDYVRVS+DCR LLSQ
Sbjct: 181 VADVWSCGVTLYVMLVGSYPFEDPGDPRNFRKTISRILGVQYSIPDYVRVSSDCRRLLSQ 240
Query: 241 IFVADPSKD---PHSRDQKASL--VPEEFAERDN 269
IFVADPSK P + L +P+E +ER+
Sbjct: 241 IFVADPSKRITIPEIKKHTWFLKNLPKEISEREK 274
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 269 | ||||||
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.914 | 0.679 | 0.845 | 4.4e-116 | |
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.910 | 0.678 | 0.832 | 6.6e-113 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.914 | 0.717 | 0.837 | 1.2e-111 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.914 | 0.683 | 0.817 | 6.1e-110 | |
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.914 | 0.681 | 0.817 | 6.1e-110 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 0.914 | 0.702 | 0.800 | 5.5e-109 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.914 | 0.696 | 0.800 | 2.4e-108 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.907 | 0.719 | 0.774 | 2.6e-102 | |
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.862 | 0.475 | 0.433 | 1.8e-46 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.933 | 0.564 | 0.404 | 4.8e-46 |
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1144 (407.8 bits), Expect = 4.4e-116, P = 4.4e-116
Identities = 208/246 (84%), Positives = 235/246 (95%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
+RYE VK++GSGNFGVARL+RDK++ ELVAVKYIERG+KIDENV+REIINHRSLRHPNI+
Sbjct: 19 DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEV+LTPTHLAIVMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGVSYCH+M++CH
Sbjct: 79 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL +KEYDGK++
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGVTLYVMLVGAYPFEDPE+P+NFRKTI RI NVQY +PDYV +S +CRHL+S+IF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 243 VADPSK 248
VADP+K
Sbjct: 259 VADPAK 264
|
|
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1114 (397.2 bits), Expect = 6.6e-113, P = 6.6e-113
Identities = 204/245 (83%), Positives = 232/245 (94%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
+RY+ VK++GSGNFGVARL+RDK TKELVAVKYIERG KIDENVQREIINHRSLRHPNI+
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 79
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEV+LTPTHLAI+MEYA+GGEL+ RIC+AGRFSEDEARFFFQQL+SGVSYCHSM+ICH
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL R+EYDGKI+
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIA 199
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGVTLYVMLVGAYPFEDPE+PR++RKTI RI +V+Y +PD +R+S +C HL+S+IF
Sbjct: 200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF 259
Query: 243 VADPS 247
VADP+
Sbjct: 260 VADPA 264
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1102 (393.0 bits), Expect = 1.2e-111, P = 1.2e-111
Identities = 206/246 (83%), Positives = 229/246 (93%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
ERYE VK++GSGNFGVA+LVRDK +KEL AVK+IERG+KIDE+VQREI+NHRSL HPNII
Sbjct: 2 ERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNII 61
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEVLLT THLA+VMEYAAGGELF RICSAGRFSEDEARFFFQQLISGV+YCHS++ICH
Sbjct: 62 RFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICH 121
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGS PR+KICDFGYSKSG+LHSQPK+TVGTPAYIAPEVL+ KEYDGKI+
Sbjct: 122 RDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIA 181
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGVTLYVMLVGAYPFEDP DP++FRKTI RI QY +PDYVRVS +CRHLLS+IF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRIF 241
Query: 243 VADPSK 248
VA+P K
Sbjct: 242 VANPEK 247
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1086 (387.4 bits), Expect = 6.1e-110, P = 6.1e-110
Identities = 201/246 (81%), Positives = 225/246 (91%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
++YE VK+LG+GNFGVARL+R K TKELVA+KYIERG+KIDENV REIINHRSLRHPNII
Sbjct: 2 DKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNII 61
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEV+LTPTHLAIVMEYA+GGELF RIC+AGRFSE EAR+FFQQLI GV YCHS++ICH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGSP P LKICDFGYSKS LLHS+PKSTVGTPAYIAPEVL+R+EYDGK +
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGVTLYVMLVG YPFEDP+DPRNFRKTI RI VQY +PDYV +S +CRHLLS+IF
Sbjct: 182 DVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRHLLSRIF 241
Query: 243 VADPSK 248
V + +K
Sbjct: 242 VTNSAK 247
|
|
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1086 (387.4 bits), Expect = 6.1e-110, P = 6.1e-110
Identities = 201/246 (81%), Positives = 226/246 (91%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
++YE VK++G+GNFGVARL+R K +KELVA+KYIERG KIDENV REIINHRSLRHPNII
Sbjct: 2 DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEV+LTPTH+AI MEYAAGGELF RICSAGRFSEDEAR+FFQQLISGVSYCH+M+ICH
Sbjct: 62 RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGSP PRLKICDFGYSKS LLHS PKSTVGTPAYIAPEVL+R EYDGK++
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMA 181
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGVTLYVMLVGAYPFED EDP+NF+KTI RI V+Y +PDYV +S DC+HLLS+IF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLSRIF 241
Query: 243 VADPSK 248
V + +K
Sbjct: 242 VTNSNK 247
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1077 (384.2 bits), Expect = 5.5e-109, P = 5.5e-109
Identities = 197/246 (80%), Positives = 224/246 (91%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
ERY+ +++LGSGNFGVA+LVR+K E AVKYIERG KIDE+VQREIINHR L+HPNII
Sbjct: 2 ERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNII 61
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEV +TPTHLAIVMEYAAGGELF RIC+AGRFSEDE R++F+QLISGVSYCH+M+ICH
Sbjct: 62 RFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQICH 121
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGSP LKICDFGYSKS +LHSQPKSTVGTPAY+APEVL+RKEY+GKI+
Sbjct: 122 RDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKIA 181
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGVTLYVMLVGAYPFEDPEDPRN R TI RI +V Y +PDYVR+S++C+HLLS+IF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRILSVHYTIPDYVRISSECKHLLSRIF 241
Query: 243 VADPSK 248
VADP K
Sbjct: 242 VADPDK 247
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1071 (382.1 bits), Expect = 2.4e-108, P = 2.4e-108
Identities = 197/246 (80%), Positives = 225/246 (91%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
++Y+ VK+LG+GNFGVARL+R K TKELVA+KYIERG+KIDENV REIINHRSL+HPNII
Sbjct: 2 DKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNII 61
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEV+LTPTHLAIVMEYA+GGELF RIC+AGRFSE EAR+FFQQLI GV YCHS++ICH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGSP P LKICDFGYSKS +LHS+PKSTVGTPAYIAPEVL+R+EYDGK +
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGVTLYVMLVGAYPFEDP DP+NFRKTI RI VQY +PDYV +S +C+HLLS+IF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKHLLSRIF 241
Query: 243 VADPSK 248
V + +K
Sbjct: 242 VTNSAK 247
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1014 (362.0 bits), Expect = 2.6e-102, P = 2.6e-102
Identities = 189/244 (77%), Positives = 212/244 (86%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
E+YE VK+LG GNFG+ARL+R+K+T ELVAVK+I+RG KIDENV REIINHR+L HPNI+
Sbjct: 2 EKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNIV 61
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEV+LTPTHL IVMEYAAGGELF RI S GRFSE EAR+FFQQLI GV Y H+++ICH
Sbjct: 62 RFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQICH 121
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGSP PRLKICDFGYSKS +LHS PKSTVGTPAYIAPEV R EYDGK
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKSV 181
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGV LYVMLVGAYPFEDP+DPRNFRKT+ +I V Y +P YV +S DCR LLS+IF
Sbjct: 182 DVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLLSRIF 241
Query: 243 VADP 246
VA+P
Sbjct: 242 VANP 245
|
|
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 487 (176.5 bits), Expect = 1.8e-46, P = 1.8e-46
Identities = 111/256 (43%), Positives = 153/256 (59%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KID---ENVQREIINHRSLRHP 59
+YE + LG G FG ++ T E VA+K I + + K + E ++REI R +RHP
Sbjct: 42 KYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQIKREISIMRLVRHP 101
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
NI+ KEV+ T T + +MEY GGELF++I G+ ED AR +FQQLIS V +CHS
Sbjct: 102 NIVELKEVMATKTKIFFIMEYVKGGELFSKIVK-GKLKEDSARKYFQQLISAVDFCHSRG 160
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYS-------KSGLLHSQPKSTVGTPAYIAPEVL 172
+ HRDLK EN L+D + LK+ DFG S + GLLH+Q GTPAY+APEVL
Sbjct: 161 VSHRDLKPENLLVDENGD--LKVSDFGLSALPEQILQDGLLHTQ----CGTPAYVAPEVL 214
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
+K YDG D+WSCG+ LYV+L G PF+D N K +I ++ P + S
Sbjct: 215 RKKGYDGAKGDIWSCGIILYVLLAGFLPFQD----ENLMKMYRKIFKSEFEYPPWF--SP 268
Query: 233 DCRHLLSQIFVADPSK 248
+ + L+S++ V DP+K
Sbjct: 269 ESKRLISKLLVVDPNK 284
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 483 (175.1 bits), Expect = 4.8e-46, P = 4.8e-46
Identities = 110/272 (40%), Positives = 165/272 (60%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHP 59
+YE + +G G F + ++ T E VA+K ++R +K+ + ++REI + +RHP
Sbjct: 8 KYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKLVRHP 67
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
++R EVL + T + I++EY GGELF +I GR SE EAR +F QLI GV YCHS
Sbjct: 68 CVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYCHSKG 127
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTVGTPAYIAPEVLARKE 176
+ HRDLK EN LLD Q LKI DFG S + G+ + K+T GTP Y+APEVL+ K
Sbjct: 128 VYHRDLKPENLLLDS--QGNLKISDFGLSALPEQGV--TILKTTCGTPNYVAPEVLSHKG 183
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
Y+G ++D+WSCGV LYV++ G PF++ + P + K ID+ ++ P Y + A +
Sbjct: 184 YNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSK-IDK---AEFSCPSYFALGA--KS 237
Query: 237 LLSQIFVADPSKDPHSRDQKASLVPEEFAERD 268
L+++I DP+ P +R A + +E+ +D
Sbjct: 238 LINRIL--DPN--PETRITIAEIRKDEWFLKD 265
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| A2ZAB5 | SAPK3_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.8321 | 1.0 | 0.8053 | N/A | no |
| P0C5D6 | SAPK3_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.8321 | 1.0 | 0.8053 | yes | no |
| Q02066 | AAIP_WHEAT | 2, ., 7, ., 1, 1, ., 1 | 0.8396 | 0.8810 | 0.7138 | N/A | no |
| Q940H6 | SRK2E_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8455 | 0.9144 | 0.6795 | yes | no |
| A2YNT8 | SAPK2_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.8658 | 0.9144 | 0.7256 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 269 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-93 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-80 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-66 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-65 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-60 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-55 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-55 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-54 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-48 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-48 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-44 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-43 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-43 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-42 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-42 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-42 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-42 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-41 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-41 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-40 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-40 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-40 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-40 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-39 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-38 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-38 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-38 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-38 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-38 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-38 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-38 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-38 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-37 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-37 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-37 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-36 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-36 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-36 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-35 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-35 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-35 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-35 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-35 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-35 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-35 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-35 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-35 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-34 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-34 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-34 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-34 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-34 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-33 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-33 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-33 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-33 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-33 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-33 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-33 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-33 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-32 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-32 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-32 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-32 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-32 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-32 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-31 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-31 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-31 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-30 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-30 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-30 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-30 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-30 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-29 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-28 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-28 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-28 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-28 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-28 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-28 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-28 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-28 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-27 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-27 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-27 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-27 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-27 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-27 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-26 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-26 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-26 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-26 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-26 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-26 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-25 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-25 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-25 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-25 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-25 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-24 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-24 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-24 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-24 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-24 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-24 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-24 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-24 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-24 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-24 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-23 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-23 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-23 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-22 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-22 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-22 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-22 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-22 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-22 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-22 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-22 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-21 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-21 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-21 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-21 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-21 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-21 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-21 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-21 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-20 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-20 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-20 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-20 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-20 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-20 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-19 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-19 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-19 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-19 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-19 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-18 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-18 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-17 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-17 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-16 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-14 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-12 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.001 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 274 bits (704), Expect = 3e-93
Identities = 100/247 (40%), Positives = 142/247 (57%), Gaps = 9/247 (3%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPNII 62
YE +++LG G+FG L RDK+T +LVA+K I ++ KK E + REI + L+HPNI+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
R +V L +VMEY GG+LF + GR SEDEARF+ +Q++S + Y HS I H
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLK EN LLD +K+ DFG ++ + + VGTP Y+APEVL K Y +
Sbjct: 121 RDLKPENILLDEDGH--VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV- 177
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSADCRHLLSQI 241
D+WS GV LY +L G PF + + +I + F P +S + + L+ ++
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQL---LELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 242 FVADPSK 248
V DP K
Sbjct: 235 LVKDPEK 241
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 241 bits (616), Expect = 8e-80
Identities = 101/250 (40%), Positives = 137/250 (54%), Gaps = 9/250 (3%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHPNI 61
YE +++LGSG+FG + K T ++VAVK + K D+ +REI R L HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
+R + HL +VMEY GG+LF + G SEDEA+ Q++ G+ Y HS I
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGK 180
HRDLK EN LLD + +KI DFG +K L S +T VGTP Y+APEVL G
Sbjct: 121 HRDLKPENILLDENGV--VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI--RNVQYFLPDYVRVSADCRHLL 238
DVWS GV LY +L G PF E+ + + I RI +++ P + S + + L+
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 239 SQIFVADPSK 248
+ DPSK
Sbjct: 238 KKCLNKDPSK 247
|
Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 205 bits (525), Expect = 6e-66
Identities = 91/260 (35%), Positives = 134/260 (51%), Gaps = 18/260 (6%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHPN 60
+YE +K++G G+FG LVR K +L +K I +K E+ E+ + L HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARI---CSAGR-FSEDEARFFFQQLISGVSYCH 116
II++ E L IVMEYA GG+L +I G+ F E++ +F QL + Y H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAYIAPEVLAR 174
S +I HRD+K +N L +K+ DFG SK L + K+ VGTP Y++PE+
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKV-LSSTVDLAKTVVGTPYYLSPELCQN 177
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
K Y+ K SD+WS G LY + +PFE N + +I QY P + S++
Sbjct: 178 KPYNYK-SDIWSLGCVLYELCTLKHPFEG----ENLLELALKILKGQY-PPIPSQYSSEL 231
Query: 235 RHLLSQIFVADPSKDPHSRD 254
R+L+S + DP + P
Sbjct: 232 RNLVSSLLQKDPEERPSIAQ 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 6e-65
Identities = 84/188 (44%), Positives = 107/188 (56%), Gaps = 5/188 (2%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPNIIRFKEVL 68
LG G FG L RDK+T + VA+K I++ E + REI + L HPNI++ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 69 LTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
HL +VMEY GG L + G+ SEDE Q++ G+ Y HS I HRDLK
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 128 ENTLLDGSPQPRLKICDFGYSK-SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWS 186
EN LLD S ++K+ DFG SK S K+ VGTPAY+APEVL K Y + SD+WS
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 187 CGVTLYVM 194
GV LY +
Sbjct: 180 LGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 2e-60
Identities = 91/243 (37%), Positives = 132/243 (54%), Gaps = 14/243 (5%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS----LRHPNIIRFKE 66
LG G+FG LVR K T +L A+K +++ K I + R+ + HP I++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 67 VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
T L +V+EYA GGELF+ + GRFSE+ ARF+ +++ + Y HS+ I +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
EN LLD +K+ DFG +K S+ + GTP Y+APEVL K Y GK D W
Sbjct: 121 PENILLDA--DGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWW 177
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
S GV LY ML G PF + ++ ++I P++ +S + R L+S + D
Sbjct: 178 SLGVLLYEMLTGKPPFYAE----DRKEIYEKILKDPLRFPEF--LSPEARDLISGLLQKD 231
Query: 246 PSK 248
P+K
Sbjct: 232 PTK 234
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 2e-55
Identities = 80/251 (31%), Positives = 126/251 (50%), Gaps = 14/251 (5%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNIIR 63
+E ++++G G FG R KRT + VA+K I K+ E + EI + +HPNI++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEICH 122
+ L L IVME+ +GG L + S + +E + + ++L+ G+ Y HS I H
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 123 RDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
RD+K N LL DG +K+ DFG S + VGTP ++APEV+ K YD K
Sbjct: 122 RDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRVSADCRHLLS 239
+D+WS G+T + G P+ + K + +I N L + + S + + L
Sbjct: 178 -ADIWSLGITAIELAEGKPPYSEL----PPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232
Query: 240 QIFVADPSKDP 250
+ +P K P
Sbjct: 233 KCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 5e-55
Identities = 83/259 (32%), Positives = 129/259 (49%), Gaps = 14/259 (5%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV---QREIINHRSLRHPN 60
+ + LG G+FG L DK T EL+AVK +E +E + +REI SL+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 61 IIRFK--EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
I+R+ E L I +EY +GG L + + G+ E R + +Q++ G++Y HS
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARK 175
I HRD+K N L+D +K+ DFG +K S GTP ++APEV+ R
Sbjct: 121 GIVHRDIKGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI-RG 177
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
E G+ +D+WS G T+ M G P+ + +P I +P++ +S + +
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE-IPEH--LSEEAK 234
Query: 236 HLLSQIFVADPSKDPHSRD 254
L + DP K P + +
Sbjct: 235 DFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 9e-54
Identities = 89/255 (34%), Positives = 141/255 (55%), Gaps = 29/255 (11%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRHPN 60
+E +K LG+G+FG LVR K + + A+K + + K + E+V E +S+RHP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 61 IIR----FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
++ F++ ++L +VMEY GGELF+ + +GRF E ARF+ Q++ + Y H
Sbjct: 63 LVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118
Query: 117 SMEICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
S++I +RDLK EN LLD G +KI DFG++K + + + GTP Y+APE++
Sbjct: 119 SLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEIILS 172
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSAD 233
K Y GK D W+ G+ +Y ML G PF D + + K + ++R +F S D
Sbjct: 173 KGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFF-------SPD 224
Query: 234 CRHLLSQIFVADPSK 248
+ L+ + D +K
Sbjct: 225 AKDLIRNLLQVDLTK 239
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 1e-48
Identities = 83/251 (33%), Positives = 125/251 (49%), Gaps = 20/251 (7%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRHPNIIRFKE 66
+ G +G L + K T ++ A+K I++ I +N +++ R + P +++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 67 VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
+L +VMEY GG+L + + + G ED AR + +++ + Y HS I HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS---------TVGTPAYIAPEVLARKEY 177
+N L+D + LK+ DFG SK GL+ Q VGTP YIAPEV+ + +
Sbjct: 121 PDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
K D WS G LY LVG PF E P + I N + P+ V VS + L
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPFHG-ETP---EEIFQNILNGKIEWPEDVEVSDEAIDL 233
Query: 238 LSQIFVADPSK 248
+S++ V DP K
Sbjct: 234 ISKLLVPDPEK 244
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 5e-48
Identities = 81/275 (29%), Positives = 124/275 (45%), Gaps = 45/275 (16%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVK-----YIERGKKIDE-NVQREIINHRSLRH 58
++ K +G G+F L ++K T + A+K + + KK+ +++E++ R H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVL-TRLNGH 61
Query: 59 PNIIR----FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
P II+ F++ +L V+EYA GEL I G E RF+ +++ + Y
Sbjct: 62 PGIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---------------------SGLL 153
HS I HRDLK EN LLD +KI DFG +K
Sbjct: 118 LHSKGIIHRDLKPENILLDK--DMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT 213
+ S VGT Y++PE+L K GK SD+W+ G +Y ML G PF + T
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEY----LT 230
Query: 214 IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK 248
+I ++Y P D + L+ ++ V DP
Sbjct: 231 FQKILKLEYSFPP--NFPPDAKDLIEKLLVLDPQD 263
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 154 bits (389), Expect = 1e-44
Identities = 89/280 (31%), Positives = 131/280 (46%), Gaps = 24/280 (8%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHP- 59
Y +++LG G+FG L RD++ VA+K + + + REI SL HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICS---AGRFSEDEARFFFQQLISGVSYCH 116
NI++ + L +VMEY GG L + G SE EA F Q++S + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSK-------SGLLHSQPKSTVGTPAYIAP 169
S I HRD+K EN LLD +K+ DFG +K + + + P ++VGTP Y+AP
Sbjct: 119 SKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 170 EVL--ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---QYFL 224
EVL Y SD+WS G+TLY +L G PFE ++ +T+ I +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 225 PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264
P S + +KDP +R +S + +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277
|
Length = 384 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 3e-43
Identities = 91/247 (36%), Positives = 127/247 (51%), Gaps = 17/247 (6%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHPNIIR 63
K LG G+FG L K T EL AVK +++ + D++V+ + R L +HP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
T L VMEY GG+L I +GRF E ARF+ +++ G+ + H I +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
DLKL+N LLD + +KI DFG K G+L ST GTP YIAPE+L+ + Y G
Sbjct: 121 DLKLDNVLLDS--EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAV 177
Query: 183 DVWSCGVTLYVMLVGAYPFE-DPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
D W+ GV LY ML G PFE D ED + I + P ++ A + +L
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDED-----ELFQSILEDEVRYPRWLSKEA--KSILKSF 230
Query: 242 FVADPSK 248
+P K
Sbjct: 231 LTKNPEK 237
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 3e-43
Identities = 87/249 (34%), Positives = 127/249 (51%), Gaps = 22/249 (8%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH--------RSLRHPN 60
K LG G FG LVR+K T + A+K + K + + ++ + H ++ RHP
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKIL----KKEVIIAKDEVAHTLTESRVLQNTRHPF 56
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+ K T L VMEYA GGELF + FSED ARF+ +++S + Y HS ++
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDG 179
+RDLKLEN +LD +KI DFG K G+ T GTP Y+APEVL +Y G
Sbjct: 117 VYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-G 173
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
+ D W GV +Y M+ G PF + ++ K + I + P +S + + LL+
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYN----QDHEKLFELILMEEIRFPR--TLSPEAKSLLA 227
Query: 240 QIFVADPSK 248
+ DP +
Sbjct: 228 GLLKKDPKQ 236
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-42
Identities = 75/205 (36%), Positives = 114/205 (55%), Gaps = 9/205 (4%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRH 58
+ E +K +G+G FG LVRD+ ++ A+K + + I ++V E + + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
P IIR L ++MEY GGELF+ + ++GRFS F+ +++ + Y HS
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
EI +RDLK EN LLD + +K+ DFG++K L + + GTP Y+APEV+ K +
Sbjct: 121 EIVYRDLKPENILLD--KEGHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH- 175
Query: 179 GKISDVWSCGVTLYVMLVGAYPFED 203
K D W+ G+ +Y MLVG PF D
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 6e-42
Identities = 73/228 (32%), Positives = 114/228 (50%), Gaps = 11/228 (4%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS----LRHPNIIRFKE 66
LG G FG LV+ K A+K +++ ++ Q I + + HP I++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 67 VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
++ ++MEY GGEL+ + G F E ARF+ ++ Y H+ I +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWS 186
EN LLD +K+ DFG++K + + GTP Y+APE++ K YD D WS
Sbjct: 121 PENLLLDS--NGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWS 177
Query: 187 CGVTLYVMLVGAYPF-EDPEDP-RNFRKTIDRIRNVQYFLPDYVRVSA 232
G+ LY +L G PF ED EDP + + +++ P+Y+ +A
Sbjct: 178 LGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKAA 223
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 6e-42
Identities = 86/281 (30%), Positives = 128/281 (45%), Gaps = 43/281 (15%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN------VQREIINHRSLR 57
++ +K LG G+ G LVR K T +L A+K +++ + I N ++EI+ +L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATLD 59
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFA--RICSAGRFSEDEARFFFQQLISGVSYC 115
HP + T T+L +VM+Y GGELF + SE+ ARF+ +++ + Y
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 116 HSMEICHRDLKLENTLLDGS-----------------PQPRLKICDFGYSKSGLLHSQP- 157
H + I +RDLK EN LL S P P K G +S +
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 158 ----------KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP 207
S VGT YIAPEV++ + + D W+ G+ LY ML G PF+
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKG---- 234
Query: 208 RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK 248
N +T I + P VS+ R L+ ++ V DPSK
Sbjct: 235 SNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSK 275
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 6e-42
Identities = 94/249 (37%), Positives = 130/249 (52%), Gaps = 21/249 (8%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSL----RHPN 60
K LG G+FG L K T E A+K + KK D++V+ ++ R L HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKAL---KKDVVLEDDDVECTMVERRVLALAWEHPF 57
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+ T HL VMEY GG+L I S+GRF E ARF+ ++I G+ + H I
Sbjct: 58 LTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGI 117
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDG 179
+RDLKL+N LLD +KI DFG K + ST GTP YIAPE+L ++Y+
Sbjct: 118 IYRDLKLDNVLLD--KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
+ D WS GV LY ML+G PF ++ F D I N + P + +S + + LS
Sbjct: 176 SV-DWWSFGVLLYEMLIGQSPFHGEDEDELF----DSILNDRPHFPRW--ISKEAKDCLS 228
Query: 240 QIFVADPSK 248
++F DP+K
Sbjct: 229 KLFERDPTK 237
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-41
Identities = 81/264 (30%), Positives = 127/264 (48%), Gaps = 29/264 (10%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPN 60
YE ++ +G G+FG R VR K +++ K I+ G + E ++++++ R L+HPN
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHPN 60
Query: 61 IIRF--KEVLLTPTHLAIVMEYAAGGELFARI--CSA--GRFSEDEARFFFQQLISGVSY 114
I+R+ + + + L IVMEY GG+L I C E+ QL+ +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 115 CH-----SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAY 166
CH + HRDLK N LD +K+ DFG +K +L K+ VGTP Y
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDA--NNNVKLGDFGLAK--ILGHDSSFAKTYVGTPYY 176
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
++PE L YD K SD+WS G +Y + + PF RN + +I+ + F
Sbjct: 177 MSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFT----ARNQLQLASKIKEGK-FRRI 230
Query: 227 YVRVSADCRHLLSQIFVADPSKDP 250
R S++ ++ + DP K P
Sbjct: 231 PYRYSSELNEVIKSMLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 8e-41
Identities = 73/245 (29%), Positives = 120/245 (48%), Gaps = 18/245 (7%)
Query: 12 GSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRHPNIIRFKEV 67
G G FG +V+ + TK++ A+KY+ + K +++ R ++N R L HP ++
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68
Query: 68 LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
++ +V++ GG+L + +FSE++ +F+ +++ + Y HS I HRD+K
Sbjct: 69 FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKP 128
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEYDGKISDVW 185
+N LLD Q + I DF + + +T GTP Y+APEVL R+ Y D W
Sbjct: 129 DNILLD--EQGHVHITDFNIAT--KVTPDTLTTSTSGTPGYMAPEVLCRQGY-SVAVDWW 183
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LPDY-VRVSADCRHLLSQIFV 243
S GVT Y L G P+ + R D+IR Q Y S + ++++
Sbjct: 184 SLGVTAYECLRGKRPYR-----GHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLE 238
Query: 244 ADPSK 248
DP K
Sbjct: 239 RDPQK 243
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-40
Identities = 91/252 (36%), Positives = 122/252 (48%), Gaps = 12/252 (4%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHPN 60
+YE ++ +G G FG+ L R K ++LV +K I + K Q E + L HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSM 118
II + E L L IVMEYA GG L I ED FF Q++ + + H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
I HRDLK +N LLD + +KI DFG SK S+ + VGTP YI+PE+ K Y+
Sbjct: 121 LILHRDLKTQNILLD-KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
K SD+W+ G LY + FE P K + + D R S D R L+
Sbjct: 180 QK-SDIWALGCVLYELASLKRAFEAANLPALVLKI---MSGTFAPISD--RYSPDLRQLI 233
Query: 239 SQIFVADPSKDP 250
+ DPSK P
Sbjct: 234 LSMLNLDPSKRP 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 5e-40
Identities = 79/248 (31%), Positives = 121/248 (48%), Gaps = 18/248 (7%)
Query: 10 ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---VQREIINHRSLRHPNIIRFKE 66
+G G FGV + T + VA+K I K +E + +EI ++L+HPNI+++
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 67 VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
+ T L I++EYA G L I G F E + Q++ G++Y H + HRD+K
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIK 126
Query: 127 LENTLL--DGSPQPRLKICDFGYS-KSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
N L DG +K+ DFG + K + S VGTP ++APEV+ SD
Sbjct: 127 AANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA-SD 181
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRVSADCRHLLSQIF 242
+WS G T+ +L G P+ D N + RI ++ LP+ +S + + L Q F
Sbjct: 182 IWSLGCTVIELLTGNPPYYD----LNPMAALFRIVQDDHPPLPE--GISPELKDFLMQCF 235
Query: 243 VADPSKDP 250
DP+ P
Sbjct: 236 QKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 6e-40
Identities = 73/207 (35%), Positives = 107/207 (51%), Gaps = 18/207 (8%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRHPN 60
YE +++LG G +GV RDK+T E+VA+K I R +E + REI + L+HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSME 119
I++ +V+ T L +V EY +L + G S + + QL+ G++YCHS
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEVLAR- 174
I HRDLK +N L++ LK+ DFG +++ P T V T Y APE+L
Sbjct: 119 ILHRDLKPQNILINRDGV--LKLADFGLARA---FGIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPF 201
K Y + D+WS G M+ G F
Sbjct: 174 KHYSTAV-DIWSVGCIFAEMITGKPLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 6e-40
Identities = 81/261 (31%), Positives = 132/261 (50%), Gaps = 28/261 (10%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
E Y+ ++++G G G D+ T + VA+K + K+ E + EI+ + +HPNI
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+ + + L L +VMEY GG L I + R +E + + ++++ G+ Y HS +
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137
Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLL---HSQPKSTVGTPAYIAPEVLARK 175
HRD+K +N LL DGS +K+ DFG+ + L S+ S VGTP ++APEV+ RK
Sbjct: 138 IHRDIKSDNILLSKDGS----VKLADFGF--AAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYP-FEDPEDPRNFRKTID-----RIRNVQYFLPDYVR 229
+Y K+ D+WS G+ M G P +P P I ++N + +
Sbjct: 192 DYGPKV-DIWSLGIMCIEMAEGEPPYLREP--PLRALFLITTKGIPPLKNPE-------K 241
Query: 230 VSADCRHLLSQIFVADPSKDP 250
S + + L++ V DP K P
Sbjct: 242 WSPEFKDFLNKCLVKDPEKRP 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-39
Identities = 87/246 (35%), Positives = 125/246 (50%), Gaps = 15/246 (6%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS-----LRHPNIIR 63
K +G G+FG L + K + AVK +++ + + Q+ I+ R+ ++HP ++
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
T L V++Y GGELF + F E ARF+ ++ S + Y HS+ I +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
DLK EN LLD Q + + DFG K G+ HS+ ST GTP Y+APEVL ++ YD +
Sbjct: 121 DLKPENILLDS--QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTV 177
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
D W G LY ML G PF R+ + D I N L + VS RHLL +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYS----RDTAEMYDNILNKPLRLKPNISVS--ARHLLEGLL 231
Query: 243 VADPSK 248
D +K
Sbjct: 232 QKDRTK 237
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 5e-39
Identities = 88/288 (30%), Positives = 130/288 (45%), Gaps = 58/288 (20%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----- 57
+ +E +K +G G FG LVRDK T ++ A+K + +K D + +I + R+ R
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL---RKSDMIKRNQIAHVRAERDILAD 57
Query: 58 --HPNIIR----FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
P I++ F++ HL +VMEY GG+L + F E+ ARF+ +L+
Sbjct: 58 ADSPWIVKLYYSFQDE----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---------------------- 149
+ H + HRD+K +N L+D +K+ DFG K
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 150 ----SGLLHSQPK----STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
H Q + STVGTP YIAPEVL Y + D WS GV LY ML G PF
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPF 230
Query: 202 EDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLLSQIFVADPS 247
++T ++I N + L P VS + L+ + + DP
Sbjct: 231 YSD----TLQETYNKIINWKESLRFPPDPPVSPEAIDLICR-LLCDPE 273
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-38
Identities = 78/255 (30%), Positives = 121/255 (47%), Gaps = 18/255 (7%)
Query: 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH-RSLR---HPNI 61
E VK LG G+ GV VR K T ++ A+K I DE +++++ ++LR P +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVD--GDEEFRKQLLRELKTLRSCESPYV 61
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM-EI 120
++ ++IV+EY GG L + G+ E + +Q++ G+ Y H+ I
Sbjct: 62 VKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121
Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEY 177
HRD+K N L+ G KI DFG SK +T VGT Y++PE + + E
Sbjct: 122 IHRDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGES 176
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRH 236
+D+WS G+TL +G +PF P P +F + + I + LP S + R
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPPPSLPA-EEFSPEFRD 234
Query: 237 LLSQIFVADPSKDPH 251
+S DP K P
Sbjct: 235 FISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-38
Identities = 71/217 (32%), Positives = 110/217 (50%), Gaps = 15/217 (6%)
Query: 10 ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RHPNIIRFK 65
++G G +G L + K T E+VA+K +++ N R ++ R + + +++
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 66 EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
+L + MEY GG+ + + G SED ARF+ ++ V H + HRDL
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDL 127
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
K EN L+D S +K+ DFG SK + + S VG+P Y+APEVL K YD + D W
Sbjct: 128 KPENFLIDASGH--IKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTV-DYW 182
Query: 186 SCGVTLYVMLVGAYPF------EDPEDPRNFRKTIDR 216
S G LY L G PF E E+ + +++T+ R
Sbjct: 183 SLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR 219
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-38
Identities = 90/245 (36%), Positives = 132/245 (53%), Gaps = 14/245 (5%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL---RHPNIIRF 64
K LG G FG LVR+K + + A+K +++ I + V + R L RHP +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 65 KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
K T L VMEY GGELF + FSED RF+ +++S + Y HS +I +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLARKEYDGKISD 183
LKLEN +LD +KI DFG K G+ + K+ GTP Y+APEVL +Y G+ D
Sbjct: 121 LKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV 243
W GV +Y M+ G PF + + + F + + ++++ P +SAD + LLS + +
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKF--PR--TLSADAKSLLSGLLI 231
Query: 244 ADPSK 248
DP+K
Sbjct: 232 KDPNK 236
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-38
Identities = 84/258 (32%), Positives = 140/258 (54%), Gaps = 24/258 (9%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPN 60
+Y VK++G G+FG A LV+ K + +K I K K E ++E+ +++HPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSYCHS 117
I++++E +L IVM+Y GG+L+ +I +A R F ED+ +F Q+ + + H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 118 MEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVL 172
+I HRD+K +N L DG+ +K+ DFG ++ +L+S ++ +GTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGT----IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEIC 173
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
+ Y+ K SD+W+ G LY M + FE N + + +I Y P S
Sbjct: 174 ENRPYNNK-SDIWALGCVLYEMCTLKHAFE----AGNMKNLVLKIIRGSY-PPVSSHYSY 227
Query: 233 DCRHLLSQIFVADPSKDP 250
D R+L+SQ+F +P P
Sbjct: 228 DLRNLVSQLFKRNPRDRP 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-38
Identities = 76/259 (29%), Positives = 128/259 (49%), Gaps = 18/259 (6%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGK-KIDENVQREIINHRSLRHPN 60
R++ ++G G FG + T EL+AVK I + K + + E+ L+HPN
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEA--RFFFQQLISGVSYCHSM 118
++++ V + + I MEY +GG L + GR DE R + QL+ G++Y HS
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSH 118
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPEVLA 173
I HRD+K N LD + +K+ DFG + + + + +S GTPAY+APEV+
Sbjct: 119 GIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 174 RKEYDGKI--SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
+ G +D+WS G + M G P+ + ++ F+ + +PD +++S
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGAGHKPPIPDSLQLS 234
Query: 232 ADCRHLLSQIFVADPSKDP 250
+ + L + +DP K P
Sbjct: 235 PEGKDFLDRCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 7e-38
Identities = 82/243 (33%), Positives = 125/243 (51%), Gaps = 17/243 (6%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKY-----IERGKKIDENVQREIINHRSLRHPNIIRFK 65
LG+G+FG R+ + K T E A+K I + K++ Q + I L HP I+
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSI-LMELSHPFIVNMM 84
Query: 66 EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
+ ++E+ GGELF + AGRF D A+F+ +L+ Y HS +I +RDL
Sbjct: 85 CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDL 144
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
K EN LLD + +K+ DFG++K + + + GTP Y+APEV+ K + GK D W
Sbjct: 145 KPENLLLDN--KGHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKGH-GKAVDWW 199
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
+ GV LY + G PF D + P FR ++I + P++ A R L+ + D
Sbjct: 200 TMGVLLYEFIAGYPPFFD-DTP--FR-IYEKILAGRLKFPNWFDGRA--RDLVKGLLQTD 253
Query: 246 PSK 248
+K
Sbjct: 254 HTK 256
|
Length = 329 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 8e-38
Identities = 81/213 (38%), Positives = 108/213 (50%), Gaps = 28/213 (13%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERG--------------KKIDENVQREIINHRSL 56
LG G+FG L K+T EL A+K +++G K+I E E
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE------- 59
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
RHP ++ T H+ VMEYAAGG+L I FSE A F+ ++ G+ Y H
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLH 118
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARK 175
+I +RDLKL+N LLD + +KI DFG K G+ ST GTP ++APEVL
Sbjct: 119 ENKIVYRDLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTET 176
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF--EDPED 206
Y + D W GV +Y MLVG PF +D E+
Sbjct: 177 SYTRAV-DWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 8e-38
Identities = 88/246 (35%), Positives = 127/246 (51%), Gaps = 16/246 (6%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL---RHPNIIRF 64
K LG G FG LVR+K T A+K + + I + V + R L RHP +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 65 KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
K T L VMEYA GGELF + F+E+ ARF+ +++S + Y HS ++ +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGKISD 183
+KLEN +LD +KI DFG K G+ + K+ GTP Y+APEVL +Y G+ D
Sbjct: 121 IKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHLLSQIF 242
W GV +Y M+ G PF + + R F + + IR P +S + + LL+ +
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-----FPR--TLSPEAKSLLAGLL 230
Query: 243 VADPSK 248
DP +
Sbjct: 231 KKDPKQ 236
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-37
Identities = 82/262 (31%), Positives = 129/262 (49%), Gaps = 27/262 (10%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIE----------RGKKIDENVQREIINHRSLRHPN 60
+GSG+FG L + + EL+AVK +E R + + + + REI + L+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
I+++ L HL I +EY GG + A + + G F E R F +Q++ G++Y H+ I
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSK-------SGLLHSQPKSTVGTPAYIAPEVLA 173
HRD+K N L+D + +KI DFG SK S + S G+ ++APEV+
Sbjct: 128 IHRDIKGANILVDN--KGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRVSA 232
+ Y K +D+WS G + ML G +PF D + I +I N +P + A
Sbjct: 186 QTSYTRK-ADIWSLGCLVVEMLTGKHPFPD----CTQLQAIFKIGENASPEIPSNISSEA 240
Query: 233 DCRHLLSQIFVADPSKDPHSRD 254
L + F D +K P + +
Sbjct: 241 --IDFLEKTFEIDHNKRPTAAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 5e-37
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPN 60
RY+ + +G G G+ +D+ T E VA+K + + I REI ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
+++ +V + +VMEY L + R E + + + + L+ GV+Y H+
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVL--ARK 175
I HRDLK N L+ LKI DFG ++ S V T Y APE+L ARK
Sbjct: 120 IMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 176 EYDGKISDVWSCGVTLYVMLVGA 198
YD + D+W+ G +L G+
Sbjct: 178 -YDPGV-DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 6e-37
Identities = 69/205 (33%), Positives = 107/205 (52%), Gaps = 9/205 (4%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
E + ++ +G G+FG DKRT ++VA+K I+ + D E++Q+EI R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
I ++ L + L I+MEY GG + G+ E F ++++ G+ Y H
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEYD 178
HRD+K N LL S + +K+ DFG S L + K + VGTP ++APEV+ + YD
Sbjct: 120 IHRDIKAANILL--SEEGDVKLADFGVSGQ-LTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176
Query: 179 GKISDVWSCGVTLYVMLVGAYPFED 203
K +D+WS G+T + G P D
Sbjct: 177 EK-ADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-36
Identities = 85/261 (32%), Positives = 118/261 (45%), Gaps = 30/261 (11%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPN 60
++ +K+LG G++G V+ + A+K ++ G +K E+ EI S+ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVSYCH 116
II +KE L L IVMEYA G+L I + E E F QL+ G+ H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLA 173
+I HRDLK N LL + +KI D G SK + +Q +GTP Y+APEV
Sbjct: 121 EQKILHRDLKSANILLVANDL--VKIGDLGISKVLKKNMAKTQ----IGTPHYMAPEVWK 174
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFE--DPEDPRN--FRKTIDRIRNVQYFLPDYVR 229
+ Y K SD+WS G LY M A PFE +D R R I
Sbjct: 175 GRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPP---------I 224
Query: 230 VSADCRHLLSQIFVADPSKDP 250
S D ++ + + P P
Sbjct: 225 YSQDLQNFIRSMLQVKPKLRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 4e-36
Identities = 83/246 (33%), Positives = 127/246 (51%), Gaps = 15/246 (6%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHPNIIR 63
K LG G+FG L K T + A+K +++ + D++V+ ++ R L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
T +L VMEY GG+L I S +F A F+ ++I G+ + HS I +R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
DLKL+N LLD +KI DFG K +L T GTP YIAPE+L ++Y+ +
Sbjct: 121 DLKLDNILLD--TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV- 177
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
D WS GV LY ML+G PF ++ F+ IR P + ++ + + +L ++F
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQS----IRMDNPCYPRW--LTREAKDILVKLF 231
Query: 243 VADPSK 248
V +P +
Sbjct: 232 VREPER 237
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 8e-36
Identities = 85/248 (34%), Positives = 126/248 (50%), Gaps = 19/248 (7%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSL----RHPNIIR 63
K LG G+FG L K E AVK +++ ID++V+ ++ R L +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
T HL VME+ GG+L I GRF A F+ +++ G+ + HS I +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
DLKL+N +LD +KI DFG K + ST GTP YIAPE+L +Y +
Sbjct: 121 DLKLDNVMLDR--DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV- 177
Query: 183 DVWSCGVTLYVMLVGAYPFE-DPEDPRNFRKTIDRIRNVQYFLPDYVR-VSADCRHLLSQ 240
D WS GV LY ML+G PF D ED + +++ P Y R ++ + + +L +
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVDTPHYPRWITKESKDILEK 229
Query: 241 IFVADPSK 248
+F DP++
Sbjct: 230 LFERDPTR 237
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-35
Identities = 83/254 (32%), Positives = 122/254 (48%), Gaps = 16/254 (6%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS----LRHP 59
Y P++ LG G FG A L R LV K + ++ E +R+ +N L+HP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNL-TRLSEKERRDALNEIVILSLLQHP 59
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARIC--SAGRFSEDEARFFFQQLISGVSYCHS 117
NII + + L I MEYA GG L+ +I F E+ ++ Q++S VSY H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKE 176
I HRD+K N L + +K+ DFG SK G +S ++ VGTP Y++PE+ +
Sbjct: 120 AGILHRDIKTLNIFLTKA--GLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
Y+ K SD+W+ G LY +L F D N + +I Y P S++
Sbjct: 178 YNFK-SDIWALGCVLYELLTLKRTF----DATNPLNLVVKIVQGNY-TPVVSVYSSELIS 231
Query: 237 LLSQIFVADPSKDP 250
L+ + DP K P
Sbjct: 232 LVHSLLQQDPEKRP 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-35
Identities = 72/210 (34%), Positives = 110/210 (52%), Gaps = 16/210 (7%)
Query: 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHRSLRHPN 60
E + ELG+GN GV V + T +++AVK I I+E +Q++I I H+ P
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKC-NSPY 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHS- 117
I+ F ++I MEY GG L + GR E ++ G++Y H
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK 119
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
+I HRD+K N L++ Q +K+CDFG S L++S K+ VGT +Y+APE + +Y
Sbjct: 120 HKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQ-LVNSLAKTFVGTSSYMAPERIQGNDY 176
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDP 207
K SD+WS G++L + G +P+ DP
Sbjct: 177 SVK-SDIWSLGLSLIELATGRFPYPPENDP 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-35
Identities = 77/281 (27%), Positives = 114/281 (40%), Gaps = 48/281 (17%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNI 61
Y+ + ++G G +GV RDK T E+VA+K I+ + I + REI + L HPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARIC-----SAGRFSEDEARFFFQQLISGVSYCH 116
I+ +V L +V E+ + + E + + QL+ G+++CH
Sbjct: 61 IKLLDVFRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFG-----YSKSGLLHSQPKSTVGTPAYIAPEV 171
S I HRDLK EN L++ LK+ DFG S V T Y APE+
Sbjct: 116 SHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTHY----VVTRWYRAPEL 169
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDR 216
L + D+WS G +L +P + D P + K
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229
Query: 217 IRNVQYFLPDYVRV---------SADCRHLLSQIFVADPSK 248
RN ++ P + S LLSQ+ DP K
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHK 270
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 4e-35
Identities = 74/205 (36%), Positives = 109/205 (53%), Gaps = 10/205 (4%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHPNIIR 63
K LG G+FG L K T E+ A+K +++ + D++V + R L +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
T L VMEY GG+L +I + +F E +RF+ ++ + + H + +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
DLKL+N LLD + K+ DFG K G+L+ +T GTP YIAPE+L EY +
Sbjct: 121 DLKLDNILLDA--EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV- 177
Query: 183 DVWSCGVTLYVMLVGAYPFE-DPED 206
D W+ GV +Y M+ G PFE D ED
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-35
Identities = 73/199 (36%), Positives = 103/199 (51%), Gaps = 9/199 (4%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR-----SLRHPNIIR 63
K +G G+FG L + K AVK +++ + + Q I+ R +L+HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
T L V++Y GGELF + F E ARF+ ++ S + Y HS+ I +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
DLK EN LLD Q + + DFG K G+ + ST GTP Y+APEVL ++ YD +
Sbjct: 121 DLKPENILLDS--QGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTV 177
Query: 183 DVWSCGVTLYVMLVGAYPF 201
D W G LY ML G PF
Sbjct: 178 DWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-35
Identities = 88/247 (35%), Positives = 127/247 (51%), Gaps = 17/247 (6%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL---RHPNIIRF 64
K LG G FG LV++K T A+K +++ + + V + +R L RHP +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 65 KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHR 123
K T L VMEYA GGELF + FSED ARF+ +++S + Y HS + +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGKIS 182
DLKLEN +LD +KI DFG K G+ + K+ GTP Y+APEVL +Y G+
Sbjct: 121 DLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHLLSQI 241
D W GV +Y M+ G PF + + + F + + IR + P + + LLS +
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSP-------EAKSLLSGL 230
Query: 242 FVADPSK 248
DP +
Sbjct: 231 LKKDPKQ 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-35
Identities = 79/218 (36%), Positives = 115/218 (52%), Gaps = 11/218 (5%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHPNIIRFK 65
LG G+FG L K T EL A+K +++ I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 66 EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
T L VMEY GG+L I G+F E A F+ ++ G+ + HS I +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKISDV 184
KL+N +LD +KI DFG K + + T GTP YIAPE++A + Y GK D
Sbjct: 128 KLDNVMLDAEGH--IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY 222
W+ GV LY ML G PF+ ++ F+ ++ NV Y
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSY 220
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 8e-35
Identities = 73/209 (34%), Positives = 112/209 (53%), Gaps = 10/209 (4%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIE-----RGKKIDENV-QREIINHRSLRH-PNIIR 63
+G G FG VR K T+ + A+K + K++ + +R I+ L P I+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
K T + L +V +Y +GGELF + GRFSED A+F+ +L+ + + H +I +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
DLK EN LLD + + +CDFG SK+ L ++ +T GT Y+APEVL ++ K
Sbjct: 121 DLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFR 211
D WS GV ++ M G PF + + +R
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQQMYR 207
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 9e-35
Identities = 84/254 (33%), Positives = 126/254 (49%), Gaps = 21/254 (8%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERG------KKIDENVQREIINHRSLRHPNII 62
K LG G FG L D T +AVK + KK ++ EI ++L+H I+
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
++ L L+I MEY GG + ++ + G +E R + +Q++ GV Y HS I H
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQ---PKSTVGTPAYIAPEVLARKEYD 178
RD+K N L D + +K+ DFG SK + S KS GTP +++PEV++ + Y
Sbjct: 128 RDIKGANILRDSAGN--VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY- 184
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI--RNVQYFLPDYVRVSADCRH 236
G+ +DVWS G T+ ML P+ + E I +I + LP + VS D R+
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIATQPTNPQLPSH--VSPDARN 238
Query: 237 LLSQIFVADPSKDP 250
L + FV + K P
Sbjct: 239 FLRRTFVENAKKRP 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-34
Identities = 77/198 (38%), Positives = 106/198 (53%), Gaps = 9/198 (4%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHPNIIRFK 65
LG G+FG L R K + L AVK +++ + D++V+ + R L HP + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 66 EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
TP L VME+ GG+L I + RF E ARF+ ++ S + + H I +RDL
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKISDV 184
KL+N LLD + K+ DFG K G+ + + ST GTP YIAPE+L Y G D
Sbjct: 123 KLDNVLLDH--EGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDW 179
Query: 185 WSCGVTLYVMLVGAYPFE 202
W+ GV LY ML G PFE
Sbjct: 180 WAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-34
Identities = 84/236 (35%), Positives = 124/236 (52%), Gaps = 11/236 (4%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHPNIIRFK 65
LG G+FG L K T EL A+K +++ I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 66 EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
T L VMEY GG+L +I GRF E A F+ ++ G+ + HS I +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDGKISDV 184
KL+N +LD + +KI DFG K + K+ GTP YIAPE++A + Y GK D
Sbjct: 128 KLDNVMLDS--EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
W+ GV LY ML G PFE ++ F+ ++ NV Y A C+ L+++
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAVAICKGLMTK 238
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 6e-34
Identities = 86/246 (34%), Positives = 125/246 (50%), Gaps = 15/246 (6%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RHPNIIR 63
K +G G+FG L R K ++ AVK +++ + + ++ I++ R++ +HP ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
T L V++Y GGELF + F E ARF+ ++ S + Y HS+ I +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
DLK EN LLD Q + + DFG K + H+ ST GTP Y+APEVL ++ YD +
Sbjct: 121 DLKPENILLDS--QGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
D W G LY ML G PF RN + D I N L + SA RHLL +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYS----RNTAEMYDNILNKPLQLKPNITNSA--RHLLEGLL 231
Query: 243 VADPSK 248
D +K
Sbjct: 232 QKDRTK 237
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 7e-34
Identities = 87/254 (34%), Positives = 128/254 (50%), Gaps = 15/254 (5%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPN 60
RYE +K++G G+FG L + K E +K I+ K K E ++E+I ++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARIC--SAGRFSEDEARFFFQQLISGVSYCHSM 118
I+ F L IVMEY GG+L RI FSED+ +F Q+ G+ + H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKE 176
+I HRD+K +N L + K+ DFG ++ L S + VGTP Y++PE+ +
Sbjct: 121 KILHRDIKSQNIFLSKNGMVA-KLGDFGIARQ-LNDSMELAYTCVGTPYYLSPEICQNRP 178
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
Y+ K +D+WS G LY + +PFE N + + +I YF P S D R
Sbjct: 179 YNNK-TDIWSLGCVLYELCTLKHPFEG----NNLHQLVLKICQ-GYFAPISPNFSRDLRS 232
Query: 237 LLSQIFVADPSKDP 250
L+SQ+F P P
Sbjct: 233 LISQLFKVSPRDRP 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 7e-34
Identities = 74/202 (36%), Positives = 108/202 (53%), Gaps = 21/202 (10%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHP 59
+E YE ++ +GSG +G RD T ELVA+K I E G + +Q+EI + RHP
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-IQQEISMLKECRHP 60
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGG---ELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
NI+ + L L IVMEY GG +++ G SE + + ++ + G++Y H
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLH 118
Query: 117 SMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVL 172
HRD+K N LL DG +K+ DFG S + L + K S +GTP ++APEV
Sbjct: 119 ETGKIHRDIKGANILLTEDGD----VKLADFGVS-AQLTATIAKRKSFIGTPYWMAPEVA 173
Query: 173 A---RKEYDGKISDVWSCGVTL 191
A + YDGK D+W+ G+T
Sbjct: 174 AVERKGGYDGKC-DIWALGITA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-33
Identities = 78/224 (34%), Positives = 118/224 (52%), Gaps = 11/224 (4%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHP 59
+ + LG G+FG L K T EL A+K +++ I D++V+ ++ R L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+ + T L VMEY GG+L I G+F E +A F+ ++ G+ + H
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 178
I +RDLKL+N +LD + +KI DFG K ++ T GTP YIAPE++A + Y
Sbjct: 122 IIYRDLKLDNVMLDS--EGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY- 178
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY 222
GK D W+ GV LY ML G PF+ ++ F+ ++ NV Y
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSY 220
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-33
Identities = 82/249 (32%), Positives = 127/249 (51%), Gaps = 22/249 (8%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENV---QREIINHRSL 56
E ++ +K +G G FG +LVR K +K++ A+K + E K+ D +R+I+ H +
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN- 101
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
I++ +L +VMEY GG+L + S E ARF+ +++ + H
Sbjct: 102 -SEWIVQLHYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEKWARFYTAEVVLALDAIH 159
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVL 172
SM HRD+K +N LLD S LK+ DFG +G++ + VGTP YI+PEVL
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEVL 215
Query: 173 ARKEYD---GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
+ D G+ D WS GV LY MLVG PF + K +D ++ + PD +
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF--PDDIE 273
Query: 230 VSADCRHLL 238
+S + L+
Sbjct: 274 ISKQAKDLI 282
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-33
Identities = 85/255 (33%), Positives = 120/255 (47%), Gaps = 20/255 (7%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPN 60
+E + ++G G+FGV V K K + A+K I+ K++ + E I+ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-SKMNRREREEAIDEARVLAKLDSSY 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSM 118
IIR+ E L L IVMEYA G+L + ED+ FF Q++ G+++ HS
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARK 175
+I HRD+K N LD +KI D G +K LL + VGTP Y++PE+ K
Sbjct: 121 KILHRDIKSLNLFLDAYDN--VKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
Y+ K SDVW+ GV LY G +PF+ K IR V F P S
Sbjct: 177 PYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKI---IRGV--FPPVSQMYSQQLA 230
Query: 236 HLLSQIFVADPSKDP 250
L+ Q D + P
Sbjct: 231 QLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 2e-33
Identities = 73/255 (28%), Positives = 105/255 (41%), Gaps = 23/255 (9%)
Query: 9 KELGSGNFGV---ARLV-RDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPNII 62
K+LG G FG L + + VAVK ++ E RE R L HPNI+
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 63 RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+ V L IVMEY GG+L + R S + F Q+ G+ Y S
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNF 124
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-----LHSQPKSTVGTPAYIAPEVLARK 175
HRDL N L+ +KI DFG S+ K + ++APE L
Sbjct: 125 IHRDLAARNCLVGE--NLVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPESLKEG 179
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
++ K SDVWS GV L+ + E+P + + ++ ++ Y LP +
Sbjct: 180 KFTSK-SDVWSFGVLLWEIFTLG---EEPYPGMSNAEVLEYLKK-GYRLPKPPNCPPELY 234
Query: 236 HLLSQIFVADPSKDP 250
L+ Q + DP P
Sbjct: 235 KLMLQCWAEDPEDRP 249
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-33
Identities = 78/244 (31%), Positives = 117/244 (47%), Gaps = 16/244 (6%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RHPNIIRFKE 66
+G G+FG VR + T+ + A+K I + + + + R++ P I+ K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 67 VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
+P L +V+ + GGELF + GRF ARF+ +L+ + H + +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKISDVW 185
EN LLD Q + +CDFG K + +T GTP Y+APE+L Y K D W
Sbjct: 121 PENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
+ GV LY ML G PF D +RK + + +R PD D + LL +
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR-----FPDGFD--RDAKDLLIGLLSR 230
Query: 245 DPSK 248
DP++
Sbjct: 231 DPTR 234
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 3e-33
Identities = 71/195 (36%), Positives = 102/195 (52%), Gaps = 20/195 (10%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG-KKIDENVQ-REIINHRSLR----H 58
Y+ +K+LG G FG L R+K T ELVA+K +++ +E + RE+ +SLR H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCH 116
PNI++ KEV L V EY G L+ + FSE R Q++ G+++ H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLAR 174
HRDLK EN L+ S +KI DFG ++ + S+P T V T Y APE+L R
Sbjct: 117 KHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172
Query: 175 -KEYDGKISDVWSCG 188
Y + D+W+ G
Sbjct: 173 STSYSSPV-DIWALG 186
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-33
Identities = 77/228 (33%), Positives = 113/228 (49%), Gaps = 29/228 (12%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN------VQREIINHRSL 56
E +E +K + +G +G LVR K T++ A+K I + I N V+R+I+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE- 59
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
+P ++ T HL +VMEY GG+ + + G D AR +F + + + Y H
Sbjct: 60 -NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----------------QPKST 160
+ I HRDLK +N L+ + +K+ DFG SK GL+ K
Sbjct: 119 NYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF--EDPED 206
GTP YIAPEV+ R+ Y GK D W+ G+ LY LVG PF + PE+
Sbjct: 177 CGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-33
Identities = 81/261 (31%), Positives = 125/261 (47%), Gaps = 21/261 (8%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIE-----------RGKKIDENVQREIINHRSLRHP 59
+G G +G L + T E++AVK +E R K + + ++ EI + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
NI+++ T +L+I +EY GG + + + + GRF E RFF +Q++ G++Y HS
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSG---LLHSQPKSTVGTPAYIAPEV--LAR 174
I HRDLK +N L+D KI DFG SK + Q S G+ ++APEV
Sbjct: 129 ILHRDLKADNLLVDA--DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-RVSAD 233
+ Y K+ D+WS G + M G P+ D E K + R+ PD +S
Sbjct: 187 QGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFK-LGNKRSAPPIPPDVSMNLSPV 244
Query: 234 CRHLLSQIFVADPSKDPHSRD 254
L+ F +P P +R+
Sbjct: 245 ALDFLNACFTINPDNRPTARE 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 5e-33
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 10/206 (4%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
EE ++ +++LG G++G K T ++VA+K + + + + + +EI + P I
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYI 60
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+++ T L IVMEY G + +I + +E+E Q + G+ Y HS +
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEY 177
HRD+K N LL+ Q K+ DFG S L + K + +GTP ++APEV+ Y
Sbjct: 120 KIHRDIKAGNILLNEEGQA--KLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFED 203
+ K D+WS G+T M G P+ D
Sbjct: 177 NNKA-DIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-33
Identities = 74/257 (28%), Positives = 121/257 (47%), Gaps = 18/257 (7%)
Query: 5 YEPVKELGSGNFGVARLVRD---KRTKELVAVKY------IERGKKIDENVQREIINHRS 55
+E ++ LG+G +G LVR +L A+K +++ K + +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
R P ++ T T L ++++Y GGELF + F+E E R + +++ + +
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLA 173
H + I +RD+KLEN LLD + + + DFG SK L + + S GT Y+APEV+
Sbjct: 122 HQLGIIYRDIKLENILLDS--EGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 174 RKEYD-GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVS 231
K D WS GV + +L GA PF + +N + I RI + P +S
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFT-VDGEQNSQSEISRRILKSKPPFPK--TMS 236
Query: 232 ADCRHLLSQIFVADPSK 248
A+ R + ++ DP K
Sbjct: 237 AEARDFIQKLLEKDPKK 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 6e-33
Identities = 82/255 (32%), Positives = 129/255 (50%), Gaps = 19/255 (7%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPNI 61
+Y ++ +G G+FG A LV+ + + A+K I K E+ ++E + ++HPNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGR-FSEDEARFFFQQLISGVSYCHSME 119
+ FKE HL IVMEY GG+L +I G+ F ED +F Q+ GV + H
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS----TVGTPAYIAPEVLARK 175
+ HRD+K +N L + ++K+ DFG S L + P + VGTP Y+ PE+
Sbjct: 121 VLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
Y+ K SD+WS G LY + +PF+ +++ I ++ Y P S + R
Sbjct: 176 PYNNK-SDIWSLGCILYELCTLKHPFQ----ANSWKNLILKVCQGSY-KPLPSHYSYELR 229
Query: 236 HLLSQIFVADPSKDP 250
L+ Q+F +P P
Sbjct: 230 SLIKQMFKRNPRSRP 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 6e-33
Identities = 80/244 (32%), Positives = 125/244 (51%), Gaps = 24/244 (9%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV------QREIINHRSLRHPNIIRF 64
+G G+FG ++VR+K T ++ A+K +++ + + +R+I++ + P I +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN--SPWIPQL 66
Query: 65 KEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
+ +L +VMEY GG+L + + +F ED A+F+ +L+ + H M HR
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR 126
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
D+K EN L+D + +K+ DFG + + K VGTP YIAPEVL DGK
Sbjct: 127 DIKPENVLIDRTGH--IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKG 184
Query: 182 S-----DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADC 234
+ D WS GV Y M+ G PF E KT + I N Q FL P+ +VS+D
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSPFH--EG--TSAKTYNNIMNFQRFLKFPEDPKVSSDF 240
Query: 235 RHLL 238
L+
Sbjct: 241 LDLI 244
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 1e-32
Identities = 75/254 (29%), Positives = 108/254 (42%), Gaps = 22/254 (8%)
Query: 9 KELGSGNFGV---ARLV-RDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPNII 62
K+LG G FG +L + + K VAVK ++ E RE R L HPN++
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 63 RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+ V L IVMEY GG+L + R + + S + F Q+ G+ Y S
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGMEYLESKNF 123
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT-P-AYIAPEVLARKEYD 178
HRDL N L+ +KI DFG S+ + G P ++APE L ++
Sbjct: 124 IHRDLAARNCLVGE--NLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--YFLPDYVRVSADCRH 236
K SDVWS GV L+ + F E P + + ++ Y LP +
Sbjct: 182 SK-SDVWSFGVLLWEI------FTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYD 234
Query: 237 LLSQIFVADPSKDP 250
L+ Q + DP P
Sbjct: 235 LMLQCWAEDPEDRP 248
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 73/211 (34%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER-------GKKIDENVQREIINHRSL 56
RYE +K +GSG +GV DKRT VA+K I K+I REI R L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRI----LREIKLLRHL 56
Query: 57 RHPNIIRFKEVLLTPT-----HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
RH NII ++L P+ + IV E +L I S ++D ++F Q++ G
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRG 115
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYI 167
+ Y HS + HRDLK N L++ + LKICDFG ++ K V T Y
Sbjct: 116 LKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 168 APEV-LARKEYDGKISDVWSCGVTLYVMLVG 197
APE+ L+ Y I D+WS G +L
Sbjct: 174 APELLLSSSRYTKAI-DIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 72/202 (35%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKY---IERGKKIDENVQREIINHRSLRHP 59
+YE + +G G +GV R+K T E+VA+K E + + + RE+ R LRH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
NI+ KE L +V EY L S G D R + QL+ ++YCHS
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEVLARK 175
I HRD+K EN L+ S LK+CDFG++++ L ++P S V T Y APE+L
Sbjct: 121 IIHRDIKPENILVSESGV--LKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLVGD 176
Query: 176 EYDGKISDVWSCGVTLYVMLVG 197
GK DVW+ G + +L G
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-32
Identities = 70/199 (35%), Positives = 105/199 (52%), Gaps = 9/199 (4%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RHPNIIR 63
K +G G+FG L + K + AVK +++ ++ Q+ I+ R++ +HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
T L V+++ GGELF + F E ARF+ ++ S + Y HS+ I +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
DLK EN LLD Q + + DFG K G+ S +T GTP Y+APEV+ ++ YD +
Sbjct: 121 DLKPENILLDS--QGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV- 177
Query: 183 DVWSCGVTLYVMLVGAYPF 201
D W G LY ML G PF
Sbjct: 178 DWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-32
Identities = 77/252 (30%), Positives = 133/252 (52%), Gaps = 17/252 (6%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNI 61
+ ++G G+ G+ + DK T VAVK ++ R ++ E + E++ R +HPNI
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
+ L L +VME+ GG L I + R +E++ ++ +S+ H+ +
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVI 137
Query: 122 HRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAYIAPEVLARKEY 177
HRD+K ++ LL DG R+K+ DFG+ + + P KS VGTP ++APEV++R Y
Sbjct: 138 HRDIKSDSILLTSDG----RVKLSDFGFC-AQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRVSADCRH 236
++ D+WS G+ + M+ G P+ + E P + + RIR+ L + +VS R
Sbjct: 193 GTEV-DIWSLGIMVIEMVDGEPPYFN-EPP---LQAMKRIRDNLPPKLKNLHKVSPRLRS 247
Query: 237 LLSQIFVADPSK 248
L ++ V DP++
Sbjct: 248 FLDRMLVRDPAQ 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-32
Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKK-IDENVQREIINHRSLRHPNI 61
YE + ++G G +G R+K+T ELVA+K I E K+ REI + LRHPNI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 62 IRFKEVLLTPTHLAI--VMEYA----AGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
+R KE++ + +I V EY G +F+E + + + +QL+ G+ Y
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTG---LLD-SPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL- 172
HS I HRD+K N L++ LK+ DFG ++ + T V T Y PE+L
Sbjct: 117 HSNGILHRDIKGSNILINN--DGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
Y ++ D+WS G L + +G F
Sbjct: 175 GATRYGPEV-DMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 76/249 (30%), Positives = 136/249 (54%), Gaps = 20/249 (8%)
Query: 8 VKELGSGNFGVARLVRDKRTKE---LVAVKYIERGK-KIDENV----QREIINHRSLRHP 59
+K LG G+FG LVR + L A+K +++ K+ + V +R+I+ + HP
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHP 58
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
I++ T L +++++ GG+LF R+ F+E++ +F+ +L + + HS+
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYD 178
I +RDLK EN LLD +K+ DFG SK + H + S GT Y+APEV+ R+ +
Sbjct: 119 IIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
+ +D WS GV ++ ML G+ PF+ ++ ++T+ I + +P + +S + + LL
Sbjct: 177 -QSADWWSFGVLMFEMLTGSLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSLL 229
Query: 239 SQIFVADPS 247
+F +P+
Sbjct: 230 RALFKRNPA 238
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 71/260 (27%), Positives = 108/260 (41%), Gaps = 26/260 (10%)
Query: 9 KELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIR 63
K+LG G FG +L VAVK ++ +E +E + L HPN++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 64 FKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLIS-------GVSY 114
V L +V+EY GG+L + R S +++ + L+S G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEV 171
S + HRDL N L+ +KI DFG S+ + G I APE
Sbjct: 121 LASKKFVHRDLAARNCLVGE--DLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 172 LARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
L + K SDVWS GV L+ + +GA P+ + + ++ +R Y LP
Sbjct: 179 LKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPG----LSNEEVLEYLRK-GYRLPKPEYC 232
Query: 231 SADCRHLLSQIFVADPSKDP 250
+ L+ + DP P
Sbjct: 233 PDELYELMLSCWQLDPEDRP 252
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 79/291 (27%), Positives = 130/291 (44%), Gaps = 57/291 (19%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVK------YIERGKKIDENVQREIINHRSLRH 58
+E +K +G G FG RLV+ K T + A+K +E+ + +R+I+ +
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILA--EADN 60
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
P +++ +L ++MEY GG++ + F+E+E RF+ + I + H +
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG-------------------------------- 146
HRD+K +N LLD +K+ DFG
Sbjct: 121 GYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178
Query: 147 YSKSGLLHSQPK-------STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAY 199
S + + STVGTP YIAPEV + Y K D WS GV +Y MLVG
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYP 237
Query: 200 PF--EDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK 248
PF ++P++ +RK I+ +Q+ PD V +S + + L+ + + +
Sbjct: 238 PFCSDNPQE--TYRKIINWKETLQF--PDEVPLSPEAKDLIKR-LCCEAER 283
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 4e-31
Identities = 77/251 (30%), Positives = 123/251 (49%), Gaps = 23/251 (9%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR--------HP 59
+K + G FG L + + T + A+K + KK D + ++ N ++ R P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVL---KKSDMIAKNQVTNVKAERAIMMIQGESP 57
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+ + + +L +VMEY GG+ + I + G ED A+ + +++ GV H
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
I HRD+K EN L+D + LK+ DFG S++GL K VGTP Y+APE + D
Sbjct: 118 IIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DD 171
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR--VSADCRHL 237
K+SD WS G ++ L G PF E P I R + + P+ V+ S + L
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFH-AETPDAVFDNILS-RRINW--PEEVKEFCSPEAVDL 227
Query: 238 LSQIFVADPSK 248
++++ DP+K
Sbjct: 228 INRLLCMDPAK 238
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 7e-31
Identities = 83/270 (30%), Positives = 138/270 (51%), Gaps = 17/270 (6%)
Query: 5 YEPVKELGSGNFGVARLVRD---KRTKELVAVK------YIERGKKIDEN-VQREIINHR 54
+E +K LG+G +G LVR T +L A+K +++ K ++ +R ++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 55 SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
+ P ++ T L ++++Y +GGE+F + FSEDE RF+ ++I + +
Sbjct: 62 R-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVL 172
H + I +RD+KLEN LLD + + + DFG SK L + + S GT Y+APE++
Sbjct: 121 LHKLGIVYRDIKLENILLDS--EGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
K GK D WS G+ ++ +L GA PF E RN + + R R ++ P +
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFT-LEGERNTQSEVSR-RILKCDPPFPSFIGP 236
Query: 233 DCRHLLSQIFVADPSKDPHSRDQKASLVPE 262
+ + LL ++ DP K + Q AS + E
Sbjct: 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-31
Identities = 70/212 (33%), Positives = 109/212 (51%), Gaps = 14/212 (6%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE--NVQREIINHRSLRH--- 58
R E + G G +G + T +VA+K I D+ ++QRE+ LR
Sbjct: 5 RLELI---GRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
PNI ++ L L I+MEYA GG + + AG +E ++++ + Y H +
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLAR-KE 176
+ HRD+K N L+ + +K+CDFG + +S +ST VGTP ++APEV+ K
Sbjct: 121 GVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR 208
YD K +D+WS G+T+Y M G P+ D + R
Sbjct: 179 YDTK-ADIWSLGITIYEMATGNPPYSDVDAFR 209
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 73/248 (29%), Positives = 119/248 (47%), Gaps = 16/248 (6%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVK---YIERGKKIDENVQ---REIINHRSLRHPNIIRF 64
LGSG+FG + + AVK + G+ E V+ +EI L+HPNI+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 65 KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
+L I +E GG L + G F E R + +Q++ G+ Y H HRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 184
+K N L+D + +K+ DFG +K + S KS G+P ++APEV+A++ G +D+
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSADCRHLLSQIF 242
WS G T+ M G P+ E + +I + +PD+ +S + + + +
Sbjct: 186 WSLGCTVLEMATGKPPWSQLE----GVAAVFKIGRSKELPPIPDH--LSDEAKDFILKCL 239
Query: 243 VADPSKDP 250
DPS P
Sbjct: 240 QRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 77/253 (30%), Positives = 131/253 (51%), Gaps = 20/253 (7%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTK-ELVAVKYIERGKKIDEN------VQREIINHRS 55
E + ++ LG+G+FG L K VA+K E+ K I + +R+I+N+
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY-- 87
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
+ HP + ++L +V+E+ GGE F + RF D F+ Q++ Y
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
S+ I +RDLK EN LLD +K+ DFG++K ++ ++ + GTP YIAPE+L
Sbjct: 148 QSLNIVYRDLKPENLLLD--KDGFIKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNV 203
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
+ GK +D W+ G+ +Y +LVG PF E ++K ++ I + P + + +C+
Sbjct: 204 GH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI----IYFPKF--LDNNCK 256
Query: 236 HLLSQIFVADPSK 248
HL+ ++ D +K
Sbjct: 257 HLMKKLLSHDLTK 269
|
Length = 340 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 81/260 (31%), Positives = 120/260 (46%), Gaps = 22/260 (8%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFKEVL 68
LG G G R K T + A+K I D Q RE+ ++S + P I+++
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 69 LTP--THLAIVMEYAAGGEL---FARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICH 122
L + + I MEY GG L + ++ GR E + ++ G+SY HS +I H
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIH 128
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RD+K N LL Q +K+CDFG S L++S + GT Y+APE + K Y S
Sbjct: 129 RDIKPSNILLTRKGQ--VKLCDFGVSGE-LVNSLAGTFTGTSFYMAPERIQGKPYSIT-S 184
Query: 183 DVWSCGVTLYVMLVGAYPF----EDPEDPRNFRKTIDRIRNVQYFLPD----YVRVSADC 234
DVWS G+TL + +PF E P P I + N + L D ++ S +
Sbjct: 185 DVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE--LKDEPGNGIKWSEEF 242
Query: 235 RHLLSQIFVADPSKDPHSRD 254
+ + Q DP++ P D
Sbjct: 243 KDFIKQCLEKDPTRRPTPWD 262
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-30
Identities = 83/251 (33%), Positives = 125/251 (49%), Gaps = 22/251 (8%)
Query: 8 VKELGSGNFGVARLVR---DKRTKELVAVKYIERGKKIDE-------NVQREIINHRSLR 57
+K LG G +G VR T ++ A+K +++ + +R I+ +++
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNIL--EAVK 58
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
HP I+ T L +++EY +GGELF + G F ED A F+ ++ + + H
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ 118
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKE 176
I +RDLK EN LLD Q +K+ DFG K + T GT Y+APE+L R
Sbjct: 119 QGIIYRDLKPENILLDA--QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG 176
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
+ GK D WS G +Y ML GA PF N +KTID+I + LP Y ++ + R
Sbjct: 177 H-GKAVDWWSLGALMYDMLTGAPPFT----AENRKKTIDKILKGKLNLPPY--LTPEARD 229
Query: 237 LLSQIFVADPS 247
LL ++ +PS
Sbjct: 230 LLKKLLKRNPS 240
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-30
Identities = 76/198 (38%), Positives = 105/198 (53%), Gaps = 17/198 (8%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQ---REIINHRSLR 57
E+ + ++E+G G+FG RD RT E+VA+K + GK+ +E Q +E+ + LR
Sbjct: 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYC 115
HPN I +K L +VMEY G + I + E E + G++Y
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYCLGSA--SDILEVHKKPLQEVEIAAICHGALQGLAYL 131
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LAR 174
HS E HRD+K N LL + +K+ DFG S L S S VGTP ++APEV LA
Sbjct: 132 HSHERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAM 186
Query: 175 KE--YDGKISDVWSCGVT 190
E YDGK+ DVWS G+T
Sbjct: 187 DEGQYDGKV-DVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 78/261 (29%), Positives = 116/261 (44%), Gaps = 17/261 (6%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-------VQREIINHRSLRHPNIIR 63
LG G FG + K T ++ A K +++ K++ + +++I+ S R I+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDK-KRLKKRKGEQMALNEKKILEKVSSRF--IVS 57
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEIC 121
T L +VM GG+L I + G F E A F+ Q+I G+ + H I
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
+RDLK EN LLD R I D G + + K GTP Y+APEVL + YD +
Sbjct: 118 YRDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
D ++ G TLY M+ G PF ++ + R + PD + S + + L +
Sbjct: 176 -DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEAL 232
Query: 242 FVADPSKDPHSRDQKASLVPE 262
DP K R A V E
Sbjct: 233 LQKDPEKRLGCRGGSADEVRE 253
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-29
Identities = 70/208 (33%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKID-----ENVQREIINHRSLRHPNI 61
++LG+G F RD +T L+AVK + R + E +++EI L HP+I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
IR +H + +E+ AGG + + G F E + +QL+ G+SY H +I
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 122 HRDLKLENTLLDGSPQPRLKICDFG--------YSKSGLLHSQPKSTVGTPAYIAPEVLA 173
HRD+K N L+D + Q RL+I DFG + +G Q +GT A++APEVL
Sbjct: 126 HRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTGAGEFQGQ---LLGTIAFMAPEVL- 180
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPF 201
R E G+ DVWS G + M P+
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-28
Identities = 70/227 (30%), Positives = 109/227 (48%), Gaps = 38/227 (16%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----H 58
+E V+ +G G +G R K+T +LVA+K ++ + +E ++ E LR H
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY---NILRKYSNH 62
Query: 59 PNIIRFKEVLLTPTH------LAIVMEYAAGG---ELFARICSAG-RFSEDEARFFFQQL 108
PNI F + L +VME GG +L + G R E+ + ++
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-------V 161
+ G++Y H ++ HRD+K +N LL + +K+ DFG S +Q ST +
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILL--TKNAEVKLVDFGVS------AQLDSTLGRRNTFI 174
Query: 162 GTPAYIAPEVLARKE-----YDGKISDVWSCGVTLYVMLVGAYPFED 203
GTP ++APEV+A E YD + SDVWS G+T + G P D
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 19/205 (9%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRH 58
+ +E + ELG G FG + K T A K I+ + D V+ +I++ +H
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS--ECKH 61
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHS 117
PNI+ E L I++E+ GG L + + R +E + R+ +Q++ +++ HS
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121
Query: 118 MEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLA- 173
++ HRDLK N LL DG +K+ DFG S Q + T +GTP ++APEV+A
Sbjct: 122 HKVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVAC 177
Query: 174 ----RKEYDGKISDVWSCGVTLYVM 194
YD K +D+WS G+TL +
Sbjct: 178 ETFKDNPYDYK-ADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-28
Identities = 71/205 (34%), Positives = 102/205 (49%), Gaps = 34/205 (16%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ-------REIINHRS 55
+ YE + + G +GV RDK+T E+VA+K + K+++ + REI
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREINILLK 60
Query: 56 LRHPNIIRFKEVLL--TPTHLAIVMEYAAGGE-----LFARICSAGRFSEDEARFFFQQL 108
L+HPNI+ KEV++ + +VMEY E L + F + E + QL
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQL 115
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTP 164
+SGV++ H I HRDLK N LL + + LKICDFG ++ + P V T
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAR---EYGSPLKPYTQLVVTL 170
Query: 165 AYIAPEVL-ARKEYDGKISDVWSCG 188
Y APE+L KEY I D+WS G
Sbjct: 171 WYRAPELLLGAKEYSTAI-DMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-28
Identities = 82/282 (29%), Positives = 122/282 (43%), Gaps = 47/282 (16%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK------IDENVQREIINHRSLR 57
RYE K+LG G + V RDK T +VA+K I+ G++ I+ REI + L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCH 116
HPNII +V +++ +V E+ +L I + + + + + + G+ Y H
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK----STVGTPAYIAPEVL 172
S I HRDLK N L+ LK+ DFG ++S P V T Y APE+L
Sbjct: 120 SNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPELL 174
Query: 173 --ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----RNFRK----TIDRIRNVQ 221
AR Y + D+WS G +L+ PF + + F T + V
Sbjct: 175 FGARH-YGVGV-DMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231
Query: 222 YFLPDYVRV---------------SADCRHLLSQIFVADPSK 248
LPDYV S D LL ++ +P+K
Sbjct: 232 S-LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNK 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 5e-28
Identities = 76/247 (30%), Positives = 125/247 (50%), Gaps = 18/247 (7%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RH 58
E Y+ VK +G G FG +LVR K ++++ A+K + + + I + R +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
P +++ +L +VMEY GG+L + S E A+F+ +++ + HSM
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
+ HRD+K +N LLD LK+ DFG ++G++ + VGTP YI+PEVL
Sbjct: 162 GLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLKS 217
Query: 175 K---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
+ Y G+ D WS GV L+ MLVG PF + K +D ++ + P+ V +S
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF--PEDVEIS 275
Query: 232 ADCRHLL 238
++L+
Sbjct: 276 KHAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-28
Identities = 76/257 (29%), Positives = 125/257 (48%), Gaps = 24/257 (9%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
LG G +G+ RD T+ +A+K I ER + + + EI H L+H NI+++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 70 TPTHLAIVMEYAAGGELFARICSAG---RFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
I ME GG L A + S + +E F+ +Q++ G+ Y H +I HRD+K
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 127 LENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLAR--KEYDGKISD 183
+N L++ + +KI DFG SK ++ ++ GT Y+APEV+ + + Y G +D
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAPAD 193
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPR------NFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
+WS G T+ M G PF + +P+ K I P+ +SA+ ++
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI-------PE--SLSAEAKNF 244
Query: 238 LSQIFVADPSKDPHSRD 254
+ + F DP K + D
Sbjct: 245 ILRCFEPDPDKRASAHD 261
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 6e-28
Identities = 82/286 (28%), Positives = 126/286 (44%), Gaps = 44/286 (15%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQR---EIINHRSLRH 58
RY+P++ +GSG +GV D R+ + VA+K I + +R E+ R +H
Sbjct: 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH 63
Query: 59 PNIIRFKEVLLTP----THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
NII +++L P + +VM+ +L I S +E+ R+F QL+ G+ Y
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKY 122
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST------VGTPAYIA 168
HS + HRDLK N L++ + L+I DFG ++ GL S + V T Y A
Sbjct: 123 IHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMAR-GLSSSPTEHKYFMTEYVATRWYRA 179
Query: 169 PEVL-ARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKT 213
PE+L + EY I D+WS G ML +P ++
Sbjct: 180 PELLLSLPEYTTAI-DMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238
Query: 214 I--DRIRNVQYFLPD---------YVRVSADCRHLLSQIFVADPSK 248
I DR+R LP + + S + LLSQ+ DP +
Sbjct: 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEE 284
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 80/296 (27%), Positives = 121/296 (40%), Gaps = 62/296 (20%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN------VQREIINHRSLRH 58
+ +K +G G FG LVR T L A+K + + + N +R+I+ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--N 60
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
+++ +L VM+Y GG++ + + G F ED ARF+ +L + H M
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG------------YSKSGLLHSQ---------- 156
HRD+K +N L+D +K+ DFG Y + G H Q
Sbjct: 121 GFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 157 ------PK----------------STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVM 194
K S VGTP YIAPEVL R Y ++ D WS GV LY M
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM 237
Query: 195 LVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLLSQIFVADPSK 248
LVG PF +T ++ N + L P ++S + L+ ++
Sbjct: 238 LVGQPPFLADTPA----ETQLKVINWETTLHIPSQAKLSREASDLILRL-CCGAED 288
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-28
Identities = 62/198 (31%), Positives = 106/198 (53%), Gaps = 9/198 (4%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREI-INHRSLRHPNIIRFK 65
+G G++ LV K+T+ + A+K I++ D+ VQ E + + HP ++
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 66 EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
T + L V+E+ +GG+L + + E+ ARF+ ++ +++ H I +RDL
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKISDV 184
KL+N LLD + +K+ D+G K G+ ST GTP YIAPE+L ++Y + D
Sbjct: 123 KLDNVLLDA--EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV-DW 179
Query: 185 WSCGVTLYVMLVGAYPFE 202
W+ GV ++ M+ G PF+
Sbjct: 180 WALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 63/204 (30%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYI-----ERGKKIDENVQREIINHRSLR-- 57
YE + E+G G +G RD T VA+K + E G I + REI + L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58
Query: 58 -HPNIIRFKEVLLTP-----THLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLIS 110
HPNI+R +V P L +V E+ + C + + +QL+
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
GV + HS I HRDLK +N L+ + ++KI DFG ++ S V T Y APE
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILV--TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPE 176
Query: 171 VLARKEYDGKISDVWSCGVTLYVM 194
VL + Y + D+WS G +
Sbjct: 177 VLLQSSYATPV-DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 81/247 (32%), Positives = 125/247 (50%), Gaps = 18/247 (7%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RH 58
E YE VK +G G FG +LVR K T+++ A+K + + + I + R +
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
P +++ +L +VMEY GG+L + S E ARF+ +++ + HSM
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
HRD+K +N LLD S LK+ DFG +K G++ + VGTP YI+PEVL
Sbjct: 162 GFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLKS 217
Query: 175 K---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
+ Y G+ D WS GV LY MLVG PF + K ++ ++ + PD +S
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDIS 275
Query: 232 ADCRHLL 238
+ ++L+
Sbjct: 276 KEAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 65/207 (31%), Positives = 92/207 (44%), Gaps = 16/207 (7%)
Query: 9 KELGSGNFGV---ARLVRDKR-TKELVAVKYIERG--KKIDENVQREIINHRSLRHPNII 62
K+LG G FG L D T+ VAVK ++ G ++ E E + L HPNI+
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 63 RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
R V L IV EY GG+L F R + + + Q+ G+ Y S
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEYLESKNF 123
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEY 177
HRDL N L+ + +KI DFG S+ + G ++APE L ++
Sbjct: 124 VHRDLAARNCLVTENLV--VKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181
Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFED 203
K SDVWS GV L+ + +G P+
Sbjct: 182 TSK-SDVWSFGVLLWEIFTLGEQPYPG 207
|
Length = 258 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-27
Identities = 86/251 (34%), Positives = 127/251 (50%), Gaps = 27/251 (10%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYI-------ERGKKIDENVQREIINHRSLRHPNI 61
K LG G FG L D T +AVK + E K+++ ++ EI ++LRH I
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNA-LECEIQLLKNLRHDRI 66
Query: 62 IRFKEVLLTPTH--LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+++ L P L+I +EY GG + ++ + G +E+ R + +Q++ GVSY HS
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM 126
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSK-------SGLLHSQPKSTVGTPAYIAPEVL 172
I HRD+K N L D + +K+ DFG SK SG + KS GTP +++PEV+
Sbjct: 127 IVHRDIKGANILRDSAGN--VKLGDFGASKRIQTICMSG---TGIKSVTGTPYWMSPEVI 181
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
+ + Y G+ +DVWS T+ ML P+ + E K + LPD VS
Sbjct: 182 SGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPM--LPD--GVSD 236
Query: 233 DCRHLLSQIFV 243
CR L QIFV
Sbjct: 237 ACRDFLKQIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-27
Identities = 86/266 (32%), Positives = 127/266 (47%), Gaps = 28/266 (10%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTK---ELVAVKYIERG-----KKIDENVQREIINHRS 55
RY + LG G+FG LV+DK+ L +K I G + + N + ++++
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLS--K 58
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARI----CSAGRFSEDEARFFFQQLISG 111
L HP I++F L I+ EY G +L ++ + SE++ +F QL+ G
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAP 169
V Y H I HRDLK +N L + LKI DFG S+ L+ S +T GTP Y++P
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRL-LMGSCDLATTFTGTPYYMSP 174
Query: 170 EVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYV 228
E L + YD K SD+WS G LY M A+ FE +NF + RI LP+
Sbjct: 175 EALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEG----QNFLSVVLRIVEGPTPSLPE-- 227
Query: 229 RVSADCRHLLSQIFVADPSKDPHSRD 254
S ++ + DPS P + +
Sbjct: 228 TYSRQLNSIMQSMLNKDPSLRPSAAE 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 6e-27
Identities = 71/206 (34%), Positives = 111/206 (53%), Gaps = 9/206 (4%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE--NVQREIINHRSLRHP 59
EE + ++ +G G+FG D RT+++VA+K I+ + DE ++Q+EI P
Sbjct: 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+ ++ L T L I+MEY GG + AG F E + ++++ G+ Y HS +
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEY 177
HRD+K N LL S Q +K+ DFG + L +Q K + VGTP ++APEV+ + Y
Sbjct: 122 KIHRDIKAANVLL--SEQGDVKLADFGVAGQ-LTDTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFED 203
D K +D+WS G+T + G P D
Sbjct: 179 DSK-ADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 80/286 (27%), Positives = 131/286 (45%), Gaps = 56/286 (19%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRHP 59
+YE ++++G G +G +++ T E+VA+K + R DE V REI + L+H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 59
Query: 60 NIIRFKEVLLTPTHLAIVMEY----------AAGGELFARICSAGRFSEDEARFFFQQLI 109
NI+R +VL + L +V EY + G++ I + F QL+
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIV----------KSFMFQLL 109
Query: 110 SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIA 168
G+++CHS + HRDLK +N L++ + + LK+ DFG +++ G+ + V T Y
Sbjct: 110 KGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYSAEVVTLWYRP 167
Query: 169 PEVL-ARKEYDGKISDVWSCGVTLYVMLVGA---YPFEDPEDP--RNFR----KTIDRIR 218
P+VL K Y I D+WS G + +P D +D R FR T +
Sbjct: 168 PDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226
Query: 219 NVQYFLPDYV----------------RVSADCRHLLSQIFVADPSK 248
V LPDY ++++ R LL + V +P +
Sbjct: 227 GVSK-LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQ 271
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-26
Identities = 78/262 (29%), Positives = 118/262 (45%), Gaps = 24/262 (9%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KID-ENVQREIINHRSLRHPNII 62
YE ++ +G G V E VA+K I+ K + + +++E+ HPN++
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELF---ARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
++ + L +VM Y +GG L G E ++++ G+ Y HS
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 120 ICHRDLKLENTLL--DGSPQPRLKICDFGYSKS-----GLLHSQPKSTVGTPAYIAPEVL 172
HRD+K N LL DGS +KI DFG S S K+ VGTP ++APEV+
Sbjct: 123 QIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 173 A-RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP---DYV 228
YD K +D+WS G+T + GA P+ + T ++N L DY
Sbjct: 179 EQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLT---LQNDPPSLETGADYK 234
Query: 229 RVSADCRHLLSQIFVADPSKDP 250
+ S R ++S DPSK P
Sbjct: 235 KYSKSFRKMISLCLQKDPSKRP 256
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 71/203 (34%), Positives = 104/203 (51%), Gaps = 16/203 (7%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYI----ERGKKIDENVQREIINHRSLRHPN 60
+E + +G G +G+ RD + E+VA+K + ER I + REI +LRHPN
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG-IPISSLREITLLLNLRHPN 67
Query: 61 IIRFKEVLLTPTHLA---IVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCH 116
I+ KEV+ HL +VMEY +L + + + FSE + + QL+ G+ Y H
Sbjct: 68 IVELKEVV-VGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYIAPEVL-AR 174
I HRDLK+ N LL LKI DFG +++ L ++P + V T Y APE+L
Sbjct: 126 ENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC 183
Query: 175 KEYDGKISDVWSCGVTLYVMLVG 197
Y I D+W+ G L +L
Sbjct: 184 TTYTTAI-DMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-26
Identities = 84/248 (33%), Positives = 126/248 (50%), Gaps = 21/248 (8%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYI-------ERGKKIDENVQREIINHRSLRHPNI 61
K LG G FG L D T +AVK + E K+++ ++ EI ++L H I
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNA-LECEIQLLKNLLHERI 66
Query: 62 IRFKEVLLTPTH--LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+++ L P L+I ME+ GG + ++ S G +E+ R + +Q++ GVSY HS
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS----GLLHSQPKSTVGTPAYIAPEVLARK 175
I HRD+K N L D +K+ DFG SK L + KS GTP +++PEV++ +
Sbjct: 127 IVHRDIKGANILRDSVGN--VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
Y G+ +D+WS G T+ ML P+ + E K + N LP + VS CR
Sbjct: 185 GY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPV--LPPH--VSDHCR 239
Query: 236 HLLSQIFV 243
L +IFV
Sbjct: 240 DFLKRIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-26
Identities = 78/255 (30%), Positives = 120/255 (47%), Gaps = 11/255 (4%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHP 59
+E +E ++ +GSG +G R+ T EL A+K I E G+ VQ+EII + +H
Sbjct: 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHS 66
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
NI+ + L L I ME+ GG L G SE + + ++ + G+ Y HS
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLA--RKE 176
HRD+K N LL + +K+ DFG S ++ KS +GTP ++APEV A RK
Sbjct: 127 KMHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN-FRKTIDRIRNVQYFLPDYVRVSADCR 235
++ D+W+ G+T + P D R F T + + L D ++ S
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK--LKDKMKWSNSFH 242
Query: 236 HLLSQIFVADPSKDP 250
H + +P K P
Sbjct: 243 HFVKMALTKNPKKRP 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-26
Identities = 69/211 (32%), Positives = 112/211 (53%), Gaps = 16/211 (7%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRH 58
+++Y +++G G G D T + VA+K + ++ KK E + EI+ R +H
Sbjct: 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK--ELIINEILVMRENKH 75
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
PNI+ + + L L +VMEY AGG L + + E + ++ + + + HS
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN 134
Query: 119 EICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARK 175
++ HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ RK
Sbjct: 135 QVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 190
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF--EDP 204
Y K+ D+WS G+ M+ G P+ E+P
Sbjct: 191 AYGPKV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-26
Identities = 73/206 (35%), Positives = 107/206 (51%), Gaps = 9/206 (4%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHP 59
EE + ++ +G G+FG D RTKE+VA+K I+ + D E++Q+EI P
Sbjct: 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
I R+ L T L I+MEY GG + G E ++++ G+ Y HS
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEY 177
HRD+K N LL S Q +K+ DFG + L +Q K + VGTP ++APEV+ + Y
Sbjct: 122 KIHRDIKAANVLL--SEQGDVKLADFGVAGQ-LTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFED 203
D K +D+WS G+T + G P D
Sbjct: 179 DFK-ADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-26
Identities = 71/258 (27%), Positives = 128/258 (49%), Gaps = 20/258 (7%)
Query: 5 YEPVKELGSGNFGVARLVRD---KRTKELVAVKYIERGKKIDE-------NVQREIINHR 54
+E +K LG+G +G LVR + +L A+K +++ + + +R+++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 55 SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
+ P ++ T T L ++++Y GGELF + RF E E + + +++ + +
Sbjct: 62 R-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVL 172
H + I +RD+KLEN LLD + + + DFG SK + S GT Y+AP+++
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 173 ARKE--YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
+ +D K D WS GV +Y +L GA PF + + + RI + P +
Sbjct: 179 RGGDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EM 235
Query: 231 SADCRHLLSQIFVADPSK 248
SA + ++ ++ + DP K
Sbjct: 236 SALAKDIIQRLLMKDPKK 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 64/198 (32%), Positives = 106/198 (53%), Gaps = 9/198 (4%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIER-----GKKIDENVQREIINHRSLRHPNIIRFK 65
+G G++ LVR K+T+ + A+K +++ + ID + + ++ HP ++
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 66 EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
T + L V+EY GG+L + + E+ ARF+ ++ ++Y H I +RDL
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKISDV 184
KL+N LLD + +K+ D+G K GL ST GTP YIAPE+L ++Y G D
Sbjct: 123 KLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 179
Query: 185 WSCGVTLYVMLVGAYPFE 202
W+ GV ++ M+ G PF+
Sbjct: 180 WALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-25
Identities = 76/259 (29%), Positives = 112/259 (43%), Gaps = 22/259 (8%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIE----RGKKIDENVQREIINHRSLRHPN 60
++ K++G G F V +VA+K ++ K ++ +EI + L HPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARI---CSAGR-FSEDEARFFFQQLISGVSYCH 116
+I++ + L IV+E A G+L I R E +F QL S + + H
Sbjct: 64 VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGY-----SKSGLLHSQPKSTVGTPAYIAPEV 171
S I HRD+K N + + +K+ D G SK+ HS VGTP Y++PE
Sbjct: 124 SKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSPER 177
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
+ Y+ K SD+WS G LY M PF D N +I Y S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEKCDYPPLPADHYS 234
Query: 232 ADCRHLLSQIFVADPSKDP 250
+ R L+S+ DP K P
Sbjct: 235 EELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 75/264 (28%), Positives = 124/264 (46%), Gaps = 31/264 (11%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIER-----GKKIDENVQREIINHRSLRHPNIIRFK 65
+G G++ LVR K+ ++ A+K +++ + ID + + ++ +P ++
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 66 EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
T + L +V+EY GG+L + + E+ ARF+ ++ +++ H I +RDL
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKISDV 184
KL+N LLD +K+ D+G K GL ST GTP YIAPE+L +EY G D
Sbjct: 123 KLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDW 179
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
W+ GV ++ M+ G PF+ D PD + L Q+ +
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDN-----------------PD-----MNTEDYLFQVILE 217
Query: 245 DPSKDPHSRDQKASLVPEEFAERD 268
P + P KAS V + F +D
Sbjct: 218 KPIRIPRFLSVKASHVLKGFLNKD 241
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-25
Identities = 67/206 (32%), Positives = 108/206 (52%), Gaps = 9/206 (4%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE--NVQREIINHRSLRHP 59
EE + ++++G G+FG D RT+++VA+K I+ + DE ++Q+EI P
Sbjct: 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+ ++ L T L I+MEY GG + G E + ++++ G+ Y HS +
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEY 177
HRD+K N LL S +K+ DFG + L +Q K VGTP ++APEV+ + Y
Sbjct: 122 KIHRDIKAANVLL--SEHGEVKLADFGVAGQ-LTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFED 203
D K +D+WS G+T + G P +
Sbjct: 179 DSK-ADIWSLGITAIELAKGEPPHSE 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 82/247 (33%), Positives = 120/247 (48%), Gaps = 37/247 (14%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQR--EIINHRSLRHPNI 61
YE +K++G+G FG LV+ KRT+E K I RG K E Q E+ R L+H NI
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 62 IRFKEVLLTPTH--LAIVMEYAAGGELFARICSA----GRFSEDEARFFFQQLISGVSYC 115
+R+ + L + L I+ME+ G+L I G+ E +QL+ ++YC
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 116 HSME-------ICHRDLKLENTLLDG---------------SPQPRLKICDFGYSKSGLL 153
H+++ + HRDLK +N L + +P KI DFG SK+ +
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194
Query: 154 HSQPKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFR 211
S S VGTP Y +PE+L K YD K SD+W+ G +Y + G PF NF
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKTPFHKAN---NFS 250
Query: 212 KTIDRIR 218
+ I ++
Sbjct: 251 QLISELK 257
|
Length = 1021 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 7e-25
Identities = 65/200 (32%), Positives = 109/200 (54%), Gaps = 10/200 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
++YE V+++G G +GV RD+ T E +A+K I R ++ DE V REI + ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQH 60
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQQLISGVSYCH 116
NI+R ++V+ + L +V EY +L + S+ F+++ + + Q++ G++YCH
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARK 175
S + HRDLK +N L+D LK+ DFG +++ G+ V T Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS 178
Query: 176 EYDGKISDVWSCGVTLYVML 195
+ D+WS G M+
Sbjct: 179 RHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-24
Identities = 74/215 (34%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 5 YEPVKELGSGNFGVARLVRDKRT-KELVAVKYI------------ERGKKIDENVQREII 51
Y ++ LGSG FG VR K + L+A+K I ER K I + V I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 52 NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG---GELFARICSAG-RFSEDEARFFFQQ 107
LRHPNI+R+ + L L IVM+ G GE F + RF+E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 108 LISGVSYCH-SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 166
++ + Y H I HRDL N +L ++ I DFG +K S+ S VGT Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
PE++ + Y G+ +DVW+ G LY M PF
Sbjct: 180 SCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-24
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH----PNI 61
E + +LG+GN G V+ T ++A K + G K +V+++I+ + H P I
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYI 65
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM-EI 120
+ F L ++ + ME+ G L G + ++ G++Y +++ I
Sbjct: 66 VSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRI 125
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
HRD+K N L++ Q +K+CDFG S L++S + VGT Y++PE + +Y K
Sbjct: 126 MHRDIKPSNILVNSRGQ--IKLCDFGVSGE-LINSIADTFVGTSTYMSPERIQGGKYTVK 182
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPED 206
SDVWS G+++ + +G +PF
Sbjct: 183 -SDVWSLGISIIELALGKFPFAFSNI 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 3e-24
Identities = 68/192 (35%), Positives = 104/192 (54%), Gaps = 13/192 (6%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRHPN 60
Y+ V+++G G +GV RDK T E+VA+K I R + DE V REI + L HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVSYCHSM 118
I+R +V+ + L +V E+ +L + S+ D + QL+ G++YCHS
Sbjct: 60 IVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEV-LARKE 176
+ HRDLK +N L+D + LK+ DFG +++ G+ V T Y APE+ L ++
Sbjct: 119 RVLHRDLKPQNLLID--REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 177 YDGKISDVWSCG 188
Y + D+WS G
Sbjct: 177 YSTPV-DIWSIG 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 3e-24
Identities = 69/196 (35%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQ---REIINHRSLR 57
E+ + ++E+G G+FG RD R E+VA+K + GK+ +E Q +E+ + LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
HPN I+++ L +VMEY G E E + G++Y HS
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LARKE 176
+ HRD+K N LL +K+ DFG S + + VGTP ++APEV LA E
Sbjct: 134 HNMIHRDVKAGNILLSEPGL--VKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDE 188
Query: 177 --YDGKISDVWSCGVT 190
YDGK+ DVWS G+T
Sbjct: 189 GQYDGKV-DVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-24
Identities = 72/203 (35%), Positives = 106/203 (52%), Gaps = 15/203 (7%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
EE +E + ELG G FG ++K T L A K I+ + + E+ EI S HPN
Sbjct: 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
I++ + +L I++E+ AGG + A + R +E + R +Q + ++Y H +
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 120 ICHRDLKLENTL--LDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVL---- 172
I HRDLK N L LDG +K+ DFG S Q + S +GTP ++APEV+
Sbjct: 124 IIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 173 -ARKEYDGKISDVWSCGVTLYVM 194
+ YD K +DVWS G+TL M
Sbjct: 180 SKDRPYDYK-ADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-24
Identities = 79/271 (29%), Positives = 125/271 (46%), Gaps = 34/271 (12%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYI----ERGKKIDENVQREIINHRSLRHPN 60
++ +++LG G + R++ T E+VA+K I E G REI + L+H N
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHEN 59
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSYCHS 117
I+R +V+ T L +V EY +L + + G + + F QL+ G+++CH
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVL-ARK 175
+ HRDLK +N L++ + LK+ DFG +++ G+ + + V T Y AP+VL +
Sbjct: 119 NRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 176 EYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRN--FR-------KTIDRIRNVQYFL 224
Y I D+WS G + M+ G +P + ED FR T I L
Sbjct: 177 TYSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ----L 231
Query: 225 PDYVRVSADCRHL-LSQIFVADPSKDPHSRD 254
P+Y L Q+F P DP D
Sbjct: 232 PEYKPTFPRYPPQDLQQLF---PHADPLGID 259
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 3e-24
Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRHPN 60
++ V+++G G +GV R+K T E+VA+K I R E V REI + L HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
I++ +V+ T L +V E+ + F + + QL+ G+++CHS
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEYD 178
+ HRDLK +N L++ + +K+ DFG +++ G+ V T Y APE+L +Y
Sbjct: 121 VLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178
Query: 179 GKISDVWSCGVTLYVML 195
D+WS G M+
Sbjct: 179 STAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-24
Identities = 71/251 (28%), Positives = 132/251 (52%), Gaps = 17/251 (6%)
Query: 10 ELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
++G G+ G+ + R+K + VAVK ++ R ++ E + E++ R +H N++ +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 69 LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
L L ++ME+ GG L I S R +E++ + ++ + Y HS + HRD+K +
Sbjct: 88 LVGEELWVLMEFLQGGAL-TDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSD 146
Query: 129 NTL--LDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEYDGKISDV 184
+ L LDG R+K+ DFG+ + + PK S VGTP ++APEV++R Y ++ D+
Sbjct: 147 SILLTLDG----RVKLSDFGFC-AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV-DI 200
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRHLLSQIFV 243
WS G+ + M+ G P+ + P K R+R+ L + ++S R L ++
Sbjct: 201 WSLGIMVIEMVDGEPPYFS-DSPVQAMK---RLRDSPPPKLKNAHKISPVLRDFLERMLT 256
Query: 244 ADPSKDPHSRD 254
+P + +++
Sbjct: 257 REPQERATAQE 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 4e-24
Identities = 72/196 (36%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQ---REIINHRSLR 57
E+ + ++E+G G+FG RD RT E+VA+K + GK+ +E Q +E+ + ++
Sbjct: 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK 83
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
HPN I +K L +VMEY G E E + G++Y HS
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LARKE 176
+ HRD+K N LL Q +K+ DFG S + S S VGTP ++APEV LA E
Sbjct: 144 HNMIHRDIKAGNILLTEPGQ--VKLADFG---SASIASPANSFVGTPYWMAPEVILAMDE 198
Query: 177 --YDGKISDVWSCGVT 190
YDGK+ DVWS G+T
Sbjct: 199 GQYDGKV-DVWSLGIT 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 4e-24
Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKY-IERGKKIDE-NVQREIINHRSLR-HPNI 61
Y+ + ++G G F + ++T + A+K + K +++ N REI R L HPNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 62 IRFKEVLLTPTH--LAIVMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSYCH 116
+R EVL LA+V E L+ I GR E + + QL+ + + H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDM-NLYELI--KGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLAR 174
I HRD+K EN L+ LK+ DFG + ++S+P T + T Y APE L
Sbjct: 118 RNGIFHRDIKPENILIK---DDILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLT 172
Query: 175 KEYDGKISDVWSCGVTLYVML 195
Y G D+W+ G + +L
Sbjct: 173 DGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 5e-24
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIE-------RGKKIDENVQREIINHRSLRHPNIIR 63
LG G +G +L+AVK +E +K E +Q E+ +SL+H NI++
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
+ L ++I ME+ GG + + + G E + +Q++ GV+Y H+ + HR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSK-------SGLLHSQPKSTVGTPAYIAPEVLARKE 176
D+K N +L P +K+ DFG ++ G + KS GTP ++APEV+
Sbjct: 127 DIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
Y G+ SD+WS G T++ M G P
Sbjct: 185 Y-GRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 7e-24
Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 13/203 (6%)
Query: 6 EPVKELGSGNFGVARLVRDKRTKELVAVK--YIERGKKIDENVQREIINHRSLRHPNIIR 63
E V +GSG G V + T L A+K Y + + REI R + HPN+++
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
++ + +++E+ GG L + +F D AR Q++SG++Y H I HR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHR 192
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEV----LARKEYD 178
D+K N L++ + +KI DFG S+ P S+VGT AY++PE L YD
Sbjct: 193 DIKPSNLLINSA--KNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250
Query: 179 GKISDVWSCGVTLYVMLVGAYPF 201
G D+WS GV++ +G +PF
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 9e-24
Identities = 70/241 (29%), Positives = 128/241 (53%), Gaps = 9/241 (3%)
Query: 10 ELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
++G G+ G+ + +K T + VAVK ++ R ++ E + E++ R H N++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 69 LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
L L +VME+ GG L I + R +E++ ++ +SY H+ + HRD+K +
Sbjct: 89 LVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 147
Query: 129 NTLLDGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSC 187
+ LL + R+K+ DFG+ ++ + KS VGTP ++APEV++R Y ++ D+WS
Sbjct: 148 SILL--TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV-DIWSL 204
Query: 188 GVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPS 247
G+ + M+ G P+ + + R+ D N+ + D +VS+ R L + V +PS
Sbjct: 205 GIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDSHKVSSVLRGFLDLMLVREPS 261
Query: 248 K 248
+
Sbjct: 262 Q 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 1e-23
Identities = 66/209 (31%), Positives = 110/209 (52%), Gaps = 12/209 (5%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPN 60
+++Y +++G G G D T + VA+K + + + E + EI+ R ++PN
Sbjct: 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
I+ + + L L +VMEY AGG L + + E + ++ + + + HS ++
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALDFLHSNQV 136
Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEY 177
HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ RK Y
Sbjct: 137 IHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 178 DGKISDVWSCGVTLYVMLVGAYPF--EDP 204
K+ D+WS G+ M+ G P+ E+P
Sbjct: 193 GPKV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 1e-23
Identities = 68/209 (32%), Positives = 111/209 (53%), Gaps = 12/209 (5%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPN 60
+++Y +++G G G D T + VA+K I K+ E + EI+ + L++PN
Sbjct: 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
I+ F + L L +VMEY AGG L + + E + ++ + + + H+ ++
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSL-TDVVTETCMDEAQIAAVCRECLQALEFLHANQV 136
Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEY 177
HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ RK Y
Sbjct: 137 IHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 178 DGKISDVWSCGVTLYVMLVGAYPF--EDP 204
K+ D+WS G+ M+ G P+ E+P
Sbjct: 193 GPKV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-23
Identities = 72/196 (36%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQ---REIINHRSLR 57
EE + + E+G G+FG + T E+VAVK + GK+ +E Q +E+ + L+
Sbjct: 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
HPN I +K L +VMEY G E E + G++Y HS
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LARKE 176
+ HRD+K N LL Q +K+ DFG S S S VGTP ++APEV LA E
Sbjct: 140 HNMIHRDIKAGNILLTEPGQ--VKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDE 194
Query: 177 --YDGKISDVWSCGVT 190
YDGK+ DVWS G+T
Sbjct: 195 GQYDGKV-DVWSLGIT 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-23
Identities = 75/277 (27%), Positives = 124/277 (44%), Gaps = 39/277 (14%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHP 59
RY ++ +G G FG+ RD+ T + VA+K I + + + RE+ + LRH
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 60 NIIRFKEVLLTP-THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
NII ++ ++P + V E G R+ ++ + ++F Q++ G+ Y HS
Sbjct: 70 NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LARKEY 177
+ HRDLK N L++ + LKICDFG ++ + Q V T Y APE+ L ++Y
Sbjct: 128 GVVHRDLKPSNILINENCD--LKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQKY 183
Query: 178 DGKISDVWSCGVTLYVMLVGA--YPFEDP------------------------EDPRNFR 211
D ++ D+WS G ML G +P +D E+ F
Sbjct: 184 DVEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242
Query: 212 KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK 248
+++ + R F + LL ++ V DP K
Sbjct: 243 QSLPK-REPVPFSEKFKNADPSAIDLLEKMLVFDPQK 278
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-23
Identities = 64/193 (33%), Positives = 103/193 (53%), Gaps = 6/193 (3%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSLRHPN 60
+ YE ++ +GSG +G R+ T EL AVK I+ D + +Q+EI + +H N
Sbjct: 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
I+ + L+ L I MEY GG L G SE + + ++ + G++Y HS
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
HRD+K N LL + +K+ DFG +K ++ KS +GTP ++APEV A ++ G
Sbjct: 128 MHRDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 180 --KISDVWSCGVT 190
++ D+W+ G+T
Sbjct: 186 YNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-23
Identities = 66/195 (33%), Positives = 99/195 (50%), Gaps = 12/195 (6%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHPN 60
++E + +G G +GV R K TKE+VA+K E +++ E RE+ R+L+ N
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGG--ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
I+ KE L +V EY EL + + ++ R + QLI + +CH
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHKN 119
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKE 176
+I HRD+K EN L+ S LK+CDFG++++ S T V T Y +PE+L
Sbjct: 120 DIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 177 YDGKISDVWSCGVTL 191
Y GK D+WS G L
Sbjct: 178 Y-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (236), Expect = 4e-23
Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 12/209 (5%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPN 60
+++Y +++G G G D T + VA++ + + + E + EI+ R ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
I+ + + L L +VMEY AGG L + + E + ++ + + + HS ++
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
HRD+K +N LL DGS +K+ DFG+ ++ S+ + VGTP ++APEV+ RK Y
Sbjct: 138 IHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 178 DGKISDVWSCGVTLYVMLVGAYPF--EDP 204
K+ D+WS G+ M+ G P+ E+P
Sbjct: 194 GPKV-DIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 6e-23
Identities = 65/209 (31%), Positives = 108/209 (51%), Gaps = 11/209 (5%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--- 58
++ +E + ELG+GN GV V+ K + ++A K I +I ++ +II + H
Sbjct: 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECN 61
Query: 59 -PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
P I+ F + ++I ME+ GG L + A R E+ ++ G++Y
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 118 M-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
+I HRD+K N L++ + +K+CDFG S L+ S S VGT +Y++PE L
Sbjct: 122 KHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTH 178
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPE 205
Y + SD+WS G++L + +G YP P+
Sbjct: 179 YSVQ-SDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 9e-23
Identities = 84/282 (29%), Positives = 125/282 (44%), Gaps = 43/282 (15%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG--KKID-ENVQREIINHRSLRHPN 60
+Y P+K +G G +G+ ++ T E VA+K I +ID + REI R L H N
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 61 IIRFKEVLLTPTH------LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
+I K+++ P H + IV E +L I S+ S+D ++F QL+ G+ Y
Sbjct: 66 VIAIKDIM-PPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV-L 172
HS + HRDLK N LL+ + LKICDFG +++ + V T Y APE+ L
Sbjct: 124 IHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 173 ARKEYDGKISDVWSCG---------------------VTLYVMLVGA-----YPFEDPED 206
EY I DVWS G + L L+G+ F E
Sbjct: 182 NCSEYTTAI-DVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK 248
R + +++ F + + LL ++ V DPSK
Sbjct: 241 ARRYIRSLPYTPRQS-FARLFPHANPLAIDLLEKMLVFDPSK 281
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-22
Identities = 69/202 (34%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPNI 61
E +E + ELG G FG ++K T L A K IE + + E+ EI + HP I
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI 71
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEI 120
++ L I++E+ GG + A + R +E + + +Q++ + Y HSM+I
Sbjct: 72 VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKI 131
Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEV-----L 172
HRDLK N LL DG +K+ DFG S + Q + S +GTP ++APEV +
Sbjct: 132 IHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 173 ARKEYDGKISDVWSCGVTLYVM 194
YD K +D+WS G+TL M
Sbjct: 188 KDTPYDYK-ADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-22
Identities = 83/271 (30%), Positives = 129/271 (47%), Gaps = 26/271 (9%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYI-------ERGKKIDENVQREIINHRSLRHPNI 61
K LG G FG L D T +A K + E K++ ++ EI ++L+H I
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSA-LECEIQLLKNLQHERI 66
Query: 62 IRFKEVLLTPTH--LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+++ L L I MEY GG + ++ + G +E R + +Q++ G+SY HS
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS----GLLHSQPKSTVGTPAYIAPEVLARK 175
I HRD+K N L D + +K+ DFG SK + + +S GTP +++PEV++ +
Sbjct: 127 IVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
Y G+ +DVWS G T+ ML P+ + E K + N Q LP + +S R
Sbjct: 185 GY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQ--LPSH--ISEHAR 239
Query: 236 HLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266
L IFV + R L+ FA+
Sbjct: 240 DFLGCIFV-----EARHRPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-22
Identities = 74/276 (26%), Positives = 121/276 (43%), Gaps = 45/276 (16%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN-- 60
E +E +K +G G FG RLV+ K T + A+K + + +++ I R +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 61 --IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
+++ +L ++ME+ GG++ + +E+E +F+ + + + H +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-----------GLLHSQPK--------- 158
HRD+K +N LLD + +K+ DFG L HS P
Sbjct: 121 GFIHRDIKPDNLLLDS--KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 159 ----------------STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFE 202
STVGTP YIAPEV + Y+ K+ D WS GV +Y ML+G PF
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237
Query: 203 DPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
E P+ K + + F P+ V +S + L+
Sbjct: 238 S-ETPQETYKKVMNWKETLIFPPE-VPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-22
Identities = 66/251 (26%), Positives = 109/251 (43%), Gaps = 43/251 (17%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN---- 60
+E +K +G G FG RLV+ K T + A+K + + +++ I R +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+++ +L ++ME+ GG++ + SE+ +F+ + + + H +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKS-----------GLLHSQPK----------- 158
HRD+K +N LLD + +K+ DFG L H+ P
Sbjct: 123 IHRDIKPDNLLLDA--KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 159 --------------STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDP 204
STVGTP YIAPEV + Y+ K+ D WS GV +Y ML+G PF
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 205 EDPRNFRKTID 215
+RK ++
Sbjct: 240 TPQETYRKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-22
Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 13/208 (6%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH---- 58
+ +E + ELG+GN GV V + + ++A K I +I ++ +II + H
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL--EIKPAIRNQIIRELKVLHECNS 58
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS- 117
P I+ F + ++I ME+ GG L + AGR E+ ++ G++Y
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKE 176
+I HRD+K N L++ + +K+CDFG S G L S S VGT +Y++PE L
Sbjct: 119 HKIMHRDVKPSNILVNSRGE--IKLCDFGVS--GQLIDSMANSFVGTRSYMSPERLQGTH 174
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDP 204
Y + SD+WS G++L M +G YP P
Sbjct: 175 YTVQ-SDIWSLGLSLVEMAIGRYPIPPP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 2e-22
Identities = 72/238 (30%), Positives = 117/238 (49%), Gaps = 24/238 (10%)
Query: 5 YEPVKELGS--GNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNI 61
E VK+L G FG +++ K T++L K I+ K + E + H+ ++ +PN
Sbjct: 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKA-KNFNAI---EPMVHQLMKDNPNF 71
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
I+ + T ++M+Y G+LF + G+ SE E + +QL+ ++ H I
Sbjct: 72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNII 131
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
H D+KLEN L D + + R+ +CD+G K P GT Y +PE + YD +
Sbjct: 132 HNDIKLENVLYDRA-KDRIYLCDYGLCKI---IGTPSCYDGTLDYFSPEKIKGHNYD--V 185
Query: 182 S-DVWSCGVTLYVMLVGAYPFEDPED---------PRNFRKTIDRIRNVQYFLPDYVR 229
S D W+ GV Y +L G +PF++ ED R +K + I+NV D+V+
Sbjct: 186 SFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK-LPFIKNVSKNANDFVQ 242
|
Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-22
Identities = 72/244 (29%), Positives = 131/244 (53%), Gaps = 15/244 (6%)
Query: 10 ELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
++G G+ G+ + K + +LVAVK ++ R ++ E + E++ R +H N++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 69 LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
L L +VME+ GG L I + R +E++ ++ +S H+ + HRD+K +
Sbjct: 87 LVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSD 145
Query: 129 NTLL--DGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
+ LL DG R+K+ DFG+ ++ + KS VGTP ++APE+++R Y ++ D+W
Sbjct: 146 SILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV-DIW 200
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-NVQYFLPDYVRVSADCRHLLSQIFVA 244
S G+ + M+ G P+ + E P K + IR N+ L + +VS + L ++ V
Sbjct: 201 SLGIMVIEMVDGEPPYFN-EPP---LKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256
Query: 245 DPSK 248
DP++
Sbjct: 257 DPAQ 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-22
Identities = 76/251 (30%), Positives = 104/251 (41%), Gaps = 59/251 (23%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN------VQREIINHRSLRH 58
+ +K LG G FG L R TK L A+K + + + N +R+I+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--N 60
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
++R +L VM+Y GG++ + + G F ED ARF+ +L V H M
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG------------YSKSGLLHSQ---------- 156
HRD+K +N L+D +K+ DFG Y +SG Q
Sbjct: 121 GFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 157 --------------------------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVT 190
S VGTP YIAPEVL R Y ++ D WS GV
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVI 237
Query: 191 LYVMLVGAYPF 201
LY MLVG PF
Sbjct: 238 LYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-22
Identities = 68/209 (32%), Positives = 107/209 (51%), Gaps = 11/209 (5%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--- 58
++ +E + ELG+GN GV V K + ++A K I +I ++ +II + H
Sbjct: 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECN 61
Query: 59 -PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
P I+ F + ++I ME+ GG L + AGR E +I G++Y
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 118 M-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
+I HRD+K N L++ + +K+CDFG S L+ S S VGT +Y++PE L
Sbjct: 122 KHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTH 178
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPE 205
Y + SD+WS G++L M +G YP P+
Sbjct: 179 YSVQ-SDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 6e-22
Identities = 72/229 (31%), Positives = 107/229 (46%), Gaps = 23/229 (10%)
Query: 2 EERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIER--GKKIDENVQREIINHR 54
E+R+ + +K+LG G+FG L R T E VAVK + ++ + +REI R
Sbjct: 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILR 61
Query: 55 SLRHPNIIRFKEVLLTPTH--LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLIS 110
+L H NI+++K V P L ++MEY G L + + + + F Q+
Sbjct: 62 TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICK 120
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
G+ Y S HRDL N L++ + +KI DFG +K L + V P
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVES--EDLVKISDFGLAKV-LPEDKDYYYVKEPGESPIF 177
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
+ APE L ++ SDVWS GVTLY + P + P P F + I
Sbjct: 178 WYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSP--PAEFLRMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 9e-22
Identities = 79/255 (30%), Positives = 115/255 (45%), Gaps = 18/255 (7%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPN---IIRFKE 66
LG G FG + + T +L A K + + + K + + ++ R L + I+
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 67 VLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVSYCHSMEICH 122
T T L +VM GG+L I + F E A F+ Q+ISG+ + H I +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
RDLK EN LLD R I D G + K G S+ K GTP ++APE+L +EYD
Sbjct: 121 RDLKPENVLLDNDGNVR--ISDLGLAVELKDG--QSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
+ D ++ GVTLY M+ PF + ++ RI N PD + S +
Sbjct: 177 SV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCE 233
Query: 240 QIFVADPSKDPHSRD 254
+ DP K RD
Sbjct: 234 ALLAKDPEKRLGFRD 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-21
Identities = 69/217 (31%), Positives = 92/217 (42%), Gaps = 30/217 (13%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNII 62
RY ++ LG G+ G+ D + VAVK I + ++ REI R L H NI+
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65
Query: 63 RFKEVLLT-----------PTHLA---IVMEYAAGGELFARICSAGRFSEDEARFFFQQL 108
+ EVL T L IV EY A + G SE+ AR F QL
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMYQL 123
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG--------YSKSGLLHSQPKST 160
+ G+ Y HS + HRDLK N ++ + LKI DFG YS G L
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYL----SEG 178
Query: 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVG 197
+ T Y +P +L K D+W+ G ML G
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-21
Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 22/199 (11%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH----PNIIRFKE 66
LG GN G T+ ++AVK I I +Q++I++ + + P II F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 67 VLLTPTHLAIVMEYAAGGEL--FARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICH 122
++I E+ GG L + +I GR + ++ G++Y S++I H
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA--------VAVVKGLTYLWSLKILH 118
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RD+K N L++ Q +K+CDFG S L++S K+ VGT AY+APE ++ ++Y G S
Sbjct: 119 RDVKPSNMLVNTRGQ--VKLCDFGVSTQ-LVNSIAKTYVGTNAYMAPERISGEQY-GIHS 174
Query: 183 DVWSCGVTLYVMLVGAYPF 201
DVWS G++ + +G +P+
Sbjct: 175 DVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 3e-21
Identities = 67/230 (29%), Positives = 110/230 (47%), Gaps = 25/230 (10%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDEN---VQREIINHRSLRHPNIIRF 64
LG G FG V+ K T ++ A K +++ KK E +++EI+ + P I+
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 65 KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEAR--FFFQQLISGVSYCHSMEICH 122
+ THL +VM GG+L I + G + R + Q+ G+ + HSM+I +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
RD+K EN LLD RL D G + K G +Q GT Y+APE+L + Y
Sbjct: 119 RDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQ---RAGTNGYMAPEILKEEPYSY 173
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
+ D ++ G ++Y M+ G PF ++ ++ + + + L D V+
Sbjct: 174 PV-DWFAMGCSIYEMVAGRTPF------KDHKEKVAKEELKRRTLEDEVK 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-21
Identities = 69/209 (33%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYI-----ERGKKIDENVQREIINHRSLRHP 59
++ + ++G G +G RDK T ELVA+K + + G I REI R L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPI--TAIREIKILRQLNHR 66
Query: 60 NIIRFKEVLLTPTH----------LAIVMEYAAG---GELFARICSAGRFSEDEARFFFQ 106
NI+ KE++ +V EY G L + + FSED + F +
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSFMK 123
Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK----STVG 162
QL+ G++YCH HRD+K N LL+ Q +K+ DFG ++ L +S+ + V
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGLAR--LYNSEESRPYTNKVI 179
Query: 163 TPAYIAPEVLARKEYDGKISDVWSCGVTL 191
T Y PE+L +E G DVWSCG L
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 3e-21
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH----PNI 61
E + ELG GN+G V + T +A+K I ++DE+ +II + H P I
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVSPYI 61
Query: 62 IRFKEVLLTPTHLAIVMEYAAGG---ELFARICSAGRFSEDEARFFFQQLISGVSYC-HS 117
+ F + + MEY G +L+A + ED R ++ G+ +
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
I HRD+K N L++G+ Q +K+CDFG S L+ S K+ +G +Y+APE +
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQ--VKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKSGGP 178
Query: 178 DGKI-----SDVWSCGVTLYVMLVGAYPFEDPE 205
+ SDVWS G+++ M +G YP+ PE
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYP-PE 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 4e-21
Identities = 69/255 (27%), Positives = 120/255 (47%), Gaps = 24/255 (9%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE------NVQREIINHRSL 56
+ +E +K +G G FG +V+ K T+ + A+K + + + + +R ++ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYC 115
+ + + +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 QWITTLHY--AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEV 171
H + HRD+K +N LLD + RL DFG ++ G + Q VGTP YI+PE+
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRL--ADFGSCLKMNQDGTV--QSSVAVGTPDYISPEI 174
Query: 172 LARKEYD----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227
L E G D WS GV +Y ML G PF + K ++ Q+ P +
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF--PSH 232
Query: 228 VR-VSADCRHLLSQI 241
+ VS + + L+ ++
Sbjct: 233 ITDVSEEAKDLIQRL 247
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 5e-21
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 8/200 (4%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVK-YIER--GKKIDENVQREIINHRSLRHP 59
E+YE + +G G++G+ + K T ++VA+K ++E K + + REI + LRH
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
N++ EV L +V E+ L E R + Q++ G+ +CHS
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEY 177
I HRD+K EN L+ S +K+CDFG++++ L T V T Y APE+L
Sbjct: 121 IIHRDIKPENILV--SQSGVVKLCDFGFART-LAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 178 DGKISDVWSCGVTLYVMLVG 197
G+ D+W+ G + ML G
Sbjct: 178 YGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 5e-21
Identities = 76/288 (26%), Positives = 118/288 (40%), Gaps = 61/288 (21%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN------VQREIINHRSLRHPNI 61
+K LG G FG L T L A+K + + ++ N +R+I+ + +
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWV 63
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
++ +L VM+Y GG++ + + F E ARF+ +L + H M
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123
Query: 122 HRDLKLENTLLDGSPQPRLKICDFG-------------YSKSGLLHS---QPK------- 158
HRD+K +N L+D +K+ DFG Y K + +P
Sbjct: 124 HRDIKPDNILID--LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 159 -------------------------STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYV 193
S VGTP YIAPEVL RK Y ++ D WS GV L+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE 240
Query: 194 MLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
MLVG PF P K I+ + +P V++S + L++++
Sbjct: 241 MLVGQPPFLAPTPTETQLKVINWENTLH--IPPQVKLSPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 5e-21
Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPN 60
RY+ + +G G +G+ K T VA+K I + + REI R +H N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 61 IIRFKEVLLTPT-----HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
II +++ P+ + IV E +L+ ++ S D ++F Q++ G+ Y
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEV 171
HS + HRDLK N LL+ + LKICDFG ++ V T Y APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 172 -LARKEYDGKISDVWSCGVTLYVMLVG 197
L K Y I D+WS G L ML
Sbjct: 181 MLNSKGYTKAI-DIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-20
Identities = 75/266 (28%), Positives = 119/266 (44%), Gaps = 25/266 (9%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH-------PNIIR 63
+G G FG R T ++ A+K +++ + + + +N R + P I+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
TP L+ +++ GG+L + G FSE E RF+ ++I G+ + H+ + +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 124 DLKLENTLLDGSPQPRLK----ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK-EYD 178
DLK N LLD R+ CDF K P ++VGT Y+APEVL + YD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 174
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR-IRNVQYFLPDYVRVSADCRHL 237
+D +S G L+ +L G PF + + IDR + LPD S + R L
Sbjct: 175 SS-ADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAVELPD--SFSPELRSL 229
Query: 238 LSQIFVADPSKDPHSRDQKASLVPEE 263
L + D ++ + A V E
Sbjct: 230 LEGLLQRDVNRRLGCLGRGAQEVKEH 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-20
Identities = 74/297 (24%), Positives = 125/297 (42%), Gaps = 69/297 (23%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDE----NVQREIINHRSL 56
E + VK +G G FG RLV+ K T ++ A+K + + + K D+ +R+++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
P ++ +L ++ME+ GG+L + FSED RF+ + + + H
Sbjct: 60 -SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS----------------- 159
+ HRD+K +N L+D +K+ DFG S H Q S
Sbjct: 119 KLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTG--FHKQHDSAYYQKLLQGKSNKNRID 174
Query: 160 ---------------------------------TVGTPAYIAPEVLARKEYDGKISDVWS 186
TVGTP YIAPE+ ++ Y G+ D WS
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWS 233
Query: 187 CGVTLYVMLVGAYPF--EDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
G ++ L+G PF E+ + +RK I+ + + PD + +S + L+ ++
Sbjct: 234 LGAIMFECLIGWPPFCSENSHE--TYRKIINWRETLYF--PDDIHLSVEAEDLIRRL 286
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 70/209 (33%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQR---EIINHRSLR- 57
+YE +++LG G +G+ D+RTKE+VA+K I + + QR EI+ + L
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD 65
Query: 58 HPNIIRFKEVLLTPTHLAI--VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
HPNI++ V+ I V EY +L A I A + R+ QL+ + Y
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-RANILEDVHKRYIMYQLLKALKYI 123
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST------VGTPAYIAP 169
HS + HRDLK N LL+ R+K+ DFG ++S + V T Y AP
Sbjct: 124 HSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 170 EVL-ARKEYDGKISDVWSCGVTLYVMLVG 197
E+L Y K D+WS G L ML+G
Sbjct: 182 EILLGSTRYT-KGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-20
Identities = 76/255 (29%), Positives = 120/255 (47%), Gaps = 24/255 (9%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVK------YIERGKKIDENVQREIINHRSL 56
+ +E +K +G G FG +V+ K T ++ A+K ++R + +R+++ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYC 115
R I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEV 171
H + HRD+K +N LLD + RL DFG G + S VGTP YI+PE+
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFGSCLRLLADGTVQSN--VAVGTPDYISPEI 174
Query: 172 LARKEYDGKIS-----DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
L E DGK D WS GV +Y ML G PF + K ++ + Q F PD
Sbjct: 175 LQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ-FPPD 232
Query: 227 YVRVSADCRHLLSQI 241
VS + + L+ ++
Sbjct: 233 VTDVSEEAKDLIRRL 247
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-20
Identities = 72/250 (28%), Positives = 113/250 (45%), Gaps = 23/250 (9%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH-------PNIIR 63
+G G FG R T ++ A+K +++ + + + +N R + P I+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
TP L +++ GG+L + G FSE E RF+ ++I G+ + H+ + +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 124 DLKLENTLLDGSPQPRLK----ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
DLK N LLD R+ CDF K P ++VGT Y+APEVL +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAYD 174
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-NVQYFLPDYVRVSADCRHLL 238
+D +S G L+ +L G PF + + IDR+ V LPD S + + LL
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTVNVELPD--SFSPELKSLL 230
Query: 239 SQIFVADPSK 248
+ D SK
Sbjct: 231 EGLLQRDVSK 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 4e-20
Identities = 74/228 (32%), Positives = 112/228 (49%), Gaps = 23/228 (10%)
Query: 2 EERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIER--GKKIDENVQREIINHR 54
+RY + ++ LG G+FG L + T E+VAVK ++R G++ ++EI +
Sbjct: 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILK 61
Query: 55 SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
+L H NI+++K L ++MEY G L + + + + F QQ+ G+
Sbjct: 62 TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGM 120
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKS---GLLHSQPKSTVGTPAY-I 167
+Y HS HRDL N LLD RL KI DFG +K+ G + + + +P +
Sbjct: 121 AYLHSQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 177
Query: 168 APEVLARKEYD-GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
A E L KE SDVWS GVTLY +L + P P+ F + I
Sbjct: 178 AVECL--KENKFSYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEMI 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 6e-20
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 33/223 (14%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----- 57
+RY+ + +GSG +G D +T VA+K K+ Q I R+ R
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------KLSRPFQSAIHAKRTYRELRLL 68
Query: 58 ----HPNIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQ 107
H N+I +V + L +V G +L I + S+D +F Q
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQ 126
Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPA 165
++ G+ Y HS I HRDLK N ++ + LKI DFG ++ H+ + T V T
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRW 180
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED 206
Y APE++ + + D+WS G + +L G +P D D
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID 223
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-20
Identities = 79/267 (29%), Positives = 124/267 (46%), Gaps = 32/267 (11%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIR 63
+E ++ +G G +G V +K+ L AVK ++ +DE ++ E +SL HPN+++
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 64 FKEVLLTPTHLA-----IVMEYAAGG---ELFARICSAG-RFSEDEARFFFQQLISGVSY 114
F + L +V+E GG EL + G R E + + G+ +
Sbjct: 84 FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQH 143
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEV 171
H+ I HRD+K N LL + + +K+ DFG S L S + ++VGTP ++APEV
Sbjct: 144 LHNNRIIHRDVKGNNILL--TTEGGVKLVDFGVSAQ--LTSTRLRRNTSVGTPFWMAPEV 199
Query: 172 LA-RKEYDGKIS---DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPD 226
+A ++YD DVWS G+T + G P D KT+ +I RN P
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV----KTLFKIPRNPP---PT 252
Query: 227 YVRVSADCR---HLLSQIFVADPSKDP 250
+ CR H +SQ + D P
Sbjct: 253 LLHPEKWCRSFNHFISQCLIKDFEARP 279
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 9e-20
Identities = 68/215 (31%), Positives = 103/215 (47%), Gaps = 19/215 (8%)
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGV 112
H I++ + + L ++MEY +GG+L +I + F E E F Q++ +
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS---GLLHSQPKSTVGTPAYIAP 169
HS ++ HRDLK N L P +K+ DFG+SK + S GTP Y+AP
Sbjct: 183 DEVHSRKMMHRDLKSANIFL--MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAP 240
Query: 170 EVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
E+ RK Y K +D+WS GV LY +L PF+ P R+ + ++ +Y P
Sbjct: 241 ELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQ----REIMQQVLYGKYD-PFPCP 294
Query: 230 VSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264
VS+ + LL + SK+P R L+ EF
Sbjct: 295 VSSGMKALLDPLL----SKNPALRPTTQQLLHTEF 325
|
Length = 478 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 9e-20
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVK-YIERG-----KKIDENVQREIINHRSL 56
E+YE + ++G G++GV R++ T ++VA+K ++E KKI REI + L
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI---ALREIRMLKQL 57
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
+HPN++ EV L +V EY L + E + Q + V++CH
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS---TVGTPAYIAPEVLA 173
HRD+K EN L+ + Q ++K+CDFG+++ +L V T Y APE+L
Sbjct: 118 KHNCIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVATRWYRAPELLV 173
Query: 174 RKEYDGKISDVWSCGVTLYVMLVG 197
G DVW+ G +L G
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-19
Identities = 71/259 (27%), Positives = 113/259 (43%), Gaps = 30/259 (11%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIRF 64
K++G G F ++ VA+K ++ + +D +++ + + L HPN+I++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67
Query: 65 KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--------FFQQLISGVSYCH 116
+ + L IV+E A G+L I ++ + + R +F QL S V + H
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMI----KYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGY-----SKSGLLHSQPKSTVGTPAYIAPEV 171
S + HRD+K N + + +K+ D G SK+ H S VGTP Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPER 177
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
+ Y+ K SD+WS G LY M PF D N +I Y S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQKIEQCDYPPLPTEHYS 234
Query: 232 ADCRHLLSQIFVADPSKDP 250
R L+S DP + P
Sbjct: 235 EKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-19
Identities = 72/257 (28%), Positives = 119/257 (46%), Gaps = 22/257 (8%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE------NVQREIINHRSL 56
E +E +K +G G FG +V+ K ++ A+K + + + + +R+++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYC 115
+ + + +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 QWITTLHY--AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVL 172
H + HRD+K +N L+D + RL DFG S L+ Q VGTP YI+PE+L
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRL--ADFG-SCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 173 ARKEYDGK-----ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227
E DGK D WS GV +Y ML G PF + K ++ Q F
Sbjct: 176 QAME-DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ-FPAQV 233
Query: 228 VRVSADCRHLLSQIFVA 244
VS D + L+ ++ +
Sbjct: 234 TDVSEDAKDLIRRLICS 250
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-19
Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF 64
Y +K L G+ G + + V +K ++G + E + + +NH P++IR
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNH-----PSVIRM 122
Query: 65 KEVLLTPTHLAIVMEYAAGGELFARIC-SAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
K+ L++ +V+ + + +L+ + + D+A +Q++ G+ Y H+ I HR
Sbjct: 123 KDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
D+K EN ++ Q + I D G ++ ++ GT APEVLAR +Y+ K D
Sbjct: 182 DVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKA-D 238
Query: 184 VWSCGVTLYVMLVGAYP---FEDP 204
+WS G+ L+ ML AYP FEDP
Sbjct: 239 IWSAGIVLFEML--AYPSTIFEDP 260
|
Length = 357 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-19
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKK-IDENVQREIINHRSLRHPN 60
+YE + ++G G FG R K+TK++VA+K + E K+ REI + L+H N
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHEN 72
Query: 61 IIRFKEVLLTPT--------HLAIVMEYAAGGELFARICS--AGRFSEDEARFFFQQLIS 110
++ E+ T +V E+ A + S +F+ E + + L++
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEHD--LAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 111 GVSYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-----VGT 163
G+ Y H +I HRD+K N L+ DG LK+ DFG +++ L K V T
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 164 PAYIAPEVLARKEYDGKISDVWSCG 188
Y PE+L + G D+W G
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAG 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-19
Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHPNIIR 63
+E V+ +G+G +G R +T +L A+K ++ + +E ++ EI + + H NI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 64 FKEVLLT---PTH---LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYC 115
+ + P H L +VME+ G + + ED + ++++ G+++
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLAR 174
H+ ++ HRD+K +N LL + +K+ DFG S ++T +GTP ++APEV+A
Sbjct: 138 HAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 175 KE-----YDGKISDVWSCGVTLYVMLVGAYPFED 203
E YD + SD+WS G+T M GA P D
Sbjct: 196 DENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-19
Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPN 60
E Y + +LG G + R K T+ LVA+K I E + RE+ ++L+H N
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN 64
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRF-SEDEARFFFQQLISGVSYCHSME 119
I+ +++ T L +V EY +L + + G S + F QL+ G+SYCH +
Sbjct: 65 IVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV-LARKEY 177
I HRDLK +N L++ + LK+ DFG +++ + ++ S V T Y P+V L EY
Sbjct: 124 ILHRDLKPQNLLIN--EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 178 DGKISDVWSCGVTLYVMLVG 197
I D+W G LY M G
Sbjct: 182 STPI-DMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-19
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRHPN 60
Y ++++G G +GV R+K+T ++VA+K I R + +E V REI + L+HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGG--ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
I+ ++VL+ + L ++ E+ + + + + + + Q++ G+ +CHS
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVL-ARKE 176
+ HRDLK +N L+D +K+ DFG +++ G+ V T Y APEVL
Sbjct: 121 RVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 177 YDGKISDVWSCGVTLYVMLVGAYP 200
Y + D+WS G T++ + P
Sbjct: 179 YSTPV-DIWSIG-TIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 6e-19
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
+KELG+G FGV + + R + VA+K I+ G ++ E L H +++ V
Sbjct: 9 LKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 68 LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI-------SGVSYCHSMEI 120
+ IV EY + G L + G+ RF QL+ G++Y S +
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGK------RFQPSQLLEMCKDVCEGMAYLESKQF 121
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEY 177
HRDL N L+D Q +K+ DFG S+ +L + S+VG+ + PEVL ++
Sbjct: 122 IHRDLAARNCLVDD--QGCVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFE 202
K SDVW+ GV ++ V +G P+E
Sbjct: 179 SSK-SDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 7e-19
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ------REIINHRSLR 57
RY+ + +G G++GV D T E VA+K I + E+V REI R LR
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLR 57
Query: 58 HPNIIRFKEVLLTPTH-----LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
HP+I+ K ++L P+ + +V E +L I + + + +FF QL+ +
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK----STVGTPAYIA 168
Y H+ + HRDLK +N L + +LKICDFG ++ + V T Y A
Sbjct: 117 KYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 169 PEVLAR--KEYDGKISDVWSCGVTLYVMLVG 197
PE+ +Y I D+WS G +L G
Sbjct: 175 PELCGSFFSKYTPAI-DIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 7e-19
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 10 ELGSGNFG--VARLVRDKRTKELVAVKYIERGKKIDENV---QREIINHRSLRHPNIIRF 64
+G + L + K T LVAVK I E++ Q+EII R L+HPNI+ +
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 65 KEVLLTPTHLAIVMEYAAGG---ELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
+ + L +V A G +L G E F + +++ + Y HS
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFI 123
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYS--------KSGLLHSQPKSTVGTPAYIAPEVLA 173
HR +K + LL G + + + YS + ++H PKS+V +++PEVL
Sbjct: 124 HRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 174 R--KEYDGKISDVWSCGVTLYVMLVGAYPFED 203
+ + Y+ K SD++S G+T + G PF+D
Sbjct: 182 QNLQGYNEK-SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 60/188 (31%), Positives = 97/188 (51%), Gaps = 17/188 (9%)
Query: 74 LAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVSYCHSMEICHRDLKLEN 129
+A+V++YA G+L I S + F E EA F Q++ V + HS + HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 130 TLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWS 186
LL +K+ DFG+SK + + ++ GTP Y+APE+ RK Y K +D++S
Sbjct: 174 ILL--CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFS 230
Query: 187 CGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LPDYVRVSADCRHLLSQIFVAD 245
GV LY +L PF D N + + + +Y LP +S + + +++ + +D
Sbjct: 231 LGVLLYELLTLKRPF----DGENMEEVMHKTLAGRYDPLPP--SISPEMQEIVTALLSSD 284
Query: 246 PSKDPHSR 253
P + P S
Sbjct: 285 PKRRPSSS 292
|
Length = 496 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-18
Identities = 69/213 (32%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 2 EERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHRS 55
EER+ + +++LG GNFG L R T E+VAVK ++ + +REI +S
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61
Query: 56 LRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQ------- 106
L+H NI+++K V + +L +VMEY G L + R +
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSL------RDYLQKHRERLDHRKLLLYAS 115
Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS--TVGTP 164
Q+ G+ Y S HRDL N L++ + R+KI DFG +K + Q K V P
Sbjct: 116 QICKGMEYLGSKRYVHRDLATRNILVES--ENRVKIGDFGLTK---VLPQDKEYYKVREP 170
Query: 165 A-----YIAPEVLARKEYDGKISDVWSCGVTLY 192
+ APE L ++ SDVWS GV LY
Sbjct: 171 GESPIFWYAPESLTESKFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-18
Identities = 71/227 (31%), Positives = 100/227 (44%), Gaps = 47/227 (20%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTK--ELVAVKYIERGKKIDENVQREIINHRSLR---- 57
RYE +KELG G +G+ R+ T E VA+K KI ++I+ R+LR
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIK------KITNVFSKKILAKRALRELKL 54
Query: 58 ------HPNII-----------RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE 100
H NI F E+ L +ME +L I S ++
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEE----LMEA----DLHQIIRSGQPLTDAH 106
Query: 101 ARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS---GLLHSQP 157
+ F Q++ G+ Y HS + HRDLK N L++ + LKICDFG ++ +
Sbjct: 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSENPGENAG 164
Query: 158 KST--VGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
T V T Y APE+ L+ + Y I DVWS G L L+G P
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAI-DVWSVGCIL-AELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-18
Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYI------ERGKKIDENVQREIINHRSLRH 58
Y V+ +G G++G LVR + + +K + R +K E + ++++ L+H
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ-EAQLLSQ--LKH 58
Query: 59 PNIIRFKEVLL-TPTHLAIVMEYAAGGELFARI--CSAGRFSEDEARFFFQQLISGVSYC 115
PNI+ ++E L IVM + GG+L+ ++ E++ +F Q+ + Y
Sbjct: 59 PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLAR 174
H I HRDLK +N L + +K+ D G ++ ST +GTP Y++PE+ +
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPF 201
K Y+ K SDVW+ G +Y M + F
Sbjct: 177 KPYNYK-SDVWALGCCVYEMATLKHAF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 8e-18
Identities = 68/217 (31%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----- 57
ERY +K++GSG +G DKRT E VA+K K+ Q EI R+ R
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIK------KLSRPFQSEIFAKRAYRELTLL 68
Query: 58 ----HPNIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQ 107
H N+I +V + +VM Y +I SED+ ++ Q
Sbjct: 69 KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQ 125
Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPA 165
++ G+ Y HS I HRDLK N ++ + LKI DFG ++ H+ + T V T
Sbjct: 126 MLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLAR----HADAEMTGYVVTRW 179
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFE 202
Y APEV+ + + D+WS G + ML G F+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-18
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLR 57
+ +RY +K++GSG +G D+RT VA+K + R + + + RE+ + ++
Sbjct: 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK 72
Query: 58 HPNIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
H N+I +V L +VM + G ++ + SED +F Q++ G
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
+ Y H+ I HRDLK N L + LKI DFG ++ S+ V T Y APEV
Sbjct: 131 LKYIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEV 186
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFE 202
+ + + D+WS G + ML G F+
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 9e-18
Identities = 67/207 (32%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 9 KELGSGNFGVAR--LVRDKRTKEL-VAVKYIERGKKIDENVQREIINHRS----LRHPNI 61
KELG GNFG + K KE+ VAVK +++ ++E + S L HP I
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH--IAAGKKEFLREASVMAQLDHPCI 58
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
+R V L +VME A G L + + + Q+ G++Y S
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGT--P-AYIAPEVLARKEY 177
HRDL N LL Q KI DFG S++ G ++T P + APE + ++
Sbjct: 118 HRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 178 DGKISDVWSCGVTLYVML-VGAYPFED 203
K SDVWS GVTL+ GA P+ +
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 72/318 (22%), Positives = 124/318 (38%), Gaps = 76/318 (23%)
Query: 4 RYEPVKELGSGNFGVARLVRDK--RTKELVAVKYIERGKKIDENVQ----REIINHRSLR 57
+YE +G G +G + K + + A+K + K+ + REI R L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 58 HPNIIRFKEVLLTPTHLAIVM--EYAAGGELFARICSAGRFSEDEARFFFQ--------- 106
H N++ EV L ++ + +YA +L+ I +F R
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQII----KFHRQAKRVSIPPSMVKSLLW 115
Query: 107 QLISGVSYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKS----- 159
Q+++GV Y HS + HRDLK N L+ +G + +KI D G ++ L ++ K
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLD 173
Query: 160 -TVGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVGAYPF----EDPEDPRN-FRK 212
V T Y APE+ L + Y I D+W+ G ++ L+ P E N F++
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAI-DIWAIGC-IFAELLTLEPIFKGREAKIKKSNPFQR 231
Query: 213 T-IDRIRNVQYF-----------LPDY------------------------VRVSADCRH 236
++RI V +P+Y + +
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291
Query: 237 LLSQIFVADPSKDPHSRD 254
LL ++ DP+K + +
Sbjct: 292 LLRKLLEYDPTKRITAEE 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-17
Identities = 71/255 (27%), Positives = 106/255 (41%), Gaps = 22/255 (8%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIRF 64
K++G G F VA+K ++ +D + + I + L HPN+I++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 65 KEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVSYCHSMEI 120
+ L IV+E A G+L I + E +F QL S + + HS +
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGY-----SKSGLLHSQPKSTVGTPAYIAPEVLARK 175
HRD+K N + + +K+ D G SK+ H S VGTP Y++PE +
Sbjct: 128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPERIHEN 181
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
Y+ K SD+WS G LY M PF D N +I Y S + R
Sbjct: 182 GYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238
Query: 236 HLLSQIFVADPSKDP 250
L++ DP K P
Sbjct: 239 QLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 2e-17
Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 18/214 (8%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHPNIIR 63
+E V+ +G+G +G R +T +L A+K ++ +E +++EI + + H NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 64 FKEVLLTPT------HLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYC 115
+ + L +VME+ G + + E+ + ++++ G+S+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLAR 174
H ++ HRD+K +N LL + +K+ DFG S ++T +GTP ++APEV+A
Sbjct: 128 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 175 KE-----YDGKISDVWSCGVTLYVMLVGAYPFED 203
E YD K SD+WS G+T M GA P D
Sbjct: 186 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-17
Identities = 66/202 (32%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI----ERGKKIDENVQREIINHRSLRH 58
E Y+ + +LG G++ R K T +LVA+K I E G RE + L+H
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKH 62
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRF-SEDEARFFFQQLISGVSYCHS 117
NI+ +++ T L +V EY +L + G S R F QL+ G++YCH
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL-ARK 175
+ HRDLK +N L+ S + LK+ DFG +++ + S+ S V T Y P+VL
Sbjct: 122 RRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179
Query: 176 EYDGKISDVWSCGVTLYVMLVG 197
EY + D+W G Y M G
Sbjct: 180 EYSTSL-DMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 11/211 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPN 60
E Y +++LG G + R K T+ LVA+K I E + RE+ + L+H N
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
I+ +++ T L +V EY +L + G S + F Q++ G++YCH +
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV-LARKEY 177
+ HRDLK +N L++ + LK+ DFG +++ + ++ S V T Y P+V L EY
Sbjct: 125 VLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 178 DGKISDVWSCGVTLYVMLVGA--YPFEDPED 206
+I D+W G + M G +P ED
Sbjct: 183 STQI-DMWGVGCIFFEMASGRPLFPGSTVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-17
Identities = 63/218 (28%), Positives = 110/218 (50%), Gaps = 21/218 (9%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNI 61
+ +E ++ +G G +G V +K+ AVK ++ IDE ++ E ++L HPN+
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77
Query: 62 IRF-----KEVLLTPTHLAIVMEYAAGG---ELFARICSAG-RFSEDEARFFFQQLISGV 112
++F K+ + L +V+E GG +L G R E + + + G+
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPE 170
+ H + HRD+K N LL + + +K+ DFG S + L ++ + ++VGTP ++APE
Sbjct: 138 QHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVS-AQLTSTRLRRNTSVGTPFWMAPE 194
Query: 171 VLARKE-----YDGKISDVWSCGVTLYVMLVGAYPFED 203
V+A ++ YD + DVWS G+T + G P D
Sbjct: 195 VIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-17
Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR--SLRH--PNI 61
E + E+GSG G +R K+T ++AVK + R +EN +R +++ H P I
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSHDCPYI 76
Query: 62 IRFKEVLLTPTHLAIVMEYAAG--GELFARICSAGRFSEDEARFFFQQLISGVSYC---H 116
++ +T + + I ME + +L RI G ED ++ + Y H
Sbjct: 77 VKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH 134
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYIAPEVL--- 172
+ HRD+K N LLD S +K+CDFG S L+ S+ K+ + G AY+APE +
Sbjct: 135 G--VIHRDVKPSNILLDASGN--VKLCDFGISGR-LVDSKAKTRSAGCAAYMAPERIDPP 189
Query: 173 -ARKEYDGKISDVWSCGVTLYVMLVGAYPFE 202
+YD + +DVWS G++L + G +P++
Sbjct: 190 DPNPKYDIR-ADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-17
Identities = 67/201 (33%), Positives = 95/201 (47%), Gaps = 23/201 (11%)
Query: 9 KELGSGNFGVARLVRDKRTKEL-----VAVKYIERGK--KIDENVQREIINHRSLRHPNI 61
K+LG G+FGV R R + + VAVK ++ K I ++ +E SL H N+
Sbjct: 1 KKLGDGSFGVVR--RGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARI-CSA-GRFSEDEARFFFQQLISGVSYCHSME 119
IR V+LT L +V E A G L R+ A G F + Q+ +G+ Y S
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-----SQPKSTVGTP-AYIAPEVLA 173
HRDL N LL + ++KI DFG ++ + + V P A+ APE L
Sbjct: 118 FIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173
Query: 174 RKEYDGKISDVWSCGVTLYVM 194
+ + SDVW GVTL+ M
Sbjct: 174 TRTFS-HASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-17
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN------VQREIINHRSLRHP 59
EP + +G G FGV V D R + VA+K + + +N V RE+ +H
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKM---PNVFQNLVSCKRVFRELKMLCFFKHD 59
Query: 60 NIIRFKEVLLTP-----THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
N++ ++L P + +V E +L I S S D + F Q++ G+ Y
Sbjct: 60 NVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
HS I HRD+K N L++ + LKICDFG ++ T V T Y APE+L
Sbjct: 119 LHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 173 -ARKEYDGKISDVWSCGVTLYVMLVGAYPFE 202
+ Y + D+WS G +L F+
Sbjct: 177 MGSRHYTSAV-DIWSVGCIFAELLGRRILFQ 206
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-17
Identities = 64/201 (31%), Positives = 91/201 (45%), Gaps = 12/201 (5%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
+KELGSG FGV L + R K VA+K I G +++ E L HPN+++ V
Sbjct: 9 LKELGSGQFGVVHLGK-WRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 68 LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
+ IV EY A G L + R G+ + + + Y S HRDL
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYDGKIS 182
N L+ +K+ DFG ++ +L Q S+ GT + PEV + K S
Sbjct: 127 AARNCLV--GEDNVVKVSDFGLARY-VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK-S 182
Query: 183 DVWSCGVTLY-VMLVGAYPFE 202
DVWS GV ++ V G P+E
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-17
Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPN 60
E Y + +LG G + R K T LVA+K I E + RE+ + L+H N
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
I+ +++ T L +V EY +L + G + + F QL+ G++YCH +
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV-LARKEY 177
+ HRDLK +N L++ + LK+ DFG +++ + ++ S V T Y P++ L +Y
Sbjct: 125 VLHRDLKPQNLLIN--ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182
Query: 178 DGKISDVWSCGVTLYVMLVG 197
+I D+W G Y M G
Sbjct: 183 STQI-DMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-17
Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 34/219 (15%)
Query: 1 MEERYEPV-KELGSGNFGVARLVRDKRTKELVA---VKYIERGKKIDENVQ--------- 47
+ ERY LG G +G D T ++VA VK IE + ++ Q
Sbjct: 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHF 65
Query: 48 ---REIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFF 104
RE+ ++H NI+ +V + + +VM+ A +L + R +E + +
Sbjct: 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCI 124
Query: 105 FQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK-----------SGLL 153
Q+++G++ H HRDL N ++ + KI DFG ++ S
Sbjct: 125 LLQILNGLNVLHKWYFMHRDLSPANIFINS--KGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 154 HSQPK----STVGTPAYIAPEVLARKEYDGKISDVWSCG 188
Q + S V T Y APE+L E D+WS G
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221
|
Length = 335 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 8e-17
Identities = 66/201 (32%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
+KELGSG FGV L + R + VA+K I G +E+ E L HP +++ V
Sbjct: 9 MKELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 68 LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
L IV E+ G L + R G+ S+D Q + G+ Y HRDL
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKIS 182
N L+ S +K+ DFG ++ +L + S+ G + PEV +Y K S
Sbjct: 127 AARNCLV--SSTGVVKVSDFGMTRY-VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-S 182
Query: 183 DVWSCGVTLY-VMLVGAYPFE 202
DVWS GV ++ V G PFE
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 6/151 (3%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RH 58
E + VK + G FG L R K +L AVK +++ I++N+ ++ R +
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
P I+ L + ++ +VMEY GG++ + + G F E+ A + ++ + Y H
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH 123
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK 149
I HRDLK +N L+ S + +K+ DFG SK
Sbjct: 124 GIIHRDLKPDNMLI--SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-16
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI-----ERGKKIDENVQREIINHRSLR- 57
+YEPV E+G G +G RD + VA+K + E G + + RE+ + L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPL--STVREVALLKRLEA 58
Query: 58 --HPNIIRFKEVLLT-----PTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLI 109
HPNI+R +V T T + +V E+ + + + +Q +
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 110 SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAP 169
G+ + H+ I HRDLK EN L+ Q +K+ DFG ++ V T Y AP
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQMALTPVVVTLWYRAP 176
Query: 170 EVLARKEYDGKISDVWSCGVTLYVML 195
EVL + Y + D+WS G M
Sbjct: 177 EVLLQSTYATPV-DMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-16
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI----ERGKKIDENVQREIINHRSLRH 58
+ YE +++LG G++ + K +LVA+K I E G RE + L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLKH 62
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-----AGRFSEDEARFFFQQLISGVS 113
NI+ +++ T L +V EY + +C G + + F QL+ G+S
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEY-----VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL 172
Y H I HRDLK +N L+ + + LK+ DFG +++ + S S V T Y P+VL
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED 206
D+W G M+ G F +D
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-16
Identities = 73/276 (26%), Positives = 125/276 (45%), Gaps = 29/276 (10%)
Query: 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHRSLRHPN 60
E ++ELG G +GV +R T ++AVK I E Q+ + I+ RS+ P
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPY 61
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGG--ELFARICSAGRFSEDE--ARFFFQQLISGVSYCH 116
+ F L + I ME + + ++ G ++ + ++ + Y H
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS-IVKALEYLH 120
Query: 117 S-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPE---- 170
S + + HRD+K N L++ + Q +K+CDFG S L+ S K+ G Y+APE
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGY-LVDSVAKTIDAGCKPYMAPERINP 177
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
L +K YD K SDVWS G+T+ + G +P++ + P F++ + LP +
Sbjct: 178 ELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEPSPQLPAE-KF 233
Query: 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266
S + + +++ K+ R L+ F E
Sbjct: 234 SPEFQDFVNKCL----KKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 59/186 (31%), Positives = 83/186 (44%), Gaps = 13/186 (6%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT 70
+G G FG L + K VAVK ++ + E +LRHPN+++ V+L
Sbjct: 14 IGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 71 PTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
L IV EY A G L + S GR + + F + G+ Y HRDL
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAAR 131
Query: 129 NTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT-PA-YIAPEVLARKEYDGKISDVWS 186
N L+ S K+ DFG +K + G P + APE L K++ K SDVWS
Sbjct: 132 NVLV--SEDLVAKVSDFGLAKE----ASQGQDSGKLPVKWTAPEALREKKFSTK-SDVWS 184
Query: 187 CGVTLY 192
G+ L+
Sbjct: 185 FGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 59/225 (26%), Positives = 89/225 (39%), Gaps = 39/225 (17%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI----ER-GKKIDENVQREIINHRSLR 57
YE + +LG G FG R +T +VA+K I E+ G I REI + L+
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPI--TALREIKILKKLK 65
Query: 58 HPNIIRF--------KEVLLTPTHLAIVMEYAA---GGELF-ARICSAGRFSEDEARFFF 105
HPN++ + + +V Y G L + + +E + + +
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV----KLTESQIKCYM 121
Query: 106 QQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY------------SKSGLL 153
QL+ G++Y H I HRD+K N L+D LKI DFG G
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 154 HSQPKSTVGTPAYIAPE-VLARKEYDGKISDVWSCGVTLYVMLVG 197
+ + V T Y PE +L + Y + D+W G M
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-16
Identities = 72/259 (27%), Positives = 111/259 (42%), Gaps = 13/259 (5%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL- 69
LG G FG + + T ++ A K +E+ + + +N + + RF L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 70 ---TPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
T L +V+ GG+L I G F E A F+ ++ G+ H I +RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRD 127
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 184
LK EN LLD ++I D G + K VGT Y+APEV+ + Y D
Sbjct: 128 LKPENILLDD--HGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDW 184
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY-VRVSADCRHLLSQIFV 243
W+ G LY M+ G PF+ + R+ ++R+ V+ +Y + S D R L +
Sbjct: 185 WALGCLLYEMIAGQSPFQQ-RKKKIKREEVERL--VKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 244 ADPSKDPHSRDQKASLVPE 262
DP + + A V E
Sbjct: 242 KDPKERLGCQGGGAREVKE 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-16
Identities = 75/276 (27%), Positives = 119/276 (43%), Gaps = 48/276 (17%)
Query: 8 VKELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RHPN 60
K +G G FG RL + + VA+K ++ G + + + + S+ HPN
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPN 66
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLI-------SG 111
IIR + V+ + I+ EY G L F R E++ +F QL+ SG
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASG 118
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT-----PA- 165
+ Y M HRDL N L+ + K+ DFG S+ ++T T P
Sbjct: 119 MKYLSEMNYVHRDLAARNILV--NSNLVCKVSDFGLSR---RLEDSEATYTTKGGKIPIR 173
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 224
+ APE +A +++ SDVWS G+ ++ VM G P+ D + + I + Y L
Sbjct: 174 WTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSN----QDVIKAV-EDGYRL 227
Query: 225 PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260
P + DC L Q+ + KD + R + +V
Sbjct: 228 PPPM----DCPSALYQLMLDCWQKDRNERPTFSQIV 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-16
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 10 ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIRFK 65
E+G G FG + K + ++AVK I R ++ +R +++ RS P I++F
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 66 EVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYC--------- 115
L I ME + F + E ++++ ++
Sbjct: 70 GALFREGDCWICMELMDISLDKFYKYVY-----EVLKSVIPEEILGKIAVATVKALNYLK 124
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLA- 173
++I HRD+K N LLD + +K+CDFG S L+ S K+ G Y+APE +
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQ-LVDSIAKTRDAGCRPYMAPERIDP 181
Query: 174 --RKEYDGKISDVWSCGVTLYVMLVGAYPF 201
R YD + SDVWS G+TLY + G +P+
Sbjct: 182 SARDGYDVR-SDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-16
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 17/208 (8%)
Query: 2 EERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYI--ERGKKIDENVQREIINHR 54
E+R+ + +++LG G+FG L R T E VAVK + E G ++++EI R
Sbjct: 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 61
Query: 55 SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARIC-SAGRFSEDEARFFFQQLISG 111
+L H NI+++K + + ++ME+ G L + + + + + + Q+ G
Sbjct: 62 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKG 121
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAY-I 167
+ Y S + HRDL N L++ + ++KI DFG +K+ + K + +P +
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVES--EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179
Query: 168 APEVLARKEYDGKISDVWSCGVTLYVML 195
APE L + ++ SDVWS GVTLY +L
Sbjct: 180 APECLIQSKF-YIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 1e-15
Identities = 52/178 (29%), Positives = 89/178 (50%), Gaps = 14/178 (7%)
Query: 26 RTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTH-LAIVMEYAAGG 84
+ + L+A K ++ G + ++ EI+ L H NI++ +E+L + + I +Y
Sbjct: 191 KCERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-- 247
Query: 85 ELFARICSAGRFSED-----EARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR 139
+L++ + +D + R +QL+ V Y H ++ HRD+KLEN L+ +
Sbjct: 248 DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV 307
Query: 140 LKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML 195
L DFG + + VGT A +PE+LA Y +I+D+WSCG+ L ML
Sbjct: 308 LG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
ERY+ + +GSG +G D +T VAVK + R + + RE+ + ++H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 60 NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
N+I +V L ++ + G +L I + ++D +F Q++ G+ Y
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
HS +I HRDLK N ++ + LKI DFG ++ H+ + T V T Y APE++
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
+ + D+WS G + +L G F
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-15
Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 12/202 (5%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
V+E+GSG FG+ L K VA+K I G +E+ E L HP +++ V
Sbjct: 9 VQEIGSGQFGLVWL-GYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 68 LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
+ + +V E+ G L + R G+FS++ + G++Y S + HRDL
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKIS 182
N L+ +K+ DFG ++ +L Q S+ GT + +PEV + +Y K S
Sbjct: 127 AARNCLV--GENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK-S 182
Query: 183 DVWSCGVTLY-VMLVGAYPFED 203
DVWS GV ++ V G P+E+
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-15
Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 11/244 (4%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RHPNIIRFKE 66
LG G FG + + T ++ A K +E+ + + +N + + ++
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 67 VLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
T L +V+ GG+L I + G F E+ A F+ ++ G+ H I +RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRD 127
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 184
LK EN LLD R I D G + + VGT Y+APEV+ + Y D
Sbjct: 128 LKPENILLDDYGHIR--ISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY-TFSPDW 184
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
W G +Y M+ G PF ++ + R++ Q + + S R + Q+
Sbjct: 185 WGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARSICRQLLTK 242
Query: 245 DPSK 248
DP
Sbjct: 243 DPGF 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-15
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 11/206 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
ERY+ + +GSG +G D R ++ VAVK + R + RE+ + ++H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 60 NIIRFKEVLLTPTHLA----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
N+I +V T + + + G I + S++ +F QL+ G+ Y
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
HS I HRDLK N ++ + L+I DFG ++ + V T Y APE++
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQA--DDEMTGYVATRWYRAPEIMLNW 190
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF 201
+ + D+WS G + +L G F
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-15
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 5 YEPVKELGSGNF-----GVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRS 55
Y +++LG G++ G++R+ +LVA+K I K +E V RE +
Sbjct: 7 YLNLEKLGEGSYATVYKGISRI-----NGQLVALKVISM--KTEEGVPFTAIREASLLKG 59
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
L+H NI+ +++ T L V EY I G R F QL+ G++Y
Sbjct: 60 LKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL-A 173
H I HRDLK +N L+ S LK+ DFG +++ + SQ S+ V T Y P+VL
Sbjct: 120 HGQHILHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLG 177
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPF 201
+Y + D+W G ML G F
Sbjct: 178 ATDYSSAL-DIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-15
Identities = 65/256 (25%), Positives = 108/256 (42%), Gaps = 11/256 (4%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL- 69
LG G FG + + T ++ A K +E+ + + +N + + RF L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 70 ---TPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
T L +V+ GG+L I + G F E A F+ +L G+ I +RD
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRD 127
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 184
LK EN LLD + ++I D G + + VGT Y+APEV+ ++Y D
Sbjct: 128 LKPENILLDD--RGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS-PDW 184
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
W G +Y M+ G PF ++ + R++ Q + + S D + + +
Sbjct: 185 WGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAKSICRMLLTK 242
Query: 245 DPSKDPHSRDQKASLV 260
+P + R A+ V
Sbjct: 243 NPKERLGCRGNGAAGV 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 57/294 (19%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
+RY+ +K +GSG G+ D VAVK + R + + RE++ + + H
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80
Query: 60 NIIRFKEVLLTPTH-------LAIVMEYAAGGELFARICSAGRFSEDEAR--FFFQQLIS 110
NII V TP + +VME + A +C D R + Q++
Sbjct: 81 NIISLLNVF-TPQKSLEEFQDVYLVMEL-----MDANLCQVIHMELDHERMSYLLYQMLC 134
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
G+ + HS I HRDLK N ++ LKI DFG +++ + V T Y APE
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR-------------- 216
V+ Y + D+WS G + ++ G+ F+ + + K I++
Sbjct: 193 VILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 217 -IRNV-----QY-------FLPDYVRVS---------ADCRHLLSQIFVADPSK 248
+RN QY PD++ S + R LLS++ V DP K
Sbjct: 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDK 305
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-14
Identities = 66/218 (30%), Positives = 96/218 (44%), Gaps = 25/218 (11%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
+ YE ++++G G +G RDK T +LVA+K R + +E + REI + L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSE 59
Query: 59 -PNIIRFKEVLLTPTH-----LAIVMEYAAGGELFARICSAGR-----FSEDEARFFFQQ 107
I+R +V L +V EY +L + S GR + F Q
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KST--VGT 163
L+ GV++CH + HRDLK +N L+D + LKI D G ++ S P T + T
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQ-KGLLKIADLGLGRA---FSIPVKSYTHEIVT 174
Query: 164 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
Y APEVL + D+WS G M F
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 28/207 (13%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT 70
+G+G+FGV T E VA+K + + + RE++ ++L H NII K+ T
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK---NRELLIMKNLNHINIIFLKDYYYT 130
Query: 71 PT--------HLAIVMEYAAGG-----ELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
L +VME+ + +AR A + + QL ++Y HS
Sbjct: 131 ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHA--LPLFLVKLYSYQLCRALAYIHS 188
Query: 118 MEICHRDLKLENTLLDGSPQPR---LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LA 173
ICHRDLK +N L+D P LK+CDFG +K+ L + S + + Y APE+ L
Sbjct: 189 KFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYP 200
Y I D+WS G + M++G YP
Sbjct: 245 ATNYTTHI-DLWSLGCIIAEMILG-YP 269
|
Length = 440 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-14
Identities = 60/256 (23%), Positives = 105/256 (41%), Gaps = 20/256 (7%)
Query: 3 ERYEPVKELGSGNFGVARLVRDK-RTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
E + ++LGSG FG + + + VA+K ++ + ++ Q+E+ + LRH +
Sbjct: 6 EEFTLERKLGSGYFG--EVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKH 63
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVSYCHSM 118
+I V + I+ E G L A + S A Q+ G++Y
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARK 175
HRDL N L+ K+ DFG ++ L+ + + APE +
Sbjct: 124 NSIHRDLAARNILVG--EDLVCKVADFGLAR--LIKEDVYLSSDKKIPYKWTAPEAASHG 179
Query: 176 EYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
+ K SDVWS G+ LY + G P+ N + D+I Y +P + +
Sbjct: 180 TFSTK-SDVWSFGILLYEMFTYGQVPYPG----MNNHEVYDQI-TAGYRMPCPAKCPQEI 233
Query: 235 RHLLSQIFVADPSKDP 250
++ + + A+P P
Sbjct: 234 YKIMLECWAAEPEDRP 249
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-14
Identities = 63/244 (25%), Positives = 94/244 (38%), Gaps = 41/244 (16%)
Query: 1 MEERYEPVKELGSGNFGV----------------ARLVRDKRTKELVAVKYIERG--KKI 42
+ V++LG G FG + LVAVK +
Sbjct: 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNA 62
Query: 43 DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSE 98
E+ +E+ L PNI R V L ++MEY G+ L + +
Sbjct: 63 REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 99 DEARFFFQQLI-------SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151
+ F L+ SG+ Y S+ HRDL N L+ + +KI DFG S++
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT--IKIADFGMSRN- 179
Query: 152 LLHSQPKSTVG--TPAYI---APEVLARKEYDGKISDVWSCGVTLY--VMLVGAYPFEDP 204
L+S V P I A E + ++ K SDVW+ GVTL+ + L P+E
Sbjct: 180 -LYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHL 237
Query: 205 EDPR 208
D +
Sbjct: 238 TDQQ 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-14
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 2 EERYEPVKELGSGNFGVAR----LVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRS 55
E E +K LGSG FG + ++ K VA+K + E K ++ + E S
Sbjct: 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS 65
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLIS----- 110
+ HP+++R + L+ ++ + G L + + Q L++
Sbjct: 66 VDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYV------RNHKDNIGSQYLLNWCVQI 118
Query: 111 --GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--- 165
G+SY + HRDL N L+ +PQ +KI DFG +K LL K
Sbjct: 119 AKGMSYLEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLDVDEKEYHAEGGKVP 174
Query: 166 --YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
++A E + + Y K SDVWS GVT++ +M GA P+E
Sbjct: 175 IKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 18/229 (7%)
Query: 3 ERYEPVKELGSGNFGVARLVRD-KRTKELVAVKYI-----ERGKKIDENVQREIINH-RS 55
++YE V E+G G +G RD K VA+K + E G + + ++ H +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 56 LRHPNIIRFKEVLLTP-----THLAIVMEYAAGG--ELFARICSAGRFSEDEARFFFQQL 108
HPN++R +V T L +V E+ ++ G +E FQ L
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 119
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIA 168
+ G+ + HS + HRDLK +N L+ S Q +K+ DFG ++ S V T Y A
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMALTSVVVTLWYRA 177
Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI 217
PEVL + Y + D+WS G M F D K +D I
Sbjct: 178 PEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 21/227 (9%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
+RY+ +K +GSG G+ D + VA+K + R + + RE++ + + H
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 60 NIIRFKEVLLTPTH-------LAIVMEYAAGGELFARICSAGRFSEDEAR--FFFQQLIS 110
NII V TP + IVME + A +C + D R + Q++
Sbjct: 84 NIIGLLNVF-TPQKSLEEFQDVYIVMEL-----MDANLCQVIQMELDHERMSYLLYQMLC 137
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
G+ + HS I HRDLK N ++ LKI DFG +++ V T Y APE
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI 217
V+ Y + D+WS G + M+ G F + + K I+++
Sbjct: 196 VILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-14
Identities = 62/236 (26%), Positives = 97/236 (41%), Gaps = 54/236 (22%)
Query: 2 EERYEPVKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS- 55
E+ ++ELG G+FG +A+ V + VA+K + + E E +N S
Sbjct: 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASV 62
Query: 56 ---LRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARF------- 103
+++R V+ T +VME A G+L + R R +
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQ 119
Query: 104 -FFQ---QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG----------YSK 149
F Q ++ G++Y + + HRDL N ++ + +KI DFG Y K
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV--AEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 150 SG--LLHSQPKSTVGTPA-YIAPEVLARKEYDGKISDVWSCGVTLYVML-VGAYPF 201
G LL P ++APE L + K SDVWS GV L+ M + P+
Sbjct: 178 GGKGLL----------PVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-14
Identities = 71/268 (26%), Positives = 120/268 (44%), Gaps = 35/268 (13%)
Query: 11 LGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RHPNIIR 63
+G+G FG RL + + VA+K ++ G E +R+ ++ S+ HPNII
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 64 FKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
+ V+ + I+ E+ G L F R + G+F+ + + + +G+ Y M
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--------YIAPEVLA 173
HRDL N L++ + K+ DFG S+ L T + + APE +A
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
+++ SDVWS G+ ++ VM G P+ D + + I+ I Y LP
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSN----QDVINAIEQ-DYRLPP----PM 234
Query: 233 DCRHLLSQIFVADPSKDPHSRDQKASLV 260
DC L Q+ + KD ++R + +V
Sbjct: 235 DCPTALHQLMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-14
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 10/212 (4%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL- 69
LG G FG + + T ++ A K +E+ + + +N + + +F L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 70 ---TPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
T L +V+ GG+L I + G F E+ A F+ +++ G+ H +RD
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRD 127
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 184
LK EN LLD ++I D G + + VGT Y+APEVL + Y D
Sbjct: 128 LKPENILLDDYGH--IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-TLSPDY 184
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR 216
W G +Y M+ G PF ++ + R+ +DR
Sbjct: 185 WGLGCLIYEMIEGQSPFRGRKE-KVKREEVDR 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-14
Identities = 70/262 (26%), Positives = 105/262 (40%), Gaps = 40/262 (15%)
Query: 9 KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL---RHPNII 62
+++G GNFG L + VAVK R + ++ + L HPNI+
Sbjct: 1 EKIGKGNFGDVYKGVL----KGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIV 55
Query: 63 RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAG-------RFSEDEARFFFQQLISGVS 113
+ V + + IVME GG L F R + S D A +G+
Sbjct: 56 KLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAA--------AGME 107
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTP-AYIAPE 170
Y S HRDL N L+ + LKI DFG S+ G +++ P + APE
Sbjct: 108 YLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE 165
Query: 171 VLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
L Y + SDVWS G+ L+ +G P+ + + R+ I+ Y +P
Sbjct: 166 ALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQT-RERIES----GYRMPAPQL 219
Query: 230 VSADCRHLLSQIFVADPSKDPH 251
+ L+ Q + DP P
Sbjct: 220 CPEEIYRLMLQCWAYDPENRPS 241
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-14
Identities = 73/262 (27%), Positives = 117/262 (44%), Gaps = 29/262 (11%)
Query: 9 KELGSGNFG-VAR--LVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
K +G+G FG V R L R + VA+K ++ G E +++ ++ S+ H NI
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNI 68
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
IR + V+ I+ EY G L + R G FS + + + +G+ Y M
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
HRDL N L++ K+ DFG S+ +L P+ T T + APE +A
Sbjct: 128 YVHRDLAARNILVNS--NLECKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
+++ SDVWS G+ ++ VM G P+ D + K I N + LP + +
Sbjct: 184 YRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAI----NDGFRLPAPMDCPS 237
Query: 233 DCRHLLSQIFVADPSKDPHSRD 254
L+ Q + D ++ P D
Sbjct: 238 AVYQLMLQCWQQDRARRPRFVD 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-13
Identities = 75/268 (27%), Positives = 123/268 (45%), Gaps = 33/268 (12%)
Query: 9 KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
K +G+G FG RL + + VA+K ++ G E +R+ ++ S+ HPNI
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNI 67
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
I + V+ + IV EY G L F R G+F+ + + + SG+ Y M
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDMG 126
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
HRDL N L++ + K+ DFG S+ +L P++ T + APE +A
Sbjct: 127 YVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
+++ SDVWS G+ ++ VM G P+ + + ++ K I+ Y LP
Sbjct: 183 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEE----GYRLP----APM 232
Query: 233 DCRHLLSQIFVADPSKDPHSRDQKASLV 260
DC L Q+ + KD + R + +V
Sbjct: 233 DCPAALHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-13
Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ------REIINHRSLR 57
RY+ +K +GSG G+ D T + VA+K + R +NV RE++ + +
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVN 73
Query: 58 HPNIIRFKEVLLTP-------THLAIVMEYAAGGELFARICSAGRFSEDEAR--FFFQQL 108
H NII V TP + +VME + A +C + D R + Q+
Sbjct: 74 HKNIIGLLNVF-TPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHERMSYLLYQM 127
Query: 109 ISGVSYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 166
+ G+ + HS I HRDLK N ++ D + LKI DFG +++ V T Y
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFMMTPYVVTRYY 183
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
APEV+ Y + D+WS G + M+ G F
Sbjct: 184 RAPEVILGMGYKENV-DIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-13
Identities = 75/288 (26%), Positives = 114/288 (39%), Gaps = 45/288 (15%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
+RY+ +K +GSG G+ D VA+K + R + + RE++ + + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
NII V L + EL A +C + D R + Q++ G+ + H
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
S I HRDLK N ++ LKI DFG +++ V T Y APEV+
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
Y + D+WS G + M+ +P D D P +K +RN
Sbjct: 195 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSK 248
P Y ++ AD H LLS++ V DP+K
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-13
Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 10 ELGSGNFG-VARLVRDKRTKEL-VAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFK 65
ELGSGNFG V + V R K++ VA+K ++ K + + + RE L +P I+R
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 66 EVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHR 123
V L +VME A+GG L + S + + Q+ G+ Y HR
Sbjct: 62 GVC-EAEALMLVMEMASGGPL-NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTP---AYIAPEVLARKEYDG 179
DL N LL Q KI DFG SK+ G S K+ + APE + +++
Sbjct: 120 DLAARNVLLVN--QHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 180 KISDVWSCGVTLYVML-VGAYPFEDPEDP 207
+ SDVWS G+T++ G P++ + P
Sbjct: 178 R-SDVWSYGITMWEAFSYGQKPYKKMKGP 205
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 8e-13
Identities = 64/198 (32%), Positives = 90/198 (45%), Gaps = 20/198 (10%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFKEV 67
+G G FG +++ + T + VAVK I K D Q E L H N++R V
Sbjct: 14 IGEGEFGA--VLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 68 LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVSYCHSMEICHRDL 125
+L L IVME + G L + + GR + F + G+ Y S ++ HRDL
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-YIAPEVLARKEYDGKISDV 184
N L+ S K+ DFG ++ G S P + APE L K++ K SDV
Sbjct: 127 AARNILV--SEDGVAKVSDFGLARVG---SMGVDNSKLPVKWTAPEALKHKKFSSK-SDV 180
Query: 185 WSCGVTLY-VMLVGAYPF 201
WS GV L+ V G P+
Sbjct: 181 WSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 71/247 (28%), Positives = 112/247 (45%), Gaps = 29/247 (11%)
Query: 5 YEPVKELGSGNFGVARLVR--DKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
YE K +G G +G + D + ++ A+K IE G I + REI R L+HPN+I
Sbjct: 4 YEGCK-VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACREIALLRELKHPNVI 61
Query: 63 RFKEVLLTPT--HLAIVMEYAAGGEL----FARICSAGR----FSEDEARFFFQQLISGV 112
++V L+ + + ++ +YA F R A + + Q++ G+
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 113 SYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPK------STVGTP 164
Y H+ + HRDLK N L+ +G + R+KI D G+++ L +S K V T
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLKPLADLDPVVVTF 179
Query: 165 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF----EDPEDPRNF-RKTIDRIRN 219
Y APE+L + K D+W+ G +L F ED + F +DRI +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239
Query: 220 VQYFLPD 226
V F D
Sbjct: 240 VMGFPAD 246
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 58/194 (29%), Positives = 89/194 (45%), Gaps = 15/194 (7%)
Query: 9 KELGSGNFGVAR--LVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNII 62
ELGSGNFG + + + K++++ VAVK I + D ++ E++ + L +P I+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIV 59
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
R + +VME A G L + +E Q+ G+ Y H
Sbjct: 60 RMIGI-CEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPA-YIAPEVLARKEYD 178
RDL N LL Q KI DFG SK + + + K+ P + APE + ++
Sbjct: 119 RDLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 179 GKISDVWSCGVTLY 192
K SDVWS GV ++
Sbjct: 177 SK-SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-12
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 39/222 (17%)
Query: 9 KELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREI-------INHRSLRH 58
K LG G FG +L +D ++ VAVK + K+D + EI + H
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 59 PNIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQLI--- 109
PN+++ V + L +++ + G+L + + + R + Q L+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS-RLGGLPEKLPLQTLLKFM 119
Query: 110 ----SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKIC--DFGYSK---SGLLHSQPKST 160
G+ Y + HRDL N +L + +C DFG SK SG + Q +
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
+IA E LA + Y K SDVW+ GVT++ + G P+
Sbjct: 176 KMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 76/267 (28%), Positives = 122/267 (45%), Gaps = 20/267 (7%)
Query: 3 ERYEPVKELGSGNFG---VARLVRDKRTKELVAVKY--IERGKKIDENVQREIINHRSLR 57
E + +G G FG + + K VAVK + E +E R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVSYC 115
HP+I++ V+ T + IVME A GEL + + ++S D A + QL + ++Y
Sbjct: 66 HPHIVKLIGVI-TENPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYL 123
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT-P-AYIAPEVLA 173
S HRD+ N L+ SP +K+ DFG S+ S K++ G P ++APE +
Sbjct: 124 ESKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
+ + SDVW GV ++ ++++G PF+ ++ I RI N + LP
Sbjct: 182 FRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKN----NDVIGRIENGER-LPMPPNCPP 235
Query: 233 DCRHLLSQIFVADPSKDPHSRDQKASL 259
L+++ + DPSK P + KA L
Sbjct: 236 TLYSLMTKCWAYDPSKRPRFTELKAQL 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-12
Identities = 73/247 (29%), Positives = 111/247 (44%), Gaps = 29/247 (11%)
Query: 5 YEPVKELGSGNFG-VARLVR-DKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
YE K +G G +G V + R D + A+K IE G I + REI R L+HPN+I
Sbjct: 4 YEGCK-VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNVI 61
Query: 63 RFKEVLLTPT--HLAIVMEYAAGGEL----FARICSAGR----FSEDEARFFFQQLISGV 112
++V L+ + ++ +YA F R A + + Q++ G+
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 113 SYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPK------STVGTP 164
Y H+ + HRDLK N L+ +G + R+KI D G+++ L +S K V T
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLKPLADLDPVVVTF 179
Query: 165 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF----EDPEDPRNF-RKTIDRIRN 219
Y APE+L + K D+W+ G +L F ED + + +DRI N
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239
Query: 220 VQYFLPD 226
V F D
Sbjct: 240 VMGFPAD 246
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-12
Identities = 55/198 (27%), Positives = 81/198 (40%), Gaps = 26/198 (13%)
Query: 8 VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKE 66
++LG+G FG V + TK VAVK ++ G E +E + LRH +++
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 67 VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFF-FQQLI-------SGVSYCHSM 118
V + IV EY + G L + E + QL+ G++Y S
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTP-AYIAPEVLAR 174
HRDL N L+ KI DFG ++ L+ + P + APE
Sbjct: 123 NYIHRDLAARNILV--GENLVCKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAANY 178
Query: 175 KEYDGKISDVWSCGVTLY 192
+ K SDVWS G+ L
Sbjct: 179 GRFTIK-SDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-12
Identities = 67/255 (26%), Positives = 105/255 (41%), Gaps = 27/255 (10%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKE 66
+ +G GNFG R + VAVK + +E + HPNI+R
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 67 VLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
V + IVME GG+ + + G R E + +G+ Y S HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 126 KLENTLLDGSPQPRLKICDFG---------YSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
N L+ + + LKI DFG Y+ +G + P + APE L
Sbjct: 121 AARNCLV--TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK------WTAPEALNYGR 172
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
Y + SDVWS G+ L+ +GA P+ + + + R+ I+ + V+ P+
Sbjct: 173 YSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQT-REAIE--QGVRLPCPE--LCPDAVY 226
Query: 236 HLLSQIFVADPSKDP 250
L+ + + DP + P
Sbjct: 227 RLMERCWEYDPGQRP 241
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-12
Identities = 48/187 (25%), Positives = 79/187 (42%), Gaps = 7/187 (3%)
Query: 10 ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
+LG G +G K+ VAVK ++ E +E + ++HPN+++ V
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 70 TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQ--QLISGVSYCHSMEICHRDLKL 127
I+ E+ G L + R + + Q+ S + Y HRDL
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 132
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
N L+ +K+ DFG S+ +G ++ + APE LA ++ K SDVW
Sbjct: 133 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 189
Query: 186 SCGVTLY 192
+ GV L+
Sbjct: 190 AFGVLLW 196
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 26/205 (12%)
Query: 18 VARLVRDKRTKELVAVKYIERGKKIDENV---QREIINHRSLRHPNIIRFKEVLLTPTHL 74
L R K T E V V+ I +E V Q E+ + HPNI+ ++ + L
Sbjct: 15 TVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 74
Query: 75 AIVMEYAAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTL- 131
+V + A G IC+ SE + Q ++ + Y H M HR +K + L
Sbjct: 75 WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 134
Query: 132 -LDGSPQPRLKICDFGY----------SKSGLLHSQPKSTVGTPAYIAPEVLAR--KEYD 178
+DG K+ G + ++H PK +V +++PEVL + + YD
Sbjct: 135 SVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD 188
Query: 179 GKISDVWSCGVTLYVMLVGAYPFED 203
K SD++S G+T + G PF+D
Sbjct: 189 AK-SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-11
Identities = 62/189 (32%), Positives = 84/189 (44%), Gaps = 19/189 (10%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQR---EIINHRSLRHPNIIRFKEV 67
+G G FG ++ D R + VAVK I K D Q E LRH N+++ V
Sbjct: 14 IGKGEFGDV-MLGDYRGNK-VAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 68 LLTP-THLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
++ L IV EY A G L + S GR D F + + Y + HRD
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRD 127
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-YIAPEVLARKEYDGKISD 183
L N L+ S K+ DFG +K S + T P + APE L K++ K SD
Sbjct: 128 LAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTK-SD 181
Query: 184 VWSCGVTLY 192
VWS G+ L+
Sbjct: 182 VWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-11
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 8 VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKE 66
VK+LG+G FG V + TK VAVK ++ G + E ++L+H ++R
Sbjct: 11 VKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 67 VLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
V+ + I+ EY A G L F + G+ + F Q+ G++Y HRD
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 128
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKI 181
L+ N L+ S KI DFG ++ + ++ + G + APE + + K
Sbjct: 129 LRAANVLV--SESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIK- 184
Query: 182 SDVWSCGVTLY-VMLVGAYPF 201
SDVWS G+ LY ++ G P+
Sbjct: 185 SDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-11
Identities = 49/185 (26%), Positives = 75/185 (40%), Gaps = 15/185 (8%)
Query: 27 TKELVAVKYIE----RGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI-VMEYA 81
T VA+K + + +RE L HPNI+ + P L V EY
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRL 140
G L + + G E Q++ ++ H+ I HRDLK +N ++ + +P
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 141 KICDFGYSKSG--------LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY 192
K+ DFG ++ +GTP Y APE L R E SD+++ G+
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDLYAWGLIFL 180
Query: 193 VMLVG 197
L G
Sbjct: 181 ECLTG 185
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-11
Identities = 76/283 (26%), Positives = 118/283 (41%), Gaps = 55/283 (19%)
Query: 9 KELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDE--NVQREIINHRSLRHPNI 61
K LG G FG A ++ + VAVK ++ E ++ E + + HP++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGEL--FARIC---------------SAGRFSEDEARFF 104
I+ L +++EYA G L F R S+ + DE
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 105 FQQLIS-------GVSYCHSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSK------S 150
LIS G+ Y M++ HRDL N L+ +G ++KI DFG S+ S
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR---KMKISDFGLSRDVYEEDS 182
Query: 151 GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGA--YPFEDPEDP 207
+ S+ + V ++A E L Y + SDVWS GV L+ ++ +G YP PE
Sbjct: 183 YVKRSKGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPERL 238
Query: 208 RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDP 250
N KT R+ P+ S + +L+ + +P K P
Sbjct: 239 FNLLKTGYRMER-----PE--NCSEEMYNLMLTCWKQEPDKRP 274
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 9e-11
Identities = 71/279 (25%), Positives = 107/279 (38%), Gaps = 56/279 (20%)
Query: 11 LGSGNFG------VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RHPN 60
LGSG FG ++ VAVK + +G E ++E + L HPN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLIS-------GVS 113
I++ V L I+ME GG+L + + A ++L+ G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 114 YCHSMEICHRDLKLENTLL---DGSPQPRLKICDFG----------YSKSGLLHSQPKST 160
Y M HRDL N L+ +KI DFG Y K G +
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG----EGLLP 176
Query: 161 VGTPAYIAPEVLARKEYDGKI---SDVWSCGVTLY-VMLVG--AYPFEDPEDPRNFRKTI 214
V ++APE L DGK SDVWS GV ++ ++ +G YP + ++
Sbjct: 177 V---RWMAPESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG 229
Query: 215 DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSR 253
R++ + PD L++ + DPS+ P
Sbjct: 230 GRLQKPEN-CPD------KIYQLMTNCWAQDPSERPTFD 261
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 60/219 (27%), Positives = 90/219 (41%), Gaps = 34/219 (15%)
Query: 9 KELGSGNFGVARLVRDKRTKE--------------LVAVKYI--ERGKKIDENVQREIIN 52
++LG G FG L + E LVAVK + + K + +EI
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70
Query: 53 HRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL------------FARICSAGRFSEDE 100
L++PNIIR V ++ L ++ EY G+L F + S
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 101 ARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQP 157
+ Q+ SG+ Y S+ HRDL N L+ +KI DFG S+ SG +
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLYSGDYYRIQ 188
Query: 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
V ++A E + ++ SDVW+ GVTL+ M
Sbjct: 189 GRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 4 RYEPVKELGSGNFGVARLV--RDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
+Y + L G+ G + ++ V VK + GK REI +++ H I
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAI 148
Query: 62 IRFKEVLLTPTHLAIVM-EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
I + + +VM +Y +LF + +G ++A ++L+ ++Y H I
Sbjct: 149 INLIHAYRWKSTVCMVMPKYKC--DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGI 206
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYS-KSGLLHSQPKST--VGTPAYIAPEVLARKEY 177
HRD+K EN LD L DFG + K P+ GT +PE+LA Y
Sbjct: 207 IHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY 264
Query: 178 DGKISDVWSCGVTLYVMLVGAYPF 201
K +D+WS G+ L+ M V
Sbjct: 265 CAK-TDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-10
Identities = 50/186 (26%), Positives = 73/186 (39%), Gaps = 32/186 (17%)
Query: 54 RSLRHPNIIRFKEVLLTPTHLAI--------VMEYAAGGEL--FARICSAGR------FS 97
L H NI L H+ I + Y G L F + C G S
Sbjct: 63 YGLSHQNI-------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115
Query: 98 EDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS---GLLH 154
+ Q+ G+SY H + H+D+ N ++D Q +KI D S+ H
Sbjct: 116 TQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITDNALSRDLFPMDYH 173
Query: 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE--DPEDPRNFR 211
+ ++A E L KEY SDVWS GV L+ +M +G P+ DP + +
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL 232
Query: 212 KTIDRI 217
K R+
Sbjct: 233 KDGYRL 238
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 64/258 (24%), Positives = 98/258 (37%), Gaps = 61/258 (23%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----- 57
+RY+ ++ +G G G L D VA+K I + + EN ++ R LR
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR--EDLSEN---PLLKKRFLREAKIA 56
Query: 58 ----HPNIIRFKEVLLTPTHLAIVMEYAAGGEL----------------FARICSAGRFS 97
HP I+ + + M Y G L A S G F
Sbjct: 57 ADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116
Query: 98 EDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG----------- 146
F ++ + + Y HS + HRDLK +N LL + + I D+G
Sbjct: 117 S-----IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWGAAIFKKLEEED 169
Query: 147 -----YSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA 198
+ + +S P VGTP Y+APE L +D+++ GV LY ML +
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLS 228
Query: 199 YPFEDPEDPRNFRKTIDR 216
+P+ + RK R
Sbjct: 229 FPYRR----KKGRKISYR 242
|
Length = 932 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 8e-10
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 40/223 (17%)
Query: 9 KELGSGNFGVARLVR-----DKRTKELVAVKYIERGKKIDENVQREIINHR------SLR 57
+ELG G FG L ++ K LVAVK + K +N +++ HR +L+
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDF--HREAELLTNLQ 65
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-------------RFSEDEARFF 104
H +I++F V + L +V EY G+L + + G ++ +
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 105 FQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP 164
QQ+ +G+ Y S HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLV--GENLLVKIGDFGMSRD--VYSTDYYRVGGH 181
Query: 165 A-----YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
++ PE + +++ + SDVWS GV L+ + G P+
Sbjct: 182 TMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-10
Identities = 63/202 (31%), Positives = 88/202 (43%), Gaps = 39/202 (19%)
Query: 11 LGSGNFG--VARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFKE 66
LG GNFG ++DK VAVK + + ++ E + HPNI++
Sbjct: 3 LGKGNFGEVFKGTLKDKTP---VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 67 VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI-------SGVSYCHSME 119
V + IVME GG+ + + R +DE + +QL+ +G++Y S
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESKN 113
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFG---------YSKSGLLHSQPKSTVGTPAYIAPE 170
HRDL N L+ + LKI DFG YS SGL K T APE
Sbjct: 114 CIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIKWT-------APE 164
Query: 171 VLARKEYDGKISDVWSCGVTLY 192
L Y + SDVWS G+ L+
Sbjct: 165 ALNYGRYSSE-SDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-10
Identities = 54/235 (22%), Positives = 97/235 (41%), Gaps = 41/235 (17%)
Query: 9 KELGSGNFG------VARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPN 60
E+G+G FG R + R V VK + DE + +E+ +R L HPN
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKAR----VVVKELRASATPDEQLLFLQEVQPYRELNHPN 56
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQL----ISGVSY 114
+++ + +V+E+ G+L + R G ++ + Q++ SG+ +
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNR-GMVAQMAQKDVLQRMACEVASGLLW 115
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--------Y 166
H + H DL L N L + +KI D+ GL Q +
Sbjct: 116 LHQADFIHSDLALRNCQL--TADLSVKIGDY-----GLALEQYPEDYYITKDCHAVPLRW 168
Query: 167 IAPEVLARKEYD------GKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTI 214
+APE++ + D K S++WS GVT++ + P+ D D + ++ +
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 74/274 (27%), Positives = 114/274 (41%), Gaps = 36/274 (13%)
Query: 11 LGSGNFGVAR---LVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRF 64
LG G FG R L + + + VAVK ++ +++ RE + HPN+I+
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 65 KEVLL---TPTHLAIVM---EYAAGGELFARICSAGRFSEDEARFFFQQLI-------SG 111
V L L I M + G+L + R E+ Q L+ SG
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKIC--DFGYSK---SGLLHSQPKSTVGTPAY 166
+ Y S HRDL N +L+ + + +C DFG SK SG + Q ++ +
Sbjct: 126 MEYLSSKNFIHRDLAARNCMLNEN----MTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
+A E LA Y SDVW+ GVT++ +M G P+ E+ + I R Q P
Sbjct: 182 LALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ--PP 238
Query: 226 DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259
D + D L+ Q + +P P + + L
Sbjct: 239 DCL---EDVYELMCQCWSPEPKCRPSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 39/215 (18%)
Query: 8 VKELGSGNFGVARL-----VRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
+ELG G FG L + + KELVAVK ++ D ++ +RE + +H N
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGEL----------FARICSA----GRFSEDEARFFFQ 106
I++F V +V EY G+L A + S G + +
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA- 165
Q+ SG+ Y S HRDL N L+ +KI DFG S+ +++ VG
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRD--VYTTDYYRVGGHTM 185
Query: 166 ----YIAPE-VLARK---EYDGKISDVWSCGVTLY 192
++ PE ++ RK E SDVWS GV L+
Sbjct: 186 LPIRWMPPESIMYRKFTTE-----SDVWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 23/206 (11%)
Query: 8 VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKE 66
+++LG+G FG V + + T VAVK ++ G ++ E + LRHP +I+
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 67 VLLTPTHLAIVMEYAAGGELF-------ARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
V + IV E G L R + + A Q+ SG++Y +
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA-----QVASGMAYLEAQN 123
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKE 176
HRDL N L+ + K+ DFG ++ + ++ G I APE
Sbjct: 124 YIHRDLAARNVLVGENNI--CKVADFGLARV-IKEDIYEAREGAKFPIKWTAPEAALYNR 180
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPF 201
+ K SDVWS G+ L ++ G P+
Sbjct: 181 FSIK-SDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-09
Identities = 53/183 (28%), Positives = 79/183 (43%), Gaps = 21/183 (11%)
Query: 30 LVAVKYI--ERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELF 87
LVAVK + + K + +EI L+ PNIIR V +T L ++ EY G+L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 88 ARICSAGRFSEDEA------------RFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS 135
+ E F Q+ SG+ Y S+ HRDL N L+
Sbjct: 108 QFLSRH-EPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV--G 164
Query: 136 PQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY 192
+KI DFG S+ SG + V +++ E + ++ SDVW+ GVTL+
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLW 223
Query: 193 VML 195
+L
Sbjct: 224 EIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 31/209 (14%)
Query: 10 ELGSGNFGVARLVR-----DKRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNIIR 63
ELG G FG L ++ K LVAVK + E + ++ QRE L+H +I+R
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 64 FKEVLLTPTHLAIVMEYAAGGEL--FAR-------------ICSAGRFSEDEARFFFQQL 108
F V L +V EY G+L F R + G+ + + Q+
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--- 165
SG+ Y S+ HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLV--GQGLVVKIGDFGMSRD--IYSTDYYRVGGRTMLP 187
Query: 166 --YIAPEVLARKEYDGKISDVWSCGVTLY 192
++ PE + +++ + SD+WS GV L+
Sbjct: 188 IRWMPPESILYRKFTTE-SDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 68/239 (28%), Positives = 104/239 (43%), Gaps = 55/239 (23%)
Query: 3 ERYEPVKELGSGNFGVARLVR------DKRTKEL-VAVKYIERGKKIDENVQREIINHRS 55
+R K LG G FG ++V+ D + VAVK ++ D+ ++++ + S
Sbjct: 12 DRLTLGKPLGEGAFG--QVVKAEAVGLDNPNETSTVAVKMLK-----DDATEKDLSDLVS 64
Query: 56 L--------RHPNIIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARF-- 103
+H NII V L +V+EYAA G L F R A R + A
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLR---ARRPPGEYASPDD 121
Query: 104 ---------------FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS 148
F Q+ G+ + S + HRDL N L+ + +KI DFG +
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLA 179
Query: 149 KSGLLHSQP---KSTVG-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
+ +H K+T G P ++APE L + Y + SDVWS GV L+ + +G P+
Sbjct: 180 RD--IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-09
Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 9 KELGSGNFG-VAR----LVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNI 61
+ELG G FG V + ++ + VA+K ++ K+ + ++E L+HPNI
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELF------ARICSAGRFSED-------EARFFFQ-- 106
+ V ++ EY A G+L + G S D + F
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 107 -QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVG 162
Q+ +G+ Y S HRDL N L+ +KI DFG S+ S + ++
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
++ PE + ++ + SD+WS GV L+ + G P+
Sbjct: 189 PVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 33/221 (14%)
Query: 9 KELGSGNFGVARL-----VRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNII 62
+ELG G FG L + + K LVAVK ++ ++ QRE +L+H +I+
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 63 RFKEVLLTPTHLAIVMEYAAGGEL--FAR--------------ICSAGRFSEDEARFFFQ 106
+F V L +V EY G+L F R + G +
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA- 165
Q+ SG+ Y S HRDL N L+ + +KI DFG S+ ++S VG
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRD--VYSTDYYRVGGHTM 186
Query: 166 ----YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
++ PE + +++ + SDVWS GV L+ + G P+
Sbjct: 187 LPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-09
Identities = 71/235 (30%), Positives = 104/235 (44%), Gaps = 27/235 (11%)
Query: 11 LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
+G G+FG L+ K AVK + R ++E Q +E I + HPN++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 66 EVLLTPTHLA-IVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
+ L +V+ Y G+L F R + +D F Q + G+ Y S + H
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQ-VAKGMEYLASKKFVH 121
Query: 123 RDLKLENTLLDGSPQPRLKICDFG-----YSK---SGLLHSQPKSTVGTPAYIAPEVLAR 174
RDL N +LD S +K+ DFG Y K S H+ K V ++A E L
Sbjct: 122 RDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESLQT 176
Query: 175 KEYDGKISDVWSCGVTLY-VMLVGA--YPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
+++ K SDVWS GV L+ +M GA YP D D + R+ +Y PD
Sbjct: 177 QKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEY-CPD 229
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-09
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
VK+LG+G FG + + VA+K +++G E E + L+HP ++R V
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 68 LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
+ T + I+ EY G L F + + + ++ Q+ G+++ HRDL
Sbjct: 70 V-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDL 128
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGK 180
+ N L+ S KI DFG ++ L + T A + APE + + K
Sbjct: 129 RAANILV--SETLCCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 181 ISDVWSCGVTLY-VMLVGAYPF---EDPEDPRNFRK 212
SDVWS G+ L ++ G P+ +PE +N +
Sbjct: 184 -SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER 218
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-09
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 9 KELGSGNFGV---ARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNII 62
K LG G FG +L +D + VAVK ++ + E+ E + + HPN++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILK-VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 63 RFKEVLLTPTHL------AIVMEYAAGGEL-----FARICSAGRFSEDEARF-FFQQLIS 110
R V L +++ + G+L ++R+ ++ + F + S
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYI 167
G+ Y S HRDL N +L+ + + + DFG SK +G + Q + +I
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 168 APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPED 206
A E LA + Y K SDVWS GVT++ + G P+ E+
Sbjct: 182 AIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVEN 220
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 2 EERYEPVKELGSGNFGVAR----LVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
E ++ +K LGSG FG + ++ K VA+K + K ++ + E S
Sbjct: 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 65
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLIS----- 110
+ +P++ R + LT T I +L C E + Q L++
Sbjct: 66 VDNPHVCRLLGICLTSTVQLIT-------QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 118
Query: 111 --GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--- 165
G++Y + HRDL N L+ PQ +KI DFG +K LL + K
Sbjct: 119 AKGMNYLEERRLVHRDLAARNVLVKT-PQ-HVKITDFGLAK--LLGADEKEYHAEGGKVP 174
Query: 166 --YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
++A E + + Y + SDVWS GVT++ +M G+ P++
Sbjct: 175 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-09
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 32/225 (14%)
Query: 6 EPVKELGSGNFGVARLVRDKRTKE-----LVAVKYIERGKKIDENVQ----REIINHRSL 56
+ + LG G FG L + K +E LV VK +++ K DEN+Q RE+ R L
Sbjct: 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKL 65
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLIS---- 110
H N++R + +++EY G+L F R + +Q ++
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 111 ---GVSYCHSMEICHRDLKLENTLLDGSPQPRLKI-----CDFGYSKSGLLHSQPKSTVG 162
G+ + + HRDL N L+ S Q +K+ Y+ +
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLV--SSQREVKVSLLSLSKDVYNSEYYKLRNALIPL- 182
Query: 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPED 206
++APE + ++ K SDVWS GV ++ V G PF D
Sbjct: 183 --RWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 23/154 (14%)
Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVG 162
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 242
Query: 163 TP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE----DPEDPRNFRKTIDR 216
P ++APE + + Y + SDVWS GV L+ + +GA P+ D E R ++ R
Sbjct: 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-R 300
Query: 217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDP 250
+R Y P+ + DC H +PS+ P
Sbjct: 301 MRAPDYTTPEMYQTMLDCWH-------GEPSQRP 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 10 ELGSG--NFGVARLVRDKRTKELVAVKYIERGKKIDENV---QREIINHRSLRHPNIIRF 64
E+G G N L R T LV V+ + +E++ Q E++ RHPNI+
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 65 KEVLLTPTHLAIV---MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
V T + L ++ M Y + L G SE + G++Y H
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQNGYI 123
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYS------KSGLLHSQPKSTVGTPAYIAPEVLARK 175
HR++K + L+ G L YS K+ +++ P+ + +++PE+L +
Sbjct: 124 HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD 183
Query: 176 EYDGKI-SDVWSCGVTLYVMLVGAYPFED 203
Y + SD++S G+T + G PF+D
Sbjct: 184 LYGYNVKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 52/228 (22%), Positives = 97/228 (42%), Gaps = 19/228 (8%)
Query: 21 LVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80
LV D RT++ +K + + + + II H PN++ + +++ + +V+++
Sbjct: 11 LVMDTRTQQTFILKGLRKSSEYSRE-RLTIIPHCV---PNMVCLHKYIVSEDSVFLVLQH 66
Query: 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRL 140
A GG+L++ I E+ + + +++ + H I RDL N LLD +L
Sbjct: 67 AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL 126
Query: 141 KICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYP 200
+S+ + Y APEV E + + D WS G L+ +L G
Sbjct: 127 TY----FSRWSEVEDSCDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTL 181
Query: 201 FEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK 248
E N + +P++ VS + R LL Q+ +P++
Sbjct: 182 VECHPSGIN--------THTTLNIPEW--VSEEARSLLQQLLQFNPTE 219
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 46/140 (32%), Positives = 69/140 (49%), Gaps = 16/140 (11%)
Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVG 162
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 236
Query: 163 TP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE----DPEDPRNFRKTIDR 216
P ++APE + K Y + SDVWS GV L+ + +GA P+ D E R ++ R
Sbjct: 237 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT-R 294
Query: 217 IRNVQYFLPDYVRVSADCRH 236
+R +Y P+ + DC H
Sbjct: 295 MRAPEYATPEIYSIMLDCWH 314
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 52/195 (26%), Positives = 86/195 (44%), Gaps = 17/195 (8%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
++ G G A D +T E V +K +RG E I+ R++ HP+II+ K
Sbjct: 97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATE---AHIL--RAINHPSIIQLKGT 151
Query: 68 LLTPTHLAIVM-EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
+++ Y +L+ + + + + + ++ + Y H I HRD+K
Sbjct: 152 FTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIK 209
Query: 127 LENTLLDGSPQPRLKIC--DFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEYDGKIS 182
EN ++ P +C DFG + + + K GT A APE+LAR Y G
Sbjct: 210 AENIFIN---HPG-DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAV 264
Query: 183 DVWSCGVTLYVMLVG 197
D+WS G+ L+ M
Sbjct: 265 DIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 2 EERYEPVKELGSGNFGVAR----LVRDKRTKELVAVKYIER--GKKIDENVQREIINHRS 55
E + VK LGSG FG + + K VA+K + G K + E + S
Sbjct: 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS 65
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSY 114
+ HP+++R V L+PT + +V + G L + + Q+ G+ Y
Sbjct: 66 MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAP 169
+ HRDL N L+ SP +KI DFG ++ LL K ++A
Sbjct: 125 LEERRLVHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMAL 180
Query: 170 EVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
E + +++ + SDVWS GVT++ +M G P++
Sbjct: 181 ECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 21/153 (13%)
Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVG 162
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K +
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGSAR 237
Query: 163 TP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTID---RI 217
P ++APE + K Y + SDVWS GV L+ + +GA P+ + F + + R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKDP 250
R + P+ R+ C DP + P
Sbjct: 297 RAPENATPEIYRIMLACWQ-------GDPKERP 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 33/217 (15%)
Query: 11 LGSGNFG--VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RHPNIIR 63
+G GNFG + +++ K A+K ++ + EN R+ + HPNII
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 64 FKEVLLTPTHLAIVMEYAAGGEL---------------FARI-CSAGRFSEDEARFFFQQ 107
+L I +EYA G L FA+ +A + + F
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT-PA- 165
+ +G+ Y + HRDL N L+ + KI DFG S+ ++ K T+G P
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMGRLPVR 183
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
++A E L Y K SDVWS GV L+ ++ +G P+
Sbjct: 184 WMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-08
Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 37/220 (16%)
Query: 6 EPVKELGSGNFGV---AR---LVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLR 57
E V+++G G FG AR L+ +VAVK ++ D + QRE
Sbjct: 8 EYVRDIGQGAFGRVFQARAPGLLPY-EPFTMVAVKMLKEEASADMQADFQREAALMAEFD 66
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGR-------------------- 95
HPNI++ V + ++ EY A G+L F R S
Sbjct: 67 HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 96 FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGL 152
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+ S
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRNIYSAD 184
Query: 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY 192
+ ++ ++ PE + Y + SDVW+ GV L+
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 223
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-08
Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 38/243 (15%)
Query: 9 KELGSGNFGVARL--VRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRF 64
KE+G+G FG L V T V VK + + E ++ E +RSL+H N+++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 65 KEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQ---QLISGVSYCHSME 119
T +VME+ G+L + R C + + ++ G+ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--------YIAPEV 171
H DL L N LL + +KI D+G S H++ K +IAPE+
Sbjct: 121 FIHSDLALRNCLL--TADLTVKIGDYGLS-----HNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 172 LARKEYDG--------KISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQY 222
+ E G K S+VWS GVT++ + +G+ P+ D + T +R Q
Sbjct: 174 V--DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT---VREQQL 228
Query: 223 FLP 225
LP
Sbjct: 229 KLP 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-08
Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 2 EERYEPVKELGSGNFGVAR----LVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRS 55
E +K LGSG FG + K VA+K I+ G++ + + ++ S
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVS 113
L H I+R + + L +V + + G L + R S D R + Q+ G+
Sbjct: 66 LDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQIAKGMY 123
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK----STVGTP-AYIA 168
Y + HR+L N LL ++I DFG + LL+ K S TP ++A
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSI--VQIADFGVAD--LLYPDDKKYFYSEHKTPIKWMA 179
Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPF 201
E + Y + SDVWS GVT++ M+ GA P+
Sbjct: 180 LESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-08
Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 11 LGSGNFG--VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RHPNIIR 63
+G GNFG + ++ + A+K ++ + ++ R+ + HPNII
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 64 FKEVLLTPTHLAIVMEYAAGGEL---------------FARI-CSAGRFSEDEARFFFQQ 107
+L + +EYA G L FA +A S + F
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT-PA- 165
+ G+ Y + HRDL N L+ + KI DFG S+ ++ K T+G P
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 176
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
++A E L Y SDVWS GV L+ ++ +G P+
Sbjct: 177 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 14/210 (6%)
Query: 9 KELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
K+LG+G FG V +K TK VAVK ++ G E E ++L+H +++ V
Sbjct: 12 KKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 68 LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
+ T + I+ E+ A G L F + + + F Q+ G+++ HRDL
Sbjct: 70 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKIS 182
+ N L+ S KI DFG ++ + ++ + G + APE + + K S
Sbjct: 129 RAANILV--SASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-S 184
Query: 183 DVWSCGVTLY-VMLVGAYPFEDPEDPRNFR 211
DVWS G+ L ++ G P+ +P R
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 33/223 (14%)
Query: 9 KELGSGNFGVARLVR----DK-RTKELVAVKYIERGKKIDENVQREIINHRSL-----RH 58
K LG G FG + DK + KE V V E ++++ + +H
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELF----ARICSAGRFSEDEAR-----FFFQQLI 109
NII L +++EYA+ G L AR +S D AR F+ L+
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 110 S-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTV 161
S G+ Y S + HRDL N L+ + +KI DFG ++ + K+T
Sbjct: 141 SCTYQVARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 162 GT-PA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
G P ++APE L + Y + SDVWS GV ++ + +G P+
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 44/123 (35%), Positives = 57/123 (46%), Gaps = 19/123 (15%)
Query: 106 QQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKIC--DFGY------SKSGLLHSQP 157
+QL+S + Y H I HRD+K EN L++G P+ IC DFG S S H
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNG-PE---DICLGDFGAACFARGSWSTPFHYGI 322
Query: 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDP--RNFRKTI 214
TV T APEVLA Y + D+WS G+ ++ V A F R + I
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI 378
Query: 215 DRI 217
RI
Sbjct: 379 LRI 381
|
Length = 461 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 9 KELGSGNFGVARLV------RDKRTKEL-VAVKYIE---RGKKIDENVQREIINHRSLRH 58
K LG G FG + +DK K + VAVK ++ K + + V + +H
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELF----ARICSAGRFSED-----EARFFFQQLI 109
NII L +++EYA+ G L AR +S D E + F+ L+
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 110 S-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKS 159
S G+ Y S + HRDL N L+ + +KI DFG ++ +H+ K+
Sbjct: 138 SCAYQVARGMEYLASQKCIHRDLAARNVLV--TEDNVMKIADFGLARD--VHNIDYYKKT 193
Query: 160 TVGT-PA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
T G P ++APE L + Y + SDVWS GV L+ + +G P+
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-07
Identities = 63/253 (24%), Positives = 98/253 (38%), Gaps = 23/253 (9%)
Query: 11 LGSGNFG-VAR--LVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFK 65
LG+G FG + R L + + VA+ + G K E + H NI+R +
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 66 EVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
V+ + IV EY + G L F R G+ + L SG+ Y M H+
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEMGYVHK 131
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG-TPA-YIAPEVLARKEYDGKI 181
L L++ KI F + + + G +P + APE + +
Sbjct: 132 GLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA- 188
Query: 182 SDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
SDVWS G+ ++ VM G P+ D + D R LP +C +LL Q
Sbjct: 189 SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-----LP----APRNCPNLLHQ 239
Query: 241 IFVADPSKDPHSR 253
+ + K+ R
Sbjct: 240 LMLDCWQKERGER 252
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 5e-07
Identities = 63/242 (26%), Positives = 97/242 (40%), Gaps = 49/242 (20%)
Query: 9 KELGSGNFGVARL-----------------VRDKRTKELVAVKYI--ERGKKIDENVQRE 49
++LG G FG L VR R LVAVK + + K + +E
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPL-LVAVKILRPDANKNARNDFLKE 69
Query: 50 IINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEAR------- 102
+ L+ PNIIR V + L ++ EY G+L + S+ + E
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPP 128
Query: 103 -------------FFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149
Q+ SG+ Y S+ HRDL N L+ + +KI DFG S+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSR 186
Query: 150 ---SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY--VMLVGAYPFEDP 204
+G + V ++A E + ++ SDVW+ GVTL+ +ML P+ +
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKEQPYGEL 245
Query: 205 ED 206
D
Sbjct: 246 TD 247
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 75/265 (28%), Positives = 117/265 (44%), Gaps = 37/265 (13%)
Query: 3 ERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
E + +K+LG+G FG V + TK VAVK ++ G E+ E + LRH +
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSE-----DEARFFFQQLISGVSYC 115
++ V+ + + IV EY + G L + GR + D A Q+ +G++Y
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYI 118
Query: 116 HSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAP 169
M HRDL+ N L+ DG KI DFG ++ L + T A + AP
Sbjct: 119 ERMNYIHRDLRSANILVGDGLV---CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAP 172
Query: 170 EVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228
E + K SDVWS G+ L ++ G P+ N R+ ++++ Y +P
Sbjct: 173 EAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPG----MNNREVLEQVER-GYRMP--- 223
Query: 229 RVSADCRHLLSQIFVADPSKDPHSR 253
DC L ++ + KDP R
Sbjct: 224 -CPQDCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 30/219 (13%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN-- 60
+R++ + LG G FG D++ KE AVK + K + + EI +R +
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPA 188
Query: 61 ----IIRFKEVLLTPT-HLAIVM-EYAAGGELFARICSAGRFSEDE-ARFFFQQLISGVS 113
+++ + T H+ IVM +Y G L I G FS A+ FQ ++ +
Sbjct: 189 DRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGVA-LD 245
Query: 114 YCHS-MEICHRDLKLENTLLDGS-------------PQP-RLKICDFGYSKSGLLHSQPK 158
Y H+ + + H DLK EN L++ S P P R++ICD G HS+
Sbjct: 246 YFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSR-T 303
Query: 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVG 197
+ V T Y +PEV+ + +D+WS G +Y + G
Sbjct: 304 AIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 58/215 (26%), Positives = 86/215 (40%), Gaps = 24/215 (11%)
Query: 8 VKELGSGNFG-----VARLVRDKRTKELVAVKYI-ERGKKIDE-NVQREIINHRSLRHPN 60
++ LG G FG + R + VAVK + E + DE + E + H N
Sbjct: 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQN 70
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGEL--FARIC--SAGRFSE---DEARFFFQQLISGVS 113
I+R V I++E AGG+L F R R S + F + + G
Sbjct: 71 IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 114 YCHSMEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YI 167
Y HRD+ N LL P KI DFG ++ ++ G A ++
Sbjct: 131 YLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARD--IYRASYYRKGGRAMLPIKWM 188
Query: 168 APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
PE + K +DVWS GV L+ + +G P+
Sbjct: 189 PPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 25/166 (15%)
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSED-----EARFFFQQ 107
+H NII V L +++EYAA G L AR ++ D E + F+
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 108 LIS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PK 158
L+S G+ Y S HRDL N L+ + +KI DFG ++ G+ K
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLV--TEDNVMKIADFGLAR-GVHDIDYYKK 192
Query: 159 STVG-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
++ G P ++APE L + Y + SDVWS G+ ++ + +G P+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 62/221 (28%), Positives = 92/221 (41%), Gaps = 41/221 (18%)
Query: 11 LGSGNFGV---ARLVRD--------KRTKELVAVKYIERGKKIDENVQREIINHRSLRHP 59
+G GNFG AR+ +D KR KE Y + D + E++ + HP
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-----YASKDDHRDFAGELEVLC-KLGHHP 68
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELF-----ARIC-----------SAGRFSEDEARF 103
NII +L + +EYA G L +R+ +A S +
Sbjct: 69 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 104 FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT 163
F + G+ Y + HRDL N L+ KI DFG S+ ++ K T+G
Sbjct: 129 FAADVARGMDYLSQKQFIHRDLAARNILV--GENYVAKIADFGLSRGQEVYV--KKTMGR 184
Query: 164 -PA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
P ++A E L Y SDVWS GV L+ ++ +G P+
Sbjct: 185 LPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 64/254 (25%), Positives = 108/254 (42%), Gaps = 41/254 (16%)
Query: 29 ELVAVKYIERGKKIDE--NVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL 86
+LVA+K ++ + Q+E L HPNI+ V+ + ++ EY G+L
Sbjct: 35 QLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94
Query: 87 FARI----------CSAG-----RFSEDEARFFFQ--QLISGVSYCHSMEICHRDLKLEN 129
+ CS+ + S D F Q+ +G+ Y S H+DL N
Sbjct: 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN 154
Query: 130 TLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
L+ Q +KI D G S+ + QPKS + ++ PE + ++ SD+W
Sbjct: 155 ILI--GEQLHVKISDLGLSREIYSADYYRVQPKSLLPI-RWMPPEAIMYGKFSSD-SDIW 210
Query: 186 SCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC----RHLLSQ 240
S GV L+ + G P+ + ++ I+ +R Q LP S DC L+++
Sbjct: 211 SFGVVLWEIFSFGLQPYYGFSN----QEVIEMVRKRQ-LLP----CSEDCPPRMYSLMTE 261
Query: 241 IFVADPSKDPHSRD 254
+ PS+ P +D
Sbjct: 262 CWQEGPSRRPRFKD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 40/120 (33%), Positives = 59/120 (49%), Gaps = 13/120 (10%)
Query: 104 FFQQLISGVSYCHSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQ---PKS 159
F Q+ +G+ + S HRDL N L+ +G +KICDFG ++ + S S
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGK---LVKICDFGLARDIMRDSNYISKGS 300
Query: 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRN--FRKTIDR 216
T ++APE + Y +SDVWS G+ L+ + +G P+ PE P N F I R
Sbjct: 301 TFLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPY--PELPMNEQFYNAIKR 357
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 15/212 (7%)
Query: 2 EERYEPVKELGSGNFGVAR----LVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
E + VK LGSG FG + + K VA+K + K ++ + E
Sbjct: 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAG 65
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARIC-SAGRFSEDEARFFFQQLISGVSY 114
+ P + R + LT T + +V + G L + + R + + Q+ G+SY
Sbjct: 66 VGSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSY 124
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA---YIAPEV 171
+ + HRDL N L+ SP +KI DFG ++ + G ++A E
Sbjct: 125 LEEVRLVHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 172 LARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
+ + + + SDVWS GVT++ +M GA P++
Sbjct: 183 ILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-06
Identities = 59/245 (24%), Positives = 99/245 (40%), Gaps = 41/245 (16%)
Query: 9 KELGSGNFG------------VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL 56
+E+G+G FG VAR+V KEL A K ++ +R L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVV----VKELKA----NASSKEQNEFLQQGDPYRIL 52
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQ----QLISGV 112
+HPNI++ + +V EY G+L + + + Q ++ +GV
Sbjct: 53 QHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGV 112
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS----KSGLLHSQPKSTVGTPAYIA 168
++ H H DL L N L +K+ D+G K + ++ V ++A
Sbjct: 113 THMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPL-RWLA 169
Query: 169 PEVLARKEYDG-------KISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNV 220
PE++ G K S+VW+ GVTL+ + A P+ D R + + + V
Sbjct: 170 PELVGEFH-GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKDQQV 227
Query: 221 QYFLP 225
+ F P
Sbjct: 228 KLFKP 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 6e-06
Identities = 44/203 (21%), Positives = 79/203 (38%), Gaps = 29/203 (14%)
Query: 11 LGSGNF-----GVARLVRDK----RTKEL-VAVKYIERGKKIDENVQREIINHRSLRHPN 60
LG G F GV R+ D +E+ V +K + + L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGEL-----FARICSAGRFSEDEARFFFQQLISGVSYC 115
+++ V + ++ +V EY G L + + + D A +QL S + Y
Sbjct: 63 LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVA----KQLASALHYL 117
Query: 116 HSMEICHRDLKLENTLL-----DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
++ H ++ +N L+ + P +K+ D G + L + + +IAPE
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI---PWIAPE 174
Query: 171 VLARKEYDGKI-SDVWSCGVTLY 192
+ + I +D WS G TL
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLL 197
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-06
Identities = 63/250 (25%), Positives = 104/250 (41%), Gaps = 23/250 (9%)
Query: 10 ELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
+LG G FG V + T+ VA+K ++ G E +E + LRH +++ V+
Sbjct: 13 KLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 69 LTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
+ + IV EY + G L F + + Q+ SG++Y M HRDL+
Sbjct: 71 -SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 129
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKI 181
N L+ K+ DFG ++ L + T A + APE + K
Sbjct: 130 AANILV--GENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK- 183
Query: 182 SDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
SDVWS G+ L + G P+ + R+ +D++ Y +P L+ Q
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQ 238
Query: 241 IFVADPSKDP 250
+ +P + P
Sbjct: 239 CWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 8e-06
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 25/226 (11%)
Query: 9 KELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHP 59
K LG+G FG A + VAVK ++ E + +I++H H
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG-NHE 99
Query: 60 NIIRFKEVLLTPTH---LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSY 114
NI+ +L T + ++ EY G+L F R + ++ F Q+ G+++
Sbjct: 100 NIV---NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPA-YIAPEV 171
S HRDL N LL + +KICDFG ++ + S K P ++APE
Sbjct: 157 LASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214
Query: 172 LARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDR 216
+ Y + SDVWS G+ L+ + +G+ P+ F K I
Sbjct: 215 IFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 9e-06
Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 16/166 (9%)
Query: 104 FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT 163
F Q+ G+ + S HRDL N LL + +KICDFG ++ ++H + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLARD-IMHDSNYVSKGS 298
Query: 164 P----AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIR 218
++APE + Y +SDVWS G+ L+ + +G P+ F I
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK--S 355
Query: 219 NVQYFLPDYVRVSADCRHLLSQIFVADPSKDP---HSRDQKASLVP 261
+ PD+ + + ++ + + ++P K P H D SL+P
Sbjct: 356 GYRMAKPDH--ATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 41/227 (18%)
Query: 9 KELGSGNFGVARLV------RDKRTK-ELVAVKYIERGKKIDENVQREIINHRSL----- 56
K LG G FG + ++K + VAVK ++ E ++I+ +
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLK--SDATEKDLSDLISEMEMMKMIG 81
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELF----ARICSAGRFSED-----EARFFFQQ 107
+H NII L +++EYA+ G L AR + + E + F+
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 108 LIS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QP 157
L+S G+ Y S + HRDL N L+ + +KI DFG ++ +H
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLARD--IHHIDYYK 197
Query: 158 KSTVGT-PA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
K+T G P ++APE L + Y + SDVWS GV L+ + +G P+
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 22/173 (12%)
Query: 40 KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSED 99
++ EI + L+HPNI++ + + ++ EY G L + + +
Sbjct: 724 NDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL-SEVLRNLSW--- 779
Query: 100 EARFFFQQLISGVS------YCH-SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152
E R +++ G++ +C S + +L E ++DG +P L++ S GL
Sbjct: 780 ERR---RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRL-----SLPGL 831
Query: 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE 205
L + K + + AY+APE K+ K SD++ G+ L +L G P D E
Sbjct: 832 LCTDTKCFISS-AYVAPETRETKDITEK-SDIYGFGLILIELLTGKSP-ADAE 881
|
Length = 968 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 9e-05
Identities = 21/56 (37%), Positives = 32/56 (57%), Gaps = 1/56 (1%)
Query: 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR 216
+GTP Y+APE+L K + + D W+ GV L+ L G PF D + F+ ++R
Sbjct: 541 LGTPDYLAPELLLGKPHGPAV-DWWALGVCLFEFLTGIPPFNDETPQQVFQNILNR 595
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 61/249 (24%), Positives = 100/249 (40%), Gaps = 21/249 (8%)
Query: 10 ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
+LG G FG + T + VA+K ++ G + E +E + LRH ++ V+
Sbjct: 13 KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV- 70
Query: 70 TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
+ + IV E+ G L F + + Q+ G++Y M HRDL+
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRA 130
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
N L+ KI DFG ++ L + T A + APE + K S
Sbjct: 131 ANILV--GDNLVCKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 184
Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
DVWS G+ L ++ G P+ + R + ++R Y +P L+
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVN-REVLEQVER----GYRMPCPQGCPESLHELMKLC 239
Query: 242 FVADPSKDP 250
+ DP + P
Sbjct: 240 WKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 51/224 (22%)
Query: 3 ERYEPVKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR 57
E+ ++ELG G+FG AR + + VAVK + + E + E +N S+
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63
Query: 58 HP----NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSED----------EARF 103
+++R V+ +VME A G+L + + S +E+ E
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 104 FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK------------SG 151
++ G++Y ++ + HRDL N ++ + +KI DFG ++ G
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMV--AHDFTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKI---SDVWSCGVTLY 192
LL + ++APE L DG SD+WS GV L+
Sbjct: 182 LLPVR---------WMAPESLK----DGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 6e-04
Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 9/103 (8%)
Query: 104 FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQ--PKST 160
F Q+ G+S+ S HRDL N LL R+ KICDFG ++ S K
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSNYVVKGN 275
Query: 161 VGTPA-YIAPEVLARKEYDGKISDVWSCGVTLYVML-VGAYPF 201
P ++APE + Y + SDVWS G+ L+ + +G+ P+
Sbjct: 276 ARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 8e-04
Identities = 40/134 (29%), Positives = 60/134 (44%), Gaps = 10/134 (7%)
Query: 98 EDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ- 156
+D RF Q + G+ + S HRD+ N LL + KICDFG ++ + S
Sbjct: 212 DDLLRFSSQ-VAQGMDFLASKNCIHRDVAARNVLL--TDGRVAKICDFGLARDIMNDSNY 268
Query: 157 -PKSTVGTPA-YIAPEVLARKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKT 213
K P ++APE + Y + SDVWS G+ L+ + +G P+ F K
Sbjct: 269 VVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327
Query: 214 IDRIRNVQYFLPDY 227
+ R Q PD+
Sbjct: 328 VK--RGYQMSRPDF 339
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 53/236 (22%), Positives = 98/236 (41%), Gaps = 38/236 (16%)
Query: 44 ENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARIC------SAGRFS 97
E + E + L+HPNI+ V+ L+++ Y + +L + G
Sbjct: 53 EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112
Query: 98 EDE--------ARFF--FQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY 147
+D+ A F Q+ +G+ + S + H+DL N L+ + +KI D G
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV--FDKLNVKISDLGL 170
Query: 148 SK---SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
+ + + +++ +++PE + ++ SD+WS GV L+ V G P+
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCG 229
Query: 204 PEDPRNFRKTIDRIRNVQYFL-PDYVRVSADC----RHLLSQIFVADPSKDPHSRD 254
+ + I+ IRN Q PD DC L+ + + PS+ P +D
Sbjct: 230 YSN----QDVIEMIRNRQVLPCPD------DCPAWVYTLMLECWNEFPSRRPRFKD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 51/221 (23%), Positives = 93/221 (42%), Gaps = 45/221 (20%)
Query: 3 ERYEPVKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR 57
E+ +ELG G+FG +A+ V + VA+K + + E + E +N S+
Sbjct: 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVM 63
Query: 58 HP----NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEA-------RFFFQ 106
+++R V+ ++ME G+L + + S E+ + Q
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 107 ---QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK------------SG 151
++ G++Y ++ + HRDL N ++ + +KI DFG ++ G
Sbjct: 124 MAGEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY 192
LL + +++PE L + SDVWS GV L+
Sbjct: 182 LLPVR---------WMSPESLKDGVFTTY-SDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 21/69 (30%), Positives = 33/69 (47%), Gaps = 5/69 (7%)
Query: 105 FQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTV 161
+Q++ + HS I HRD+K +N + KI D G + + G ++ PK +
Sbjct: 261 MRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG-SFKIIDLGAAADLRVG-INYIPKEFL 318
Query: 162 GTPAYIAPE 170
P Y APE
Sbjct: 319 LDPRYAAPE 327
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 269 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.94 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.93 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.88 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.83 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.81 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.74 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.73 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.66 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.64 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.61 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.59 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.54 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.53 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.51 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.42 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.41 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.37 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.28 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.25 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.21 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.1 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.08 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.97 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.9 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.88 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.79 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.75 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.67 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.67 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.64 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.63 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.62 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.48 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.43 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.41 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.41 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.4 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.29 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.27 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.25 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 98.12 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.08 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.08 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.06 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.03 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.97 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.91 | |
| PLN02236 | 344 | choline kinase | 97.89 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.72 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.65 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.65 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.53 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.49 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.48 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.47 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.32 | |
| PTZ00384 | 383 | choline kinase; Provisional | 97.29 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.28 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.07 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.01 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.99 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.97 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.8 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 96.58 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.46 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.19 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.98 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-61 Score=379.16 Aligned_cols=259 Identities=36% Similarity=0.572 Sum_probs=228.3
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcccc--------HHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--------ENVQREIINHRSLRHPNIIRFKEVLLTPTH 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (269)
.+.|.+.+.||+|+||.|-+|....+|+.||||++.+..... ....+|+++|++|+|||||+++++|..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 467899999999999999999999999999999997532211 235689999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC-CCCcEEEeecCCcccCC
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGL 152 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~-~~~~~~l~df~~~~~~~ 152 (269)
.|+|+||++||.|.+.+..++.+.+..-..+++|++.|+.|||++||+||||||+||++..+ ..+.+||+|||+|+...
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG 330 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence 99999999999999999999999999999999999999999999999999999999999877 33568999999999877
Q ss_pred CCCCCCcccCCCcccCchhhccccC--CCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC--CCcC
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEY--DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYV 228 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 228 (269)
......+.+|||.|.|||++.+... +..+.|+|||||++|-+++|.+||....... ...+.+.++.+.+ +.|.
T Consensus 331 ~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---sl~eQI~~G~y~f~p~~w~ 407 (475)
T KOG0615|consen 331 EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---SLKEQILKGRYAFGPLQWD 407 (475)
T ss_pred cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc---cHHHHHhcCcccccChhhh
Confidence 7788889999999999999986543 3445899999999999999999998755433 3455566666544 4577
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 229 RVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.++++..+||.+||..||++|||+.++|.|||++-
T Consensus 408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 408 RISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 89999999999999999999999999999999983
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-59 Score=386.74 Aligned_cols=250 Identities=36% Similarity=0.602 Sum_probs=233.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeec----CccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER----GKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.+|...+.||+|||..+|.+++..+|+.||+|++++ .....+.+.+|+++.++|+|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 469999999999999999999999999999999987 4556678999999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~ 157 (269)
|.|..++|..++.+.+++++.+++.+++||+.||.|||+.+|+|||||..|+|++.+-+ |||+|||+|...... +..
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCccccc
Confidence 99999999999999999999999999999999999999999999999999999998888 999999999865544 677
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
.+.+|||.|.|||++.....+-. +||||+||++|.|++|++||.. ..+.+....++..++.+|. .++.+.++|
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFet----k~vkety~~Ik~~~Y~~P~--~ls~~A~dL 248 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFET----KTVKETYNKIKLNEYSMPS--HLSAEAKDL 248 (592)
T ss_pred ceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCccc----chHHHHHHHHHhcCccccc--ccCHHHHHH
Confidence 78899999999999987666555 9999999999999999999987 4568888899999999988 899999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccCh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
|.+||++||.+|||++++|.|+||
T Consensus 249 I~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 249 IRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred HHHHhcCCcccCCCHHHHhcCHhh
Confidence 999999999999999999999999
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-59 Score=366.71 Aligned_cols=258 Identities=30% Similarity=0.479 Sum_probs=227.7
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeec--CccccHHHHHHHHHHHhCCCCCcceeeEEEEeCC-eEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT-HLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e~ 80 (269)
+.+.++.||+|..|+||+++|..|++.+|+|.+.. +.....++.+|+++++..+||+||+++++|..+. .++++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 56778999999999999999999999999999953 3344567889999999999999999999999999 59999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 159 (269)
|++|+|.+.+...+.+++..+..++.++++||.|||+ .+|+||||||+||+++..|. |||||||.+...... ...+
T Consensus 160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~a~t 236 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-IANT 236 (364)
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-hccc
Confidence 9999999999988999999999999999999999995 99999999999999998888 999999999765444 6678
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCC-CChhhHHHHHHHHhhc-cccCCCcCCCCHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDP-EDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRHL 237 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 237 (269)
..||..|||||.+.+..++.+ +||||||+.++|+++|+.||... .......++...+... ...+|. ..+|+++++|
T Consensus 237 fvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~-~~fS~ef~~F 314 (364)
T KOG0581|consen 237 FVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE-GEFSPEFRSF 314 (364)
T ss_pred ccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc-ccCCHHHHHH
Confidence 899999999999999988777 99999999999999999999875 3334455556666553 444554 2499999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
|..||++||.+||++.|++.|+|...+..
T Consensus 315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 315 VSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 99999999999999999999999998764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-57 Score=352.98 Aligned_cols=255 Identities=35% Similarity=0.571 Sum_probs=226.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++++.||+|+||.|++|+..++++.||+|++.+.. ...+...+|..++.+++||.||+++-.|++.+.+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 68999999999999999999999999999999997643 23456788999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~ 157 (269)
||+.||.|...+++.+.+++..+.-++..|+.||.|||+.||+|||+||+|||++.+|+ ++|+|||+|+..... ...
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~~~~t 182 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKDGDAT 182 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccCCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999 999999999854444 445
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
.+.+||+.|+|||++....++.. +|.||||+++|+|++|.+||...+. ..+.+.+.......+. .-++.+.+++
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~----~~~~~~I~~~k~~~~p-~~ls~~ardl 256 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDV----KKMYDKILKGKLPLPP-GYLSEEARDL 256 (357)
T ss_pred ccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccH----HHHHHHHhcCcCCCCC-ccCCHHHHHH
Confidence 56699999999999998877555 9999999999999999999988654 5566666666633333 1489999999
Q ss_pred HHHHhhhCCCCCC----CcHHHhhccChhhhh
Q 024336 238 LSQIFVADPSKDP----HSRDQKASLVPEEFA 265 (269)
Q Consensus 238 i~~~l~~~p~~Rp----s~~~~l~~~~~~~~~ 265 (269)
++++|+.||++|. ++.++-+|+||..+.
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 9999999999995 789999999998743
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-57 Score=367.58 Aligned_cols=254 Identities=33% Similarity=0.509 Sum_probs=224.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|.+++.||.|+|++|++|.+..+++.||||++.+... ..+-...|-.+|.+| .||+|++++-.|.++..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 589999999999999999999999999999999876432 223456788888888 899999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ- 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 156 (269)
+||+++|.|.++|.+.+.|++...+.++.+|+.||+|||++|||||||||+||+++.+++ ++|+|||.+........
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChhhcc
Confidence 999999999999999999999999999999999999999999999999999999999998 99999998863221111
Q ss_pred -------------CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcccc
Q 024336 157 -------------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF 223 (269)
Q Consensus 157 -------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (269)
.....||..|.+||.+..+..... +|+|+|||++|+|+.|.+||...++... .+++....+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-sDiWAlGCilyQmlaG~PPFra~Neyli----FqkI~~l~y~ 305 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS-SDLWALGCILYQMLAGQPPFRAANEYLI----FQKIQALDYE 305 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcc-cchHHHHHHHHHHhcCCCCCccccHHHH----HHHHHHhccc
Confidence 134678999999999987777555 9999999999999999999998777444 4556667888
Q ss_pred CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 224 LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
++. +.++.+.+||+++|..||++|+++.||.+|+||..+.
T Consensus 306 fp~--~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 306 FPE--GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred CCC--CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 888 8999999999999999999999999999999998753
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-55 Score=347.92 Aligned_cols=257 Identities=35% Similarity=0.538 Sum_probs=225.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
..+|.+.+.||+|+|++||++++..++..||||.+.+.. +..+.+..|+.+|+.++|||||.+++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 468999999999999999999999999999999997643 34456788999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC-CC---CcEEEeecCCcccCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS-PQ---PRLKICDFGYSKSGLLH 154 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~-~~---~~~~l~df~~~~~~~~~ 154 (269)
|||+||+|.+++++.+.+++..++.++.||+.||++||+++|+||||||.||+++.. +. ..+||+|||+++.....
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 999999999999999999999999999999999999999999999999999999865 33 56899999999988888
Q ss_pred CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC-cCCCCHH
Q 024336 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-YVRVSAD 233 (269)
Q Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 233 (269)
....+.+|+|.|||||++....|+.+ +|+||+|+++|++++|..||...+..+ +...++......+. ....+..
T Consensus 169 ~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~e----L~~~~~k~~~~~~~~~~~~s~~ 243 (429)
T KOG0595|consen 169 SMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKE----LLLYIKKGNEIVPVLPAELSNP 243 (429)
T ss_pred hHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHH----HHHHHhccccccCchhhhccCc
Confidence 88889999999999999998999777 999999999999999999998766533 33344444332222 2256667
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
..+++...+..+|.+|.+..+-+.|++..+
T Consensus 244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 244 LRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred hhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 779999999999999999999999887654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-56 Score=339.22 Aligned_cols=262 Identities=26% Similarity=0.441 Sum_probs=221.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|+.+..+|+|+||+||++++++||+.||||.+..+.. ..+...+|+++|++++|+|+|.++++|...+.+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 689999999999999999999999999999999975543 23457899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC-CCCCC
Q 024336 80 YAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQP 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~-~~~~~ 157 (269)
||+. ++++.++.. ...+.+.+..+++|++.|+.|+|+++++||||||+||+++.++. +||||||.|+... ++...
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcchh
Confidence 9987 555656554 45899999999999999999999999999999999999999988 9999999998655 44455
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc---------------cc
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QY 222 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------------~~ 222 (269)
.....|.+|+|||.+.+...+.++.|||++||++.||++|.+.|.+.++-+.+-......... ..
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 566789999999999987777777999999999999999999999988766554433222211 11
Q ss_pred cCCC----------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhhc
Q 024336 223 FLPD----------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAER 267 (269)
Q Consensus 223 ~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~~ 267 (269)
.+|. ...++.-+.+|++.||+.||.+|++.+|++.|++|..|.+|
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er 293 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER 293 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence 1121 13455678899999999999999999999999999998765
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-55 Score=357.58 Aligned_cols=255 Identities=47% Similarity=0.760 Sum_probs=231.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecC----c--cccHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----K--KIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (269)
.++|.+.+.||+|.||.|+.+.+..++..||+|++.+. . ...+.+.+|+.+++.+. ||||+++++++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 46899999999999999999999999999999977653 1 23456778999999998 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC-CCCcEEEeecCCcccC-C
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSG-L 152 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~-~~~~~~l~df~~~~~~-~ 152 (269)
++||||+.||.|.+++.+.+++.+.++..+++|++.|++|+|++||+||||||+||+++.+ ++ +||+|||++... .
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~--~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN--LKLSDFGLSAISPG 173 (370)
T ss_pred EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC--EEEeccccccccCC
Confidence 9999999999999999998999999999999999999999999999999999999999988 66 999999999866 4
Q ss_pred CCCCCCcccCCCcccCchhhcccc-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
......+.+|++.|+|||++.+.. +..+++|+||+|+++|.|++|..||...+ ...+...+..+.+.+|.+.. +
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~----~~~l~~ki~~~~~~~p~~~~-S 248 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN----VPNLYRKIRKGEFKIPSYLL-S 248 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc----HHHHHHHHhcCCccCCCCcC-C
Confidence 566778889999999999999988 88888999999999999999999999843 35555668888888888434 9
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+++.+||.+||..||.+|+++.++++|+|++.
T Consensus 249 ~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 249 PEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 99999999999999999999999999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=352.63 Aligned_cols=257 Identities=30% Similarity=0.506 Sum_probs=223.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|+++..||+|+||.||+|+.+.||..+|+|++.++. .+.+..+.|-.+|...++|+||+++-.|++.+.+|+||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 68999999999999999999999999999999998753 33456788999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-----
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL----- 153 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~----- 153 (269)
||++||++.+++.+.+.+++..++.++.+++.|++.+|+.|++||||||+|++||..|+ +||+|||+|.....
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999 99999999841100
Q ss_pred ------------------CCC-----C--------------------CcccCCCcccCchhhccccCCCccchhhhHHHH
Q 024336 154 ------------------HSQ-----P--------------------KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVT 190 (269)
Q Consensus 154 ------------------~~~-----~--------------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 190 (269)
... . ....|||.|+|||++.+..+... +|.||||||
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cDwWSLG~I 377 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CDWWSLGCI 377 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-ccHHHHHHH
Confidence 000 0 12348999999999999987666 999999999
Q ss_pred HHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCC---cHHHhhccChhhhh
Q 024336 191 LYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPH---SRDQKASLVPEEFA 265 (269)
Q Consensus 191 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~~~~~~~~ 265 (269)
+|||+.|.+||.+.+..+....++..-. .+.+|....++++..+||.+||. ||.+|.. ++||.+||||..+.
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~--~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRE--TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhh--hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 9999999999998776555544444322 24566667889999999999999 9999986 89999999998753
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-55 Score=362.16 Aligned_cols=255 Identities=36% Similarity=0.690 Sum_probs=240.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
+-|+.++.||.|+.|.|-+|++..||+.+|||++.+. ......+.+|+-+++.+.|||++++++++++...+|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3588999999999999999999999999999999764 233456899999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||++||-|.+++-..+++++.+...+++||+.|+.|+|..+|+|||+||+|++++..++ +||+|||+|.....+....
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLLE 169 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCcccc
Confidence 99999999999999999999999999999999999999999999999999999999888 9999999998878888889
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
+.+|+|.|.|||++.+..|...++||||-|+|+|.|+||+.||++ +++..+...++.+.+.+|. .+|++..+||
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~G~f~MPs--~Is~eaQdLL 243 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQRGVFEMPS--NISSEAQDLL 243 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHcCcccCCC--cCCHHHHHHH
Confidence 999999999999999999999999999999999999999999985 4668888999999999997 8999999999
Q ss_pred HHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 239 SQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
++||..||+.|.|.+||++|||...+.
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHhccCccccccHHHHhhCchhhcCC
Confidence 999999999999999999999998764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-55 Score=350.15 Aligned_cols=260 Identities=29% Similarity=0.439 Sum_probs=225.8
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHH--HHHHHHHHHhCC-CCCcceeeEEEEeCC-eEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN--VQREIINHRSLR-HPNIIRFKEVLLTPT-HLAIV 77 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~~v 77 (269)
-++|.++++||.|.||.||+|+...+|+.||||.+.+.....++ -.+|+..|++|+ ||||+++.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 47899999999999999999999999999999998764444443 568999999998 999999999999888 89999
Q ss_pred EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 78 MEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
||||+. +|.+++.. ++.|++..++.|+.||++||+|+|++|+.|||+||+||++..... +||+|||+|+......+
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREVRSKPP 165 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEecccccccccccCCC
Confidence 999975 89999865 456999999999999999999999999999999999999997665 99999999998777777
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh---------------cc
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN---------------VQ 221 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~---------------~~ 221 (269)
......|.+|+|||++....+++.+.|+|++||+++|+.+-++.|.+.++.+++..+.+-+.. .+
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn 245 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN 245 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence 788889999999999988877777799999999999999999999998877666555433322 23
Q ss_pred ccCCCc---------CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 222 YFLPDY---------VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 222 ~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+.+|.. ...+.++.++|.+||+.||.+||||.|+++|+||+.-
T Consensus 246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 344432 2467889999999999999999999999999999863
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-54 Score=325.16 Aligned_cols=252 Identities=34% Similarity=0.592 Sum_probs=230.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++++.||.|+||.|.+++++.+|..+|+|++.+.. ++.+...+|..+|+.+.||.++++.+.+.+.+.+|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 57999999999999999999999999999999997653 33456778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||++||-|..++++.+++++..++-++.||+.||+|||+.+|++||+||+||++|.+|+ +|++|||.++. .....-
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~--v~~rT~ 199 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKR--VSGRTW 199 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEE--ecCcEE
Confidence 99999999999999999999999999999999999999999999999999999999999 99999999984 344467
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
+.+|||.|+|||.+.+..+... +|.|+||+++|||+.|.+||...+. ..+.+.+..+...+|. -+++++++||
T Consensus 200 TlCGTPeYLAPEii~sk~ynka-vDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v~fP~--~fs~~~kdLl 272 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKA-VDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKVKFPS--YFSSDAKDLL 272 (355)
T ss_pred EecCCccccChHHhhcCCCCcc-hhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcccCCc--ccCHHHHHHH
Confidence 7899999999999988887554 9999999999999999999987655 6677888888998888 7999999999
Q ss_pred HHHhhhCCCCC-----CCcHHHhhccChhhhh
Q 024336 239 SQIFVADPSKD-----PHSRDQKASLVPEEFA 265 (269)
Q Consensus 239 ~~~l~~~p~~R-----ps~~~~l~~~~~~~~~ 265 (269)
+++|+.|-.+| ...+++..|+||....
T Consensus 273 ~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 273 KKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred HHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 99999999999 5678999999998753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-55 Score=328.56 Aligned_cols=244 Identities=32% Similarity=0.497 Sum_probs=210.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC---ccccHHHHHHHHHHHhCCCCCcceeeE-EEEeCCe-EEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKE-VLLTPTH-LAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~-~~~v 77 (269)
.+|++++.||+|.||+||++++..+|+.+|.|.+... ....+....|+.+|++|+|||||++++ .|.++.. +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3599999999999999999999999999999998743 344556788999999999999999998 5555554 8999
Q ss_pred EeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 78 MEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHS--ME--ICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~--~~--i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
||+|++|+|...++. .+.+++..+|.++.|++.||.++|+ .. ++||||||.||+++.+|. |||+|||+++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r 176 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGR 176 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhHh
Confidence 999999999999864 3459999999999999999999998 44 899999999999998888 9999999998
Q ss_pred cCCCCCC-CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcccc-CCCc
Q 024336 150 SGLLHSQ-PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LPDY 227 (269)
Q Consensus 150 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~ 227 (269)
....... ..+..|||.|++||.+.+..++.+ ||||||||++|||+.-++||.+. .+.++..++..+++. .| .
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~~~p-~ 250 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYPPLP-D 250 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCCCCc-H
Confidence 6544443 335679999999999999998666 99999999999999999999986 556777788887764 33 1
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCCCcHH
Q 024336 228 VRVSADCRHLLSQIFVADPSKDPHSRD 254 (269)
Q Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~~ 254 (269)
.-+|.++..+|..|+..||..||+.-.
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t~~ 277 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDTVP 277 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCcch
Confidence 368899999999999999999999533
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-53 Score=335.48 Aligned_cols=253 Identities=33% Similarity=0.508 Sum_probs=211.5
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEeCC--eEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPT--HLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~ 80 (269)
+|...+.||+|+||.||++.+.++|...|+|.+..... ..+.+.+|+.++++++|||||+++|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 57889999999999999999999999999999876421 1456899999999999999999999744444 69999999
Q ss_pred cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCCcEEEeecCCcccCCC----C
Q 024336 81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLL----H 154 (269)
Q Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~-~~~~~~~l~df~~~~~~~~----~ 154 (269)
+++|+|.+++.+.+ .+++..+..+.+|+++||.|||++|++||||||+||+++. ++. +||+|||++..... .
T Consensus 98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKGTKS 175 (313)
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCccccccccccccc
Confidence 99999999998877 7999999999999999999999999999999999999998 576 99999998875442 2
Q ss_pred CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc--cccCCCcCCCCH
Q 024336 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--QYFLPDYVRVSA 232 (269)
Q Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 232 (269)
.......+|+.|+|||.+..+....+++|||||||++.+|+||..||..... . ....-.+... .+.+|. .+|+
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~--~-~~~~~~ig~~~~~P~ip~--~ls~ 250 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE--E-AEALLLIGREDSLPEIPD--SLSD 250 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc--h-HHHHHHHhccCCCCCCCc--ccCH
Confidence 2234567999999999998644444469999999999999999999987411 1 1112222222 234444 6999
Q ss_pred HHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 233 DCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+.++|+.+|+..||++|||+.++|+|+|...
T Consensus 251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 251 EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 9999999999999999999999999999865
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-52 Score=312.28 Aligned_cols=258 Identities=29% Similarity=0.419 Sum_probs=221.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.+|...+.||+|.||.||++++..+|+.||||.+...... .-...+|+..|+.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 5899999999999999999999999999999999865433 4568899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-C
Q 024336 80 YAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-P 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~ 157 (269)
|++. +|...+... ..+++..+..++.+++.|++|||++.|+||||||.|++++++|. +||+|||+++....... .
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCccc
Confidence 9975 888888654 46999999999999999999999999999999999999999998 99999999985433332 3
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cCCCc---------
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY--------- 227 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~--------- 227 (269)
.....|.+|+|||.+.+...+....|+||.||++.||+-|.+-|.+.++-+++............ .+|+.
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 33468899999999998887777799999999999999999999998887777666655444321 22221
Q ss_pred ------------CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 228 ------------VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 228 ------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
...+.+..+|+.+|+..||.+|+++.|+++|++|..
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 234567899999999999999999999999999985
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=343.00 Aligned_cols=253 Identities=29% Similarity=0.475 Sum_probs=222.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc-cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
..|...+.||+|+.|.||.+....+++.||||.+...... .+.+.+|+.+++..+|+|||.+++.|..++.+|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 5788899999999999999999999999999999865444 456889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCcc
Q 024336 82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKST 160 (269)
Q Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~~ 160 (269)
+||+|.+.+... .+++.++..+++.++.||+|||.+||+|||||.+||+++.++. +||+|||.|....... ...+.
T Consensus 353 ~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~Tm 429 (550)
T KOG0578|consen 353 EGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRSTM 429 (550)
T ss_pred CCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCccccc
Confidence 999988888554 4899999999999999999999999999999999999999998 9999999987655544 34566
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (269)
.|||.|+|||+.....+..+ .||||||++++||+.|.+||-.. ..++.+......+...+..+..+|+.+++|+.+
T Consensus 430 VGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE---~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNE---NPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred cCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCC---ChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 89999999999988888666 99999999999999999999762 344444444445555666666899999999999
Q ss_pred HhhhCCCCCCCcHHHhhccChh
Q 024336 241 IFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 241 ~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
||..|+.+|+++.++|+|+|++
T Consensus 506 cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred HhhcchhcCCCHHHHhcChhhh
Confidence 9999999999999999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-53 Score=344.43 Aligned_cols=251 Identities=33% Similarity=0.566 Sum_probs=227.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcccc---HHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|.+.+.||+|.||.||+++.+.+.+.||+|.+.+..+.. .++.+|+++++.++||||+.++++|++...+++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 68999999999999999999999999999999998765444 457889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC-
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK- 158 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~- 158 (269)
|+.| +|.+++...+.++++.+..++.+++.||.|||+.+|.|||+||.||++..++. +|+||||+++.........
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceeee
Confidence 9987 99999999999999999999999999999999999999999999999998888 9999999998665555433
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...|||.|+|||...+..++-. +|+|||||++||+++|++||.. ..+....+.|...+..+|. ..+..+.+|+
T Consensus 159 sikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a----~si~~Lv~~I~~d~v~~p~--~~S~~f~nfl 231 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYA----RSITQLVKSILKDPVKPPS--TASSSFVNFL 231 (808)
T ss_pred eccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchH----HHHHHHHHHHhcCCCCCcc--cccHHHHHHH
Confidence 4469999999999997777655 9999999999999999999976 3456667777777777777 8999999999
Q ss_pred HHHhhhCCCCCCCcHHHhhccChhh
Q 024336 239 SQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
..+|.+||.+|.+..+++.|+|.++
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhh
Confidence 9999999999999999999999876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-52 Score=330.63 Aligned_cols=259 Identities=27% Similarity=0.387 Sum_probs=217.2
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.+.|++...||.|..++||+|+...+++.||||++..+. ...+.+..|+..++.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 368999999999999999999999999999999997543 334678999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-C
Q 024336 80 YAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-Q 156 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~ 156 (269)
|+.+|++.+++...- .+++..+..++++++.||.|||++|.+|||+|+.||+++.+|. |+|+|||.+....... .
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSGDR 182 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeeeeecccCce
Confidence 999999999997643 3899999999999999999999999999999999999999998 9999999765433222 1
Q ss_pred C----CcccCCCcccCchhh-ccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-------cC
Q 024336 157 P----KSTVGTPAYIAPEVL-ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-------FL 224 (269)
Q Consensus 157 ~----~~~~~~~~~~aPE~~-~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-------~~ 224 (269)
. ....++++|+|||.+ ..-.-+..++||||||++..|+++|+.||........+. ..++...+ ..
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl---~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL---LTLQNDPPTLLTSGLDK 259 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH---HHhcCCCCCcccccCCh
Confidence 1 344789999999994 444444566999999999999999999998765533332 22222221 22
Q ss_pred CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 225 PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
...+.++..++.+|..||.+||.+|||+.++|+|.||+...
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 23456778899999999999999999999999999998754
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-52 Score=335.71 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=219.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcccc---HHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHPNIIRFKEVLLTP--THLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (269)
+.|+.+++||+|.||.||+|++..+|+.||+|.+..+.... .-..+||.+|++|+||||+++.++..+. ..+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 56899999999999999999999999999999998654332 3467899999999999999999999887 689999
Q ss_pred EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC--
Q 024336 78 MEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-- 154 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-- 154 (269)
+|||+. +|.-++.+. -.|++.++.-+++||+.||+|+|++|++|||||.+||+++.+|. +||+|||+|+.....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGS 273 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCCCC
Confidence 999987 676666553 36999999999999999999999999999999999999999998 999999999843332
Q ss_pred CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc------cCCC--
Q 024336 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY------FLPD-- 226 (269)
Q Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~-- 226 (269)
.......-|.+|+|||.+.+...++.+.|+||.|||+.||++|++.|.+.++-+++..+.+....... .+|.
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~ 353 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT 353 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence 24456678999999999999888888899999999999999999999998887777666554443211 1110
Q ss_pred ---------------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 227 ---------------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 227 ---------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
...+++...+|+..||..||.+|.|+.++|.+.||
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 14567888999999999999999999999999999
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-52 Score=335.31 Aligned_cols=251 Identities=32% Similarity=0.531 Sum_probs=216.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.++..+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 57999999999999999999999999999999986532 23345788999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||+++++|.+++.+.+.+++..+..++.|++.||++||++|++||||||+||+++.++. ++|+|||++.... ....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~--~~~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLR--DRTW 156 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEEecCcchhcc--CCcc
Confidence 99999999999988888999999999999999999999999999999999999998877 9999999987432 2223
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...+++.|+|||.+.+..++ .++||||||+++|+|++|..||...... .....+......++. .++..+.++|
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~~~--~~~~~~~~li 229 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPF----GIYEKILAGKLEFPR--HLDLYAKDLI 229 (291)
T ss_pred cccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCcCCCc--cCCHHHHHHH
Confidence 45688999999999877665 4499999999999999999999875543 233344444444554 6789999999
Q ss_pred HHHhhhCCCCCCC-----cHHHhhccChhhh
Q 024336 239 SQIFVADPSKDPH-----SRDQKASLVPEEF 264 (269)
Q Consensus 239 ~~~l~~~p~~Rps-----~~~~l~~~~~~~~ 264 (269)
.+||+.||.+||+ +.++++|+|+..+
T Consensus 230 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 230 KKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred HHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 9999999999995 9999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-52 Score=332.79 Aligned_cols=255 Identities=35% Similarity=0.540 Sum_probs=220.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---------------ccHHHHHHHHHHHhCCCCCcceeeEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---------------IDENVQREIINHRSLRHPNIIRFKEV 67 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~~~ 67 (269)
++|++.+.||+|.||.|-+|++..+++.||||++.+... ..+...+|+.+++++.|||||+++++
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 689999999999999999999999999999999865221 12467899999999999999999999
Q ss_pred EEeC--CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeec
Q 024336 68 LLTP--THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDF 145 (269)
Q Consensus 68 ~~~~--~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df 145 (269)
..+. +.+|+|+|||..|.+...-.....+++.+.+.++++++.||+|||.+||+||||||+|++++.++. |||+||
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--VKIsDF 254 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--VKISDF 254 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc--EEeecc
Confidence 8765 479999999998877655433333899999999999999999999999999999999999999987 999999
Q ss_pred CCcccCCCC------CCCCcccCCCcccCchhhcc---ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 024336 146 GYSKSGLLH------SQPKSTVGTPAYIAPEVLAR---KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR 216 (269)
Q Consensus 146 ~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~ 216 (269)
|.+.....+ .......|||.|+|||...+ ..+..++.||||||++||.|+.|..||-+. ...++...
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~----~~~~l~~K 330 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD----FELELFDK 330 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc----hHHHHHHH
Confidence 988643222 11234679999999999887 456678899999999999999999999874 34677788
Q ss_pred HhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+......+|....+.+++++||.+||.+||.+|.+..++..|||...
T Consensus 331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 88888888887788999999999999999999999999999999754
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=337.37 Aligned_cols=250 Identities=32% Similarity=0.517 Sum_probs=216.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++.+.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999987532 23356788999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||+.+++|.+.+.+.+.+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++.... ....
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~--~~~~ 173 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVP--DRTF 173 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcC--CCcc
Confidence 99999999999988888999999999999999999999999999999999999998887 9999999987432 2223
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...+++.|+|||.+.+..++ .++|+||||+++|+|++|..||..... ......+......++. .++..+.+||
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~~p~--~~~~~~~~li 246 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTP----FRIYEKILAGRLKFPN--WFDGRARDLV 246 (329)
T ss_pred eecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCCcCCCC--CCCHHHHHHH
Confidence 45688999999999877765 449999999999999999999976543 2333444455555554 5889999999
Q ss_pred HHHhhhCCCCCCC-----cHHHhhccChhh
Q 024336 239 SQIFVADPSKDPH-----SRDQKASLVPEE 263 (269)
Q Consensus 239 ~~~l~~~p~~Rps-----~~~~l~~~~~~~ 263 (269)
.+||+.||.+||+ +++++.|+|+..
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 9999999999997 699999999976
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-53 Score=314.79 Aligned_cols=258 Identities=31% Similarity=0.554 Sum_probs=226.9
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeec---CccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
+.++|++-+.||+|.|+.|+++.+..+|+.+|+|++.. .....+.+.+|+.+-+.|+||||+++++.+.++...|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 35789999999999999999999999999999998753 334567899999999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CCcEEEeecCCcccCCCCCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~~~~~~ 156 (269)
+|+++|+.|..-|-....+++..+...++||++||.|+|.+||+|||+||+|+++-+.. ..-+||+|||++........
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 99999999977665556689999999999999999999999999999999999985332 34589999999987665566
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC--CcCCCCHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADC 234 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 234 (269)
.....|+|.|+|||++...++..+ +|||+-|+++|-++.|.+||++.+. ..+.+.++.+.+.++ .|..++++.
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~----~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQ----HRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccH----HHHHHHHhccccCCCCcccCcCCHHH
Confidence 667789999999999988887655 9999999999999999999998544 456677777776554 578899999
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
++||++||..||++|+|+.|.|+|||...
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 99999999999999999999999999865
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-51 Score=327.73 Aligned_cols=257 Identities=23% Similarity=0.364 Sum_probs=215.5
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.|+..+.||+|+||.||++.+..+|+.||+|.+.... .....+.+|+.+++.++|++++++.+.+.+++..++++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3788999999999999999999999999999986532 222356789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 80 YAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
|+++++|...+... ..+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETV 158 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCee
Confidence 99999998877543 35899999999999999999999999999999999999998877 999999998754333333
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....++..|+|||.+.+..++.. +||||||+++|+|++|..||...............+.......+. .++.++.+|
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~l 235 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAKSI 235 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCc--cCCHHHHHH
Confidence 44568899999999987777555 999999999999999999998765543333344433333333333 689999999
Q ss_pred HHHHhhhCCCCCCC-----cHHHhhccChhhhh
Q 024336 238 LSQIFVADPSKDPH-----SRDQKASLVPEEFA 265 (269)
Q Consensus 238 i~~~l~~~p~~Rps-----~~~~l~~~~~~~~~ 265 (269)
|++||..||.+||+ ++++++|+|+..+.
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 99999999999997 89999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-51 Score=332.89 Aligned_cols=247 Identities=34% Similarity=0.564 Sum_probs=210.8
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG 84 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (269)
+.||+|+||.||++.+..+|+.||+|++.... .....+.+|+.++++++||||+++++.+..++.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987532 22245678999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCCCcccCC
Q 024336 85 ELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGT 163 (269)
Q Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~ 163 (269)
+|.+.+...+.+++..+..++.||+.||+|||+.|++||||||+||+++.++. ++|+|||++..... ........++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecC
Confidence 99999988888999999999999999999999999999999999999998887 99999999864222 2223345689
Q ss_pred CcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhh
Q 024336 164 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV 243 (269)
Q Consensus 164 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 243 (269)
+.|+|||.+.+..++.. +|+||||+++|+|++|..||...+.. .....+......++. .+++++.++|.+||.
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~ 231 (323)
T cd05571 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEEIRFPR--TLSPEAKSLLAGLLK 231 (323)
T ss_pred ccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCHH----HHHHHHHcCCCCCCC--CCCHHHHHHHHHHcc
Confidence 99999999987776554 99999999999999999999765432 233333444444454 789999999999999
Q ss_pred hCCCCCC-----CcHHHhhccChhhh
Q 024336 244 ADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 244 ~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
.||++|| ++.++++|+|+...
T Consensus 232 ~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 232 KDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=327.60 Aligned_cols=247 Identities=31% Similarity=0.428 Sum_probs=206.3
Q ss_pred cccccceecccCceEEEEEEEecCCeE-EEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCC-eEEEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKEL-VAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPT-HLAIVM 78 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~-vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~ 78 (269)
...+.+.||.|+||+||++.+. |.. ||+|++...... .+.+.+|+.++++++|||||+++|++.+.. .+++||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 3456677999999999999997 455 999999764433 447999999999999999999999999987 799999
Q ss_pred eecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeecCCCCcEEecCCC-CCcEEEeecCCcccCCCC
Q 024336 79 EYAAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSME-ICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 79 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~-i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~~~~ 154 (269)
||+++|+|..++.. .+.++...+..++.+|+.|+.|||+++ |+||||||+||+++.++ + +||+|||+++.....
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~--~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKT--LKIADFGLSREKVIS 197 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCE--EEECCCccceeeccc
Confidence 99999999999987 678999999999999999999999999 99999999999999887 6 999999999754443
Q ss_pred -CCCCcccCCCcccCchhhcc--ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 155 -SQPKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 155 -~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
.......||+.|+|||.+.+ ..++. ++||||+|+++|||+||..||........ ...+.......+-+..++
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~-K~DvySFgIvlWEl~t~~~Pf~~~~~~~~----~~~v~~~~~Rp~~p~~~~ 272 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYTE-KSDVYSFGIVLWELLTGEIPFEDLAPVQV----ASAVVVGGLRPPIPKECP 272 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCCc-cchhhhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhcCCCCCCCccCC
Confidence 33444789999999999994 45544 49999999999999999999998776222 222222222222223589
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+.+..+|.+||..||+.||++.+++..+
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~~l 300 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVSRL 300 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHHHH
Confidence 9999999999999999999999998754
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=332.63 Aligned_cols=251 Identities=29% Similarity=0.476 Sum_probs=214.8
Q ss_pred ccccccceecccCceEEEEEEEecCC-eEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTK-ELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~-~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++.+.||+|+||.||+|.+..++ ..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+++.+++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 57999999999999999999976554 689999986432 2334677899999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
|||+.+++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++.... ...
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~--~~~ 185 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVD--TRT 185 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCeecC--CCc
Confidence 999999999999988888999999999999999999999999999999999999998887 9999999987432 223
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....+++.|+|||.+.+..++. ++|+||||+++|+|++|..||...+.. .....+......++. .+++.+.++
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvil~ell~G~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~~~~~~~l 258 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHGK-AADWWTLGIFIYEILVGCPPFYANEPL----LIYQKILEGIIYFPK--FLDNNCKHL 258 (340)
T ss_pred ceecCChhhcCHHHHhCCCCCc-cccccchhhHHHHHhcCCCCCCCCCHH----HHHHHHhcCCCCCCC--CCCHHHHHH
Confidence 4456899999999998766654 499999999999999999999875542 233344444444554 688999999
Q ss_pred HHHHhhhCCCCCC-----CcHHHhhccChhhh
Q 024336 238 LSQIFVADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 238 i~~~l~~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
|++||+.||.+|+ +++++++|+|+..+
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999995 89999999999764
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-50 Score=325.41 Aligned_cols=261 Identities=23% Similarity=0.378 Sum_probs=208.3
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.++|||++++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 578999999999999999999999999999999987533 223457789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCC
Q 024336 80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQP 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~ 157 (269)
|+++ +|.+.+.. .+.+++..+..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++...... ...
T Consensus 84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 84 YVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHTY 160 (303)
T ss_pred CCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCccC
Confidence 9965 77776654 356899999999999999999999999999999999999998887 999999988643221 222
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHH-HHHHHHhhcc---------------
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFR-KTIDRIRNVQ--------------- 221 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~-~~~~~~~~~~--------------- 221 (269)
....+++.|+|||.+.+....+.++|+||||+++|+|++|..||....+..... ..........
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 345678899999998765544556999999999999999999998755432221 1111110000
Q ss_pred --cc--CC-------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 222 --YF--LP-------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 222 --~~--~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.. .+ .....++++.+||.+||+.||++|||+.|+++|+||..+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00 00 0012456789999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-50 Score=323.48 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=208.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++|++.+.||.|+||.||++.+..++..||+|.+.... .....+.+|+.+++.++||||+++++++.+++..++|+||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999999999999999986432 2344677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCC
Q 024336 81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK 158 (269)
Q Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 158 (269)
+++ +|.+++...+ .++...+..++.|++.||++||+.|++||||||+||+++.++. ++|+|||++....... ...
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCcccc
Confidence 986 8888886544 4789999999999999999999999999999999999998887 9999999986432222 223
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc---------------ccc
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QYF 223 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------------~~~ 223 (269)
...+++.|+|||.+.+....+.++|+||||+++|+|+||.+||......+............ ...
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence 44678899999998765544566999999999999999999998766544443332221110 000
Q ss_pred CCC---------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 224 LPD---------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 224 ~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
++. ...+++++.+||.+||..||.+|||++|+++|+||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 111 12467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=321.62 Aligned_cols=256 Identities=26% Similarity=0.390 Sum_probs=208.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|++.+.||+|+||.||++++..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 57999999999999999999999999999999987542 233567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--CC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QP 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~ 157 (269)
|++++++..+......+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccc
Confidence 9998777665555567899999999999999999999999999999999999998887 9999999987532222 12
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh----------c-----cc
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN----------V-----QY 222 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~----------~-----~~ 222 (269)
....+++.|+|||.+.+..++. ++|+||||+++|+|++|.+||.................. . ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~-~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGK-AVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCCCC-chhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 2345788999999998777654 599999999999999999999876543332222111000 0 00
Q ss_pred cCCC-----------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 223 FLPD-----------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 223 ~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
..+. ...+|.++.+||.+||+.||++|||++++++|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0111 11367889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=325.56 Aligned_cols=260 Identities=26% Similarity=0.409 Sum_probs=214.0
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.++|++.+.||+|+||.||++++..++..+|+|.+.... ...+.+.+|+.++++++|||++++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 479999999999999999999999999999999987542 223568899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
|+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||||+||+++.++. ++|+|||++.... .....
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~-~~~~~ 160 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI-DSMAN 160 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCccccccc-ccccc
Confidence 999999999998888899999999999999999999986 5999999999999998887 9999999886432 22233
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHH---------------------------
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFR--------------------------- 211 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~--------------------------- 211 (269)
...+++.|+|||.+.+..++. ++|+||||+++|+|+||..||..........
T Consensus 161 ~~~g~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHYSV-QSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred cCCCCcCcCCHhHhcCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence 456889999999998776655 4999999999999999999996543321110
Q ss_pred ---------------HHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 212 ---------------KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 212 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.....+............+++++.+||.+||..||++|||+.++++|+|+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 011111111111111224788999999999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=335.37 Aligned_cols=254 Identities=32% Similarity=0.509 Sum_probs=217.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||+||++.+..+++.||+|++.... .....+.+|+.+++.++|+|++++++++.+++.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 57999999999999999999999999999999987532 23456788999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC---
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--- 155 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--- 155 (269)
||+++++|.+++.+.+.+++..++.++.|++.||++||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence 99999999999988888999999999999999999999999999999999999998887 9999999886433222
Q ss_pred ---------------------------CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChh
Q 024336 156 ---------------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR 208 (269)
Q Consensus 156 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~ 208 (269)
......+++.|+|||.+.+..++.. +|||||||++|+|++|..||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHHH
Confidence 2234468899999999988766555 999999999999999999998766433
Q ss_pred hHHHHHHHHhh--ccccCCCcCCCCHHHHHHHHHHhhhCCCCCCC-cHHHhhccChhhh
Q 024336 209 NFRKTIDRIRN--VQYFLPDYVRVSADCRHLLSQIFVADPSKDPH-SRDQKASLVPEEF 264 (269)
Q Consensus 209 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~~l~~~~~~~~ 264 (269)
... .+.. .....+....+++++.++|.+||. ||.+||+ +.++++|+|+..+
T Consensus 238 ~~~----~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 238 TYN----KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHH----HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 322 2222 233444444579999999999997 9999999 9999999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-50 Score=327.69 Aligned_cols=257 Identities=36% Similarity=0.577 Sum_probs=227.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 76 (269)
.+.|++.+.||+|.||.||++++..+|+.+|+|.+.+... ..+...+|+.+++++. |||++.+++.|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4689999999999999999999999999999999976443 3357999999999998 9999999999999999999
Q ss_pred EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC--CcEEEeecCCcccCCCC
Q 024336 77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ--PRLKICDFGYSKSGLLH 154 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~--~~~~l~df~~~~~~~~~ 154 (269)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+.|++|+|+||+|+++..... +.++++|||++......
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 99999999999999776 4999999999999999999999999999999999999975532 46999999999876665
Q ss_pred CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc--cCCCcCCCCH
Q 024336 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRVSA 232 (269)
Q Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 232 (269)
......+||+.|+|||.+....+... .|+||+|+++|.|++|.+||.......... .+..+.+ ..+.|..++.
T Consensus 193 ~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFL----AILRGDFDFTSEPWDDISE 267 (382)
T ss_pred ceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHH----HHHcCCCCCCCCCccccCH
Confidence 56677889999999999987777666 999999999999999999999877654444 4444444 4456778999
Q ss_pred HHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 233 DCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
.+.++|+.||..||..|+|+.++|.|||....
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999998764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-50 Score=332.05 Aligned_cols=254 Identities=27% Similarity=0.467 Sum_probs=211.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||+||++.+..+++.||+|++.... .....+.+|+.+++.++|++|+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 58999999999999999999999999999999987532 22345778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC---
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--- 155 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--- 155 (269)
||+++++|.+++.+.+.+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999998887 9999999886321110
Q ss_pred ---------------------------------CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCC
Q 024336 156 ---------------------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFE 202 (269)
Q Consensus 156 ---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~ 202 (269)
......||+.|+|||.+.+..++.+ +|+||||+++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCCC
Confidence 0113468999999999987776554 999999999999999999998
Q ss_pred CCCChhhHHHHHHHHhh--ccccCCCcCCCCHHHHHHHHHHhhhCCC---CCCCcHHHhhccChhhh
Q 024336 203 DPEDPRNFRKTIDRIRN--VQYFLPDYVRVSADCRHLLSQIFVADPS---KDPHSRDQKASLVPEEF 264 (269)
Q Consensus 203 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~---~Rps~~~~l~~~~~~~~ 264 (269)
........ ..+.. ....++....+++++.++|.+|+. +|. .||+++|+++|+|+...
T Consensus 238 ~~~~~~~~----~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 238 SETPQETY----KKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCHHHHH----HHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 75543332 22322 223345444688999999999775 444 46899999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=316.49 Aligned_cols=255 Identities=29% Similarity=0.444 Sum_probs=220.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc----cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
+.|+.++.||.|.-|+||+|+...++..+|+|++.+.... ......|.++|+.++||.++.++..|+.+...|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 4688999999999999999999999999999999875322 234566889999999999999999999999999999
Q ss_pred eecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC----
Q 024336 79 EYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL---- 152 (269)
Q Consensus 79 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~---- 152 (269)
|||+||+|..+.++. +.+++..++-++..++.||+|||..|||+|||||+||||..+|+ |.|+||+++....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRCPVSPT 234 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccCCCCCe
Confidence 999999999998764 45999999999999999999999999999999999999999999 9999999863100
Q ss_pred ------------------------------CCC-----------------------CCCcccCCCcccCchhhccccCCC
Q 024336 153 ------------------------------LHS-----------------------QPKSTVGTPAYIAPEVLARKEYDG 179 (269)
Q Consensus 153 ------------------------------~~~-----------------------~~~~~~~~~~~~aPE~~~~~~~~~ 179 (269)
... ......||-.|.|||++.+.....
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 000 001223677899999999888755
Q ss_pred ccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCC----cHHH
Q 024336 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPH----SRDQ 255 (269)
Q Consensus 180 ~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~ 255 (269)
. .|.|+||+.+|||+.|..||.+.++.+++ .++......+|....++..+++||+++|.+||.+|.. ++||
T Consensus 315 A-VDWWtfGIflYEmLyG~TPFKG~~~~~Tl----~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 315 A-VDWWTFGIFLYEMLYGTTPFKGSNNKETL----RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred h-hhHHHHHHHHHHHHhCCCCcCCCCchhhH----HHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 5 99999999999999999999998885554 4555567777877788899999999999999999999 9999
Q ss_pred hhccChhhh
Q 024336 256 KASLVPEEF 264 (269)
Q Consensus 256 l~~~~~~~~ 264 (269)
.+|+||+++
T Consensus 390 K~HpFF~gV 398 (459)
T KOG0610|consen 390 KRHPFFEGV 398 (459)
T ss_pred hcCccccCC
Confidence 999999875
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-50 Score=329.30 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=214.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987532 22345778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||+++++|.+++.+.+.+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++..... ...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YAN 156 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccC
Confidence 99999999999988888999999999999999999999999999999999999998887 99999999874322 334
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCc----CCCCHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY----VRVSADC 234 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 234 (269)
...+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||................. ....+.. ..+++++
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~s~~~ 233 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE--TLQRPVYDDPRFNLSDEA 233 (333)
T ss_pred CcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc--cccCCCCCccccccCHHH
Confidence 5568999999999987766554 9999999999999999999987554333322221111 1111111 2568999
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
.++|.+||..+|.+||+++++++|+|+...
T Consensus 234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 234 WDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=321.90 Aligned_cols=253 Identities=36% Similarity=0.640 Sum_probs=231.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccH----HHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE----NVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
..+|++.+.||.|.||.|-++.....|+.||||.+.++....+ .+++|+++++.|+||||+.++++|+..+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4689999999999999999999999999999999987654433 478999999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
|||..+|.|.+++.+.+.+++.+.+.+++||++|+.|+|+++++|||+|.+||+++.+++ +||.|||++.........
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFL 209 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHH
Confidence 999999999999999999999999999999999999999999999999999999999998 999999999766666667
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
.+.+|+|-|.+||+..+..+..+..|.||||+++|.|+.|..||++.+. ..++.++..+.+.-|. -|.+..-|
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvrQIs~GaYrEP~---~PSdA~gL 282 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVRQISRGAYREPE---TPSDASGL 282 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHHHHhhcccccCCC---CCchHHHH
Confidence 7889999999999999999998889999999999999999999998654 5667777777766555 56788899
Q ss_pred HHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
|++||..||.+|.|+.++..|-|.+.
T Consensus 283 IRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhheeec
Confidence 99999999999999999999999764
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-50 Score=334.69 Aligned_cols=256 Identities=29% Similarity=0.513 Sum_probs=213.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||+||++++..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 57999999999999999999999999999999997532 22345678999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC---
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--- 155 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--- 155 (269)
||+++++|.+++...+.+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence 99999999999988888999999999999999999999999999999999999998887 9999999875321110
Q ss_pred ------------------------------------CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCC
Q 024336 156 ------------------------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAY 199 (269)
Q Consensus 156 ------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~ 199 (269)
......||+.|+|||.+....++.+ +|+|||||++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCCC
Confidence 0012358899999999987776554 999999999999999999
Q ss_pred CCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCC---cHHHhhccChhhh
Q 024336 200 PFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPH---SRDQKASLVPEEF 264 (269)
Q Consensus 200 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~~~~~~~ 264 (269)
||............... ......+....+++++.++|.+|+. +|.+|++ +++++.|+|+..+
T Consensus 238 Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 238 PFCSDNPQETYRKIINW--KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCHHHHHHHHHcC--CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99876543322222111 1122344444678999999999996 9999998 9999999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=310.17 Aligned_cols=262 Identities=29% Similarity=0.395 Sum_probs=221.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCC-cceeeEEEEeCC------
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPN-IIRFKEVLLTPT------ 72 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------ 72 (269)
..|..+++||+|+||+||+|++..+|+.||+|.+..+.. ......+|+.+++.++|+| |+++++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 358889999999999999999999999999999986654 4566889999999999999 999999999877
Q ss_pred eEEEEEeecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCc
Q 024336 73 HLAIVMEYAAGGELFARICSAG----RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS 148 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~ 148 (269)
.+++|+||.+. +|..++.... .++...++.+++||+.||+|||+++|+||||||.||+++.+|. +||+|||++
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGlA 167 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGLA 167 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--EeeeccchH
Confidence 89999999975 8888887654 4778899999999999999999999999999999999999887 999999999
Q ss_pred ccCC-CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cCCC
Q 024336 149 KSGL-LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPD 226 (269)
Q Consensus 149 ~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~ 226 (269)
+... ..........|.+|+|||++.+...++...||||+|||++||+++.+.|.+..+.+.+....+....... .+|.
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 8544 2333556678899999999998866666699999999999999999999998887666665554443211 1211
Q ss_pred -------------c----------CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhhc
Q 024336 227 -------------Y----------VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAER 267 (269)
Q Consensus 227 -------------~----------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~~ 267 (269)
+ ...+++..+++.+||+.+|.+|.|++.++.|++|..+..+
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 1 1223478899999999999999999999999999987543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=327.59 Aligned_cols=257 Identities=30% Similarity=0.498 Sum_probs=214.1
Q ss_pred cccccceecccCceEEEEEEEe---cCCeEEEEEEeecCc-----cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeE
Q 024336 4 RYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK-----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 74 (269)
+|++.+.||+|+||.||++++. .+++.||+|++.+.. ...+.+..|+.+++.+ +|++|+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 478899999986532 2234567899999999 589999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
++||||+++++|.+.+.+...+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCcccccc
Confidence 999999999999999988888999999999999999999999999999999999999998887 999999998643222
Q ss_pred C--CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCH
Q 024336 155 S--QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232 (269)
Q Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
. ......+++.|+|||.+.+....+.++||||||+++|+|+||..||...............+......++. .+++
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 236 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS--FIGP 236 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCH
Confidence 2 12234689999999999866544566999999999999999999997554433334444444444444443 6899
Q ss_pred HHHHHHHHHhhhCCCCCC-----CcHHHhhccChhhh
Q 024336 233 DCRHLLSQIFVADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
.+.++|.+||..||++|| +++++++|+|+...
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999999 78899999998763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=325.01 Aligned_cols=245 Identities=30% Similarity=0.527 Sum_probs=208.8
Q ss_pred ecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCch
Q 024336 11 LGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 11 l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
||+|+||.||++.+..+++.||+|.+... ......+.+|+.++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999998753 22234567899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCcccCCCc
Q 024336 87 FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPA 165 (269)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~ 165 (269)
.+.+...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++...... .......+++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcc
Confidence 999988888999999999999999999999999999999999999998887 999999998742222 22234468999
Q ss_pred ccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhC
Q 024336 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245 (269)
Q Consensus 166 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 245 (269)
|+|||.+.+..++.+ +|+||||+++|+|++|..||...... .....+......++. .+++++.++|.+||..|
T Consensus 159 y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~d 231 (312)
T cd05585 159 YLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENVN----EMYRKILQEPLRFPD--GFDRDAKDLLIGLLSRD 231 (312)
T ss_pred cCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCHH----HHHHHHHcCCCCCCC--cCCHHHHHHHHHHcCCC
Confidence 999999987766554 99999999999999999999865432 333444444444554 78999999999999999
Q ss_pred CCCCC---CcHHHhhccChhhh
Q 024336 246 PSKDP---HSRDQKASLVPEEF 264 (269)
Q Consensus 246 p~~Rp---s~~~~l~~~~~~~~ 264 (269)
|.+|| ++.+++.|+|+...
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCC
Confidence 99997 57999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-50 Score=326.69 Aligned_cols=247 Identities=33% Similarity=0.557 Sum_probs=209.5
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG 84 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (269)
+.||+|+||.||++.+..+|..||+|.+.... .....+.+|+.+++.++||||+++++.+..++.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987532 22334667999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCcccCC
Q 024336 85 ELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGT 163 (269)
Q Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~ 163 (269)
+|...+...+.+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++....... ......++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCC
Confidence 99999988888999999999999999999999999999999999999998887 9999999886432222 22345688
Q ss_pred CcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhh
Q 024336 164 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV 243 (269)
Q Consensus 164 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 243 (269)
+.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+... ....+......++. .+++++.++|.+||.
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~----~~~~~~~~~~~~p~--~~~~~~~~li~~~L~ 231 (323)
T cd05595 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHER----LFELILMEEIRFPR--TLSPEAKSLLAGLLK 231 (323)
T ss_pred cCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCCCCCCC--CCCHHHHHHHHHHcc
Confidence 99999999987776544 999999999999999999997655432 22333333444444 789999999999999
Q ss_pred hCCCCCC-----CcHHHhhccChhhh
Q 024336 244 ADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 244 ~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
.||.+|| ++.++++|+|+...
T Consensus 232 ~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 232 KDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 9999998 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-51 Score=299.54 Aligned_cols=252 Identities=33% Similarity=0.563 Sum_probs=228.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|-||.||+++...++-.||+|++.++. .....+.+|+++.+.|+||||++++++|.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 68999999999999999999999999999999987653 23456889999999999999999999999999999999
Q ss_pred eecCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 79 EYAAGGELFARIC--SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 79 e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
||...|.+...++ ...++++...+.++.|++.|+.|+|..+++||||||+|++++..+. ++++|||-+.... ...
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-~~k 178 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SNK 178 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-CCC
Confidence 9999999999998 6678999999999999999999999999999999999999998888 9999999887543 445
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
..+.+||..|.+||...+...+.. .|+|++|++.|+++.|.+||.... ..+...++...+..+|. .++.+..+
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~----~~etYkrI~k~~~~~p~--~is~~a~d 251 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQS----HSETYKRIRKVDLKFPS--TISGGAAD 251 (281)
T ss_pred ceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhh----hHHHHHHHHHccccCCc--ccChhHHH
Confidence 567789999999999998888776 999999999999999999998755 35667778888888886 89999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+|.+|+.++|.+|.+..|+++|+|..+.
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHHhccCccccccHHHHhhhHHHHhc
Confidence 9999999999999999999999998764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=334.22 Aligned_cols=253 Identities=33% Similarity=0.538 Sum_probs=224.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|+.++.||+|.||.|+++..+.+++.+|||++++.. ...+....|.+++... +||.++.++..|++.+.+|+|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 68999999999999999999999999999999998743 3445677788888777 599999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC-CCCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~-~~~~ 156 (269)
|||+.||++ -.++..+.+++..+.-++..++.||.|||++||+|||||.+||++|.+|+ +||+|||+++... .+..
T Consensus 448 mey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~~g~~ 524 (694)
T KOG0694|consen 448 MEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMGQGDR 524 (694)
T ss_pred EEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCCCCCc
Confidence 999999994 44446678999999999999999999999999999999999999999999 9999999998655 4556
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
..+.+|||.|+|||++.+..|+.. .|.||||++||+|+.|+.||.+.++ .++.+.+...+..+|. .+|.+..+
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddE----ee~FdsI~~d~~~yP~--~ls~ea~~ 597 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDE----EEVFDSIVNDEVRYPR--FLSKEAIA 597 (694)
T ss_pred cccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCCCCCCC--cccHHHHH
Confidence 678899999999999998888555 9999999999999999999998776 4555667777777777 79999999
Q ss_pred HHHHHhhhCCCCCCCc-----HHHhhccChhhhh
Q 024336 237 LLSQIFVADPSKDPHS-----RDQKASLVPEEFA 265 (269)
Q Consensus 237 li~~~l~~~p~~Rps~-----~~~l~~~~~~~~~ 265 (269)
+++++|.++|++|..+ .++.+||||..+.
T Consensus 598 il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 598 IMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred HHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 9999999999999986 7999999998753
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-51 Score=306.38 Aligned_cols=258 Identities=33% Similarity=0.514 Sum_probs=227.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-----c----ccHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-----K----IDENVQREIINHRSL-RHPNIIRFKEVLLTPT 72 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-----~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 72 (269)
++|...+.||+|..++|.++.+..+|..+|+|++.... . ..+.-.+|+.+|+++ .||+|+++.++++++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 46888899999999999999999999999999986421 1 123455789999988 6999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
.+++|+|.++.|-|.+++.+.-.+++.....+++|+++++.|||.++|+|||+||+||+++++-+ ++|+|||.++...
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccC
Confidence 99999999999999999988888999999999999999999999999999999999999998888 9999999999888
Q ss_pred CCCCCCcccCCCcccCchhhccc-----cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc--cCC
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARK-----EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLP 225 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~ 225 (269)
.++.....+|||.|+|||.+... +-+++..|+|+.|+|+|.++.|.+||+.. ...-+...+..+.+ ..|
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR----kQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR----KQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH----HHHHHHHHHHhcccccCCc
Confidence 88888889999999999998632 33355599999999999999999999873 33445666777766 446
Q ss_pred CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 226 DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
+|.+++...++||.+||+.||.+|.|++|+|+|||+..+..
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 78999999999999999999999999999999999987664
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=325.80 Aligned_cols=247 Identities=35% Similarity=0.572 Sum_probs=209.6
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG 84 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (269)
+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.++||||+++++.+..++.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999987532 22345678999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCcccCC
Q 024336 85 ELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGT 163 (269)
Q Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~ 163 (269)
+|...+...+.+++..+..++.||+.||+|||+.|++||||||+||+++.++. ++|+|||++...... .......++
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCC
Confidence 99999988888999999999999999999999999999999999999998887 999999998643222 222344689
Q ss_pred CcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhh
Q 024336 164 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV 243 (269)
Q Consensus 164 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 243 (269)
+.|+|||.+.+..++.+ +|+||||+++|+|++|..||...... .....+......++. .+++++.++|.+||.
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~~~----~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~ 231 (328)
T cd05593 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEDIKFPR--TLSADAKSLLSGLLI 231 (328)
T ss_pred cCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCCHH----HHHHHhccCCccCCC--CCCHHHHHHHHHHcC
Confidence 99999999987766544 99999999999999999999765432 223333334444444 789999999999999
Q ss_pred hCCCCCC-----CcHHHhhccChhhh
Q 024336 244 ADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 244 ~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
.||.+|+ ++.++++|+|+...
T Consensus 232 ~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 232 KDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999997 89999999998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-50 Score=307.60 Aligned_cols=258 Identities=29% Similarity=0.391 Sum_probs=219.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcccc---HHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHPNIIRFKEVLLTP--THLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (269)
+.|+.+..|++|.||.||++++..|++.||+|.+..+.... -.-.+|+.++.+++|||||.+.++.... +.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 56899999999999999999999999999999998654322 2467899999999999999999987643 579999
Q ss_pred EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-C
Q 024336 78 MEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-S 155 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~ 155 (269)
||||+. +|..++.+.+ ++...++.-++.|++.|+.|||.+.|+|||+||+|++++..|. +|++|||+|+..... .
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPLK 232 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhhhcCCcc
Confidence 999987 8999998766 7999999999999999999999999999999999999998888 999999999854333 2
Q ss_pred CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-ccCCCc-------
Q 024336 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDY------- 227 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~------- 227 (269)
......-|.+|+|||.+.+...++.+.|+||+|||+.+|+++.+.|.+....+++........... ..+|..
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 344556789999999999988877779999999999999999999999888777766654443321 112211
Q ss_pred ------------------CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 228 ------------------VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 228 ------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
..+++...+|+..+|..||.+|.|+.|.|+|.||.+
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 124577889999999999999999999999999987
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=314.06 Aligned_cols=261 Identities=29% Similarity=0.419 Sum_probs=216.2
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeec---CccccHHHHHHHHHHHhCCCCCcceeeEEEEe-----CCe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHPNIIRFKEVLLT-----PTH 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 73 (269)
..+|...+.||.|++|.|+.+.+..+|+.||||.+.. .....+...+|+.+++.++|+||+.+.+++.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4677778999999999999999999999999999863 33345667889999999999999999999876 245
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
+|+|+|+++ .+|...++.++.+++..+..++.|++.||.|+|+.|++|||+||.|++++.+-. +|++|||+|+....
T Consensus 101 vYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 101 VYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLDK 177 (359)
T ss_pred eEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeeccc
Confidence 999999995 488888888777999999999999999999999999999999999999986665 99999999986543
Q ss_pred ---CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh-----------
Q 024336 154 ---HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN----------- 219 (269)
Q Consensus 154 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~----------- 219 (269)
.........|.+|.|||.+.+...++++.||||+|||+.||++|++.|.+.+.-.++.....-...
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 333345567899999999988777788899999999999999999999987764444332211111
Q ss_pred --------ccccCC------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 220 --------VQYFLP------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 220 --------~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.....+ -..+.++...+|+.+||..||.+|+|++|+|+||++..+.
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 011111 1246778999999999999999999999999999998875
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=331.95 Aligned_cols=256 Identities=27% Similarity=0.489 Sum_probs=211.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++++.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 57999999999999999999999999999999986532 22345778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC---
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--- 155 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--- 155 (269)
||+++++|.+++...+.+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeecccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999998877 9999999885211000
Q ss_pred ---------------------------------------------CCCcccCCCcccCchhhccccCCCccchhhhHHHH
Q 024336 156 ---------------------------------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVT 190 (269)
Q Consensus 156 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 190 (269)
......+++.|+|||.+.+..++.+ +|+|||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecchh
Confidence 0012358899999999987776544 999999999
Q ss_pred HHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCC---CCcHHHhhccChhhh
Q 024336 191 LYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKD---PHSRDQKASLVPEEF 264 (269)
Q Consensus 191 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---ps~~~~l~~~~~~~~ 264 (269)
+|+|+||.+||............... .....++....++.++.+||.+||. +|.+| +++.+++.|+|+..+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINW--RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHcc--CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99999999999875543332222211 1223445545688999999999997 77765 599999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=322.89 Aligned_cols=247 Identities=33% Similarity=0.507 Sum_probs=208.7
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||.||++.+..+++.||+|++.+.. ...+.+..|..+++.+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987532 2234566788888766 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCCCcccC
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 162 (269)
++|.+.+...+.+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence 999999988888999999999999999999999999999999999999998887 99999998864322 222334568
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.. .....+.......+. .++.++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~i~~~~~~~~~--~~~~~~~~li~~~L 231 (320)
T cd05590 159 TPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENED----DLFEAILNDEVVYPT--WLSQDAVDILKAFM 231 (320)
T ss_pred CccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHHhcCCCCCCC--CCCHHHHHHHHHHc
Confidence 999999999987666554 99999999999999999999875542 233344444444444 68899999999999
Q ss_pred hhCCCCCCCc------HHHhhccChhhh
Q 024336 243 VADPSKDPHS------RDQKASLVPEEF 264 (269)
Q Consensus 243 ~~~p~~Rps~------~~~l~~~~~~~~ 264 (269)
+.||.+||++ ++++.|+|+..+
T Consensus 232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 232 TKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred ccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999 999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=330.58 Aligned_cols=256 Identities=30% Similarity=0.446 Sum_probs=211.2
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.|++++.||+|+||+||++.+..+++.||+|++.... .....+.+|+.+++.++|+||+++++++.+++.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 6899999999999999999999999999999987532 223457889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC----
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---- 155 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~---- 155 (269)
|+++++|.+++.+.+.+++..+..++.|++.||.+||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC--EEEeeCcCCccccccccccc
Confidence 9999999999988888999999999999999999999999999999999999998877 9999999864210000
Q ss_pred --------------------------------------------CCCcccCCCcccCchhhccccCCCccchhhhHHHHH
Q 024336 156 --------------------------------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTL 191 (269)
Q Consensus 156 --------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l 191 (269)
......+++.|+|||.+.+..++.+ +|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhhHH
Confidence 0112358899999999987776544 9999999999
Q ss_pred HHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh--hhCCCCCCCcHHHhhccChhhh
Q 024336 192 YVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF--VADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 192 ~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l--~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
|+|+||..||............... ......+....+++++.+||.+|+ ..+|..||++.+++.|+|+..+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINW--ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHcc--ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999999876543333222211 122344444568999999999965 4566669999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=332.39 Aligned_cols=256 Identities=29% Similarity=0.471 Sum_probs=212.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.+|++++.||+|+||.||++++..+++.||+|++.... .....+.+|+.+++.++|+||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986432 23355778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC----
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---- 154 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~---- 154 (269)
||+++++|.+++.+.+.+++..+..++.||+.||++||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999998887 999999987421000
Q ss_pred ----------------------------------------CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHH
Q 024336 155 ----------------------------------------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVM 194 (269)
Q Consensus 155 ----------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l 194 (269)
.......|++.|+|||.+.+..++.+ +|||||||++|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeeeh
Confidence 00012358899999999987776554 9999999999999
Q ss_pred HhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCC---CcHHHhhccChhhh
Q 024336 195 LVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDP---HSRDQKASLVPEEF 264 (269)
Q Consensus 195 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~~l~~~~~~~~ 264 (269)
++|..||............... ......+....+++++.++|.+|+ .+|.+|+ ++.++++|+|+..+
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINW--ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhcc--CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 9999999876543332222111 112233444468999999999987 5999999 99999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-49 Score=322.33 Aligned_cols=252 Identities=30% Similarity=0.498 Sum_probs=212.7
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCC-CCcceeeEEEEeCCeEEEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH-PNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~ 78 (269)
+|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+..|..++..+.| ++++++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999987532 223456778888888876 56888999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~ 157 (269)
||+++++|.+.+...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCce
Confidence 99999999999988888999999999999999999999999999999999999998887 99999998864222 2223
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....+++.|+|||.+.+..++.+ +|+||||+++|+|+||..||...... .....+......++. .++.++.++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~~~~~~~~~--~~~~~~~~l 231 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDED----ELFQSIMEHNVSYPK--SLSKEAVSI 231 (324)
T ss_pred eeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCC--CCCHHHHHH
Confidence 34568999999999987776554 99999999999999999999865543 233334444444444 689999999
Q ss_pred HHHHhhhCCCCCCCc-----HHHhhccChhhh
Q 024336 238 LSQIFVADPSKDPHS-----RDQKASLVPEEF 264 (269)
Q Consensus 238 i~~~l~~~p~~Rps~-----~~~l~~~~~~~~ 264 (269)
+.+||.+||.+|+++ +++++|+|+...
T Consensus 232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999999987 899999998764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=331.48 Aligned_cols=256 Identities=31% Similarity=0.477 Sum_probs=212.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.+|++++.||+|+||.||++++..+++.||+|.+.... .....+.+|+.++++++|+||+++++.+.+++.+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999987532 22345778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC----
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---- 154 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~---- 154 (269)
||+++++|.+++.+.+.+++..+..++.|++.||++||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999998887 999999986421000
Q ss_pred --------------------------------------------CCCCcccCCCcccCchhhccccCCCccchhhhHHHH
Q 024336 155 --------------------------------------------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVT 190 (269)
Q Consensus 155 --------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 190 (269)
.......+++.|+|||.+.+..++.. +|+|||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechHH
Confidence 00112357899999999987777554 999999999
Q ss_pred HHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCC---cHHHhhccChhhh
Q 024336 191 LYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPH---SRDQKASLVPEEF 264 (269)
Q Consensus 191 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~~~~~~~ 264 (269)
+|+|++|.+||............... ......+....+++++.++|.+|+ .+|.+|++ +.+++.|+|+..+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINW--QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcc--CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 99999999999876543332222211 122334444578999999999987 59999998 9999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=323.97 Aligned_cols=245 Identities=27% Similarity=0.413 Sum_probs=210.8
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
.++.++.||+|-||.||.+....+ ..||+|.+.......+.+.+|++++++|+|++||++++++..++.+||||||+..
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 456788999999999999999854 3699999988777778899999999999999999999999999999999999999
Q ss_pred CchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC--CCc
Q 024336 84 GELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKS 159 (269)
Q Consensus 84 ~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~--~~~ 159 (269)
|+|.++++. ...++..+.+.++.|||+|++||+++++|||||.+.||+|+.+.. +||+|||+++....+.- ...
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccCCCceeecCC
Confidence 999999987 456999999999999999999999999999999999999998887 99999999983222221 222
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
......|+|||.+..+.++.+ |||||+|++|+|++| |+.||......+. ++.+.. .+.+|.+..+|+.+.+++
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev----~~~le~-GyRlp~P~~CP~~vY~lM 437 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEV----LELLER-GYRLPRPEGCPDEVYELM 437 (468)
T ss_pred CCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHH----HHHHhc-cCcCCCCCCCCHHHHHHH
Confidence 234567999999999999777 999999999999999 8899988776433 333333 456777779999999999
Q ss_pred HHHhhhCCCCCCCcHHHhh
Q 024336 239 SQIFVADPSKDPHSRDQKA 257 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~ 257 (269)
..||+.+|++|||++.+..
T Consensus 438 ~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 438 KSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred HHHhhCCcccCCCHHHHHH
Confidence 9999999999999986654
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-49 Score=315.72 Aligned_cols=256 Identities=24% Similarity=0.361 Sum_probs=214.7
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.|++.+.||+|+||.||++.+..+++.||+|.+..... ....+.+|+.+++.++|||++++++.+.+++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999998999999999865321 12346679999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 80 YAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
|+++++|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPEGETI 158 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCCCCcc
Confidence 99999998887543 35899999999999999999999999999999999999998877 999999998754333333
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....+++.|+|||.+.+..++.. +|+||+|+++|++++|..||.+.............+.......+. .++..+.++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 235 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARSI 235 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCc--ccCHHHHHH
Confidence 34567899999999987766554 999999999999999999998765544444444444433333333 688999999
Q ss_pred HHHHhhhCCCCCC-----CcHHHhhccChhhh
Q 024336 238 LSQIFVADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 238 i~~~l~~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
|.+||..||.+|| ++++++.|+|+...
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 9999999999999 89999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=313.19 Aligned_cols=258 Identities=31% Similarity=0.482 Sum_probs=219.4
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----eEEEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT-----HLAIVM 78 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~ 78 (269)
.|+..+.+|.|+||.||++....+++.||||.+-.+.+. ..+|+.+++.++|||||++.-+|.... .+.+|+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 477889999999999999999999999999998766542 336999999999999999998887432 467999
Q ss_pred eecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 79 EYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 79 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
||++. +|...++. +..++.-.++-+.+||+.||+|||+.||+||||||.|+++|.+.. .+||||||+|+....+
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg-~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTG-VLKICDFGSAKVLVKG 179 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCC-eEEeccCCcceeeccC
Confidence 99975 88888863 567899999999999999999999999999999999999997643 4999999999988888
Q ss_pred CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh--------cc-----
Q 024336 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN--------VQ----- 221 (269)
Q Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~--------~~----- 221 (269)
++..+...+..|+|||.+.+...++.+.||||.||++.||+-|++.|.+.+..+.+.+..+-... .+
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~ 259 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE 259 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence 88888889999999999999887777799999999999999999999998877776665533222 11
Q ss_pred ccCCC----------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 222 YFLPD----------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 222 ~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
..+++ ....+++..+|+.++|..+|.+|.++.|++.|+||..+..
T Consensus 260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 11111 2357889999999999999999999999999999998753
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-49 Score=321.85 Aligned_cols=251 Identities=27% Similarity=0.463 Sum_probs=208.3
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||.||++.+..+++.||+|++.... .....+..|..+++.+ +||||+++++++.+++.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999997532 2223467888888888 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCCCcccC
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 162 (269)
++|...+.+.+++++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccC
Confidence 999999988888999999999999999999999999999999999999998887 99999998864222 222334568
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh-----hhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----RNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
++.|+|||.+.+..++.+ +|+||||+++|+|+||..||...... .........+.......|. .++.++.++
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~l 235 (329)
T cd05588 159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSV 235 (329)
T ss_pred CccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCCHHHHHH
Confidence 999999999987766554 99999999999999999999632211 1112223334444444454 688999999
Q ss_pred HHHHhhhCCCCCCC------cHHHhhccChhhh
Q 024336 238 LSQIFVADPSKDPH------SRDQKASLVPEEF 264 (269)
Q Consensus 238 i~~~l~~~p~~Rps------~~~~l~~~~~~~~ 264 (269)
|.+||..||.+|++ ++++++|+|+..+
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 99999999999997 6899999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-49 Score=333.21 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=206.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeC--------CeE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTP--------THL 74 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~ 74 (269)
++|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++||||+++++++... ..+
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 57999999999999999999999999999999886432 3345799999999999999999887532 247
Q ss_pred EEEEeecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCccc
Q 024336 75 AIVMEYAAGGELFARIC----SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~ 150 (269)
++||||+++ ++.+.+. ....+++..++.++.|++.||.|||+.||+||||||+||+++.++. .++|+|||++..
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla~~ 220 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAKN 220 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC-ceeeeccccchh
Confidence 799999976 6666653 3456899999999999999999999999999999999999986542 399999999975
Q ss_pred CCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc----------
Q 024336 151 GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------- 220 (269)
Q Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------- 220 (269)
...........+++.|+|||.+.+....+.++|||||||++|+|++|.+||.+......+..........
T Consensus 221 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 300 (440)
T PTZ00036 221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300 (440)
T ss_pred ccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch
Confidence 4444444456778999999998766544556999999999999999999998776655544443221110
Q ss_pred ---cccCCC----------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 221 ---QYFLPD----------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 221 ---~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
...++. +...|+++.+||.+||.+||.+|||+.|++.|+|+..+.
T Consensus 301 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred hhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 001111 114678999999999999999999999999999998764
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-50 Score=324.05 Aligned_cols=254 Identities=30% Similarity=0.476 Sum_probs=224.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC---ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCe-EEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTH-LAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~ 78 (269)
++|..++.+|+|+||.+++++++.+++.+|+|.+... ........+|+.+++++.|||||.+.+.|..++. +++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 6899999999999999999999999999999998743 3344578899999999999999999999999988 99999
Q ss_pred eecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-
Q 024336 79 EYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS- 155 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~- 155 (269)
+||+||++.+.+.+.+ .++++.+..|+.|++.|+.|||++.|+|||||+.|||.+.++. |+|+|||+++......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPEDS 161 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCchh
Confidence 9999999999996544 5999999999999999999999999999999999999999998 9999999999766665
Q ss_pred CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
...+..|||.|++||.+.+.++..+ +|||||||++|+|++-+++|...+- ...+..+.... ..|-+..++.+++
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m----~~Li~ki~~~~-~~Plp~~ys~el~ 235 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNM----SELILKINRGL-YSPLPSMYSSELR 235 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccch----HHHHHHHhhcc-CCCCCccccHHHH
Confidence 6677889999999999999998777 9999999999999999999987554 44444444444 2344448999999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
.+|+.||..+|..||++.++|.+|.....
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 99999999999999999999999877653
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=325.61 Aligned_cols=252 Identities=28% Similarity=0.433 Sum_probs=219.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
..|+.++.||+|.||.||++.+..+++.||+|++..... ..+.+.+|+.++.+++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 468889999999999999999999999999999986543 345788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 159 (269)
+.||++.++++..+.+.+..+..++++++.|+.|||..+.+|+|||+.||++..++. ++|+|||.+....... ...+
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~~rr~t 170 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTVKRRKT 170 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechhhcccc
Confidence 999999999988887899999999999999999999999999999999999998877 9999999987543333 2367
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh-ccccCCCcCCCCHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 238 (269)
..|||.|||||++....++.+ +||||||++.++|++|.+|+...... ...-.+.+ ..+.+.. .+++.+++|+
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPm----rvlflIpk~~PP~L~~--~~S~~~kEFV 243 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPM----RVLFLIPKSAPPRLDG--DFSPPFKEFV 243 (467)
T ss_pred ccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcc----eEEEeccCCCCCcccc--ccCHHHHHHH
Confidence 789999999999997778777 99999999999999999999876652 22222222 2223333 7889999999
Q ss_pred HHHhhhCCCCCCCcHHHhhccChhh
Q 024336 239 SQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
..||.+||+.||+|.++|+|.|.+.
T Consensus 244 ~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 244 EACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHHhhcCcccCcCHHHHhhhHHHHh
Confidence 9999999999999999999999876
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=323.70 Aligned_cols=247 Identities=34% Similarity=0.554 Sum_probs=208.9
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG 84 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (269)
+.||+|+||.||++.+..+|+.||+|++.... .....+.+|+.+++.++||||+++++.+..++.+++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987532 22345667899999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCCCcccC
Q 024336 85 ELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG 162 (269)
Q Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 162 (269)
+|...+...+.+++..+..++.||+.||.|||+ .|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccC
Confidence 999999888889999999999999999999997 79999999999999998887 99999998864222 222334568
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
++.|+|||.+.+..++. ++|+||||+++|+|+||..||...... .....+......++. .+++++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~-~~DiwslG~il~el~tG~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~~~~~~~li~~~L 231 (325)
T cd05594 159 TPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEEIRFPR--TLSPEAKSLLSGLL 231 (325)
T ss_pred CcccCCHHHHccCCCCC-ccccccccceeeeeccCCCCCCCCCHH----HHHHHHhcCCCCCCC--CCCHHHHHHHHHHh
Confidence 99999999998777654 499999999999999999999765442 223333334444444 68999999999999
Q ss_pred hhCCCCCC-----CcHHHhhccChhhh
Q 024336 243 VADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 243 ~~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
+.||.+|+ ++.++++|+|+...
T Consensus 232 ~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 99999997 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=326.46 Aligned_cols=257 Identities=27% Similarity=0.444 Sum_probs=213.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||+||++.+..+|+.||+|++..... ..+.+.+|+.+++.++|+|++++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 579999999999999999999999999999999875422 3345778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-
Q 024336 79 EYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ- 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 156 (269)
||+++++|.+++.+. ..+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCce
Confidence 999999999999776 67999999999999999999999999999999999999998887 99999999864332222
Q ss_pred -CCcccCCCcccCchhhcc-----ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 157 -PKSTVGTPAYIAPEVLAR-----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 157 -~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
.....+++.|+|||.+.. ....+.++||||||+++|+|++|..||............... .....++....+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~ 236 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDPKV 236 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCCC
Confidence 223468899999999863 223345599999999999999999999876554333322211 111234444468
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
++++.+||.+||. +|.+||++++++.|+|+...
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 9999999999997 99999999999999998763
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=319.16 Aligned_cols=260 Identities=28% Similarity=0.425 Sum_probs=211.7
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.++|++.+.||+|+||.||++.+..++..+|+|.+..... ....+.+|+.+++.++|+||+++++++.+++.+++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 5789999999999999999999999999999998875422 23568899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
|+.+++|.+++.+.+.+++..+..++.|++.||.|||+. +++|+||||+||+++.++. ++|+|||++.... .....
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~-~~~~~ 160 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI-DSMAN 160 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhh-hhccc
Confidence 999999999998888899999999999999999999975 7999999999999998877 9999999886422 22223
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHH---------------------------
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFR--------------------------- 211 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~--------------------------- 211 (269)
...++..|+|||.+.+..++.+ +|+||||+++|+|++|..||..........
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 161 SFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred cCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence 4467889999999987666554 999999999999999999997543311110
Q ss_pred -------------HHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 212 -------------KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 212 -------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.....+.............+.++.+||.+||+.||++|||+.|++.|+|++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 001111111111111123678899999999999999999999999999997653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=320.32 Aligned_cols=250 Identities=34% Similarity=0.553 Sum_probs=208.2
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHH---HhCCCCCcceeeEEEEeCCeEEEE
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINH---RSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
|++++.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|..++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999987532 2234456666554 566899999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~ 156 (269)
|||+++++|...+.. +.+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++...... ..
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence 999999999888754 56899999999999999999999999999999999999998887 999999988643222 22
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||....... ....+.......+. .+++.+.+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~ 230 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEEE----VFDSIVNDEVRYPR--FLSREAIS 230 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCC--CCCHHHHH
Confidence 334568899999999987766544 999999999999999999998765432 23334444444444 68999999
Q ss_pred HHHHHhhhCCCCCC-----CcHHHhhccChhhh
Q 024336 237 LLSQIFVADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 237 li~~~l~~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
+|.+||..||.+|| ++.++++|+|+..+
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 99999999999999 68999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=323.11 Aligned_cols=259 Identities=28% Similarity=0.426 Sum_probs=205.6
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeC-----CeEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP-----THLA 75 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (269)
+|++.+.||+|+||.||++.+..++..||+|.+.... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6999999999999999999999999999999886432 2234577899999999999999999988643 2589
Q ss_pred EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
+||||++ ++|.+.+.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCcccccccccc
Confidence 9999996 589999988888999999999999999999999999999999999999998887 9999999986432221
Q ss_pred C----CCcccCCCcccCchhhccc-cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHH---------------
Q 024336 156 Q----PKSTVGTPAYIAPEVLARK-EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID--------------- 215 (269)
Q Consensus 156 ~----~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~--------------- 215 (269)
. .....+++.|+|||.+.+. ...+.++||||||+++|+|+||.+||..............
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 1 1234688999999998652 2334559999999999999999999976554322211110
Q ss_pred --------HHhhccc-c-CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 216 --------RIRNVQY-F-LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 216 --------~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.+..... . ......+++.+.++|.+||..||++|||+.|+++|+|++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 0000000 0 001124678899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-49 Score=326.47 Aligned_cols=254 Identities=30% Similarity=0.460 Sum_probs=212.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++++..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.++..+++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 57999999999999999999999999999999986432 22345678999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--C
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--Q 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~ 156 (269)
||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++....... .
T Consensus 123 Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~~~ 199 (370)
T cd05596 123 EYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGMVR 199 (370)
T ss_pred cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCccc
Confidence 99999999998855 46899999999999999999999999999999999999998887 9999999986432222 1
Q ss_pred CCcccCCCcccCchhhcccc---CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh--ccccCCCcCCCC
Q 024336 157 PKSTVGTPAYIAPEVLARKE---YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN--VQYFLPDYVRVS 231 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 231 (269)
.....+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||......... ..+.. ....++....++
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s 275 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY----SKIMDHKNSLTFPDDIEIS 275 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH----HHHHcCCCcCCCCCcCCCC
Confidence 23456899999999987543 2355699999999999999999999876543332 23322 223445555689
Q ss_pred HHHHHHHHHHhhhCCCC--CCCcHHHhhccChhh
Q 024336 232 ADCRHLLSQIFVADPSK--DPHSRDQKASLVPEE 263 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~--Rps~~~~l~~~~~~~ 263 (269)
.++.++|.+||..+|.+ |+++.+++.|+|+..
T Consensus 276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 99999999999999988 999999999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=319.31 Aligned_cols=247 Identities=31% Similarity=0.498 Sum_probs=208.5
Q ss_pred cceecccCceEEEEEEEe---cCCeEEEEEEeecCc-----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 8 VKELGSGNFGVARLVRDK---RTKELVAVKYIERGK-----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++.||+|+||.||++.+. .+++.||+|++.... .....+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 468999999999999874 468899999987532 223456789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK 158 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 158 (269)
|+++++|.+.+.+.+.+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++....... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCccc
Confidence 9999999999988888999999999999999999999999999999999999998887 9999999886432222 223
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...+++.|+|||.+.+..+.. ++||||||+++|+|++|..||...... .....+.......+. .+++++.++|
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~G~~pf~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~li 231 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGK-AVDWWSLGALMYDMLTGAPPFTAENRK----KTIDKILKGKLNLPP--YLTPEARDLL 231 (323)
T ss_pred ccCCCccccChhhccCCCCCC-cceecccHHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCCC--CCCHHHHHHH
Confidence 346889999999998766644 599999999999999999999875543 233344444444444 6889999999
Q ss_pred HHHhhhCCCCCC-----CcHHHhhccChhh
Q 024336 239 SQIFVADPSKDP-----HSRDQKASLVPEE 263 (269)
Q Consensus 239 ~~~l~~~p~~Rp-----s~~~~l~~~~~~~ 263 (269)
.+||+.||++|| ++++++.|+|+..
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 999999999999 8999999999865
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=319.71 Aligned_cols=247 Identities=30% Similarity=0.495 Sum_probs=208.1
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||.||++.+..+++.||+|++.... ...+.+..|..+++.+ +||||+++++++.+++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999987532 2223466788888765 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCcccC
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 162 (269)
++|...+...+.+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcccccccc
Confidence 999999988888999999999999999999999999999999999999998887 999999988643222 22334468
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...... .....+.......+. .++.++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~~~~~~~ll~~~L 231 (321)
T cd05591 159 TPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNED----DLFESILHDDVLYPV--WLSKEAVSILKAFM 231 (321)
T ss_pred CccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence 899999999987766554 99999999999999999999876543 233344444444444 57899999999999
Q ss_pred hhCCCCCC-------CcHHHhhccChhhh
Q 024336 243 VADPSKDP-------HSRDQKASLVPEEF 264 (269)
Q Consensus 243 ~~~p~~Rp-------s~~~~l~~~~~~~~ 264 (269)
..||.+|| ++.++++|+|+..+
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 99999999 89999999998763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=316.83 Aligned_cols=262 Identities=24% Similarity=0.397 Sum_probs=212.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.++++++|||++++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999999999999999987432 2234577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCC
Q 024336 81 AAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK 158 (269)
Q Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 158 (269)
+++ +|.+.+... ..++...+..++.|++.||++||+.|++||||||+||+++.++. ++|+|||++....... ...
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~ 162 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKTYS 162 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCccccc
Confidence 986 777777554 45899999999999999999999999999999999999998877 9999999986432222 223
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc---------------ccc
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QYF 223 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------------~~~ 223 (269)
...+++.|+|||.+.+....+.++|+||||+++|+|+||.+||...+..+............ ...
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence 34578899999998765545566999999999999999999998766544433332221100 000
Q ss_pred CC---------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhhc
Q 024336 224 LP---------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAER 267 (269)
Q Consensus 224 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~~ 267 (269)
.+ ....+++++.++|.+||..||.+|||+.|++.|+|+..+..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 295 (309)
T cd07872 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR 295 (309)
T ss_pred cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence 01 112468899999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=319.57 Aligned_cols=251 Identities=28% Similarity=0.468 Sum_probs=207.5
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||.||++.+..+++.||+|++.+.. .....+..|+.++.++ +||||+++++++..++.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999987542 2223466788887766 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCCCcccC
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 162 (269)
++|...+...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccC
Confidence 999999988888999999999999999999999999999999999999998887 99999999864322 222334568
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCC-----hhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED-----PRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||..... ..........+.......|. .++..+.++
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~l 235 (329)
T cd05618 159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASV 235 (329)
T ss_pred CccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC--CCCHHHHHH
Confidence 999999999987776554 9999999999999999999953211 11122233334444444554 788999999
Q ss_pred HHHHhhhCCCCCCCc------HHHhhccChhhh
Q 024336 238 LSQIFVADPSKDPHS------RDQKASLVPEEF 264 (269)
Q Consensus 238 i~~~l~~~p~~Rps~------~~~l~~~~~~~~ 264 (269)
|.+||..||.+||++ .++++|+|+..+
T Consensus 236 l~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999999995 799999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=317.68 Aligned_cols=247 Identities=31% Similarity=0.510 Sum_probs=206.5
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||.||++.+..+|+.||+|.+.... ........|..++... +||+++++++++.+++.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999987532 2234456677777654 899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCCCcccC
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 162 (269)
++|...+...+.+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCC
Confidence 999999988888999999999999999999999999999999999999998887 99999998864222 222334568
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...... .....+.......+. .++.++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~li~~~l 231 (316)
T cd05620 159 TPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDED----ELFESIRVDTPHYPR--WITKESKDILEKLF 231 (316)
T ss_pred CcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCC--CCCHHHHHHHHHHc
Confidence 999999999987776554 99999999999999999999765432 233333434444444 58899999999999
Q ss_pred hhCCCCCCCc-HHHhhccChhhh
Q 024336 243 VADPSKDPHS-RDQKASLVPEEF 264 (269)
Q Consensus 243 ~~~p~~Rps~-~~~l~~~~~~~~ 264 (269)
..||.+||++ .+++.|+|+...
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCC
Confidence 9999999998 588899999774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=312.75 Aligned_cols=255 Identities=27% Similarity=0.377 Sum_probs=203.0
Q ss_pred ccccccceecccCceEEEEEEEec-CCeEEEEEEeecCcc---ccHHHHHHHHHHHhC---CCCCcceeeEEEEe-----
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKR-TKELVAVKYIERGKK---IDENVQREIINHRSL---RHPNIIRFKEVLLT----- 70 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~----- 70 (269)
++|++.+.||+|+||.||++.+.. ++..||+|.+..... ......+|+..++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 589999999999999999999854 578899998864322 223456677777665 69999999998852
Q ss_pred CCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCc
Q 024336 71 PTHLAIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS 148 (269)
Q Consensus 71 ~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~ 148 (269)
...+++|+|++++ +|.+++... ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccce
Confidence 3568999999974 888888653 34899999999999999999999999999999999999998887 999999998
Q ss_pred ccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-ccCCC-
Q 024336 149 KSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPD- 226 (269)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~- 226 (269)
.............+++.|+|||.+.+..++.+ +|+||||+++|+|++|.+||........+........... ..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 75433333445568899999999977766554 9999999999999999999988776555544443221100 00000
Q ss_pred -------------------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 227 -------------------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 227 -------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
...+++.+.++|.+||+.||++|||+.++++|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 12467888999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=326.12 Aligned_cols=256 Identities=27% Similarity=0.470 Sum_probs=212.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+++.||+|++... ......+.+|+.++..++|++++++++.+.+++.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5799999999999999999999999999999998743 223346778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC---
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--- 155 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--- 155 (269)
||+++++|.+++.+.+.+++..+..++.|++.||++||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEeeccCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999998887 9999999875321110
Q ss_pred ---------------------------------CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCC
Q 024336 156 ---------------------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFE 202 (269)
Q Consensus 156 ---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~ 202 (269)
......+++.|+|||.+.+..++.. +|+|||||++|+|+||..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCCC
Confidence 0113458899999999987777555 999999999999999999998
Q ss_pred CCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCC---cHHHhhccChhhh
Q 024336 203 DPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPH---SRDQKASLVPEEF 264 (269)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~~~~~~~ 264 (269)
.............. .....++....+++++.++|.+|+. ||.+|++ +++++.|+|+..+
T Consensus 238 ~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 238 SETPQETYRKVMNW--KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCHHHHHHHHHcC--CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 76543332222211 1223344444578999999999874 9999995 7999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=318.02 Aligned_cols=252 Identities=32% Similarity=0.495 Sum_probs=212.1
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
+|++.+.||+|+||.||++.+..+++.||+|.+.+... .......|..++..+ .|++++++++++.+.+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999999875321 223455677777766 5799999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~ 157 (269)
||+++++|.+.+...+.+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++..... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCcc
Confidence 99999999999988888999999999999999999999999999999999999998887 99999999864322 2223
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....+++.|+|||.+.+..++.+ +|+||||+++|+|+||..||...... .....+......++. .++.++.++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~~l 231 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIMEHNVAYPK--SMSKEAVAI 231 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCC--cCCHHHHHH
Confidence 34568999999999987777554 99999999999999999999875543 233344444444554 789999999
Q ss_pred HHHHhhhCCCCCCCc-----HHHhhccChhhh
Q 024336 238 LSQIFVADPSKDPHS-----RDQKASLVPEEF 264 (269)
Q Consensus 238 i~~~l~~~p~~Rps~-----~~~l~~~~~~~~ 264 (269)
+.+||+.||.+|++. .++++|+|+...
T Consensus 232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999999985 899999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=317.79 Aligned_cols=247 Identities=35% Similarity=0.559 Sum_probs=208.6
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||+||++.+..++..||+|++.+.. .....+..|..+++.+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987532 2234566788888777 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCCCcccC
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 162 (269)
++|...+.+.+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence 999999988888999999999999999999999999999999999999998887 99999998864222 222233468
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.. .....+.......+. .++..+.++|.+||
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~~----~~~~~i~~~~~~~~~--~~~~~~~~li~~~l 231 (318)
T cd05570 159 TPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDED----ELFQSILEDEVRYPR--WLSKEAKSILKSFL 231 (318)
T ss_pred CccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCHH----HHHHHHHcCCCCCCC--cCCHHHHHHHHHHc
Confidence 899999999987777555 99999999999999999999765432 223333344444444 68899999999999
Q ss_pred hhCCCCCCCc-----HHHhhccChhhh
Q 024336 243 VADPSKDPHS-----RDQKASLVPEEF 264 (269)
Q Consensus 243 ~~~p~~Rps~-----~~~l~~~~~~~~ 264 (269)
..||.+||++ .+++.|+|+...
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999 999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-49 Score=311.72 Aligned_cols=255 Identities=34% Similarity=0.512 Sum_probs=209.4
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHH---HHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---VQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
|++++.||+|+||+||++.+..+++.||+|.+......... ..+|+..+++++||||+++++++......++++|++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999876543333 345999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC-CCCCCCCcc
Q 024336 82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG-LLHSQPKST 160 (269)
Q Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~-~~~~~~~~~ 160 (269)
++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+... .........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 99999999987888999999999999999999999999999999999999997777 999999998642 233344456
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh-ccccCCCcCCCCHHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 239 (269)
.+++.|+|||.+......+.++|+||||+++++|++|..||.................. ...........+..+.++|.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 238 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIK 238 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHH
Confidence 67889999999883334455599999999999999999999876322222222222211 11111111123479999999
Q ss_pred HHhhhCCCCCCCcHHHhhccCh
Q 024336 240 QIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
+||+.||++||++.++++|||+
T Consensus 239 ~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 239 KMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999996
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=318.47 Aligned_cols=247 Identities=32% Similarity=0.540 Sum_probs=204.8
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHH-HHHhCCCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREII-NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||+||++.+..+|+.||+|++..... ....+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999875321 1223344443 56788999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCcccC
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 162 (269)
++|...+.+.+.+++..+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccC
Confidence 999999988888999999999999999999999999999999999999998887 999999988643222 22334468
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
++.|+|||.+.+..++. ++|+||||+++|+|++|..||...+. ......+.......+. .++..+.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~-~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l 231 (323)
T cd05575 159 TPEYLAPEVLRKQPYDR-TVDWWCLGAVLYEMLYGLPPFYSRDT----AEMYDNILNKPLRLKP--NISVSARHLLEGLL 231 (323)
T ss_pred ChhhcChhhhcCCCCCc-cccccccchhhhhhhcCCCCCCCCCH----HHHHHHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence 99999999998776655 49999999999999999999987543 2333334444444443 67999999999999
Q ss_pred hhCCCCCCCc----HHHhhccChhhh
Q 024336 243 VADPSKDPHS----RDQKASLVPEEF 264 (269)
Q Consensus 243 ~~~p~~Rps~----~~~l~~~~~~~~ 264 (269)
+.||.+||++ .+++.|+|+..+
T Consensus 232 ~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 232 QKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred hcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 9999999998 599999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=328.01 Aligned_cols=257 Identities=27% Similarity=0.357 Sum_probs=217.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC-C-----CCcceeeEEEEeCCeEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-H-----PNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~~ 76 (269)
-+|.+++.||+|.||.|.+|.+..|++.||||+++...........|+.+|..|+ | -|+|+++++|...+.+|+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 4799999999999999999999999999999999887777777888999999996 4 389999999999999999
Q ss_pred EEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 77 VMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
|+|.++ .+|.+++..++ .++...++.++.||+.||.+||+.||||+||||+|||+.....+.|||+|||++... .
T Consensus 266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~--~ 342 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE--S 342 (586)
T ss_pred eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc--C
Confidence 999996 49999997765 588999999999999999999999999999999999998877778999999999742 3
Q ss_pred CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-------------
Q 024336 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ------------- 221 (269)
Q Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~------------- 221 (269)
........+..|+|||++.+..+... .||||||||++||++|.+.|.+.+..+.+..+++-.....
T Consensus 343 q~vytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kf 421 (586)
T KOG0667|consen 343 QRVYTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKF 421 (586)
T ss_pred CcceeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccccee
Confidence 33336778889999999999999877 9999999999999999999998877666555442221110
Q ss_pred -----------------------------------ccCC-Cc--------CCCCHHHHHHHHHHhhhCCCCCCCcHHHhh
Q 024336 222 -----------------------------------YFLP-DY--------VRVSADCRHLLSQIFVADPSKDPHSRDQKA 257 (269)
Q Consensus 222 -----------------------------------~~~~-~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 257 (269)
...| .. ..-...+.+||++||..||.+|+|+.|+|+
T Consensus 422 f~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 422 FTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN 501 (586)
T ss_pred hhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 00 011245899999999999999999999999
Q ss_pred ccChhh
Q 024336 258 SLVPEE 263 (269)
Q Consensus 258 ~~~~~~ 263 (269)
|+|+..
T Consensus 502 Hpfl~~ 507 (586)
T KOG0667|consen 502 HPFLTG 507 (586)
T ss_pred Cccccc
Confidence 999984
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=311.43 Aligned_cols=249 Identities=29% Similarity=0.410 Sum_probs=205.3
Q ss_pred ecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCch
Q 024336 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 11 l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
||+|+||+||++.+..+++.||+|.+..... ..+.+..|+.+++.++|+|++++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 7999999999999999999999999865322 224567799999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCccc
Q 024336 87 FARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTV 161 (269)
Q Consensus 87 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~~~ 161 (269)
.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccC
Confidence 887743 346899999999999999999999999999999999999998777 9999999886432222 223346
Q ss_pred CCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHH
Q 024336 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241 (269)
Q Consensus 162 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 241 (269)
+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...............+.......+. .+++.+.+++.+|
T Consensus 159 g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~ 235 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCEAL 235 (280)
T ss_pred CCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcc--cCCHHHHHHHHHH
Confidence 7889999999987776554 999999999999999999998654433333333333333333333 6899999999999
Q ss_pred hhhCCCCCC-----CcHHHhhccChhhh
Q 024336 242 FVADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 242 l~~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
|+.||++|| +++++++|+|++.+
T Consensus 236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 236 LAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred hcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 999999999 78999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=322.95 Aligned_cols=254 Identities=20% Similarity=0.301 Sum_probs=204.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
++|++++.||+|+||.||++.+..+++.||+|... ...+.+|+.++++++||||+++++++..+...++++|++.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 57999999999999999999999999999999643 2456789999999999999999999999999999999996
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC--CCCCcc
Q 024336 83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--SQPKST 160 (269)
Q Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~--~~~~~~ 160 (269)
++|..++.....+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++...... ......
T Consensus 167 -~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~~~ 243 (391)
T PHA03212 167 -TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYYGW 243 (391)
T ss_pred -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCcccccccccccccccc
Confidence 588888887788999999999999999999999999999999999999998887 999999998632211 122345
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCC-------hhhHHHHHHHHh---------------
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED-------PRNFRKTIDRIR--------------- 218 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~-------~~~~~~~~~~~~--------------- 218 (269)
.+++.|+|||.+.+..++. ++|+||||+++|+|+||..||..... ...+........
T Consensus 244 ~gt~~y~aPE~~~~~~~~~-~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 244 AGTIATNAPELLARDPYGP-AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred cCccCCCChhhhcCCCCCc-HHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 6899999999998776644 59999999999999999987643221 111111111100
Q ss_pred -------hccc----cCC---CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 219 -------NVQY----FLP---DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 219 -------~~~~----~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.... ..+ ....++.++.+||.+||+.||.+|||+.|+|+|+|++.+.
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 0000 000 1113567899999999999999999999999999998753
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=315.36 Aligned_cols=247 Identities=33% Similarity=0.533 Sum_probs=206.0
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHh-CCCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRS-LRHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||.||++.+..+++.||+|.+.... ........|..+++. ++||||+++++++.+++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999987542 223445667777765 4899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCcccC
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 162 (269)
++|.+.+.....+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecC
Confidence 999999988788999999999999999999999999999999999999998887 999999988642222 22334568
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||...... .....+.......+. .++.++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~----~~~~~i~~~~~~~~~--~~~~~~~~li~~~l 231 (316)
T cd05619 159 TPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEE----ELFQSIRMDNPCYPR--WLTREAKDILVKLF 231 (316)
T ss_pred CccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCc--cCCHHHHHHHHHHh
Confidence 899999999987766554 99999999999999999999875432 233333333333443 57889999999999
Q ss_pred hhCCCCCCCcH-HHhhccChhhh
Q 024336 243 VADPSKDPHSR-DQKASLVPEEF 264 (269)
Q Consensus 243 ~~~p~~Rps~~-~~l~~~~~~~~ 264 (269)
..||.+||++. +++.|+|+...
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 232 VREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred ccCHhhcCCChHHHHcCcccCCC
Confidence 99999999996 89999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=313.40 Aligned_cols=262 Identities=25% Similarity=0.405 Sum_probs=212.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++|++.+.||.|++|.||++.+..+++.||+|.+.... .....+.+|+..++.++||||+++++++..++..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999999899999999987533 2234577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCC
Q 024336 81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK 158 (269)
Q Consensus 81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 158 (269)
+++ +|.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 86 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~ 162 (301)
T cd07873 86 LDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYS 162 (301)
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCccc
Confidence 975 88887765 346899999999999999999999999999999999999998887 9999999886432222 222
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc---------------ccc
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QYF 223 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------------~~~ 223 (269)
...+++.|+|||.+.+....+.++|+||||+++|+|+||.+||...+............... ...
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence 34568899999998766555666999999999999999999998765443332222111100 000
Q ss_pred CCC---------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhhc
Q 024336 224 LPD---------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAER 267 (269)
Q Consensus 224 ~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~~ 267 (269)
.+. ...+++.+.+||.+||..||.+|||+.|++.|+|++.+.++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence 111 12468889999999999999999999999999999998865
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=315.27 Aligned_cols=247 Identities=36% Similarity=0.561 Sum_probs=204.6
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHh-CCCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRS-LRHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||.||++.+..+++.||+|.+.... ...+....|..++.. .+||||+++++++..++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987532 222334556666654 4899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCcccC
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 162 (269)
++|...+...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccC
Confidence 999999988888999999999999999999999999999999999999998887 999999998643222 22334568
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+... ....+......++. .++.++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~~----~~~~i~~~~~~~~~--~~~~~~~~ll~~~l 231 (316)
T cd05592 159 TPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDE----LFDSILNDRPHFPR--WISKEAKDCLSKLF 231 (316)
T ss_pred CccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCC--CCCHHHHHHHHHHc
Confidence 999999999987776555 999999999999999999998765432 22333333333444 68899999999999
Q ss_pred hhCCCCCCCcH-HHhhccChhhh
Q 024336 243 VADPSKDPHSR-DQKASLVPEEF 264 (269)
Q Consensus 243 ~~~p~~Rps~~-~~l~~~~~~~~ 264 (269)
..||.+||++. ++++|+|+...
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 232 ERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred cCCHHHcCCChHHHHcCcccCCC
Confidence 99999999975 88899998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=322.95 Aligned_cols=254 Identities=29% Similarity=0.448 Sum_probs=210.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+++.+|+|++.+.. .....+.+|+.+++.++||||+++++.+.++..+++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999986422 22345778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--C
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--Q 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~ 156 (269)
||+++++|.+++... .+++..+..++.||+.||++||+.|++||||||+||+++.++. ++|+|||++....... .
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGMVR 199 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCcee
Confidence 999999999998654 5899999999999999999999999999999999999998887 9999999987432222 1
Q ss_pred CCcccCCCcccCchhhcccc---CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh--ccccCCCcCCCC
Q 024336 157 PKSTVGTPAYIAPEVLARKE---YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN--VQYFLPDYVRVS 231 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 231 (269)
.....+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||......... ..+.. ....++....++
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~----~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY----SKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCcccCCCCcccCC
Confidence 23456899999999987543 2345699999999999999999999876543333 22322 223445545679
Q ss_pred HHHHHHHHHHhhhCCCC--CCCcHHHhhccChhh
Q 024336 232 ADCRHLLSQIFVADPSK--DPHSRDQKASLVPEE 263 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~--Rps~~~~l~~~~~~~ 263 (269)
..+.++|.+||..++.+ |+++.++++|+|++.
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 99999999999855543 899999999999976
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-50 Score=303.13 Aligned_cols=258 Identities=34% Similarity=0.508 Sum_probs=226.3
Q ss_pred cccccc-ceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEEe----CCeEEE
Q 024336 3 ERYEPV-KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLT----PTHLAI 76 (269)
Q Consensus 3 ~~y~~~-~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~~ 76 (269)
++|++. +.||-|-.|.|..+.++.+|+.+|+|++..+ ...++|+++.-.. .|||||.+++++.. ..++.+
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi 136 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI 136 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence 456654 5689999999999999999999999988644 5577888876444 69999999998764 357899
Q ss_pred EEeecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CCcEEEeecCCcccCCC
Q 024336 77 VMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLL 153 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~~~ 153 (269)
|||.++||.|.+.++..+. +++.++..|++||+.|+.|||+.+|.|||+||+|++++..+ ++.+||+|||.++....
T Consensus 137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 9999999999999988775 99999999999999999999999999999999999997544 35689999999987666
Q ss_pred CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC--CcCCCC
Q 024336 154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVS 231 (269)
Q Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 231 (269)
.....+.+.||.|.|||++...+++.. +|+||+|+++|-|++|.+||.+.........+..++..+.+.+| +|+.+|
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydks-cdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VS 295 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVS 295 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCC-CCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHH
Confidence 667778899999999999987776444 99999999999999999999988887777788899999988776 478999
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
+..+++|+.+|+.+|++|.|+.++++|+|.....
T Consensus 296 e~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 296 EAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred HHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 9999999999999999999999999999987644
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=320.85 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=204.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++|+.++.||+|+||.||++.+..+++.||+|++..... ....+.+|+.+++.++|+||+++++++..++.+++|+||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 468889999999999999999999999999999865432 235678999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 159 (269)
+++++|... ...++..+..++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||++....... ....
T Consensus 154 ~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~ 227 (353)
T PLN00034 154 MDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCNS 227 (353)
T ss_pred CCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceecccccccccc
Confidence 999988643 23577888999999999999999999999999999999998887 9999999987432221 2234
Q ss_pred ccCCCcccCchhhcc----ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 160 TVGTPAYIAPEVLAR----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
..++..|+|||.+.. ..+...++||||||+++|+|++|..||....... .......+.... .......++.++.
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~l~ 305 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASLMCAICMSQ-PPEAPATASREFR 305 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhccC-CCCCCCccCHHHH
Confidence 568899999998753 2333456999999999999999999997433222 222222221111 1112236889999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+||.+||..||++||++.|+++|+|+..
T Consensus 306 ~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 306 HFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred HHHHHHccCChhhCcCHHHHhcCccccc
Confidence 9999999999999999999999999876
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=320.16 Aligned_cols=256 Identities=26% Similarity=0.380 Sum_probs=204.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCC------
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPT------ 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 72 (269)
.++|++.+.||+|+||.||++.+..+|..||+|.+.... .....+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999999999999999986432 23345778999999999999999999987543
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
.+++||||+++ ++...+. ..++...+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++....
T Consensus 100 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~ 174 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAC 174 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccc
Confidence 47999999976 5666553 34789999999999999999999999999999999999998887 9999999987543
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH---------------
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI--------------- 217 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~--------------- 217 (269)
.........+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+............
T Consensus 175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 175 TNFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred cCccCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 3333445567899999999987777555 999999999999999999998765433322221111
Q ss_pred ---hhccccC--------------C----CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 218 ---RNVQYFL--------------P----DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 218 ---~~~~~~~--------------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
....... + .....++.+.+||.+||..||++|||+.|++.|+|+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 0000000 0 01124577899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=319.46 Aligned_cols=248 Identities=30% Similarity=0.512 Sum_probs=207.9
Q ss_pred cceecccCceEEEEEEEe---cCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 8 VKELGSGNFGVARLVRDK---RTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
++.||+|+||.||++++. .+|+.||+|++.... .....+..|+.++++++||||+++++++.+++.+|+|+||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 467999999999999873 578999999987532 22344677999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCcc
Q 024336 82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKST 160 (269)
Q Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~ 160 (269)
++++|.+.+.+...+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++...... ......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecc
Confidence 99999999988888999999999999999999999999999999999999998887 999999998753333 222345
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (269)
.+++.|+|||.+.+..++. ++|+||||+++|+|++|..||...... .....+.......+. .+++++.++|.+
T Consensus 159 ~g~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~tg~~p~~~~~~~----~~~~~i~~~~~~~p~--~~~~~~~~li~~ 231 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQ-SADWWSFGVLMFEMLTGSLPFQGKDRK----ETMTMILKAKLGMPQ--FLSPEAQSLLRA 231 (318)
T ss_pred cCChhhcCHHHHcCCCCCC-ccceeccceEeeeeccCCCCCCCCCHH----HHHHHHHcCCCCCCC--CCCHHHHHHHHH
Confidence 6889999999998766654 499999999999999999999865442 223333344444444 688999999999
Q ss_pred HhhhCCCCCCC-----cHHHhhccChhhh
Q 024336 241 IFVADPSKDPH-----SRDQKASLVPEEF 264 (269)
Q Consensus 241 ~l~~~p~~Rps-----~~~~l~~~~~~~~ 264 (269)
||+.||.+||+ +++++.|+|+..+
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 99999999999 6779999998653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=303.76 Aligned_cols=252 Identities=31% Similarity=0.442 Sum_probs=210.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc------ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
+.|++.+.||+|++|.||.+.+..++..+++|.+..... ....+.+|+.++++++|||++++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 579999999999999999999998999999998865321 22457789999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
++|++++++|.+.+...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecccccc
Confidence 9999999999999988888999999999999999999999999999999999999998877 99999998864322111
Q ss_pred C----CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCH
Q 024336 157 P----KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232 (269)
Q Consensus 157 ~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
. ....++..|+|||.+.+...+ .++|+||||+++|++++|..||...+....... .........-...++.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 234 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPQLPSHVSP 234 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccCCCCCCCccCCH
Confidence 1 233467789999999877654 459999999999999999999977554333222 2222122222236889
Q ss_pred HHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 233 DCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.+.++|.+||..+|.+|||+.++++|+|+
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 235 DARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=307.13 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=204.1
Q ss_pred ecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCch
Q 024336 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 11 l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
||+|+||.||++.+..+|+.||+|.+..... ....+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999999999999999999864221 223455699999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccCCC
Q 024336 87 FARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP 164 (269)
Q Consensus 87 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 164 (269)
.+.+.... .+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++.............++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCC
Confidence 88875543 4889999999999999999999999999999999999998887 9999999887543333333456888
Q ss_pred cccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhh
Q 024336 165 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244 (269)
Q Consensus 165 ~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 244 (269)
.|+|||.+.+..++. ++|+||||+++|+|++|..||.......................+ ...+++++.++|.+||++
T Consensus 159 ~y~aPE~~~~~~~~~-~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 159 GYMAPEILKEEPYSY-PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAK 236 (277)
T ss_pred CccCHHHHccCCCCC-chhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHHhcc
Confidence 999999998777544 499999999999999999999765443333333333332222221 236889999999999999
Q ss_pred CCCCCCCc----HHHhhccChhhh
Q 024336 245 DPSKDPHS----RDQKASLVPEEF 264 (269)
Q Consensus 245 ~p~~Rps~----~~~l~~~~~~~~ 264 (269)
||.+||++ ++++.|+|++.+
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcCC
Confidence 99999999 667789998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=314.40 Aligned_cols=252 Identities=30% Similarity=0.495 Sum_probs=211.2
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 78 (269)
+|++.+.||+|+||.||++.+..+|+.||+|++.... ...+.+..|..+++.+. |++++++++++.+.+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999987532 22234667888888775 577888999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~ 157 (269)
||+++++|.+++...+.+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++....... ..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccc
Confidence 99999999999988888999999999999999999999999999999999999998887 9999999886432222 23
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....+++.|+|||.+.+..++. ++|+||||+++|+|++|..||...... .....+.......+. .++.++.++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~-~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~~~~~~~p~--~~~~~~~~l 231 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGK-SVDWWAYGVLLYEMLAGQPPFDGEDED----ELFQSIMEHNVSYPK--SLSKEAVSI 231 (323)
T ss_pred cCccCCccccCHHHHcCCCCCC-ccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCc--cCCHHHHHH
Confidence 3445889999999998776654 499999999999999999999875542 233334444444444 688999999
Q ss_pred HHHHhhhCCCCCCCc-----HHHhhccChhhh
Q 024336 238 LSQIFVADPSKDPHS-----RDQKASLVPEEF 264 (269)
Q Consensus 238 i~~~l~~~p~~Rps~-----~~~l~~~~~~~~ 264 (269)
+.+||+++|.+|++. +++++|+|+..+
T Consensus 232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 999999999999985 789999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=307.87 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=210.2
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCccc----cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.|++.+.||+|+||.||++.+..+++.||+|.+...... ...+.+|+.++++++|++++++.+.+.+++..++|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 478899999999999999999999999999998754221 2346679999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 80 YAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
|+.+++|.+.+...+ .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTI 158 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccc
Confidence 999999998885433 5899999999999999999999999999999999999998877 999999988654333333
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....++..|+|||.+.+..++.+ +|+||+|+++|+|++|..||.......................+. .+++++.+|
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 235 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE--KFSPDARSL 235 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCc--cCCHHHHHH
Confidence 34568899999999987776544 999999999999999999998654322211111111111122222 688999999
Q ss_pred HHHHhhhCCCCCCC-----cHHHhhccChhhh
Q 024336 238 LSQIFVADPSKDPH-----SRDQKASLVPEEF 264 (269)
Q Consensus 238 i~~~l~~~p~~Rps-----~~~~l~~~~~~~~ 264 (269)
+.+||+.||.+||| ++|+++|+|+..+
T Consensus 236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 99999999999999 8999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=308.16 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=202.3
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhC---CCCCcceeeEEEEe-----CC
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSL---RHPNIIRFKEVLLT-----PT 72 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~ 72 (269)
+|++.+.||+|+||+||++.+..+++.||+|.+..... ......+|+..++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999998865322 223456677776665 79999999998864 24
Q ss_pred eEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCccc
Q 024336 73 HLAIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~ 150 (269)
..++++|++.+ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence 58999999975 788888653 34899999999999999999999999999999999999998887 99999998875
Q ss_pred CCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-ccCC----
Q 024336 151 GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLP---- 225 (269)
Q Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~---- 225 (269)
...........++..|+|||.+.+..++.+ +|+||||+++|+|++|.+||.................... ..++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 433333344567889999999987766554 9999999999999999999987665544444333221100 0000
Q ss_pred ----------------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 226 ----------------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 226 ----------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
....++..+.++|.+||+.||.+|||+.|++.|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 012467789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=315.15 Aligned_cols=247 Identities=32% Similarity=0.546 Sum_probs=203.4
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHH-HHHHhCCCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREI-INHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||+||++.+..+++.||+|++.... .....+..|. .+++.++||||+++++++..++.+++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999987532 1122333343 456778999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCCCcccC
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 162 (269)
++|.+.+...+.+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCcccccCCCCcccccC
Confidence 999999988888999999999999999999999999999999999999998887 99999999864322 222334568
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||........ ...+.......+. .++..+.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li~~~l 231 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEM----YDNILNKPLQLKP--NITNSARHLLEGLL 231 (325)
T ss_pred CccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHHHH----HHHHHhCCcCCCC--CCCHHHHHHHHHHc
Confidence 999999999987766554 9999999999999999999986554322 2333333333333 68999999999999
Q ss_pred hhCCCCCCCcH----HHhhccChhhh
Q 024336 243 VADPSKDPHSR----DQKASLVPEEF 264 (269)
Q Consensus 243 ~~~p~~Rps~~----~~l~~~~~~~~ 264 (269)
+.||.+||++. ++++|+|+..+
T Consensus 232 ~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 232 QKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred ccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 99999999987 89999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=307.36 Aligned_cols=257 Identities=23% Similarity=0.365 Sum_probs=214.7
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.|+..+.||+|+||+||++.+..+++.+|+|.+..... ....+.+|+.+++.++|++++++.+.+..++..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999865421 12346789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 80 YAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
|+.+++|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPEGESI 158 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC--EEEecCCcceecCCCCcc
Confidence 99999998887543 35899999999999999999999999999999999999998876 999999988643333333
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....++..|+|||.+.+..++.+ +|+||||+++|++++|..||...............+.......+. .++..+.+|
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 235 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSA--KFSEEAKSI 235 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCc--cCCHHHHHH
Confidence 34568899999999987766554 999999999999999999998765544444444444443333333 688999999
Q ss_pred HHHHhhhCCCCCCC-----cHHHhhccChhhhh
Q 024336 238 LSQIFVADPSKDPH-----SRDQKASLVPEEFA 265 (269)
Q Consensus 238 i~~~l~~~p~~Rps-----~~~~l~~~~~~~~~ 265 (269)
+.+||+.||.+||+ +.+++.|+|+..+.
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred HHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 99999999999999 88999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=314.57 Aligned_cols=251 Identities=28% Similarity=0.472 Sum_probs=208.2
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||.||++.+..+++.||+|++.... ...+.+..|..++.++ +||+|+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999997542 2234467888888887 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC-CCCCCCcccC
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~ 162 (269)
++|...+...+.+++..+..++.|++.||++||+.|++||||||+||+++.++. ++|+|||++.... .........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence 999999988888999999999999999999999999999999999999998887 9999999886422 2223334568
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh---hhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...... .........+.......+. .++..+.++|.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~ 235 (327)
T cd05617 159 TPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR--FLSVKASHVLK 235 (327)
T ss_pred CcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC--CCCHHHHHHHH
Confidence 999999999987776554 99999999999999999999643221 1222233333334444444 68899999999
Q ss_pred HHhhhCCCCCCCc------HHHhhccChhhh
Q 024336 240 QIFVADPSKDPHS------RDQKASLVPEEF 264 (269)
Q Consensus 240 ~~l~~~p~~Rps~------~~~l~~~~~~~~ 264 (269)
+||..||.+|+++ .++++|+|+...
T Consensus 236 ~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 236 GFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 9999999999985 699999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=316.25 Aligned_cols=247 Identities=30% Similarity=0.501 Sum_probs=205.0
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHH-HHHhCCCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREII-NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||.||++.+..+|+.||+|++.... .....+..|.. +++.++||||+++++.+..++.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999987532 12233444544 46778999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCCCcccC
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 162 (269)
++|...+...+.+++..+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccC
Confidence 999999988888999999999999999999999999999999999999998887 99999999864322 222334568
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+... ....+.......+. ..+..+.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~ll~~ll 231 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAE----MYDNILHKPLVLRP--GASLTAWSILEELL 231 (325)
T ss_pred ChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHHH----HHHHHHcCCccCCC--CCCHHHHHHHHHHh
Confidence 899999999987776554 999999999999999999998754432 33333333333333 58899999999999
Q ss_pred hhCCCCCCCcH----HHhhccChhhh
Q 024336 243 VADPSKDPHSR----DQKASLVPEEF 264 (269)
Q Consensus 243 ~~~p~~Rps~~----~~l~~~~~~~~ 264 (269)
..+|.+||+++ ++++|+|+..+
T Consensus 232 ~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 232 EKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred ccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 99999999885 89999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-48 Score=320.91 Aligned_cols=257 Identities=28% Similarity=0.377 Sum_probs=207.7
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----eEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPT-----HLA 75 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (269)
+|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5889999999999999999999899999999886432 22345778999999999999999999998776 789
Q ss_pred EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
+|+||+. ++|...+...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCc
Confidence 9999997 478888877788999999999999999999999999999999999999998887 9999999886432221
Q ss_pred --CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHH-----------------
Q 024336 156 --QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR----------------- 216 (269)
Q Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~----------------- 216 (269)
......+++.|+|||.+.+....+.++|+|||||++|+|++|..||...............
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 2223456889999999987655456699999999999999999999876544333222111
Q ss_pred --HhhccccC-------CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 217 --IRNVQYFL-------PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 217 --~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+....... .-....++++.+||.+||..||.+|||+.|++.|+|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 00000000 011245788999999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=319.47 Aligned_cols=254 Identities=31% Similarity=0.469 Sum_probs=209.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+++.+|+|++.... .....+.+|+.+++.++||||+++++.+.++..+++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999986422 22344678999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--C
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--Q 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~ 156 (269)
||+++++|.+++.. ..+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++....... .
T Consensus 123 Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~~~~ 199 (371)
T cd05622 123 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVR 199 (371)
T ss_pred cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCCccc
Confidence 99999999998865 45899999999999999999999999999999999999998887 9999999987432222 2
Q ss_pred CCcccCCCcccCchhhcccc---CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc--cccCCCcCCCC
Q 024336 157 PKSTVGTPAYIAPEVLARKE---YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--QYFLPDYVRVS 231 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 231 (269)
.....+++.|+|||.+.... ..+.++|+||||+++|+|++|..||...+..... ..+... ...++....++
T Consensus 200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY----SKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCcccCCCcCCCC
Confidence 23456899999999987543 2355699999999999999999999875543322 333222 23445555789
Q ss_pred HHHHHHHHHHhhhCCCC--CCCcHHHhhccChhh
Q 024336 232 ADCRHLLSQIFVADPSK--DPHSRDQKASLVPEE 263 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~--Rps~~~~l~~~~~~~ 263 (269)
..+.++|.+||..++.+ |++++++++|+|+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 99999999999844433 789999999999865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=317.81 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=205.0
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeC------C
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTP------T 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 72 (269)
.++|++.+.||+|+||.||++.+..+++.||+|.+..... ....+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 4789999999999999999999999999999999865322 234567899999999999999999988654 3
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
..+++|||+++ ++...+.. .++...+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++....
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~ 170 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 170 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccCC
Confidence 57999999976 66666643 4789999999999999999999999999999999999998887 9999999997544
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh-------------
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN------------- 219 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~------------- 219 (269)
.........+++.|+|||.+.+..+..+ +|+||||+++|+|++|..||..................
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 171 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred CccccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 3333445568899999999987776555 99999999999999999999876543333222221110
Q ss_pred -----ccc-----c---------CC----CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 220 -----VQY-----F---------LP----DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 220 -----~~~-----~---------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
... . ++ .....+.++.+||.+||..||++|||+.|+++|+|+..+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 000 0 00 011235678999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=313.55 Aligned_cols=246 Identities=31% Similarity=0.524 Sum_probs=204.0
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHH-HHHHhCCCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREI-INHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||.||++++..+++.||+|++.+.. .....+..|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987532 1222344454 457888999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCCCcccC
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 162 (269)
++|...+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccC
Confidence 999999988888999999999999999999999999999999999999998887 99999998864222 222334468
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+. ......+.......+. ..+..+.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l 231 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDV----SQMYDNILHKPLQLPG--GKTVAACDLLVGLL 231 (321)
T ss_pred CcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCH----HHHHHHHhcCCCCCCC--CCCHHHHHHHHHHc
Confidence 899999999987766554 9999999999999999999987543 2333444444444444 67889999999999
Q ss_pred hhCCCCCCCcH----HHhhccChhh
Q 024336 243 VADPSKDPHSR----DQKASLVPEE 263 (269)
Q Consensus 243 ~~~p~~Rps~~----~~l~~~~~~~ 263 (269)
+.||.+||++. ++++|+|+..
T Consensus 232 ~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 232 HKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 99999999875 9999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=317.54 Aligned_cols=257 Identities=26% Similarity=0.386 Sum_probs=205.7
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeC------C
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP------T 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 72 (269)
.++|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.++|||++++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 478999999999999999999999999999999986532 2334677899999999999999999987643 3
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
.+|+||||+++ ++...+.. .++...+..++.|++.||.+||++|++||||||+||+++.++. ++|+|||++....
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~ 177 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 177 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccccC
Confidence 57999999976 67676643 4789999999999999999999999999999999999998887 9999999997544
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh-------------
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN------------- 219 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~------------- 219 (269)
.........+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+..............
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 178 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred CCCcccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 3333445568899999999987776555 99999999999999999999876654433333221110
Q ss_pred -----cccc--------------CC----CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 220 -----VQYF--------------LP----DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 220 -----~~~~--------------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
.... .+ .....+..+.+||.+||..||.+|||+.|+|+|+|+..+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0000 00 001134678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=314.09 Aligned_cols=259 Identities=34% Similarity=0.586 Sum_probs=231.3
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
|.+=|...+.||+|.|.+|-++++--+|+.||||++.+.+.. ...+.+|++-++.++|||||+++++..+...+|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 345688899999999999999999999999999999876533 34578999999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 78 MEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
+|.=++|+|.++|.+.. .+.++....++.||+.|+.|+|+..+||||+||+||.+.... +-|||+|||.+....++..
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKl-GlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKL-GLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeec-CceEeeeccccccCCCcch
Confidence 99999999999997654 589999999999999999999999999999999998886433 2499999999988888888
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
..+.+|+..|.|||++.+..|..++.||||||+|+|.|++|++||...++.+.+ .-+....+..|. .++.++++
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL----TmImDCKYtvPs--hvS~eCrd 248 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL----TMIMDCKYTVPS--HVSKECRD 248 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh----hhhhcccccCch--hhhHHHHH
Confidence 889999999999999999999999999999999999999999999988775544 344555565566 88999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
||..||..||.+|.+.++|..+.|.++..+
T Consensus 249 LI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 249 LIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 999999999999999999999999998654
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=312.54 Aligned_cols=258 Identities=27% Similarity=0.462 Sum_probs=207.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+++.||+|++.+.. ...+.+.+|..+++.++|+||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 58999999999999999999999999999999987521 22345778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-
Q 024336 79 EYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ- 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 156 (269)
||+++++|.+++.+ ...+++..+..++.|++.||++||++|++||||||+||+++.++. ++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCc
Confidence 99999999999976 456899999999999999999999999999999999999998887 99999998864332222
Q ss_pred -CCcccCCCcccCchhhcc----ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC-CcCCC
Q 024336 157 -PKSTVGTPAYIAPEVLAR----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP-DYVRV 230 (269)
Q Consensus 157 -~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 230 (269)
.....+++.|+|||.+.. ....+.++|+||||+++|+|++|..||............... .....++ ....+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 236 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--KEHFQFPPDVTDV 236 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCcccCCCccCCC
Confidence 122458999999999863 223345599999999999999999999765443322222111 1111222 22357
Q ss_pred CHHHHHHHHHHhhhCCC--CCCCcHHHhhccChhhh
Q 024336 231 SADCRHLLSQIFVADPS--KDPHSRDQKASLVPEEF 264 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~--~Rps~~~~l~~~~~~~~ 264 (269)
++++.++|.+||..++. .|++++++++|+|+...
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 89999999999865443 38899999999999653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=303.53 Aligned_cols=257 Identities=26% Similarity=0.414 Sum_probs=209.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|++.+.||+|++|.||++.+..+|+.||+|.+..... ..+.+.+|+.+++.++|+|++++++++..+...++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 579999999999999999999998999999998865322 23457789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK 158 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 158 (269)
|++++++..+......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc--EEECccccceecCCCccccc
Confidence 9999888887777677999999999999999999999999999999999999998877 9999999887433222 222
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc-----------c----cc
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-----------Q----YF 223 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-----------~----~~ 223 (269)
...++..|+|||.+.+....+.++|+||||+++++|++|.+||......+............ . ..
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 34567889999998765544556999999999999999999998766544333222211100 0 00
Q ss_pred CCC----------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 224 LPD----------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 224 ~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.+. ...++..+.+||.+||..+|++||++.|++.|+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 12467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=327.45 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=202.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCC------CCcceeeEEEEeC-CeEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH------PNIIRFKEVLLTP-THLA 75 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~-~~~~ 75 (269)
++|++.+.||+|+||+||++.+..+++.||+|++............|+.+++.+.| .+++++++++..+ ..++
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 67999999999999999999999999999999987544444456677777777654 4588898988765 4789
Q ss_pred EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCC--------------CcE
Q 024336 76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQ--------------PRL 140 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~--------------~~~ 140 (269)
+|++++ +++|.+++.+.+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++. +.+
T Consensus 209 iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~v 287 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287 (467)
T ss_pred EEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceE
Confidence 999988 66888988888889999999999999999999998 59999999999999986542 248
Q ss_pred EEeecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc
Q 024336 141 KICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 220 (269)
Q Consensus 141 ~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 220 (269)
||+|||.+... ........+++.|+|||.+.+..+... +|||||||++|+|++|.+||......+.+..+.......
T Consensus 288 kl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 364 (467)
T PTZ00284 288 RICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364 (467)
T ss_pred EECCCCccccC--ccccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence 99999987532 222334578999999999988777555 999999999999999999998766543332221111000
Q ss_pred c--------------------ccCC--C--------------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 221 Q--------------------YFLP--D--------------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 221 ~--------------------~~~~--~--------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
. ...+ . ....++.+.+||.+||..||.+|||++|+|+|||+..+
T Consensus 365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 0 0000 0 00113567899999999999999999999999999875
Q ss_pred h
Q 024336 265 A 265 (269)
Q Consensus 265 ~ 265 (269)
.
T Consensus 445 ~ 445 (467)
T PTZ00284 445 Y 445 (467)
T ss_pred C
Confidence 3
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-47 Score=304.84 Aligned_cols=252 Identities=35% Similarity=0.560 Sum_probs=215.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|++|.||++.+..+++.+|+|.+.... ...+.+.+|+.++++++||||+++++++......++++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 57999999999999999999999999999999987532 23456788999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TY 156 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CC
Confidence 99999999999988888999999999999999999999999999999999999998887 999999988753322 33
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...+++.|+|||.+.+...+ .++|+||||+++|+|++|..||..... ......+......++. .++..+.++|
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~--~~~~~l~~li 229 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNP----IQIYEKILEGKVRFPS--FFSPDAKDLI 229 (290)
T ss_pred CCCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCccCCc--cCCHHHHHHH
Confidence 44678899999998776554 449999999999999999999976553 2223333344444444 6789999999
Q ss_pred HHHhhhCCCCCC-----CcHHHhhccChhhhh
Q 024336 239 SQIFVADPSKDP-----HSRDQKASLVPEEFA 265 (269)
Q Consensus 239 ~~~l~~~p~~Rp-----s~~~~l~~~~~~~~~ 265 (269)
.+||..||.+|+ +++++++|+|+..+.
T Consensus 230 ~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 230 RNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred HHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 999999999999 899999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=296.98 Aligned_cols=258 Identities=28% Similarity=0.451 Sum_probs=221.7
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCcc-ccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEeecCCCc
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAGGE 85 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (269)
.+.||+|+++.|-.+....+|..||||++.+... ......+|++.+.+. .|+||+.++++|+++..+|+|||.+.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4678999999999999999999999999987543 356688999999998 59999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC-CcEEEeecCCcccCCCC--------CC
Q 024336 86 LFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLH--------SQ 156 (269)
Q Consensus 86 l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~-~~~~l~df~~~~~~~~~--------~~ 156 (269)
|+..|++...+++.++.++.++|+.||.+||++||.|||+||+||+.....+ +-||||||.+....... ..
T Consensus 163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~ 242 (463)
T KOG0607|consen 163 LLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPE 242 (463)
T ss_pred HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCcc
Confidence 9999999999999999999999999999999999999999999999975444 45899999987532111 11
Q ss_pred CCcccCCCcccCchhhc----cccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh-----------hhHHHHHHHHhhcc
Q 024336 157 PKSTVGTPAYIAPEVLA----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----------RNFRKTIDRIRNVQ 221 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~-----------~~~~~~~~~~~~~~ 221 (269)
..+.+|+..|||||+.. ...++.+++|.||||+++|-|+.|.+||.+.-.. .=...+.+.++.+.
T Consensus 243 L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk 322 (463)
T KOG0607|consen 243 LLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 322 (463)
T ss_pred ccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC
Confidence 23455778899999864 3456678899999999999999999999754331 22466778889998
Q ss_pred ccCCC--cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 222 YFLPD--YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 222 ~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
+.+|+ |..+|.+.+++|+.+|..|+.+|.++.+++.|||++...
T Consensus 323 YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 323 YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 88875 788999999999999999999999999999999998754
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=291.38 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=209.9
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeC-----CeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTP-----THLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (269)
+++|++.+.||+|||+-||+++...++..||+|.+.... +..+...+|++..++++|||+++++++...+ ...|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 479999999999999999999999999999999987554 5667788999999999999999999886543 3499
Q ss_pred EEEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 76 IVMEYAAGGELFARICSA----GRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
++++|+..|+|.+.++.. ..+++.+++.|+.++++||.+||... ++|+||||.||++++++. +++.|||++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl~D~GS~~ 177 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVLMDLGSAT 177 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEEEeccCcc
Confidence 999999999999998652 35999999999999999999999999 999999999999998777 9999999887
Q ss_pred cCCCCCCCC----------cccCCCcccCchhhccccC--CCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 024336 150 SGLLHSQPK----------STVGTPAYIAPEVLARKEY--DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI 217 (269)
Q Consensus 150 ~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~ 217 (269)
.....-... ....|..|+|||.+.-... -+.++|||||||++|.|+.|..||..... .-..+.-.+
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--~GgSlaLAv 255 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--QGGSLALAV 255 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--cCCeEEEee
Confidence 433222211 2235788999999874432 25559999999999999999999964221 001122234
Q ss_pred hhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
..+.+.+|....+|+.+.++|++||+.||.+||++.+++.+.
T Consensus 256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~ 297 (302)
T KOG2345|consen 256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKL 297 (302)
T ss_pred eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 455677888888999999999999999999999999999864
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=316.34 Aligned_cols=259 Identities=24% Similarity=0.406 Sum_probs=206.3
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeC------
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTP------ 71 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 71 (269)
+.++|++.+.||+|+||+||++.+..+++.||+|.+..... ....+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 35789999999999999999999999999999999865322 234567899999999999999999987643
Q ss_pred CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 72 THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 72 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
...+++++++ +++|.+++. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceec
Confidence 3478999988 668877764 456899999999999999999999999999999999999998887 999999998743
Q ss_pred CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc-----------
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV----------- 220 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----------- 220 (269)
. .......+++.|+|||.+.+....+.++||||||+++|+|++|..||........+..........
T Consensus 169 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 169 D--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred C--CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 2 223345678999999998775545566999999999999999999997655433333222111000
Q ss_pred --------cccCCC------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 221 --------QYFLPD------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 221 --------~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
....+. ....++.+.+||.+||..||.+|||+.|+++|+|+..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 000000 124567789999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=304.06 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=205.3
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+|++.+.||+|++|.||++.+..++..||+|.+.... .....+.+|+.++++++|||++++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5899999999999999999999899999999886432 2235678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-C
Q 024336 81 AAGGELFARICSA---GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-Q 156 (269)
Q Consensus 81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~ 156 (269)
++ ++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence 97 4788877543 45899999999999999999999999999999999999998887 9999999886432221 1
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc----------------
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------- 220 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------------- 220 (269)
.....+++.|+|||.+.+....+.++|+||||+++++|+||.+||...................
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 2233567889999998765544556999999999999999999998655433332222111000
Q ss_pred -------cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 221 -------QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 221 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.........+++++.++|.+||..||.+|||+.++++|+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00000123578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=323.92 Aligned_cols=254 Identities=27% Similarity=0.399 Sum_probs=209.1
Q ss_pred ccccccceecccCceEEEEEEEecC-CeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRT-KELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
..|.+.+.||+|++|.||++.+..+ +..||+|.+..... ....+.+|+..++.++||||+++++++..++.+++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3499999999999999999998877 78889887654322 234577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-
Q 024336 81 AAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS- 155 (269)
Q Consensus 81 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~- 155 (269)
+++++|.+.+.. ..++++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCccc
Confidence 999999887743 446899999999999999999999999999999999999998887 9999999987432221
Q ss_pred --CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 156 --QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
......+++.|+|||.+.+..++. ++||||||+++|+|++|..||...... .....+...... +....++.+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~tg~~Pf~~~~~~----~~~~~~~~~~~~-~~~~~~s~~ 298 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSK-KADMWSLGVILYELLTLHRPFKGPSQR----EIMQQVLYGKYD-PFPCPVSSG 298 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCc-HHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCC-CCCccCCHH
Confidence 123446899999999998776654 499999999999999999999765432 223333332221 222368899
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+.++|.+||..||++||++++++.++|+..+
T Consensus 299 ~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 299 MKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 9999999999999999999999999988654
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=302.27 Aligned_cols=253 Identities=28% Similarity=0.412 Sum_probs=207.3
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+..+++++|||++++++.+..+...++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 467999999999999999999999899999999987443 2334577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 159 (269)
+++++|.+++...+++++..+..++.|++.||.+||+.|++|+|++|+||+++.++. ++|+|||++....... ....
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRKS 165 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccCc
Confidence 999999999988888999999999999999999999999999999999999998887 9999999987432221 2233
Q ss_pred ccCCCcccCchhhcc--ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc---cCCCcCCCCHHH
Q 024336 160 TVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY---FLPDYVRVSADC 234 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 234 (269)
..+++.|+|||.+.. ....+.++|+||+|+++|+|++|..||.......... .+..... .......++..+
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF----LMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe----eeecCCCCCCCCccccccCHHH
Confidence 457789999998752 2223455999999999999999999986543321111 1111111 112223578899
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
.++|.+||..+|++||+++++++|+|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=314.83 Aligned_cols=247 Identities=30% Similarity=0.474 Sum_probs=202.8
Q ss_pred ecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhC---CCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSL---RHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 11 l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
||+|+||+||++++..+++.||+|++..... .......|..++... .||+|+++++.+.++..+++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999865321 112233455555544 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCcccC
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 162 (269)
++|...+.+.+.+++..+..++.||+.||+|||+.|++||||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccC
Confidence 999999988888999999999999999999999999999999999999998887 999999998643222 22334568
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
++.|+|||.+.+....+.++|+||||+++|+|+||..||..... ......+......++. ..+++++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~-~~~~~~~~~li~~~L 233 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT----QQMYRNIAFGKVRFPK-NVLSDEGRQFVKGLL 233 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH----HHHHHHHHcCCCCCCC-ccCCHHHHHHHHHHc
Confidence 99999999987655445669999999999999999999976543 2333444444444443 247899999999999
Q ss_pred hhCCCCCC----CcHHHhhccChhhh
Q 024336 243 VADPSKDP----HSRDQKASLVPEEF 264 (269)
Q Consensus 243 ~~~p~~Rp----s~~~~l~~~~~~~~ 264 (269)
..||.+|| ++.++++|+|+...
T Consensus 234 ~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 234 NRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCCHHHCCCCCCCHHHHhcCccccCC
Confidence 99999998 68999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=300.68 Aligned_cols=256 Identities=29% Similarity=0.400 Sum_probs=208.0
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++|++.+.||+|+||.||++.+..+++.||+|.+..... ....+.+|+..++.++|||++++++.+..++..++++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 4689999999999999999999999999999999875432 234577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~ 159 (269)
+++++|.+++...+.+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++...... .....
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAKRKS 165 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCccccccc
Confidence 999999999988888999999999999999999999999999999999999998877 999999987643221 12234
Q ss_pred ccCCCcccCchhhcc--ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 160 TVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
..++..|+|||.+.. ....+.++|+||||+++|+|++|..||............... ............++..+.++
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS-NFQPPKLKDKMKWSNSFHHF 244 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-CCCCCcccccCCCCHHHHHH
Confidence 467889999998742 222345599999999999999999998654432222111110 00111112223578899999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccC
Q 024336 238 LSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
|.+||+.+|++||++.++++|+|
T Consensus 245 i~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 245 VKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHccCCchhCcCHHHHhcCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=312.14 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=198.6
Q ss_pred cccccccceecccCceEEEEEEEe-----cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeCC-
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPT- 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~- 72 (269)
.++|++.+.||+|+||.||++.+. .++..||+|.+..... ....+.+|+.+++.+ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 468999999999999999999853 3456799999864322 234678899999999 8999999999887644
Q ss_pred eEEEEEeecCCCchHHHHHhc-----------------------------------------------------------
Q 024336 73 HLAIVMEYAAGGELFARICSA----------------------------------------------------------- 93 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~----------------------------------------------------------- 93 (269)
.++++|||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 689999999999999988642
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC---CCCcccCCCccc
Q 024336 94 ---GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYI 167 (269)
Q Consensus 94 ---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~ 167 (269)
.++++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++....... ......+++.|+
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcchhcccCCCCCcccc
Confidence 23778889999999999999999999999999999999998776 9999999986432211 112233457899
Q ss_pred CchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCC
Q 024336 168 APEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADP 246 (269)
Q Consensus 168 aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 246 (269)
|||.+.+..++.+ +||||||+++|+|++ |..||.......... ..+.... .......+++.+.++|.+||+.||
T Consensus 244 aPE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 244 APESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFC---QRLKDGT-RMRAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred CcHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HHHhcCC-CCCCCCCCCHHHHHHHHHHccCCh
Confidence 9999987776555 999999999999997 999998755433222 2222221 122233688999999999999999
Q ss_pred CCCCCcHHHhhcc
Q 024336 247 SKDPHSRDQKASL 259 (269)
Q Consensus 247 ~~Rps~~~~l~~~ 259 (269)
.+|||+.++++.+
T Consensus 319 ~~RPs~~el~~~l 331 (338)
T cd05102 319 KERPTFSALVEIL 331 (338)
T ss_pred hhCcCHHHHHHHH
Confidence 9999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=298.34 Aligned_cols=250 Identities=32% Similarity=0.480 Sum_probs=208.0
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCccc----------cHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----------DENVQREIINHRSLRHPNIIRFKEVLLTPTH 73 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (269)
+|++...||+|++|.||++.+..++..+|+|.+...... .+.+.+|+.++++++|||++++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 588999999999999999999888999999988643221 1357789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
.++++||+++++|.+++...+.+++..+..++.|++.||++||+.|++|+||+|+||++++++. ++|+|||.+.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccc
Confidence 9999999999999999988888999999999999999999999999999999999999998877 99999998864321
Q ss_pred CC-------CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC
Q 024336 154 HS-------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226 (269)
Q Consensus 154 ~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (269)
.. ......++..|+|||.+.+..++.. +|+||||+++|+|++|..||............. .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~- 233 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG---ENASPEIP- 233 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh---ccCCCcCC-
Confidence 11 1112346788999999987766544 999999999999999999998755433222111 11111222
Q ss_pred cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 227 YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
..++..+.++|.+||+.||.+||++.++++|+|+
T Consensus 234 -~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 -SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 3678999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=300.24 Aligned_cols=252 Identities=28% Similarity=0.472 Sum_probs=214.4
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
+|++.+.||.|++|.||++.+..++..||+|.+.... ...+.+.+|+..+++++|||++++++.+..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999999899999999987532 234568889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCc
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 159 (269)
|+.+++|...+....++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence 9999999999987778999999999999999999999999999999999999998887 99999998875444433445
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
..++..|+|||.+.+...+.+ +|+||||+++|++++|..||...... ................+. .++..+.++|.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~ 234 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQETADVLYPA--TWSTEAIDAIN 234 (258)
T ss_pred cCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhccccccCcc--cCcHHHHHHHH
Confidence 567888999999987775444 99999999999999999999876542 122222222222333333 68899999999
Q ss_pred HHhhhCCCCCCCc--HHHhhccCh
Q 024336 240 QIFVADPSKDPHS--RDQKASLVP 261 (269)
Q Consensus 240 ~~l~~~p~~Rps~--~~~l~~~~~ 261 (269)
+||..||.+||++ +|+++|+|+
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHccCChhHcCCccHHHHhcCCCC
Confidence 9999999999999 999999996
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=300.02 Aligned_cols=256 Identities=28% Similarity=0.434 Sum_probs=213.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++|++.+.||.|++|.||++.+..+++.||+|.+.... .....+.+|+.+++.++|+|++++++++.++...++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 57999999999999999999999999999999987543 2234678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~ 159 (269)
+++++|.+++... ++++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++...... .....
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence 9999999998765 7899999999999999999999999999999999999998887 999999988654332 22234
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
..+++.|+|||.+.+..++. ++|+||||+++|+|+||..||...+... ....+............++.++.+++.
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~-~sDv~slG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~ 232 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDE-KADIWSLGITAIELAKGEPPLSDLHPMR----VLFLIPKNNPPSLEGNKFSKPFKDFVS 232 (274)
T ss_pred ccCCccccChhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCcccCchHH----HHHHhhhcCCCCCcccccCHHHHHHHH
Confidence 45778899999998777544 4999999999999999999997654322 222222222211111237889999999
Q ss_pred HHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 240 QIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
+||..+|.+||++++++.|+|+....+
T Consensus 233 ~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 233 LCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred HHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 999999999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=300.21 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=206.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++|++.+.||+|++|.||++.+..++..||+|.+.... .....+.+|+.++++++|||++++++.+..++..++++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 57899999999999999999999999999999987542 2234578899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST 160 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (269)
+++++|... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..... ......
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~-~~~~~~ 153 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVN-SIAKTY 153 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceeccc-ccccCC
Confidence 999988654 34788999999999999999999999999999999999998887 99999998864322 223345
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhh---HHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN---FRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
.++..|+|||.+.+..++.+ +|+||||+++|+|++|..||........ .......+.............++++.++
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence 67889999999987766554 9999999999999999999975332211 1111121111111111122578899999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
|.+||..+|.+||++++++.|+|+....
T Consensus 233 i~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 233 ITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHhhCChhhCCCHHHHhcCccccccc
Confidence 9999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=303.39 Aligned_cols=256 Identities=28% Similarity=0.447 Sum_probs=209.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++|++.+.||+|+||.||++.+..++..+|+|.+..... ....+.+|++++++++||||+++++.+.+++.+++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 579999999999999999999999999999998865322 234577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 159 (269)
+++++|.+++.+.+++++..+..++.|++.||.|||+ .+++|+||+|+||+++.++. ++|+|||++.... ......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~-~~~~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI-DSMANS 157 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCccccc-cccccc
Confidence 9999999999888889999999999999999999997 58999999999999998877 9999999886432 222334
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHH-------------------------
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI------------------------- 214 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~------------------------- 214 (269)
..++..|+|||.+.+..++. ++|+||||+++++|++|..||...+.... ....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~-~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTV-QSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred CCCCcCccChhHhcCCCCCc-cchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccCCCCCccc
Confidence 56788999999987666544 49999999999999999999865432111 1111
Q ss_pred --------HHHhhc-cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 215 --------DRIRNV-QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 215 --------~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
...... ....+. ..++.++.++|.+||..+|++||++.+++.|+|+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000000 011111 1367889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=303.03 Aligned_cols=255 Identities=25% Similarity=0.444 Sum_probs=203.3
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+|++.+.||+|++|.||++.+..+|+.+|+|.+.... .....+.+|+..+++++|+|++++++++.+...+++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5899999999999999999999999999999986432 2234577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCC
Q 024336 81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK 158 (269)
Q Consensus 81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 158 (269)
+++ +|.+.+.+ .+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcC
Confidence 975 77777654 567899999999999999999999999999999999999998877 9999999887432221 122
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh-hhHHHHHHHHhhc------------cc-cC
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNV------------QY-FL 224 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~------------~~-~~ 224 (269)
...+++.|+|||.+.+....+.++|+||||+++|+|+||..|+....+. ..+.......... .. ..
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 3456788999999877665556699999999999999998886443332 2222221111000 00 00
Q ss_pred C----------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 225 P----------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 225 ~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
+ ....+++++.++|.+||..||.+|||+++++.|+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 012467899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=309.70 Aligned_cols=258 Identities=26% Similarity=0.444 Sum_probs=207.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+++.+|+|++.+.. .....+.+|+.++..++|++++++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999999986421 22234778899999999999999999999999999999
Q ss_pred eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-
Q 024336 79 EYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ- 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 156 (269)
||+++++|.+++.+ ...+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcc
Confidence 99999999999976 457899999999999999999999999999999999999998887 99999998864322221
Q ss_pred -CCcccCCCcccCchhhcc----ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC-CcCCC
Q 024336 157 -PKSTVGTPAYIAPEVLAR----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP-DYVRV 230 (269)
Q Consensus 157 -~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 230 (269)
.....+++.|+|||.+.. ....+.++|+||||+++|+|++|..||...+............ ....++ ....+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~~ 236 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--ERFQFPAQVTDV 236 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--ccccCCCccccC
Confidence 223468999999999863 2233455999999999999999999998755433332222111 111222 22367
Q ss_pred CHHHHHHHHHHhhhCCC--CCCCcHHHhhccChhhh
Q 024336 231 SADCRHLLSQIFVADPS--KDPHSRDQKASLVPEEF 264 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~--~Rps~~~~l~~~~~~~~ 264 (269)
++++.++|.+||..++. .|++++++++|+|+..+
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 99999999999965444 47899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=301.60 Aligned_cols=259 Identities=27% Similarity=0.388 Sum_probs=210.3
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.+.|++++.||+|++|.||++++..++..+++|.+.... ...+.+.+|+..++.++|+|++++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 467999999999999999999999999999999987543 2345677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCC
Q 024336 81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPK 158 (269)
Q Consensus 81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~ 158 (269)
+++++|...+.+ ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+...... ....
T Consensus 91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC--EEEccCccceeccccccccc
Confidence 999999887754 456899999999999999999999999999999999999988777 999999987642221 1223
Q ss_pred cccCCCcccCchhhccc----cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHH
Q 024336 159 STVGTPAYIAPEVLARK----EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
...+++.|+|||.+... ...+.++|+||||+++|+|++|..||............ .............++.++
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 245 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---AKSEPPTLSQPSKWSMEF 245 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH---hcCCCccCCCCcccCHHH
Confidence 34577899999998532 22244599999999999999999999765432222111 111112223334678899
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.++|.+||..+|.+||++.++++|+|+..+.
T Consensus 246 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 246 RDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred HHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 9999999999999999999999999998654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=311.95 Aligned_cols=252 Identities=25% Similarity=0.419 Sum_probs=199.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
.+|++.+.||+|+||.||++.+..++..||+|+.... ....|+.++++++|+||+++++++......++|++++.
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 4699999999999999999999999999999975432 23568999999999999999999999999999999996
Q ss_pred CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCccc
Q 024336 83 GGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 161 (269)
Q Consensus 83 ~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 161 (269)
+ +|.+++.+ ..++++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++.............
T Consensus 141 ~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 141 S-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred C-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCccccccc
Confidence 5 77777654 557899999999999999999999999999999999999998887 9999999987433333334456
Q ss_pred CCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCC-CCCCCCh---------hhHHHHHHHHhhccccCC------
Q 024336 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYP-FEDPEDP---------RNFRKTIDRIRNVQYFLP------ 225 (269)
Q Consensus 162 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~p-f~~~~~~---------~~~~~~~~~~~~~~~~~~------ 225 (269)
+++.|+|||.+.+..+..+ +|+||||+++|+|+++..+ |...... ..+.............++
T Consensus 218 gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 296 (357)
T PHA03209 218 GTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296 (357)
T ss_pred ccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence 8899999999987776555 9999999999999985544 4432211 011111111110000011
Q ss_pred ----------------------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 226 ----------------------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 226 ----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
....++.++.+||.+||..||.+|||+.|++.|+|++.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 11245677888999999999999999999999999975
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=298.36 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=210.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++|++.+.||.|++|+||++....++..+++|.+.... .....+.+|+..++.++|+|++++++.+..+...++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 57999999999999999999998889999999986433 2345688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 81 AAGGELFARICSA---GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
+++++|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDR 158 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccc
Confidence 9999999999764 35899999999999999999999999999999999999998877 999999988643322221
Q ss_pred -----CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC---cCC
Q 024336 158 -----KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD---YVR 229 (269)
Q Consensus 158 -----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 229 (269)
....++..|+|||.+......+.++|+||||+++++|++|..||.............. ......+. ...
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 235 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ---NDPPSLETGADYKK 235 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc---CCCCCcCCcccccc
Confidence 2335778899999988774445569999999999999999999976654333332222 11111111 236
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 230 VSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
+++.+.+++.+||..||.+||++.+++.|+|+
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 78899999999999999999999999999996
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=302.33 Aligned_cols=258 Identities=25% Similarity=0.382 Sum_probs=211.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++|++++.||+|++|.||++.+..++..||+|.+.... .....+.+|+..+++++|+|++++++.+..++..++++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 57999999999999999999999899999999886432 2234678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 81 AAGGELFARICSA---GRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
+++++|..++... ..+++..+..++.|++.||.+||+ .|++|+||+|+||+++.++. ++|+|||++.... ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~-~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLV-ASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC--EEEeecCCccccc-CCc
Confidence 9999998888663 368999999999999999999996 59999999999999998776 9999999886432 222
Q ss_pred CCcccCCCcccCchhhccccC-----CCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc-cccCCCcCCC
Q 024336 157 PKSTVGTPAYIAPEVLARKEY-----DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRV 230 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 230 (269)
.....+++.|+|||.+.+... .+.++|+||||+++|+|++|..||.......... ....+... ....+. .+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~--~~ 234 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA-QLSAIVDGDPPTLPS--GY 234 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH-HHHHHhhcCCCCCCc--cc
Confidence 334457788999999865432 2455999999999999999999997654433222 22222222 222333 58
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
+.++.++|.+||..+|.+||++.+++.|+|+.....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 899999999999999999999999999999977653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=323.51 Aligned_cols=256 Identities=28% Similarity=0.417 Sum_probs=209.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCC------
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPT------ 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 72 (269)
.++|++.+.||+|+||+||++.+..+|+.||+|.+..... ....+.+|+..+..++|+|++++++.+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 4789999999999999999999999999999999875432 2345678999999999999999988775432
Q ss_pred --eEEEEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecC
Q 024336 73 --HLAIVMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG 146 (269)
Q Consensus 73 --~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~ 146 (269)
.+++|+||+++|+|.+.+.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DFG 188 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFG 188 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEecc
Confidence 37899999999999998864 346899999999999999999999999999999999999998887 9999999
Q ss_pred CcccCCC---CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcccc
Q 024336 147 YSKSGLL---HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF 223 (269)
Q Consensus 147 ~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (269)
++..... ........+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...... .....+......
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~~----~~~~~~~~~~~~ 263 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENME----EVMHKTLAGRYD 263 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHhcCCCC
Confidence 9864221 122234568999999999987776544 99999999999999999999765432 223333322221
Q ss_pred CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 224 LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
+....+++++.+++.+||..||.+||++.+++.|+|++.+.
T Consensus 264 -~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 264 -PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred -CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 22236899999999999999999999999999999877643
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=304.74 Aligned_cols=255 Identities=33% Similarity=0.490 Sum_probs=213.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|++|.||++.+..+++.||+|.+..... ....+.+|+..++.++|+||+++++.+......++++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 479999999999999999999999999999999876432 2245778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 79 EYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
||+.+++|.+++... ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhccccccc
Confidence 999999999998754 46899999999999999999999999999999999999998877 99999998763221111
Q ss_pred ------------------------------CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Q 024336 157 ------------------------------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED 206 (269)
Q Consensus 157 ------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~ 206 (269)
.....++..|+|||.+.+..++. ++|+||||+++|+|++|..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS-AVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc-hHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 11224677899999998776644 59999999999999999999987665
Q ss_pred hhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCC----cHHHhhccChhhh
Q 024336 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPH----SRDQKASLVPEEF 264 (269)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~~~~~~~~ 264 (269)
...... +......++....++..+.++|.+||..||.+||+ +++++.|+|++..
T Consensus 238 ~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 238 DETFSN----ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHH----HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 433332 23333344443357899999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=296.44 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=211.0
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|++|.||++.+..++..+++|.+..... .+.+.+|+..++.++|+|++++++.+.++...++++|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 4789999999999999999999998899999999875533 567889999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCc
Q 024336 82 AGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS 159 (269)
Q Consensus 82 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 159 (269)
++++|.+++.. ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCcccccc
Confidence 99999999865 456899999999999999999999999999999999999998887 9999999887533322 2233
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
..++..|+|||.+.+...+.+ +|+||+|+++++|++|..||............ .......+.....++.++.++|.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI---PNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred ccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh---ccCCCCCCCchhhcCHHHHHHHH
Confidence 446788999999887766544 99999999999999999999765432221111 11111122222357789999999
Q ss_pred HHhhhCCCCCCCcHHHhhccCh
Q 024336 240 QIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
+||+.||.+|||+.|++.|+|+
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=298.11 Aligned_cols=254 Identities=25% Similarity=0.365 Sum_probs=207.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEEeC------CeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTP------THL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~~ 74 (269)
.+.|++.+.||+|+||.||++.+..+++.||+|.+.........+.+|+..++++ +|+|++++++++... ..+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 4679999999999999999999999999999999987666667788999999998 699999999998753 468
Q ss_pred EEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 75 AIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
++++||+++++|.+++... ..+++..+..++.|++.|+++||+.+++|+||+|+||+++.++. ++|+|||++....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~ 162 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceecc
Confidence 9999999999999998763 35899999999999999999999999999999999999998887 9999999986432
Q ss_pred CC-CCCCcccCCCcccCchhhccc----cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCc
Q 024336 153 LH-SQPKSTVGTPAYIAPEVLARK----EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227 (269)
Q Consensus 153 ~~-~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (269)
.. .......++..|+|||.+... ...+.++|+||+|+++|+|++|..||.......... ............
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~ 238 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF----LIPRNPAPRLKS 238 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH----HHhcCCCCCCCC
Confidence 22 222344678899999998632 223445999999999999999999997544322221 111111112222
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 228 VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
..++.++.+||.+||..||.+|||+.++++|+|+
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 3678899999999999999999999999999996
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=301.28 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=211.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
..+|++.+.||+|++|.||++.+..++..|++|.+..... ..+.+.+|+.+++.+.|+|++++++.+..+...++|+||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 4689999999999999999999998999999998875432 345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-CCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~~ 159 (269)
+++++|.+++.+ ..+++.++..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........ ...
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred cCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhccccccccCc
Confidence 999999998854 46899999999999999999999999999999999999998877 99999998864322221 223
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
..+++.|+|||.+.+...+. ++|+||||+++|+|++|..||........... .........+....++..+.++|.
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~-~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred ccCCccccCHHHHcCCCCCc-cchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH---HhcCCCCCCCCccccCHHHHHHHH
Confidence 46788999999988766644 49999999999999999999976554222211 111122222233468889999999
Q ss_pred HHhhhCCCCCCCcHHHhhccChhh
Q 024336 240 QIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+||..+|.+||++.+++.|+|+..
T Consensus 252 ~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHCcCCcccCcCHHHHhhChhhhc
Confidence 999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=300.15 Aligned_cols=258 Identities=29% Similarity=0.483 Sum_probs=213.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++|++.+.||.|++|.||++.+..+++.+++|.+.... .....+.+|+..+++++|||++++++.+..+...++++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 47899999999999999999999999999999987643 2335678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 81 AAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
+++++|.+++... ..+++..+..++.|++.|+.+||+ .|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~-~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLA-K 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC--EEEeecccchhhHHHHh-h
Confidence 9999999999776 778999999999999999999999 99999999999999998777 99999998764322211 2
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCC-hhhHHHHHHHHhhccc-cCCCcCCCCHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED-PRNFRKTIDRIRNVQY-FLPDYVRVSADCRH 236 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (269)
...++..|+|||.+.+..++. ++|+||||++++++++|..||..... ................ ..+. ..++.++.+
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 235 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSV-KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS-GKFSPDFQD 235 (265)
T ss_pred cccCChhccCHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh-hhcCHHHHH
Confidence 256778899999997776654 49999999999999999999975431 1222233333322221 2222 127889999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
+|.+||..||.+|||+.+++.|+|++.++
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~~ 264 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEHPFIKKYE 264 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence 99999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=298.96 Aligned_cols=240 Identities=19% Similarity=0.204 Sum_probs=197.6
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCcccc----HHHHHHHHHHHhCCCCCcceeeEEEEe----CCeEEEEEee
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRHPNIIRFKEVLLT----PTHLAIVMEY 80 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v~e~ 80 (269)
..|++|+++.||++.. +|+.||+|.+....... +.+.+|+.++++++||||+++++++.+ ...+++|+||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6789999999999988 58899999987654333 456799999999999999999999877 3478999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 159 (269)
+++|+|.+++.+.+.++......++.+++.||.+||+. +++|+||||+||+++.++. ++|+|||++.... .....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~--~~~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKILS--SPPFK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhhhc--ccccc
Confidence 99999999998888899999999999999999999984 9999999999999998887 9999999886422 22234
Q ss_pred ccCCCcccCchhhcc--ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 160 TVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
..++..|+|||.+.+ ..+ +.++||||||+++|+|++|..||....... ....+.......+....+++.+.++
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~l~~l 254 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKE----IYDLIINKNNSLKLPLDCPLEIKCI 254 (283)
T ss_pred ccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhcCCCCCCCCcCcHHHHHH
Confidence 567889999999875 344 455999999999999999999998765432 2222222222222223688999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhcc
Q 024336 238 LSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~ 259 (269)
|.+||+.||.+|||+.+++..+
T Consensus 255 i~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 255 VEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred HHHHhcCCcccCcCHHHHHHHH
Confidence 9999999999999999998754
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=300.74 Aligned_cols=259 Identities=26% Similarity=0.391 Sum_probs=212.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++|++.+.||.|++|.||++.+..++..+|+|.+.... ...+.+.+|+.++++++|+|++++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 368999999999999999999998889999999986542 2334677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCC
Q 024336 81 AAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK 158 (269)
Q Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 158 (269)
+++++|.+++.+. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ...
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhcccccccc
Confidence 9999999998764 46899999999999999999999999999999999999998887 9999999876432221 223
Q ss_pred cccCCCcccCchhhccc----cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-ccCCCcCCCCHH
Q 024336 159 STVGTPAYIAPEVLARK----EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRVSAD 233 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (269)
...+++.|+|||.+... ...+.++|+||||+++|+|++|..||......... ..+.... ..+.....++.+
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 237 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL----LKILKSEPPTLDQPSKWSSS 237 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH----HHHhcCCCCCcCCcccCCHH
Confidence 34578889999997532 22344599999999999999999999765443222 2222221 122223368899
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
+.++|.+||..+|.+||++.++++|+|+....+
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence 999999999999999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=332.84 Aligned_cols=258 Identities=29% Similarity=0.479 Sum_probs=209.0
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP--THLAI 76 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~ 76 (269)
.++|++++.||+|+||+||++.+..++..+|+|.+.... .....+..|+.+++.++||||++++++|... ..+|+
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 368999999999999999999999999999999987432 2335678899999999999999999988653 56899
Q ss_pred EEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeecCCCCcEEecCC----------
Q 024336 77 VMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSM-------EICHRDLKLENTLLDGS---------- 135 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~-------~i~H~di~p~ni~i~~~---------- 135 (269)
||||+++++|.+++.. .+.+++..++.++.||+.||.|||+. +|+|+||||+|||++.+
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 9999999999998865 35699999999999999999999985 49999999999999642
Q ss_pred -----CCCcEEEeecCCcccCCCCCCCCcccCCCcccCchhhccc-cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhh
Q 024336 136 -----PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK-EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN 209 (269)
Q Consensus 136 -----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~ 209 (269)
+...++|+|||++.............+++.|+|||++... ...+.++|||||||++|+|+||..||........
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q 251 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251 (1021)
T ss_pred ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence 2334899999998754333333455789999999998643 2234559999999999999999999976554333
Q ss_pred HHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 210 FRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+. ..+.... .++ ....+.++.+||..||..+|.+||++.|+|.|+|+...
T Consensus 252 li---~~lk~~p-~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 252 LI---SELKRGP-DLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HH---HHHhcCC-CCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 32 2222221 111 22578999999999999999999999999999998754
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=295.80 Aligned_cols=255 Identities=31% Similarity=0.412 Sum_probs=210.0
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++|++.+.||.|++|.||++.+..+++.+++|.+..... ..+.+.+|+.+++.++|||++++++.+.....++++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 5789999999999999999999998899999999875432 346788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCC
Q 024336 81 AAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK 158 (269)
Q Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 158 (269)
+++++|.+++... .++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ...
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhccc
Confidence 9999999998776 68999999999999999999999999999999999999998887 9999999886433222 222
Q ss_pred cccCCCcccCchhhccc---cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 159 STVGTPAYIAPEVLARK---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
...++..|+|||.+... ..+ .++|+||||+++|+|+||..||................. ..........++.++.
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF-PPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCccccchhhhhHHHH
Confidence 34567789999998765 554 459999999999999999999976554332222111100 0111112225678899
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
++|.+||..+|.+|||+.+++.|+|
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhcCCC
Confidence 9999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=306.31 Aligned_cols=259 Identities=22% Similarity=0.341 Sum_probs=201.6
Q ss_pred cccceeccc--CceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 6 EPVKELGSG--NFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 6 ~~~~~l~~g--~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++++.||+| ++++||++.+..+|+.||+|.+..... ....+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 357889999 788999999999999999999875432 234577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC---
Q 024336 81 AAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--- 155 (269)
Q Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--- 155 (269)
+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++. ++++||+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhccccccccc
Confidence 9999999998653 45899999999999999999999999999999999999998887 9999998643211111
Q ss_pred -----CCCcccCCCcccCchhhccc-cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc---------
Q 024336 156 -----QPKSTVGTPAYIAPEVLARK-EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------- 220 (269)
Q Consensus 156 -----~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--------- 220 (269)
......++..|+|||.+.+. ...+.++|+||||+++|+|++|..||...................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 11122356679999998754 223455999999999999999999997654332222111100000
Q ss_pred -c------------------------------ccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 221 -Q------------------------------YFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 221 -~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
. ...+....+++.+.+||.+||+.||++|||++++++|+|++.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~ 315 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 315 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcch
Confidence 0 000011235678999999999999999999999999999987653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=299.30 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=213.1
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
..+|++.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++|||++++++++..+..+++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 357999999999999999999999999999999886533 2345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-CCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~~ 159 (269)
+++++|..++.. ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++........ ...
T Consensus 98 ~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06655 98 LAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKRST 174 (296)
T ss_pred cCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccCCC
Confidence 999999998854 46899999999999999999999999999999999999998877 99999998764332222 223
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
..++..|+|||.+.+..++.+ +|+||||+++|++++|..||...+......... .........+..+++.+.++|.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~ 250 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSPIFRDFLN 250 (296)
T ss_pred cCCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCcccCCcccCCHHHHHHHH
Confidence 457788999999887766555 999999999999999999998765433322211 1112223334478899999999
Q ss_pred HHhhhCCCCCCCcHHHhhccChhhh
Q 024336 240 QIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+||..||.+||++.+++.|+|+...
T Consensus 251 ~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 251 RCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHhhcChhhCCCHHHHhhChHhhhc
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=299.46 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=209.5
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+|++.+.||+|++|.||++.+..+|+.||+|.+.... .....+.+|+.++++++|||++++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 6899999999999999999999899999999987543 2235688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--CC
Q 024336 81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QP 157 (269)
Q Consensus 81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~ 157 (269)
+ +++|.+.+.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCCcc
Confidence 9 8999998865 456899999999999999999999999999999999999998777 9999999887443322 12
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc---------------c
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ---------------Y 222 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---------------~ 222 (269)
....++..|+|||.+.+....+.++|+||||+++++|+||.+||....+............... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 3446788999999987666556669999999999999999888876655444433332211100 0
Q ss_pred cCCC---------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 223 FLPD---------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 223 ~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.++. ....+..+.++|.+||..+|.+||++++++.|+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 0000 12457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=293.31 Aligned_cols=251 Identities=28% Similarity=0.431 Sum_probs=210.2
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc------cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK------KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
+|+..+.||+|++|.||++....++..|++|.+.... ...+.+.+|+.+++.++|+|++++++++..+..++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5889999999999999999999889999999886533 1335688899999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
+||+++++|.+++.+.+++++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccc
Confidence 999999999999988888999999999999999999999999999999999999998887 999999988754333333
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHh-hccccCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-NVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (269)
....++..|+|||.+......+.++|+||||+++|++++|..||.......... .... ......+. .+++++.+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~~ 233 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF---KIGRSKELPPIPD--HLSDEAKD 233 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH---HHHhcccCCCcCC--CcCHHHHH
Confidence 455678889999998766523455999999999999999999997655322221 1111 11112222 57899999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
++.+||..+|.+||++.+++.|+|+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=298.38 Aligned_cols=250 Identities=28% Similarity=0.425 Sum_probs=207.1
Q ss_pred ecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCch
Q 024336 11 LGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 11 l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
||+|+||+||++.+..+|+.||+|.+.... .....+.+|+.+++.++|||++++++.+...+..|+|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999999999999999986532 2233456899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccCCC
Q 024336 87 FARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP 164 (269)
Q Consensus 87 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 164 (269)
.+.+.+.+ .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.............++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTP 158 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCC
Confidence 99987765 6899999999999999999999999999999999999998887 9999999886543333334456778
Q ss_pred cccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhh
Q 024336 165 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244 (269)
Q Consensus 165 ~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 244 (269)
.|+|||.+.+..++ .++|+||||+++++|++|..||.......................+. .+++.+.++|.+||+.
T Consensus 159 ~y~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~ 235 (277)
T cd05577 159 GYMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALLQK 235 (277)
T ss_pred CcCCHHHhcCCCCC-chhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCc--cCCHHHHHHHHHHccC
Confidence 89999998877754 44999999999999999999997765433333333332222223333 6789999999999999
Q ss_pred CCCCCC-----CcHHHhhccChhhhh
Q 024336 245 DPSKDP-----HSRDQKASLVPEEFA 265 (269)
Q Consensus 245 ~p~~Rp-----s~~~~l~~~~~~~~~ 265 (269)
||.+|| ++.+++.|+|+..+.
T Consensus 236 ~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 236 DPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred ChhHccCCCcccHHHHHhChhhhcCC
Confidence 999999 888899999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=295.28 Aligned_cols=248 Identities=30% Similarity=0.495 Sum_probs=209.2
Q ss_pred ecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCch
Q 024336 11 LGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 11 l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+.+++.++|||++++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999999889999999987543 2335688899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccCCCcc
Q 024336 87 FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 166 (269)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 166 (269)
.+.+.+...++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.............+++.|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEY 158 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCc
Confidence 999988888999999999999999999999999999999999999998887 999999998754433333344678899
Q ss_pred cCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHh--hccccCCCcCCCCHHHHHHHHHHhhh
Q 024336 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR--NVQYFLPDYVRVSADCRHLLSQIFVA 244 (269)
Q Consensus 167 ~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~ 244 (269)
+|||.+.+..++.+ +|+||+|+++|++++|..||...... .......+. ......+. ..++++.++|.+||..
T Consensus 159 ~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 159 VAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRR 233 (262)
T ss_pred cChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHccC
Confidence 99999877666555 99999999999999999999876531 122223333 22223333 4588999999999999
Q ss_pred CCCCCCC-----cHHHhhccChhhhh
Q 024336 245 DPSKDPH-----SRDQKASLVPEEFA 265 (269)
Q Consensus 245 ~p~~Rps-----~~~~l~~~~~~~~~ 265 (269)
+|.+||+ ++|+++|+|+..+.
T Consensus 234 ~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 234 NPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred ChhhCcCCcccCHHHHhcChhhhCCC
Confidence 9999999 99999999999874
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=307.44 Aligned_cols=256 Identities=27% Similarity=0.447 Sum_probs=207.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++++..+++.||+|++.... .....+.+|..++..++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999986521 22334678889999999999999999999999999999
Q ss_pred eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-
Q 024336 79 EYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ- 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 156 (269)
||++|++|.+++.+ ...+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCce
Confidence 99999999999976 467899999999999999999999999999999999999998887 99999999864322221
Q ss_pred -CCcccCCCcccCchhhccc----cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc--ccCCC-cC
Q 024336 157 -PKSTVGTPAYIAPEVLARK----EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--YFLPD-YV 228 (269)
Q Consensus 157 -~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~-~~ 228 (269)
.....+++.|+|||.+.+. ...+.++|+||||+++|+|++|..||...+..... ..+.... ..++. ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~~~p~~~~ 234 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY----GKIMNHEERFQFPSHIT 234 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH----HHHHcCCCcccCCCccc
Confidence 1234689999999998652 22345599999999999999999999765443322 2222211 22222 23
Q ss_pred CCCHHHHHHHHHHhhhCCCC--CCCcHHHhhccChhhh
Q 024336 229 RVSADCRHLLSQIFVADPSK--DPHSRDQKASLVPEEF 264 (269)
Q Consensus 229 ~~~~~~~~li~~~l~~~p~~--Rps~~~~l~~~~~~~~ 264 (269)
.+++++.++|.+||..++.+ |++++++++|+|++..
T Consensus 235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 57899999999999866544 5689999999998763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=301.51 Aligned_cols=259 Identities=28% Similarity=0.375 Sum_probs=210.1
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCccc------cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI------DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
+|++.+.||+|++|.||++.+..+++.|++|.+...... ...+..|+..++.++|+|++++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588999999999999999999988999999998754322 34567899999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-
Q 024336 78 MEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS- 155 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~- 155 (269)
+||+ +++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc
Confidence 9999 889999997766 7999999999999999999999999999999999999998877 9999999887433222
Q ss_pred CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cCC---------
Q 024336 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLP--------- 225 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~--------- 225 (269)
......+++.|+|||.+.+....+.++|+||||+++++|++|.++|..................... .++
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 2233346778999999866555566699999999999999998888766654433333221110000 000
Q ss_pred ------------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 226 ------------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 226 ------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.....+..+.++|.+||..||.+|||+.|++.|+|+..-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 0124567899999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=297.85 Aligned_cols=258 Identities=27% Similarity=0.354 Sum_probs=209.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
+-|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+.+++.++|||++++++++..+...++|+||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 45789999999999999999999999999999886432 33456788999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCc
Q 024336 82 AGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKS 159 (269)
Q Consensus 82 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~ 159 (269)
++++|...+.+ ..++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... .....
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEcccccccccccccccccc
Confidence 99999887754 457899999999999999999999999999999999999998877 999999988642221 12233
Q ss_pred ccCCCcccCchhhcc----ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 160 TVGTPAYIAPEVLAR----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
..+++.|+|||.+.. ....+.++|+||+|+++|+|++|.+||............ .............++.++.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI---AKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH---hhcCCCCCCCccccCHHHH
Confidence 457889999999742 222245599999999999999999999765432222221 1111122233346889999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
++|.+||..||.+||++.++++|+|+....
T Consensus 240 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 240 DFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 999999999999999999999999987544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=293.61 Aligned_cols=254 Identities=28% Similarity=0.457 Sum_probs=212.0
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+|++.+.||+|++|.||++.+..++..|++|.+..... ....+.+|+..++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 69999999999999999999988899999999876543 345688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC---
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--- 157 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~--- 157 (269)
+++++|.+++.+...+++..+..++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccc
Confidence 999999999988777899999999999999999999999999999999999998777 999999988643322221
Q ss_pred --CcccCCCcccCchhhcccc--CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 158 --KSTVGTPAYIAPEVLARKE--YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 158 --~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
....+++.|+|||.+.+.. ....++|+||+|++++++++|..||............ .........+....+++.
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 236 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--VGAGHKPPIPDSLQLSPE 236 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH--HhcCCCCCCCcccccCHH
Confidence 1235678999999987655 2345599999999999999999999765432222111 111223344554456899
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
+.++|.+||+.+|.+||++.+++.|+|+
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 237 GKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=324.19 Aligned_cols=250 Identities=28% Similarity=0.442 Sum_probs=209.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeec-CccccHHHHHHHHHHHhCC-CCCcceeeEEE-Ee------CCe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER-GKKIDENVQREIINHRSLR-HPNIIRFKEVL-LT------PTH 73 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~------~~~ 73 (269)
.+++|.+.|.+|||+.||+|++...|..||+|++.. +....+.+.+|+.+++.|+ |+|||.+++.. .. ...
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 467899999999999999999998878899998754 4445567899999999996 99999999932 21 125
Q ss_pred EEEEEeecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 74 LAIVMEYAAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
+.++||||.||.|.+++.+ ...|++.+|++|+.++++|+.+||... |+|||||-+|||++.+++ .||||||.+.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCcccccc
Confidence 7899999999999999974 345999999999999999999999998 999999999999999998 9999999987
Q ss_pred cCCCCCCC----------CcccCCCcccCchhhc--cccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 024336 150 SGLLHSQP----------KSTVGTPAYIAPEVLA--RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI 217 (269)
Q Consensus 150 ~~~~~~~~----------~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~ 217 (269)
........ .....|+.|+|||.+. ++..-..++|||+|||+||.|+....||+.... -.|
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------laI 266 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------LAI 266 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------eeE
Confidence 43333211 1234689999999875 333335559999999999999999999987432 346
Q ss_pred hhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChh
Q 024336 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
..+.+.+|....++..+.+||+.||+.||.+||++-|++++.+..
T Consensus 267 lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 267 LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 678888898889999999999999999999999999999987654
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=311.66 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=204.8
Q ss_pred cccccccceecccCceEEEEEEEe--cCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK--RTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
..+|++++.||+|+||.||++... .++..||+|.+... ....+|+.+++.++||||+++++++......+++|+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 457999999999999999999764 35678999987643 345689999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC---
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--- 156 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~--- 156 (269)
++. ++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++........
T Consensus 167 ~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 167 KYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred hcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCccccccc
Confidence 996 588888877788999999999999999999999999999999999999998887 99999999864322221
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh---hhHHHHHHHHhhcccc----------
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---RNFRKTIDRIRNVQYF---------- 223 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~---------- 223 (269)
.....+++.|+|||.+....++.+ +|+||||+++|+|++|..||.+.... ..+.............
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred ccccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 123468899999999987776555 99999999999999999999764432 1222222211111100
Q ss_pred ---------------CCC---cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 224 ---------------LPD---YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 224 ---------------~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
.+. ...++.++.++|.+||..||.+|||+.+++.|+||...
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 010 12356788999999999999999999999999999764
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=292.76 Aligned_cols=249 Identities=31% Similarity=0.448 Sum_probs=208.3
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecC---ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+|++.+.||+|++|.||++.+..+++.|++|.+... ......+.+|+..++.++|||++++++.+.+++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 588899999999999999999999999999998643 23345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CC
Q 024336 81 AAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QP 157 (269)
Q Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~ 157 (269)
+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchh
Confidence 9999999998764 56899999999999999999999999999999999999998877 9999999876433222 12
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (269)
....+++.|+|||.+.+..++.+ +|+||||+++++|++|..||....... ....+..... ..+. .++.++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~ 231 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGA----LILKIIRGVFPPVSQ--MYSQQLAQ 231 (256)
T ss_pred hccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCcc--ccCHHHHH
Confidence 23457788999999987776555 999999999999999999997665322 2222222221 1222 67889999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
+|.+||+.+|++||++.++++|+|.
T Consensus 232 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 232 LIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHccCCcccCcCHHHHhhCCCC
Confidence 9999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=294.16 Aligned_cols=259 Identities=29% Similarity=0.451 Sum_probs=216.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++|++.+.||.|++|.||++.+..+++.|++|.+..... ....+.+|+..++.++|+|++++++++..+...++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 478999999999999999999999999999999876542 346788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC-
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK- 158 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~- 158 (269)
+++++|.+++....++++..++.++.|++.|+.+||+ .|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCN 158 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCccc
Confidence 9999999999888889999999999999999999999 99999999999999998887 9999999887543333222
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...++..|.|||.+.+...+. ++|+||||+++|+++||..||...... ........+............++..+.++|
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~-~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 236 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSY-AADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPPPSLPAEEFSPEFRDFI 236 (264)
T ss_pred ceeecccccCHhhhCCCCCCc-hhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence 345778899999987775544 499999999999999999999776521 122233333332221111112789999999
Q ss_pred HHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 239 SQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.+||..+|++||++.++++|+|++.+.
T Consensus 237 ~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 237 SACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred HHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=300.58 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=211.3
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
..+|++.+.||+|++|.||++.+..++..||+|.+.... ...+.+.+|+.+++.++|+|++++++++..++..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 468999999999999999999999899999999987543 2335677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-CCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~~ 159 (269)
+++++|.+++.+ ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++........ ...
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCccCcCc
Confidence 999999998854 45799999999999999999999999999999999999998877 99999998864322221 223
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
..+++.|+|||.+.+..++. ++|+||||+++|++++|..||...+....... ..............++..+.++|.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~-~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred ccCCccccCHHHHcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCcchheee---eccCCCCCCCCccccCHHHHHHHH
Confidence 45778899999998766654 49999999999999999999976543222111 111111122223367889999999
Q ss_pred HHhhhCCCCCCCcHHHhhccChhhh
Q 024336 240 QIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+||..+|.+||++++++.|+|+...
T Consensus 251 ~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 251 RCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred HHccCChhhCcCHHHHhcCchhccc
Confidence 9999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=295.26 Aligned_cols=254 Identities=30% Similarity=0.440 Sum_probs=206.3
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-----------ccHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-----------IDENVQREIINHRSLRHPNIIRFKEVLLTPT 72 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (269)
+|.+.+.||+|++|.||++.+..+|+.+|+|.+..... ..+.+.+|+..++.++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 68899999999999999999998899999998753211 1135678999999999999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
..++|+||+++++|.+.+.+.+++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeecccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999998877 9999999886432
Q ss_pred CCC---CCCcccCCCcccCchhhcccc-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC--
Q 024336 153 LHS---QPKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-- 226 (269)
Q Consensus 153 ~~~---~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 226 (269)
... ......++..|+|||.+.... ..+.++|+||||++++++++|..||............... ......+.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~ 237 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK--RSAPPIPPDV 237 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc--ccCCcCCccc
Confidence 211 112334678899999987654 2355599999999999999999999754433222221111 11111111
Q ss_pred cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 227 YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
...++.++.++|.+||.++|.+||++++++.|+|+
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 22568899999999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=299.95 Aligned_cols=254 Identities=26% Similarity=0.354 Sum_probs=199.7
Q ss_pred cccccccceecccCceEEEEEEEec----------------CCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcce
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKR----------------TKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIR 63 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~----------------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~ 63 (269)
.++|++.+.||+|+||.||++.+.. ++..||+|.+..... ....+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4789999999999999999998642 345799998875322 2346888999999999999999
Q ss_pred eeEEEEeCCeEEEEEeecCCCchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeec
Q 024336 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAG-------------------RFSEDEARFFFQQLISGVSYCHSMEICHRD 124 (269)
Q Consensus 64 ~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d 124 (269)
+++++.+.+..++++||+++++|.+++.... .++...+..++.|++.||.+||+.|++|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 9999999999999999999999999885432 357788999999999999999999999999
Q ss_pred CCCCcEEecCCCCCcEEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh--CCC
Q 024336 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV--GAY 199 (269)
Q Consensus 125 i~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t--g~~ 199 (269)
|||+||+++.++. ++|+|||++........ .....++..|+|||.+....++.+ +|+||||+++|+|++ +..
T Consensus 164 lkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 164 LATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHHHHHccCCC
Confidence 9999999998877 99999999864322211 122334678999999887766554 999999999999987 567
Q ss_pred CCCCCCChhhHHHHHHHHhhc--cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 200 PFEDPEDPRNFRKTIDRIRNV--QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 200 pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
||................... .........++..+.++|.+||..||.+|||+.++.+.
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~ 301 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAF 301 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 887665543333322222111 11111223678899999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=291.77 Aligned_cols=250 Identities=36% Similarity=0.522 Sum_probs=209.5
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+|++.+.||+|++|.||++.+..+++.+|+|.+.... .....+.+|+..++.++|||++++++.+..++..++|+|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 6899999999999999999999999999999987542 2345688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 81 AAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
+++++|.+++... ..+++..+..++.+++.++.+||++|++|+||+|+||+++.++. .++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCcccc
Confidence 9999999999763 35899999999999999999999999999999999999986543 37999999987554444444
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-ccCCCcCCCCHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRVSADCRHL 237 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 237 (269)
...++..|+|||.+.+...+.+ +|+||||+++++|++|..||...+...... ...... ...+. .++.++.++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~--~~~~~l~~l 232 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVL----KIMSGTFAPISD--RYSPDLRQL 232 (256)
T ss_pred ccccCCcccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcccCchHHHHH----HHHhcCCCCCCC--CcCHHHHHH
Confidence 4567889999999987665444 999999999999999999997655433222 222221 12233 688999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccCh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
|.+||..+|.+|||+.|++.|||+
T Consensus 233 i~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 233 ILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=296.40 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=211.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++|++.+.||+|++|+||++.+..+++.||+|++.... .....+.+|+.+++.++|||++++++.+.....+++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 68999999999999999999999999999999876542 2345688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 159 (269)
+++++|.+++.+.+.+++..+..++.+++.+|.+||+ .+++|+||+|+||+++.++. ++|+|||++.... ......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~-~~~~~~ 161 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGELI-NSIADT 161 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc--EEEccCCcccchh-hhccCc
Confidence 9999999999888889999999999999999999997 58999999999999998877 9999999876322 122234
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh-------hhHHHHHHHHhhccccCCCcCCCCH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-------RNFRKTIDRIRNVQYFLPDYVRVSA 232 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
..++..|+|||.+.+..++.+ +|+||||+++|+++||..||...... .........+............++.
T Consensus 162 ~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd06620 162 FVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240 (284)
T ss_pred cccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence 467889999999877766555 99999999999999999999865432 1111222222222111111123788
Q ss_pred HHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 233 DCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
++.+||.+||.+||.+|||+.|+++++|+..
T Consensus 241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 9999999999999999999999999998855
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=292.87 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=205.7
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-------ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
+|++.+.||+|+||.||++... +++.+|+|.+..... ....+.+|+..++.++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5899999999999999999874 788899998764321 12457789999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC---
Q 024336 77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL--- 153 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~--- 153 (269)
++||+++++|.+++.+..++++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccc
Confidence 9999999999999988788999999999999999999999999999999999999998877 99999998763211
Q ss_pred ----CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc-cccCCCcC
Q 024336 154 ----HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYV 228 (269)
Q Consensus 154 ----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 228 (269)
........++..|+|||.+.+...+.. +|+||||++++++++|..||...+....... .... ....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 232 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAAMFY----IGAHRGLMPRLPD 232 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHHHHHH----hhhccCCCCCCCC
Confidence 111223457788999999987666554 9999999999999999999976543322211 1111 11111223
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 229 RVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.++.++.++|.+||..+|.+||++.+++.|+|+
T Consensus 233 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 233 SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 688999999999999999999999999999996
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=295.56 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=207.8
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCC------eE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPT------HL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~~ 74 (269)
.++|++.+.||+|++|.||++.+..+++.+++|.+.......+.+.+|+.+++++ .|+|++++++++.... .+
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 4789999999999999999999998899999999887666567789999999999 7999999999997644 48
Q ss_pred EEEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCccc
Q 024336 75 AIVMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~ 150 (269)
++|+||+++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~~ 162 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSAQ 162 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCcccee
Confidence 999999999999998865 347899999999999999999999999999999999999998877 99999998864
Q ss_pred CCCCC-CCCcccCCCcccCchhhcccc----CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC
Q 024336 151 GLLHS-QPKSTVGTPAYIAPEVLARKE----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225 (269)
Q Consensus 151 ~~~~~-~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (269)
..... ......++..|+|||.+.... ..+.++|+||||++++++++|..||............. ........
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~ 239 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP---RNPPPTLK 239 (275)
T ss_pred cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh---ccCCCCCC
Confidence 32222 223345788899999875432 22445999999999999999999997654333222211 11111222
Q ss_pred CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 226 DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
....++..+.++|.+||..||++|||+.++++|+|.
T Consensus 240 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 223478899999999999999999999999999995
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=290.35 Aligned_cols=250 Identities=31% Similarity=0.491 Sum_probs=210.1
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+|++.+.||.|++|.||.+++..++..+++|.+.... .....+.+|+.++++++|+|++++++++.+.+.+++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5899999999999999999999999999999886432 3345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CC
Q 024336 81 AAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QP 157 (269)
Q Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~ 157 (269)
+++++|.+.+.+. ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccc
Confidence 9999999999764 45899999999999999999999999999999999999998887 9999999886432222 22
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....+++.|.|||.+.+..++.. +|+||||+++++|++|..||...... +....+....... ....++.++.++
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPL----NLVVKIVQGNYTP-VVSVYSSELISL 232 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHcCCCCC-CccccCHHHHHH
Confidence 34567889999999887766544 99999999999999999999765432 2233333333221 224678999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccCh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
|.+||..+|.+||++.++++++|+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=291.70 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=205.5
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEe-CCeEEEEEe
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLT-PTHLAIVME 79 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (269)
+|++.+.||.|++|.||++.+..+++.+|+|.+.... ...+.+.+|+..+++++|+|++++.+.+.. +..+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999999889999999986532 233467889999999999999999998764 446899999
Q ss_pred ecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-C
Q 024336 80 YAAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-Q 156 (269)
Q Consensus 80 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~ 156 (269)
++++++|.+.+.. ...+++.++..++.+++.++++||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCc
Confidence 9999999998865 345899999999999999999999999999999999999998877 9999999886432222 2
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+++.|+|||.+.+..++.+ +|+||||++++++++|..||...+... ....+...... +....+++.+.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~----~~~~~~~~~~~-~~~~~~~~~~~~ 232 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNS----LVYRIIEGKLP-PMPKDYSPELGE 232 (257)
T ss_pred cccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHhcCCC-CCccccCHHHHH
Confidence 233457889999999987776555 999999999999999999997654322 22222222221 112368899999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
+|.+|++.||.+||++.++++|+|+
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=332.10 Aligned_cols=256 Identities=31% Similarity=0.459 Sum_probs=222.1
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeec---C-ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---G-KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~---~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
+++|.+++.||+|+||.|.++++..+++.||+|++.+ - .....-|+.|-.++..-+.+-|+.++-.|.++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 4789999999999999999999999999999999876 2 22334577888888888899999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-- 155 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-- 155 (269)
|||++||+|..++.+..++++..++.++..|+.||..||+.|+|||||||+||+++..|+ ++|+|||.|-.....+
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCCcE
Confidence 999999999999999889999999999999999999999999999999999999999999 9999999886544333
Q ss_pred CCCcccCCCcccCchhhccc----cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc--cccCCCcCC
Q 024336 156 QPKSTVGTPAYIAPEVLARK----EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--QYFLPDYVR 229 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 229 (269)
......|||.|.|||++... ..+.+.+|.||||+++|+|+.|..||.. +.+.+....|..- .+.+|+...
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa----dslveTY~KIm~hk~~l~FP~~~~ 307 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA----DSLVETYGKIMNHKESLSFPDETD 307 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH----HHHHHHHHHHhchhhhcCCCcccc
Confidence 23456899999999998631 2334559999999999999999999976 3455666666554 567787778
Q ss_pred CCHHHHHHHHHHhhhCCCCCCC---cHHHhhccChhhh
Q 024336 230 VSADCRHLLSQIFVADPSKDPH---SRDQKASLVPEEF 264 (269)
Q Consensus 230 ~~~~~~~li~~~l~~~p~~Rps---~~~~l~~~~~~~~ 264 (269)
+|.+.++||.+++ .+|..|.. ++++..||||.+.
T Consensus 308 VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 308 VSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred cCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCC
Confidence 9999999999998 56899999 9999999999874
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=298.97 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=207.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|++.+.||+|++|.||++.+..+++.||+|.+..... ..+.+.+|+.+++.++|||++++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 579999999999999999999998899999998764322 23467789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK 158 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 158 (269)
|++++++..+......+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccC
Confidence 9999888887766667899999999999999999999999999999999999998887 9999999886432222 122
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc---------------ccc
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QYF 223 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------------~~~ 223 (269)
...++..|+|||.+.+....+.++|+||||+++++|++|.+||................... ...
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 34567889999998765544566999999999999999999997655433222222110000 000
Q ss_pred CC----------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 224 LP----------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 224 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.+ ....++..+.+++.+||..+|.+||++.++++|+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 122568889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=296.29 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=205.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEEe------CCeEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLT------PTHLA 75 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~ 75 (269)
+.|++.+.||.|+||.||++.+..+++.+|+|.+.........+..|+.+++++ +|+|++++++++.. ....+
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 579999999999999999999999999999999876655556788899999888 69999999999853 45789
Q ss_pred EEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 76 IVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
++|||+++++|.+++... ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~ 173 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDR 173 (282)
T ss_pred EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhc
Confidence 999999999999988653 35888999999999999999999999999999999999998887 99999998764322
Q ss_pred C-CCCCcccCCCcccCchhhccc----cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcC
Q 024336 154 H-SQPKSTVGTPAYIAPEVLARK----EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228 (269)
Q Consensus 154 ~-~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (269)
. .......+++.|+|||.+... ...+.++|+||||+++|+|++|..||........... +...........
T Consensus 174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~ 249 (282)
T cd06636 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPPPKLKSK 249 (282)
T ss_pred cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh----HhhCCCCCCccc
Confidence 1 222344578899999987631 2224459999999999999999999976543222221 122211112223
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 229 RVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.++.++.++|.+||..||.+||++.|+++|+|+
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 688999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=296.33 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=207.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEEeC-----CeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTP-----THLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~~~~ 75 (269)
.++|++.+.||+|++|.||++.+..+++.+|+|.+.........+.+|+.+++++ +|||++++++++... +..+
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 4689999999999999999999999999999999876555556778899999988 799999999998754 3589
Q ss_pred EEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 76 IVMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
+|+||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~ 178 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQL 178 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchhc
Confidence 99999999999988753 456899999999999999999999999999999999999998877 999999988643
Q ss_pred CCCC-CCCcccCCCcccCchhhccccC----CCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC
Q 024336 152 LLHS-QPKSTVGTPAYIAPEVLARKEY----DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226 (269)
Q Consensus 152 ~~~~-~~~~~~~~~~~~aPE~~~~~~~----~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (269)
.... ......++..|+|||.+..... .+.++|+||||+++|+|++|..||............. .........
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~ 255 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP---RNPPPTLLH 255 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh---cCCCCCCCc
Confidence 3222 1223457788999999764331 2455999999999999999999997655433322211 111122222
Q ss_pred cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChh
Q 024336 227 YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
...++..+.++|.+||..+|.+||++.+++.|+|++
T Consensus 256 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 235778899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=311.05 Aligned_cols=252 Identities=20% Similarity=0.257 Sum_probs=198.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
..|.+.+.||+|+||.||++.+..++..||+|... .....+|+.++++++|+||+++++++..++..+++++++.
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 47999999999999999999999999999999632 2345789999999999999999999999999999999996
Q ss_pred CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC---CC
Q 024336 83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PK 158 (269)
Q Consensus 83 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~---~~ 158 (269)
++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++........ ..
T Consensus 244 -~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 244 -SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceeccccccccccc
Confidence 5787777553 46999999999999999999999999999999999999998877 99999999864322111 12
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCC-C------hhhHHHHHHHHhhcc----------
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE-D------PRNFRKTIDRIRNVQ---------- 221 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~-~------~~~~~~~~~~~~~~~---------- 221 (269)
...+++.|+|||.+.+..++.+ +||||||+++|+|++|..|+-... . ...+...+.......
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 3458999999999987776554 999999999999999876543211 1 111222221111000
Q ss_pred -------------------ccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 222 -------------------YFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 222 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
..+.....++.++.+||.+||..||.+|||+.|+|+|+||+.
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 001111235668999999999999999999999999999964
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=296.49 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=205.2
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEE-----eCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLL-----TPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~~ 75 (269)
.++|++.+.||+|++|.||++.+..+++.+|+|.+.........+.+|+.+++.+ +|+|++++++++. .+...+
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 4789999999999999999999999999999998876544456788899999999 6999999999874 345789
Q ss_pred EEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 76 IVMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
++|||+++++|.+++.. ...+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++...
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~ 174 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQL 174 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceeec
Confidence 99999999999887742 346889999999999999999999999999999999999998887 999999988643
Q ss_pred CCCC-CCCcccCCCcccCchhhccc----cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC
Q 024336 152 LLHS-QPKSTVGTPAYIAPEVLARK----EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226 (269)
Q Consensus 152 ~~~~-~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (269)
.... ......+++.|+|||.+... ...+.++|+||+|+++|+|++|..||............. .........
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~ 251 (286)
T cd06638 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP---RNPPPTLHQ 251 (286)
T ss_pred ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc---ccCCCcccC
Confidence 2222 22334678899999987532 223455999999999999999999997654422221111 111111222
Q ss_pred cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 227 YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
...++..+.++|.+||+.||.+|||+.++++|+|+
T Consensus 252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 23567899999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=295.29 Aligned_cols=253 Identities=27% Similarity=0.409 Sum_probs=201.9
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCccc--cHHHHHHHHHHHhCC-CCCcceeeEEEEeC--CeEEEEEe
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI--DENVQREIINHRSLR-HPNIIRFKEVLLTP--THLAIVME 79 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~~v~e 79 (269)
|++.+.||+|++|.||++.+..++..||+|.+...... .....+|+..++++. |+|++++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 78899999999999999999999999999988754222 223456888888885 99999999999987 88999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 80 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
|+++ ++.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++. +. ++|+|||++..........
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~--~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DI--LKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CC--eEEEecccccccccCCCcC
Confidence 9975 77777765 456899999999999999999999999999999999999998 55 9999999987544333334
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh--------------ccccC
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN--------------VQYFL 224 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~ 224 (269)
...++..|+|||.+......+.++|+||||+++|+|++|.+||...+..+........... ....+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 4557889999998766555566699999999999999999999876543333222211100 11111
Q ss_pred CC---------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 225 PD---------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 225 ~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
+. ...++.++.++|.+||.++|.+||++++++.|+|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 11 12467899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=293.35 Aligned_cols=256 Identities=29% Similarity=0.432 Sum_probs=208.8
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-------ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
+|+..+.||+|++|.||++.+..+++.+|+|.+..... ..+.+.+|+..+++++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 58899999999999999999999999999999875331 23567889999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
|+||+.+++|.+++.+.+++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccc
Confidence 9999999999999988888999999999999999999999999999999999999976653 389999998864322211
Q ss_pred -----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 157 -----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 157 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
.....++..|+|||.+.+..++ .++|+||||++++++++|..||............ ...............++
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI-FKIASATTAPSIPEHLS 237 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH-HHHhccCCCCCCchhhC
Confidence 1223567889999998776654 4599999999999999999999755433222222 12111111111122578
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhccChh
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
+++.+++.+||..+|.+||++.++++|+|+.
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 8999999999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=300.46 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=190.5
Q ss_pred cceecccCceEEEEEEEe--cCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEe--CCeEEEEEeecCC
Q 024336 8 VKELGSGNFGVARLVRDK--RTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT--PTHLAIVMEYAAG 83 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~ 83 (269)
...||+|+||+||++.+. .+++.||+|.+.... ....+.+|+.++++++||||+++++++.. +..+++++||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 468999999999999975 467889999886542 34567889999999999999999999864 4568999999965
Q ss_pred CchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC--CCCcEEEeecCCcccCC
Q 024336 84 GELFARICSA---------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS--PQPRLKICDFGYSKSGL 152 (269)
Q Consensus 84 ~~l~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~--~~~~~~l~df~~~~~~~ 152 (269)
+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+ ..+.++|+|||++....
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 777776432 248999999999999999999999999999999999999532 22349999999986432
Q ss_pred CCC----CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh---------hhHHHHHHH---
Q 024336 153 LHS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---------RNFRKTIDR--- 216 (269)
Q Consensus 153 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~---------~~~~~~~~~--- 216 (269)
... ......+++.|+|||.+.+....+.++|+||+|+++|+|++|.+||...... ..+......
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence 211 1234467889999999987665566699999999999999999999754321 111111100
Q ss_pred --------Hhhc-------------cccC--------CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 217 --------IRNV-------------QYFL--------PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 217 --------~~~~-------------~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.... .... ......+..+.+||.+||+.||.+|||++|+++|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 0000 0001234678899999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=293.05 Aligned_cols=252 Identities=29% Similarity=0.426 Sum_probs=204.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc------ccHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK------IDENVQREIINHRSLRHPNIIRFKEVLLTP--THL 74 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 74 (269)
.+|++.+.||+|++|.||++.+..++..|++|.+..... ....+.+|+.+++.++|||++++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 479999999999999999999999999999998864321 223577899999999999999999998753 578
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
++++|++++++|.+.+.+.+.+++..++.++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccc
Confidence 999999999999999988888999999999999999999999999999999999999998877 999999988643211
Q ss_pred ----CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 155 ----SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 155 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
.......++..|+|||.+.+..++. ++|+||+|+++|++++|..||.............. ......++. .+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~--~~ 234 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGR-KADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTNPQLPS--HI 234 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCc-hhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc--CCCCCCCch--hc
Confidence 1112234678899999998766644 49999999999999999999986544332221111 111122222 56
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccChh
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
++.+.++| +||..+|.+||+++|+++|+|++
T Consensus 235 ~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 235 SEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 78899998 67778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=296.02 Aligned_cols=255 Identities=27% Similarity=0.419 Sum_probs=206.1
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+|++.+.||.|++|.||++.+..+|..||+|.+..... ....+.+|+..+++++|||++++++++.+++..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48999999999999999999998999999998864322 235688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CC
Q 024336 81 AAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QP 157 (269)
Q Consensus 81 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~ 157 (269)
+. ++|..++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence 96 578888755 346899999999999999999999999999999999999998887 9999999886432221 12
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc--------------ccc
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------------QYF 223 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--------------~~~ 223 (269)
....+++.|+|||.+.+....+.++|+||||+++|+|+||..||................... ...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 233457789999988766655666999999999999999999998765544433332211110 000
Q ss_pred CCC---------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 224 LPD---------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 224 ~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
++. ...+++++.++|.+||+.||.+|||+++++.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 010 12467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=296.55 Aligned_cols=255 Identities=30% Similarity=0.485 Sum_probs=210.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+++.|++|.+.... ...+.+.+|+.+++.++||||+++++.+..++.+++|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999887543 22345678999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC---
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--- 155 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--- 155 (269)
||++|++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCcccc
Confidence 99999999999988888999999999999999999999999999999999999998877 9999999875311110
Q ss_pred -------------CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc
Q 024336 156 -------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY 222 (269)
Q Consensus 156 -------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 222 (269)
......++..|+|||.+....++.+ +|+||||+++|++++|..||.+.... +..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~----~~~~~~~~~~~ 233 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPE----ELFGQVISDDI 233 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccc
Confidence 0012345778999999877666544 99999999999999999999765432 22333333332
Q ss_pred cCCC-cCCCCHHHHHHHHHHhhhCCCCCCC---cHHHhhccChhhh
Q 024336 223 FLPD-YVRVSADCRHLLSQIFVADPSKDPH---SRDQKASLVPEEF 264 (269)
Q Consensus 223 ~~~~-~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~~~~~~~ 264 (269)
..+. ...++.++.++|.+||+.||.+||+ +.++++|+|+...
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 234 EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 2222 1257899999999999999999998 6999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=307.57 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=200.0
Q ss_pred ccccccceecccCceEEEEEEE-----ecCCeEEEEEEeecCc--cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeE
Q 024336 3 ERYEPVKELGSGNFGVARLVRD-----KRTKELVAVKYIERGK--KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 74 (269)
++|++.+.||+|+||.||++.+ ..++..||+|++.... ...+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 5799999999999999999974 3457789999986432 2334678899999999 899999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcC------------------------------------------------------------
Q 024336 75 AIVMEYAAGGELFARICSAG------------------------------------------------------------ 94 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~------------------------------------------------------------ 94 (269)
++||||+++|+|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999886421
Q ss_pred ---------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC---
Q 024336 95 ---------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--- 156 (269)
Q Consensus 95 ---------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~--- 156 (269)
.+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccCcccccc
Confidence 3678889999999999999999999999999999999997776 99999999864322211
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
.....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||............. ... .....+...+.++.
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~l~ 347 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI---KEG-YRMLSPECAPSEMY 347 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH---HhC-ccCCCCCCCCHHHH
Confidence 111234567999999987776554 999999999999998 889997655433332222 211 11122235688999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
++|.+||..||++|||+.++++.+.
T Consensus 348 ~li~~cl~~dP~~RPs~~eil~~l~ 372 (375)
T cd05104 348 DIMKSCWDADPLKRPTFKQIVQLIE 372 (375)
T ss_pred HHHHHHccCChhHCcCHHHHHHHHH
Confidence 9999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=316.77 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=218.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEee-cCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
+-|.|+..||.|+||.||++....++...|.|.+. ++....+.+.-|+.+|..++||+||++++.|..++.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 45789999999999999999999999888999886 34455667888999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCccc-CCCCCCCCc
Q 024336 82 AGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKS 159 (269)
Q Consensus 82 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~-~~~~~~~~~ 159 (269)
.||-....+-. ...+++.++..+++|++.||.|||+++|+|||||..||+++.+|. ++|.|||.+.. .........
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhcc
Confidence 99988777644 567999999999999999999999999999999999999999999 99999997753 333344567
Q ss_pred ccCCCcccCchhhcc----ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 160 TVGTPAYIAPEVLAR----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
..|||+|+|||++.. ..++..++||||||+++.+|..+.+|....+. +..++...+...+.+..++.++..+.
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---MRVllKiaKSePPTLlqPS~Ws~~F~ 266 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPTLLQPSHWSRSFS 266 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch---HHHHHHHhhcCCCcccCcchhhhHHH
Confidence 789999999998652 23334459999999999999999999876443 33344444445556666779999999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+|+.+||.+||..||++.++++|+|+...
T Consensus 267 DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 267 DFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 99999999999999999999999999853
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=296.29 Aligned_cols=257 Identities=30% Similarity=0.445 Sum_probs=208.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC---ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|++.+.||+|++|.||++.+..+++.|++|.+... ....+.+.+|+.+++.++|+|++++++++..++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4799999999999999999999999999999988643 2334678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--CC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QP 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~ 157 (269)
|++++.+..+..+...+++..+..++.|++.||.+||+.|++|+|++|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPL 158 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccc
Confidence 9998777666666667999999999999999999999999999999999999998777 9999999887533332 22
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc---------------c
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ---------------Y 222 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---------------~ 222 (269)
....++..|+|||.+.+....+.++|+||||+++|+|++|.+||......+............. .
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 3345678899999998774445569999999999999999999986654333222211110000 0
Q ss_pred cCCC-----------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 223 FLPD-----------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 223 ~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.++. ...++.++.++|.+||..+|.+||+++++++|+|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000 11347889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=295.66 Aligned_cols=255 Identities=30% Similarity=0.408 Sum_probs=206.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTP--THLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (269)
++|++.+.||+|++|.||++.+..+++.+++|.+...... ...+.+|+..+++++|||++++++++..+ ...+++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5799999999999999999999989999999998754322 23467899999999999999999998877 789999
Q ss_pred EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-C
Q 024336 78 MEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-S 155 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~ 155 (269)
+||+++ +|.+.+.... .+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCcc
Confidence 999975 8888886644 5899999999999999999999999999999999999998877 999999988743332 2
Q ss_pred CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh----------------
Q 024336 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN---------------- 219 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~---------------- 219 (269)
......+++.|+|||.+.+....+.++|+||||+++++|++|.+||..................
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 2233456788999999876655455699999999999999999999876654444333221110
Q ss_pred -cc----------ccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 220 -VQ----------YFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 220 -~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.. ..++. ..+++.+.++|.+||+.||++|||+.|++.|+||
T Consensus 242 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPA-LSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccccchhhhccccc-cCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00 00111 0147889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=291.80 Aligned_cols=248 Identities=20% Similarity=0.309 Sum_probs=201.6
Q ss_pred ccccccceecccCceEEEEEEEe---cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++.+.||+|+||.||++... ..+..||+|.+..... ....+.+|+..+++++|||++++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 57999999999999999999875 3467899998875432 234678899999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 78 MEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
|||+++++|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++++|||.+........
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAI 162 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc--EEECCCcccccccccch
Confidence 9999999999998764 46899999999999999999999999999999999999998877 99999997754322211
Q ss_pred C--CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 157 P--KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 157 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
. ....++..|+|||.+.+..++.+ +|+||||+++|++++ |..||......... ..+... ...+....++..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~ 236 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVI----KAVEDG-FRLPAPRNCPNL 236 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHH----HHHHCC-CCCCCCCCCCHH
Confidence 1 12234567999999887776554 999999999999775 99999876553322 222222 222334478999
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
+.+++.+||+.+|.+||+++++++.
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~~ 261 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHSI 261 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHHH
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=292.29 Aligned_cols=248 Identities=21% Similarity=0.307 Sum_probs=205.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
.+|++.+.||+|++|.||++.+..+++.||+|.+..+......+.+|+..++.++|+|++++++++..+..+++++||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 56889999999999999999999999999999987665555678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC--
Q 024336 83 GGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-- 158 (269)
Q Consensus 83 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~-- 158 (269)
+++|.+++... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++..........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceeeccC
Confidence 99999998653 35889999999999999999999999999999999999998877 9999999887433222111
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....+..|+|||.+.+..++.. +|+||||+++|+|++ |..||........ ...+... ........+|..+.++
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~l 237 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQV----YELLEKG-YRMERPEGCPPKVYEL 237 (263)
T ss_pred CCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHHCC-CCCCCCCCCCHHHHHH
Confidence 1223567999999877776555 999999999999998 8999976543222 2222221 1122233788999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhc
Q 024336 238 LSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~ 258 (269)
|.+||..||++||++.++++.
T Consensus 238 i~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 238 MRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHccCCcccCCCHHHHHHH
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=289.54 Aligned_cols=252 Identities=31% Similarity=0.439 Sum_probs=204.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc------ccHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK------IDENVQREIINHRSLRHPNIIRFKEVLLTP--THL 74 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 74 (269)
++|++.+.||+|+||.||.+.+..++..|++|.+..... ..+.+.+|+.+++++.|||++++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 689999999999999999999999999999998753221 124577899999999999999999998764 468
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
++++||+++++|.+++.+.+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCccccccccc
Confidence 899999999999999988778899999999999999999999999999999999999998887 999999988643211
Q ss_pred ----CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 155 ----SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 155 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
.......++..|+|||.+.+...+ .++|+||||+++|+|++|..||........... ..........+..+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~ 234 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPVLPPHV 234 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCC-cchhHHHHHHHHHHHhhCCCCCCccchHHHHHH----HhcCCCCCCCchhh
Confidence 112234577889999998876654 459999999999999999999976543322221 11111111112256
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccChh
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
+..+.++|.+|+. +|.+||++++++.|+|.+
T Consensus 235 ~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 235 SDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred CHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 7889999999994 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=294.17 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=200.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++|++.+.||+|++|.||++.+..+|..|++|.+.... .....+.+|+..++.++|+|++++++++..++..++|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 67999999999999999999999899999999986542 2234677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCC
Q 024336 81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK 158 (269)
Q Consensus 81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 158 (269)
+. +++.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCCCC
Confidence 96 466666544 456788999999999999999999999999999999999998877 9999999886432221 223
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhh-HHHHHHHHh-----------hcc----c
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN-FRKTIDRIR-----------NVQ----Y 222 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~-~~~~~~~~~-----------~~~----~ 222 (269)
...+++.|+|||.+.+....+.++|+||||+++|+|++|..||........ +........ ... .
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 345688999999987654334559999999999999999999976544211 111111000 000 0
Q ss_pred cC----C-------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 223 FL----P-------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 223 ~~----~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.. + .....+..+.+++.+|+..||++|||+.|++.|+|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 0 001235688999999999999999999999999996
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=294.99 Aligned_cols=257 Identities=26% Similarity=0.351 Sum_probs=204.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCC-CCCcceeeEEEEeCCe-----
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLR-HPNIIRFKEVLLTPTH----- 73 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~----- 73 (269)
++|++.+.||+|++|.||++.+..+++.||+|....... ....+.+|+.+++.+. |+|++++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 579999999999999999999999999999998765422 2356788999999995 6999999999887665
Q ss_pred EEEEEeecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCCcEEEeecCC
Q 024336 74 LAIVMEYAAGGELFARICSA-----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGY 147 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~-~~~~~~~l~df~~ 147 (269)
.++++||+++ +|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++. ++. ++|+|||.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~--~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--LKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe--EEEeeccc
Confidence 8999999986 787877542 35799999999999999999999999999999999999987 555 99999998
Q ss_pred cccCCCC-CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-c--
Q 024336 148 SKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-F-- 223 (269)
Q Consensus 148 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~-- 223 (269)
+...... .......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+................. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8643222 11223356788999999876554456699999999999999999999876654444333322111000 0
Q ss_pred ----------CC---------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChh
Q 024336 224 ----------LP---------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 224 ----------~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
.+ ....++..+.++|.+||..||.+||++.|++.|+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 0124788899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=303.07 Aligned_cols=262 Identities=28% Similarity=0.421 Sum_probs=208.6
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecC---ccccHHHHHHHHHHHhCCCCCcceeeEEEEeC-----C
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTP-----T 72 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 72 (269)
+.++|++.+.||+|++|+||++.+..++..||+|.+... ......+.+|+..++.++|+|++++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 468999999999999999999999999999999988643 22234567899999999999999999987654 2
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
..++++||+. ++|.+.+...+++++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~ 159 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTS 159 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccC
Confidence 4899999996 588888888888999999999999999999999999999999999999998877 9999999987533
Q ss_pred CC-CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHh-------------
Q 024336 153 LH-SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR------------- 218 (269)
Q Consensus 153 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~------------- 218 (269)
.. .......++..|+|||.+......+.++|+||||+++|+|++|.+||...+.............
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 22 1223345678899999987544345569999999999999999999976543222211111000
Q ss_pred -------hcc----cc-CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 219 -------NVQ----YF-LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 219 -------~~~----~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
... .. ......+++++.++|.+||..+|++|||++++++|+|+..+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000 00 001125788999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=287.72 Aligned_cols=252 Identities=32% Similarity=0.471 Sum_probs=212.4
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEEEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP--THLAIVM 78 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (269)
+|+..+.||+|++|.||++.+..+++.+++|.+.... ...+.+.+|+..+++++|+|++++++.+... ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5889999999999999999999899999999987654 3456788999999999999999999999988 8999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC--
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-- 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~-- 156 (269)
|++++++|.+++.+...+++..++.++.|++.+|.+||+.|++|+|++|+||+++.++. ++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEcccccEEecccccccc
Confidence 99999999999988878999999999999999999999999999999999999998777 99999998875444432
Q ss_pred -CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 157 -PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 157 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
.....++..|.|||.+.....+.+ +|+||||++++++++|..||........ ..................+..+.
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIGSSGEPPEIPEHLSEEAK 234 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhccccCCCcCCCcccCHHHH
Confidence 344567889999999877765444 9999999999999999999987663222 11222211111112226789999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
++|.+|+..||.+||++.+++.|+|+
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 235 DFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=292.33 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=199.1
Q ss_pred eecccCceEEEEEEEecCCeEEEEEEeecCccc----cHHHHHHHHHHH---hCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 10 ELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHR---SLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 10 ~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~---~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
.||+|+||.||++.+..+++.+|+|.+...... .....+|...++ ..+|++++.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999988653221 122334443333 3479999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccC
Q 024336 83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG 162 (269)
Q Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 162 (269)
+++|.+++...+.+++..+..++.|++.||++||+.|++|+||||+||+++.++. ++|+|||++..... .......+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~-~~~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-KKPHASVG 157 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceeccc-cCccCcCC
Confidence 9999999988888999999999999999999999999999999999999998877 99999998863322 12233468
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
+..|+|||.+..+...+.++|+||+|+++|+|++|..||........ ..............+. .++.++.++|.+||
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l 234 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPD--SFSPELKSLLEGLL 234 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCcc--ccCHHHHHHHHHHh
Confidence 89999999986544445559999999999999999999976543221 1111112222233333 68899999999999
Q ss_pred hhCCCCCC-----CcHHHhhccChhhh
Q 024336 243 VADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 243 ~~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
..||.+|| +++++++|+|+..+
T Consensus 235 ~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred cCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 99999999 69999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=304.27 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=204.2
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeC------C
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP------T 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 72 (269)
.++|++.+.||+|++|.||++.+..+++.||+|.+.... .....+.+|+.++++++|+|++++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 578999999999999999999999999999999986432 2234566899999999999999999988654 3
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
..++|+||+.+ +|.+.+... ++...+..++.|++.||++||+.|++|+||||+||+++.++. ++|+|||++....
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~ 169 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 169 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeCC
Confidence 47999999965 788877544 899999999999999999999999999999999999998887 9999999987543
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc------------
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV------------ 220 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~------------ 220 (269)
.........++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...+...............
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCCCCCCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 3333334457888999999987776554 999999999999999999997665433322222111000
Q ss_pred ------cc--------------cCCC-----cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 221 ------QY--------------FLPD-----YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 221 ------~~--------------~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.. .++. ....++.+.++|.+||..||++|||+.|+|.|+|+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 00 0000 1134667899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=294.72 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=203.9
Q ss_pred ccccccceecccCceEEEEEEEecCC-----eEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTK-----ELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
++|++.+.||+|++|.||++.+...+ ..|++|.+..... ....+.+|+..++.++|||++++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 57999999999999999999986554 6799998864322 2345788999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCc
Q 024336 76 IVMEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR 139 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~ 139 (269)
+++||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||||+||+++.++.
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~-- 162 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT-- 162 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc--
Confidence 999999999999998664 44788999999999999999999999999999999999998877
Q ss_pred EEEeecCCcccCCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHH
Q 024336 140 LKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTID 215 (269)
Q Consensus 140 ~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~ 215 (269)
++|+|||++....... ......+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||.+....+ ...
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~il~el~~~g~~p~~~~~~~~----~~~ 237 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQE----VIE 237 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh-hhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH
Confidence 9999999886432221 1223345678999999887776554 999999999999998 999998755432 222
Q ss_pred HHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 216 RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+..... .+....+|+++.+++.+||+.||.+||++.++++++
T Consensus 238 ~i~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 238 MIRSRQL-LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred HHHcCCc-CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 3332221 122337899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=293.56 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=203.1
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
-++|++.+.||+|++|.||++.+..+++.||+|.+..... ....+.+|+.+++.++|+||+++++++.+++..++|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 3689999999999999999999998899999999865322 23456789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CC
Q 024336 80 YAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QP 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~ 157 (269)
|+++ +|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKTY 160 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCccc
Confidence 9985 888888654 46899999999999999999999999999999999999998887 9999999886432221 11
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHH-HHHHHhhc---------------c
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK-TIDRIRNV---------------Q 221 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~-~~~~~~~~---------------~ 221 (269)
....++..|+|||.+.+....+.++|+||+|+++|+|++|..||........... ........ .
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 2234577899999987655445569999999999999999999976553222111 11110000 0
Q ss_pred ccC---------CCcCCCC--HHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 222 YFL---------PDYVRVS--ADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 222 ~~~---------~~~~~~~--~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
... .....++ .++.++|.+||..+|.+|||+.+++.|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0001233 788899999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=292.58 Aligned_cols=256 Identities=26% Similarity=0.426 Sum_probs=209.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCC---CCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLR---HPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~v 77 (269)
+.|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+.+++.+. |||++++++++..+...+++
T Consensus 1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 36899999999999999999999899999999886532 23456778999998886 99999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-C
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-Q 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~ 156 (269)
+||+++++|.+++.. +.+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSSK 157 (277)
T ss_pred EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC--EEEccCCceeecCCCccc
Confidence 999999999998855 47899999999999999999999999999999999999998776 9999999886433322 1
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....++..|+|||.+.++...+.++|+||||+++|+|++|..||......... ...............++.++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM----MLIPKSKPPRLEDNGYSKLLRE 233 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh----hccccCCCCCCCcccCCHHHHH
Confidence 233457888999999876555555699999999999999999999765432211 1111111111111237889999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
++.+||..||.+||++.+++.|+|+....
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=293.11 Aligned_cols=256 Identities=28% Similarity=0.427 Sum_probs=210.7
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.+.|+..+.||.|++|.||++.+..++..||+|.+.... .....+.+|+..++.+.|+|++++++.+.++...++|+|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 467899999999999999999999899999999887542 234567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK 158 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 158 (269)
|+++++|.+++.. +++++..+..++.|++.||++||+.+++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCccccc
Confidence 9999999998864 56899999999999999999999999999999999999998877 9999999886433222 122
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...++..|+|||.+.+...+.+ +|+||||+++|+|+||..||......... ..+..... ......++..+.++|
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~li 233 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVL----FLIPKNNP-PTLTGEFSKPFKEFI 233 (277)
T ss_pred cccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChHhHh----hhhhcCCC-CCCchhhhHHHHHHH
Confidence 3356778999999887766544 99999999999999999999765432222 11111111 111225678899999
Q ss_pred HHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 239 SQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
.+||..+|.+||++.+++.|+|+.....
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 234 DACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHHcccCcccCcCHHHHHhChHhhhcch
Confidence 9999999999999999999999876554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=288.92 Aligned_cols=250 Identities=31% Similarity=0.518 Sum_probs=207.6
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+|++.+.||+|+||.+|.+.+..+|+.|++|.+.... .....+.+|+..+++++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 6999999999999999999999999999999986432 2334688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-C
Q 024336 81 AAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-P 157 (269)
Q Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~ 157 (269)
+.+++|.+.+.... .+++..+..++.|++.|+.+||++|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence 99999999886543 5789999999999999999999999999999999999988777 99999998864322221 1
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....+++.|+|||.+.+...+.+ +|+||||++++++++|..||....... ....+...... +....++.++.++
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~----~~~~~~~~~~~-~~~~~~~~~~~~l 232 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKN----LVLKIIRGSYP-PVSSHYSYDLRNL 232 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCCHHH----HHHHHhcCCCC-CCcccCCHHHHHH
Confidence 23346788999999887766554 999999999999999999997654322 22222222221 1223678999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccCh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
|.+||..+|.+||++.++++|+|+
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=297.58 Aligned_cols=258 Identities=29% Similarity=0.427 Sum_probs=206.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTP--THLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (269)
++|++.+.||+|++|.||++.+..+|+.||+|.+...... .....+|+.++++++|+|++++++++... +.+++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 6899999999999999999999999999999998744322 23456899999999999999999998765 568999
Q ss_pred EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-
Q 024336 78 MEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS- 155 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~- 155 (269)
+||+.+ +|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAK 163 (309)
T ss_pred EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecCCccC
Confidence 999975 78777765 356899999999999999999999999999999999999998887 9999999887533221
Q ss_pred CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc---------------
Q 024336 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------------- 220 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--------------- 220 (269)
.......++.|+|||.+.+....+.++|+||||+++|+|++|.+||...+....+..........
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 22223457789999998765555566999999999999999999998766554444333321110
Q ss_pred cccCCC---------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 221 QYFLPD---------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 221 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
....+. ....++.+.++|.+||..||++|||+.+++.|+|+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 000000 1125788999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=306.20 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=199.1
Q ss_pred ccccccceecccCceEEEEEEEecC-----CeEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRT-----KELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 74 (269)
++|++.+.||+|+||.||++.+... +..||+|.+..... ..+.+.+|+.+++.+ +|+||+++++++...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 5799999999999999999986543 35799999865432 234577899999999 899999999999999999
Q ss_pred EEEEeecCCCchHHHHHhc-------------------------------------------------------------
Q 024336 75 AIVMEYAAGGELFARICSA------------------------------------------------------------- 93 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~------------------------------------------------------------- 93 (269)
++||||+++++|.+++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999999999988542
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC---Cccc
Q 024336 94 ---------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTV 161 (269)
Q Consensus 94 ---------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~---~~~~ 161 (269)
.+++...+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++......... ....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccCCcceeeccCCC
Confidence 13678889999999999999999999999999999999998776 999999998643222211 1222
Q ss_pred CCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHH
Q 024336 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240 (269)
Q Consensus 162 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (269)
++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||.............. ..........+++++.++|.+
T Consensus 276 ~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~ 350 (374)
T cd05106 276 LPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK----RGYQMSRPDFAPPEIYSIMKM 350 (374)
T ss_pred CccceeCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH----cccCccCCCCCCHHHHHHHHH
Confidence 4567999999977666554 999999999999997 9999976544332222221 122222223578999999999
Q ss_pred HhhhCCCCCCCcHHHhhcc
Q 024336 241 IFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 241 ~l~~~p~~Rps~~~~l~~~ 259 (269)
||+.||.+|||+.++++.+
T Consensus 351 cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 351 CWNLEPTERPTFSQISQLI 369 (374)
T ss_pred HcCCChhhCcCHHHHHHHH
Confidence 9999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=285.58 Aligned_cols=251 Identities=30% Similarity=0.475 Sum_probs=210.6
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
+|++.+.||+|++|.||++.+..+++.+++|.+..... ....+.+|+..++.++|++++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 58899999999999999999998899999999876543 45678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCccc
Q 024336 83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 161 (269)
Q Consensus 83 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 161 (269)
+++|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeecccccccccccccccee
Confidence 99999998776 57899999999999999999999999999999999999998877 9999999887543333234456
Q ss_pred CCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHH
Q 024336 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241 (269)
Q Consensus 162 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 241 (269)
++..|+|||.+.+...+ .++|+||||+++++|++|..||...+......... .......+....++..+.++|.+|
T Consensus 159 ~~~~~~~PE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 159 GTPYWMAPEVINGKPYD-YKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---TNGPPGLRNPEKWSDEFKDFLKKC 234 (253)
T ss_pred cCCcccCHHHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hcCCCCcCcccccCHHHHHHHHHH
Confidence 78899999998876654 44999999999999999999997654322222111 122222233223588999999999
Q ss_pred hhhCCCCCCCcHHHhhccC
Q 024336 242 FVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 242 l~~~p~~Rps~~~~l~~~~ 260 (269)
|..||++|||+.++++|+|
T Consensus 235 l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 235 LQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ccCChhhCCCHHHHhcCCC
Confidence 9999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=288.11 Aligned_cols=248 Identities=26% Similarity=0.372 Sum_probs=202.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
++|++.+.||+|+||.||++.... +..+|+|.+.......+.+.+|+..+++++|||++++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 578999999999999999998764 5579999887655555678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC--Cc
Q 024336 83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KS 159 (269)
Q Consensus 83 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~--~~ 159 (269)
+++|.+.+... +.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......... ..
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceeccCC
Confidence 99999998653 46899999999999999999999999999999999999998776 999999988643222211 12
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
..++..|+|||.+.+..++. ++|+||||+++|++++ |..||.......... .+..... .......+..+.+++
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~-~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~----~i~~~~~-~~~~~~~~~~~~~li 234 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSS-KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE----MISRGFR-LYRPKLASMTVYEVM 234 (256)
T ss_pred CCCchhhCChhhcccCccch-hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHCCCC-CCCCCCCCHHHHHHH
Confidence 23455799999987766654 4999999999999999 899997765433322 2222221 112225678899999
Q ss_pred HHHhhhCCCCCCCcHHHhhcc
Q 024336 239 SQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+||+.+|.+||++.+++..+
T Consensus 235 ~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 235 YSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHccCCcccCcCHHHHHHhh
Confidence 999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=293.03 Aligned_cols=263 Identities=27% Similarity=0.397 Sum_probs=208.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|++.+.||+|++|+||++.+..+|+.||+|.+.... .....+.+|+..+++++|||++++++++..+...++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999999899999999886532 223567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-C
Q 024336 80 YAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-Q 156 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~ 156 (269)
|+++ ++.+.+..... +++..++.++.|++.||++||++|++|+||+|+||+++.++. .++|+|||++....... .
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC-EEEEcccccccccCCCccc
Confidence 9965 77777755443 578889999999999999999999999999999999985432 38999999886432221 1
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc--------------
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-------------- 222 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 222 (269)
.....+++.|+|||.+.+....+.++|+||||+++|+|+||.+||.....................
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 223356788999999876554555699999999999999999999876554443333221111100
Q ss_pred ---cCC------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhhc
Q 024336 223 ---FLP------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAER 267 (269)
Q Consensus 223 ---~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~~ 267 (269)
.++ ....+++++.++|.+||+.+|++||++.++++|+|+..+.+-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~ 293 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhcC
Confidence 000 012467889999999999999999999999999999987653
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=297.13 Aligned_cols=256 Identities=29% Similarity=0.436 Sum_probs=210.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.+.|+..+.||+|++|.||++.+..++..||+|.+.... ...+.+.+|+..++.++|||++++++.+..+...++|+|
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 467889999999999999999999889999999886432 233568899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-CC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PK 158 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~ 158 (269)
|+++++|.+.+.. +.+++..+..++.|++.|+.+||++|++|+||+|+||+++.++. ++|+|||++........ ..
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhh
Confidence 9999999988854 56899999999999999999999999999999999999998877 99999998864332221 12
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-ccCCCcCCCCHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRVSADCRHL 237 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 237 (269)
...++..|+|||.+.+..++.+ +|+||||+++++|+||..||.......... .+.... ...+ ..++.++.++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~l 232 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLF----LIPKNSPPTLE--GQYSKPFKEF 232 (277)
T ss_pred cccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchhhHHh----hhhcCCCCCCC--cccCHHHHHH
Confidence 2346788999999987766544 999999999999999999987544322221 111111 1111 2578899999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccChhhhhhc
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVPEEFAER 267 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~~~~~~~ 267 (269)
|.+||..+|.+||++.+++.|+|+..+..+
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKHKFITRYTKK 262 (277)
T ss_pred HHHHccCCcccCcCHHHHHHhHHHHHHhhh
Confidence 999999999999999999999999876543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=292.63 Aligned_cols=254 Identities=28% Similarity=0.403 Sum_probs=205.4
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
|++.+.||.|++|.||++.+..+|+.||+|.+.... .....+.+|+..++.++|||++++++++.+++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 788999999999999999999899999999987543 22356788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCC
Q 024336 82 AGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK 158 (269)
Q Consensus 82 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 158 (269)
+ ++|.+++.... .+++..+..++.|++.||++||+.+++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc--EEEeecccccccCCCccccC
Confidence 6 58999887765 6899999999999999999999999999999999999998776 9999999986432222 112
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc--------------cccC
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------------QYFL 224 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~ 224 (269)
...++..|+|||.+.+....+.++|+||||+++|+|++|.+||...+............... ....
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 33457889999988765544556999999999999999999998765443333322211000 0000
Q ss_pred ---------CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 225 ---------PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 225 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.....++..+.++|.+||+.||.+|||++|+++|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0123567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=290.06 Aligned_cols=252 Identities=27% Similarity=0.383 Sum_probs=204.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.++|||++++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999999999999999876422 22235778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 79 EYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 79 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
||+++++|.+++.. ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccch
Confidence 99999999888753 344889999999999999999999999999999999999998877 999999987643222
Q ss_pred CC-CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 155 SQ-PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 155 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
.. .....+++.|+|||.+.+...+.+ +|+||+|+++|+|++|..||...... .......+............++..
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYSEK 236 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCCCChhhcCHH
Confidence 11 123457788999999987766554 99999999999999999998654321 122223333222211112357789
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+.++|.+||..+|.+||++.++++.+
T Consensus 237 ~~~li~~cl~~~p~~Rp~~~~vl~~~ 262 (267)
T cd08228 237 LRELVSMCIYPDPDQRPDIGYVHQIA 262 (267)
T ss_pred HHHHHHHHCCCCcccCcCHHHHHHHH
Confidence 99999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=288.26 Aligned_cols=248 Identities=27% Similarity=0.424 Sum_probs=199.6
Q ss_pred cccccccee--cccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKEL--GSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l--~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|++.+.+ |+|+||.||++.+..++..+|+|.+....... .|+.....+ +|+|++++++.+..++..++|||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 456777776 99999999999999999999999987542211 122222222 79999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CCcEEEeecCCcccCCCCCCCC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~~~~~~~~ 158 (269)
|+++++|.+++.+..++++..+..++.|++.||.+||+.|++|+||+|+||+++.++ . ++|+|||++.... ...
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~--~~l~dfg~~~~~~---~~~ 164 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDR--IYLCDYGLCKIIG---TPS 164 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCe--EEEecCccceecC---CCc
Confidence 999999999998877899999999999999999999999999999999999999887 5 9999999886432 222
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...++..|+|||.+.+..++.+ +|+||+|+++|+|++|..||.................... .+....+++.+.++|
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li 241 (267)
T PHA03390 165 CYDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK--LPFIKNVSKNANDFV 241 (267)
T ss_pred cCCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc--CCcccccCHHHHHHH
Confidence 3457889999999987776544 9999999999999999999985543321111111111222 222336899999999
Q ss_pred HHHhhhCCCCCCC-cHHHhhccChh
Q 024336 239 SQIFVADPSKDPH-SRDQKASLVPE 262 (269)
Q Consensus 239 ~~~l~~~p~~Rps-~~~~l~~~~~~ 262 (269)
.+||+.+|.+||+ ++++++|+|+.
T Consensus 242 ~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 242 QSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHhccChhhCCchHHHHhcCCccc
Confidence 9999999999996 59999999985
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=291.56 Aligned_cols=259 Identities=29% Similarity=0.446 Sum_probs=206.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTP--THLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~ 78 (269)
++|...+.||.|++|.||++.+..++..+|+|.+..... ....+.+|++.+++++||||+++++++... ..+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 478999999999999999999998999999999875432 335688999999999999999999988654 4789999
Q ss_pred eecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 79 EYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 79 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
||+++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS 158 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence 99999999887643 345899999999999999999999999999999999999998877 999999988643222
Q ss_pred CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh-hhHHHHHHHHhhcc-ccCCC----cC
Q 024336 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNVQ-YFLPD----YV 228 (269)
Q Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~-~~~~~----~~ 228 (269)
. .....++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...... ....+....+.... ..++. ..
T Consensus 159 ~-~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 159 L-AGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred c-cccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 2 223456778999999887776555 99999999999999999999865221 01112222222211 11111 12
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 229 RVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.+++.+.++|.+||..+|++|||+.|+++|+|+....
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 3567899999999999999999999999999997644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=295.49 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=205.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|+..+.||+|+||.||++.+..++..+|+|.+..... ....+.+|+..+.++. |+|++++++++..+...++++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 467888999999999999999999999999999875432 2345778999998886 9999999999999989999999
Q ss_pred ecCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 80 YAAGGELFARIC-----SAGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 80 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
++.. ++.++.. ....+++..+..++.|++.||+|||+. |++||||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhcc
Confidence 9864 5544321 245689999999999999999999975 9999999999999998877 99999999864333
Q ss_pred CCCCCcccCCCcccCchhhccc--cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-ccCC--CcC
Q 024336 154 HSQPKSTVGTPAYIAPEVLARK--EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLP--DYV 228 (269)
Q Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~--~~~ 228 (269)
........++..|+|||.+.+. ...+.++|+||+|+++|+|++|..||..... . ........... ...+ ...
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--V-FDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--H-HHHHhhhcCCCCCcCCCcCCC
Confidence 3333344678889999998766 2345559999999999999999999976542 1 12222222111 1111 112
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhhcc
Q 024336 229 RVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAERD 268 (269)
Q Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~~~ 268 (269)
.++.++.+||.+||..||.+|||++++++|+|+..+..++
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~ 277 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERN 277 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcc
Confidence 5788999999999999999999999999999998876543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=298.99 Aligned_cols=258 Identities=27% Similarity=0.402 Sum_probs=230.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
+.|+.-+.||+|+||.||-++...||+.||.|.+.+. ........+|-.++++++.+.||.+--.|++++.+|+|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 5678889999999999999999999999999988642 233445778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 79 EYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
..|+||+|.-.|.+.+ .+++..+.-++.+|+.+|++||+++||+||+||+||++|+.|+ |+|+|+|+|.....+..
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGKP 342 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCCCc
Confidence 9999999988887766 6999999999999999999999999999999999999999999 99999999998777777
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....||..|+|||++.+..++.. .|.|||||++|+|+.|+.||........-.++...+......+++ ..|++.++
T Consensus 343 ~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~--kFS~eaks 419 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD--KFSEEAKS 419 (591)
T ss_pred cccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc--ccCHHHHH
Confidence 777899999999999999887555 999999999999999999998776665656677777777777776 89999999
Q ss_pred HHHHHhhhCCCCCCC-----cHHHhhccChhhhh
Q 024336 237 LLSQIFVADPSKDPH-----SRDQKASLVPEEFA 265 (269)
Q Consensus 237 li~~~l~~~p~~Rps-----~~~~l~~~~~~~~~ 265 (269)
+.+.+|.+||++|.. ++++.+||||+.+.
T Consensus 420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred HHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 999999999999975 45999999998753
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=291.97 Aligned_cols=249 Identities=26% Similarity=0.367 Sum_probs=204.2
Q ss_pred ccccccceecccCceEEEEEEEec-----CCeEEEEEEeecCccc--cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKKI--DENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
++|.+.+.||+|++|.||++.+.. ++..||+|.+...... .+.+.+|+.+++.++|+|++++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 579999999999999999998753 3578999998754332 357889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEE
Q 024336 76 IVMEYAAGGELFARICSAG--------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLK 141 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~ 141 (269)
++|||+++++|.+++...+ .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~k 162 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV--VK 162 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--EE
Confidence 9999999999999986542 3788899999999999999999999999999999999998877 99
Q ss_pred EeecCCcccCCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHH
Q 024336 142 ICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRI 217 (269)
Q Consensus 142 l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~ 217 (269)
|+|||++....... .......++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||........ ...+
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~----~~~~ 237 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEV----IECI 237 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHH----HHHH
Confidence 99999886432221 1123334678999999987776555 999999999999998 9999977655332 2333
Q ss_pred hhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
...... .....++..+.+++.+||..||.+||++.|+++.+
T Consensus 238 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 238 TQGRLL-QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred HcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 332222 12236889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=299.09 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=210.7
Q ss_pred Cccccccc-ceecccCceEEEEEEEecCCeEEEEEEeecCcccc---------------HHHHHHHHHHHhCCCCCccee
Q 024336 1 MEERYEPV-KELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---------------ENVQREIINHRSLRHPNIIRF 64 (269)
Q Consensus 1 i~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---------------~~~~~e~~~l~~l~h~~i~~~ 64 (269)
+.++|..+ +.||+|++|+||++.+..+++.||+|.+....... ..+.+|+.+++.++|+|++++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 45788754 67999999999999999899999999986532221 246789999999999999999
Q ss_pred eEEEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEee
Q 024336 65 KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICD 144 (269)
Q Consensus 65 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~d 144 (269)
++++..++..++++|+++ ++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~d 162 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIAD 162 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECC
Confidence 999999999999999997 489999988778999999999999999999999999999999999999998887 99999
Q ss_pred cCCcccCCC---------------CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhh
Q 024336 145 FGYSKSGLL---------------HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN 209 (269)
Q Consensus 145 f~~~~~~~~---------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~ 209 (269)
||.+..... ........+++.|+|||.+.+....+.++|+||||+++|+|+||.+||...+....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 998863320 01111234577899999987655556669999999999999999999987766554
Q ss_pred HHHHHHHHhhccc-cCC---------------------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 210 FRKTIDRIRNVQY-FLP---------------------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 210 ~~~~~~~~~~~~~-~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
+............ .++ .....+.++.++|.+||+.+|.+|||++|++.|+|++...
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 4433332211110 000 0124578899999999999999999999999999998754
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=295.94 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=198.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeE--EEEEEeecCc--cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKEL--VAVKYIERGK--KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~--vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++.+.||+|+||.||+|.+..++.. +++|.+.... .....+.+|+.++.++ +|+|++++++++..++..+++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 4789999999999999999998877654 5666655322 2234677899999999 899999999999999999999
Q ss_pred EeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEE
Q 024336 78 MEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLK 141 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~ 141 (269)
+||+++++|.+++...+ .+++..++.++.|++.|+++||++|++||||||+||+++.++. ++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~--~k 164 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AK 164 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--EE
Confidence 99999999999986542 4789999999999999999999999999999999999998877 99
Q ss_pred EeecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhc
Q 024336 142 ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV 220 (269)
Q Consensus 142 l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 220 (269)
|+|||++..............+..|+|||.+.+..++ .++|+||||+++|+|+| |..||......... ..+..
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----~~~~~- 238 (303)
T cd05088 165 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY----EKLPQ- 238 (303)
T ss_pred eCccccCcccchhhhcccCCCcccccCHHHHhccCCc-ccccchhhhhHHHHHHhcCCCCcccCChHHHH----HHHhc-
Confidence 9999988632211112222335679999998766654 45999999999999998 99999765443222 22222
Q ss_pred cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 221 QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 221 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
..........++++.++|.+||+.+|.+||++.+++.++.
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1122223357889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=301.08 Aligned_cols=263 Identities=27% Similarity=0.423 Sum_probs=209.6
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEe----CCe
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLT----PTH 73 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 73 (269)
+.++|++.+.||+|++|.||++.+..+|+.||+|.+.... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 3578999999999999999999999999999999987532 234557789999999999999999998763 346
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
+++|+||+. ++|.+.+...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~ 159 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSS 159 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecc
Confidence 899999996 589999887788999999999999999999999999999999999999998887 99999998864322
Q ss_pred CCC-----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHh----------
Q 024336 154 HSQ-----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR---------- 218 (269)
Q Consensus 154 ~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~---------- 218 (269)
... .....++..|+|||.+.+....+.++|+||||+++|+|++|..||...+.............
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 111 12345788899999987654456669999999999999999999976554332221111100
Q ss_pred ----------hccc--cCC---CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 219 ----------NVQY--FLP---DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 219 ----------~~~~--~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
.... ..+ .....++++.++|.+||+.+|.+||++.+++.|+|+..+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 0000 000 01246889999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=296.21 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=209.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
+.|.....||+|+||.||++.+..++..||+|.+.... ...+.+.+|+..++.++|+|++++++.+..++..++|+||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 45667788999999999999999899999999886433 23445788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCcc
Q 024336 82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKST 160 (269)
Q Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~~ 160 (269)
++++|.+++. .+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... .....
T Consensus 102 ~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~ 178 (292)
T cd06658 102 EGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRKSL 178 (292)
T ss_pred CCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccCcee
Confidence 9999988874 456899999999999999999999999999999999999998877 9999999886422211 12334
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (269)
.++..|+|||.+.+..++. ++|+||+|+++|++++|..||.............. ......+....++..+.+++.+
T Consensus 179 ~~~~~y~aPE~~~~~~~~~-~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGT-EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ecCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCCccccccccCHHHHHHHHH
Confidence 5788999999987766654 59999999999999999999986554333222111 1122222333578899999999
Q ss_pred HhhhCCCCCCCcHHHhhccChhhh
Q 024336 241 IFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 241 ~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
||..||.+|||++++++|+|+...
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhcc
Confidence 999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=287.95 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=202.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
++|++.+.||+|++|.||.+.... +..+|+|.+.......+.+.+|+..+++++|||++++++++......+++|||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 579999999999999999998764 4459999887655555678999999999999999999999999889999999999
Q ss_pred CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC--CCc
Q 024336 83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKS 159 (269)
Q Consensus 83 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~--~~~ 159 (269)
+++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........ ...
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC--EEECCCccceecCCCceeecCC
Confidence 99999998764 36899999999999999999999999999999999999998776 99999998864322211 112
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
..++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||......... ..+..... .+.....+..+.+++
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~li 234 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETV----EKVSQGLR-LYRPHLASEKVYAIM 234 (256)
T ss_pred CccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHH----HHHhcCCC-CCCCCCCCHHHHHHH
Confidence 234567999999987666554 999999999999998 99999765543222 22222211 122235688999999
Q ss_pred HHHhhhCCCCCCCcHHHhhcc
Q 024336 239 SQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+||..+|.+||++.++++++
T Consensus 235 ~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 235 YSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHHcCCCcccCCCHHHHHHhh
Confidence 999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=290.36 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=206.4
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
+|++.+.||.|++|.||++.+..+|..||+|.+..... ..+.+.+|+.+++.++|+|++++++++...+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58999999999999999999999999999999875432 2356778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CC
Q 024336 82 AGGELFARICSA---GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QP 157 (269)
Q Consensus 82 ~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~ 157 (269)
++ +|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTF 157 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCcccc
Confidence 86 788877654 35899999999999999999999999999999999999998877 9999999886432221 12
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc--------------ccc
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------------QYF 223 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--------------~~~ 223 (269)
....++..|+|||.+.+....+.++|+||||+++|++++|..||...+..+............ ...
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 234467889999998765554566999999999999999999998776554444332221100 000
Q ss_pred CCC---------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 224 LPD---------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 224 ~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.+. ....+..+.++|.+||+.||.+||++.++++|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000 01357789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=285.65 Aligned_cols=248 Identities=31% Similarity=0.491 Sum_probs=205.1
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
+|++.+.||+|++|.||++.+..++..+|+|.+.... ...+.+.+|+..++.++|+|++++++.+.+++.+++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5899999999999999999999999999999886432 33456788999999999999999999999999999999999
Q ss_pred CCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCC
Q 024336 82 AGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK 158 (269)
Q Consensus 82 ~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 158 (269)
++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++++|||.+....... ...
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccc
Confidence 99999998864 345899999999999999999999999999999999999998877 9999999886432222 223
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...+++.|+|||.+.+...+.+ +|+||||+++|+|++|..||...+.. .....+...... +....++..+.++|
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~li 232 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSWK----NLILKVCQGSYK-PLPSHYSYELRSLI 232 (255)
T ss_pred cccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCHH----HHHHHHhcCCCC-CCCcccCHHHHHHH
Confidence 3457888999999877766454 99999999999999999999764432 222222222221 12236788999999
Q ss_pred HHHhhhCCCCCCCcHHHhhcc
Q 024336 239 SQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+||..||.+||++.+++...
T Consensus 233 ~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 233 KQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred HHHHhCCcccCCCHHHHhhcc
Confidence 999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=291.02 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=202.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHH-HHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIIN-HRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|++.+.||+|+||.||++.+..+|+.||+|.+..... ....+..|+.. ++.++|||++++++++..+...++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 579999999999999999999999999999999875432 22344556554 566789999999999999999999999
Q ss_pred ecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 80 YAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 80 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
|+++ +|.+++.. ...+++..++.++.|++.||.+||++ +++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDS 157 (283)
T ss_pred hhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence 9974 77776643 34689999999999999999999997 9999999999999998887 999999998743322
Q ss_pred CCCCcccCCCcccCchhhcccc---CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 155 SQPKSTVGTPAYIAPEVLARKE---YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
.......++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...... ...............+ ...+|
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~ 234 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEPSPQLP-AEKFS 234 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHHHHHHhcCCCCCC-ccccC
Confidence 2223345778899999886422 2245599999999999999999999753321 1111111222222222 22578
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.++.++|.+||..+|.+||++.++++|+|+....
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=290.31 Aligned_cols=259 Identities=29% Similarity=0.462 Sum_probs=215.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.+.|++...||+|++|.||++.+..++..+++|.+.......+.+.+|+..++.++|+|++++++.+..+...++++||+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 97 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM 97 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEecc
Confidence 46789999999999999999999988999999999865544567889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCc
Q 024336 82 AGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS 159 (269)
Q Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 159 (269)
++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 98 ~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~ 175 (286)
T cd06614 98 DGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKRNS 175 (286)
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhhhcc
Confidence 9999999998876 8999999999999999999999999999999999999998887 9999999876332221 1123
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
..++..|+|||.+.+..++.+ +|+||||+++|+|++|..||........... ..............++..+.++|.
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFL---ITTKGIPPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCCCCcchhhCCHHHHHHHH
Confidence 346788999999877666544 9999999999999999999976544322221 111122222333347899999999
Q ss_pred HHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 240 QIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
+||+.+|.+||++.++++|+|+.....
T Consensus 252 ~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred HHhccChhhCcCHHHHhhChHhhccCc
Confidence 999999999999999999999987443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=320.73 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=202.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+|+.||+|.+..... ..+.+.+|+.+++.++|||++++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 689999999999999999999999999999999875322 2345788999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCC
Q 024336 79 EYAAGGELFARICSA-----------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY 147 (269)
Q Consensus 79 e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~ 147 (269)
||++|++|.+++.+. ...+...+..++.|++.||++||+.|++||||||+||+++.++. ++|+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecCc
Confidence 999999999988642 23556778899999999999999999999999999999998887 99999999
Q ss_pred cccCCCC-------------------CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChh
Q 024336 148 SKSGLLH-------------------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR 208 (269)
Q Consensus 148 ~~~~~~~-------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~ 208 (269)
+...... .......|++.|+|||.+.+..++. ++|+||||+++|+|+||..||.......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~-kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE-STDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCc-HhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 8643110 0111235899999999998777644 4999999999999999999997644322
Q ss_pred hHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
... ...............+|+.+.+++.+||..||++||++.+.+.+.+
T Consensus 239 i~~---~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L 287 (932)
T PRK13184 239 ISY---RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287 (932)
T ss_pred hhh---hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 111 1111111122223468899999999999999999998877665543
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=288.31 Aligned_cols=251 Identities=27% Similarity=0.370 Sum_probs=204.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|++|.||++.+..+++.+++|.+.... .....+.+|+.+++.++|+|++++++++..++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999899999999876432 22346778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 79 EYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 79 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
|++++++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhccccC
Confidence 99999999998863 345899999999999999999999999999999999999998877 999999987643222
Q ss_pred CC-CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 155 SQ-PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 155 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
.. .....++..|+|||.+.+...+.+ +|+||||+++|+|++|..||...... .......+............+++.
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEE 236 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccHH
Confidence 21 223457889999999987766544 99999999999999999999654321 222333333322222222357889
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
+.++|.+||..||.+|||+.++++.
T Consensus 237 ~~~li~~~l~~~p~~Rpt~~~i~~~ 261 (267)
T cd08229 237 LRQLVNMCINPDPEKRPDITYVYDV 261 (267)
T ss_pred HHHHHHHhcCCCcccCCCHHHHHHH
Confidence 9999999999999999999977753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=300.16 Aligned_cols=261 Identities=27% Similarity=0.428 Sum_probs=204.0
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----e
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPT-----H 73 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 73 (269)
+.++|++.+.||+|++|.||++.+..+|+.||+|.+.... .....+.+|+.+++.++|+|++++++++.... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4689999999999999999999999999999999886422 23345778999999999999999999876543 5
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
.++++|++++ ++...+ ..+++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 83 ~~lv~e~~~~-~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~ 158 (336)
T cd07849 83 VYIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADP 158 (336)
T ss_pred EEEEehhccc-CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeeccc
Confidence 8999999975 777776 4457899999999999999999999999999999999999998887 99999998864322
Q ss_pred CCC----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh----------
Q 024336 154 HSQ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN---------- 219 (269)
Q Consensus 154 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~---------- 219 (269)
... .....+++.|+|||.+.+....+.++|+||||+++|+|++|..||..................
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 111 122356888999998766544456699999999999999999999765432222211110000
Q ss_pred ----------ccc--cCC---CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 220 ----------VQY--FLP---DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 220 ----------~~~--~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
... ..+ .....++++.++|.+||..+|++|||+.++++|+|+..+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000 000 0124577899999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=291.71 Aligned_cols=250 Identities=32% Similarity=0.514 Sum_probs=211.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++.+.||+|++|.||++.+..+++.|++|++.... .....+.+|..+++++. |+|++++++.+..++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 57999999999999999999999999999999987532 22356778999999998 99999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ- 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 156 (269)
||++++++|.+.+.+.+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCcccc
Confidence 999999999999988888999999999999999999999999999999999999998887 99999998764322111
Q ss_pred --------------------CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 024336 157 --------------------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR 216 (269)
Q Consensus 157 --------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~ 216 (269)
.....++..|+|||.+.....+. ++|+||||++++++++|..||......... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~ 233 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK-SSDLWALGCIIYQMLTGKPPFRGSNEYLTF----QK 233 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCCh-hhhHHHHHHHHHHHHhCCCCCCCccHHHHH----HH
Confidence 11234578899999987766544 499999999999999999999876543322 22
Q ss_pred HhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCc----HHHhhccCh
Q 024336 217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHS----RDQKASLVP 261 (269)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~~l~~~~~ 261 (269)
+.......+. .+++.+.++|.+||..+|.+||++ ++++.|+|+
T Consensus 234 ~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCCCCC--ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 2333334444 678999999999999999999999 999999996
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=286.78 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=203.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
.+|++.+.||+|++|.||++.+. ++..+|+|.+.........+.+|+.+++.++|+|++++++++...+..++++|+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 46899999999999999999886 46679999887655555678889999999999999999999999999999999999
Q ss_pred CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC--Cc
Q 024336 83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KS 159 (269)
Q Consensus 83 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~--~~ 159 (269)
+++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......... ..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceecccccccccCC
Confidence 99999998653 46899999999999999999999999999999999999998887 999999988643222111 11
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...+..|+|||.+.+..++.+ +|+||||+++|++++ |..||......... ..+... ...+....++..+.+++
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~li 234 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVV----ESVSAG-YRLYRPKLAPTEVYTIM 234 (256)
T ss_pred CCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHH----HHHHcC-CcCCCCCCCCHHHHHHH
Confidence 123357999999987776555 999999999999999 89999765443222 222221 12222336899999999
Q ss_pred HHHhhhCCCCCCCcHHHhhcc
Q 024336 239 SQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+||..+|.+|||+.++++.+
T Consensus 235 ~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 235 YSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHhcCChhhCcCHHHHHHHh
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=286.89 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=203.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
++|++.+.||+|++|.||++... ++..||+|.+.......+.+.+|+.+++.++|+|++++++.+...+..++++|+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 68999999999999999999975 45679999887655556778899999999999999999999999999999999999
Q ss_pred CCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC--CC
Q 024336 83 GGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PK 158 (269)
Q Consensus 83 ~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~--~~ 158 (269)
+++|.+++.. ...++...+..++.|++.||++||+.+++|+||+|+||+++.++. ++|+|||++........ ..
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEYTARE 162 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCceeccC
Confidence 9999999865 345888999999999999999999999999999999999998877 99999999874322211 11
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
...++..|+|||.+....++.+ +|+||||+++|+|+| |..||......... ..+... ...+....++.++.++
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~l 236 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVM----SALQRG-YRMPRMENCPDELYDI 236 (261)
T ss_pred CCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCCHHHHH----HHHHcC-CCCCCCCCCCHHHHHH
Confidence 2234567999999877666544 999999999999998 99999765443222 222222 2233344688999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhcc
Q 024336 238 LSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+.+||..+|++||+++++.+.+
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~~l 258 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQSVL 258 (261)
T ss_pred HHHHccCCcccCcCHHHHHHHH
Confidence 9999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=285.87 Aligned_cols=249 Identities=31% Similarity=0.532 Sum_probs=206.5
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEe--CCeEEEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLT--PTHLAIVM 78 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (269)
+|++.+.||.|++|.||++.+..++..+|+|.+.... ...+.+.+|+..++.++|+|++++++++.. +...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999886532 223457789999999999999999998764 45689999
Q ss_pred eecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 79 EYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCH-----SMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 79 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh-----~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
||+++++|.+++.. ..++++..++.++.|++.||.+|| +.+++|+||+|+||+++.++. ++|+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC--EEEecccccc
Confidence 99999999999865 357899999999999999999999 899999999999999998877 9999999887
Q ss_pred cCCCCCC-CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cCCCc
Q 024336 150 SGLLHSQ-PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY 227 (269)
Q Consensus 150 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 227 (269)
....... .....+++.|+|||.+.+...+ .++|+||||+++++|++|..||...... .....+..... ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~-- 231 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQL----QLASKIKEGKFRRIP-- 231 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCHH----HHHHHHhcCCCCCCc--
Confidence 5433332 3344678899999998876654 4499999999999999999999876532 22233333222 222
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 228 VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
..++..+.+++.+||..+|.+||++.++++|||.
T Consensus 232 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 2678999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=285.34 Aligned_cols=243 Identities=28% Similarity=0.420 Sum_probs=203.1
Q ss_pred ceecccCceEEEEEEEecC---CeEEEEEEeecCccc--cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKRT---KELVAVKYIERGKKI--DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~---~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||.||++.+... +..+++|.+...... .+.+.+|+..++.++|+|++++++++.....+++++||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4789999999999999866 889999998765443 46788999999999999999999999999999999999999
Q ss_pred CchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 84 GELFARICSA---------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 84 ~~l~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 158 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDD 158 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccccccccc
Confidence 9999999875 67999999999999999999999999999999999999998877 999999998754332
Q ss_pred ---CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 155 ---SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 155 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
.......++..|+|||.+....++. ++|+||||+++|+|++ |..||......... ..+.. .........+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~ 232 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTS-KSDVWSFGVLLWEIFTLGATPYPGLSNEEVL----EYLRK-GYRLPKPEYC 232 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcch-hhccHHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHHc-CCCCCCCccC
Confidence 2233445678899999988776544 4999999999999999 69999876443222 22222 1222223367
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+.++.+++.+||..+|.+|||+.|+++++
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 233 PDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred ChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 89999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=287.79 Aligned_cols=247 Identities=33% Similarity=0.525 Sum_probs=207.7
Q ss_pred ecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCch
Q 024336 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 11 l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
||.|++|.||++.+..+|+.+++|.+..... ..+.+.+|+..+++++|+|++++++.+..+...++++|++++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999998899999999865432 345688899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC---------CC
Q 024336 87 FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---------QP 157 (269)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~---------~~ 157 (269)
.+++.+.+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence 999988778999999999999999999999999999999999999998887 9999999886433321 11
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....++..|+|||....... +.++|+||||++++++++|..||...... .....+......++....++..+.++
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPE----EIFQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred cCcccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCCcCCCccccCCHHHHHH
Confidence 23346778999999877665 44599999999999999999999765543 22333333444444433458999999
Q ss_pred HHHHhhhCCCCCCCc---HHHhhccChhhh
Q 024336 238 LSQIFVADPSKDPHS---RDQKASLVPEEF 264 (269)
Q Consensus 238 i~~~l~~~p~~Rps~---~~~l~~~~~~~~ 264 (269)
+.+||+.+|.+|||+ .++++|+|+..+
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 999999999999999 999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=285.09 Aligned_cols=249 Identities=22% Similarity=0.312 Sum_probs=204.1
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|++|.||++.+.. ++.||+|.+.......+.+.+|+..+++++|+|++++++++...+..++++|++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 3689999999999999999999764 567999998766555677889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC--
Q 024336 82 AGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-- 157 (269)
Q Consensus 82 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~-- 157 (269)
++++|.+++.... .++...+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCccccc
Confidence 9999999997644 6899999999999999999999999999999999999998887 999999988743322111
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+..|+|||.+.+..++.+ +|+||||+++++|+| |..||......... ..+... ...+.....+..+.+
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~ 235 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVL----QQVDQG-YRMPCPPGCPKELYD 235 (261)
T ss_pred CCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHHcC-CCCCCCCcCCHHHHH
Confidence 11122357999999877766555 999999999999999 99999765543222 222221 222233367899999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhcc
Q 024336 237 LLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
++.+|+..+|.+||++.++++.+
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~~l 258 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQWKL 258 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHHHH
Confidence 99999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=289.86 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=205.7
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEEEEEe
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP--THLAIVME 79 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e 79 (269)
|++.+.||+|++|.||++.+..+++.+|+|.+.... .....+.+|+.+++.++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 788999999999999999999899999999998653 2334678899999999999999999999988 78999999
Q ss_pred ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--C
Q 024336 80 YAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--Q 156 (269)
Q Consensus 80 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~ 156 (269)
|+++ +|.+.+... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence 9975 888887655 57899999999999999999999999999999999999998887 9999999887443332 1
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-ccCCC---------
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPD--------- 226 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~--------- 226 (269)
.....++..|+|||.+.+....+.++|+||||+++++|+||..||.................... ..++.
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 22335677899999877655445669999999999999999999987665444333332211100 00000
Q ss_pred --------------cCC-CCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 227 --------------YVR-VSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 227 --------------~~~-~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
... .+..+.++|.+||..+|.+||++.+++.|+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 012 37889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=292.97 Aligned_cols=255 Identities=24% Similarity=0.383 Sum_probs=198.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCC-------
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPT------- 72 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------- 72 (269)
++|++.+.||+|++|.||++.+..+++.||+|.+..... ......+|+..+++++|||++++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 579999999999999999999999999999998864322 2234568999999999999999999987653
Q ss_pred -eEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCccc
Q 024336 73 -HLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 73 -~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~ 150 (269)
..++|+||+.+ ++.+.+.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~ 168 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LKLADFGLARA 168 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EEECcCCCccc
Confidence 45999999975 7777775543 6899999999999999999999999999999999999998877 99999998864
Q ss_pred CCCCCC-----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh-cc---
Q 024336 151 GLLHSQ-----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQ--- 221 (269)
Q Consensus 151 ~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~--- 221 (269)
...... .....++..|+|||.+.+....+.++|+||||+++|+|+||.+||........... ...+.. ..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 247 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL-ISQLCGSITPEV 247 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCChhh
Confidence 322221 12234677899999987655445569999999999999999999976554322221 111110 00
Q ss_pred ------------ccCCC-----------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 222 ------------YFLPD-----------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 222 ------------~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
...+. ....+..+.++|.+||..||.+|||++++++|+||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00000 00124677899999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=287.80 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=205.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
++|++.+.||.|++|.||++.+.. +..+++|.+..... ....+.+|+..++.++|+|++++++++......++++||+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 579999999999999999999987 88899999876543 4567888999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-CC
Q 024336 82 AGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PK 158 (269)
Q Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~ 158 (269)
++++|.+++.+. ..++...+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+........ ..
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCcccccc
Confidence 999999999753 45899999999999999999999999999999999999998887 99999998864322211 11
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
...++..|+|||.+....+..+ +|+||||+++|+|++ |..||......+..... .. ....+.....++.+.++
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~ 236 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI----TA-GYRMPCPAKCPQEIYKI 236 (261)
T ss_pred CCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH----Hh-CCcCCCCCCCCHHHHHH
Confidence 2234567999999877666554 999999999999998 89999775543333322 22 22223334788999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhcc
Q 024336 238 LSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~ 259 (269)
|.+||..||.+|||+.++++.+
T Consensus 237 i~~~l~~~p~~Rpt~~~l~~~L 258 (261)
T cd05148 237 MLECWAAEPEDRPSFKALREEL 258 (261)
T ss_pred HHHHcCCCchhCcCHHHHHHHH
Confidence 9999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=298.87 Aligned_cols=260 Identities=30% Similarity=0.423 Sum_probs=212.4
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----eEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPT-----HLA 75 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (269)
+|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++|+|++++.+++.... .++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6899999999999999999999889999999887532 23456888999999999999999999988775 789
Q ss_pred EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
++++|+++ +|.+.+.+..++++..++.++.|++.||.+||+.|++|+||+|.||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccCceEeecccc
Confidence 99999975 88888887778999999999999999999999999999999999999998877 9999999987543332
Q ss_pred ----CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc---------
Q 024336 156 ----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--------- 222 (269)
Q Consensus 156 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~--------- 222 (269)
......+++.|+|||.+.+....+.++|+||||+++++|++|.+||......+..............
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 1233456888999999987744455699999999999999999999876654433332221111000
Q ss_pred ---------------cC-CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 223 ---------------FL-PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 223 ---------------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
.+ .....++..+.++|.+||+.+|.+||++++++.|+|+..+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00 001246788999999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=293.79 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=188.9
Q ss_pred cceecccCceEEEEEEEec--CCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEe--CCeEEEEEeecCC
Q 024336 8 VKELGSGNFGVARLVRDKR--TKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT--PTHLAIVMEYAAG 83 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~ 83 (269)
...||+|+||.||++.+.. ++..||+|.+.... ....+.+|+.+++.++|||++++++++.. +...++++||+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 3589999999999999753 56789999886543 34567889999999999999999998854 4578999999975
Q ss_pred CchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC--CCcEEEeecCCcccCC
Q 024336 84 GELFARICSA---------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP--QPRLKICDFGYSKSGL 152 (269)
Q Consensus 84 ~~l~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~--~~~~~l~df~~~~~~~ 152 (269)
+|.+.+... ..+++..++.++.|++.||.+||+.|++|+||||+||++..++ .++++|+|||++....
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 777776421 2478999999999999999999999999999999999994322 2349999999986432
Q ss_pred CCC----CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChh---------hHHHHHHH---
Q 024336 153 LHS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR---------NFRKTIDR--- 216 (269)
Q Consensus 153 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~---------~~~~~~~~--- 216 (269)
... ......+++.|+|||.+.+....+.++|+||||+++|+|+||.+||....... ........
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCC
Confidence 221 12234578899999998776555666999999999999999999997543210 01110000
Q ss_pred --------Hhh-------------cccc-------C-CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 217 --------IRN-------------VQYF-------L-PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 217 --------~~~-------------~~~~-------~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
+.. .... . ......+..+.++|.+||..||.+|||++|+++|||+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0000 0 0001234568899999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=291.16 Aligned_cols=252 Identities=27% Similarity=0.366 Sum_probs=203.8
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
.++|++.+.||+|++|.||++.+..+++.||+|.+..... ....+.+|+.+++.++|||++++.+++.+++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 4679999999999999999999998999999998864322 224577899999999999999999999999999999
Q ss_pred EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 78 MEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
+||+.+ ++.+.+.. .+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.... .
T Consensus 94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~---~ 167 (307)
T cd06607 94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVS---P 167 (307)
T ss_pred HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecC---C
Confidence 999975 66666653 456899999999999999999999999999999999999998887 9999999886422 2
Q ss_pred CCcccCCCcccCchhhcc--ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHH
Q 024336 157 PKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
.....+++.|+|||.+.+ ....+.++|+||||+++|+|+||..||...+...... .+............++..+
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 243 (307)
T cd06607 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----HIAQNDSPTLSSNDWSDYF 243 (307)
T ss_pred CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH----HHhcCCCCCCCchhhCHHH
Confidence 233457788999998742 2223445999999999999999999997654322221 1111111111122578899
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.++|.+||..+|.+||++.+++.|+|+..
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 99999999999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=288.08 Aligned_cols=253 Identities=28% Similarity=0.466 Sum_probs=208.2
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
.|...+.||+|++|.||++.+..+++.+++|.+.... ...+.+.+|+.+++.++|||++++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 5667789999999999999998889999999886432 233457889999999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCccc
Q 024336 83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTV 161 (269)
Q Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~~~ 161 (269)
+++|.+.+.. .+++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+....... ......
T Consensus 100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCccccccc
Confidence 9999999876 67899999999999999999999999999999999999998877 9999999876332221 122345
Q ss_pred CCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cCCCcCCCCHHHHHHHHH
Q 024336 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSADCRHLLSQ 240 (269)
Q Consensus 162 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ 240 (269)
+++.|+|||.+.+..++.+ +|+||+|+++++|++|..||...+.... ...+..... .......++..+.++|.+
T Consensus 177 ~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQA----MKRIRDNLPPKLKNLHKVSPRLRSFLDR 251 (285)
T ss_pred CCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHHHH----HHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence 7889999999877666554 9999999999999999999976443222 222222221 222222478899999999
Q ss_pred HhhhCCCCCCCcHHHhhccChhhh
Q 024336 241 IFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 241 ~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
||..+|.+||++.++++|+|+...
T Consensus 252 ~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 252 MLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred HcccChhhCcCHHHHccCcccccC
Confidence 999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=292.10 Aligned_cols=257 Identities=28% Similarity=0.435 Sum_probs=205.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCC------
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPT------ 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 72 (269)
.++|++.+.||+|++|.||++.+..+|+.||+|.+.... .....+.+|+.+++.++|||++++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 468999999999999999999999999999999987532 22346778999999999999999999987654
Q ss_pred ----eEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCC
Q 024336 73 ----HLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY 147 (269)
Q Consensus 73 ----~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~ 147 (269)
.+++++||+++ ++...+.+. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~ 162 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGL 162 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccc
Confidence 79999999987 666666543 46899999999999999999999999999999999999998887 99999998
Q ss_pred cccCCCCC--CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cC
Q 024336 148 SKSGLLHS--QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FL 224 (269)
Q Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 224 (269)
+....... .......+..|+|||.+.+....+.++|+||||+++++|++|.+||...+....+............ .+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 86432222 1122345678999998876544455699999999999999999999876654444443332211100 00
Q ss_pred -----------------------CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 225 -----------------------PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 225 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.....+|..+.++|.+||..||.+||++.+++.|+|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0122468899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=281.90 Aligned_cols=250 Identities=30% Similarity=0.446 Sum_probs=210.9
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+|++.+.||+|++|.||++.+..+++.|++|.+..... ..+.+.+|++.+++++|+|++++++++.++...++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58999999999999999999998899999999876543 345688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-CCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~~ 159 (269)
+++++|.+++....++++..++.++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+........ ...
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC--EEEeccccceecCCCcccccc
Confidence 999999999988888999999999999999999999999999999999999998776 99999998874333222 223
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
..++..|+|||...+... +.++|+||||++++++++|..||........... .........+ ..++..+.++|.
T Consensus 159 ~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~i~ 232 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFR---IVQDDHPPLP--EGISPELKDFLM 232 (254)
T ss_pred cccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH---HhccCCCCCC--CCCCHHHHHHHH
Confidence 457888999999876664 4459999999999999999999976553222221 1122222223 367899999999
Q ss_pred HHhhhCCCCCCCcHHHhhccCh
Q 024336 240 QIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
+||..+|++||++.+++.++|+
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=292.86 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=198.8
Q ss_pred ccccccceecccCceEEEEEEEecCCe--EEEEEEeecC--ccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKE--LVAVKYIERG--KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~--~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++.+.||+|+||.||++....++. .+++|.+... ....+.+.+|+..++++ +|||++++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 689999999999999999999876664 4688877532 12234678899999999 799999999999999999999
Q ss_pred EeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEE
Q 024336 78 MEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLK 141 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~ 141 (269)
+||+++++|.+++.... .+++..++.++.|++.||++||+.|++|+||||+||+++.++. ++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~k 159 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--SK 159 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--EE
Confidence 99999999999986532 4788999999999999999999999999999999999988776 99
Q ss_pred EeecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhc
Q 024336 142 ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV 220 (269)
Q Consensus 142 l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 220 (269)
|+|||++..............+..|+|||.+.+..++. ++|+||||+++|+|++ |..||......... ..+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlG~il~el~t~g~~pf~~~~~~~~~----~~~~~~ 234 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTT-KSDVWSFGVLLWEIVSLGGTPYCGMTCAELY----EKLPQG 234 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHhcC
Confidence 99999886322211112222345799999987766654 4999999999999997 99999765543222 222221
Q ss_pred cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 221 QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 221 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
...+....++..+.++|.+||..+|.+||++++++..+
T Consensus 235 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 272 (297)
T cd05089 235 -YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272 (297)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11222236889999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=290.74 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=202.3
Q ss_pred cccccccceecccCceEEEEEEEe-----cCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
+++|.+.+.||+|+||.||++.+. .++..+|+|.+.... ...+.+.+|+..+++++|||++++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 367999999999999999999863 345678999886432 23456889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEE
Q 024336 76 IVMEYAAGGELFARICSAG-------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKI 142 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l 142 (269)
+++||+++++|.+++...+ .+++..+..++.|++.||++||+.|++||||||+||+++.++. ++|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~kl 161 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKI 161 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EEe
Confidence 9999999999999986543 3899999999999999999999999999999999999998887 999
Q ss_pred eecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHh
Q 024336 143 CDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIR 218 (269)
Q Consensus 143 ~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~ 218 (269)
+|||++........ .....++..|+|||.+.+..++.+ +|+||||+++|+|+| |.+||....... ....+.
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~t~g~~p~~~~~~~~----~~~~i~ 236 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNE----VIECIT 236 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH
Confidence 99998864322211 122334668999999887666554 999999999999998 899997655432 223333
Q ss_pred hccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 219 NVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.... .+.....+.++.+++.+||+.||.+|||+.++++.+
T Consensus 237 ~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l 276 (288)
T cd05093 237 QGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276 (288)
T ss_pred cCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 3322 122236789999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=286.19 Aligned_cols=247 Identities=30% Similarity=0.457 Sum_probs=199.5
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCccc----cHHHHHHHHH-HHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIIN-HRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
++.||+|++|.||+|.+..+++.||+|.+...... ......|... ....+|+|++++++++..++..++++||++
T Consensus 1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 36799999999999999989999999998654221 1223344443 345589999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccC
Q 024336 83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG 162 (269)
Q Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 162 (269)
+++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..... .....+
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCC
Confidence 9999999988888999999999999999999999999999999999999998776 99999998864322 233457
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC--CcCCCCHHHHHHHHH
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQ 240 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~ 240 (269)
+..|+|||.+.+..+ +.++|+||||+++|++++|..||........ ...+......++ ....+++++.++|.+
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 230 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAV----FDNILSRRINWPEEVKEFCSPEAVDLINR 230 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhcccCCCCcccccCCHHHHHHHHH
Confidence 788999999887765 4559999999999999999999976554322 222222222222 122578999999999
Q ss_pred HhhhCCCCCCCc---HHHhhccChhhh
Q 024336 241 IFVADPSKDPHS---RDQKASLVPEEF 264 (269)
Q Consensus 241 ~l~~~p~~Rps~---~~~l~~~~~~~~ 264 (269)
||..+|.+||++ +|++.|+|+...
T Consensus 231 ~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 231 LLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HccCCHHHccCCCcHHHHHcChHhhcC
Confidence 999999999965 799999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=303.13 Aligned_cols=256 Identities=38% Similarity=0.624 Sum_probs=231.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
..|.+.+.||.|.|+.|.++.+..++..||||++.++.-. ...+.+|+++++.++|||||+++.+......+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 4588999999999999999999999999999999875433 3457789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCc
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 159 (269)
|+.+|.+.+++.+.+...+..+..++.|++.|++|||+.+|+|||||++||+++.+-+ ++|+|||++..........+
T Consensus 136 ya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~lqt 213 (596)
T KOG0586|consen 136 YASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLMLQT 213 (596)
T ss_pred eccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccccccc
Confidence 9999999999999999999999999999999999999999999999999999998888 99999999998787888889
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
.++++.|.|||.+.+..+..+..|+||||+++|.|+.|..||.+..- .+...+...+.+..+- -++.++.++|+
T Consensus 214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----k~Lr~rvl~gk~rIp~--~ms~dce~lLr 287 (596)
T KOG0586|consen 214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----KELRPRVLRGKYRIPF--YMSCDCEDLLR 287 (596)
T ss_pred cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc----ccccchheeeeecccc--eeechhHHHHH
Confidence 99999999999999999998889999999999999999999987543 4555555556665555 67889999999
Q ss_pred HHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 240 QIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
++|..+|.+|++.+++.+|.|.....+
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred HhhccCccccCCHHHhhhhcccchhhh
Confidence 999999999999999999999876543
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=284.41 Aligned_cols=243 Identities=27% Similarity=0.386 Sum_probs=195.8
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCch
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
+.||+|+||.||++.+..+++.+|+|.+.... .....+.+|+.+++.++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999999899999999876432 2235688899999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC---CcccC
Q 024336 87 FARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVG 162 (269)
Q Consensus 87 ~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~ 162 (269)
.+++.+.+ .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCCCCCC
Confidence 99986644 5899999999999999999999999999999999999998877 999999988643221111 11122
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHH
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 241 (269)
+..|+|||.+.+..++.+ +|+||||+++|++++ |..||........ ...+... ...+....++..+.+++.+|
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~li~~~ 232 (252)
T cd05084 159 PVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQT----REAIEQG-VRLPCPELCPDAVYRLMERC 232 (252)
T ss_pred ceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHHH----HHHHHcC-CCCCCcccCCHHHHHHHHHH
Confidence 356999999877776555 999999999999998 8888876544222 1122111 11222236789999999999
Q ss_pred hhhCCCCCCCcHHHhhcc
Q 024336 242 FVADPSKDPHSRDQKASL 259 (269)
Q Consensus 242 l~~~p~~Rps~~~~l~~~ 259 (269)
|..+|++|||+.++++.+
T Consensus 233 l~~~p~~Rps~~~~~~~l 250 (252)
T cd05084 233 WEYDPGQRPSFSTVHQEL 250 (252)
T ss_pred cCCChhhCcCHHHHHHHH
Confidence 999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=284.76 Aligned_cols=247 Identities=24% Similarity=0.331 Sum_probs=200.1
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|++|.||++.+..++ .||+|.+.......+.+.+|+.+++.++|+|++++++.+. +...++++||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 368999999999999999999887554 5999998865555567889999999999999999999875 45689999999
Q ss_pred CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC--
Q 024336 82 AGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-- 157 (269)
Q Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~-- 157 (269)
++++|.+++.+. ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeeccccccccc
Confidence 999999999753 34789999999999999999999999999999999999998877 999999988643222211
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
....++..|+|||...+..++.. +|+||||+++|+++| |..||......... ..+... ...+....++..+.+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~l~~ 234 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVL----DQVERG-YRMPCPPECPESLHD 234 (262)
T ss_pred cCCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHH----HHHhcC-CCCCCccccCHHHHH
Confidence 12335567999999877776555 999999999999999 88899765543222 222221 122223368899999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhc
Q 024336 237 LLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~ 258 (269)
+|.+|++.||.+||++.++++.
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~~ 256 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQAF 256 (262)
T ss_pred HHHHHccCCcccCCCHHHHHHH
Confidence 9999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-46 Score=305.83 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=200.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC---ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++..+.+.||+|.||+||++.+..+ ||||.+... ....+.|++|+.++++-+|.||+-+.|++..+.. .+|+.
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 4567889999999999999999744 999998753 3455679999999999999999999999998876 99999
Q ss_pred ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC---C
Q 024336 80 YAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---S 155 (269)
Q Consensus 80 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~---~ 155 (269)
+|+|.+|..+++-. -+|.....+.|++|+++|+.|||.++|+|+|||..|||+.+++. |+|+|||++...... .
T Consensus 468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeeeecccc
Confidence 99999999988543 35899999999999999999999999999999999999998877 999999998632222 2
Q ss_pred CCCcccCCCcccCchhhcc--ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC----CcCC
Q 024336 156 QPKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP----DYVR 229 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~ 229 (269)
......+...|+|||++.. ..+.++.+||||+|+++|||+||..||.. +..+.+.-++ ..+ +..+ ...+
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIifmV---GrG-~l~pd~s~~~s~ 620 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIFMV---GRG-YLMPDLSKIRSN 620 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEEEe---ccc-ccCccchhhhcc
Confidence 2334457788999999874 34456779999999999999999999984 3322221111 111 1122 2346
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 230 VSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
++.++++|+..||+.++++||++.++|..+.
T Consensus 621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~ 651 (678)
T KOG0193|consen 621 CPKAMKRLLSDCWKFDREERPLFPQLLSKLE 651 (678)
T ss_pred CHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence 7789999999999999999999999998543
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=291.66 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=209.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++|++.+.||+|+||.||++.+..++..|++|.+.... ...+.+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 468999999999999999999998889999999986432 3345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 159 (269)
+++++|.+++.+ ..++...+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 98 ~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred CCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceeccccccccccc
Confidence 999999998865 35789999999999999999999999999999999999998877 9999999876432222 1223
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
..+++.|+|||.+....++. ++|+||||+++|++++|..||............ .......+.....++..+.++|.
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred ccCChhhcCchhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---hcCCCCCCCCccccCHHHHHHHH
Confidence 35778899999987766655 499999999999999999999765432221111 11112223333467889999999
Q ss_pred HHhhhCCCCCCCcHHHhhccChhh
Q 024336 240 QIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+||..+|.+||++.+++.|+|+..
T Consensus 251 ~~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 251 RCLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred HHccCChhhCcCHHHHhcCHHHhc
Confidence 999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=285.50 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=200.4
Q ss_pred eecccCceEEEEEEEecCCeEEEEEEeecCccc----cHHHHHHHH---HHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 10 ELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREII---NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 10 ~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
.||+|+||.||++.+..+++.||+|.+...... ......|.. .++...||+++++.+.+..++..++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999998754221 112333433 3444579999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccC
Q 024336 83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG 162 (269)
Q Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 162 (269)
|++|..++.+.+.+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++..... .......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~-~~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-KKPHASVG 157 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCc-cCCcCcCC
Confidence 9999999988888999999999999999999999999999999999999998877 99999998864322 22334568
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
+..|+|||.+.++...+.++|+||+|+++|+|++|..||........ .............++. .++.++.+++.+||
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~--~~s~~~~~li~~~l 234 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPD--SFSPELRSLLEGLL 234 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHHhhccCCCCCC--cCCHHHHHHHHHHh
Confidence 88999999987654344559999999999999999999976533221 1122222223333443 57899999999999
Q ss_pred hhCCCCCC-----CcHHHhhccChhhh
Q 024336 243 VADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 243 ~~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
..+|.+|| ++.++++|+|+..+
T Consensus 235 ~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 235 QRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred hcCHHhccCCCCCCHHHHHhCccccCC
Confidence 99999999 99999999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=288.39 Aligned_cols=258 Identities=28% Similarity=0.475 Sum_probs=212.6
Q ss_pred cccccceecccCceEEEEEEEe---cCCeEEEEEEeecCc-----cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeE
Q 024336 4 RYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK-----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 74 (269)
.|++.+.||.|+||.||.+.+. .+|..||+|++.... ...+.+.+|+.+++++ +|++|+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999985 478999999987532 2235677899999999 589999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
++|+||+++++|.+++....++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccc
Confidence 999999999999999988888999999999999999999999999999999999999998876 999999988643222
Q ss_pred C--CCCcccCCCcccCchhhcccc-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 155 S--QPKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
. ......++..|+|||.+.... ..+.++|+||||+++|+|++|..||...............+.......+. .++
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 236 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMS 236 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCc--cCC
Confidence 1 112345788899999987533 23455999999999999999999997544433444444444443333333 688
Q ss_pred HHHHHHHHHHhhhCCCCCC-----CcHHHhhccChhhhh
Q 024336 232 ADCRHLLSQIFVADPSKDP-----HSRDQKASLVPEEFA 265 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rp-----s~~~~l~~~~~~~~~ 265 (269)
+.+.+++.+||..||.+|| +++++++|+|+..+.
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999999999999999997 889999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=287.81 Aligned_cols=252 Identities=28% Similarity=0.396 Sum_probs=196.8
Q ss_pred cccc-cccceecccCceEEEEEE----EecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeC--C
Q 024336 2 EERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTP--T 72 (269)
Q Consensus 2 ~~~y-~~~~~l~~g~~g~v~~~~----~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~ 72 (269)
.++| ++.+.||+|+||+||++. ...++..||+|.+..... ....+.+|+..++.++|||++++++++... .
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 4667 999999999999998865 335678899999875432 345678899999999999999999987653 4
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
.++++|||+++++|.+++... .+++..++.++.|++.||.+||++|++|+||||+||+++.++. ++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~ 158 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVP 158 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccC
Confidence 689999999999999998654 5899999999999999999999999999999999999998877 9999999986433
Q ss_pred CCCC----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhh-----------HHHHHHHH
Q 024336 153 LHSQ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN-----------FRKTIDRI 217 (269)
Q Consensus 153 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~-----------~~~~~~~~ 217 (269)
.... .....++..|+|||.+.....+.+ +|+||||+++++|+||..||........ ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 2211 122234567999999877666554 9999999999999999999865432100 00011111
Q ss_pred hhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
. .....+....++..+.+++.+||+.+|++|||++++++.
T Consensus 238 ~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~ 277 (283)
T cd05080 238 E-RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPI 277 (283)
T ss_pred h-cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 1 111122233678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=284.93 Aligned_cols=253 Identities=35% Similarity=0.553 Sum_probs=223.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|..++.||+|.||.|-+++.+.+++.||+|++.+.-. ....-..|-++|+..+||.+..+.-.|+..+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 578999999999999999999999999999999876432 2233456888999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~ 157 (269)
||..||.|...+.+.+.+++...+-+...|+.||.|||+++|++||+|.+|.+++.+|+ +||+|||+++..... ...
T Consensus 248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t~ 325 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDTT 325 (516)
T ss_pred EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhccccccee
Confidence 99999999999988888999999999999999999999999999999999999999999 999999999854443 345
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
.+.+|||.|+|||++....+... .|.|.+|+++|+|++|..||.+.+.. .+.+-+.-.+..+|. .++++.+.|
T Consensus 326 kTFCGTPEYLAPEVleDnDYgra-VDWWG~GVVMYEMmCGRLPFyn~dh~----kLFeLIl~ed~kFPr--~ls~eAktL 398 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRA-VDWWGVGVVMYEMMCGRLPFYNKDHE----KLFELILMEDLKFPR--TLSPEAKTL 398 (516)
T ss_pred ccccCChhhcCchhhccccccce-eehhhhhHHHHHHHhccCcccccchh----HHHHHHHhhhccCCc--cCCHHHHHH
Confidence 67899999999999998887544 99999999999999999999887663 344455556677777 899999999
Q ss_pred HHHHhhhCCCCCCC-----cHHHhhccChhhh
Q 024336 238 LSQIFVADPSKDPH-----SRDQKASLVPEEF 264 (269)
Q Consensus 238 i~~~l~~~p~~Rps-----~~~~l~~~~~~~~ 264 (269)
+..+|.+||.+|.. +.++.+|.||..+
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 99999999999974 7899999998764
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=289.81 Aligned_cols=245 Identities=34% Similarity=0.485 Sum_probs=193.8
Q ss_pred cccceecccCceEEEEEEEe----cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 6 EPVKELGSGNFGVARLVRDK----RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 6 ~~~~~l~~g~~g~v~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++.+.||.|.||.||+|... ..+..|++|.+..... ..+.+.+|++.+++++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 45789999999999999998 4567899999954322 24678899999999999999999999998888999999
Q ss_pred ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--
Q 024336 80 YAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-- 155 (269)
Q Consensus 80 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-- 155 (269)
|+++++|.+++... ..+++..+..++.|++.||.|||+++++|++|+++||+++.++. +||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccc
Confidence 99999999999886 67999999999999999999999999999999999999998886 9999999887542111
Q ss_pred -CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 156 -QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
..........|+|||.+.+..+ +.++||||||+++|++++ |..||....... ....+.... ..+....++..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~ 233 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEE----IIEKLKQGQ-RLPIPDNCPKD 233 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH----HHHHHHTTE-ETTSBTTSBHH
T ss_pred ccccccccccccccccccccccc-ccccccccccccccccccccccccccccccc----ccccccccc-cceeccchhHH
Confidence 1223345678999999987776 445999999999999999 679987764422 222222222 22333378999
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
+.++|.+||+.||.+|||+.++++.
T Consensus 234 ~~~li~~C~~~~p~~RPs~~~i~~~ 258 (259)
T PF07714_consen 234 IYSLIQQCWSHDPEKRPSFQEILQE 258 (259)
T ss_dssp HHHHHHHHT-SSGGGS--HHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHhc
Confidence 9999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=296.26 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=198.7
Q ss_pred cccccccceecccCceEEEEEEEe-----cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeC-C
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTP-T 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~ 72 (269)
+++|++.+.||+|+||.||++.+. .+++.||+|.+..... ..+.+..|+.+++++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 468999999999999999999754 3457899998864322 224567899999999 799999999988654 5
Q ss_pred eEEEEEeecCCCchHHHHHhc-----------------------------------------------------------
Q 024336 73 HLAIVMEYAAGGELFARICSA----------------------------------------------------------- 93 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~----------------------------------------------------------- 93 (269)
.+++++||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 789999999999999888542
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC---CCcccCCCcccC
Q 024336 94 --GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIA 168 (269)
Q Consensus 94 --~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~a 168 (269)
.++++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++........ .....++..|+|
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCccccC
Confidence 25788999999999999999999999999999999999998776 99999999874322211 122334567999
Q ss_pred chhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCC
Q 024336 169 PEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPS 247 (269)
Q Consensus 169 PE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 247 (269)
||.+.+..++.+ +|+|||||++|+|++ |..||............. .... ........++++.+++.+||+.+|+
T Consensus 244 PE~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 244 PESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL---KEGT-RMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred cHHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH---hccC-CCCCCccCCHHHHHHHHHHccCChh
Confidence 999988777665 999999999999998 999997654433322222 1111 1112236788999999999999999
Q ss_pred CCCCcHHHhhcc
Q 024336 248 KDPHSRDQKASL 259 (269)
Q Consensus 248 ~Rps~~~~l~~~ 259 (269)
+||++.++++++
T Consensus 319 ~RPs~~ell~~l 330 (337)
T cd05054 319 DRPTFSELVEIL 330 (337)
T ss_pred hCcCHHHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=289.44 Aligned_cols=255 Identities=27% Similarity=0.389 Sum_probs=204.4
Q ss_pred cccccccceecccCceEEEEEEEecCC----------------eEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcce
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTK----------------ELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIR 63 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~----------------~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~ 63 (269)
.++|++++.||+|+||.||++.+...+ ..||+|.+.... ...+.+.+|+.++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 468999999999999999999876543 568999887543 23456788999999999999999
Q ss_pred eeEEEEeCCeEEEEEeecCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe
Q 024336 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAG-----------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL 132 (269)
Q Consensus 64 ~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i 132 (269)
+++++..+...++++|++++++|.+++.+.. .+++..++.++.|++.||.+||+.|++|+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 9999999999999999999999999987765 68999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCcccCCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh--CCCCCCCCCCh
Q 024336 133 DGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV--GAYPFEDPEDP 207 (269)
Q Consensus 133 ~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t--g~~pf~~~~~~ 207 (269)
+.++. ++|+|||++....... ......+++.|+|||.+.+..++.. +|+||||+++|++++ +..||......
T Consensus 164 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 164 GKNYT--IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred cCCCc--eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc-chhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 98877 9999999886432221 1223345678999999887666544 999999999999998 67888765544
Q ss_pred hhHHHHHHHHhhc--cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 208 RNFRKTIDRIRNV--QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 208 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
............. ....+....+|.++.++|.+||+.||.+|||+.+++..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 3333332211111 112223335778999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=292.64 Aligned_cols=255 Identities=24% Similarity=0.325 Sum_probs=199.9
Q ss_pred cccccceecccCceEEEEEEEec--CCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKR--TKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTP--THLA 75 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~--~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (269)
+|++.+.||+|++|.||++.+.. ++..||+|.+.... ...+...+|+.+++.++|||++++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 88999999987632 2345678899999999999999999999988 7899
Q ss_pred EEEeecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC----CCCCcEEEeecC
Q 024336 76 IVMEYAAGGELFARICSA-----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG----SPQPRLKICDFG 146 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~----~~~~~~~l~df~ 146 (269)
+|+|++++ ++.+.+... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++. ++. ++|+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~--~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV--VKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce--EEECCCc
Confidence 99999976 666665432 26899999999999999999999999999999999999987 555 9999999
Q ss_pred CcccCCCCCC----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChh---------hHHHH
Q 024336 147 YSKSGLLHSQ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR---------NFRKT 213 (269)
Q Consensus 147 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~---------~~~~~ 213 (269)
++........ .....+++.|+|||.+.+....+.++|+||||+++++|++|.+||....... .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 8874322221 2233567889999988765544556999999999999999999997654322 11111
Q ss_pred HHHHh---------------------h-ccccCC---------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 214 IDRIR---------------------N-VQYFLP---------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 214 ~~~~~---------------------~-~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
...+. . .....+ .....+.++.++|.+||..||++|||+.|++.|+||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 11000 0 000000 011456789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=287.89 Aligned_cols=251 Identities=20% Similarity=0.294 Sum_probs=202.1
Q ss_pred ccccccceecccCceEEEEEEEec-----CCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
++|++.+.||+|++|.||++.+.. ++..|++|.+..... ....+..|+..++.++|+|++++++++.+....+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 679999999999999999999987 678899998764322 2345788999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC-CcEEEeecCC
Q 024336 76 IVMEYAAGGELFARICSAG-------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGY 147 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~-~~~~l~df~~ 147 (269)
+++||+++++|.+++...+ .+++..+..++.|++.||++||+.+++|+||+|+||+++.++. ..++|+|||+
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence 9999999999999987653 4889999999999999999999999999999999999986542 3489999998
Q ss_pred cccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhcccc
Q 024336 148 SKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYF 223 (269)
Q Consensus 148 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (269)
+........ ......+..|+|||.+.+..++.+ +||||||+++|+|++ |..||.......... .... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~~~-~~~~--~~~~~ 241 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVME-FVTG--GGRLD 241 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHc--CCcCC
Confidence 874321111 112223457999999987776555 999999999999997 999998755433221 1111 11222
Q ss_pred CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 224 LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
. ...++..+.+++.+||+.+|.+|||+.++++++
T Consensus 242 ~--~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 242 P--PKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred C--CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence 2 236889999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=284.99 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=203.3
Q ss_pred cccccccceecccCceEEEEEEEecC---CeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
.++|++.+.||+|+||.||++.+..+ ...||+|.+..... ....+.+|+..++.++|||++++++.+...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 36899999999999999999998643 45799998865432 23457789999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 77 VMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
++||+++++|.+++... +.+++..+..++.|++.|+.+||++|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhcccccc
Confidence 99999999999998664 46899999999999999999999999999999999999998887 9999999987543111
Q ss_pred C---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 156 Q---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 156 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
. ......+..|+|||.+.+..++.+ +|+||||+++|++++ |..||........ ...+... ...+....++
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~----~~~~~~~-~~~~~~~~~~ 234 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDV----IKAVEDG-YRLPPPMDCP 234 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHH----HHHHHcC-CCCCCCCCCC
Confidence 1 112234567999999887766554 999999999999998 9999976554322 2222222 2223334788
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+.+.+++.+||+.+|++||++.++++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=284.51 Aligned_cols=251 Identities=33% Similarity=0.503 Sum_probs=206.4
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+|++.+.||+|++|.||++.+..+|..+|+|.+.... ...+.+.+|+..++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5899999999999999999999999999999986532 3345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-C
Q 024336 81 AAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-P 157 (269)
Q Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~ 157 (269)
+++++|.+++.... .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. .++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence 99999999986643 4789999999999999999999999999999999999987754 369999998864332221 1
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....+++.|+|||.+.+..++.+ +|+||||++++++++|..||......... ........ .+....++.++.++
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~ 233 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLV----LKICQGYF-APISPNFSRDLRSL 233 (257)
T ss_pred cccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHH----HHHhcccC-CCCCCCCCHHHHHH
Confidence 23357888999999877666544 99999999999999999999765432222 22222211 11223578899999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccCh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
|.+||..+|++|||+.++++|+|+
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=281.85 Aligned_cols=250 Identities=33% Similarity=0.484 Sum_probs=205.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc------cccHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK------KIDENVQREIINHRSLRHPNIIRFKEVLLTP--THL 74 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 74 (269)
++|++.+.||+|++|.||++.+..+++.|++|.+.... .....+.+|+.++++++|+|++++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 68999999999999999999999999999999875321 1224677899999999999999999998764 468
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
++++|++++++|.+.+.+.+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECccccccccccc
Confidence 999999999999999988778999999999999999999999999999999999999998777 999999988643221
Q ss_pred ----CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh-ccccCCCcCC
Q 024336 155 ----SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQYFLPDYVR 229 (269)
Q Consensus 155 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 229 (269)
.......++..|+|||.+.+..++. ++|+||||++++++++|..||......... ...... .....+. .
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~p~--~ 233 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGR-KADVWSVACTVVEMLTEKPPWAEYEAMAAI---FKIATQPTKPMLPD--G 233 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCc-cccHHHHHHHHHHHHhCCCCCCccCHHHHH---HHHHcCCCCCCCCc--c
Confidence 1112335778899999998766644 499999999999999999999765433222 221111 1122333 6
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 230 VSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
+++.+.++|.+||. +|..||++.+++.|||.
T Consensus 234 ~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 234 VSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred cCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 88999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=283.12 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=202.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|+||.||++... +++.||+|.+.......+.+.+|+.++++++|+|++++++++. .+..++++|++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 578999999999999999999865 5678999998876666678899999999999999999999864 45689999999
Q ss_pred CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC--C
Q 024336 82 AGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--P 157 (269)
Q Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~--~ 157 (269)
.+++|.+.+... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCcccc
Confidence 999999988653 35899999999999999999999999999999999999998887 99999998864331111 1
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
....++..|+|||.+....++.+ +|+||||+++|++++ |..||........... +.. ....+.....+.++.+
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN----LER-GYRMPRPDNCPEELYE 234 (260)
T ss_pred cCCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCChHHHHHH----HHc-CCCCCCCCCCCHHHHH
Confidence 12234568999999877666544 999999999999999 9999987654333222 221 1222333467889999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhcc
Q 024336 237 LLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+|.+||..+|++||++++++..+
T Consensus 235 li~~~l~~~p~~Rp~~~~l~~~l 257 (260)
T cd05067 235 LMRLCWKEKPEERPTFEYLRSVL 257 (260)
T ss_pred HHHHHccCChhhCCCHHHHHHHh
Confidence 99999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=285.44 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=208.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+=|++.+.||.|+||.||++.+..++..+|+|.+.... .....+.+|+..+++++|||++++++.+..+...++|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45889999999999999999998889999999876432 2234678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 159 (269)
+++++|.+++.+ ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhcc
Confidence 999999988854 46899999999999999999999999999999999999998877 9999999876432221 1223
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cCCCcCCCCHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSADCRHLL 238 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 238 (269)
..++..|+|||.+.+...+.. +|+||||++++++++|..||......... ..+..... ..+ ..++.++.++|
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~~i 233 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKVL----FLIPKNNPPTLE--GNYSKPLKEFV 233 (277)
T ss_pred ccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccchHHHH----HHHhcCCCCCCC--cccCHHHHHHH
Confidence 356778999999877666444 99999999999999999999764432222 11222111 122 25788999999
Q ss_pred HHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 239 SQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
.+||..+|.+||++.+++.|+|+.....
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 234 EACLNKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred HHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence 9999999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=296.45 Aligned_cols=259 Identities=26% Similarity=0.393 Sum_probs=206.5
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPT----- 72 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 72 (269)
+.++|++.+.||+|++|.||++.+..++..||+|.+..... ....+.+|+.+++.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 35789999999999999999999999999999998864322 2345778999999999999999999987654
Q ss_pred -eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 73 -HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 73 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
.+++|++++ +++|..++. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeccccccc
Confidence 368999998 668887775 457899999999999999999999999999999999999998877 999999988743
Q ss_pred CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh------------
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN------------ 219 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~------------ 219 (269)
. .......+++.|+|||.+.+....+.++|+||||+++|++++|..||..................
T Consensus 169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07880 169 D--SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246 (343)
T ss_pred c--cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence 2 22233456788999999876444456699999999999999999999866543333222111000
Q ss_pred --------cc-cc---C-CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 220 --------VQ-YF---L-PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 220 --------~~-~~---~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.. .. + .-...+++.+.++|.+||..||.+|||+.+++.|+|+..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 00 00 0 00125678899999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=292.87 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=200.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeE----EEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKEL----VAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~----vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
..+|++.+.||+|+||.||++.+..++.. ||+|.+.... ...+.+.+|+..++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 36799999999999999999998665553 8999886432 2345678899999999999999999998765 567
Q ss_pred EEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 76 IVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
++++++.+|+|.+.+.... .++...+..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++......
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~~ 162 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAD 162 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccCC
Confidence 9999999999999987643 5889999999999999999999999999999999999998887 999999998743322
Q ss_pred CCC---CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 155 SQP---KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 155 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
... .....+..|+|||.+....++.+ +|+||||+++|++++ |..||.+..... .. .+.......+....+
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~~-~~----~~~~~~~~~~~~~~~ 236 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE-IS----SILEKGERLPQPPIC 236 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHH-HH----HHHhCCCCCCCCCCC
Confidence 221 12223567999999987776555 999999999999998 999997654322 11 122222233333467
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
+.++.+++.+||..+|.+||++.+++.++.
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~l~ 266 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIEFS 266 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 889999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=287.13 Aligned_cols=249 Identities=20% Similarity=0.273 Sum_probs=199.1
Q ss_pred cccccccceecccCceEEEEEEEec-----CCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
.++|++.+.||+|++|.||++.+.. ++..||+|.+..... ....+.+|+.+++.++|+|++++++++......
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 5789999999999999999998642 356799998754322 234577899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEee
Q 024336 75 AIVMEYAAGGELFARICSAG----------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICD 144 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~d 144 (269)
++|+||+++++|.+++.+.. .++...+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l~d 162 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGD 162 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEECC
Confidence 99999999999999986532 2567889999999999999999999999999999999998877 99999
Q ss_pred cCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhc
Q 024336 145 FGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV 220 (269)
Q Consensus 145 f~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 220 (269)
||++........ .....+++.|+|||.+.+..++.. +|+||||+++|+|++ |..||......... ..+...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~~~~~~~~~~----~~~~~~ 237 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVL----RFVMEG 237 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHcC
Confidence 998863222111 112334678999999987666554 999999999999999 78898765443222 222222
Q ss_pred c-ccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 221 Q-YFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 221 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
. ...+ ...+..+.++|.+||+.||.+|||+.++++++
T Consensus 238 ~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 238 GLLDKP--DNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred CcCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 2 1223 36788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=288.23 Aligned_cols=254 Identities=30% Similarity=0.425 Sum_probs=206.0
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
|++.+.||+|++|.||++.+..+++.+++|.+..... ....+.+|+..+++++|+|++++++++..+...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 7788999999999999999998999999998865432 2456778999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCc
Q 024336 82 AGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS 159 (269)
Q Consensus 82 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 159 (269)
++ ++.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCcccccC
Confidence 76 77777755 457899999999999999999999999999999999999998877 9999999886443332 2223
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc---------------ccC
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ---------------YFL 224 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~ 224 (269)
..++..|.|||.+.+....+.++|+||||+++|+++||..||...+..+............. ...
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 45677899999988764445669999999999999999999977665444333322211100 000
Q ss_pred C---------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 225 P---------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 225 ~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
+ ....++.++.++|.+||..||.+||++.+++.|+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0 012467889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=282.67 Aligned_cols=252 Identities=28% Similarity=0.392 Sum_probs=205.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|++|.||++.+..+|+.||+|.+.... ...+.+.+|+..+++++|++++++++.+..++..++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999999899999999886422 22456888999999999999999999999999999999
Q ss_pred eecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 79 EYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 79 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
||+++++|..++.. ...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccCC
Confidence 99999999988854 245899999999999999999999999999999999999998887 999999987643222
Q ss_pred C-CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 155 S-QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
. ......+++.|.|||.+.+..++.+ +|+||||+++|+|++|..||..... ........+............++..
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEKCDYPPLPADHYSEE 236 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCc--cHHHHHhhhhcCCCCCCChhhcCHH
Confidence 2 2233457788999999887766555 9999999999999999999965432 2223333333222211112257789
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+.++|.+||..+|.+|||+.++++.+
T Consensus 237 ~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 237 LRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 99999999999999999999988754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=281.44 Aligned_cols=245 Identities=26% Similarity=0.400 Sum_probs=203.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
++|++.+.||.|++|.||++... |+.||+|.+.......+.+.+|+.+++.++|+|++++++++.+....++|+|+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 57999999999999999999875 7889999987665445678899999999999999999999999899999999999
Q ss_pred CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcc
Q 024336 83 GGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST 160 (269)
Q Consensus 83 ~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (269)
+++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...... ....
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~--~~~~ 159 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQG--QDSG 159 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEcccccccccccc--cccC
Confidence 999999997665 6899999999999999999999999999999999999998877 999999988754221 1233
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
..+..|.|||.+.+..+..+ +|+||||++++++++ |..||....... ....+.. .........+++.+.++|.
T Consensus 160 ~~~~~~~ape~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05039 160 KLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPHVEK-GYRMEAPEGCPPEVYKVMK 233 (256)
T ss_pred CCcccccCchhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHhc-CCCCCCccCCCHHHHHHHH
Confidence 34567999999877666554 999999999999997 999997654322 2222222 1122223367899999999
Q ss_pred HHhhhCCCCCCCcHHHhhcc
Q 024336 240 QIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~ 259 (269)
+||..+|.+|||+.++++.+
T Consensus 234 ~~l~~~p~~Rp~~~~l~~~l 253 (256)
T cd05039 234 DCWELDPAKRPTFKQLREQL 253 (256)
T ss_pred HHhccChhhCcCHHHHHHHH
Confidence 99999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=290.28 Aligned_cols=252 Identities=25% Similarity=0.450 Sum_probs=206.5
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
|.....||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+..++.++|||++++++.+..++..++++||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 555678999999999999999889999999986432 3345678899999999999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCcccC
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~ 162 (269)
++|...+.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ......+
T Consensus 103 ~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~ 179 (297)
T cd06659 103 GALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLVG 179 (297)
T ss_pred CCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccceec
Confidence 999887744 56899999999999999999999999999999999999998887 9999999886322221 1223457
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc-cccCCCcCCCCHHHHHHHHHH
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRHLLSQI 241 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 241 (269)
+..|+|||.+.+..++. ++|+||||+++++|++|..||.......... .+... .........++..+.++|.+|
T Consensus 180 ~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 180 TPYWMAPEVISRTPYGT-EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK----RLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred CccccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhccCCCCccccCCCCHHHHHHHHHH
Confidence 88999999998776644 4999999999999999999997654433222 22211 112222336788999999999
Q ss_pred hhhCCCCCCCcHHHhhccChhhh
Q 024336 242 FVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 242 l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
|..+|.+||++.+++.|+|+...
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred hcCCcccCcCHHHHhhChhhccC
Confidence 99999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=281.17 Aligned_cols=249 Identities=35% Similarity=0.525 Sum_probs=209.2
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+|++.+.||.|++|.||++.+..++..+++|.+.... .....+.+|++.++.++|+|++++.+.+......++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5899999999999999999999899999999987543 2345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-
Q 024336 81 AAGGELFARICSA----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS- 155 (269)
Q Consensus 81 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~- 155 (269)
+++++|.+.+.+. ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcc
Confidence 9999999998764 67999999999999999999999999999999999999998777 9999999886433322
Q ss_pred CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-ccCCCcCCCCHHH
Q 024336 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRVSADC 234 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (269)
......+++.|+|||.+.....+.+ +|+||+|+++++|++|..||....... ......... ...+. .++..+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~--~~~~~~ 231 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLE----LALKILKGQYPPIPS--QYSSEL 231 (258)
T ss_pred eecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcHHH----HHHHHhcCCCCCCCC--CCCHHH
Confidence 2233457888999999877766554 999999999999999999997654322 222222221 12222 688999
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.+++.+||..+|.+||++.++++|+|+
T Consensus 232 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 232 RNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=283.31 Aligned_cols=252 Identities=29% Similarity=0.434 Sum_probs=200.7
Q ss_pred cccceecccCceEEEEEEEecCCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCC
Q 024336 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG 84 (269)
Q Consensus 6 ~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (269)
.....||+|+||.||++.+..++..|++|.+..... ..+.+.+|+.+++.++|+|++++++++..++..++++||++++
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 345689999999999999998999999998865432 3456889999999999999999999999999999999999999
Q ss_pred chHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCcc
Q 024336 85 ELFARICSA-GRF--SEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKST 160 (269)
Q Consensus 85 ~l~~~~~~~-~~~--~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~~ 160 (269)
+|.+.+... ..+ ++..+..++.|++.||++||+.|++|+||+|+||+++.+.. .++|+|||.+....... .....
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~ 169 (268)
T cd06624 91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG-VVKISDFGTSKRLAGINPCTETF 169 (268)
T ss_pred CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC-eEEEecchhheecccCCCccccC
Confidence 999998764 445 88889999999999999999999999999999999976332 39999999886432211 12233
Q ss_pred cCCCcccCchhhcccc-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
.+++.|+|||.+.... ..+.++|+||+|+++|++++|..||............ ..........+. .+++++.+++.
T Consensus 170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~li~ 246 (268)
T cd06624 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPE--SLSAEAKNFIL 246 (268)
T ss_pred CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCc--ccCHHHHHHHH
Confidence 5788999999986543 2345599999999999999999999764432221111 111111222233 67889999999
Q ss_pred HHhhhCCCCCCCcHHHhhccCh
Q 024336 240 QIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
+||..+|.+|||+.+++.|+|+
T Consensus 247 ~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 247 RCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999995
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=286.24 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=201.9
Q ss_pred cccccccceecccCceEEEEEEEecC-----CeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRT-----KELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
.++|++.+.||+|+||.||++.+... +..||+|.+.... .....+.+|+.+++.++|+|++++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 47899999999999999999998643 4789999986443 2234577899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEee
Q 024336 75 AIVMEYAAGGELFARICSAG----------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICD 144 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~d 144 (269)
++++||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl~d 162 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGD 162 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEECC
Confidence 99999999999999986432 3678899999999999999999999999999999999998887 99999
Q ss_pred cCCcccCCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhc
Q 024336 145 FGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV 220 (269)
Q Consensus 145 f~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 220 (269)
||++....... ......++..|+|||.+.+..++.+ +|+||||+++|+++| |..||......... ..+...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~----~~~~~~ 237 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVL----KFVIDG 237 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCCHHHHH----HHHhcC
Confidence 99886432221 1223345678999999877766554 999999999999998 99999765443222 222222
Q ss_pred cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 221 QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 221 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
...+....++..+.++|.+||..+|++|||+.++++.+
T Consensus 238 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 275 (277)
T cd05032 238 -GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275 (277)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence 12222236789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=286.25 Aligned_cols=249 Identities=22% Similarity=0.355 Sum_probs=199.5
Q ss_pred ccccccceecccCceEEEEEEEe----cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDK----RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
.+|++.+.||+|+||.||++... .++..+++|.+..... ....+.+|+.+++.++|||++++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46899999999999999999853 3567899998864322 22457889999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCc
Q 024336 77 VMEYAAGGELFARICSA-----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR 139 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~ 139 (269)
+|||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~-- 162 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-- 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc--
Confidence 99999999999988532 23688899999999999999999999999999999999998877
Q ss_pred EEEeecCCcccCCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHH
Q 024336 140 LKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTID 215 (269)
Q Consensus 140 ~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~ 215 (269)
++|+|||++....... ......++..|+|||.+.+..++. ++|+||||+++|+|++ |..||...... ....
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~~g~~p~~~~~~~----~~~~ 237 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS-DSDIWSFGVVLWEIFSFGLQPYYGFSNQ----EVIE 237 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHH
Confidence 9999999986432221 122233456799999987766644 4999999999999998 88999765432 2222
Q ss_pred HHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 216 RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+.. ....+.+..+++.+.+++.+||+.||.+||++.++++++
T Consensus 238 ~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 238 MVRK-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 2222 222233347899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=295.65 Aligned_cols=262 Identities=27% Similarity=0.365 Sum_probs=204.1
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeC--------
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTP-------- 71 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------- 71 (269)
+..+|++.+.||.|++|.||++.+..+|..||+|.+.... ...+.+.+|+.+++.++|||++++++.+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 4679999999999999999999999999999999886543 3345678899999999999999999776543
Q ss_pred ------CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeec
Q 024336 72 ------THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDF 145 (269)
Q Consensus 72 ------~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df 145 (269)
...++++||+++ +|.+.+. .+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. .++|+||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~df 159 (342)
T cd07854 83 GSLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDF 159 (342)
T ss_pred ccccccceEEEEeecccc-cHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCc
Confidence 357999999974 8887774 456899999999999999999999999999999999999975432 3899999
Q ss_pred CCcccCCCCC----CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh--
Q 024336 146 GYSKSGLLHS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-- 219 (269)
Q Consensus 146 ~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~-- 219 (269)
|.+....... ......++..|+|||.+......+.++|+||||+++|+|++|..||..................
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9886432111 1122346778999998766554556699999999999999999999766543333222211100
Q ss_pred -------------------ccccCC---CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 220 -------------------VQYFLP---DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 220 -------------------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.....+ -...++.++.+||.+||..||.+|||+.+++.|+|++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 000000 0124678899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=281.98 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=200.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|++|.||++.+. ++..+|+|.+.......+.+.+|+.++++++|++++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 478999999999999999999876 4566999998776555677899999999999999999999875 45688999999
Q ss_pred CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC--
Q 024336 82 AGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-- 157 (269)
Q Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~-- 157 (269)
++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce--EEeCCceeeeeccCcccccc
Confidence 999999998653 35899999999999999999999999999999999999998776 999999998643222111
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
....++..|+|||.+.+..++.+ +|+||||+++|++++ |..||......... ..+... ...+.....+..+.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~ 234 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVL----EQVERG-YRMPCPQDCPISLHE 234 (260)
T ss_pred cCCCCCccccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHHcC-CCCCCCCcCCHHHHH
Confidence 11224457999999877666544 999999999999999 88999765443222 222221 222333468899999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhcc
Q 024336 237 LLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
++.+||.++|.+|||++++.+.+
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~~l 257 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQSFL 257 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHH
Confidence 99999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=294.88 Aligned_cols=261 Identities=30% Similarity=0.423 Sum_probs=207.7
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecC---ccccHHHHHHHHHHHhC-CCCCcceeeEEEEeC--CeE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSL-RHPNIIRFKEVLLTP--THL 74 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~ 74 (269)
+.++|++.+.||+|++|.||++.+..+++.+|+|.+... ......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 357899999999999999999999988999999987542 22334567899999999 999999999998654 368
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
++|+||+++ +|...+... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 85 ~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSEL 160 (337)
T ss_pred EEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhccccc
Confidence 999999975 888888665 7889999999999999999999999999999999999998887 999999988643222
Q ss_pred C------CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh---------
Q 024336 155 S------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN--------- 219 (269)
Q Consensus 155 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~--------- 219 (269)
. ......++..|+|||.+.+....+.++|+||||+++|+|+||.+||..................
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 1 1122346788999998876555566699999999999999999999766554433322211100
Q ss_pred --------------ccc--cCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 220 --------------VQY--FLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 220 --------------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
... .......++.++.++|.+||+.||.+|||+.+++.|+|+..+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 000 0001123688999999999999999999999999999998774
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=293.98 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=202.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc-cHHHHHHHHHHHhCCCCCcceeeEEEEeCC-eEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSLRHPNIIRFKEVLLTPT-HLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e~ 80 (269)
+.|.....||+|+||.||++.-.+ |..||||.+...... ..+|.+|+.++.+++|||+|+++|+|.+.+ ..++|+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy 153 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY 153 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence 467777899999999999999875 488999988765544 566999999999999999999999999998 59999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-C
Q 024336 81 AAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSME---ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-H 154 (269)
Q Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~---i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~ 154 (269)
+++|+|.+.+.... ++++.....|+..+|.||+|||... |+||||||+||++|.+.. +||+|||++..... .
T Consensus 154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEGD 231 (361)
T ss_pred cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCccc
Confidence 99999999997655 8999999999999999999999865 999999999999998888 99999999975443 3
Q ss_pred CCCCcc-cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCC--ChhhHHH-HHHHHhhc---cccCCCc
Q 024336 155 SQPKST-VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE--DPRNFRK-TIDRIRNV---QYFLPDY 227 (269)
Q Consensus 155 ~~~~~~-~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~--~~~~~~~-~~~~~~~~---~~~~~~~ 227 (269)
...... .+|..|+|||.+..+..+.+ +||||+|++++|++||+.+..... ....+.. ....+... .+.-+..
T Consensus 232 ~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l 310 (361)
T KOG1187|consen 232 TSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL 310 (361)
T ss_pred cceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence 333333 78999999999988777666 999999999999999998887543 2222222 11222221 1111111
Q ss_pred --CCCC--H---HHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 228 --VRVS--A---DCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 228 --~~~~--~---~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
...+ . .+..+..+|++.+|.+||++.|+++.+
T Consensus 311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 1333 2 256778899999999999999997766
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=297.97 Aligned_cols=260 Identities=24% Similarity=0.399 Sum_probs=208.1
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCe----
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTH---- 73 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 73 (269)
+.++|++...||+|++|.||++.+..++..||+|.+.... .....+.+|+.+++.++|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3578999999999999999999999999999999886432 223456679999999999999999998876554
Q ss_pred --EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 74 --LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 74 --~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
.++|+|++ +++|.+++.. .++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEccccccccc
Confidence 89999999 5589888854 56899999999999999999999999999999999999998877 999999998743
Q ss_pred CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc----------
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ---------- 221 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---------- 221 (269)
. .......++..|+|||.+.+....+.++|+||||+++|++++|..||........+...........
T Consensus 169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07851 169 D--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246 (343)
T ss_pred c--ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence 2 2233445678899999987654445669999999999999999999987655433333222110000
Q ss_pred ----------cc----C-CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 222 ----------YF----L-PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 222 ----------~~----~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
.. + ......++.+.++|.+||..||.+|||+.+++.|+|+..+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 00 0 001245889999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=287.11 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=201.1
Q ss_pred cccccccceecccCceEEEEEEEe-----cCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
..+|.+.+.||+|+||.||++... .++..+++|.+.... ...+.+.+|+..++.++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 357899999999999999999753 356789999876432 23456889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcE
Q 024336 76 IVMEYAAGGELFARICSAG---------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRL 140 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~ 140 (269)
+++||+++++|.+++...+ .+++..+..++.|++.|+++||+.|++|+||+|+||+++.++. +
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~--~ 161 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV--V 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC--E
Confidence 9999999999999987643 3788999999999999999999999999999999999998776 9
Q ss_pred EEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHH
Q 024336 141 KICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDR 216 (269)
Q Consensus 141 ~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~ 216 (269)
+|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |.+||.......... .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~----~ 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE----C 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHHH----H
Confidence 9999998864322211 122234578999999887776555 999999999999998 899997655433222 2
Q ss_pred HhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+.... .......+++.+.++|.+||+.||.+||++.++++.+
T Consensus 237 ~~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l 278 (280)
T cd05092 237 ITQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278 (280)
T ss_pred HHcCc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 22211 1222236889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=291.16 Aligned_cols=257 Identities=24% Similarity=0.353 Sum_probs=200.8
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeC-------
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTP------- 71 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 71 (269)
.++|++.+.||+|++|.||++.+..+++.+|+|.+..... ......+|+.+++.++|+|++++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 3689999999999999999999999999999998864322 234567899999999999999999987543
Q ss_pred -CeEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 72 -THLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 72 -~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
..++++++|+.+ ++...+.. ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccch
Confidence 347999999976 56666544 457999999999999999999999999999999999999998887 9999999886
Q ss_pred cCCCCCCC------------CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 024336 150 SGLLHSQP------------KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI 217 (269)
Q Consensus 150 ~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~ 217 (269)
........ ....+++.|+|||.+.+....+.++|+||||+++|+|++|.+||................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 32221111 112356789999988765544556999999999999999999998766544443333221
Q ss_pred hhccc-cC------------------C-----CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 218 RNVQY-FL------------------P-----DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 218 ~~~~~-~~------------------~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
..... .+ + .....++.+.++|.+||..||.+|||+.+++.|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 11000 00 0 012345678899999999999999999999999996
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=280.67 Aligned_cols=241 Identities=25% Similarity=0.345 Sum_probs=193.1
Q ss_pred eecccCceEEEEEEE--ecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCC
Q 024336 10 ELGSGNFGVARLVRD--KRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG 84 (269)
Q Consensus 10 ~l~~g~~g~v~~~~~--~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (269)
.||+|+||.||++.+ ..++..+|+|++..... ..+.+.+|+..++.++|||++++++++. .+..++|+||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999965 45678899998864322 2346788999999999999999999875 45678999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC----CCcc
Q 024336 85 ELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKST 160 (269)
Q Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~----~~~~ 160 (269)
+|.+++...+.+++..+..++.|++.||.+||+.|++|+||||.||+++.++. ++|+|||++........ ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe--EEECCCccccccCCCCCeeeecCCC
Confidence 99999988788999999999999999999999999999999999999998776 99999999864322221 1122
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
.++..|+|||.+.....+. ++|+||||+++|+|++ |..||....... ....+..... .+.+..+++++.++|.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~i~~~~~-~~~~~~~~~~l~~li~ 232 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSS-KSDVWSFGVLMWEAFSYGQKPYKGMKGNE----VTQMIESGER-MECPQRCPPEMYDLMK 232 (257)
T ss_pred CCCccccCHhHhccCCcCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHCCCC-CCCCCCCCHHHHHHHH
Confidence 2346899999987665544 4999999999999998 999997654422 2222232221 1222368999999999
Q ss_pred HHhhhCCCCCCCcHHHhhcc
Q 024336 240 QIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~ 259 (269)
+||..||.+||++.++.+.+
T Consensus 233 ~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 233 LCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred HHhccCchhCcCHHHHHHHH
Confidence 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=282.68 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=204.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|++|.||++.+. ++..+|+|.+.......+.+.+|+..++.++|+|++++++++......++++|++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 578999999999999999999976 4577999998876666678999999999999999999999999988999999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC--C
Q 024336 82 AGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--P 157 (269)
Q Consensus 82 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~--~ 157 (269)
++++|.+++.... .++...+..++.+++.|+.+||++|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhhhh
Confidence 9999999997643 6899999999999999999999999999999999999998877 99999998864322111 1
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+..|+|||.+.+...+. ++|+||||++++++++ |..||.......... .+.. ....+.....+.++.+
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~ 235 (261)
T cd05034 162 EGAKFPIKWTAPEAANYGRFTI-KSDVWSFGILLTEIVTYGRVPYPGMTNREVLE----QVER-GYRMPRPPNCPEELYD 235 (261)
T ss_pred hccCCCccccCHHHhccCCcCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHc-CCCCCCCCCCCHHHHH
Confidence 1222456799999988766644 4999999999999998 999997655433222 2222 1222333367899999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhc
Q 024336 237 LLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~ 258 (269)
++.+||..+|.+||+++++++.
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~~ 257 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQSF 257 (261)
T ss_pred HHHHHcccCcccCCCHHHHHHH
Confidence 9999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=297.37 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=199.0
Q ss_pred cccccccceecccCceEEEEEEEecC-----CeEEEEEEeecCcc--ccHHHHHHHHHHHhCC-CCCcceeeEEEEeCCe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRT-----KELVAVKYIERGKK--IDENVQREIINHRSLR-HPNIIRFKEVLLTPTH 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 73 (269)
.++|++++.||+|+||.||++.+... +..||+|.+..... ..+.+.+|+.+++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 46788999999999999999987432 35699999865332 2356889999999996 9999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhc------------------------------------------------------------
Q 024336 74 LAIVMEYAAGGELFARICSA------------------------------------------------------------ 93 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~------------------------------------------------------------ 93 (269)
.++||||+++|+|.+++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999887542
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC
Q 024336 94 ------------------------------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ 137 (269)
Q Consensus 94 ------------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~ 137 (269)
..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE
Confidence 13677888999999999999999999999999999999998776
Q ss_pred CcEEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHH
Q 024336 138 PRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKT 213 (269)
Q Consensus 138 ~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~ 213 (269)
++|+|||++........ .....+++.|+|||.+.+..++. ++||||||+++|+|++ |..||..........
T Consensus 276 --~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~-- 350 (400)
T cd05105 276 --VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT-LSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY-- 350 (400)
T ss_pred --EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCcccchhHHHH--
Confidence 99999999864322211 12234567899999998776655 4999999999999997 889987654322222
Q ss_pred HHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 214 IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
..+.. ....+....++.++.++|.+||..||++||++.++.+.+
T Consensus 351 -~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 351 -NKIKS-GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred -HHHhc-CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 12222 122233347889999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=287.84 Aligned_cols=255 Identities=26% Similarity=0.372 Sum_probs=200.2
Q ss_pred cccccccceecccCceEEEEEEEecC--------------CeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRT--------------KELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFK 65 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~--------------~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~ 65 (269)
.++|++.+.||+|+||.||++.+..+ ...||+|.+.... ...+.+.+|++.+++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 36899999999999999999987543 2358999886532 2234678899999999999999999
Q ss_pred EEEEeCCeEEEEEeecCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec
Q 024336 66 EVLLTPTHLAIVMEYAAGGELFARICSAG------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLD 133 (269)
Q Consensus 66 ~~~~~~~~~~~v~e~~~~~~l~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~ 133 (269)
+++..+...++||||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 99999999999999999999999885432 367889999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh--CCCCCCCCCChh
Q 024336 134 GSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV--GAYPFEDPEDPR 208 (269)
Q Consensus 134 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t--g~~pf~~~~~~~ 208 (269)
.++. ++|+|||++........ .....++..|+|||.+....++. ++|+||||+++++|++ +..||.......
T Consensus 164 ~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 164 NHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTT-ASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred CCCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCc-hhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 8777 99999998864322211 11223456899999988777654 4999999999999998 667887665544
Q ss_pred hHHHHHHHHhhc--cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 209 NFRKTIDRIRNV--QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 209 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
............ ..........|+.+.++|.+||+.||.+|||+.++++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 333322211111 111222335789999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=287.03 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=200.5
Q ss_pred ccccccceecccCceEEEEEEEecC-----CeEEEEEEeecCccc--cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRT-----KELVAVKYIERGKKI--DENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
.+|++.+.||.|+||.||++.+..+ +..||+|.+...... .+.+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4688999999999999999987543 578999998754322 345778999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCc
Q 024336 76 IVMEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR 139 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~ 139 (269)
++++|+.+++|.+++... ..+++..+..++.|++.||.+||+.|++||||||+||+++.++.
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~-- 162 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN-- 162 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc--
Confidence 999999999999988532 24788899999999999999999999999999999999998777
Q ss_pred EEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHH
Q 024336 140 LKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTID 215 (269)
Q Consensus 140 ~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~ 215 (269)
++|+|||++........ .....+++.|+|||.+.+..++.. +|+||||+++|+|++ |..||...... ....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~ 237 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQ----DVIE 237 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH
Confidence 99999998764322211 122345678999999877776554 999999999999998 88888765442 2233
Q ss_pred HHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 216 RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+...... +-...++..+.+++.+||+.+|.+||++++++..+
T Consensus 238 ~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 238 MIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred HHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 33333221 12237899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=283.85 Aligned_cols=251 Identities=22% Similarity=0.383 Sum_probs=205.5
Q ss_pred ccccccceecccCceEEEEEEEec-----CCeEEEEEEeecCccc--cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKKI--DENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
++|++.+.||+|+||.||+++... +.+.+++|.+...... .+.+.+|+.++++++|+|++++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 689999999999999999999753 3467999987654332 356889999999999999999999999989999
Q ss_pred EEEeecCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecC
Q 024336 76 IVMEYAAGGELFARICSAG---------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG 146 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~ 146 (269)
+|+||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++++|||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~~ 162 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLLS 162 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEcccc
Confidence 9999999999999997655 6899999999999999999999999999999999999998887 9999999
Q ss_pred CcccCCCCC--CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhcccc
Q 024336 147 YSKSGLLHS--QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYF 223 (269)
Q Consensus 147 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (269)
++....... ......++..|+|||.+.+.... .++|+||||+++|++++ |..||...... ............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~----~~~~~~~~~~~~ 237 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDE----EVLNRLQAGKLE 237 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchH----HHHHHHHcCCcC
Confidence 876332211 12233456679999998776664 44999999999999998 78898765442 233333433433
Q ss_pred CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 224 LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
++....++..+.+++.+||+.+|.+||++.|++..+.
T Consensus 238 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 4444478899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=308.93 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=189.9
Q ss_pred ccccccceecccCceEEEEEEEecC-CeEEEEE------------------EeecCccccHHHHHHHHHHHhCCCCCcce
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRT-KELVAVK------------------YIERGKKIDENVQREIINHRSLRHPNIIR 63 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~-~~~vaiK------------------~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 63 (269)
++|++++.||+|+||+||++..... +...+.| .+.........+.+|+.++++++|+||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 6899999999999999999876432 2212222 11112222345788999999999999999
Q ss_pred eeEEEEeCCeEEEEEeecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCC
Q 024336 64 FKEVLLTPTHLAIVMEYAAGGELFARICSA-----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP 138 (269)
Q Consensus 64 ~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~ 138 (269)
+++++..++..|++++++.+ ++..++... .......+..++.|++.||.|||+.||+||||||+||+++.++.
T Consensus 228 l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~- 305 (501)
T PHA03210 228 IEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK- 305 (501)
T ss_pred EeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-
Confidence 99999999999999999965 666665432 22346678889999999999999999999999999999998887
Q ss_pred cEEEeecCCcccCCCCCC--CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCC-CCCCCC--hhhHHHH
Q 024336 139 RLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYP-FEDPED--PRNFRKT 213 (269)
Q Consensus 139 ~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~p-f~~~~~--~~~~~~~ 213 (269)
++|+|||++........ .....++..|+|||.+.+..++.. +|||||||++|+|++|..+ +..... ...+...
T Consensus 306 -vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 306 -IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred -EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 99999999864332221 223468999999999987776555 9999999999999998754 432221 1122222
Q ss_pred HHHHhhccccCC--------------------------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 214 IDRIRNVQYFLP--------------------------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 214 ~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+..+......++ ....++.++.++|.+||..||.+|||+.|+|.|+||...
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 211110000000 012456778889999999999999999999999999764
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=286.67 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=201.7
Q ss_pred cccccccceecccCceEEEEEEEe-----cCCeEEEEEEeecCc--cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGK--KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTH 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 73 (269)
.++|.+.+.||+|+||.||++.+. .++..+|+|.+.... ...+.+.+|+.+++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357899999999999999999863 345679999886542 2234688899999999 79999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 74 LAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
.++++||+.+++|.+++.... .+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++...
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~dfg~~~~~ 191 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI--VKICDFGLARDI 191 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe--EEECCCcccccc
Confidence 999999999999999987543 3899999999999999999999999999999999999987776 999999998743
Q ss_pred CCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCc
Q 024336 152 LLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227 (269)
Q Consensus 152 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (269)
..... .....++..|+|||.+.+..++.+ +|+||+|+++|++++ |..||.............. ........
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~ 266 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----EGYRMAQP 266 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH----cCCcCCCC
Confidence 22211 112234678999999887776554 999999999999998 9999976554333322221 11222223
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 228 VRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
...++.+.+++.+||..+|.+|||+.|+++.+
T Consensus 267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l 298 (302)
T cd05055 267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298 (302)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 35788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=292.34 Aligned_cols=257 Identities=21% Similarity=0.290 Sum_probs=198.4
Q ss_pred cceeccc--CceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 8 VKELGSG--NFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 8 ~~~l~~g--~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
...||.| ++|+||++.+..+|+.||+|++...... .+.+.+|+.+++.++||||++++++|..++..++|+||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3467776 8999999999999999999998754322 3567889999999999999999999999999999999999
Q ss_pred CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC----
Q 024336 83 GGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---- 156 (269)
Q Consensus 83 ~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~---- 156 (269)
++++.+++.+.. .+++..+..++.|++.||+|||+.|++|+||||+||+++.++. ++++||+.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccCccccc
Confidence 999999987643 4899999999999999999999999999999999999998877 99999975432111110
Q ss_pred ----CCcccCCCcccCchhhcccc-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH--------------
Q 024336 157 ----PKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-------------- 217 (269)
Q Consensus 157 ----~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~-------------- 217 (269)
.....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 11122345699999987642 23455999999999999999999997654432221111000
Q ss_pred ---------------------------hhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 218 ---------------------------RNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 218 ---------------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
.......+....+++.+.+||++||..||++|||+.++++|+|+....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0000001111235678999999999999999999999999999988654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=279.76 Aligned_cols=242 Identities=28% Similarity=0.354 Sum_probs=195.5
Q ss_pred ceecccCceEEEEEEEecCC---eEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKRTK---ELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||.||++....++ ..+|+|.+..... ..+.+.+|+.+++.++|+|++++++++. ....++++||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999876544 7899999875543 3456888999999999999999999876 4467999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC----c
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK----S 159 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~----~ 159 (269)
++|.+++...+.+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+.......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccC
Confidence 999999988888999999999999999999999999999999999999998887 9999999886432222111 1
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
..++..|+|||.+.+..++.+ +|+||||+++|++++ |..||....... ....+... ...+....++..+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~l~~li 231 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAE----VIAMLESG-ERLPRPEECPQEIYSIM 231 (257)
T ss_pred ccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHH----HHHHHHcC-CcCCCCCCCCHHHHHHH
Confidence 112357999999977776555 999999999999998 999997655422 22222222 12233346889999999
Q ss_pred HHHhhhCCCCCCCcHHHhhcc
Q 024336 239 SQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+||..+|.+||++.++++.+
T Consensus 232 ~~cl~~~p~~Rp~~~~l~~~l 252 (257)
T cd05060 232 LSCWKYRPEDRPTFSELESTF 252 (257)
T ss_pred HHHhcCChhhCcCHHHHHHHH
Confidence 999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=309.91 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=213.1
Q ss_pred cccccceecccCceEEEEEEEe-----cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
+-...+.||+|+||.||+++.. +....||||.++.... ..++|++|++++..++|||||+++|.|..++.+++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 4567889999999999999864 3356799999875433 45689999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEE
Q 024336 77 VMEYAAGGELFARICSAG--------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKI 142 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l 142 (269)
|+||+..|+|.+++.... +++..+.+.|+.||+.|+.||-++.+|||||-.+|++|..+-. |||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--VKI 644 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--VKI 644 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--EEe
Confidence 999999999999985432 2788999999999999999999999999999999999998887 999
Q ss_pred eecCCcccCCCCCCCC---cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHh
Q 024336 143 CDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIR 218 (269)
Q Consensus 143 ~df~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~ 218 (269)
+|||+++......-.. ...-..+|||||.+..++++++ |||||+|+++||+++ |..||.+..+ .++++-++
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn----~EVIe~i~ 719 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSN----QEVIECIR 719 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccch----HHHHHHHH
Confidence 9999998544433222 3344578999999999999888 999999999999998 8899998887 45566666
Q ss_pred hccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 219 NVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+.. ++.+..+|.++++|+..||..+|++||++.||-..+
T Consensus 720 ~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L 759 (774)
T KOG1026|consen 720 AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRL 759 (774)
T ss_pred cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 6666 666669999999999999999999999999986543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=299.87 Aligned_cols=240 Identities=33% Similarity=0.460 Sum_probs=207.6
Q ss_pred cccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCc
Q 024336 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGE 85 (269)
Q Consensus 6 ~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (269)
.-++.||.|+.|.||+++.. ++.||||.+. +..+.+|+-|++|+|+||+.+.|+|...-.+|+|||||..|.
T Consensus 127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVR------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc--CceehhHHHh------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 34788999999999999986 6789999764 344568888999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccCCCc
Q 024336 86 LFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA 165 (269)
Q Consensus 86 l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 165 (269)
|.+.+...++++......|..+|+.++.|||...|+|||||.-||+|+-+.. |||+|||.+.........-...||..
T Consensus 199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGTVa 276 (904)
T KOG4721|consen 199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGTVA 276 (904)
T ss_pred HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhhHh
Confidence 9999999999999999999999999999999999999999999999998887 99999998875433344446789999
Q ss_pred ccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhC
Q 024336 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245 (269)
Q Consensus 166 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 245 (269)
|+|||++.+...+.+ .||||+|++||+|+||..||.+-+.. .++-.+......+|-+..+|+.+.-||++||+..
T Consensus 277 WMAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sK 351 (904)
T KOG4721|consen 277 WMAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSK 351 (904)
T ss_pred hhCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccchh----eeEEeccCCcccccCcccCchHHHHHHHHHHhcC
Confidence 999999987777565 99999999999999999999875442 2222333344556666689999999999999999
Q ss_pred CCCCCCcHHHhhccC
Q 024336 246 PSKDPHSRDQKASLV 260 (269)
Q Consensus 246 p~~Rps~~~~l~~~~ 260 (269)
|.+||++++++.|+-
T Consensus 352 pRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 352 PRNRPSFRQILLHLD 366 (904)
T ss_pred CCCCccHHHHHHHHh
Confidence 999999999999864
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=280.43 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=199.8
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|++|.||++.+..++ .+|+|.+.......+.+.+|+.+++.++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 368999999999999999999887554 5999988765555567889999999999999999999875 45688999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC--C
Q 024336 82 AGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--P 157 (269)
Q Consensus 82 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~--~ 157 (269)
.+++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||++++++. ++|+|||++........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCccccc
Confidence 9999999996533 4789999999999999999999999999999999999998877 99999998864322211 1
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
....++..|+|||...+...+. ++|+||||+++|+|+| |..||......... ..+.. ....+.....+..+.+
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELVTKGRVPYPGMVNREVL----EQVER-GYRMPCPQGCPESLHE 234 (260)
T ss_pred CCCccchhhCCHHHhccCCcCh-HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHc-CCCCCCCcccCHHHHH
Confidence 1223456799999987766644 4999999999999999 89999875543322 22222 1222223368899999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhcc
Q 024336 237 LLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
++.+||.+||.+||+++++++.+
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~~l 257 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQSFL 257 (260)
T ss_pred HHHHHccCCcccCcCHHHHHHHH
Confidence 99999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=283.01 Aligned_cols=249 Identities=23% Similarity=0.364 Sum_probs=198.9
Q ss_pred cccccccceecccCceEEEEEEEecCCe----EEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKE----LVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
.++|++.+.||+|+||+||++.+..++. .||+|.+.... .....+.+|+..++.++|+|++++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 3689999999999999999999877665 48999876432 2234677899999999999999999998754 467
Q ss_pred EEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 76 IVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
++++++++|+|.+.+... +.+++..+..++.|++.||.+||++|++|+||||+||+++.++. ++|+|||++......
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~~ 162 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDID 162 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeecccc
Confidence 999999999999998763 46899999999999999999999999999999999999988777 999999988743322
Q ss_pred CC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 155 SQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 155 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
.. ......++.|+|||.+.+..++.+ +|+||||+++|++++ |..||....... .. ..+... ...+....+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~-~~---~~~~~~-~~~~~~~~~ 236 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPARE-IP---DLLEKG-ERLPQPPIC 236 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHH-HH---HHHHCC-CcCCCCccC
Confidence 21 112234567999999977766555 999999999999998 889987654322 22 222222 122333468
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+.++.++|.+||..||++||++.+++..+
T Consensus 237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~~l 265 (279)
T cd05109 237 TIDVYMIMVKCWMIDSECRPRFRELVDEF 265 (279)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 89999999999999999999999999654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=287.68 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=200.8
Q ss_pred cccccccceecccCceEEEEEEEecC-----CeEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRT-----KELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPTH 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 73 (269)
.++|++.+.||+|++|.||++.+... ...+|+|.+..... ....+.+|+.+++++ +|+|++++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 36899999999999999999998643 37899998875322 224577899999999 79999999999999999
Q ss_pred EEEEEeecCCCchHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC
Q 024336 74 LAIVMEYAAGGELFARICS----------------AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ 137 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~----------------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~ 137 (269)
+++++||+.+++|..++.. ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCe
Confidence 9999999999999999854 235889999999999999999999999999999999999998877
Q ss_pred CcEEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHH
Q 024336 138 PRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKT 213 (269)
Q Consensus 138 ~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~ 213 (269)
++|+|||.+........ .....++..|+|||.+.+..++.+ +|+||||+++|++++ |..||.........
T Consensus 171 --~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~--- 244 (293)
T cd05053 171 --MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELF--- 244 (293)
T ss_pred --EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCCCHHHHH---
Confidence 99999998874322211 112224567999999877666555 999999999999997 99999765443322
Q ss_pred HHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 214 IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
..+... .........+.++.+++.+||..||.+|||+.++++++
T Consensus 245 -~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 245 -KLLKEG-YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred -HHHHcC-CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 222221 12222336788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=280.25 Aligned_cols=249 Identities=34% Similarity=0.478 Sum_probs=207.7
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+|++.+.||+|++|.||++.+..+++.+++|.+.... .....+.+|+..++.++|+|++++.+++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999999899999999987543 2234567899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 81 AAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 81 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~-~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL--VKIGDLGISKVLKKN-M 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc--EEEeeccchhhhccC-C
Confidence 999999998866 356899999999999999999999999999999999999998776 999999988654333 3
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+++.|+|||.+.+..++.+ +|+||||++++++++|..||...+... ....+...... +....++.++.+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~-~~~~~~~~~~~~ 231 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQD----LRYKVQRGKYP-PIPPIYSQDLQN 231 (256)
T ss_pred cccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCCCC-CCchhhCHHHHH
Confidence 334567889999999977666544 999999999999999999997765422 22222222221 112267889999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
++.+||..+|.+||++.+++.||+.
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999973
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=285.11 Aligned_cols=254 Identities=29% Similarity=0.436 Sum_probs=204.6
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEEeec
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
|++.+.||+|++|+||++....+++.|++|.+..... ......+|+..++++. |+|++++++++..++..++|+||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999998899999998865432 2223457889999998 999999999999999999999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCc
Q 024336 82 AGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159 (269)
Q Consensus 82 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 159 (269)
+++|.+.+.... .+++..+..++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCC
Confidence 678988887654 6899999999999999999999999999999999999998877 99999998875443333344
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh---------------ccccC
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN---------------VQYFL 224 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~ 224 (269)
..++..|+|||.+......+.++|+||||+++++|++|.+||.................. .....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 567788999998865554456699999999999999999999776554443322211100 00000
Q ss_pred CC---------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 225 PD---------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 225 ~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
+. ....+.++.++|.+||+.+|.+||++.|++.|+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 01236789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=285.39 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=200.9
Q ss_pred cccccccceecccCceEEEEEEEec----------------CCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcce
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKR----------------TKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIR 63 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~----------------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~ 63 (269)
.++|++.+.||+|+||.||++.+.. ++..+|+|.+..... ....+.+|+..++.++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4689999999999999999986532 345789998865422 2356889999999999999999
Q ss_pred eeEEEEeCCeEEEEEeecCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe
Q 024336 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAG-----------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL 132 (269)
Q Consensus 64 ~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i 132 (269)
+++++..++..++++||+++++|.+++.... .++...+..++.|++.||++||+.|++|+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 9999999999999999999999999986643 26677899999999999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh--CCCCCCCCCCh
Q 024336 133 DGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV--GAYPFEDPEDP 207 (269)
Q Consensus 133 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t--g~~pf~~~~~~ 207 (269)
+.++. ++|+|||++........ ......++.|+|||......++. ++|+||||+++|+|++ |..||......
T Consensus 164 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 164 GKNYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTT-ASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred cCCCC--EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccc-hhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 88776 99999998864322211 11223356799999887766644 4999999999999998 77888765554
Q ss_pred hhHHHHHHHHhhc--cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 208 RNFRKTIDRIRNV--QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 208 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
............. ....+....+++.+.++|.+||..||.+||++.++++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 4333222221111 122333446789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=283.01 Aligned_cols=253 Identities=28% Similarity=0.396 Sum_probs=202.5
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhC---CCCCcceeeEEEEeCCe-----
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSL---RHPNIIRFKEVLLTPTH----- 73 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~----- 73 (269)
|++.+.||+|++|.||++.+..+++.||+|.+...... ...+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78899999999999999999988999999998743222 23456677776655 69999999999988776
Q ss_pred EEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 74 LAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
.++++|++++ +|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC--EEEeccCcceec
Confidence 9999999975 7888886643 4899999999999999999999999999999999999998876 999999988754
Q ss_pred CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-ccCC-----
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLP----- 225 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~----- 225 (269)
..........++..|+|||.+.+..++.+ +|+||||+++|+|++|.+||......+............. ..++
T Consensus 158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 158 SFEMALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred cCCcccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 33333334456788999999987776555 9999999999999999999987666555544443322100 0000
Q ss_pred ------C---------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 226 ------D---------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 226 ------~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
. ...++..+.++|.+||+.||.+||++.+++.|+|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01345778899999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=277.82 Aligned_cols=242 Identities=38% Similarity=0.597 Sum_probs=205.1
Q ss_pred ecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCch
Q 024336 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 11 l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
||+|++|.||++.+..+++.+++|.+..... ....+.+|+..++.++|+|++++++.+..+...++++|++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999998899999999876432 234678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCcccCCCc
Q 024336 87 FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPA 165 (269)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~ 165 (269)
.+++.....+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||.+...... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCcc
Confidence 999988888999999999999999999999999999999999999998877 999999988753332 22334457788
Q ss_pred ccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhC
Q 024336 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245 (269)
Q Consensus 166 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 245 (269)
|+|||...+...+. ++|+||||+++|++++|..||...+. ......+......++. ..+..+.++|.+||..|
T Consensus 159 ~~~Pe~~~~~~~~~-~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~--~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 159 YLAPEVLLGKGYGK-AVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILKDPLRFPE--FLSPEARDLISGLLQKD 231 (250)
T ss_pred ccChHHhCCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhcCC
Confidence 99999987766544 49999999999999999999976544 2223333333334444 67899999999999999
Q ss_pred CCCCCCc---HHHhhccCh
Q 024336 246 PSKDPHS---RDQKASLVP 261 (269)
Q Consensus 246 p~~Rps~---~~~l~~~~~ 261 (269)
|.+||++ +++++|+||
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 9999999 999999996
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=286.59 Aligned_cols=249 Identities=25% Similarity=0.357 Sum_probs=201.5
Q ss_pred ccccccceecccCceEEEEEEEec-----CCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
.+|.+.+.||+|++|.||++.+.. ++..+++|.+..... ..+.+.+|+..+++++|+|++++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 568999999999999999998643 456688888764332 23568899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcE
Q 024336 77 VMEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRL 140 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~ 140 (269)
||||+++++|.+++...+ .+++..++.++.|++.||++||++|++|+||+|+||+++.++. +
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~--~ 162 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--V 162 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--E
Confidence 999999999999986543 3789999999999999999999999999999999999998877 9
Q ss_pred EEeecCCcccCCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHH
Q 024336 141 KICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDR 216 (269)
Q Consensus 141 ~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~ 216 (269)
+|+|||++....... ......++..|+|||.+.+..++.+ +|+||||+++|+|+| |..||....... ....
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~----~~~~ 237 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTE----VIEC 237 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH
Confidence 999999886432221 1223345678999999887766554 999999999999999 999987655433 2222
Q ss_pred HhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+...... ......|..+.+++.+||..+|++||++.++++.+
T Consensus 238 ~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l 279 (291)
T cd05094 238 ITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279 (291)
T ss_pred HhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 3332221 12235788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=285.16 Aligned_cols=252 Identities=27% Similarity=0.380 Sum_probs=204.0
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc----cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
.+.|...+.||+|+||.||++.+..++..+|+|.+...... ...+.+|+..++.++|+|++++++++.++...++|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 35688999999999999999999989999999998754222 23577899999999999999999999999999999
Q ss_pred EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 78 MEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
+||+.+ ++.+.+.. ..++++..+..++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++.... .
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~---~ 177 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIAS---P 177 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccC---C
Confidence 999976 67666643 556899999999999999999999999999999999999998877 9999999876322 2
Q ss_pred CCcccCCCcccCchhhcc--ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHH
Q 024336 157 PKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
.....+++.|+|||.+.. ....+.++|+||+|+++|+|++|..||.......... .+............+++.+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l 253 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----HIAQNESPTLQSNEWSDYF 253 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH----HHHhccCCCCCCccccHHH
Confidence 234467788999999742 2223455999999999999999999997654322222 2222222222233578899
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.++|.+||+.+|.+||++.++++|+|+..
T Consensus 254 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 254 RNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 99999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=291.60 Aligned_cols=258 Identities=24% Similarity=0.404 Sum_probs=204.2
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeC------C
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTP------T 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 72 (269)
.++|++.+.||+|+||.||++.+..+++.||+|.+..... ..+.+.+|+.++++++|+||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 5789999999999999999999998999999998865322 234577899999999999999999988643 3
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
..+++++++ +++|.+.+.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~- 170 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT- 170 (345)
T ss_pred cEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEecccccccc-
Confidence 478888887 6688877754 46899999999999999999999999999999999999998887 999999988743
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh-------------
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN------------- 219 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~------------- 219 (269)
........++..|+|||.+.+....+.++|+||||+++|+|++|..||..................
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (345)
T cd07877 171 -DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249 (345)
T ss_pred -cccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence 222334467888999999876444455699999999999999999999765543333222111100
Q ss_pred ------ccccCCC------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 220 ------VQYFLPD------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 220 ------~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.....+. ....++++.++|.+||..||.+||++.+++.|+|+..+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 0000000 123578899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=283.19 Aligned_cols=254 Identities=28% Similarity=0.407 Sum_probs=197.6
Q ss_pred cccccccceecccCceEEEEEEE----ecCCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEe--CCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRD----KRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLT--PTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~----~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 74 (269)
.++|++.+.||+|+||.||++.. ..++..||+|.+..... ..+.+.+|+.++++++|||++++++++.. ...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46899999999999999999974 45788999999865432 23567899999999999999999998754 3468
Q ss_pred EEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 75 AIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
++|+||+++++|.+++.+. ..+++..+..++.|++.||.+||++|++|+||||+||+++.++. ++|+|||++.....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~ 160 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCcccccccC
Confidence 9999999999999998664 45899999999999999999999999999999999999998887 99999999874322
Q ss_pred CCCC----CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChh------------hHHHHHHHH
Q 024336 154 HSQP----KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR------------NFRKTIDRI 217 (269)
Q Consensus 154 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~------------~~~~~~~~~ 217 (269)
.... .....+..|+|||.+.+..++. ++|+||||+++++|++|..++....... ....... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 238 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSV-ASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE-L 238 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcCh-HHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH-H
Confidence 2211 1112334599999987766644 5999999999999999877654332110 0011111 1
Q ss_pred hhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.......+....++.++.++|.+||+.+|++|||+.++++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 122222333446889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=300.60 Aligned_cols=249 Identities=24% Similarity=0.401 Sum_probs=207.5
Q ss_pred cccceecccCceEEEEEEEecCCeEEEEEEee-----cCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCe--EEEEE
Q 024336 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIE-----RGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTH--LAIVM 78 (269)
Q Consensus 6 ~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~~v~ 78 (269)
+....||+|+|-+||+|.|..+|..||.-.+. +.....+.+..|+.+|+.|+||||++++++|.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45678999999999999999999999866543 233444778999999999999999999999998765 89999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
|.+..|+|..++.+.+..+...+..|++||+.+|.|||++. |+|||||.+||||+.+. +.|||+|+|+|.......
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~-G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNL-GEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCc-CceeecchhHHHHhhccc-
Confidence 99999999999999999999999999999999999999987 99999999999998443 469999999998543333
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhH-HHHHHHHhhccccCCCcCCCCHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF-RKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
.....|||.|||||.+. ..|+.. .||||||++++||+|+..||..+.+...+ +.+...++...+.. --.++++
T Consensus 201 aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k----V~dPevr 274 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK----VKDPEVR 274 (632)
T ss_pred cceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc----cCCHHHH
Confidence 33478999999999986 555555 99999999999999999999988775433 22332222222211 2257899
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+||.+||.. .++|||+.|+|+|+||..
T Consensus 275 ~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 275 EFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred HHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 999999999 999999999999999976
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=293.55 Aligned_cols=253 Identities=25% Similarity=0.321 Sum_probs=198.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeec---CccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
..|+++++||.||.+.||+|...+.+- ||+|.+.. +......+.+|+..|.+| .|.+|+++++|-..++.+|+||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~i-yalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQI-YALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcc-hhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 579999999999999999999976554 55555432 334456789999999999 5899999999999999999999
Q ss_pred eecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-
Q 024336 79 EYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ- 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 156 (269)
|+=+ .+|..++++... .+.-.++.+..|++.|+.++|+.||||.||||.|+++. .|. +||+|||+|.....+..
T Consensus 440 E~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~--LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGR--LKLIDFGIANAIQPDTTS 515 (677)
T ss_pred eccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eee--EEeeeechhcccCccccc
Confidence 9864 488888876654 33358899999999999999999999999999999987 444 99999999975544443
Q ss_pred --CCcccCCCcccCchhhccccCC----------CccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc--cc
Q 024336 157 --PKSTVGTPAYIAPEVLARKEYD----------GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--QY 222 (269)
Q Consensus 157 --~~~~~~~~~~~aPE~~~~~~~~----------~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--~~ 222 (269)
....+||+.|++||.+...... +++|||||||||+|+|+.|++||+.-.+ ....+..+... .+
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---~~aKl~aI~~P~~~I 592 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---QIAKLHAITDPNHEI 592 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---HHHHHHhhcCCCccc
Confidence 3567899999999998743322 4559999999999999999999975321 12222222222 22
Q ss_pred cCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 223 FLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 223 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
.+|+... +.++.++++.||+.||.+||++.++|.|+|.+.+
T Consensus 593 efp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 593 EFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred cccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 4444211 2238999999999999999999999999999874
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=286.59 Aligned_cols=250 Identities=24% Similarity=0.327 Sum_probs=199.4
Q ss_pred ccccccceecccCceEEEEEEEec-------CCeEEEEEEeecCc--cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKR-------TKELVAVKYIERGK--KIDENVQREIINHRSL-RHPNIIRFKEVLLTPT 72 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 72 (269)
++|.+.+.||+|+||.||++.+.. +...+|+|.+.... .....+.+|+.+++.+ +|+|++++++++..++
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 689999999999999999998753 23469999887542 2234577899999999 7999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC
Q 024336 73 HLAIVMEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP 136 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~ 136 (269)
..++|+||+++++|.+++...+ .++...+..++.|++.||++||+.|++|+||+|+||+++.++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 177 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence 9999999999999999997542 378899999999999999999999999999999999999887
Q ss_pred CCcEEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 024336 137 QPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRK 212 (269)
Q Consensus 137 ~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~ 212 (269)
. ++|+|||.+........ ......++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||..... ..
T Consensus 178 ~--~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~~~g~~p~~~~~~----~~ 250 (307)
T cd05098 178 V--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPV----EE 250 (307)
T ss_pred c--EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH-HHHHHHHHHHHHHHcCCCCCCCcCCH----HH
Confidence 6 99999998864322111 111223467999999987766544 999999999999998 8888865432 22
Q ss_pred HHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
....+.... .......++.++.++|.+||..+|.+|||+.++++++.
T Consensus 251 ~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~ 297 (307)
T cd05098 251 LFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297 (307)
T ss_pred HHHHHHcCC-CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 222222221 22223367899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=284.21 Aligned_cols=254 Identities=30% Similarity=0.458 Sum_probs=206.4
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
|++.+.||+|++|.||++....+++.+++|.+.... ...+.+.+|+..++.++|+|++++++++.+.+..++|+|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 678899999999999999999999999999987642 23456778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCc
Q 024336 82 AGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS 159 (269)
Q Consensus 82 ~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 159 (269)
++ +|.+++.+. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCc
Confidence 85 899999776 57999999999999999999999999999999999999998877 9999999887433322 2223
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc--------------cccCC
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------------QYFLP 225 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~~ 225 (269)
...+..|+|||.+.+....+.++|+||||++++++++|.+||................... ...++
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 3456789999998776444556999999999999999999998766544333332211100 00001
Q ss_pred C---------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 226 D---------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 226 ~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
. ....+..+.++|.+||..||++||++.+++.|+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0 11347789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=292.52 Aligned_cols=259 Identities=27% Similarity=0.418 Sum_probs=203.9
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPT----- 72 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 72 (269)
+.++|.+.+.||+|++|.||++.+..+|+.||+|.+.... .....+.+|+.+++.++|+|++++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3578999999999999999999999899999999886432 22345778999999999999999999987543
Q ss_pred -eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 73 -HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 73 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
.+++|++++.. ++.... ...+++..+..++.|++.||++||+.|++||||+|+||+++.++. ++|+|||++...
T Consensus 93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~ 167 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHA 167 (342)
T ss_pred ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCC
Confidence 46999999964 666554 346899999999999999999999999999999999999998877 999999998643
Q ss_pred CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHh-------------
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR------------- 218 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~------------- 218 (269)
........+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+....+........
T Consensus 168 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 168 --DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred --CCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 22223345678899999987654445569999999999999999999987554333322221100
Q ss_pred ------hccccCCC------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 219 ------NVQYFLPD------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 219 ------~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
......+. ....+.++.++|.+||..||.+||++.+++.|+|+..+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000000 1246778999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=271.80 Aligned_cols=256 Identities=24% Similarity=0.360 Sum_probs=210.6
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+.+.+..||.|..|.|+++....+|...|||.+..+. +..+.+...+.+.... ++|+||+++|+|..+..+++-||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 4567788999999999999999999999999998653 2334466666666555 489999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
+.. .+..++.+ .+++++..+-.+...++.||.||-. .|++|||+||+||++|..|+ +||||||++..........
T Consensus 173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSkAht 249 (391)
T KOG0983|consen 173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSKAHT 249 (391)
T ss_pred HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeecccccc
Confidence 854 55555543 5578999999999999999999986 57999999999999999998 9999999998777777777
Q ss_pred cccCCCcccCchhhccc---cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 159 STVGTPAYIAPEVLARK---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
...|.+.|+|||.+.-. .++.. +|+||||++++||+||..||.+...+-.....+.+ .....++.-.++|+++.
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--~ePP~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--EEPPLLPGHMGFSPDFQ 326 (391)
T ss_pred cccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh--cCCCCCCcccCcCHHHH
Confidence 78899999999998743 34444 99999999999999999999986654333322222 33445555556999999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
+|+..||.+|+.+||...++|+|+|....+
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 999999999999999999999999987655
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=288.50 Aligned_cols=260 Identities=27% Similarity=0.445 Sum_probs=205.2
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEe-CCeEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLT-PTHLAI 76 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~ 76 (269)
+.++|++.+.||.|+||.||++.+..++..||+|.+.... ...+.+.+|+.+++.++|||++++.+++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 3678999999999999999999999999999999875422 234567789999999999999999999876 457899
Q ss_pred EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
++|++. ++|...+. ..++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+... ...
T Consensus 88 v~e~~~-~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~--~~~ 161 (328)
T cd07856 88 VTELLG-TDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQ--DPQ 161 (328)
T ss_pred Eeehhc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCcccccccc--CCC
Confidence 999985 58877774 456789999999999999999999999999999999999998777 999999988642 222
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH-------------------
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI------------------- 217 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~------------------- 217 (269)
.....++..|+|||.+.+....++++|+||||+++|+++||.+||.............+..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 2334567789999988764444566999999999999999999997654322221111100
Q ss_pred -hhcc--ccCC---CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 218 -RNVQ--YFLP---DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 218 -~~~~--~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
.... ...+ ....+++.+.++|.+||+.+|++||++.+++.|+|+.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 0000 0000 01246789999999999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=296.90 Aligned_cols=249 Identities=29% Similarity=0.392 Sum_probs=208.7
Q ss_pred ccccccceecccCceEEEEEEEecCCe---E-EEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKE---L-VAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~---~-vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
++-...++||+|+||.||++.....+. . ||+|..... ......+.+|.+++++++|||||+++|+...+..+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 345567999999999999999875422 3 899988742 33445688999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 75 AIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
++|||+|.||+|.+++++.+. ++..+...++.+.+.||+|||+.+++||||-.+|++++.++. +||+|||++.....
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCcc
Confidence 999999999999999998874 999999999999999999999999999999999999998776 89999999986542
Q ss_pred CCCCC-cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 154 HSQPK-STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 154 ~~~~~-~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
..... ...-...|+|||.+....++.+ +||||+|+++||+++ |..||.+.... .....+....+..+.+...|
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~~~~r~~~~~~~p 389 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVKNGYRMPIPSKTP 389 (474)
T ss_pred eeeccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHHhcCccCCCCCCCH
Confidence 22222 2234578999999998866555 999999999999998 88899887653 44455545555555555888
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
..+..++.+|+..+|++||++.++.+.
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~~i~~~ 416 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMSTIKKK 416 (474)
T ss_pred HHHHHHHHHhccCChhhccCHHHHHHH
Confidence 999999999999999999999998764
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=283.39 Aligned_cols=257 Identities=29% Similarity=0.485 Sum_probs=207.4
Q ss_pred cccccceecccCceEEEEEEEe---cCCeEEEEEEeecCc-----cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeE
Q 024336 4 RYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK-----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 74 (269)
+|++.+.||+|++|.||++.+. .+++.||+|.+.... ...+.+.+|+.+++++ +||+++++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 467889999886432 2234577899999999 599999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
++|+||+++++|.+.+.....+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEEECccccccccc
Confidence 999999999999999987778999999999999999999999999999999999999998876 999999988643322
Q ss_pred CCC--CcccCCCcccCchhhcccc-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 155 SQP--KSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 155 ~~~--~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
... ....++..|+|||.+.+.. ..+.++|+||||+++++|++|..||...............+.......+. .++
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 236 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK--TMS 236 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCc--ccC
Confidence 211 1234688999999986654 23455999999999999999999996543322333333333333333333 678
Q ss_pred HHHHHHHHHHhhhCCCCCCCc---HHHhhccChhhh
Q 024336 232 ADCRHLLSQIFVADPSKDPHS---RDQKASLVPEEF 264 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~---~~~l~~~~~~~~ 264 (269)
..+.++|.+||+.||++|||+ .++++|+|++.+
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 899999999999999999984 677999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=279.35 Aligned_cols=244 Identities=25% Similarity=0.370 Sum_probs=197.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEE-eCCeEEEEEeec
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL-TPTHLAIVMEYA 81 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~ 81 (269)
++|++.+.||+|++|.||++... |..+++|...... ..+.+.+|+..+++++|+|++++++++. .+...++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 57899999999999999999775 7779999876443 3456889999999999999999999764 456789999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCc
Q 024336 82 AGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159 (269)
Q Consensus 82 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 159 (269)
++++|.+++.+.+ .+++..+..++.|++.||++||++|++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~--~~~ 158 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST--QDT 158 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceecccc--CCC
Confidence 9999999987644 3789999999999999999999999999999999999998887 999999988743222 223
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...+..|+|||.+....++.+ +|+||||+++|+|++ |..||...... .....+... ........+++.+.++|
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~li 232 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRVEKG-YKMDAPDGCPPVVYDVM 232 (256)
T ss_pred CccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHhcC-CCCCCCCCCCHHHHHHH
Confidence 334567999999877666554 999999999999998 99998764432 222222222 11122236889999999
Q ss_pred HHHhhhCCCCCCCcHHHhhcc
Q 024336 239 SQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+||..+|.+|||+.++++.+
T Consensus 233 ~~~l~~~p~~Rpt~~~l~~~l 253 (256)
T cd05082 233 KQCWHLDAATRPSFLQLREQL 253 (256)
T ss_pred HHHhcCChhhCcCHHHHHHHH
Confidence 999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=281.52 Aligned_cols=248 Identities=24% Similarity=0.393 Sum_probs=200.4
Q ss_pred ccccccceecccCceEEEEEEEecCCe---EEEEEEeecC--ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKE---LVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
..|++.+.||+|+||.||++.+..+++ .||+|.+... ......+..|+..++.++|||++++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 468999999999999999999876654 6999988653 22345688899999999999999999999999999999
Q ss_pred EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 78 MEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
+||+++++|.+++.. .+.++...+..++.|++.||++||++|++|+||+|+||+++.++. ++|+|||++........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTS 161 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc--EEECCCccccccccCcc
Confidence 999999999998865 346899999999999999999999999999999999999987776 99999998764322211
Q ss_pred CCc---cc---CCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCC
Q 024336 157 PKS---TV---GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229 (269)
Q Consensus 157 ~~~---~~---~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (269)
... .. .+..|+|||.+.+..++.+ +|+||||+++|++++ |..||........ ...+.. ....+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~~----~~~i~~-~~~~~~~~~ 235 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDV----INAIEQ-DYRLPPPMD 235 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHHH----HHHHHc-CCcCCCccc
Confidence 111 11 1346999999987776554 999999999999886 9999977554322 222221 223333347
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 230 VSADCRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
++..+.+++.+||..+|.+||++++++..
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=277.22 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=202.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
.+|++.+.||+|++|.||++.+. ++..+|+|.+.........+.+|+.++++++||+++++++++......++++||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 47899999999999999999886 46679999887665556778999999999999999999999999999999999999
Q ss_pred CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC--CCc
Q 024336 83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKS 159 (269)
Q Consensus 83 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~--~~~ 159 (269)
+++|.+++... +.+++..++.++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+........ ...
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe--EEECCCcceeecccCcccccCC
Confidence 99999998654 46899999999999999999999999999999999999998776 99999998864322111 112
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...+..|+|||.+.+..++. ++|+||||+++|++++ |..||....... ....+.... ........+..+.+++
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~-~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~l~ 234 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSS-KSDVWSFGVLMWEVFSEGKTPYENRSNSE----VVETINAGF-RLYKPRLASQSVYELM 234 (256)
T ss_pred CccchhhcCHhHhccCCcCh-HHHHHHHHHHHHHHHcCCCCCCCcCCHHH----HHHHHhCCC-CCCCCCCCCHHHHHHH
Confidence 23456799999988766654 4999999999999998 899997654322 222222221 1112235789999999
Q ss_pred HHHhhhCCCCCCCcHHHhhcc
Q 024336 239 SQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+||+.+|.+|||+.++++++
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHcccChhhCCCHHHHHHhh
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=283.49 Aligned_cols=254 Identities=25% Similarity=0.428 Sum_probs=206.2
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
|.....||+|++|.||++....+++.||+|.+.... .....+.+|+..++.++|+|++++++.+..++..++++||+++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 344567999999999999999999999999876432 2334578899999999999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCcccC
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~ 162 (269)
++|.+++. ...+++..+..++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||.+....... ......+
T Consensus 102 ~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 102 GALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred CcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceeccccccccccccc
Confidence 99988774 456899999999999999999999999999999999999998877 9999999876432221 1223457
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
++.|+|||.+.+..++ .++|+||+|+++|+|++|..||.............. .....+.....++..+.+++.+||
T Consensus 179 ~~~y~~pE~~~~~~~~-~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l 254 (292)
T cd06657 179 TPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPKLKNLHKVSPSLKGFLDRLL 254 (292)
T ss_pred CccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---hCCcccCCcccCCHHHHHHHHHHH
Confidence 7889999998766664 459999999999999999999986544333222111 111222233367899999999999
Q ss_pred hhCCCCCCCcHHHhhccChhhhh
Q 024336 243 VADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 243 ~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
..+|.+||++.+++.|+|+....
T Consensus 255 ~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 255 VRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred hCCcccCcCHHHHhcChHHhccC
Confidence 99999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=281.18 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=196.5
Q ss_pred ccccceecccCceEEEEEEEecC---CeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCe-----
Q 024336 5 YEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTH----- 73 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~---~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 73 (269)
|++.+.||+|+||.||++....+ +..||+|.+..... ....+.+|+..++.++|||++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999997653 47899998875432 23467889999999999999999998876544
Q ss_pred -EEEEEeecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecC
Q 024336 74 -LAIVMEYAAGGELFARICSA------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG 146 (269)
Q Consensus 74 -~~~v~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~ 146 (269)
.++++||+++++|...+... ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT--VCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe--EEECCcc
Confidence 79999999999998887442 25899999999999999999999999999999999999998877 9999999
Q ss_pred CcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccc
Q 024336 147 YSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQY 222 (269)
Q Consensus 147 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 222 (269)
++........ ......+..|+|||.+.+..++. ++|+||||+++|+|++ |..||........ ...+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Dv~SlG~il~el~~~g~~p~~~~~~~~~----~~~~~~~~- 232 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTS-KSDVWAFGVTMWEIATRGQTPYPGVENHEI----YDYLRHGN- 232 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHcCC-
Confidence 9874332221 11223456799999987666654 4999999999999999 8899976554332 22222221
Q ss_pred cCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 223 FLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 223 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.......++..+.++|.+||..||.+||++.++++++
T Consensus 233 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l 269 (273)
T cd05035 233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269 (273)
T ss_pred CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1222236889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=284.59 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=203.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|++.+.||+|++|.||++.+..++..||+|.+..... ....+..|+..+... .|+|++++++++.++...++++|
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 678999999999999999999998899999999875432 223455677666666 59999999999999999999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
++.+ ++.+.+.. ..++++..+..++.|++.|++|||+ .|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 95 ~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~--~kL~dfg~~~~~~~~~~~ 171 (296)
T cd06618 95 LMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN--VKLCDFGISGRLVDSKAK 171 (296)
T ss_pred ccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC--EEECccccchhccCCCcc
Confidence 9865 67666654 4578999999999999999999997 59999999999999998776 999999988643333333
Q ss_pred CcccCCCcccCchhhcccc---CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHH
Q 024336 158 KSTVGTPAYIAPEVLARKE---YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||....... ..............+....++.++
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l 249 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVLTKILQEEPPSLPPNEGFSPDF 249 (296)
T ss_pred cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HHHHHHhcCCCCCCCCCCCCCHHH
Confidence 3345677899999986543 23445999999999999999999997543221 111111122222233333578999
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
.+||.+||..||.+||++.+++.|+|+..+..
T Consensus 250 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 250 CSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred HHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 99999999999999999999999999887554
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=282.01 Aligned_cols=254 Identities=20% Similarity=0.295 Sum_probs=200.1
Q ss_pred cccccccceecccCceEEEEEEEec-----CCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
.++|++.+.||+|+||.||++.+.. .+..||+|.+..... ....+.+|+..++.++|+|++++++++.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 4689999999999999999997652 355799998764432 223467899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEee
Q 024336 75 AIVMEYAAGGELFARICSA----------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICD 144 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~d 144 (269)
+++|||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L~D 162 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGD 162 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEECc
Confidence 9999999999999999653 23466788999999999999999999999999999999998777 99999
Q ss_pred cCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhc
Q 024336 145 FGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV 220 (269)
Q Consensus 145 f~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 220 (269)
||++........ .....++..|+|||.+.+...+.+ +|+||||+++|+|++ |..||....... ....+...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~~~~~~p~~~~~~~~----~~~~~~~~ 237 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQ----VLKFVMDG 237 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHcC
Confidence 998864322111 112234567999999887766554 999999999999998 788987654432 22222222
Q ss_pred cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhh------ccChhh
Q 024336 221 QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKA------SLVPEE 263 (269)
Q Consensus 221 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~------~~~~~~ 263 (269)
.. .+.....++.+.+++.+||+.||.+|||+.++++ |+++.+
T Consensus 238 ~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 238 GY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 11 1122367889999999999999999999999987 666654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=286.94 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=214.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
+-|.++++||+|+||.||++.+..+|..+|||.++.+ ...+++..|+.++++++.|++|+++|.+.....+|+|||||.
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3478899999999999999999999999999998765 456778899999999999999999999998899999999999
Q ss_pred CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCcc
Q 024336 83 GGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKST 160 (269)
Q Consensus 83 ~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~ 160 (269)
.|+..+.++. ++++++.++..+++.-+.+|+|||...-+|||||..||+++.+|+ .||.|||.+...... ....+.
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHHhhCcc
Confidence 9999999864 567999999999999999999999999999999999999999998 999999988642211 223456
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (269)
.|||.|+|||++..-.+... +||||||++..+|..|++||..-... ......-.+....+..+..++.++.+||++
T Consensus 190 IGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~PPPTF~KPE~WS~~F~DFi~~ 265 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKPPPTFKKPEEWSSEFNDFIRS 265 (502)
T ss_pred ccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCCCCCCCChHhhhhHHHHHHHH
Confidence 79999999999988888787 99999999999999999999764331 111111111122222333678899999999
Q ss_pred HhhhCCCCCCCcHHHhhccChhh
Q 024336 241 IFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 241 ~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
||-++|++|-|+.++++|+|.+.
T Consensus 266 CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 266 CLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred HhcCCHHHHHHHHHHhhhhhhcC
Confidence 99999999999999999999865
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=278.22 Aligned_cols=246 Identities=28% Similarity=0.387 Sum_probs=202.0
Q ss_pred ccccceecccCceEEEEEEEecCC----eEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTK----ELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
+++.+.||.|+||.||++.+...+ ..+|+|.+..... ..+.+.+|+..++.++|+|++++++++.+.+..++++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 467899999999999999998766 8899999875543 3567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 79 EYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
|++++++|.+.+..... +++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDY 158 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceecccccc
Confidence 99999999999976554 899999999999999999999999999999999999998887 99999999874433322
Q ss_pred CC--cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 157 PK--STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 157 ~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
.. ...+++.|+|||.+.+..++ .++|+||||+++++|++ |.+||......... ..+..... .+.....+.+
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~ 232 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFT-SKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL----EYLKKGYR-LPKPENCPPE 232 (258)
T ss_pred cccccCCCcccccChHHhccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHhcCCC-CCCCCcCCHH
Confidence 11 12356789999998665554 45999999999999998 78888764432222 22222221 2222358899
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
+.+++.+||..||.+|||+.|+++.
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 233 IYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred HHHHHHHHCcCChhhCcCHHHHHhh
Confidence 9999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=280.71 Aligned_cols=243 Identities=25% Similarity=0.340 Sum_probs=192.8
Q ss_pred ceecccCceEEEEEEEecCCe--EEEEEEeecC--ccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKRTKE--LVAVKYIERG--KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~--~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||.||++.+..++. .+++|.+... ....+.+.+|+..++++ +|||++++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999987765 4688877642 22335678899999999 799999999999999999999999999
Q ss_pred CchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCC
Q 024336 84 GELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY 147 (269)
Q Consensus 84 ~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~ 147 (269)
++|.+++.... .+++..+..++.|++.||++||+.|++|+||||+||+++.++. ++|+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCC
Confidence 99999986543 3788999999999999999999999999999999999998877 99999998
Q ss_pred cccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCC
Q 024336 148 SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226 (269)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (269)
+..............+..|+|||.+....++. ++|+||||+++++|++ |..||........ ...+... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~il~el~~~g~~pf~~~~~~~~----~~~~~~~-~~~~~ 232 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----YEKLPQG-YRLEK 232 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCc-hhhHHHHHHHHHHHHcCCCCCccccCHHHH----HHHHhCC-CCCCC
Confidence 85322211112222355799999987666544 4999999999999997 9999976543222 2222221 12222
Q ss_pred cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 227 YVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
....+.++.+++.+||..||.+|||+.+++..+
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 336788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=303.28 Aligned_cols=251 Identities=30% Similarity=0.496 Sum_probs=209.8
Q ss_pred eecccCceEEEEEEEecCCeEEEEEEee-cCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCchHH
Q 024336 10 ELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFA 88 (269)
Q Consensus 10 ~l~~g~~g~v~~~~~~~~~~~vaiK~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 88 (269)
.||+|.||+||.+++..+...+|||-++ ++....+-+..|+.+.++|+|.|||++.|.+.+++.+-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6899999999999999999999999987 444556678899999999999999999999999999999999999999999
Q ss_pred HHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC-CCCCCCCcccCCC
Q 024336 89 RICSA-GRF--SEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG-LLHSQPKSTVGTP 164 (269)
Q Consensus 89 ~~~~~-~~~--~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~-~~~~~~~~~~~~~ 164 (269)
+++.. +++ ++..+-.+.+||++||.|||.+.|||||||-+||+|+. ..+.+||+|||.++.. .......+..||.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-ySGvlKISDFGTsKRLAginP~TETFTGTL 740 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-YSGVLKISDFGTSKRLAGINPCTETFTGTL 740 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-ccceEEecccccchhhccCCccccccccch
Confidence 99653 566 78899999999999999999999999999999999973 3345999999988753 3344556778999
Q ss_pred cccCchhhccc-cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhh
Q 024336 165 AYIAPEVLARK-EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV 243 (269)
Q Consensus 165 ~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 243 (269)
.|+|||++..+ .-+.+++|||||||++.||.||++||....++.-..-.+ .+-+..+..|. .++.+.+.||.+|+.
T Consensus 741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-GmyKvHP~iPe--elsaeak~FilrcFe 817 (1226)
T KOG4279|consen 741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-GMYKVHPPIPE--ELSAEAKNFILRCFE 817 (1226)
T ss_pred hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-cceecCCCCcH--HHHHHHHHHHHHHcC
Confidence 99999999754 345777999999999999999999998665543221111 11112223333 688899999999999
Q ss_pred hCCCCCCCcHHHhhccChhhh
Q 024336 244 ADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 244 ~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+||.+||++.++|..||.+.-
T Consensus 818 pd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 818 PDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CCcccCccHHHhccCcccccC
Confidence 999999999999999998764
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=277.09 Aligned_cols=248 Identities=23% Similarity=0.360 Sum_probs=200.7
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|+||.||++.+. .+..+++|.+.......+.+.+|+.+++.++|+|++++++.+.. ...++++||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 578999999999999999999865 45669999887655455678899999999999999999999887 7789999999
Q ss_pred CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC--C
Q 024336 82 AGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--P 157 (269)
Q Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~--~ 157 (269)
++++|.+++.+. ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCCcceeeccCCCcccc
Confidence 999999999753 35788899999999999999999999999999999999998877 99999998864322211 1
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
....++..|+|||.+....++.+ +|+||||+++|+++| |..||......... ..+.. ....+.....+.++.+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVI----RALER-GYRMPRPENCPEELYN 234 (260)
T ss_pred cCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHhC-CCCCCCcccCCHHHHH
Confidence 12234567999999877666444 999999999999999 99999875543222 22222 2222333478899999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhcc
Q 024336 237 LLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
++.+||..+|.+||++.++++.+
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~~L 257 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQSVL 257 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHH
Confidence 99999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=282.97 Aligned_cols=251 Identities=26% Similarity=0.357 Sum_probs=202.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
+-|...+.||+|++|.||++.+..++..|++|.+..... ....+.+|+..++.++|||++++++++.+....++++
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 346677889999999999999998999999999875322 2235678999999999999999999999999999999
Q ss_pred eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 79 EYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
||+.+ ++.+.+.. ..++++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++... ...
T Consensus 101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~---~~~ 174 (313)
T cd06633 101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKS---SPA 174 (313)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCccc---CCC
Confidence 99965 67776654 456899999999999999999999999999999999999998877 999999987632 222
Q ss_pred CcccCCCcccCchhhcc--ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 158 KSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
....++..|+|||.+.. ....+.++|+||||+++|+|++|..||...+........ ............++..+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~ 250 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNDSPTLQSNEWTDSFR 250 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HhcCCCCCCccccCHHHH
Confidence 34567888999999753 222345599999999999999999999776543333222 111111112235678899
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+++.+||+.+|.+||++.+++.|+|+..
T Consensus 251 ~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 251 GFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 9999999999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=277.06 Aligned_cols=243 Identities=30% Similarity=0.398 Sum_probs=196.8
Q ss_pred ceecccCceEEEEEEEec-CC--eEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDKR-TK--ELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~-~~--~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|++|.||++.+.. ++ ..||+|.+..... ..+.+.+|+..+++++|||++++++.+.. ...++++|++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 33 3689998876543 34568889999999999999999999988 889999999999
Q ss_pred CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC----CC
Q 024336 84 GELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QP 157 (269)
Q Consensus 84 ~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~----~~ 157 (269)
++|.+.+.+.. .+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE--EEeccccccccccccccceecc
Confidence 99999997654 6899999999999999999999999999999999999998876 9999999886432211 11
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
....++..|+|||.+.+..++.. +|+||||+++++|++ |..||......+.... +.......+.....|..+.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 232 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK----IDKEGERLERPEACPQDIYN 232 (257)
T ss_pred cCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhcCCcCCCCccCCHHHHH
Confidence 12345678999999877776555 999999999999999 9999976544332222 22222222333367899999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhcc
Q 024336 237 LLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
++.+||..+|++||++.++++.+
T Consensus 233 li~~~l~~~p~~Rps~~~~~~~l 255 (257)
T cd05040 233 VMLQCWAHNPADRPTFAALREFL 255 (257)
T ss_pred HHHHHCCCCcccCCCHHHHHHHh
Confidence 99999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=282.08 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=197.7
Q ss_pred cccccceecccCceEEEEEEE----ecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEE
Q 024336 4 RYEPVKELGSGNFGVARLVRD----KRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTP--THLA 75 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~ 75 (269)
-|++++.||+|+||.||++.. ..++..||+|.+.... .....+.+|+.+++.++|||++++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 368999999999999999984 4568889999986432 2234688899999999999999999998875 5689
Q ss_pred EEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 76 IVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
+|+||+++++|.+++.+.. .+++..+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~ 162 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETD 162 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCccccccccC
Confidence 9999999999999986643 5899999999999999999999999999999999999998877 999999988743322
Q ss_pred CC----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCC-----------hhhHHHHHHHHhh
Q 024336 155 SQ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED-----------PRNFRKTIDRIRN 219 (269)
Q Consensus 155 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~-----------~~~~~~~~~~~~~ 219 (269)
.. .....++..|+|||.+.+..++. ++|+||||+++|+++|+..|...... .............
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYI-ASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCc-cccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 21 12334566799999987766654 49999999999999998766432111 1111112222222
Q ss_pred ccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 220 VQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 220 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
. ...+.+..++..+.+||.+||+.||.+||++.++++.+
T Consensus 242 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 242 G-KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred C-ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 1 22333446889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=279.56 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=201.3
Q ss_pred cccccccceecccCceEEEEEEEecCC---eEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTK---ELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~---~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
.++|++.+.||+|+||.||++.+..++ ..+|+|.+.... ...+.+.+|+..+++++|||++++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 368999999999999999999986443 379999886532 223567889999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 77 VMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
++||+++++|.+++... +.++...+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe--EEeCCCCccccccccc
Confidence 99999999999998764 46899999999999999999999999999999999999988776 9999999887433221
Q ss_pred CC----CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 156 QP----KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 156 ~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
.. .....+..|+|||.+.+..++.+ +|+||||+++|++++ |..||......... ..+... ...+....+
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~ 234 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVI----KAIEEG-YRLPAPMDC 234 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHH----HHHhCC-CcCCCCCCC
Confidence 11 11122457999999987666555 999999999999886 99999765543322 222222 223333468
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
++.+.+++.+|++.+|.+||++.++++.
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 262 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVSI 262 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=281.90 Aligned_cols=248 Identities=25% Similarity=0.357 Sum_probs=197.9
Q ss_pred cccccceecccCceEEEEEEEec-----CCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
+|++.+.||+|+||.||++.+.. ....+++|.+..... ....+.+|+..++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 235688888764432 23467889999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe
Q 024336 77 VMEYAAGGELFARICSA------------------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL 132 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i 132 (269)
++||+.+++|.+++... .++++..++.++.|++.||.+||+.|++|+||+|+||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999987542 247889999999999999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChh
Q 024336 133 DGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPR 208 (269)
Q Consensus 133 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~ 208 (269)
++++. ++|+|||++........ ......+..|+|||.+.+..++. ++|+||||+++++|+| |..||.......
T Consensus 161 ~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 161 AEGRK--MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT-QSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred cCCCc--EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcch-HhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 98776 99999998864322211 12223456899999987666644 4999999999999998 999997654322
Q ss_pred hHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
....... ....+....++.++.+++.+||+.+|.+||++.++++.+
T Consensus 238 ----~~~~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 238 ----LFNLLKT-GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred ----HHHHHhC-CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 2222221 122233347889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=284.44 Aligned_cols=252 Identities=26% Similarity=0.350 Sum_probs=202.9
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
.+.|...+.||+|++|.||++++..++..+++|.+..... ....+.+|+..++.++|+|++++.+++..+...++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 3568889999999999999999998999999998864322 223567899999999999999999999999999999
Q ss_pred EeecCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 78 MEYAAGGELFARIC-SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
+||+.+ ++.+.+. ...++++..+..++.|++.|+.+||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 94 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~--- 167 (308)
T cd06634 94 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP--- 167 (308)
T ss_pred EEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc--EEECCcccceeecC---
Confidence 999975 7777664 3456899999999999999999999999999999999999998776 99999998864322
Q ss_pred CCcccCCCcccCchhhcc--ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHH
Q 024336 157 PKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
.....+++.|+|||.+.+ ....+.++|+||||+++|+|++|..||.......... .+............++..+
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 243 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----HIAQNESPALQSGHWSEYF 243 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH----HHhhcCCCCcCcccccHHH
Confidence 233457789999999753 2223445999999999999999999987654322222 1122222222223678899
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.++|.+||..+|.+||++.+++.|+|+..
T Consensus 244 ~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 99999999999999999999999999765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=287.00 Aligned_cols=260 Identities=26% Similarity=0.369 Sum_probs=203.7
Q ss_pred cccccceecccCceEEEEEEEecC--CeEEEEEEeecCc---cccHHHHHHHHHHHhC-CCCCcceeeEEEEeC----Ce
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRT--KELVAVKYIERGK---KIDENVQREIINHRSL-RHPNIIRFKEVLLTP----TH 73 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~--~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~ 73 (269)
+|++.+.||+|+||.||++.+..+ +..||+|.+.... ...+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999877 8899999886432 1234567899999999 599999999875432 45
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
+++++++++ ++|.+.+.....+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE 157 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence 788999986 589999888888999999999999999999999999999999999999998887 99999998864322
Q ss_pred CCC-----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHh----------
Q 024336 154 HSQ-----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR---------- 218 (269)
Q Consensus 154 ~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~---------- 218 (269)
... .....++..|+|||.+.+....+.++|+||+|+++|++++|.+||.................
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 111 12235788899999887654445669999999999999999999976554322222111100
Q ss_pred -h------------c-cccCC-CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 219 -N------------V-QYFLP-DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 219 -~------------~-~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
. . ...+. .....+..+.+++.+||..||.+|||+.+++.|+|+..+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 0 0 00000 11245788999999999999999999999999999987753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=279.12 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=201.6
Q ss_pred ccccccceecccCceEEEEEEEecCCe---EEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKE---LVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|+..+.||+|++|.||++....++. .+++|.+.... ...+.+.+|+..++.++|+|++++.+++...+..+++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 578999999999999999999875554 69999886542 2235678899999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 78 MEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
|||+++++|.+++... +.+++..+..++.|++.|+++||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc--EEECCCccceecccccc
Confidence 9999999999998653 56899999999999999999999999999999999999998777 99999998864322211
Q ss_pred CC----cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 157 PK----STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 157 ~~----~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
.. ....+..|+|||.+....++.+ +|+||||+++|++++ |..||....... ....+... ...+....++
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~----~~~~i~~~-~~~~~~~~~~ 236 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHE----VMKAINDG-FRLPAPMDCP 236 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHH----HHHHHhcC-CCCCCCCCCC
Confidence 11 1112356999999887766554 999999999999997 999997655432 22222222 2333334688
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
..+.+++.+||+.+|.+||++.++++.+
T Consensus 237 ~~~~~li~~c~~~~p~~Rp~~~~i~~~l 264 (268)
T cd05063 237 SAVYQLMLQCWQQDRARRPRFVDIVNLL 264 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=281.62 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=202.9
Q ss_pred cccccccceecccCceEEEEEEEe----cCCeEEEEEEeecCccc--cHHHHHHHHHHHhCCCCCcceeeEEEEe--CCe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK----RTKELVAVKYIERGKKI--DENVQREIINHRSLRHPNIIRFKEVLLT--PTH 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~----~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 73 (269)
.+.|++.+.||+|+||.||++... .++..+|+|.+...... .+.+.+|+..++.++|+|++++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 357899999999999999999864 34789999998765543 5678899999999999999999999887 557
Q ss_pred EEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 74 LAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
.++++||+++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccccccccc
Confidence 899999999999999997654 5899999999999999999999999999999999999998877 9999999887533
Q ss_pred CCCC----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChh-----------hHHHHHHHH
Q 024336 153 LHSQ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR-----------NFRKTIDRI 217 (269)
Q Consensus 153 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~-----------~~~~~~~~~ 217 (269)
.... ......+..|+|||.+.+..++.. +|+||||+++++|+||..|+....... ........+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 2211 112234456999999877766544 999999999999999999986543221 011112222
Q ss_pred hhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
. .....+....++..+.+++.+||..+|.+|||+.++++.+
T Consensus 240 ~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05038 240 K-EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280 (284)
T ss_pred H-cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 2 2223333346788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=279.24 Aligned_cols=247 Identities=25% Similarity=0.369 Sum_probs=194.8
Q ss_pred ccccceecccCceEEEEEEEecCCe--EEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeC------Ce
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKE--LVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP------TH 73 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~--~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 73 (269)
+.+.+.||+|+||.||++....++. .+|+|.+.... ...+.+.+|+..++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4678999999999999999877664 68999876532 2345677899999999999999999987532 24
Q ss_pred EEEEEeecCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCC
Q 024336 74 LAIVMEYAAGGELFARICS------AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY 147 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~ 147 (269)
.++++||+.+++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence 6899999999999887742 234789999999999999999999999999999999999998877 99999999
Q ss_pred cccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhcccc
Q 024336 148 SKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYF 223 (269)
Q Consensus 148 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (269)
+........ ......++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||...... .....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~~~~~~~- 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENS----EIYDYLRQGNR- 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHcCCC-
Confidence 874322221 122345678999999887766554 999999999999999 78999765432 22222333221
Q ss_pred CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 224 LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+....++..+.++|.+||+.||.+|||+.++++++
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 222336889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=296.61 Aligned_cols=249 Identities=29% Similarity=0.421 Sum_probs=209.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc----cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
..|.-++.||.|+||.||-+++..+.+.||||.+..+.+. .+.+..|+.+|+++.|||.+.+.|+|..+...|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3467788999999999999999999999999998764433 345778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 79 EYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
|||-| +..+++.= .+++-+-+|..|+.+.+.||+|||+.+.+|||||..||+++..|. |||+|||++. ...+.
T Consensus 106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAs---i~~PA 179 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSAS---IMAPA 179 (948)
T ss_pred HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchh---hcCch
Confidence 99965 77787753 457889999999999999999999999999999999999999988 9999999886 34556
Q ss_pred CcccCCCcccCchhhc---cccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHH
Q 024336 158 KSTVGTPAYIAPEVLA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
.+..|||.|+|||++. .+.|+.+ .||||||++..++...++|+-+++. .....-|-...........++..+
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNA----MSALYHIAQNesPtLqs~eWS~~F 254 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNESPTLQSNEWSDYF 254 (948)
T ss_pred hcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchH----HHHHHHHHhcCCCCCCCchhHHHH
Confidence 6789999999999875 4667677 9999999999999999999876544 222222322222222233688999
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhccChh
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
..|+..||++-|.+|||++++|+|+|..
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~H~fv~ 282 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLKHRFVL 282 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence 9999999999999999999999999975
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=278.89 Aligned_cols=248 Identities=21% Similarity=0.317 Sum_probs=195.3
Q ss_pred ccccccceecccCceEEEEEEEecCCe----EEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKE----LVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
++|++.+.||+|+||+||++.+..++. .+++|.+.... .....+..|+..++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 579999999999999999999977665 47777765322 122456677888899999999999998754 45788
Q ss_pred EEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 77 VMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
++|++++++|.+++.. .+.+++..+..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVADLLYPDD 163 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEEcCCccceeccCCC
Confidence 9999999999999975 456899999999999999999999999999999999999998777 9999999986432222
Q ss_pred C---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 156 Q---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 156 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
. .....++..|+|||.+.+..++.+ +|+||||+++|++++ |..||....... . ...+.... ..+....++
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~-~---~~~~~~~~-~~~~~~~~~ 237 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHE-V---PDLLEKGE-RLAQPQICT 237 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHH-H---HHHHHCCC-cCCCCCCCC
Confidence 1 122345668999999987776544 999999999999998 999997654321 1 22222222 222233567
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.++.+++.+||..||.+|||+.++++.+
T Consensus 238 ~~~~~li~~c~~~~p~~Rps~~el~~~l 265 (279)
T cd05111 238 IDVYMVMVKCWMIDENVRPTFKELANEF 265 (279)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 8899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=283.09 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=200.0
Q ss_pred cccccccceecccCceEEEEEEEe-------cCCeEEEEEEeecCc--cccHHHHHHHHHHHhC-CCCCcceeeEEEEeC
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK-------RTKELVAVKYIERGK--KIDENVQREIINHRSL-RHPNIIRFKEVLLTP 71 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 71 (269)
.++|++.+.||+|+||.||++++. .++..||+|.+.... .....+.+|+..++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 367999999999999999999853 234579999886432 2335688899999999 899999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC
Q 024336 72 THLAIVMEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS 135 (269)
Q Consensus 72 ~~~~~v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~ 135 (269)
...++++||+++++|.+++.+. ..++...+..++.|++.||.|||+.|++|+||||+||+++.+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~ 173 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN 173 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCC
Confidence 9999999999999999998753 236778899999999999999999999999999999999987
Q ss_pred CCCcEEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHH
Q 024336 136 PQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFR 211 (269)
Q Consensus 136 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~ 211 (269)
+. ++|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|++++ |..||......
T Consensus 174 ~~--~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~---- 246 (304)
T cd05101 174 NV--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVE---- 246 (304)
T ss_pred Cc--EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHH----
Confidence 76 99999999874322211 122234567999999987766555 999999999999998 78888765432
Q ss_pred HHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 212 KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.....+.... .......++..+.++|.+||..+|.+|||+.++++.+
T Consensus 247 ~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 247 ELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred HHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 2233332222 1222336889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=283.57 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=198.7
Q ss_pred cccccccceecccCceEEEEEEEec-------CCeEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeC
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKR-------TKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTP 71 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 71 (269)
.++|.+.+.||+|++|.||++.+.. .+..+|+|.+..... ....+.+|+.+++.+ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 3689999999999999999998632 345799998765322 234577899999999 699999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC
Q 024336 72 THLAIVMEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS 135 (269)
Q Consensus 72 ~~~~~v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~ 135 (269)
+.+++++||+++++|.+++... ..++...+..++.|++.||.+||++|++|+||||+||+++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED 170 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCC
Confidence 9999999999999999998653 247889999999999999999999999999999999999988
Q ss_pred CCCcEEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHH
Q 024336 136 PQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFR 211 (269)
Q Consensus 136 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~ 211 (269)
+. ++|+|||.+........ ......+..|+|||.+.+..++.+ +|+||||+++|++++ |..||.......
T Consensus 171 ~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~~~~~~--- 244 (314)
T cd05099 171 NV--MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIPVEE--- 244 (314)
T ss_pred Cc--EEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc-chhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 77 99999999874322111 112223457999999987666554 999999999999999 889997654322
Q ss_pred HHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 212 KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
....+.... .......++.++.++|.+||..+|++|||+.++++.+.
T Consensus 245 -~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 245 -LFKLLREGH-RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred -HHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 222222221 11122367889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=288.13 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=196.4
Q ss_pred cccccccceecccCceEEEEEEEe-----cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeC-C
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTP-T 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~ 72 (269)
.++|++.+.||+|+||.||+|.+. .+++.||+|.+..... ....+.+|+.++.++ +|+|++++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 468999999999999999999853 4578899999875332 234577899999999 689999999987654 4
Q ss_pred eEEEEEeecCCCchHHHHHhc-----------------------------------------------------------
Q 024336 73 HLAIVMEYAAGGELFARICSA----------------------------------------------------------- 93 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~----------------------------------------------------------- 93 (269)
.+++++||+++++|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 689999999999999988642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC---CCcccC
Q 024336 94 --------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVG 162 (269)
Q Consensus 94 --------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~ 162 (269)
..++...+..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++........ .....+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCCCCC
Confidence 13577888899999999999999999999999999999998776 99999998864322111 112234
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHH
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 241 (269)
+..|+|||.+.+..++.+ +|+||||+++|++++ |..||........... .+.... ..+.....++++.+++.+|
T Consensus 244 ~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR---RLKEGT-RMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CcceECcHHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHH---HHhccC-CCCCCCCCCHHHHHHHHHH
Confidence 567999999877766555 999999999999997 8999976543322222 122211 1122225678999999999
Q ss_pred hhhCCCCCCCcHHHhhcc
Q 024336 242 FVADPSKDPHSRDQKASL 259 (269)
Q Consensus 242 l~~~p~~Rps~~~~l~~~ 259 (269)
|+.||.+|||+.++++++
T Consensus 319 l~~~p~~Rps~~eil~~l 336 (343)
T cd05103 319 WHGEPSQRPTFSELVEHL 336 (343)
T ss_pred ccCChhhCcCHHHHHHHH
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=291.40 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=199.0
Q ss_pred ccccccceecccCceEEEEEEEe-----cCCeEEEEEEeecCccc--cHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKKI--DENVQREIINHRSLR-HPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 74 (269)
++|.+.+.||+|+||.||++.+. .+++.||+|++...... .+.+.+|+.++.++. ||||+++++++...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 56888999999999999999864 34578999999754222 246778999999997 99999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcC------------------------------------------------------------
Q 024336 75 AIVMEYAAGGELFARICSAG------------------------------------------------------------ 94 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~------------------------------------------------------------ 94 (269)
++|+||+++|+|.+++...+
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999886432
Q ss_pred --------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC
Q 024336 95 --------------------------------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP 136 (269)
Q Consensus 95 --------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~ 136 (269)
.++...+..++.|++.||.|||+.+++|+||||+||+++.++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence 256677888999999999999999999999999999998777
Q ss_pred CCcEEEeecCCcccCCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 024336 137 QPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRK 212 (269)
Q Consensus 137 ~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~ 212 (269)
. ++|+|||++....... ......++..|+|||.+.+..+.. ++|+||||+++++|++ |..||...........
T Consensus 277 ~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 277 L--VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT-LSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred E--EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCc-HhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 6 9999999986432211 112234567899999998776654 4999999999999998 8899876544333222
Q ss_pred HHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.. .. ....+.+..++.++.+++.+||..+|.+||++++++..+
T Consensus 354 ~~---~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 354 AI---KR-GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred HH---Hc-CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 22 11 122223336789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=280.15 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=200.7
Q ss_pred cccccccceecccCceEEEEEEEec-----CCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
.++|++.+.||+|+||.||++.+.. ++..||+|.+..... ....+.+|+..++.++|||++++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 3689999999999999999999753 578899998865422 234578899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe
Q 024336 75 AIVMEYAAGGELFARICSAG----------------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL 132 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~----------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i 132 (269)
++++||+++++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~ 163 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV 163 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence 99999999999999986432 36788899999999999999999999999999999999
Q ss_pred cCCCCCcEEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChh
Q 024336 133 DGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPR 208 (269)
Q Consensus 133 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~ 208 (269)
+.++. ++|+|||.+........ ......+..|+|||.+.+..++.+ +|+||||+++|+|++ |..||......
T Consensus 164 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 164 GENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred cCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 98877 99999998864322211 122234567999999887776554 999999999999998 87888755432
Q ss_pred hHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+....+..... .+.....+.++.++|.+||+.+|.+|||+.|++..+
T Consensus 240 ---~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l 286 (288)
T cd05050 240 ---EVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286 (288)
T ss_pred ---HHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 22233333322 122236789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=284.51 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=192.4
Q ss_pred CceEEEEEEEecCCeEEEEEEeecC---ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCchHHHHH
Q 024336 15 NFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARIC 91 (269)
Q Consensus 15 ~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~ 91 (269)
+.|.||.+++..+++.||+|.+... ......+.+|+..++.++|+||+++++++..++..++++||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4456677777778999999998754 2334568899999999999999999999999999999999999999999987
Q ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--------CCCccc
Q 024336 92 SA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--------QPKSTV 161 (269)
Q Consensus 92 ~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--------~~~~~~ 161 (269)
+. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++++||+.+....... ......
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeecccccccccccccccccc
Confidence 53 45889999999999999999999999999999999999998877 9999999875322111 112234
Q ss_pred CCCcccCchhhcccc-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc--------------------
Q 024336 162 GTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-------------------- 220 (269)
Q Consensus 162 ~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-------------------- 220 (269)
++..|+|||.+.... ..+.++|+||+|+++++|++|..||..........+........
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 567899999987542 23455999999999999999999998755433222211100000
Q ss_pred --------cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 221 --------QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 221 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.........++.++.+++.+||..||++|||+.++++|+|+..+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000000112346788999999999999999999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=278.74 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=200.2
Q ss_pred cccccccceecccCceEEEEEEEec----CCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEe-CCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKR----TKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLT-PTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~----~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 74 (269)
.++|++.+.||+|+||.||++.+.. ++..|++|.+.... ...+.+.+|+..++.++|+|++++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4689999999999999999999875 35789999876432 223557889999999999999999998766 4678
Q ss_pred EEEEeecCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecC
Q 024336 75 AIVMEYAAGGELFARICSA--------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG 146 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~ 146 (269)
+++++++++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kl~d~g 162 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITDNA 162 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc--EEECCCC
Confidence 9999999999999998653 35889999999999999999999999999999999999998877 9999999
Q ss_pred CcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccc
Q 024336 147 YSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQY 222 (269)
Q Consensus 147 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 222 (269)
+++....... .....++..|+|||.+.+..++.+ +||||||+++|++++ |..||....... ....+.. ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~-~~ 236 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFE----MAAYLKD-GY 236 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCHHH----HHHHHHc-CC
Confidence 9864322211 122334567999999977766555 999999999999999 999997654322 2222222 22
Q ss_pred cCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 223 FLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 223 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
..+....+++.+.+++.+||..||++|||+.+++..+
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 2233346789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=282.79 Aligned_cols=260 Identities=28% Similarity=0.401 Sum_probs=212.8
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC-C-C----CcceeeEEEEeCCeE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-H-P----NIIRFKEVLLTPTHL 74 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h-~----~i~~~~~~~~~~~~~ 74 (269)
+.++|.++..+|+|.||.|..+.+..++..||+|++..-.+..+...-|++++.++. + | -++.+.++|...+..
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 468999999999999999999999999999999999877777788888999999993 2 2 267777789999999
Q ss_pred EEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC----------------
Q 024336 75 AIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP---------------- 136 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~---------------- 136 (269)
|+|+|.+ |-|+.+.+.+++ +++...++.|++|+++++.+||+.+++|.|+||+||++.++.
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 9999999 558999997754 689999999999999999999999999999999999984221
Q ss_pred --CCcEEEeecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHH
Q 024336 137 --QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214 (269)
Q Consensus 137 --~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~ 214 (269)
+..|+++|||.+... .+.......|..|.|||++.+-.|+.+ +||||+||||.|++||...|..-++.+.+ .++
T Consensus 246 ~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL-aMM 321 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL-AMM 321 (415)
T ss_pred CCCcceEEEecCCccee--ccCcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH-HHH
Confidence 124899999999843 333466678999999999999999777 99999999999999999999988776655 233
Q ss_pred HHHhh------------------ccccCCCc-----------------------CCCCHHHHHHHHHHhhhCCCCCCCcH
Q 024336 215 DRIRN------------------VQYFLPDY-----------------------VRVSADCRHLLSQIFVADPSKDPHSR 253 (269)
Q Consensus 215 ~~~~~------------------~~~~~~~~-----------------------~~~~~~~~~li~~~l~~~p~~Rps~~ 253 (269)
+.+.. +...+++. ..-..++.+||++||..||.+|+|+.
T Consensus 322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~ 401 (415)
T KOG0671|consen 322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR 401 (415)
T ss_pred HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence 22221 11111110 00013588999999999999999999
Q ss_pred HHhhccChhhhh
Q 024336 254 DQKASLVPEEFA 265 (269)
Q Consensus 254 ~~l~~~~~~~~~ 265 (269)
|+|.||||....
T Consensus 402 EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 402 EALSHPFFARLT 413 (415)
T ss_pred HHhcCHHhhcCC
Confidence 999999998653
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=275.78 Aligned_cols=249 Identities=30% Similarity=0.447 Sum_probs=199.9
Q ss_pred cccccceecccCceEEEEEEEec-CCeEEEEEEeecCcc-----------ccHHHHHHHHHHHh-CCCCCcceeeEEEEe
Q 024336 4 RYEPVKELGSGNFGVARLVRDKR-TKELVAVKYIERGKK-----------IDENVQREIINHRS-LRHPNIIRFKEVLLT 70 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~-----------~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 70 (269)
.|++.+.||+|++|.||++.+.. +++.+|+|.+..... ....+.+|+.++.+ ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 678899998753211 11235567777764 799999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCCcEEEeec
Q 024336 71 PTHLAIVMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDF 145 (269)
Q Consensus 71 ~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~~~~~l~df 145 (269)
++..++++||+++++|.+++.. ...+++..++.++.|++.+|.+||+ .|++|+||+|+||+++.++. ++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecc
Confidence 9999999999999999888743 3468999999999999999999996 78999999999999998887 999999
Q ss_pred CCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC
Q 024336 146 GYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225 (269)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (269)
|.+.............++..|+|||.+.+..+.. ++|+||||+++|++++|..||....... ....+........
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~-~~Dv~slG~ll~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~ 233 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGE-KADVWAFGCILYQMCTLQPPFYSTNMLS----LATKIVEAVYEPL 233 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCch-HHHHHHHHHHHHHHHhCCCcccccCHHH----HHHHHhhccCCcC
Confidence 9987543333333456788899999998766644 4999999999999999999997654322 2222222222222
Q ss_pred CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 226 DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
....+++.+.++|.+||+.||.+||++.|+.++.
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~ 267 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence 2235789999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=278.41 Aligned_cols=241 Identities=18% Similarity=0.231 Sum_probs=191.2
Q ss_pred ceecccCceEEEEEEEecCCe-------EEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 9 KELGSGNFGVARLVRDKRTKE-------LVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~-------~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+.||+|+||.||++.+...+. .+++|.+.... ...+.+.+|+..++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999999865443 38888775433 2235677899999999999999999999998999999999
Q ss_pred cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCC------cEEEeecCCcccCCC
Q 024336 81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP------RLKICDFGYSKSGLL 153 (269)
Q Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~------~~~l~df~~~~~~~~ 153 (269)
+++++|..++...+ .+++..+..++.|++.||++||+.|++|+||||+||+++.++.. .++++|||.+....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~- 159 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL- 159 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC-
Confidence 99999999997644 58999999999999999999999999999999999999876642 36999999876322
Q ss_pred CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCC-CCCCCCCChhhHHHHHHHHhhccccCCCcCCCCH
Q 024336 154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA-YPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232 (269)
Q Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
......++..|+|||.+.+....+.++|+||||+++|++++|. .||......... . ........+. ..+.
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~----~~~~~~~~~~--~~~~ 230 (258)
T cd05078 160 --PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-Q----FYEDRHQLPA--PKWT 230 (258)
T ss_pred --CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-H----HHHccccCCC--CCcH
Confidence 2233456778999999987554455699999999999999985 666544332211 1 1112223333 4668
Q ss_pred HHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 233 DCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
++.++|.+||+.||.+|||++++++.+
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=274.86 Aligned_cols=245 Identities=26% Similarity=0.352 Sum_probs=188.8
Q ss_pred ceecccCceEEEEEEEe--cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCC
Q 024336 9 KELGSGNFGVARLVRDK--RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG 84 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (269)
+.||+|+||.||++... .++..+++|.+..... ....+.+|+..+++++|||++++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999864 3456799998765432 2235778999999999999999999999999999999999999
Q ss_pred chHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC---C
Q 024336 85 ELFARICSAG-----RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---Q 156 (269)
Q Consensus 85 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~---~ 156 (269)
+|.+++.... ..+...+..++.|++.|+.+||+.|++|+||||+||+++.++. ++|+|||.+....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEECCccccccccCcceeec
Confidence 9999986532 3567788899999999999999999999999999999998777 9999999886422211 1
Q ss_pred CCcccCCCcccCchhhcccc------CCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCC---
Q 024336 157 PKSTVGTPAYIAPEVLARKE------YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--- 226 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 226 (269)
.....++..|+|||.+.... ..+.++|+||||+++|+|++ |..||............ +.......+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~ 235 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT---VREQQLKLPKPRL 235 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---hhcccCCCCCCcc
Confidence 12234567899999986432 12456999999999999996 99999776554332221 1111111111
Q ss_pred cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 227 YVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
....++.+.+++.+|+ .+|.+|||+++++..+
T Consensus 236 ~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 1246788999999998 6899999999998754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=272.59 Aligned_cols=242 Identities=25% Similarity=0.360 Sum_probs=194.3
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCch
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
+.||+|++|.||++... ++..+|+|.+..... ....+.+|+..++.++|||++++++++...+..++|+||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46899999999999865 678899998765432 233577899999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC--CcccCC
Q 024336 87 FARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVGT 163 (269)
Q Consensus 87 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~ 163 (269)
.+++... ..+++..+..++.+++.+|.++|+.|++|+||+|+||+++.++. ++|+|||++......... .....+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCc
Confidence 9988653 45789999999999999999999999999999999999998877 999999988632221111 122335
Q ss_pred CcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 164 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 164 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
..|+|||.+.+..++.+ +|+||||+++|++++ |..||......... ..+... ........++..+.+++.+||
T Consensus 158 ~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~li~~~l 231 (250)
T cd05085 158 IKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQAR----EQVEKG-YRMSCPQKCPDDVYKVMQRCW 231 (250)
T ss_pred ccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHH----HHHHcC-CCCCCCCCCCHHHHHHHHHHc
Confidence 67999999977766555 999999999999998 99999765443222 222222 111222368899999999999
Q ss_pred hhCCCCCCCcHHHhhcc
Q 024336 243 VADPSKDPHSRDQKASL 259 (269)
Q Consensus 243 ~~~p~~Rps~~~~l~~~ 259 (269)
..+|.+||++.++++.+
T Consensus 232 ~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 232 DYKPENRPKFSELQKEL 248 (250)
T ss_pred ccCcccCCCHHHHHHHh
Confidence 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=272.01 Aligned_cols=242 Identities=26% Similarity=0.367 Sum_probs=195.9
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCch
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
+.||+|++|.||++.+.. ++.|++|.+..... ....+.+|+.++++++|+|++++++++......++|+|++++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 478999999999999987 89999998875433 345688899999999999999999999999999999999999999
Q ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC---CcccC
Q 024336 87 FARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVG 162 (269)
Q Consensus 87 ~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~ 162 (269)
.+++.. ...++...+..++.+++.+|.+||++|++|+||+|+||+++.++. ++|+|||.+......... .....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcceeccccCcc
Confidence 999865 346889999999999999999999999999999999999998887 999999988643211111 11223
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHH
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 241 (269)
+..|+|||.+.+..++. ++|+||||+++|+|+| |..||.......... .+.. ....+.....+..+.++|.+|
T Consensus 158 ~~~y~~PE~~~~~~~~~-~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li~~~ 231 (251)
T cd05041 158 PIKWTAPEALNYGRYTS-ESDVWSYGILLWETFSLGDTPYPGMSNQQTRE----RIES-GYRMPAPQLCPEEIYRLMLQC 231 (251)
T ss_pred eeccCChHhhccCCCCc-chhHHHHHHHHHHHHhccCCCCccCCHHHHHH----HHhc-CCCCCCCccCCHHHHHHHHHH
Confidence 45699999987776644 4999999999999999 888887655422221 2221 112222336789999999999
Q ss_pred hhhCCCCCCCcHHHhhcc
Q 024336 242 FVADPSKDPHSRDQKASL 259 (269)
Q Consensus 242 l~~~p~~Rps~~~~l~~~ 259 (269)
|..+|.+||++.++++.+
T Consensus 232 l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 232 WAYDPENRPSFSEIYNEL 249 (251)
T ss_pred hccChhhCcCHHHHHHHh
Confidence 999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=272.64 Aligned_cols=240 Identities=25% Similarity=0.391 Sum_probs=190.4
Q ss_pred eecccCceEEEEEEEe--cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCc
Q 024336 10 ELGSGNFGVARLVRDK--RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGE 85 (269)
Q Consensus 10 ~l~~g~~g~v~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (269)
.||+|+||.||++.+. .++..||+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...++|+||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999765 4466799998865432 23457899999999999999999998754 56899999999999
Q ss_pred hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC----CCcc
Q 024336 86 LFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKST 160 (269)
Q Consensus 86 l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~----~~~~ 160 (269)
|.+++.. ...+++..+..++.|++.||.+||++|++|+||||+||+++.++. ++|+|||++........ ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCC
Confidence 9998864 456899999999999999999999999999999999999998877 99999998863322211 1111
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhcc-ccCCCcCCCCHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRVSADCRHLL 238 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li 238 (269)
..+..|+|||.+....++. ++|+||||+++|++++ |..||........ ...+.... ...+ ...++++.++|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~~~~l~~li 231 (257)
T cd05115 159 KWPLKWYAPECINFRKFSS-RSDVWSYGITMWEAFSYGQKPYKKMKGPEV----MSFIEQGKRLDCP--AECPPEMYALM 231 (257)
T ss_pred CCCcccCCHHHHccCCCCc-hhhHHHHHHHHHHHhcCCCCCcCcCCHHHH----HHHHHCCCCCCCC--CCCCHHHHHHH
Confidence 2346799999987766644 4999999999999996 9999987654322 22222221 2222 36789999999
Q ss_pred HHHhhhCCCCCCCcHHHhhcc
Q 024336 239 SQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+||..+|++||++.++.+.+
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~~l 252 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEERM 252 (257)
T ss_pred HHHcCCChhhCcCHHHHHHHH
Confidence 999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=285.72 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=199.2
Q ss_pred ccccccceecccCceEEEEEEEecC-------CeEEEEEEeecCc--cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRT-------KELVAVKYIERGK--KIDENVQREIINHRSL-RHPNIIRFKEVLLTPT 72 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~-------~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 72 (269)
.+|++.+.||+|+||.||++.+... +..||+|.+.... ...+.+.+|+.+++++ +||||+++++++..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 5799999999999999999987432 2368999876432 2235688899999999 7999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC
Q 024336 73 HLAIVMEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP 136 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~ 136 (269)
..++++||+++++|.+++.+.. .++...+..++.|++.||.+||+.|++|+||+|+||+++.++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~ 171 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN 171 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence 9999999999999999986532 367888999999999999999999999999999999999887
Q ss_pred CCcEEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 024336 137 QPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRK 212 (269)
Q Consensus 137 ~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~ 212 (269)
. ++|+|||++........ .....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||.......
T Consensus 172 ~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~---- 244 (334)
T cd05100 172 V--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 244 (334)
T ss_pred c--EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 7 99999998864322211 112223457999999987777555 999999999999998 888987654322
Q ss_pred HHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
....+... ...+.....+..+.++|.+||..+|.+||++.++++++.
T Consensus 245 ~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 245 LFKLLKEG-HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred HHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 22222221 122223367889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=276.12 Aligned_cols=250 Identities=27% Similarity=0.364 Sum_probs=199.1
Q ss_pred cccccccceecccCceEEEEEEEecC---CeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
.++|.+.+.||+|++|.||++.+... ...|++|...... ...+.+.+|+..++.++|||++++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 35789999999999999999987643 3468999876442 234568889999999999999999998875 45789
Q ss_pred EEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 77 VMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
++||+++++|.+++.+.. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeeccccc
Confidence 999999999999997644 5899999999999999999999999999999999999998777 9999999886432221
Q ss_pred C--CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCH
Q 024336 156 Q--PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232 (269)
Q Consensus 156 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
. ......+..|+|||.+....++.+ +|+||||++++++++ |..||.......... .+.... ..+....+|.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~----~~~~~~-~~~~~~~~~~ 235 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIG----RIENGE-RLPMPPNCPP 235 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHHcCC-cCCCCCCCCH
Confidence 1 112223457999999876666544 999999999999986 999997765433222 222221 1222347889
Q ss_pred HHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 233 DCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
.+.++|.+|+..+|.+|||+.++++.+-
T Consensus 236 ~~~~li~~~l~~~P~~Rpt~~~~~~~l~ 263 (270)
T cd05056 236 TLYSLMTKCWAYDPSKRPRFTELKAQLS 263 (270)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=273.78 Aligned_cols=240 Identities=21% Similarity=0.220 Sum_probs=191.1
Q ss_pred ceecccCceEEEEEEEecCC----------eEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 9 KELGSGNFGVARLVRDKRTK----------ELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
+.||+|+||.||++.+..++ ..+++|.+.........+.+|+..++.++|||++++++++.. ...++|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999998766 357888776554435678899999999999999999999888 7789999
Q ss_pred eecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCC-----cEEEeecCCcccCC
Q 024336 79 EYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP-----RLKICDFGYSKSGL 152 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~-----~~~l~df~~~~~~~ 152 (269)
||+++++|.+++...+ .++...+..++.|++.||.+||+.|++|+||||+||+++.++.. .++|+|||++....
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~ 159 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence 9999999999997766 78999999999999999999999999999999999999877621 49999999887432
Q ss_pred CCCCCCcccCCCcccCchhhccc-cCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARK-EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
. .....++..|+|||.+... ...+.++|+||||++++++++ |..||........ .... . .....+. ..
T Consensus 160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-~~~~---~-~~~~~~~--~~ 229 (259)
T cd05037 160 S---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-ERFY---Q-DQHRLPM--PD 229 (259)
T ss_pred c---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-HHHH---h-cCCCCCC--CC
Confidence 2 2334456789999998766 234555999999999999999 5777766542211 1111 1 1111122 22
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
...+.++|.+||..+|.+|||+.++++.+
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 37899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=274.74 Aligned_cols=245 Identities=23% Similarity=0.376 Sum_probs=188.3
Q ss_pred ceecccCceEEEEEEEec--CCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCC
Q 024336 9 KELGSGNFGVARLVRDKR--TKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG 84 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (269)
+.||+|+||.||++.... ....+++|.+..... ....+.+|+..++.++|+||+++++.+......++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 468999999999997543 345788887654322 2235678999999999999999999999999999999999999
Q ss_pred chHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC---C
Q 024336 85 ELFARICSAGR-----FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---Q 156 (269)
Q Consensus 85 ~l~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~---~ 156 (269)
+|.+++..... .++..+..++.|++.||+|||++|++|+||||+||+++.++. ++|+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheec
Confidence 99999866432 467788999999999999999999999999999999998887 9999999886422211 1
Q ss_pred CCcccCCCcccCchhhccc------cCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCC---
Q 024336 157 PKSTVGTPAYIAPEVLARK------EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--- 226 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 226 (269)
.....++..|+|||.+... ...+.++|+||||+++|+|++ |..||.............. ......+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~ 235 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR---EQDIKLPKPQL 235 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh---ccCccCCCCcc
Confidence 1223456679999987532 233556999999999999999 7888876655443333222 22212211
Q ss_pred cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 227 YVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
...++..+.+++..|+ .||.+|||++++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 2257888999999998 5999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=290.19 Aligned_cols=250 Identities=32% Similarity=0.570 Sum_probs=216.6
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecC---ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCC
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG 84 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (269)
.+.||+|-||+||-+++..+|+.||||++.+- .+....+++|+.+|+++.||+||.+...|++.+.+++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 47899999999999999999999999998753 34557899999999999999999999999999999999999966
Q ss_pred chHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CCcEEEeecCCcccCCCCCCCCccc
Q 024336 85 ELFARIC--SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQPKSTV 161 (269)
Q Consensus 85 ~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~~~~~~~~~~~ 161 (269)
+.++.|- +.+++++..-..++.||+.||.|||-+||+|+|+||+||++.+.. .+.+||||||.++............
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVV 727 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVV 727 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhc
Confidence 6666663 456799999999999999999999999999999999999996543 3679999999999766666667788
Q ss_pred CCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC--CCcCCCCHHHHHHHH
Q 024336 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLLS 239 (269)
Q Consensus 162 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~ 239 (269)
|||.|+|||++.++.+... -|+||+|+|+|--++|..||...++ .-++++...+.+ ..|+.++++..+||.
T Consensus 728 GTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEd------IndQIQNAaFMyPp~PW~eis~~AidlIn 800 (888)
T KOG4236|consen 728 GTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDED------INDQIQNAAFMYPPNPWSEISPEAIDLIN 800 (888)
T ss_pred CCccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccc------hhHHhhccccccCCCchhhcCHHHHHHHH
Confidence 9999999999999888666 8999999999999999999976543 233444444433 457889999999999
Q ss_pred HHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 240 QIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.+|+..-.+|-|.+..+.|+|.+..-
T Consensus 801 ~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 801 NLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHHHhcchHhhccchhhhcch
Confidence 99999999999999999999998754
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=275.32 Aligned_cols=248 Identities=31% Similarity=0.469 Sum_probs=199.1
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc------cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK------KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
+|.+.+.||+|++|.||++.+..++..+++|...... .....+..|+.+++.++|||++++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6899999999999999999998777667666654311 1223466788999999999999999999999999999
Q ss_pred EeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 78 MEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
+||+++++|.+.+.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++. +. ++|+|||.+.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~--~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NL--LKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CC--EeecccCceeecCC
Confidence 999999999888753 356899999999999999999999999999999999999974 33 99999998864322
Q ss_pred CC-CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc-cccCCCcCCCC
Q 024336 154 HS-QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVS 231 (269)
Q Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (269)
.. ......+++.|+|||.+.+..++.+ +|+||+|+++++|++|..||...... ......... ....+ ..++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~----~~~~~~~~~~~~~~~--~~~~ 230 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFL----SVVLRIVEGPTPSLP--ETYS 230 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHHcCCCCCCc--chhc
Confidence 22 2223457788999999876666555 99999999999999999999654332 222222222 12222 3678
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.++.++|.+||..+|.+||++.+++.|+|+
T Consensus 231 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 231 RQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=273.28 Aligned_cols=243 Identities=27% Similarity=0.388 Sum_probs=197.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
++|++.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+..++.++|||++++++++..+ ..++++||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5799999999999999999875 57789999886542 346788999999999999999999998765 4799999999
Q ss_pred CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcc
Q 024336 83 GGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST 160 (269)
Q Consensus 83 ~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (269)
+++|.+++.... .+++..+..++.|++.|+.+||+.|++||||+|+||+++.++. ++|+|||++..... .....
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~--~~~~~ 157 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSM--GVDNS 157 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceeccc--cCCCC
Confidence 999999987543 4789999999999999999999999999999999999998877 99999998864321 12223
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
..+..|+|||.+.+..++.+ +|+||||+++|+|++ |..||........ ...+... ........++..+.+++.
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~li~ 231 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEV----KECVEKG-YRMEPPEGCPADVYVLMT 231 (254)
T ss_pred CCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHHH----HHHHhCC-CCCCCCCcCCHHHHHHHH
Confidence 34567999999877666554 999999999999997 9999976554322 2222222 222223368899999999
Q ss_pred HHhhhCCCCCCCcHHHhhcc
Q 024336 240 QIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~ 259 (269)
+||+.+|.+||++.++++.+
T Consensus 232 ~~l~~~p~~Rp~~~~l~~~l 251 (254)
T cd05083 232 SCWETEPKKRPSFHKLREKL 251 (254)
T ss_pred HHcCCChhhCcCHHHHHHHH
Confidence 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=275.59 Aligned_cols=240 Identities=22% Similarity=0.263 Sum_probs=188.4
Q ss_pred eecccCceEEEEEEEecC------------------------CeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCccee
Q 024336 10 ELGSGNFGVARLVRDKRT------------------------KELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRF 64 (269)
Q Consensus 10 ~l~~g~~g~v~~~~~~~~------------------------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~ 64 (269)
.||+|+||.||++....+ ...|++|.+..... ....+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999975322 24588888765432 23457788899999999999999
Q ss_pred eEEEEeCCeEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC-----C
Q 024336 65 KEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-----P 138 (269)
Q Consensus 65 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~-----~ 138 (269)
++++.++...++||||+++++|..++.+ .+.+++..+..++.|++.||+|||++|++|+||||+||+++..+. .
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 9999999999999999999999988865 456899999999999999999999999999999999999975432 2
Q ss_pred cEEEeecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHH-hCCCCCCCCCChhhHHHHHHHH
Q 024336 139 RLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRI 217 (269)
Q Consensus 139 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~-tg~~pf~~~~~~~~~~~~~~~~ 217 (269)
.++++|||.+..... .....++..|+|||.+.+....+.++|+||||+++|+++ +|..||........ ....
T Consensus 162 ~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~~--- 234 (274)
T cd05076 162 FIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFY--- 234 (274)
T ss_pred eeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHHH---
Confidence 479999998753211 122346778999998876544456699999999999985 68999976544222 1111
Q ss_pred hhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
......+. ..++.+.++|.+||+.+|.+|||+.++++++
T Consensus 235 -~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 235 -EKKHRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -HhccCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11222232 4567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=274.12 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=199.6
Q ss_pred cccccccceecccCceEEEEEEEecCCe----EEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKE----LVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
..+|++.+.||+|+||.||++.+..+|+ .+|+|....... ....+.+|+..+++++|+|++++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3679999999999999999999876654 588998765432 23567889999999999999999999887 7889
Q ss_pred EEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 76 IVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
+++||+++++|.+.+.+. ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~~ 162 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVD 162 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccCc
Confidence 999999999999998764 46899999999999999999999999999999999999988777 999999988743322
Q ss_pred CCCC---cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 155 SQPK---STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 155 ~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
.... ....+..|+|||.+....++.. +|+||||++++++++ |..||......+ ....+... ...+.....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~~~ 236 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVE----IPDLLEKG-ERLPQPPIC 236 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHH----HHHHHhCC-CCCCCCCCC
Confidence 2111 1223467999999876666544 999999999999998 999997754422 22222222 122333357
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+..+.+++.+||..||.+||++.++++.+
T Consensus 237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l 265 (279)
T cd05057 237 TIDVYMVLVKCWMIDAESRPTFKELINEF 265 (279)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 78999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=272.28 Aligned_cols=241 Identities=21% Similarity=0.255 Sum_probs=187.7
Q ss_pred ceecccCceEEEEEEEec------------CCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 9 KELGSGNFGVARLVRDKR------------TKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~------------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
+.||+|+||.||++.... ....+++|.+..... ....+.+|+..++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998542 233588888765432 2345778889999999999999999999988999
Q ss_pred EEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC-----CcEEEeecCCcc
Q 024336 76 IVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-----PRLKICDFGYSK 149 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~-----~~~~l~df~~~~ 149 (269)
+++||+++++|..++.. ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++. ..++++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 99999999999888865 456899999999999999999999999999999999999976543 238999999876
Q ss_pred cCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHH-hCCCCCCCCCChhhHHHHHHHHhhccccCCCcC
Q 024336 150 SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228 (269)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (269)
... ......++..|+|||.+......+.++||||||+++|+|+ +|..||........ ........... .
T Consensus 161 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-----~~~~~~~~~~~--~ 230 (262)
T cd05077 161 TVL---SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-----ERFYEGQCMLV--T 230 (262)
T ss_pred ccc---CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-----HHHHhcCccCC--C
Confidence 332 1223446778999999875554455699999999999997 58888865432111 11112222111 2
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 229 RVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
..++++.++|.+||+.||.+||++.+++.++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 4567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=307.96 Aligned_cols=253 Identities=30% Similarity=0.419 Sum_probs=201.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC--ccccHHHHHHHHHHHhCCCCCcceeeEEEE-----------
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLL----------- 69 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----------- 69 (269)
++|+.++.||+||||.||+|+++-+|..||||.++.. ......+.+|+..+.+|+|||||+++..|.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 5789999999999999999999999999999999755 444566889999999999999999876542
Q ss_pred --------------------------------------------------------------------------------
Q 024336 70 -------------------------------------------------------------------------------- 69 (269)
Q Consensus 70 -------------------------------------------------------------------------------- 69 (269)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred --------------------eC--------CeEEEEEeecCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCc
Q 024336 70 --------------------TP--------THLAIVMEYAAGGELFARICSAGRF-SEDEARFFFQQLISGVSYCHSMEI 120 (269)
Q Consensus 70 --------------------~~--------~~~~~v~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~i~~~l~~lh~~~i 120 (269)
.+ ..+|+-||||+..++.+++..+... .....|+++++|++||.|+|++|+
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 00 2378999999987777777666554 588999999999999999999999
Q ss_pred eeecCCCCcEEecCCCCCcEEEeecCCcccCC-------------------CCCCCCcccCCCcccCchhhcccc--CCC
Q 024336 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-------------------LHSQPKSTVGTPAYIAPEVLARKE--YDG 179 (269)
Q Consensus 121 ~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~~~--~~~ 179 (269)
+||||||.|||++.+.+ |||+|||++.... .........||.-|.|||.+.+.. .+.
T Consensus 719 IHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred eeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999998888 9999999986411 011123456888999999998765 345
Q ss_pred ccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCc--CCCCHHHHHHHHHHhhhCCCCCCCcHHHhh
Q 024336 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY--VRVSADCRHLLSQIFVADPSKDPHSRDQKA 257 (269)
Q Consensus 180 ~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 257 (269)
.+.|+||||++++||+ .||.... .....+...+.+.+..+.. .+--+.-..+|++|++.||++||||.|+|.
T Consensus 797 ~KiDmYSLGIVlFEM~---yPF~TsM---ERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEML---YPFGTSM---ERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred chhhhHHHHHHHHHHh---ccCCchH---HHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 5599999999999998 4575432 3344556666655555410 112234568999999999999999999999
Q ss_pred ccChhh
Q 024336 258 SLVPEE 263 (269)
Q Consensus 258 ~~~~~~ 263 (269)
+-|+.+
T Consensus 871 s~llpp 876 (1351)
T KOG1035|consen 871 SELLPP 876 (1351)
T ss_pred ccCCCc
Confidence 999883
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=275.16 Aligned_cols=245 Identities=25% Similarity=0.360 Sum_probs=194.3
Q ss_pred ceecccCceEEEEEEEecCC------eEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 9 KELGSGNFGVARLVRDKRTK------ELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~------~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+.||+|++|.||++++.... ..+++|.+.... .....+.+|+..++.++||||+++++++...+..++++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999986443 679999876543 2345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC---CCcEEEeecCCccc
Q 024336 81 AAGGELFARICSA-------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP---QPRLKICDFGYSKS 150 (269)
Q Consensus 81 ~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~---~~~~~l~df~~~~~ 150 (269)
+++++|.+++.+. ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++ ...++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999998642 2378899999999999999999999999999999999998766 12499999998864
Q ss_pred CCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCC
Q 024336 151 GLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226 (269)
Q Consensus 151 ~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (269)
..... .......+..|+|||.+.+...+. ++|+||||+++|+|+| |..||......... ..+... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~ellt~g~~p~~~~~~~~~~----~~~~~~-~~~~~ 234 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTT-QSDVWSFGVLMWEILTLGQQPYPALNNQEVL----QHVTAG-GRLQK 234 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCccc-chhHHHHHHHHHHHHHcCCCCCcccCHHHHH----HHHhcC-CccCC
Confidence 32221 112234467899999998777644 4999999999999998 99999765443222 222221 11222
Q ss_pred cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 227 YVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
...+|..+.++|.+||..+|.+||++.++++.+
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 236789999999999999999999999998764
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=277.17 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=197.5
Q ss_pred cccccccceecccCceEEEEEEEecCCe----EEEEEEeecCccc--cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKE----LVAVKYIERGKKI--DENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~----~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
.++|+..+.||+|+||.||++.+..+|. .+|+|.+...... ...+.+|+.+++.++|||++++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 3678999999999999999999877775 4688877643221 23577899999999999999999998754 467
Q ss_pred EEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 76 IVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
++++++++|+|.+.+.... .+++..+..++.|++.||.+||++|++|+||||+||+++.++. ++|+|||++......
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGD 162 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEccccccccccCc
Confidence 8999999999999987644 5889999999999999999999999999999999999988776 999999998743222
Q ss_pred CC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 155 SQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 155 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
.. ......+..|+|||.+.+..++.+ +|+||||+++|++++ |..||..... ....... . .....+.....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~---~-~~~~~~~~~~~ 236 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLL---E-KGERLPQPPIC 236 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH---H-CCCCCCCCCCC
Confidence 21 112334568999999877666544 999999999999997 8899976432 1222221 1 22223333467
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
+.++.+++.+||..+|++||+++++++.+.
T Consensus 237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 237 TIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 889999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=269.56 Aligned_cols=261 Identities=26% Similarity=0.350 Sum_probs=204.6
Q ss_pred ccccccceecccCceEEEEEEEecCC----eEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEe-CCeE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTK----ELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLT-PTHL 74 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~----~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 74 (269)
..|+..+.||+|.||.||+|...+++ +.+|+|.+..++. ...+.-+|+.+++.++|||++.+..+|.+ +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46899999999999999999765443 3789998875532 23567789999999999999999999988 7899
Q ss_pred EEEEeecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC--CCcEEEeecCC
Q 024336 75 AIVMEYAAGGELFARICS-----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP--QPRLKICDFGY 147 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~--~~~~~l~df~~ 147 (269)
++++||.+. +|+..|.- .+.++...+..+++||+.++.|||++=++|||+||.||++..++ .++|||+|+|+
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999999987 88888843 24599999999999999999999999999999999999998763 25699999999
Q ss_pred cccCCCCC----CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh---------hhHHHHH
Q 024336 148 SKSGLLHS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---------RNFRKTI 214 (269)
Q Consensus 148 ~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~---------~~~~~~~ 214 (269)
++.....- ......-|.+|+|||.+.+...++++.|+|++|||+.||+|-.+.|.+.+.. +.+....
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 97422221 2234456889999999999999999999999999999999999998764431 1111111
Q ss_pred HHHhh-ccccCCCc------------------------------CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 215 DRIRN-VQYFLPDY------------------------------VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 215 ~~~~~-~~~~~~~~------------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+-... ....+|+. +.-++...+|+.+||..||.+|.|+++.++|++|..
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence 11110 01111211 122455789999999999999999999999999875
Q ss_pred h
Q 024336 264 F 264 (269)
Q Consensus 264 ~ 264 (269)
-
T Consensus 343 d 343 (438)
T KOG0666|consen 343 D 343 (438)
T ss_pred C
Confidence 3
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=305.23 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=205.9
Q ss_pred cccccceecccCceEEEEEEEecC-Ce----EEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRT-KE----LVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~-~~----~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
.-+....||+|+||.||.+...+. |. .||+|.+.+.. .....|.+|..+++.++|||||+++|++.+....++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 345678899999999999997643 32 38999887653 334578999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 77 VMEYAAGGELFARICSAG-------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
++|||+||+|+.++++.+ .++......++.+|+.++.||+++++|||||..+|+|++.... ||++|||+|+
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~--VKIaDFGlAr 850 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV--VKIADFGLAR 850 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc--EEEcccchhH
Confidence 999999999999998762 4899999999999999999999999999999999999998866 9999999998
Q ss_pred cCCCCCCC---CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCC
Q 024336 150 SGLLHSQP---KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225 (269)
Q Consensus 150 ~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (269)
........ ....-...|+|||.+..+.++++ +||||||+++||++| |..||...++.+.+. ....+. .++
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~----~~~~gg-RL~ 924 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLL----DVLEGG-RLD 924 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHH----HHHhCC-ccC
Confidence 32222211 11123468999999999888777 999999999999998 889999877644333 223333 556
Q ss_pred CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 226 DYVRVSADCRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
.+..+|+.+.++|..||+.+|++||++..+++.
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q 957 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQ 957 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHhh
Confidence 666899999999999999999999999999983
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=269.68 Aligned_cols=229 Identities=23% Similarity=0.321 Sum_probs=187.9
Q ss_pred cCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCchHHHHHhc
Q 024336 14 GNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSA 93 (269)
Q Consensus 14 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~ 93 (269)
|.+|.||++.+..+++.||+|.+.... ...+|...+....|||++++++++...+..++++||+++++|.+++.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 889999999999999999999987643 2334555555567999999999999999999999999999999999887
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccCCCcccCchhhc
Q 024336 94 GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173 (269)
Q Consensus 94 ~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 173 (269)
..+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++++|||.+.... ........+..|+|||...
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~--~~~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVE--DSCDGEAVENMYCAPEVGG 155 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhccc--cccccCCcCccccCCcccC
Confidence 78999999999999999999999999999999999999998887 9999999765322 2223344567799999987
Q ss_pred cccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCc-
Q 024336 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHS- 252 (269)
Q Consensus 174 ~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~- 252 (269)
...++. ++|+||+|+++|+|++|..|+....... . .......+. .+++.+.++|.+||+.||.+||++
T Consensus 156 ~~~~~~-~~DvwslG~il~el~~g~~~~~~~~~~~------~--~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 156 ISEETE-ACDWWSLGAILFELLTGKTLVECHPSGI------N--THTTLNIPE--WVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CCCCCc-hhhHHHHHHHHHHHHHCcchhhcCchhc------c--cccccCCcc--cCCHHHHHHHHHHccCCHHHhcCCC
Confidence 666644 4999999999999999998875432110 0 011112333 578899999999999999999996
Q ss_pred ----HHHhhccCh
Q 024336 253 ----RDQKASLVP 261 (269)
Q Consensus 253 ----~~~l~~~~~ 261 (269)
++++.|+|+
T Consensus 225 ~~~~~~~~~h~~~ 237 (237)
T cd05576 225 VAGVEDIKSHPFF 237 (237)
T ss_pred ccchHHHHcCCCC
Confidence 999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=268.73 Aligned_cols=249 Identities=22% Similarity=0.286 Sum_probs=187.6
Q ss_pred ceecccCceEEEEEEEecC--CeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCC
Q 024336 9 KELGSGNFGVARLVRDKRT--KELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG 84 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (269)
+.||+|+||.||++....+ ...+++|.+.... ...+.+.+|+..++.++|||++++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976433 3456677665432 23356888999999999999999999999999999999999999
Q ss_pred chHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC---CCC
Q 024336 85 ELFARICSA----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQP 157 (269)
Q Consensus 85 ~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~---~~~ 157 (269)
+|.+++.+. ...+...+..++.|++.||.|||+.+++|+||||+||+++.++. ++|+|||++...... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcc
Confidence 999998753 23567788899999999999999999999999999999998877 999999987532211 112
Q ss_pred CcccCCCcccCchhhcccc------CCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 158 KSTVGTPAYIAPEVLARKE------YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
....++..|+|||.+.... ..+.++|+||||+++|+|++ |..||......+.................-...+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 2345678899999875321 12455999999999999997 5678876554433333322211110111112257
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
++.+.+++..|+ .+|.+||+++++++.+.
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 888999999999 78999999999987654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=271.85 Aligned_cols=250 Identities=15% Similarity=0.139 Sum_probs=187.5
Q ss_pred cccccccceecccCceEEEEEEEecC---CeEEEEEEeecCcccc--H----------HHHHHHHHHHhCCCCCcceeeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGKKID--E----------NVQREIINHRSLRHPNIIRFKE 66 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~--~----------~~~~e~~~l~~l~h~~i~~~~~ 66 (269)
.++|++.+.||+|+||.||++.+..+ +..+|+|......... + ....+...+..++|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 57899999999999999999999877 6677887644322111 1 1112334455678999999998
Q ss_pred EEEeCC----eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEE
Q 024336 67 VLLTPT----HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKI 142 (269)
Q Consensus 67 ~~~~~~----~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l 142 (269)
.+.... ..+++++++.. ++.+.+......++..+..++.|++.||++||+.+++||||||+||+++.++. ++|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~~l 167 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--GYI 167 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--EEE
Confidence 766543 34677777743 66777766556788999999999999999999999999999999999987776 999
Q ss_pred eecCCcccCCCCC--------CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhH-HH-
Q 024336 143 CDFGYSKSGLLHS--------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF-RK- 212 (269)
Q Consensus 143 ~df~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~-~~- 212 (269)
+|||++....... ......+++.|+|||.+.+..++ .++||||||+++++|++|..||......... ..
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 9999986432111 11233588999999998877764 4599999999999999999999876432222 11
Q ss_pred ---HHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 213 ---TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 213 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
....+...... ....++.+.+++..|+..+|.+||+..++++-
T Consensus 247 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~ 292 (294)
T PHA02882 247 KCDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKI 292 (294)
T ss_pred HHHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHh
Confidence 12222222222 22568899999999999999999999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=244.49 Aligned_cols=260 Identities=25% Similarity=0.456 Sum_probs=215.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.+|.-.++||+|.||+|++++..++++.||+|.+..+. -...+..+|+-+++.++|.|||++++....+..+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 46888999999999999999999999999999987543 234678999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCC
Q 024336 80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQP 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~ 157 (269)
||+. +|..+..+ ++.++.+.++.++.|++.+|.++|+.++.|||+||.|.+++.+|. .||.|||+++.... -+..
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcy 158 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEee
Confidence 9975 77777754 667999999999999999999999999999999999999998888 99999999974322 2233
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccc-cCC------CcC-
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQY-FLP------DYV- 228 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~------~~~- 228 (269)
....-|.+|.+|.++.+...++...|+||.||++.|+.. |.+.|.+.+-.+.+............ .+| +++
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 455678899999999998887777999999999999997 66778777666666655544333211 122 211
Q ss_pred ---------------CCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 229 ---------------RVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 229 ---------------~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
+++..-++++.++|.-+|.+|.++++.++|++|..+.
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 2234578999999999999999999999999997654
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=267.84 Aligned_cols=243 Identities=23% Similarity=0.304 Sum_probs=187.7
Q ss_pred ceecccCceEEEEEEEec---CCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEE-eCCeEEEEEeecC
Q 024336 9 KELGSGNFGVARLVRDKR---TKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLL-TPTHLAIVMEYAA 82 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~~ 82 (269)
+.||+|+||.||++.+.. .+..+|+|.+.... ...+.+.+|+.+++.++|||++++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998753 34679999875422 22356778999999999999999999765 4556899999999
Q ss_pred CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-----C
Q 024336 83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----Q 156 (269)
Q Consensus 83 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-----~ 156 (269)
+++|.+++.+. ..++...+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecc
Confidence 99999998764 34677888999999999999999999999999999999998877 9999999886432111 1
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhC-CCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVG-AYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
.....++..|+|||.+.+..++.+ +|+||||+++|+|++| .+||....... ....+.... ..+....+++.+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~ 232 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFD----ITVYLLQGR-RLLQPEYCPDPLY 232 (262)
T ss_pred cccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHhcCC-CCCCCCcCCHHHH
Confidence 112334668999999877766554 9999999999999995 56665543322 222222221 1222235788999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+++.+||..+|++||++.++++.+
T Consensus 233 ~li~~cl~~~p~~Rp~~~~il~~l 256 (262)
T cd05058 233 EVMLSCWHPKPEMRPTFSELVSRI 256 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHHHHH
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=287.19 Aligned_cols=255 Identities=28% Similarity=0.464 Sum_probs=226.4
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
+.+++..||-|+||.|-++..+.....+|+|++.+. .+..+....|-+++..++.|.||+++..|.+...+|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 456788899999999999999876667899988653 2344567789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCc
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 159 (269)
.|-||.+++.+...+.+++....-++.-+++|++|||+.||++||+||+|.+++.+|- +||.|||.++....+....+
T Consensus 501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KTwT 578 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKTWT 578 (732)
T ss_pred hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCceee
Confidence 9999999999999999999999999999999999999999999999999999999998 99999999998888888889
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
.+|||.|.|||++.+...+.. .|.||||+++|||+||.+||.+.+....+....+.+... .+|. .++....++|+
T Consensus 579 FcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--~~Pr--~I~k~a~~Lik 653 (732)
T KOG0614|consen 579 FCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--EFPR--RITKTATDLIK 653 (732)
T ss_pred ecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--hccc--ccchhHHHHHH
Confidence 999999999999998887555 999999999999999999999987755555554444433 3443 88999999999
Q ss_pred HHhhhCCCCCCC-----cHHHhhccChhhhh
Q 024336 240 QIFVADPSKDPH-----SRDQKASLVPEEFA 265 (269)
Q Consensus 240 ~~l~~~p~~Rps-----~~~~l~~~~~~~~~ 265 (269)
+++..+|.+|.. +.++.+|.||..|.
T Consensus 654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 654 KLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred HHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 999999999987 79999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=286.55 Aligned_cols=243 Identities=33% Similarity=0.451 Sum_probs=204.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHh-CCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS-LRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
++|.+...+|.|+||.|-.+.+..++...++|++.... ....+|+.++.. -+|||++++.+.+.++...|+|||.+
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 67889999999999999999999999999999997652 233456644443 37999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe-cCCCCCcEEEeecCCcccCCCCCCCCcc
Q 024336 82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKST 160 (269)
Q Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i-~~~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (269)
.|+-+.+.+...+.+. .++..|+.+|+.|+.+||++|++|||+||+||++ +..++ ++|+|||.++..... ....
T Consensus 399 ~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~--lrltyFG~a~~~~~~--~~tp 473 (612)
T KOG0603|consen 399 DGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGH--LRLTYFGFWSELERS--CDTP 473 (612)
T ss_pred cccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCc--EEEEEechhhhCchh--hccc
Confidence 9999999887766655 7888899999999999999999999999999999 46776 999999988743322 3455
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (269)
+-|..|.|||.+....++.. +|+||||++||+|++|..||....+. .+....+..+.+. ..+|+..++||.+
T Consensus 474 ~~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s----~~vS~~AKdLl~~ 545 (612)
T KOG0603|consen 474 ALTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS----ECVSDEAKDLLQQ 545 (612)
T ss_pred chhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc----cccCHHHHHHHHH
Confidence 67888999999996666554 99999999999999999999876654 3334444443333 3799999999999
Q ss_pred HhhhCCCCCCCcHHHhhccCh
Q 024336 241 IFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 241 ~l~~~p~~Rps~~~~l~~~~~ 261 (269)
||+.||.+||++.+++.|+|+
T Consensus 546 LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 546 LLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred hccCChhhCcChhhhccCcch
Confidence 999999999999999999998
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=297.75 Aligned_cols=145 Identities=32% Similarity=0.474 Sum_probs=133.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc----cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+++.||+|++...... ...+..|+..++.++|+||+++++.+.....+|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 6899999999999999999999999999999998754322 245778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
||+.+++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++. ++|+|||++.
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~--vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH--IKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC--EEEEeCCCCc
Confidence 99999999999988888999999999999999999999999999999999999998877 9999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=268.86 Aligned_cols=247 Identities=25% Similarity=0.364 Sum_probs=193.2
Q ss_pred ccccceecccCceEEEEEEEe---cCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCC------
Q 024336 5 YEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPT------ 72 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 72 (269)
|++.+.||+|++|.||++... .++..||+|.+.... ...+.+.+|+..+++++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 357889999886532 22345778999999999999999999886532
Q ss_pred eEEEEEeecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecC
Q 024336 73 HLAIVMEYAAGGELFARICSA------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG 146 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~ 146 (269)
..+++++|+.+++|..++... ..++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECccc
Confidence 247889999999998876432 14788999999999999999999999999999999999988777 9999999
Q ss_pred CcccCCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccc
Q 024336 147 YSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQY 222 (269)
Q Consensus 147 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 222 (269)
.+....... .......++.|++||.+.....+.+ +|+||||+++|+|++ |.+||........ ...+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~~~~~----~~~~~~~~~ 233 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEI----YNYLIKGNR 233 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCCHHHH----HHHHHcCCc
Confidence 887432222 1122234567999999877766554 999999999999999 8899876544222 222222211
Q ss_pred cCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 223 FLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 223 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.......+..+.+++.+||+.+|.+|||+.+++..+
T Consensus 234 -~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 234 -LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 122235788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=285.14 Aligned_cols=256 Identities=30% Similarity=0.461 Sum_probs=212.8
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.|..++.||-|+||.|.++...+|...||+|.+.+.. ......+.|-.+|...+.+.||+++-.|.+++++|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 4677899999999999999999999999999987532 233457789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC--
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-- 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~-- 157 (269)
|++||++-.++.+.+-|++..++.++..+..|+++.|+.|++||||||+||+||.+|+ +||+|||+|.........
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceecccccc
Confidence 9999999999999999999999999999999999999999999999999999999999 999999998522111000
Q ss_pred -----------------------------------------CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh
Q 024336 158 -----------------------------------------KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV 196 (269)
Q Consensus 158 -----------------------------------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t 196 (269)
-...||+.|+|||++....++.- +|.||.|+|||+|+.
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEMLV 866 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHHhh
Confidence 01247899999999998888666 999999999999999
Q ss_pred CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCC---cHHHhhccChhhhh
Q 024336 197 GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPH---SRDQKASLVPEEFA 265 (269)
Q Consensus 197 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~~~~~~~~ 265 (269)
|++||-.....+....++...... .++...+++.+..++|.+++. ++..|.. ++|+..|+||+.+.
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l--~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFL--HIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhcc--ccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccc
Confidence 999998766655544444333322 344445899999999988663 4566654 56799999998854
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=312.90 Aligned_cols=255 Identities=28% Similarity=0.419 Sum_probs=214.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC---ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
-+|.....||.|.||.||.+.+.++|+..|+|-+..+ .+....+.+|..++..++|||+|+++|+=.+.+.+++.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 3677888999999999999999999999999987532 3444568899999999999999999999888899999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC----
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---- 155 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~---- 155 (269)
||++|+|.+.++..+-.++.....+..|++.|+.+||+.|||||||||.||+++.+|. +|++|||.|.......
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCC
Confidence 9999999999988877888888899999999999999999999999999999999887 9999999987433322
Q ss_pred -CCCcccCCCcccCchhhcccc--CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCH
Q 024336 156 -QPKSTVGTPAYIAPEVLARKE--YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232 (269)
Q Consensus 156 -~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
......||+.|+|||++.+.. -...+.|||||||++.||+||+.||...+++-.+.-.+.... .+..|+ ++++
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh--~Pq~P~--~ls~ 1468 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH--KPQIPE--RLSS 1468 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC--CCCCch--hhhH
Confidence 123456999999999998654 234569999999999999999999988776433333222211 234455 5999
Q ss_pred HHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 233 DCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+..+||.+||..||++|+++.|+++|-|-+.
T Consensus 1469 ~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred hHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 9999999999999999999999999988654
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=284.11 Aligned_cols=246 Identities=32% Similarity=0.405 Sum_probs=196.4
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecC--ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCC------eEEE
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPT------HLAI 76 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~~ 76 (269)
|...+.||+|+||.||++++..+|+.||||.+... ....+..-+|++++++++|+|||+++++=.+.. .-.+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 45678999999999999999999999999998763 344566778999999999999999999755433 4679
Q ss_pred EEeecCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC--CCcEEEeecCCcccC
Q 024336 77 VMEYAAGGELFARICS---AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP--QPRLKICDFGYSKSG 151 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~--~~~~~l~df~~~~~~ 151 (269)
+||||.||+|...+++ ...+++.+++.++..++.||.|||.+||+||||||.||++.... ...-||+|||+|+..
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 9999999999999965 34599999999999999999999999999999999999986443 434699999999987
Q ss_pred CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc-----------
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV----------- 220 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----------- 220 (269)
..+....+..||+.|.+||.+....+++...|.||+|+++|+++||..||..........+.+..+...
T Consensus 175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~ 254 (732)
T KOG4250|consen 175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQE 254 (732)
T ss_pred CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeec
Confidence 777777888999999999999964444555999999999999999999997665554322222222111
Q ss_pred --------cccCCCcCCCCH----HHHHHHHHHhhhCCCCCC
Q 024336 221 --------QYFLPDYVRVSA----DCRHLLSQIFVADPSKDP 250 (269)
Q Consensus 221 --------~~~~~~~~~~~~----~~~~li~~~l~~~p~~Rp 250 (269)
...+|.....++ .+..++..||..+|.+|.
T Consensus 255 ~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 255 EENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 112222223333 356688889999999998
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=273.32 Aligned_cols=265 Identities=25% Similarity=0.353 Sum_probs=220.8
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHH--------HHHHHHHHHhCCCCCcceeeEEEEe-C
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN--------VQREIINHRSLRHPNIIRFKEVLLT-P 71 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~--------~~~e~~~l~~l~h~~i~~~~~~~~~-~ 71 (269)
|.++|-.+..||+|+|+.||++.+....+.||+|+-..++.+.++ .-+|..+.+.|+||.||+++++|.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 457899999999999999999999999999999987655444432 4468999999999999999999975 4
Q ss_pred CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecCCCC-CcEEEeecCCc
Q 024336 72 THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQ-PRLKICDFGYS 148 (269)
Q Consensus 72 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~p~ni~i~~~~~-~~~~l~df~~~ 148 (269)
+.+|-|+|||+|.+|.-++..++.+++.+++.|+.||+.||.||.... |+|-||||.||++.+... +.+||+|||++
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 689999999999999999999999999999999999999999999765 999999999999864333 56999999999
Q ss_pred ccCCCCC--------CCCcccCCCcccCchhhcccc---CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHH
Q 024336 149 KSGLLHS--------QPKSTVGTPAYIAPEVLARKE---YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI 217 (269)
Q Consensus 149 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~ 217 (269)
....... ......||.+|++||++.-+. ..+.+.||||+|+|+|+++.|..||+.......+...-..+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 7432222 123456899999999986442 22555999999999999999999999877655555444444
Q ss_pred hhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
+.....+|....++.+..+||++||++-.++|....++..++++.+-.
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence 555667777668999999999999999999999999999999987743
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=260.15 Aligned_cols=258 Identities=23% Similarity=0.334 Sum_probs=204.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeC--------
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP-------- 71 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------- 71 (269)
..|.-+.+||+|.||.||+|++..+|+.||+|.+.... -......+|+.++..++|+|++.++++|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 56888899999999999999999999999998765422 1234577899999999999999999887642
Q ss_pred CeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCccc
Q 024336 72 THLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 72 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~ 150 (269)
..+|+|+++|+. +|.-++.+. .+++..++..++.++..+|.|+|++.|+|||+||.|++|+.++. ++|+|||+++.
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--lklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--LKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--EEeeccccccc
Confidence 359999999987 677777554 46999999999999999999999999999999999999998888 99999999964
Q ss_pred CCCCCCC-----CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-ccC
Q 024336 151 GLLHSQP-----KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFL 224 (269)
Q Consensus 151 ~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~ 224 (269)
....... ....-|.+|++||.+.+...+.++.|+|+.||++.+|+|+.+.+.+..+...+.....-..... ..+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 3332221 2234588999999999888777779999999999999999999988776544433221111110 011
Q ss_pred CCc-------------------C---------CCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 225 PDY-------------------V---------RVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 225 ~~~-------------------~---------~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
|.. . .-+++..+|+.+||..||.+|+++.+++.|.||-.
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 110 0 11357789999999999999999999999999853
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=248.74 Aligned_cols=259 Identities=23% Similarity=0.381 Sum_probs=212.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC-CCCcceeeEEEEeCC--eEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEVLLTPT--HLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~~v~ 78 (269)
+++|++.+++|+|.+|.|+.+....+++.++||++.+.+ .+.+.+|+.++..|. ||||++++++..++. ...+++
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 578999999999999999999999899999999998754 377999999999996 999999999998765 478999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
|++++.+...+.. .++...+..++.+++.||.|+|+.||+|||+||.|++++.... +++|+|+|++....++....
T Consensus 115 E~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~eYn 190 (338)
T KOG0668|consen 115 EYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYN 190 (338)
T ss_pred hhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCCceee
Confidence 9999877766653 4788999999999999999999999999999999999985544 69999999998766666666
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCC-CCCChhhHHHHHHHHhhc---------cccC----
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFRKTIDRIRNV---------QYFL---- 224 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~-~~~~~~~~~~~~~~~~~~---------~~~~---- 224 (269)
-...+..|.-||.+.........-|+|||||++..|+..+.||- +.++.+++.....-.... ...+
T Consensus 191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~ 270 (338)
T KOG0668|consen 191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQF 270 (338)
T ss_pred eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhH
Confidence 67778889999999888777777999999999999999998875 444444433322111100 0000
Q ss_pred -----------------CCc-CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 225 -----------------PDY-VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 225 -----------------~~~-~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
++. .-++++..+|+.++|..|-.+|+|++|.++||+|....+
T Consensus 271 ~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 271 EDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred hhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 011 124588999999999999999999999999999988654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=284.18 Aligned_cols=255 Identities=26% Similarity=0.425 Sum_probs=220.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEEe-----CCeEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLT-----PTHLAI 76 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-----~~~~~~ 76 (269)
+.|++.+.||.|.+|.||++++..+++.+|+|+........++++.|+++++.. .|||++.++++|.. ++.+|+
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 568999999999999999999999999999999999999999999999999888 68999999999874 568999
Q ss_pred EEeecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 77 VMEYAAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
|||||.|||.-+++.+ ...+.+..+..|++.++.|+.+||++.++|||||-.||+++.++. |||+|||.+......
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDST 176 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeeecc
Confidence 9999999999999965 446899999999999999999999999999999999999998888 999999988653333
Q ss_pred -CCCCcccCCCcccCchhhccc-----cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcC
Q 024336 155 -SQPKSTVGTPAYIAPEVLARK-----EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228 (269)
Q Consensus 155 -~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (269)
....+..|||.|+|||++... .+ ...+|+||||++..||.-|.+|+-.+.. ...+........+.+..+.
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~ty-d~R~D~WsLGITaIEladG~PPl~DmHP---mraLF~IpRNPPPkLkrp~ 252 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATY-DYRSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIPRNPPPKLKRPK 252 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCc-ccccchhhccceeehhcCCCCCccCcch---hhhhccCCCCCCccccchh
Confidence 344567899999999998643 23 3349999999999999999999977653 3344444445555566667
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 229 RVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.++.++.+||..||.+|-.+||+..++++|+|...
T Consensus 253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 253 KWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred hHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 89999999999999999999999999999999873
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=267.78 Aligned_cols=253 Identities=31% Similarity=0.509 Sum_probs=216.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc----cHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
.+|..+..||.|+||.|.++..+.+.+.||||++.++-.. .+--..|-++|... +-|.+++++..|++-+++|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 4788999999999999999999999999999998764211 12223455666544 457899999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-C
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-Q 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~ 156 (269)
|||+.||+|--.+++.+.+.+..+.-++..|+-+|-+||++||++||||.+||+++.+|+ +||+|||++....... .
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIFDGVT 506 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeecccccccccCCcc
Confidence 999999999999999999999999999999999999999999999999999999999999 9999999998544443 4
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
..+.+|||.|+|||++...++. ++.|.||+|+++|||+.|++||.+.++.+ +...+...+..+|. .+|.+..+
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~e----lF~aI~ehnvsyPK--slSkEAv~ 579 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDE----LFQAIMEHNVSYPK--SLSKEAVA 579 (683)
T ss_pred eeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHHccCcCcc--cccHHHHH
Confidence 5677999999999999877774 44999999999999999999999977744 44455555666666 78999999
Q ss_pred HHHHHhhhCCCCCCCc-----HHHhhccChhhh
Q 024336 237 LLSQIFVADPSKDPHS-----RDQKASLVPEEF 264 (269)
Q Consensus 237 li~~~l~~~p~~Rps~-----~~~l~~~~~~~~ 264 (269)
+.+..|.+.|.+|... +++.+|+||..+
T Consensus 580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 9999999999999865 789999999764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=255.82 Aligned_cols=241 Identities=39% Similarity=0.619 Sum_probs=202.2
Q ss_pred CceEEEEEEEecCCeEEEEEEeecCccc--cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCchHHHHHh
Q 024336 15 NFGVARLVRDKRTKELVAVKYIERGKKI--DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS 92 (269)
Q Consensus 15 ~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~ 92 (269)
+||.||++.+..++..+++|.+...... .+.+.+|+..+++++|+|++++++++......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 5899999999988999999998754432 46788999999999999999999999999999999999999999999977
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccCCCcccCchhh
Q 024336 93 AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172 (269)
Q Consensus 93 ~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~ 172 (269)
...++...++.++.+++.++.+||+.+++|+||+|+||+++.++. ++|+|||.+.............++..|+|||.+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH--VKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc--EEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 766899999999999999999999999999999999999998876 999999998754444344556678899999999
Q ss_pred ccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCC-CCHHHHHHHHHHhhhCCCCCCC
Q 024336 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR-VSADCRHLLSQIFVADPSKDPH 251 (269)
Q Consensus 173 ~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps 251 (269)
.....+. ++|+||||++++++++|..||......... ................ ++.++.+++.+|+..+|++||+
T Consensus 159 ~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 159 LGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQLLEL---FKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred ccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 8666655 599999999999999999999764333222 2222222222222112 8889999999999999999999
Q ss_pred cHHHhhccCh
Q 024336 252 SRDQKASLVP 261 (269)
Q Consensus 252 ~~~~l~~~~~ 261 (269)
+.++++|+|+
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=270.90 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=212.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.+..+.++||+|-||.|.++.-.. +..||+|.++.... ...+|..|+++|.+|+||||+.++++|..++.+++++||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 456789999999999999998863 68899999986433 346799999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC-
Q 024336 81 AAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP- 157 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~- 157 (269)
++.|+|.+++.++.. +....-.+++.||++|++||.+.++||||+.+.|++++.+.+ +||+|||+++........
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCcee
Confidence 999999999987632 355667789999999999999999999999999999998888 999999999854443322
Q ss_pred --CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh--CCCCCCCCCChhhHHHHHHHHhhcc--ccCCCcCCCC
Q 024336 158 --KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV--GAYPFEDPEDPRNFRKTIDRIRNVQ--YFLPDYVRVS 231 (269)
Q Consensus 158 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t--g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 231 (269)
.......+|+|||.+..+++++. ||+|++|+++||+++ ...||....++....+.-.-..... ..++.+.-+|
T Consensus 695 vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp 773 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP 773 (807)
T ss_pred eecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence 23345679999999999998777 999999999999775 7899998887666555544433322 2334445789
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhccChh
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
.++.+++.+||..|.++||+++++-.++...
T Consensus 774 ~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 774 QGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 9999999999999999999999997765443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=254.78 Aligned_cols=257 Identities=24% Similarity=0.333 Sum_probs=205.0
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+.+-+..||.|+||+|++..++.+|+..|||.+..... ....+..|.+...+. ++||||+++|..-.++..|+-||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 34456789999999999999999999999999986543 334566777765554 689999999999999999999999
Q ss_pred cCCCchHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 81 AAGGELFARI-----CSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
++- |+.-+. .+...++++.+-.+..-.+.||.||-. ..|+|||+||+||+++..|. |||||||++......
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQLVDS 221 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHhHHHH
Confidence 964 554433 234468999999999999999999986 57999999999999998888 999999998755444
Q ss_pred CCCCcccCCCcccCchhhccccC-CCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC-C---cCC
Q 024336 155 SQPKSTVGTPAYIAPEVLARKEY-DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP-D---YVR 229 (269)
Q Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~ 229 (269)
-......|...|+|||.+..... +.-+||+||||+++||++||..|+...++ +.+.+..+..+.+... . ...
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~gdpp~l~~~~~~~~ 298 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVIGDPPILLFDKECVH 298 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHcCCCCeecCcccccc
Confidence 44455567788999999874432 33449999999999999999999986543 5555555555544221 1 134
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 230 VSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
++..+..+|..||.+|-+.||...++++++|..-.+.
T Consensus 299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 7899999999999999999999999999999876654
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=268.92 Aligned_cols=246 Identities=22% Similarity=0.300 Sum_probs=210.9
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.++..+||.|-||.||.+.++.-.-.||||.+..+....++|..|..+++.++|||+|+++|+|..+-.+|+|+|||..
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 45677899999999999999998888999999998888889999999999999999999999999999999999999999
Q ss_pred CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC--CCc
Q 024336 84 GELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKS 159 (269)
Q Consensus 84 ~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~--~~~ 159 (269)
|+|++++.+-. .++.-.++.|+.||..|++||..++++||||-..|++|..+-. ||+.|||+++.+..+.. ...
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTYTAHAG 425 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTYTAHAG 425 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCceecccC
Confidence 99999997644 3677788899999999999999999999999999999987776 99999999985332222 122
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
.....-|+|||.+..+.++.+ +|+|+||++||++.| |-.||.+-+-. .+.......+.+..+.++|+.+.+|+
T Consensus 426 AKFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidlS-----qVY~LLEkgyRM~~PeGCPpkVYeLM 499 (1157)
T KOG4278|consen 426 AKFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYGLLEKGYRMDGPEGCPPKVYELM 499 (1157)
T ss_pred ccCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccHH-----HHHHHHhccccccCCCCCCHHHHHHH
Confidence 234567999999998888777 999999999999998 77888775432 23333444566666669999999999
Q ss_pred HHHhhhCCCCCCCcHHHhh
Q 024336 239 SQIFVADPSKDPHSRDQKA 257 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~ 257 (269)
+.||+.+|++||+++|+-.
T Consensus 500 raCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 500 RACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHHhcCCcccCccHHHHHH
Confidence 9999999999999998754
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=272.99 Aligned_cols=252 Identities=27% Similarity=0.393 Sum_probs=209.4
Q ss_pred ccccccceecccCceEEEEEEEecC---CeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
++.+..+.||+|.||.|+++.+... -..||||++..... ....|.+|+..+.+|+|+|++++||++.+ ..+-+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 4567789999999999999998632 34689999876543 34679999999999999999999999887 667899
Q ss_pred EeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 78 MEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
+|.++.|+|.+.+.+. ..|....+..++.||+.|+.||..+++||||+-..|+++-.... |||+|||+.+.....+
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKICDFGLMRALGENE 266 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eeeecccceeccCCCC
Confidence 9999999999999873 35888899999999999999999999999999999999987555 9999999998544433
Q ss_pred CCC----cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 156 QPK----STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 156 ~~~----~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
..- ...-...|+|||.+....++.. ||+|++|+++|||+| |..||.+......++ ++. ....++..+.+
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~qIL~----~iD-~~erLpRPk~c 340 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQILK----NID-AGERLPRPKYC 340 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHHHHH----hcc-ccccCCCCCCC
Confidence 322 2234567999999998888666 999999999999998 789999887744443 333 34456666689
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+++++++++.||+.+|.+||++.++.+..+...
T Consensus 341 sedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 999999999999999999999999987665544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=268.83 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=211.8
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCC------CCcceeeEEEEeCCeE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH------PNIIRFKEVLLTPTHL 74 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~~~~ 74 (269)
|..+|.+....|+|-||+|..|.+...|..||||++..+...-+.-..|+++|++|+. -|+++++..|...+.+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 4689999999999999999999999889999999999887777777889999999952 4899999999999999
Q ss_pred EEEEeecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 75 AIVMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
|+|+|.+. .+|.+.+.+.+. +....+..++.|++.||..|-+.|++|+||||+||+|+.+.. .+||||||.|...
T Consensus 510 ClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 510 CLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFA 587 (752)
T ss_pred EEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCcccccc
Confidence 99999985 589999987664 788999999999999999999999999999999999986555 5899999998753
Q ss_pred CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh--------ccc-
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN--------VQY- 222 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~--------~~~- 222 (269)
.... .....-+..|.|||++.+-.+... .|+||+||+||++.||+..|.+.++...+.-.++--.. +.+
T Consensus 588 ~ene-itPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~ 665 (752)
T KOG0670|consen 588 SENE-ITPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFK 665 (752)
T ss_pred cccc-ccHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchh
Confidence 3322 223344557999999999998777 99999999999999999999998876555443321111 000
Q ss_pred --cCCC------------------------------------cCCCC-------HHHHHHHHHHhhhCCCCCCCcHHHhh
Q 024336 223 --FLPD------------------------------------YVRVS-------ADCRHLLSQIFVADPSKDPHSRDQKA 257 (269)
Q Consensus 223 --~~~~------------------------------------~~~~~-------~~~~~li~~~l~~~p~~Rps~~~~l~ 257 (269)
.+.. ...+| ..+.+|+.+||..||++|.|..|+|+
T Consensus 666 dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 666 DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0000 00122 35889999999999999999999999
Q ss_pred ccChhh
Q 024336 258 SLVPEE 263 (269)
Q Consensus 258 ~~~~~~ 263 (269)
|||+..
T Consensus 746 HpFi~~ 751 (752)
T KOG0670|consen 746 HPFITE 751 (752)
T ss_pred CCcccC
Confidence 999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=279.02 Aligned_cols=255 Identities=18% Similarity=0.149 Sum_probs=171.7
Q ss_pred ccccccceecccCceEEEEEEEecC----CeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEE------EEeCC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRT----KELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV------LLTPT 72 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~~~~ 72 (269)
++|++.+.||+|+||.||++.+..+ +..||+|.+..... .+....+ .++...+.++..+... ...+.
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 5899999999999999999999988 89999998754321 1111111 1112222222222211 23456
Q ss_pred eEEEEEeecCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe
Q 024336 73 HLAIVMEYAAGGELFARICSAGR--------------------FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL 132 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~--------------------~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i 132 (269)
.+++|+||+++++|.+++..... .....+..++.|++.||.|||+.||+||||||+||++
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl 288 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF 288 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEE
Confidence 79999999999999998864321 1234567899999999999999999999999999999
Q ss_pred cC-CCCCcEEEeecCCcccCCCC--CCCCcccCCCcccCchhhccccCC---------------------CccchhhhHH
Q 024336 133 DG-SPQPRLKICDFGYSKSGLLH--SQPKSTVGTPAYIAPEVLARKEYD---------------------GKISDVWSCG 188 (269)
Q Consensus 133 ~~-~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~---------------------~~~~Di~slG 188 (269)
+. ++. ++|+|||++...... .......+++.|+|||.+...... ..++||||+|
T Consensus 289 ~~~~~~--~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 289 SEGSGS--FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred eCCCCc--EEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 85 345 999999999643222 223445678999999976432211 2236999999
Q ss_pred HHHHHHHhCCCCCCCCCChhhHHHHHHHHhh--------ccccCC--------CcCCCCHHHHHHHHHHhhhCCCCCCCc
Q 024336 189 VTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN--------VQYFLP--------DYVRVSADCRHLLSQIFVADPSKDPHS 252 (269)
Q Consensus 189 ~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~ 252 (269)
|++|+|+++..++.. ....+......... ...... .....+....+||.+||.+||.+|||+
T Consensus 367 viL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 367 LIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 999999987655432 11111111111000 000000 000122345689999999999999999
Q ss_pred HHHhhccChhhh
Q 024336 253 RDQKASLVPEEF 264 (269)
Q Consensus 253 ~~~l~~~~~~~~ 264 (269)
.|+|+|||+...
T Consensus 445 ~e~L~Hpff~~~ 456 (566)
T PLN03225 445 KAALAHPYFDRE 456 (566)
T ss_pred HHHhCCcCcCCC
Confidence 999999999764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=256.53 Aligned_cols=130 Identities=27% Similarity=0.416 Sum_probs=115.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC-----C---CCcceeeEEEEeC---
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-----H---PNIIRFKEVLLTP--- 71 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~~~--- 71 (269)
.+|.+.++||.|.|++||++.+..+.+.||+|+........+...+||.+|+++. | .+||++++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 7899999999999999999999999999999998877666788899999999882 3 4799999999853
Q ss_pred -CeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEec
Q 024336 72 -THLAIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLD 133 (269)
Q Consensus 72 -~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~ 133 (269)
..+|+|+|+. |.+|+.+|... +.++...+++|++||+.||.|||+ .||+|.||||+||++.
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 4799999999 56888888764 359999999999999999999996 5899999999999984
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=266.96 Aligned_cols=259 Identities=17% Similarity=0.168 Sum_probs=187.6
Q ss_pred ccccccceecccCceEEEEEEEe----------------cCCeEEEEEEeecCccc---------------cHHHHHHHH
Q 024336 3 ERYEPVKELGSGNFGVARLVRDK----------------RTKELVAVKYIERGKKI---------------DENVQREII 51 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~----------------~~~~~vaiK~~~~~~~~---------------~~~~~~e~~ 51 (269)
++|++.++||+|+||+||++... ..++.||+|.+...... .+....|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 68999999999999999998752 23567999998643211 122334666
Q ss_pred HHHhCCCCC-----cceeeEEEEe--------CCeEEEEEeecCCCchHHHHHhcC------------------------
Q 024336 52 NHRSLRHPN-----IIRFKEVLLT--------PTHLAIVMEYAAGGELFARICSAG------------------------ 94 (269)
Q Consensus 52 ~l~~l~h~~-----i~~~~~~~~~--------~~~~~~v~e~~~~~~l~~~~~~~~------------------------ 94 (269)
++.+++|.+ +++++++|.. ++..++|+||+++++|.+++....
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 777776654 3667776653 356899999999999988885321
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC--cccCCCcccCchhh
Q 024336 95 RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVL 172 (269)
Q Consensus 95 ~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~aPE~~ 172 (269)
.++...++.++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++.......... ....++.|+|||.+
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 2356778899999999999999999999999999999998877 9999999986433222222 22347899999987
Q ss_pred ccccCC---------------------CccchhhhHHHHHHHHHhCCC-CCCCCCChhh-------HHHHHHHHhhcccc
Q 024336 173 ARKEYD---------------------GKISDVWSCGVTLYVMLVGAY-PFEDPEDPRN-------FRKTIDRIRNVQYF 223 (269)
Q Consensus 173 ~~~~~~---------------------~~~~Di~slG~~l~~l~tg~~-pf~~~~~~~~-------~~~~~~~~~~~~~~ 223 (269)
...... ....|+||+|+++++|+++.. ||........ ..............
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 543211 123699999999999999875 6653221111 11112223334445
Q ss_pred CCCcCCCCHHHHHHHHHHhhhCC---CCCCCcHHHhhccChhh
Q 024336 224 LPDYVRVSADCRHLLSQIFVADP---SKDPHSRDQKASLVPEE 263 (269)
Q Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p---~~Rps~~~~l~~~~~~~ 263 (269)
++.+...++...+|+.+||..+| .+|+|+.|+|+|+||..
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 55556788999999999999766 68999999999999853
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=277.50 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=209.7
Q ss_pred ccccceecccCceEEEEEEEecCC---eEEEEEEeecC--ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTK---ELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~---~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
..|.+.||.|.||.|+.++.+..| ..||||.++.. .+....|..|..++=+.+||||+++.|+......+.+|+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 467889999999999999987555 56999999854 3455679999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC-
Q 024336 80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP- 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~- 157 (269)
||++|+|..++++ .++++..++..|++.|+.++.||.+.|+|||||...||+|+.+-- +|++|||+++....+...
T Consensus 711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeecccCCCcc
Confidence 9999999999965 457999999999999999999999999999999999999988776 999999999843333211
Q ss_pred Ccc---cCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 158 KST---VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 158 ~~~---~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
.+. ....+|+|||.+.-.++++. ||+||+|++|||.++ |..||+...+.+.+ +.+. ..+.+|.+-++|..
T Consensus 789 ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVI----kaIe-~gyRLPpPmDCP~a 862 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVI----KAIE-QGYRLPPPMDCPAA 862 (996)
T ss_pred ccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHH----HHHH-hccCCCCCCCCcHH
Confidence 111 12468999999998888666 999999999999775 99999998884444 3333 34567777799999
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+.+|+..||++|-.+||.+.|++..+
T Consensus 863 L~qLMldCWqkdR~~RP~F~qiV~~l 888 (996)
T KOG0196|consen 863 LYQLMLDCWQKDRNRRPKFAQIVSTL 888 (996)
T ss_pred HHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence 99999999999999999999998754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=250.65 Aligned_cols=256 Identities=29% Similarity=0.491 Sum_probs=212.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcccc----HHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|..+..||+|+|..|.+++...+.+.||+|++.+.-... +=...|-.+..+. +||.+|-++..|.++.++++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 57999999999999999999999999999999987642222 2233455555444 799999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC-CCCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~-~~~~ 156 (269)
.||++||+|--.+++.++++++.++.+...|+.||.|||++||++||+|.+|++++..|+ +||+|+|+++... .+..
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdygmcke~l~~gd~ 407 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGLGPGDT 407 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccchhhcCCCCCcc
Confidence 999999999888989999999999999999999999999999999999999999999999 9999999998543 3445
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCC--CCC--ChhhHHHHHHHHhhccccCCCcCCCCH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFE--DPE--DPRNFRKTIDRIRNVQYFLPDYVRVSA 232 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~--~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
..+.+|||.|.|||++.+..+.-. .|.|+||+++++|+.|..||. +.+ +.+.-..+..-+....+..|. .++-
T Consensus 408 tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--slsv 484 (593)
T KOG0695|consen 408 TSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--SLSV 484 (593)
T ss_pred cccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--eeeh
Confidence 667799999999999998888544 999999999999999999996 222 222222333444444445555 6777
Q ss_pred HHHHHHHHHhhhCCCCCCC------cHHHhhccChhh
Q 024336 233 DCRHLLSQIFVADPSKDPH------SRDQKASLVPEE 263 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps------~~~~l~~~~~~~ 263 (269)
....+++..|.+||.+|.. .+++..|+||..
T Consensus 485 kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 485 KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 7889999999999999974 578999999874
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=263.88 Aligned_cols=247 Identities=26% Similarity=0.342 Sum_probs=199.4
Q ss_pred cccccceecccCceEEEEEEEecC----CeEEEEEEeecC--ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRT----KELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~----~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
..+..+.||.|-||.||++..... .--||||..+.+ ....+.|.+|..++++++||||++++|++.+ ...|+|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 345678899999999999987532 234888887653 2345679999999999999999999999875 468999
Q ss_pred EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 78 MEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
||.++-|-|..+++.++ .++.....-++.||+.||.|||+..+|||||-..||+|.+..- |||+|||+++.......
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAY 546 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccccch
Confidence 99999999999997765 5888999999999999999999999999999999999987765 99999999985433322
Q ss_pred CC--cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 157 PK--STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 157 ~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
.. ...-..-|+|||.+.-..+++. ||+|.||+++||++. |..||.+-.+.+.+. .+.++ ..+|-+..+|+.
T Consensus 547 YkaS~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~----~iEnG-eRlP~P~nCPp~ 620 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVKNSDVIG----HIENG-ERLPCPPNCPPA 620 (974)
T ss_pred hhccccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCccccccccceEE----EecCC-CCCCCCCCCChH
Confidence 22 2223457999999987777665 999999999999886 889998866643332 22222 233444489999
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+..++.+||+++|.+||.+.++...+
T Consensus 621 LYslmskcWayeP~kRPrftei~~~l 646 (974)
T KOG4257|consen 621 LYSLMSKCWAYEPSKRPRFTEIKAIL 646 (974)
T ss_pred HHHHHHHHhccCcccCCcHHHHHHHH
Confidence 99999999999999999999987654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=287.78 Aligned_cols=243 Identities=19% Similarity=0.240 Sum_probs=184.8
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
.|...+.||+|+||.||++.+..++..||+|.+..... ....|+..+++++||||+++++++.+++..++||||+++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence 45667789999999999999988999999998864332 223568889999999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcc
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCH---SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST 160 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (269)
++|.+++.. +++..+..++.|++.|++||| +.+++|||+||+||+++.++. .++. ++...... .....
T Consensus 768 g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~---~~~~~ 838 (968)
T PLN00113 768 KNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC---TDTKC 838 (968)
T ss_pred CcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc---cCCCc
Confidence 999999853 789999999999999999999 679999999999999998776 4443 44332111 11223
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh-hhHHHHHHHHh-hc------cccCCCcC----
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIR-NV------QYFLPDYV---- 228 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~-~~~~~~~~~~~-~~------~~~~~~~~---- 228 (269)
.+++.|+|||.+.+..++.+ +||||+|+++|||+||+.||...... ........... .. +.......
T Consensus 839 ~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (968)
T PLN00113 839 FISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917 (968)
T ss_pred cccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence 57789999999987776555 99999999999999999998543221 11111111100 00 00010000
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 229 RVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
....++.+++.+||+.||++||+++|+++.+
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 948 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARPCANDVLKTL 948 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCcCHHHHHHHH
Confidence 1123567899999999999999999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=267.41 Aligned_cols=248 Identities=29% Similarity=0.343 Sum_probs=194.5
Q ss_pred cccceecccCce-EEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 6 EPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 6 ~~~~~l~~g~~g-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
.-.+.+|.|+.| .||++... |+.||||.+.... ..-..+|+..++.. .||||+++++.-.+....|+..|.|..
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 345678899998 57877774 7899999886543 35677899999988 599999999998888999999999964
Q ss_pred CchHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC---CCCCcEEEeecCCcccCCCCCC
Q 024336 84 GELFARICSAGR----FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG---SPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 84 ~~l~~~~~~~~~----~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~---~~~~~~~l~df~~~~~~~~~~~ 156 (269)
+|.+++...+. ......+.++.|+++||++||+.+|+||||||.||+|+. ++..+++|+|||+++....+..
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 99999977421 122456788999999999999999999999999999986 4555799999999985443332
Q ss_pred ----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhC-CCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 157 ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVG-AYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 157 ----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
.....||-.|.|||++....... +.|||||||++|+.++| ..||+..- ....++..++..+.......
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~-avDiFslGCvfyYvltgG~HpFGd~~------~R~~NIl~~~~~L~~L~~~~ 739 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQ-AVDIFSLGCVFYYVLTGGSHPFGDSL------ERQANILTGNYTLVHLEPLP 739 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCc-ccchhhcCceEEEEecCCccCCCchH------HhhhhhhcCccceeeeccCc
Confidence 23456889999999998777655 49999999999999986 89998642 22334444444332211111
Q ss_pred -HHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 232 -ADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 232 -~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.+..+||.+|+.++|..||++.++|.||+|=..+
T Consensus 740 d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e 774 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE 774 (903)
T ss_pred hHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence 2788999999999999999999999999986544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=242.12 Aligned_cols=252 Identities=24% Similarity=0.315 Sum_probs=193.6
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHh--CCCCCcceeeEEEEeC----CeE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS--LRHPNIIRFKEVLLTP----THL 74 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~~ 74 (269)
|+.+..+.+.||+|.||.||++.+. |+.||||+|... ...++.+|.++.+. |+|+||+.+++.=..+ .++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 4567888999999999999999997 888999999653 44667777766655 5999999999863322 269
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeecCCCCcEEecCCCCCcEEEeecC
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS--------MEICHRDLKLENTLLDGSPQPRLKICDFG 146 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~--------~~i~H~di~p~ni~i~~~~~~~~~l~df~ 146 (269)
++|++|.+.|||.+++.+ ..++.+...+++..++.+|++||. -.|+|||||..||+|..++. +.|+|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLG 361 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLG 361 (513)
T ss_pred EEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EEEeece
Confidence 999999999999999976 678999999999999999999994 24999999999999999998 9999999
Q ss_pred CcccCCC-----CCCCCcccCCCcccCchhhcccc-----CCCccchhhhHHHHHHHHHhC----------CCCCCCCCC
Q 024336 147 YSKSGLL-----HSQPKSTVGTPAYIAPEVLARKE-----YDGKISDVWSCGVTLYVMLVG----------AYPFEDPED 206 (269)
Q Consensus 147 ~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~~l~~l~tg----------~~pf~~~~~ 206 (269)
+|..... ........||.+|+|||++...- .+.+.+||||||.++||++-+ .+||.+...
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9863222 23445678999999999986432 123458999999999999863 478876555
Q ss_pred hhhHHHHHHHHhhc---cccCCC-cCCCC--HHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 207 PRNFRKTIDRIRNV---QYFLPD-YVRVS--ADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 207 ~~~~~~~~~~~~~~---~~~~~~-~~~~~--~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+...+.+..+.-. .+..|. |...+ ..+..+++.||..||.-|.|+--+.+.+
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 44444444333322 222222 11222 3477899999999999999998776643
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=236.40 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=200.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecC---ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCC------
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPT------ 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 72 (269)
..+|.-++.++.|+- .|.-+-+.-.+++||+|..... ........+|...+..+.|+|+++++.+|....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357888899999999 7788888888999999987532 233456778999999999999999999987653
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
..|+|||+++. +|.+.+.. .++=..+..++.|++.|+.+||+.||+||||||+||++..+.. +|+.|||++....
T Consensus 95 e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLARTED 169 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhhcccC
Confidence 48999999975 78777763 3677889999999999999999999999999999999987766 9999999998765
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc------------
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV------------ 220 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~------------ 220 (269)
..-.......+..|.|||++.+..+... .||||+||++.+|++|...|.+...-+..-...+.....
T Consensus 170 ~~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred cccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 5545556678889999999998886566 999999999999999999998655422221111111110
Q ss_pred ---------------cccCCCc---------CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChh
Q 024336 221 ---------------QYFLPDY---------VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 221 ---------------~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
...+|+. ..-+..+++++.+||..||++|.|++++|.||+++
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0011110 11224588999999999999999999999999997
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=256.68 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=202.1
Q ss_pred cccccceecccCceEEEEEEEec-------CCeEEEEEEeecCc--cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCe
Q 024336 4 RYEPVKELGSGNFGVARLVRDKR-------TKELVAVKYIERGK--KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTH 73 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~-------~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 73 (269)
+..+.+.||+|+||.|+++.-.. ....||+|...... ...+.+..|+.+++.+ .|+|++.+.+.+...+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 34567799999999999998541 14569999887543 3356788999999999 59999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC
Q 024336 74 LAIVMEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ 137 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~ 137 (269)
+++|.||+..|+|..++...+ .++...+..++.||+.|++||++..++|||+-.+||+++.+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence 999999999999999997765 3889999999999999999999999999999999999998876
Q ss_pred CcEEEeecCCcccCCCCCCCC--ccc--CCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 024336 138 PRLKICDFGYSKSGLLHSQPK--STV--GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRK 212 (269)
Q Consensus 138 ~~~~l~df~~~~~~~~~~~~~--~~~--~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~ 212 (269)
+|++|||+++......... ... -...|+|||.+....++.+ |||||+|+++||++| |..||.+......
T Consensus 457 --~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~~~~~--- 530 (609)
T KOG0200|consen 457 --IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPYPGIPPTEE--- 530 (609)
T ss_pred --EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCCCCCCcHHH---
Confidence 9999999998433332222 111 2446999999998777666 999999999999998 8899987432222
Q ss_pred HHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
..+.++.+ ..+..+..+++++.++++.||..+|.+||++.++.+..-.
T Consensus 531 l~~~l~~G-~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 531 LLEFLKEG-NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHHHhcC-CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 23333333 3344444789999999999999999999999998875433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=251.57 Aligned_cols=197 Identities=30% Similarity=0.496 Sum_probs=176.5
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCccccH---------HHHHHHHHHHhCC---CCCcceeeEEEEeC
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE---------NVQREIINHRSLR---HPNIIRFKEVLLTP 71 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~e~~~l~~l~---h~~i~~~~~~~~~~ 71 (269)
+|+.++.+|.|+||.|++|.++.+...|++|.+.+.+.-.+ ..-.|+.+|..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 58999999999999999999999999999999877543222 2345999999996 99999999999999
Q ss_pred CeEEEEEeec-CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCccc
Q 024336 72 THLAIVMEYA-AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 72 ~~~~~v~e~~-~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~ 150 (269)
+++|++||.- +|.+|.++|...+.+++.+...|++|++.|+.+||+.||+|||||-+||.++.+|- +||+|||.+..
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgsaa~ 719 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGSAAY 719 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccchhh
Confidence 9999999986 46789999999999999999999999999999999999999999999999998887 99999998853
Q ss_pred CCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCC
Q 024336 151 GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFED 203 (269)
Q Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~ 203 (269)
....+.....||..|.|||.+.+..+..+.-|||+||+++|.++....||.+
T Consensus 720 -~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 -TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred -hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 3455667788999999999999999998889999999999999988888853
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=239.61 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=204.8
Q ss_pred CcccccccceecccCceEEEEEEEec---CCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKR---TKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 76 (269)
+.+.|..+.+||.|.|++||++.+.. .+..||+|.+.... ....+.+|++.+..+ .+.||+++.+.+..++...+
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 35679999999999999999999887 78899999987654 456688999999999 58999999999999999999
Q ss_pred EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCccc------
Q 024336 77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS------ 150 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~------ 150 (269)
|+||++.....++... ++..++..+++.++.||.++|++||+||||||.|++++.... +-.|+|||++..
T Consensus 113 vlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred EecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC-CceEEechhHHHHHhhhh
Confidence 9999999888888754 678999999999999999999999999999999999986554 579999998750
Q ss_pred ----CC----CCCC-------------------------------CCcccCCCcccCchhhccccCCCccchhhhHHHHH
Q 024336 151 ----GL----LHSQ-------------------------------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTL 191 (269)
Q Consensus 151 ----~~----~~~~-------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l 191 (269)
.. .... .....||++|.|||++....-.+.+.|+||.|+|+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 00 0000 01234799999999998777667779999999999
Q ss_pred HHHHhCCCCCCCCCChh-hHHHHH---------------------------------HHHhhc--------cc---cCCC
Q 024336 192 YVMLVGAYPFEDPEDPR-NFRKTI---------------------------------DRIRNV--------QY---FLPD 226 (269)
Q Consensus 192 ~~l~tg~~pf~~~~~~~-~~~~~~---------------------------------~~~~~~--------~~---~~~~ 226 (269)
..++++..||-...+.. .+.+.. ...... .. ....
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 99999999986543321 111110 000000 00 0000
Q ss_pred -cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 227 -YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 227 -~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
....+..+.+|+++||..||.+|.|+++.|+|+||.+..
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 123455889999999999999999999999999999765
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=241.52 Aligned_cols=247 Identities=23% Similarity=0.281 Sum_probs=185.5
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHH--hCCCCCcceeeEEEEeCC----eEEEEE
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR--SLRHPNIIRFKEVLLTPT----HLAIVM 78 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~--~l~h~~i~~~~~~~~~~~----~~~~v~ 78 (269)
.+..+.||+|.||.||+++.. ++.||||+++.... +++.+|-++.+ .++|+||+++++.-.... .+++|+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~k--qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEK--QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc--CceeEEEecCHHHH--HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 456789999999999999996 58999999986543 56666666555 458999999998755443 799999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------CCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS---------MEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---------~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
+|.+.|+|.+++.. ..+++....+++..++.||+|||. ..|+|||||..||+|..|.. ..|+|||++.
T Consensus 288 ~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGLAl 364 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFGLAL 364 (534)
T ss_pred eeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccceeE
Confidence 99999999999954 468999999999999999999995 45999999999999999998 9999999997
Q ss_pred cCCCCCC---CCcccCCCcccCchhhccccCC-----CccchhhhHHHHHHHHHhCCCCCC-CCC---------------
Q 024336 150 SGLLHSQ---PKSTVGTPAYIAPEVLARKEYD-----GKISDVWSCGVTLYVMLVGAYPFE-DPE--------------- 205 (269)
Q Consensus 150 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~-----~~~~Di~slG~~l~~l~tg~~pf~-~~~--------------- 205 (269)
....... .-...||.+|||||++.+..-. -++.||||+|.++||++++..-+. +..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 5443332 2345799999999999865332 245899999999999999654332 100
Q ss_pred ChhhHHHHHHHHhhccccCCC-cC--CCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 206 DPRNFRKTIDRIRNVQYFLPD-YV--RVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
..+.+++..-. ++..+.+++ |. .....+.+.+..||+.||+.|.|+.=+-+..
T Consensus 445 t~e~mq~~VV~-kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~ 500 (534)
T KOG3653|consen 445 TLEEMQELVVR-KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERM 500 (534)
T ss_pred CHHHHHHHHHh-hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence 11122222111 122333332 11 2235688999999999999999997655543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=234.75 Aligned_cols=259 Identities=27% Similarity=0.383 Sum_probs=201.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----eE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPT-----HL 74 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 74 (269)
.+.+-.+.||.|+||.||-+.+..+|+.|+.|.+.... ...+.+.+|+.+++..+|.|++...++..... .+
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 35566789999999999999999999999999886432 33456788999999999999999998876543 47
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
|+++|.+.. +|...+-+..+++.+.+.-.+.||+.+|.|||+.||.||||||.|.+++++ +.+||||||+++.-...
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN--CvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN--CILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC--ceEEecccccccccchh
Confidence 888888854 777777777889999999999999999999999999999999999999755 44999999999743222
Q ss_pred C--CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHh--------------
Q 024336 155 S--QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-------------- 218 (269)
Q Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~-------------- 218 (269)
. ......-|..|+|||.+.+...++.+.||||+|||+.|++.++..|.....-..+.-..+-..
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 2 223344577899999999988888889999999999999999888876554333322221111
Q ss_pred -----hccccCCCc---------CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 219 -----NVQYFLPDY---------VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 219 -----~~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
......|+. ..-..+...++.+|+..||..|.+.++.+.|+...+.
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 111111111 1223457788999999999999999999999987653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=252.87 Aligned_cols=246 Identities=24% Similarity=0.353 Sum_probs=202.7
Q ss_pred ccccceecccCceEEEEEEEecCCe----EEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKE----LVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.+-.++||+|+||+||++.+-..|+ +||+|++.... +...++.+|+.++.+++|||++++++++.... +-+|+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3457899999999999999976654 68888876433 34577899999999999999999999988765 78999
Q ss_pred eecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 79 EYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
+|+++|+|.++++.++ ++.....+.|..||++|+.|||.++++||||-.+||+|....+ +|++|||+++........
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCccccc
Confidence 9999999999997754 6888999999999999999999999999999999999998888 999999999854444332
Q ss_pred Ccc---cCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 158 KST---VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 158 ~~~---~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
-.. .-.+-|+|-|.+....++.. +||||+|+++||++| |..|+.+... .+..+.+..++. ++++.-++.+
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~----~eI~dlle~geR-LsqPpiCtiD 928 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPA----EEIPDLLEKGER-LSQPPICTID 928 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCH----HHhhHHHhcccc-CCCCCCccHH
Confidence 222 22456889999887777666 999999999999998 8999987654 333333333333 5666689999
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+..++.+||..|+..||+++++.+..
T Consensus 929 Vy~~mvkCwmid~~~rp~fkel~~~f 954 (1177)
T KOG1025|consen 929 VYMVMVKCWMIDADSRPTFKELAEEF 954 (1177)
T ss_pred HHHHHHHHhccCcccCccHHHHHHHH
Confidence 99999999999999999999987653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=219.91 Aligned_cols=210 Identities=42% Similarity=0.661 Sum_probs=182.8
Q ss_pred ecccCceEEEEEEEecCCeEEEEEEeecCccc--cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCchHH
Q 024336 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKI--DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFA 88 (269)
Q Consensus 11 l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 88 (269)
||+|.+|.||++....+++.+++|.+...... .+.+.+|+..++.+.|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999998865442 4678999999999999999999999999999999999999899999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCCcEEEeecCCcccCCCCC-CCCcccCCCc
Q 024336 89 RICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHS-QPKSTVGTPA 165 (269)
Q Consensus 89 ~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~-~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~ 165 (269)
++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++. ++|+||+.+....... ..........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc--EEEecCCceEEccCCcchhhcccCCCC
Confidence 98765 46899999999999999999999999999999999999998 666 9999999886432221 1334557788
Q ss_pred ccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhC
Q 024336 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245 (269)
Q Consensus 166 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 245 (269)
|.+||........+.++|+|++|++++++ ..+.+++.+|+..+
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~ 201 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKD 201 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCC
Confidence 99999987763445559999999999999 47789999999999
Q ss_pred CCCCCCcHHHhhcc
Q 024336 246 PSKDPHSRDQKASL 259 (269)
Q Consensus 246 p~~Rps~~~~l~~~ 259 (269)
|.+||++.++++++
T Consensus 202 p~~R~~~~~l~~~~ 215 (215)
T cd00180 202 PEKRPSAKEILEHL 215 (215)
T ss_pred cccCcCHHHHhhCC
Confidence 99999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=227.49 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=202.0
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeE-EEEeCCeEEEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKE-VLLTPTHLAIVM 78 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~-~~~~~~~~~~v~ 78 (269)
+.+.|.+.+.||+|.||.+-++.|.+++..+++|.++........|.+|..---.| .|.||+.-++ .|++.+.+++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 46789999999999999999999999999999999998877788888888654444 5899998665 477788999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||++.|+|..-+..++ +.+..-..++.|+++|+.|+|+.++||||||.+||+|.....-+|||||||.+... +....
T Consensus 102 E~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~--g~tV~ 178 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV--GTTVK 178 (378)
T ss_pred ccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc--Cceeh
Confidence 9999999999886644 68888899999999999999999999999999999997655557999999988732 22222
Q ss_pred cccCCCcccCchhhccc----cCCCccchhhhHHHHHHHHHhCCCCCCCCCCh-hhHHHHHHHHhhccccCCC-cCCCCH
Q 024336 159 STVGTPAYIAPEVLARK----EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNVQYFLPD-YVRVSA 232 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~ 232 (269)
....+..|.+||..... -...+.+|+|.||++++.++||.+||...... ..+.+.....+......|. ...+++
T Consensus 179 ~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~ 258 (378)
T KOG1345|consen 179 YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSE 258 (378)
T ss_pred hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCH
Confidence 33345678899876532 11234489999999999999999999743322 2333333333333333443 346788
Q ss_pred HHHHHHHHHhhhCCCCC---CCcHHHhhccChhh
Q 024336 233 DCRHLLSQIFVADPSKD---PHSRDQKASLVPEE 263 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~R---ps~~~~l~~~~~~~ 263 (269)
.+..+.++-|.++|++| .++.......|.+.
T Consensus 259 ~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 259 KALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred HHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 99999999999999999 66666666665544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=253.07 Aligned_cols=258 Identities=29% Similarity=0.420 Sum_probs=214.2
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+++|..++.+|.|.+|.||++++..++++.|+|+++.... ....+.+|+.+++..+||||+.+++.+...+.+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 5789999999999999999999999999999999986543 345677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC-CCCCCCCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG-LLHSQPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~-~~~~~~~~ 159 (269)
|.||+|.+.-+-.+++++.++...++..+.++.|||+.|-+|||||-.||++++.+. +++.|||.+... ..-.....
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhhhc
Confidence 999999999988899999999999999999999999999999999999999999998 999999987532 22233456
Q ss_pred ccCCCcccCchhhc---cccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 160 TVGTPAYIAPEVLA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 160 ~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
..||+.|+|||+.. .+.+ ...+|+|++|++..++...++|.-.......+. ++..-.-..+.+.+....++-+-+
T Consensus 172 fiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~-LmTkS~~qpp~lkDk~kws~~fh~ 249 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALF-LMTKSGFQPPTLKDKTKWSEFFHN 249 (829)
T ss_pred ccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHH-HhhccCCCCCcccCCccchHHHHH
Confidence 78999999999864 2334 444999999999999998888754433211111 111111122344455678899999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
|++.+|.++|++||+++.+|.|+|..-
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeecc
Confidence 999999999999999999999998753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=213.13 Aligned_cols=199 Identities=27% Similarity=0.399 Sum_probs=162.3
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecC--ccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+...+..||+|++|.|-+.++..+|...|+|.+... ....+...+|+.+..+. .+|.+|.++|....+..+++-||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 345567899999999999999999999999998743 23334566777766555 789999999999999999999999
Q ss_pred cCCCchHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 81 AAGGELFAR----ICSAGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
++. ||..+ +..++.+++..+-+++..++.||.|||++ .++|||+||+||+++.+|+ ||+||||++-.....-
T Consensus 127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISGYLVDSI 203 (282)
T ss_pred hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccceeehhhh
Confidence 964 66443 34567799999999999999999999975 7999999999999999998 9999999986443333
Q ss_pred CCCcccCCCcccCchhhccc----cCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Q 024336 156 QPKSTVGTPAYIAPEVLARK----EYDGKISDVWSCGVTLYVMLVGAYPFEDPED 206 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~ 206 (269)
......|...|+|||.+... .+ +-+|||||||+++.||.++..||.....
T Consensus 204 Akt~daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 204 AKTMDAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred HHHHhcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhccccccccCC
Confidence 33335677889999988632 34 4449999999999999999999986554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=213.26 Aligned_cols=196 Identities=45% Similarity=0.715 Sum_probs=170.7
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
|++.+.||.|++|.||++.+..+++.+++|.+..... ..+.+.+|+..+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 6788999999999999999998899999999876543 35678889999999999999999999999899999999999
Q ss_pred CCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--CCCc
Q 024336 83 GGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKS 159 (269)
Q Consensus 83 ~~~l~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~~~ 159 (269)
+++|.+.+..... +++..+..++.+++.++.+||+.+++|+|++|.||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL--VKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeCceeeEecCcccccccc
Confidence 9999999987766 899999999999999999999999999999999999998866 9999999887543332 2234
Q ss_pred ccCCCcccCchhh-ccccCCCccchhhhHHHHHHHHHhCCCCCCC
Q 024336 160 TVGTPAYIAPEVL-ARKEYDGKISDVWSCGVTLYVMLVGAYPFED 203 (269)
Q Consensus 160 ~~~~~~~~aPE~~-~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~ 203 (269)
..++..|++||.+ ....++. ++|+|+||++++++++|..||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccc
Confidence 4567789999998 4444444 59999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=210.73 Aligned_cols=248 Identities=18% Similarity=0.223 Sum_probs=195.3
Q ss_pred cccccccceecccCceEEEEEEEecC-----CeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeC-Ce
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRT-----KELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTP-TH 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~ 73 (269)
+.+++....+-+|.||.||.+.+.+. .+.|-+|.+..... +...+..|-..+..+.|||+.++.++..++ ..
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 35677778888999999999977543 23355665543322 234567788888888999999999987765 46
Q ss_pred EEEEEeecCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeec
Q 024336 74 LAIVMEYAAGGELFARICS--------AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDF 145 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df 145 (269)
..+++.+..-|+|..++.. .+.++..++..++.|++.|++|||+.|++|.||-..|.+|++.-+ |||+|=
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq--VkltDs 440 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ--VKLTDS 440 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee--EEeccc
Confidence 7888999999999999862 123778889999999999999999999999999999999997766 999999
Q ss_pred CCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhcc
Q 024336 146 GYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQ 221 (269)
Q Consensus 146 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~ 221 (269)
.+++...+..- .........|++||.+....+++. +|+||||+++|||+| |+.|+..-+..+ +.......
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfE-----m~~ylkdG 514 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFE-----MEHYLKDG 514 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHH-----HHHHHhcc
Confidence 88875433322 233345668999999998888666 999999999999998 889987655422 22233345
Q ss_pred ccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhh
Q 024336 222 YFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKA 257 (269)
Q Consensus 222 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 257 (269)
+.+.++.++|+++..++..||+..|++||+++|+..
T Consensus 515 yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 556666799999999999999999999999999865
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=243.05 Aligned_cols=201 Identities=17% Similarity=0.164 Sum_probs=143.5
Q ss_pred hCCC-CCcceeeEEE-------EeCCeEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecC
Q 024336 55 SLRH-PNIIRFKEVL-------LTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125 (269)
Q Consensus 55 ~l~h-~~i~~~~~~~-------~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di 125 (269)
.++| +||+.++++| ...+.++.++|++ +++|.+++.. ...+++.++..++.||+.||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3455 5777777776 2335678888987 4599999965 345899999999999999999999999999999
Q ss_pred CCCcEEecCCCC-----------------CcEEEeecCCcccCCCCC-----------------CCCcccCCCcccCchh
Q 024336 126 KLENTLLDGSPQ-----------------PRLKICDFGYSKSGLLHS-----------------QPKSTVGTPAYIAPEV 171 (269)
Q Consensus 126 ~p~ni~i~~~~~-----------------~~~~l~df~~~~~~~~~~-----------------~~~~~~~~~~~~aPE~ 171 (269)
||+||+++..+. ..++++|||+++...... ......+|+.|+|||.
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999965332 235666676664211000 0011346788999999
Q ss_pred hccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCC
Q 024336 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPH 251 (269)
Q Consensus 172 ~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 251 (269)
+.+..+.. ++|||||||++|||++|.+|+..... ......... . .+......+....++.+||.++|.+||+
T Consensus 187 ~~~~~~~~-~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 187 DNGSSSNC-ASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV----L-PPQILLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred hccCCCCc-hhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh----c-ChhhhhcCHHHHHHHHHhCCCChhhCcC
Confidence 98877754 49999999999999998887653211 111111111 0 1111122455678999999999999999
Q ss_pred cHHHhhccChhhh
Q 024336 252 SRDQKASLVPEEF 264 (269)
Q Consensus 252 ~~~~l~~~~~~~~ 264 (269)
+.|+++|+|+...
T Consensus 259 ~~eil~h~~~~~~ 271 (793)
T PLN00181 259 MSELLQSEFINEP 271 (793)
T ss_pred hHHHhhchhhhhh
Confidence 9999999999764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=192.53 Aligned_cols=166 Identities=19% Similarity=0.175 Sum_probs=126.0
Q ss_pred CchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccC
Q 024336 84 GELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG 162 (269)
Q Consensus 84 ~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 162 (269)
|+|.+++.. ..++++..++.++.|++.||.|||+.+ ||+||+++.++. +++ ||++..... ....+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~----~~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTP----EQSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeecc----ccCCC
Confidence 588899876 456999999999999999999999998 999999998887 788 998864322 12357
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChh-hHHHHHHHHhhcccc-CCCcCCCCH--HHHHHH
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR-NFRKTIDRIRNVQYF-LPDYVRVSA--DCRHLL 238 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~li 238 (269)
++.|+|||.+.+..++. ++||||||+++|+|+||..||....... ............... .+....++. .+.++|
T Consensus 67 ~~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 67 DPYFMAPEVIQGQSYTE-KADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred cccccChHHhcCCCCcc-hhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 89999999998877755 4999999999999999999997644322 222222222111110 011112333 699999
Q ss_pred HHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 239 SQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
.+||..+|.+||++.++++|+|...-
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHH
Confidence 99999999999999999999987653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=195.92 Aligned_cols=252 Identities=24% Similarity=0.193 Sum_probs=194.0
Q ss_pred cccccceecccCceEEEEEEEecCC-eEEEEEEeecCccc-cHHHHHHHHHHHhCC----CCCcceeeEEE-EeCCeEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTK-ELVAVKYIERGKKI-DENVQREIINHRSLR----HPNIIRFKEVL-LTPTHLAI 76 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~-~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~~ 76 (269)
+|++.+.||+|+||.||.+.+..++ +.+|+|........ ...+..|..++..+. .+++..+++.+ ..+..-++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999998764 67899987654322 226888998888886 26899999998 47778899
Q ss_pred EEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-C--CcEEEeecCCcc--
Q 024336 77 VMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-Q--PRLKICDFGYSK-- 149 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~--~~~~l~df~~~~-- 149 (269)
||+.+ |.+|.++.... +.++...+..++.|++.+|.++|+.|++||||||.|+.+.... . ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99998 66999988544 4799999999999999999999999999999999999998654 2 359999999997
Q ss_pred cCCCCC--------C-CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc
Q 024336 150 SGLLHS--------Q-PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 220 (269)
Q Consensus 150 ~~~~~~--------~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~ 220 (269)
...... . .....||..|+++.++.+...... .|+||++.++.++..|..||...................
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~ 256 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL 256 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence 211111 1 123348999999999888777555 999999999999999999997766543333332222222
Q ss_pred cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 221 QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 221 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
.... .....+..+..+...+-..+..++|....+...
T Consensus 257 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 257 LTDR-FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred cccc-ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1110 112455677777777777899999998887665
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=222.42 Aligned_cols=257 Identities=31% Similarity=0.471 Sum_probs=199.7
Q ss_pred cccceecccCceEEEEEEEecCCeEEEEEEee----cCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIE----RGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 6 ~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~----~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.....+|.|++|.|+.+......+.++.|.+. ..... ...+..|+.+-..+.|+|++.....+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678899999988888877666666666543 11111 112445666777889999988888777766666669
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC---
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--- 155 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--- 155 (269)
|||++ +|..++...+.++..++-.+++|++.|+.|+|..|+.|||+|++|+++..++. ++++|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccCcchh
Confidence 99999 99999988878999999999999999999999999999999999999999987 9999999886432222
Q ss_pred --CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHH---HHhhccccCCCcCCC
Q 024336 156 --QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID---RIRNVQYFLPDYVRV 230 (269)
Q Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 230 (269)
......++..|.|||.+....+.....||||.|+++..|.+|+.||......+....... ..........-+..+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 234556888999999999999999999999999999999999999976554433210000 000011111122357
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
|...+.+|.+||+.||.+|.|++++++.+|++...
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 78899999999999999999999999999998764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=196.02 Aligned_cols=161 Identities=16% Similarity=0.146 Sum_probs=124.3
Q ss_pred CcccccccceecccCceEEEEEEEec-CCeEEEEEEeecC------ccccHHHHHHHHHHHhCCCCCcce-eeEEEEeCC
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKR-TKELVAVKYIERG------KKIDENVQREIINHRSLRHPNIIR-FKEVLLTPT 72 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~-~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~ 72 (269)
+.++|++.+.||+|+||+||++.+.. ++..+|+|..... ......+.+|+.++++++|+|+++ +++ .+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TG 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cC
Confidence 35789999999999999999999875 6788899986532 112346889999999999999985 443 24
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecC-CCCcEEecCCCCCcEEEeecCCcccC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL-KLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di-~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
..++||||++|++|.. +. +.. ...++.+++.+|.+||+.|++|||| ||+||+++.++. ++|+|||++...
T Consensus 92 ~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFGlA~~~ 162 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQLASVF 162 (365)
T ss_pred CcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECccceec
Confidence 5799999999988863 21 111 1467899999999999999999999 999999987776 999999998743
Q ss_pred CCCCC---------CCcccCCCcccCchhhcc
Q 024336 152 LLHSQ---------PKSTVGTPAYIAPEVLAR 174 (269)
Q Consensus 152 ~~~~~---------~~~~~~~~~~~aPE~~~~ 174 (269)
..... .....+++.|.|||.+..
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 22111 122346777899998763
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=174.63 Aligned_cols=247 Identities=21% Similarity=0.241 Sum_probs=189.0
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCC-CCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH-PNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++|+++++||.|+||.+|++.+..+|+.||||.-... ..-..+.-|..+.+.|++ .+|..+.-++.+...-.+||+.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 57899999999999999999999999999999965443 333456778888888875 7888888888888888999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCC-cEEEeecCCcccCCCC----
Q 024336 81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP-RLKICDFGYSKSGLLH---- 154 (269)
Q Consensus 81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~-~~~l~df~~~~~~~~~---- 154 (269)
. |.||.++++- ++.++...++-++-|++.-++|+|.++++||||||+|++..-+.++ ++.|+|||+++.....
T Consensus 93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~ 171 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ 171 (341)
T ss_pred c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence 9 5699998863 5569999999999999999999999999999999999999766653 6899999999632211
Q ss_pred ----CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC---Cc
Q 024336 155 ----SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP---DY 227 (269)
Q Consensus 155 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~ 227 (269)
.......||.+|.+-....+... +.+.|+-|+|.++.++.-|..||.+.......+.. +.+.+.....+ -.
T Consensus 172 HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy-EkI~EkK~s~~ie~LC 249 (341)
T KOG1163|consen 172 HIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY-EKISEKKMSTPIEVLC 249 (341)
T ss_pred cCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHH-HHHHHhhcCCCHHHHh
Confidence 22234458889988877766555 44499999999999999999999987654333222 22222111111 12
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCCCc
Q 024336 228 VRVSADCRHLLSQIFVADPSKDPHS 252 (269)
Q Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~ 252 (269)
+++|.++.-.+.-|=..-=++-|..
T Consensus 250 ~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 250 KGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred CCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 4678888888877766555555554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-25 Score=183.69 Aligned_cols=253 Identities=36% Similarity=0.544 Sum_probs=198.6
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCccc----cHHHHHHHHHHHhCCCC-CcceeeEEEEeCCeEEEEEe
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHP-NIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~v~e 79 (269)
|++.+.||.|+|+.||.+.+. ..+++|.+...... ...+.+|+..++.+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 778899999999999999998 67899988754332 45688899999999987 79999999988888899999
Q ss_pred ecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CCcEEEeecCCcccCCCCC
Q 024336 80 YAAGGELFARICSAG---RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~~~~~ 155 (269)
++.++++.+.+.... .++......++.|++.++.++|+.+++|||+||+||+++..+ . ++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~--~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRV--VKLIDFGLAKLLPDPG 156 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCe--EEEeccCcceecCCCC
Confidence 999999997776664 789999999999999999999999999999999999999777 5 8999999886322222
Q ss_pred -------CCCcccCCCcccCchhhccc--cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcccc-CC
Q 024336 156 -------QPKSTVGTPAYIAPEVLARK--EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LP 225 (269)
Q Consensus 156 -------~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 225 (269)
......++..|.|||.+.+. .......|+||+|++++++++|..||...............+...... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 23566789999999999874 344555999999999999999999977665411112222222222211 11
Q ss_pred --CcCCC----CHHHHHHHHHHhhhCCCCCCCcHHHhhccChh
Q 024336 226 --DYVRV----SADCRHLLSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 226 --~~~~~----~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
..... ...+.+++..++..+|..|.+..+...+.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~ 279 (384)
T COG0515 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279 (384)
T ss_pred cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence 11111 25789999999999999999999988874443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-26 Score=175.35 Aligned_cols=245 Identities=22% Similarity=0.278 Sum_probs=190.0
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEEeecC
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
.|++.++||.|.||+++.+...-++++||||.- +-+.....+..|.+..+.|. .++|...+-+..++..-.+|+|..
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE-PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE-PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEec-cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 699999999999999999999999999999954 44455678999999999995 699999998888887888999999
Q ss_pred CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC---CcEEEeecCCcccCCC-----
Q 024336 83 GGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ---PRLKICDFGYSKSGLL----- 153 (269)
Q Consensus 83 ~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~---~~~~l~df~~~~~~~~----- 153 (269)
|-||.+++.- .+.|+...+..++.|++.-++++|+.++|+|||||+|++|...++ ..|.++|||+++....
T Consensus 107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tkq 186 (449)
T KOG1165|consen 107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQ 186 (449)
T ss_pred CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccc
Confidence 5699999865 456999999999999999999999999999999999999976554 3588999999973222
Q ss_pred ---CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC---c
Q 024336 154 ---HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD---Y 227 (269)
Q Consensus 154 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~ 227 (269)
........||.+||+-....+.+.+-. .|+-|||-++.+++-|..||.+...... .+..+.|.......+- .
T Consensus 187 HIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA~tn-K~kYeKIGe~Kr~T~i~~Lc 264 (449)
T KOG1165|consen 187 HIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKADTN-KEKYEKIGETKRSTPIEVLC 264 (449)
T ss_pred cCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccCcch-HHHHHHhccccccCCHHHHH
Confidence 223345668999999998888777554 9999999999999999999988665332 2333333322111110 1
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCCCc
Q 024336 228 VRVSADCRHLLSQIFVADPSKDPHS 252 (269)
Q Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~ 252 (269)
.++|.++..-++-.=..+=.+-|..
T Consensus 265 ~g~P~efa~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 265 EGFPEEFATYLRYVRRLDFFETPDY 289 (449)
T ss_pred hcCHHHHHHHHHHHHhcCcccCCCH
Confidence 2456666666655555555555554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-28 Score=210.88 Aligned_cols=238 Identities=23% Similarity=0.356 Sum_probs=182.1
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHH--HHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIIN--HRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.|...+.||.+.|=.|.++++.+ |. |++|++-+.. .....+.+++.- ...+++||++++......++..|+|.+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 46778999999999999999973 55 9999986533 233444444333 444589999999998888888999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC--
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-- 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~-- 157 (269)
|... +|.+.+...+.+..-+.+.|+.|++.||..+|+.|++|||||.+||+|+.-.- +.|+||..-+.....+..
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech--hhhhcccccCCccCCCCCcc
Confidence 9976 89999988877889999999999999999999999999999999999997665 899999876643333322
Q ss_pred ------CcccCCCcccCchhhcccc---------C-CCccchhhhHHHHHHHHHh-CCCCCCCCC-------ChhhHHHH
Q 024336 158 ------KSTVGTPAYIAPEVLARKE---------Y-DGKISDVWSCGVTLYVMLV-GAYPFEDPE-------DPRNFRKT 213 (269)
Q Consensus 158 ------~~~~~~~~~~aPE~~~~~~---------~-~~~~~Di~slG~~l~~l~t-g~~pf~~~~-------~~~~~~~~ 213 (269)
.+.....+|.|||.+.... + .+++.||||+||+++|+++ |.+||.-.. +.......
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 2223456899999876421 1 3566899999999999997 678885210 01112222
Q ss_pred HHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 214 IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
.+.+. +..++.+|..|++.||++|.++++.|+.
T Consensus 259 Le~Ie------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 259 LEKIE------------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhCc------------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 22211 2478999999999999999999999986
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=181.82 Aligned_cols=231 Identities=21% Similarity=0.245 Sum_probs=148.3
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhCC----------CCCcceeeEEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLR----------HPNIIRFKEVLL 69 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~----------h~~i~~~~~~~~ 69 (269)
.....+.||.|+++.||.+.+..+|+.+|+|++..... ..+.+++|......+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34567899999999999999999999999999864332 2244556655554432 223444444433
Q ss_pred eC------------C-----eEEEEEeecCCCchHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHhCCceeecC
Q 024336 70 TP------------T-----HLAIVMEYAAGGELFARICS---AGR----FSEDEARFFFQQLISGVSYCHSMEICHRDL 125 (269)
Q Consensus 70 ~~------------~-----~~~~v~e~~~~~~l~~~~~~---~~~----~~~~~~~~~~~~i~~~l~~lh~~~i~H~di 125 (269)
-. . +.+++|+-+. ++|.+.+.. ... +.......+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 2367777774 478777532 222 223344567789999999999999999999
Q ss_pred CCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccCCCcccCchhhccc-------cCCCccchhhhHHHHHHHHHhCC
Q 024336 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK-------EYDGKISDVWSCGVTLYVMLVGA 198 (269)
Q Consensus 126 ~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~~l~~l~tg~ 198 (269)
+|+|++++.+|. +.|+||+...... ........+..|.+||..... ...+.+.|.|+||+++|.++++.
T Consensus 172 ~~~nfll~~~G~--v~Lg~F~~~~r~g--~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGG--VFLGDFSSLVRAG--TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS---EEE--GGGEEETT--EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCC--EEEcChHHHeecC--ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999988 9999998765322 111113445678999976543 22355689999999999999999
Q ss_pred CCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCC
Q 024336 199 YPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKD 249 (269)
Q Consensus 199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 249 (269)
.||........... .+....++|+.++.||..||+.||.+|
T Consensus 248 lPf~~~~~~~~~~~----------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW----------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG----------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc----------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99986543211111 233334788999999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=199.82 Aligned_cols=238 Identities=28% Similarity=0.476 Sum_probs=199.4
Q ss_pred eecccCceEEEEEEE---ecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEEeecC
Q 024336 10 ELGSGNFGVARLVRD---KRTKELVAVKYIERGKK---IDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 10 ~l~~g~~g~v~~~~~---~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
.+|+|++|.|+++.. .+.|..+|+|...+... .......|..++..++ ||.+++++..++.+..++++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999998865 34577899998764321 1123445777777776 9999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccC
Q 024336 83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG 162 (269)
Q Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 162 (269)
|+.+...+.+...+++.....+...++.+++++|+.+++|+|+|++||+++.+|+ +++.|||+++.....+.. +|
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~~---cg 155 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKIA---CG 155 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhhc---cc
Confidence 9999999988888999999999999999999999999999999999999999998 999999999754433332 88
Q ss_pred CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 163 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
+..|+|||+.. .. ..+.|.||+|+++++|+||..||.. +....+......+|. ..+..+++++..++
T Consensus 156 t~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~ 222 (612)
T KOG0603|consen 156 TYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMPR--ELSAEARSLFRQLF 222 (612)
T ss_pred chhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCch--hhhHHHHHHHHHHH
Confidence 99999999987 22 3448999999999999999999987 455666666666666 78899999999999
Q ss_pred hhCCCCCCCc-----HHHhhccChhhhh
Q 024336 243 VADPSKDPHS-----RDQKASLVPEEFA 265 (269)
Q Consensus 243 ~~~p~~Rps~-----~~~l~~~~~~~~~ 265 (269)
..+|.+|.-. .++++|.|+....
T Consensus 223 ~r~p~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 223 KRNPENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred hhCHHHHhccCcchhHHHhccchheeee
Confidence 9999999877 6888899887653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-26 Score=172.85 Aligned_cols=170 Identities=14% Similarity=0.157 Sum_probs=129.2
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHH----------HHHHHHHHHhCCCCCcceeeEEEEe
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----------VQREIINHRSLRHPNIIRFKEVLLT 70 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~----------~~~e~~~l~~l~h~~i~~~~~~~~~ 70 (269)
|+++|++.+.||.|+||.||++.. ++..+|+|.+.......+. +.+|+..+.++.|+++..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 578999999999999999999766 3667999999754333332 5789999999999999999888664
Q ss_pred C--------CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEE
Q 024336 71 P--------THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKI 142 (269)
Q Consensus 71 ~--------~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l 142 (269)
. ...+++|||++|.+|.+... +++ ....+++.++..+|+.|++|||++|.||++++++ ++|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~l 175 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRI 175 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEE
Confidence 3 35789999999999977632 333 3456999999999999999999999999998765 999
Q ss_pred eecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHH
Q 024336 143 CDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML 195 (269)
Q Consensus 143 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 195 (269)
+|||........... ........+.. ++|+||||+++..+.
T Consensus 176 iDfg~~~~~~e~~a~-----------d~~vler~y~~-~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAK-----------DRIDLERHYGI-KNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhH-----------HHHHHHhHhcc-cccccceeEeehHHH
Confidence 999977632111111 01222333443 499999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=166.24 Aligned_cols=137 Identities=21% Similarity=0.205 Sum_probs=109.0
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCccc----------c-----------------HHHHHHHHHHHhCCCCC
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----------D-----------------ENVQREIINHRSLRHPN 60 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----------~-----------------~~~~~e~~~l~~l~h~~ 60 (269)
...||+|++|.||++.+. +|+.||+|++...... . .....|+.+++++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 578999999999999997 8999999998754211 0 11234899999998877
Q ss_pred cceeeEEEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeecCCCCcEEecCCCCCc
Q 024336 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-HSMEICHRDLKLENTLLDGSPQPR 139 (269)
Q Consensus 61 i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~H~di~p~ni~i~~~~~~~ 139 (269)
+.....+... ..++||||++|+++........+++...+..++.|++.+|.++ |+.|++||||||+||+++. +.
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~~-- 155 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-GK-- 155 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-Cc--
Confidence 6443333222 2389999999877766544566789999999999999999999 7999999999999999983 44
Q ss_pred EEEeecCCccc
Q 024336 140 LKICDFGYSKS 150 (269)
Q Consensus 140 ~~l~df~~~~~ 150 (269)
++|+|||++..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999873
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=176.53 Aligned_cols=192 Identities=27% Similarity=0.417 Sum_probs=143.1
Q ss_pred CCCCcceeeEEEEe---------------------------CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHH
Q 024336 57 RHPNIIRFKEVLLT---------------------------PTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI 109 (269)
Q Consensus 57 ~h~~i~~~~~~~~~---------------------------~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~ 109 (269)
+|||||++.++|.+ ...+|+||..++. +|..++-.. ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 69999999888753 3469999999965 899998544 457778888999999
Q ss_pred HHHHHHHhCCceeecCCCCcEEe--cCCCCCcEEEeecCCcccCCCCC-------CCCcccCCCcccCchhhcccc----
Q 024336 110 SGVSYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHS-------QPKSTVGTPAYIAPEVLARKE---- 176 (269)
Q Consensus 110 ~~l~~lh~~~i~H~di~p~ni~i--~~~~~~~~~l~df~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~---- 176 (269)
+|+.|||+.|+.|||+|.+||++ ++|+.+.++++|||++-...... ......|+-..+|||+...-.
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999998 55666778999999875322211 112334677789999976321
Q ss_pred -CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh-ccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHH
Q 024336 177 -YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRD 254 (269)
Q Consensus 177 -~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 254 (269)
....++|.|+.|.+.||+++...||..... ..+.. ...++ .-..+|+ .+|+.+++++..+|+.||++|++..=
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~--r~Yqe~qLPalp~--~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDT--RTYQESQLPALPS--RVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccch-heech--hhhhhhhCCCCcc--cCChHHHHHHHHHhcCCccccCCccH
Confidence 223449999999999999999999976221 11111 11111 1223444 79999999999999999999999754
Q ss_pred H
Q 024336 255 Q 255 (269)
Q Consensus 255 ~ 255 (269)
.
T Consensus 507 A 507 (598)
T KOG4158|consen 507 A 507 (598)
T ss_pred H
Confidence 3
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-24 Score=161.26 Aligned_cols=138 Identities=19% Similarity=0.150 Sum_probs=110.6
Q ss_pred ccceecccCceEEEEEEEecCCeEEEEEEeecCccc---------------------------cHHHHHHHHHHHhCCCC
Q 024336 7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---------------------------DENVQREIINHRSLRHP 59 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~ 59 (269)
+.+.||+|++|.||++.+. +|+.||+|++...... ......|...+.++.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 4678999999999999987 8999999998754211 11235788999999998
Q ss_pred CcceeeEEEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCC
Q 024336 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQP 138 (269)
Q Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~~ 138 (269)
++.....+.... .++||||++|+++........+++...+..++.|++.++.++|+ .|++|+||||+||+++ ++.
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~- 155 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK- 155 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC-
Confidence 875544443333 47999999987654443344567889999999999999999999 9999999999999998 555
Q ss_pred cEEEeecCCccc
Q 024336 139 RLKICDFGYSKS 150 (269)
Q Consensus 139 ~~~l~df~~~~~ 150 (269)
++|+|||++..
T Consensus 156 -~~liDFG~a~~ 166 (190)
T cd05145 156 -PYIIDVSQAVE 166 (190)
T ss_pred -EEEEEccccee
Confidence 99999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=190.79 Aligned_cols=221 Identities=29% Similarity=0.494 Sum_probs=164.7
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
..+|..++.|..|++|.||.++|..+.+.+|+|+ .++... +++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li---lRn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI---LRN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh---hhc---cccccCCccee-------------------
Confidence 4689999999999999999999999999999964 322111 111 22222233333
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-----
Q 024336 82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----- 156 (269)
Q Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~----- 156 (269)
|+-.+.+...++++... +.+++|||+.||+|+|+||+|.+|+.-|+ +|++|||+++.......
T Consensus 136 --gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 136 --GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred --chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccchhhh
Confidence 34455666666666554 88999999999999999999999999998 99999998763221111
Q ss_pred -----------CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC
Q 024336 157 -----------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225 (269)
Q Consensus 157 -----------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (269)
.+..++||.|.|||++....|..+ .|.|++|+|+|+++.|..||.+...++.+..++.. ...++
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkp-vdwwamGiIlyeFLVgcvpffGdtpeelfg~visd----~i~wp 278 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD----DIEWP 278 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccCCC-ccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh----hcccc
Confidence 133468999999999988887555 99999999999999999999987765555444433 22232
Q ss_pred C-cCCCCHHHHHHHHHHhhhCCCCCCC---cHHHhhccChhhhh
Q 024336 226 D-YVRVSADCRHLLSQIFVADPSKDPH---SRDQKASLVPEEFA 265 (269)
Q Consensus 226 ~-~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~~~~~~~~ 265 (269)
+ ...++++.+++|.++|..+|..|.- +-++..|.||+.+.
T Consensus 279 E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD 322 (1205)
T KOG0606|consen 279 EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD 322 (1205)
T ss_pred ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence 2 2357889999999999999999965 46777788887754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-23 Score=155.33 Aligned_cols=186 Identities=18% Similarity=0.155 Sum_probs=137.2
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCccccH-----HHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEE
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE-----NVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 78 (269)
..+...|++|+||+||.+.. .+.+++.+.+........ .+.+|+++++++. ++++++++++ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678899999999997776 467788777765544333 4788999999995 5889999885 3469999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecC-CCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL-KLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di-~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
+|+.|.+|...... ....++.|++.+|.++|+.|++|+|| ||.||+++.++. ++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC--EEEEECCCceecCCcchH
Confidence 99999888654321 12357889999999999999999999 799999988777 999999999743221110
Q ss_pred ----C----------cccCCCcccCchhhccc-cCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 024336 158 ----K----------STVGTPAYIAPEVLARK-EYDGKISDVWSCGVTLYVMLVGAYPFEDPE 205 (269)
Q Consensus 158 ----~----------~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~pf~~~~ 205 (269)
. ....++.+++|+...-- ..+-.+.+.++.|+-+|.++|+..++.+..
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 01135667777654322 222234789999999999999998876543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=163.78 Aligned_cols=239 Identities=22% Similarity=0.333 Sum_probs=184.1
Q ss_pred cccceecccCceEEEEEEEecCCeEEEEEEeec---CccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 6 ~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
....+|.....|..|++++. |..++.|++.. .......|..|.-.++-..||||+++++.|...-.+.++..|++
T Consensus 193 nl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 34567888999999999997 44467777643 22334567788888888899999999999999999999999999
Q ss_pred CCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 83 GGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 83 ~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
-|+|...+..... .+..+..+++.+++.+++|||+.. |.---+....++++.+-..++-..|--.+. ...
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf------qe~ 344 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------QEV 344 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee------ecc
Confidence 9999999976543 677889999999999999999976 445578899999998888555555543332 112
Q ss_pred cccCCCcccCchhhccccCC--CccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYD--GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~--~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
...-.|.|++||.+.....+ -.++|+|||++++||+.|+..||......+--. .-.........|. +++..+..
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm--kialeglrv~ipp--gis~hm~k 420 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM--KIALEGLRVHIPP--GISRHMNK 420 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh--hhhhccccccCCC--CccHHHHH
Confidence 34457899999999866543 456899999999999999999998766532211 1112222334444 88999999
Q ss_pred HHHHHhhhCCCCCCCcHHHh
Q 024336 237 LLSQIFVADPSKDPHSRDQK 256 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l 256 (269)
|+.-|+..||.+||.+..++
T Consensus 421 lm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 421 LMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHhcCCCCcCCCcceeh
Confidence 99999999999999988765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=168.90 Aligned_cols=204 Identities=22% Similarity=0.319 Sum_probs=159.1
Q ss_pred HHhCCCCCcceeeEEEEeCCeEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeecCCCCcE
Q 024336 53 HRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEI-CHRDLKLENT 130 (269)
Q Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i-~H~di~p~ni 130 (269)
++.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ...++......++++++.+|.|+|+..+ .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3578999999999999999999999999999999999977 4468888999999999999999999876 8999999999
Q ss_pred EecCCCCCcEEEeecCCcccCCCC---CCCCcccCCCcccCchhhccccC------CCccchhhhHHHHHHHHHhCCCCC
Q 024336 131 LLDGSPQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKEY------DGKISDVWSCGVTLYVMLVGAYPF 201 (269)
Q Consensus 131 ~i~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~------~~~~~Di~slG~~l~~l~tg~~pf 201 (269)
+++.... +||+|||+....... ..........-|.|||.+..... .+++.|+||+|++++++++...||
T Consensus 81 lvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 81 LVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred eeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9998888 999999987643210 11111123346899999876421 355599999999999999999999
Q ss_pred CCCCChhhHHHHHHHHhh-ccc-cCCC---cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 202 EDPEDPRNFRKTIDRIRN-VQY-FLPD---YVRVSADCRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~-~~~-~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
..........+.+..+.. ... ..|. ....++++..++..||..+|.+||+++++-..
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 875444333444444444 221 1121 12456689999999999999999999988653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-21 Score=147.93 Aligned_cols=138 Identities=18% Similarity=0.212 Sum_probs=107.4
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecC-ccccHHHHHHHHHHHhC-----CCCCcceeeEEEEeCC---e-E
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG-KKIDENVQREIINHRSL-----RHPNIIRFKEVLLTPT---H-L 74 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~-~ 74 (269)
..-.+.||+|++|.||. +..++.. +||++... ....+.+.+|+..++.+ +||||+++++++.++. . +
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34567899999999995 6666655 68887653 22346789999999999 5799999999999874 3 3
Q ss_pred EEEEee--cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCceeecCCCCcEEecCCC--CCcEEEeecCCc
Q 024336 75 AIVMEY--AAGGELFARICSAGRFSEDEARFFFQQLISGV-SYCHSMEICHRDLKLENTLLDGSP--QPRLKICDFGYS 148 (269)
Q Consensus 75 ~~v~e~--~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l-~~lh~~~i~H~di~p~ni~i~~~~--~~~~~l~df~~~ 148 (269)
.+|+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+.+|+|+||||+||+++..+ ..+++|+|++-+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 378999 4478999999664 46655 35677888777 999999999999999999997532 235999995433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=178.62 Aligned_cols=193 Identities=25% Similarity=0.305 Sum_probs=153.7
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC---CCCcceeeEEEEeCCeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR---HPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.++|.|.+.||+|+||.||.|.+.+ |+.||+|+-.+...+.--+-. +++.+|+ -+.|+.+.....-.+.-++|+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~--q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICL--QVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehH--HHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 3678999999999999999999987 999999976655443221111 2223333 245666666666677789999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-----CCCCcEEEeecCCcccCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-----SPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~-----~~~~~~~l~df~~~~~~~~ 153 (269)
+|.+.|+|+++++.++.+++..+..++.|++..+++||..+||||||||+|+++.. .+..-++|+|||.+.....
T Consensus 774 ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l 853 (974)
T KOG1166|consen 774 EYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL 853 (974)
T ss_pred eccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence 99999999999998888999999999999999999999999999999999999952 2222389999998864333
Q ss_pred CC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCC
Q 024336 154 HS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA 198 (269)
Q Consensus 154 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~ 198 (269)
.. .....+.+-.+-.+|...+..|+.. .|.|+|+.+++-|+.|.
T Consensus 854 fp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 854 FPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGK 900 (974)
T ss_pred cCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHH
Confidence 22 2345567888999999998888666 99999999999999885
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-22 Score=153.38 Aligned_cols=139 Identities=17% Similarity=0.096 Sum_probs=110.6
Q ss_pred cccccceecccCceEEEEEE-EecCCeEEEEEEeecCccc-------------------------cHHHHHHHHHHHhCC
Q 024336 4 RYEPVKELGSGNFGVARLVR-DKRTKELVAVKYIERGKKI-------------------------DENVQREIINHRSLR 57 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~-~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~e~~~l~~l~ 57 (269)
-|++.+.||+|++|.||+|. +..+|..||+|++...... ...+..|+..++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37899999999999999999 6678999999998753210 012467999999997
Q ss_pred CC--CcceeeEEEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeecCCCCcEEecC
Q 024336 58 HP--NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME-ICHRDLKLENTLLDG 134 (269)
Q Consensus 58 h~--~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-i~H~di~p~ni~i~~ 134 (269)
+. .+.++++. ...++||||++|.++.........+....+..++.|++.++.+||+.| ++|+||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 33444432 235899999999888766544455677778899999999999999999 99999999999998
Q ss_pred CCCCcEEEeecCCcc
Q 024336 135 SPQPRLKICDFGYSK 149 (269)
Q Consensus 135 ~~~~~~~l~df~~~~ 149 (269)
++. ++|+|||.+.
T Consensus 184 ~~~--i~LiDFg~a~ 196 (237)
T smart00090 184 DGK--VVIIDVSQSV 196 (237)
T ss_pred CCC--EEEEEChhhh
Confidence 555 9999999876
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-20 Score=142.97 Aligned_cols=134 Identities=24% Similarity=0.224 Sum_probs=111.2
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCccc---------cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---------DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++.||+|++|.||++.+ .|..+++|........ ...+.+|+..+..+.|+++.....++......+++|
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999988 5667899976532211 124667899999999999887777777777889999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCccc
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~ 150 (269)
||++|++|.+.+.... . ....++.+++.+|.++|+.|++|+|++|.||+++ ++. ++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~--~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGK--IYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCC--EEEEECCcccC
Confidence 9999999999886532 2 8889999999999999999999999999999998 554 99999998863
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.2e-22 Score=161.75 Aligned_cols=176 Identities=26% Similarity=0.302 Sum_probs=132.7
Q ss_pred CeEEEEEeecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCc
Q 024336 72 THLAIVMEYAAGGELFARICSAG---RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS 148 (269)
Q Consensus 72 ~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~ 148 (269)
..+|+.|++|.-.+|.+++.... ..+......++.|++.++.| +|.+|+|+||.||+...+.. ++|.|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhhe
Confidence 35899999999999999996443 36778889999999999999 99999999999999998887 999999988
Q ss_pred ccCCCCC-------CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhc
Q 024336 149 KSGLLHS-------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV 220 (269)
Q Consensus 149 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 220 (269)
....... ......++..|++||.+.+..+..+ +|||+||+++++++. =..+|.. ......+..+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~~f~T~~er-------~~t~~d~r~g 475 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLIQFSTQFER-------IATLTDIRDG 475 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHHHhccHHHH-------HHhhhhhhcC
Confidence 6544433 3345568999999999999988766 999999999999996 1222211 2223333333
Q ss_pred cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 221 QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 221 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.++.....++|. -..|+.+|+.+.|.+||++.+.--|.|.
T Consensus 476 ~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 476 IIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred CCChHHhhcCcH-HHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 332112223444 3489999999999999977666655543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-19 Score=138.27 Aligned_cols=129 Identities=21% Similarity=0.173 Sum_probs=103.9
Q ss_pred eecccCceEEEEEEEecCCeEEEEEEeecCcc-c--------cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 10 ELGSGNFGVARLVRDKRTKELVAVKYIERGKK-I--------DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 10 ~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.||+|++|.||++.. ++..+++|....... . ...+.+|+.+++.+.++++.....++......+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 467799998643211 1 13466799999999888766655556666778999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCccc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~ 150 (269)
++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ ++. ++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~--~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDK--LYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCc--EEEEECCCCcC
Confidence 999999888754321 8899999999999999999999999999998 555 99999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-19 Score=137.18 Aligned_cols=133 Identities=21% Similarity=0.247 Sum_probs=105.0
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-----------------------ccHHHHHHHHHHHhCCCCC
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-----------------------IDENVQREIINHRSLRHPN 60 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~~ 60 (269)
.|.+.+.||+|++|.||++... +|+.||+|++..... .......|+..+..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888999999999999999875 789999998764321 0112567888888887763
Q ss_pred --cceeeEEEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCC
Q 024336 61 --IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP 138 (269)
Q Consensus 61 --i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~ 138 (269)
+.+.++ ....+++|||++|++|..... ......++.+++.++.++|+.|++|+||+|.||+++.++.
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~- 163 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK- 163 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc-
Confidence 444443 234589999999988866542 1445678899999999999999999999999999987776
Q ss_pred cEEEeecCCcc
Q 024336 139 RLKICDFGYSK 149 (269)
Q Consensus 139 ~~~l~df~~~~ 149 (269)
++|+|||.+.
T Consensus 164 -~~liDfg~~~ 173 (198)
T cd05144 164 -IYIIDWPQMV 173 (198)
T ss_pred -EEEEECCccc
Confidence 9999999886
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-21 Score=170.31 Aligned_cols=258 Identities=29% Similarity=0.449 Sum_probs=203.5
Q ss_pred ccccccceecccCceEEEEEEEe-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDK-RTKELVAVKYIERGK---KIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v 77 (269)
..|.+.+.||+|+++.|-.+... .....+|.|.+.... ........|..+.+.+. |+|++.+++.....+..++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 46889999999999999888774 334456666665432 22334445777777776 99999999999999999999
Q ss_pred EeecCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCceeecCCCCcEEecCCC-CCcEEEeecCCcccCCC
Q 024336 78 MEYAAGGELFARI-CSAG-RFSEDEARFFFQQLISGVSYCH-SMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLL 153 (269)
Q Consensus 78 ~e~~~~~~l~~~~-~~~~-~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~~~ 153 (269)
.++..|+++...+ .... ..+......++.|+..++.|+| ..++.|+|++|+|.+++.++ . +++.|||++.....
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~--l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSA--LKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCc--ccCCCchhhccccc
Confidence 9999999999988 5544 5778888999999999999999 99999999999999999888 5 89999999874333
Q ss_pred -CC---CCCcccC-CCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcC
Q 024336 154 -HS---QPKSTVG-TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228 (269)
Q Consensus 154 -~~---~~~~~~~-~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (269)
.. ......+ ++.|.|||...+..+..+..|+||.|+++..+++|..|+................. .......+.
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 256 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-GRFTQLPWN 256 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-cccccCccc
Confidence 11 2234456 99999999998876777779999999999999999999976554332211111111 122344456
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 229 RVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.++....+++.+++..+|..|.+.+++-.++|+..
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCChhhhhcccccccCCchhccccccccccccccc
Confidence 78889999999999999999999999999999876
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.7e-19 Score=153.27 Aligned_cols=134 Identities=22% Similarity=0.213 Sum_probs=107.8
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEee-cCcc--------ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKK--------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~-~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
.|...+.||+|+||+||++...... +++|... +... ..+.+.+|+.+++.++|++++....+.......
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3566789999999999999875433 4444322 1111 123577899999999999998888777777778
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCccc
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~ 150 (269)
++||||++|++|.+.+. ....++.+++.+|.+||+.|++|||+||+||+++ ++. ++|+|||++..
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~~--~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DDR--LYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CCc--EEEEeCccccc
Confidence 99999999999988874 4567899999999999999999999999999994 454 99999999873
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.8e-18 Score=129.76 Aligned_cols=133 Identities=22% Similarity=0.283 Sum_probs=95.7
Q ss_pred ccceecccCceEEEEEEEecCCeEEEEEEeecCccccHH-------------------------HHHHHHHHHhCCCC--
Q 024336 7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-------------------------VQREIINHRSLRHP-- 59 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-------------------------~~~e~~~l~~l~h~-- 59 (269)
+.+.||+|++|.||++.+. +++.||+|++......... ...|...+..+.+.
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999987 7889999988653221111 13455555555433
Q ss_pred CcceeeEEEEeCCeEEEEEeecCCCchHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCC
Q 024336 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFA-RICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQ 137 (269)
Q Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~~-~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~ 137 (269)
.+.++++. ...+++|||++++.+.. .+... .. ......++.+++.++.++|+ .|++|+||+|+||+++ ++.
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 24444443 23589999999854322 11111 11 16788999999999999999 9999999999999999 555
Q ss_pred CcEEEeecCCcc
Q 024336 138 PRLKICDFGYSK 149 (269)
Q Consensus 138 ~~~~l~df~~~~ 149 (269)
++|+|||.+.
T Consensus 153 --~~liDfg~a~ 162 (187)
T cd05119 153 --VYIIDVPQAV 162 (187)
T ss_pred --EEEEECcccc
Confidence 9999999886
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-17 Score=128.41 Aligned_cols=132 Identities=20% Similarity=0.242 Sum_probs=101.8
Q ss_pred ceec-ccCceEEEEEEEecCCeEEEEEEeecCc--------------cccHHHHHHHHHHHhCCCCCc--ceeeEEEEeC
Q 024336 9 KELG-SGNFGVARLVRDKRTKELVAVKYIERGK--------------KIDENVQREIINHRSLRHPNI--IRFKEVLLTP 71 (269)
Q Consensus 9 ~~l~-~g~~g~v~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~ 71 (269)
..|| .|+.|+||.+... +..+++|.+.... .....+.+|+.++..+.|+++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 8999999999885 6678999875311 122457789999999988775 6666664432
Q ss_pred C----eEEEEEeecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecC
Q 024336 72 T----HLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG 146 (269)
Q Consensus 72 ~----~~~~v~e~~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~ 146 (269)
. ..++|+|+++| .+|.+++.. .++++.. +.+++.++.+||+.|++|+||||.||+++.++. ++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEECC
Confidence 2 23599999997 688887754 4455543 568999999999999999999999999988776 9999999
Q ss_pred Ccc
Q 024336 147 YSK 149 (269)
Q Consensus 147 ~~~ 149 (269)
.+.
T Consensus 188 ~~~ 190 (239)
T PRK01723 188 RGE 190 (239)
T ss_pred Ccc
Confidence 886
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.6e-17 Score=119.21 Aligned_cols=131 Identities=24% Similarity=0.269 Sum_probs=110.8
Q ss_pred ccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCC--CCcceeeEEEEeCCeEEEEEeecCCC
Q 024336 7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--PNIIRFKEVLLTPTHLAIVMEYAAGG 84 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (269)
+++.|++|.++.||++.... ..+++|....... ...+.+|+..++.+.+ .++.+++.+....+..++++||+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 56789999999999999864 6799998865543 5678899999999976 58889988888778899999999987
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 85 ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM---EICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
.+... +......++.+++.++..+|.. +++|+|++|.||+++..+. +++.||+.+.
T Consensus 79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~--~~l~Df~~~~ 137 (155)
T cd05120 79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI--LGIIDWEYAG 137 (155)
T ss_pred ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE--EEEEeccccc
Confidence 76554 5567778899999999999985 6999999999999987555 9999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.2e-18 Score=132.09 Aligned_cols=204 Identities=19% Similarity=0.260 Sum_probs=144.8
Q ss_pred HHHHHHhCCCCCcceeeEEEEeCC-----eEEEEEeecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC
Q 024336 49 EIINHRSLRHPNIIRFKEVLLTPT-----HLAIVMEYAAGGELFARICSAG----RFSEDEARFFFQQLISGVSYCHSME 119 (269)
Q Consensus 49 e~~~l~~l~h~~i~~~~~~~~~~~-----~~~~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~ 119 (269)
-...+-++.|.|+|+++.++.+.. ...+++||+..|++..++++.+ .+......+|+-||+.||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 345666678999999999987643 4889999999999999997643 4788888999999999999999986
Q ss_pred --ceeecCCCCcEEecCCCCCcEEEeecCCcccCC-----CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHH
Q 024336 120 --ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-----LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY 192 (269)
Q Consensus 120 --i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~-----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~ 192 (269)
++|+++..+.|++..++- +++.--.-..... .........+.+.|.|||.=...+.... +|||++|.+..
T Consensus 197 PpiihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAl 273 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCAL 273 (458)
T ss_pred CccccCCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHH
Confidence 999999999999997776 6654221111000 0111123345788999997655555455 99999999999
Q ss_pred HHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 193 VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 193 ~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+|..+..--..........+...+ ..+.+.+ ..-+.+|.+|+...|..||++++++.|+..-.
T Consensus 274 emailEiq~tnseS~~~~ee~ia~---~i~~len-----~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEENIAN---VIIGLEN-----GLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred HHHHheeccCCCcceeehhhhhhh---heeeccC-----ccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 999876543333322222222221 1111111 23357899999999999999999999997644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-16 Score=134.04 Aligned_cols=249 Identities=22% Similarity=0.178 Sum_probs=188.1
Q ss_pred ccccccceecc--cCceEEEEEEE--ecCCeEEEEEEeecC---ccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeE
Q 024336 3 ERYEPVKELGS--GNFGVARLVRD--KRTKELVAVKYIERG---KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 3 ~~y~~~~~l~~--g~~g~v~~~~~--~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 74 (269)
+.+.+.+.+|. |.+|.||.+.. ..++..+|+|.-... ......-.+|+...+.+ .|++.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677889999 99999999999 788899999974321 12233445677777777 489999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCceeecCCCCcEEecCC-CCCcEEEeecCCc
Q 024336 75 AIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLIS----GVSYCHSMEICHRDLKLENTLLDGS-PQPRLKICDFGYS 148 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i~~----~l~~lh~~~i~H~di~p~ni~i~~~-~~~~~~l~df~~~ 148 (269)
++-+|.+. .++..+...-.. +++..++..+.+... ||.++|..+++|-|++|.||+...+ .. ++++||++.
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s--~~~~df~~v 270 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTS--CKLTDFGLV 270 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccce--eecCCccee
Confidence 99999996 577777655444 889999999999999 9999999999999999999999988 44 899999987
Q ss_pred ccCCCCCCC------CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCC--CChhhHHHHHHHHhhc
Q 024336 149 KSGLLHSQP------KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDP--EDPRNFRKTIDRIRNV 220 (269)
Q Consensus 149 ~~~~~~~~~------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~--~~~~~~~~~~~~~~~~ 220 (269)
......... ....+...|++||...+ ..+..+|+|+||.++.+..++..++... ..+.......
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~------ 342 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY------ 342 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc------
Confidence 643333311 22256778999998743 3355599999999999988876665443 3222221111
Q ss_pred cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 221 QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 221 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
....-....+.++...+..|++.+|..|++++.++++.+.+.
T Consensus 343 -ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 343 -IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred -CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 111111245667778999999999999999999999988765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.6e-15 Score=124.23 Aligned_cols=166 Identities=19% Similarity=0.281 Sum_probs=130.2
Q ss_pred EEEecCCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHH
Q 024336 22 VRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE 100 (269)
Q Consensus 22 ~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 100 (269)
+..+.++.+|.++....... ..+...+.+..++.++||||+++++.+..++.+|+|+|.+. .|..++.+- +...
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~ 105 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEE 105 (690)
T ss_pred cceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHH
Confidence 45566788899888775433 34567888999999999999999999999999999999985 567777553 4788
Q ss_pred HHHHHHHHHHHHHHHH-hCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC-CCcccCCCcccCchhhccccCC
Q 024336 101 ARFFFQQLISGVSYCH-SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKSTVGTPAYIAPEVLARKEYD 178 (269)
Q Consensus 101 ~~~~~~~i~~~l~~lh-~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~ 178 (269)
+...++||+.||.+|| +.+++|++++-..|+|+..|. .+|++|.++........ .........|..|+.+....+
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~- 182 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEW- 182 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCcccc-
Confidence 8889999999999997 677999999999999999998 99999998753222221 222223345677776543332
Q ss_pred CccchhhhHHHHHHHHHhC
Q 024336 179 GKISDVWSCGVTLYVMLVG 197 (269)
Q Consensus 179 ~~~~Di~slG~~l~~l~tg 197 (269)
. .|.|.||+++++++.|
T Consensus 183 -s-~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 -S-IDSWGLGCLIEELFNG 199 (690)
T ss_pred -c-hhhhhHHHHHHHHhCc
Confidence 2 5999999999999998
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.8e-15 Score=109.41 Aligned_cols=127 Identities=21% Similarity=0.261 Sum_probs=95.9
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcc-eeeEEEEeCCeEEEEEeecCCCch
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII-RFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
.+.|+.|.++.||++... +..|++|..............|+..++.+.+.+++ +++... ....++|||+++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999999875 77899998765543334567899999888655544 444433 2335799999999877
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 87 FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI-----CHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i-----~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
... .......+.+++.+|..||+.++ +|+|++|.||+++ ++. ++++||+.+.
T Consensus 79 ~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~--~~liDf~~a~ 135 (170)
T cd05151 79 LTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGR--LWLIDWEYAG 135 (170)
T ss_pred ccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCe--EEEEeccccc
Confidence 543 01123456799999999999985 9999999999998 444 9999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.4e-14 Score=105.26 Aligned_cols=136 Identities=14% Similarity=0.166 Sum_probs=98.3
Q ss_pred cceecccCceEEEEEEEec------CCeEEEEEEeecCc--------------c---------ccHHH----HHHHHHHH
Q 024336 8 VKELGSGNFGVARLVRDKR------TKELVAVKYIERGK--------------K---------IDENV----QREIINHR 54 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~------~~~~vaiK~~~~~~--------------~---------~~~~~----~~e~~~l~ 54 (269)
...||.|-.+.||.+.... .+..+|+|++..+. . ....+ +.|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998753 35789999873210 0 01122 37889998
Q ss_pred hCCC--CCcceeeEEEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeecCCCCcEE
Q 024336 55 SLRH--PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-HSMEICHRDLKLENTL 131 (269)
Q Consensus 55 ~l~h--~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~H~di~p~ni~ 131 (269)
++.. -++..++++ ..-++||||++++.+..-.-+...++......+..+++.++..+ |+.|++|||+++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8853 455556654 34579999997654322111223456667788889999999998 8999999999999999
Q ss_pred ecCCCCCcEEEeecCCccc
Q 024336 132 LDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 132 i~~~~~~~~~l~df~~~~~ 150 (269)
++. +. +.++||+.+..
T Consensus 158 ~~~-~~--v~iIDF~qav~ 173 (197)
T cd05146 158 WHD-GK--VWFIDVSQSVE 173 (197)
T ss_pred EEC-Cc--EEEEECCCcee
Confidence 973 44 99999997763
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.7e-13 Score=112.18 Aligned_cols=213 Identities=17% Similarity=0.233 Sum_probs=152.7
Q ss_pred ceEEEEEEEecCCeEEEEEEeecCccc-cHHHHHHHHHHHhCCCCCcceeeEEEEe----CCeEEEEEeecCC-CchHHH
Q 024336 16 FGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSLRHPNIIRFKEVLLT----PTHLAIVMEYAAG-GELFAR 89 (269)
Q Consensus 16 ~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v~e~~~~-~~l~~~ 89 (269)
-.+.|++..+-+|..|++|++...+.. ....-.-++.|+++.|.|+|++.++|.+ +..+++|++|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 458899999999999999999543222 1233456889999999999999999884 4579999999975 456555
Q ss_pred HH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 90 IC---------------SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 90 ~~---------------~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
.- ++...++..+|.++.|+..||.++|+.|+..+-+.|.+|+++.+.. ++++..|.......+
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~R--IriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMR--IRISGCGIMDVLQED 446 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcce--EEEecccceeeecCC
Confidence 41 1224778999999999999999999999999999999999986654 888877655422111
Q ss_pred CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHH
Q 024336 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234 (269)
Q Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
. .+| +.. ..+-|.=-||.++..|.||..--...+. ......+.+.. .++.++
T Consensus 447 ~-----------~~~--le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~--~~~s~~~~I~~---------~yS~D~ 498 (655)
T KOG3741|consen 447 P-----------TEP--LES----QQQNDLRDLGLLLLALATGTENSNRTDS--TQSSHLTRITT---------TYSTDL 498 (655)
T ss_pred C-----------Ccc--hhH----HhhhhHHHHHHHHHHHhhcccccccccc--hHHHHHHHhhh---------hhhHHH
Confidence 1 111 211 2337999999999999998643221111 11111222222 577889
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+++|.-+...++.+ -++.+++-+.
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHHH
Confidence 99999999888887 7777777643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=9e-16 Score=135.59 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=190.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
+.+.+.+.+.+|.++.++.+.-..+|...++|....... ..+....+-.++-...+|.++...-.+......++++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 456677788889999998888877775555554332211 1122222222222223466665555555667899999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC-CC----
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG-LL---- 153 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~-~~---- 153 (269)
++..+++|...+++.+..+.+.....+..+..++++||...+.|+|++|.|.+...+++ ..+.||+..... ..
T Consensus 884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccccCcC
Confidence 99999999999999988888889999999999999999999999999999999998888 889998732100 00
Q ss_pred ------C---------------------CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Q 024336 154 ------H---------------------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED 206 (269)
Q Consensus 154 ------~---------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~ 206 (269)
. .......+++.|.+||...+....+. +|.|++|+++++.++|.+||.....
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCCcch
Confidence 0 00112346889999999988887666 9999999999999999999988665
Q ss_pred hhhHHHHHHHHhhccccCCC-cCCCCHHHHHHHHHHhhhCCCCCCCcH---HHhhccChhhhh
Q 024336 207 PRNFRKTIDRIRNVQYFLPD-YVRVSADCRHLLSQIFVADPSKDPHSR---DQKASLVPEEFA 265 (269)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~---~~l~~~~~~~~~ 265 (269)
. ...+++......++. ....+....+++...+..+|.+|..+. ++-.|+|++...
T Consensus 1041 q----~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1041 Q----QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred h----hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 3 344555555555553 345778899999999999999999998 888899988753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=9.3e-14 Score=117.59 Aligned_cols=137 Identities=19% Similarity=0.198 Sum_probs=93.1
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCcccc-----------------------------------H------HH
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-----------------------------------E------NV 46 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----------------------------------~------~~ 46 (269)
.+.||.|++|.||+|+.. +|+.||||+..+.-... . .+
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999875 68999999975431000 0 12
Q ss_pred HHHHHHHHhC----CCCCcceeeEEEE-eCCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 024336 47 QREIINHRSL----RHPNIIRFKEVLL-TPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLIS-GVSYCHSME 119 (269)
Q Consensus 47 ~~e~~~l~~l----~h~~i~~~~~~~~-~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~-~l~~lh~~~ 119 (269)
.+|...+.++ .+.+-+.+-..+. .....++||||++|+++.+..... ...+ ...++.+++. .+..+|..|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 3344444444 2322233222222 233468999999999998876432 1222 3345556655 467899999
Q ss_pred ceeecCCCCcEEecCCCCCcEEEeecCCccc
Q 024336 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 120 i~H~di~p~ni~i~~~~~~~~~l~df~~~~~ 150 (269)
++|+|++|.||+++.++. ++++|||++..
T Consensus 278 ~~H~D~hPgNilv~~~g~--i~liDfG~~~~ 306 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGK--IIALDFGIVGR 306 (437)
T ss_pred ceeCCCCcccEEECCCCc--EEEEeCCCeeE
Confidence 999999999999988877 99999998863
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.1e-13 Score=100.32 Aligned_cols=129 Identities=23% Similarity=0.217 Sum_probs=100.0
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEee-cCcc---cc-----HHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIE-RGKK---ID-----ENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~-~~~~---~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
..+.+|+-+.+|.+... |..+++|.-. +.-. -+ ..-.+|..++.++.--+|.-..-+..+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 46789999999999764 4457777542 2211 11 234578899988876677666666678888899999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
|++|..|.+.+... ...++..+-.-+..||..||+|||+.++||+++.++ +.++|||++.
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCccc
Confidence 99999999888665 255677777778889999999999999999998554 8999999987
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.5e-15 Score=123.95 Aligned_cols=249 Identities=20% Similarity=0.196 Sum_probs=180.2
Q ss_pred ccccccceecccCceEEEEEEEe-cCCeEEEEEEeecCccc---cHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDK-RTKELVAVKYIERGKKI---DENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
.+|..+..||.|.|+.|+.+... .++..|++|........ +..-..|+.+...+ .|.+++.....|...+..|+-
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 57888999999999999988765 67778888876543221 11233566666666 589999988888888888999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
.|||+++++...+.-...+.+..++.+..|++.++.++|+..++|.|++|+||++..++ ...++.||++... ......
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~-~~~~~~ 422 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTR-LAFSSG 422 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccc-cceecc
Confidence 99999988877765555688999999999999999999999999999999999998764 2378999998864 112222
Q ss_pred CcccCCCcc-cCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAY-IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~-~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+..| .++..........+ .|++|||..+.+.+++.+.-...... ..+..+.. +...+....+..
T Consensus 423 ~~~~~~r~~p~~~~~~e~~~~~~~-~~~~sl~~~~~e~~~~~~ls~~~~~~-------~~i~~~~~--p~~~~~~~~~q~ 492 (524)
T KOG0601|consen 423 VFHHIDRLYPIAEILLEDYPHLSK-ADIFSLGLSVDEAITGSPLSESGVQS-------LTIRSGDT--PNLPGLKLQLQV 492 (524)
T ss_pred cccccccccccchhhccccccccc-cccccccccccccccCcccCcccccc-------eeeecccc--cCCCchHHhhhh
Confidence 222233334 34555555555555 99999999999999886543332221 11222222 222244477888
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+.+.|..+++..||++.++..+.-+..
T Consensus 493 ~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 493 LLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhhhcCCccccchhhhhhcccchhhh
Confidence 899999999999999999888776543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.2e-14 Score=124.58 Aligned_cols=138 Identities=24% Similarity=0.338 Sum_probs=90.5
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-----------------------------------ccHH---
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-----------------------------------IDEN--- 45 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----------------------------------~~~~--- 45 (269)
.|.. +.||.|++|.||+|+..++|+.||||+..+.-. ..+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 789999999999999988899999999865310 0011
Q ss_pred ---HHHHHHHHHhC----CCCCcceeeEEEEe-CCeEEEEEeecCCCchHHH--HHhcC----CCCHHHHHHHHHHHHHH
Q 024336 46 ---VQREIINHRSL----RHPNIIRFKEVLLT-PTHLAIVMEYAAGGELFAR--ICSAG----RFSEDEARFFFQQLISG 111 (269)
Q Consensus 46 ---~~~e~~~l~~l----~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~l~~~--~~~~~----~~~~~~~~~~~~~i~~~ 111 (269)
+.+|...+.++ .+...+.+-.++.+ ....++||||++|+.+.+. +...+ .+.+..+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 22333333333 23333333333322 3456799999999998764 33322 13333344444444
Q ss_pred HHHHHhCCceeecCCCCcEEecCCC--CCcEEEeecCCcc
Q 024336 112 VSYCHSMEICHRDLKLENTLLDGSP--QPRLKICDFGYSK 149 (269)
Q Consensus 112 l~~lh~~~i~H~di~p~ni~i~~~~--~~~~~l~df~~~~ 149 (269)
...|++|+|++|.||+++.++ .+++++.|||+..
T Consensus 277 ----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg 312 (537)
T PRK04750 277 ----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVG 312 (537)
T ss_pred ----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEE
Confidence 468999999999999998776 1249999999875
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.2e-13 Score=96.55 Aligned_cols=142 Identities=17% Similarity=0.110 Sum_probs=107.8
Q ss_pred ccceecccCceEEEEEEEecCCeEEEEEEee-cCc--------cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 7 PVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGK--------KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~-~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
.+..+.+|+.+.|+++... |+..+||.-. +.. -.....++|.+.+.++.--+|.-..-++.+...-.+.
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5778999999999999885 7777777532 211 1223467799999888766766666667777778899
Q ss_pred EeecCC-CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCC-cEEEeecCCccc
Q 024336 78 MEYAAG-GELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP-RLKICDFGYSKS 150 (269)
Q Consensus 78 ~e~~~~-~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~-~~~l~df~~~~~ 150 (269)
|||++| .++.+++.... ...+.....++.++-+.+..||.++++|||+..+||++.+++.. .+.+.|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 46677775532 23334447899999999999999999999999999999877653 358999999863
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.4e-12 Score=101.56 Aligned_cols=244 Identities=15% Similarity=0.156 Sum_probs=159.3
Q ss_pred cccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHh-CCCCCcce--------eeEEEEeCCeEEE
Q 024336 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS-LRHPNIIR--------FKEVLLTPTHLAI 76 (269)
Q Consensus 6 ~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~--------~~~~~~~~~~~~~ 76 (269)
.....||+|+.+.+|.+-.-.+ -+.|++.......+.- .+..+.. -.||-+-. ++|- .......+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aq--k~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQ--KVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchhhc---hhheeecCCCchHHHH--HHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEE
Confidence 4567899999999998776533 3558776543322222 2222222 24554332 1111 11223778
Q ss_pred EEeecCCCchHHHH-------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 77 VMEYAAGGELFARI-------CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 77 v~e~~~~~~l~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
+|..+.|..-...+ +......+....+.++.++.+.+.||..|.+-||++++|++|++++. |+|.|-+.-.
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfq 165 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQ 165 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEccccee
Confidence 88888775222222 22334789999999999999999999999999999999999998887 9999876554
Q ss_pred cCCCCCCCCcccCCCcccCchhhc-----cccCCCccchhhhHHHHHHHHHhC-CCCCCCCC----ChhhHHHHHHH---
Q 024336 150 SGLLHSQPKSTVGTPAYIAPEVLA-----RKEYDGKISDVWSCGVTLYVMLVG-AYPFEDPE----DPRNFRKTIDR--- 216 (269)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~~l~~l~tg-~~pf~~~~----~~~~~~~~~~~--- 216 (269)
....+....+..+...|++||.-. +..-+.. +|.|.||+++++++.| ..||.+-. ........+..
T Consensus 166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred eccCCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 445556667778999999999754 2233344 8999999999999886 89986522 11111111100
Q ss_pred ---Hhhcc-----ccCCCcCCCCHHHHHHHHHHhhh--CCCCCCCcHHHhhc
Q 024336 217 ---IRNVQ-----YFLPDYVRVSADCRHLLSQIFVA--DPSKDPHSRDQKAS 258 (269)
Q Consensus 217 ---~~~~~-----~~~~~~~~~~~~~~~li~~~l~~--~p~~Rps~~~~l~~ 258 (269)
-+... .....+.-+++++..+..+|+.. ++.-|||++.++..
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aA 296 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAA 296 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Confidence 00111 11122345788999999999964 35689999887653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.9e-12 Score=98.69 Aligned_cols=140 Identities=21% Similarity=0.258 Sum_probs=103.7
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCC--CcceeeEEEEeC---CeEEEEEee
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHP--NIIRFKEVLLTP---THLAIVMEY 80 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~---~~~~~v~e~ 80 (269)
.+.|+.|..+.+|++...+ |+.+++|....... ....+..|..+++.+.+. .+.+++.+.... +..++|+|+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3678999999999998753 57899998765433 355788999999998653 456677766553 256899999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS------------------------------------------- 117 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~------------------------------------------- 117 (269)
++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999888665432 345666777777777777777763
Q ss_pred -------------CCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 118 -------------MEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 118 -------------~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
..++|+|+.|.||+++.+....+.++||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 33699999999999987422237899999775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.9e-11 Score=93.13 Aligned_cols=133 Identities=14% Similarity=0.022 Sum_probs=95.1
Q ss_pred CceEEEEEEEecCCeEEEEEEeecCc------------cccHHHHHHHHHHHhCCCCC--cceeeEEEEe-----CCeEE
Q 024336 15 NFGVARLVRDKRTKELVAVKYIERGK------------KIDENVQREIINHRSLRHPN--IIRFKEVLLT-----PTHLA 75 (269)
Q Consensus 15 ~~g~v~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~-----~~~~~ 75 (269)
....|+++.. .|+.|.+|...... .....+.+|...+.++...+ .+++++++.. ....+
T Consensus 34 ~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~ 111 (268)
T PRK15123 34 EGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF 111 (268)
T ss_pred CCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence 3344556544 47789999764322 01114778988888874333 3344555543 23578
Q ss_pred EEEeecCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-----CCCCcEEEeecCC
Q 024336 76 IVMEYAAGG-ELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-----SPQPRLKICDFGY 147 (269)
Q Consensus 76 ~v~e~~~~~-~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~-----~~~~~~~l~df~~ 147 (269)
+|+|++++. +|.+++.. ..+.+......++.+++..+..||+.|++|+|++++||+++. ++...+.|+||+.
T Consensus 112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 999999886 78888753 344567788899999999999999999999999999999985 2344699999997
Q ss_pred cc
Q 024336 148 SK 149 (269)
Q Consensus 148 ~~ 149 (269)
+.
T Consensus 192 ~~ 193 (268)
T PRK15123 192 AQ 193 (268)
T ss_pred cc
Confidence 75
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.7e-12 Score=110.86 Aligned_cols=155 Identities=15% Similarity=0.238 Sum_probs=110.1
Q ss_pred HHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC----------CCcccCCCcccCchhh
Q 024336 104 FFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----------PKSTVGTPAYIAPEVL 172 (269)
Q Consensus 104 ~~~~i~~~l~~lh~~-~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~~aPE~~ 172 (269)
=+.+++.|+.++|+. ++||++|.|++|.++.++. +||+.|+.+........ .........|.|||.+
T Consensus 104 nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 344566999999975 7999999999999998888 99999998764333111 1112245679999999
Q ss_pred ccccCCCccchhhhHHHHHHHHH-hCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCC
Q 024336 173 ARKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPH 251 (269)
Q Consensus 173 ~~~~~~~~~~Di~slG~~l~~l~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 251 (269)
..... ..++|+||+|+++|.+. .|...+........................ ..+|+++++=+.+++..++.-||+
T Consensus 182 ~~~~~-~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s--~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 182 LGTTN-TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYS--NNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred ccccc-cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccccccc--ccCcHHHHHHHHHHhcCCcccCcc
Confidence 87444 55599999999999998 455555443322222111111111111222 478999999999999999999999
Q ss_pred cHHHhhccChhh
Q 024336 252 SRDQKASLVPEE 263 (269)
Q Consensus 252 ~~~~l~~~~~~~ 263 (269)
+.+++..+||..
T Consensus 259 ~~~l~~~~ff~D 270 (700)
T KOG2137|consen 259 LDLLLSIPFFSD 270 (700)
T ss_pred hhhhhcccccCC
Confidence 999999998875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.4e-10 Score=85.33 Aligned_cols=123 Identities=26% Similarity=0.295 Sum_probs=79.0
Q ss_pred EEEEEEEecCCeEEEEEEeecCc--------------c--------cc-----HHHHHHHHHHHhCCCCC--cceeeEEE
Q 024336 18 VARLVRDKRTKELVAVKYIERGK--------------K--------ID-----ENVQREIINHRSLRHPN--IIRFKEVL 68 (269)
Q Consensus 18 ~v~~~~~~~~~~~vaiK~~~~~~--------------~--------~~-----~~~~~e~~~l~~l~h~~--i~~~~~~~ 68 (269)
.||.|... +|..+|+|+..... . .. ...++|.+.|+++..-+ +.+++++
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 37888875 57789999874210 0 01 23567999999997664 5555543
Q ss_pred EeCCeEEEEEeecC--CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCceeecCCCCcEEecCCCCCcEEEeec
Q 024336 69 LTPTHLAIVMEYAA--GGELFARICSAGRFSEDEARFFFQQLISGVSY-CHSMEICHRDLKLENTLLDGSPQPRLKICDF 145 (269)
Q Consensus 69 ~~~~~~~~v~e~~~--~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~-lh~~~i~H~di~p~ni~i~~~~~~~~~l~df 145 (269)
.. -++||||++ |..+..+.... ++......++.+++..+.. +|+.|++|||+++.||+++.+ . +.++||
T Consensus 79 -~~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~--~~iIDf 150 (188)
T PF01163_consen 79 -NR--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K--VYIIDF 150 (188)
T ss_dssp -ET--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C--EEE--G
T ss_pred -eC--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e--EEEEec
Confidence 22 369999998 65554443221 1245566777788774444 689999999999999999876 4 999999
Q ss_pred CCccc
Q 024336 146 GYSKS 150 (269)
Q Consensus 146 ~~~~~ 150 (269)
|.+..
T Consensus 151 ~qav~ 155 (188)
T PF01163_consen 151 GQAVD 155 (188)
T ss_dssp TTEEE
T ss_pred Cccee
Confidence 98763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.1e-10 Score=88.47 Aligned_cols=133 Identities=20% Similarity=0.218 Sum_probs=98.7
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCc-----------------------cccHHHHHHHHHHHhCCCC--
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-----------------------KIDENVQREIINHRSLRHP-- 59 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-----------------------~~~~~~~~e~~~l~~l~h~-- 59 (269)
+.+...||-|--|.||.+.+. .|..+|+|.=.... ......++|..+|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 346789999999999999997 67889999632110 1123467899999998655
Q ss_pred CcceeeEEEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCc
Q 024336 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR 139 (269)
Q Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~ 139 (269)
.+.+.++ .+...+|||+++|..|...- ++.+....++..|+.-+..+=..|++|||+++-||+++.++.
T Consensus 172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~-- 240 (304)
T COG0478 172 KVPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD-- 240 (304)
T ss_pred CCCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence 6666665 35678999999986554432 234555556666666666666999999999999999999988
Q ss_pred EEEeecCCcc
Q 024336 140 LKICDFGYSK 149 (269)
Q Consensus 140 ~~l~df~~~~ 149 (269)
++++||--+.
T Consensus 241 ~~vIDwPQ~v 250 (304)
T COG0478 241 IVVIDWPQAV 250 (304)
T ss_pred EEEEeCcccc
Confidence 9999997554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.6e-09 Score=79.07 Aligned_cols=135 Identities=12% Similarity=0.091 Sum_probs=99.3
Q ss_pred cccCceEEEEEEEecCCeEEEEEEeec----C---ccccHHHHHHHHHHHhCCCC--CcceeeEEEE-e----CCeEEEE
Q 024336 12 GSGNFGVARLVRDKRTKELVAVKYIER----G---KKIDENVQREIINHRSLRHP--NIIRFKEVLL-T----PTHLAIV 77 (269)
Q Consensus 12 ~~g~~g~v~~~~~~~~~~~vaiK~~~~----~---~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~-~----~~~~~~v 77 (269)
++||.|.|+..... |..+-+|.-.. + ......+.+|+..++++..- .+.++. ++. . ...-.+|
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 55899999998765 33577776531 1 23557899999999988532 244444 222 1 1246799
Q ss_pred EeecCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 78 MEYAAG-GELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 78 ~e~~~~-~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
+|-++| .+|.+++.+. .+.+......++.+++.++..||+.|+.|+|+.+.||+++.++...+.++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997764 5777777552 34578888899999999999999999999999999999986665569999998765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.5e-09 Score=81.87 Aligned_cols=107 Identities=20% Similarity=0.188 Sum_probs=84.3
Q ss_pred cHHHHHHHHHHHhCCCC--CcceeeEEEEeC----CeEEEEEeecCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 024336 43 DENVQREIINHRSLRHP--NIIRFKEVLLTP----THLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYC 115 (269)
Q Consensus 43 ~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~----~~~~~v~e~~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 115 (269)
.....+|...+..+..- ...+++++.... ...++|+|++++. +|.+.+......+......++.+++..+..|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 34577888888777433 345556655542 2458999999874 7888887655577888899999999999999
Q ss_pred HhCCceeecCCCCcEEecCCC-CCcEEEeecCCcc
Q 024336 116 HSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSK 149 (269)
Q Consensus 116 h~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~ 149 (269)
|+.|++|+|+++.||+++.++ ..++.++||+-+.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 999999999999999998776 3359999999765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.9e-08 Score=76.13 Aligned_cols=136 Identities=17% Similarity=0.180 Sum_probs=89.0
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccH----------HHHHHHHHHHhCC---CCCcceeeEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE----------NVQREIINHRSLR---HPNIIRFKEV 67 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~e~~~l~~l~---h~~i~~~~~~ 67 (269)
++++|.+.+.+......-|.+..- +|..+++|.........+ ...+.+....++. .....+++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 356788888888877777666655 467899997754222111 1223344344442 2333333332
Q ss_pred EEe-----CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEE
Q 024336 68 LLT-----PTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKI 142 (269)
Q Consensus 68 ~~~-----~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l 142 (269)
... ....++++||++|..|.+... +++ .+...+.+++.-+|+.|+.|||..|.|+++++++ +++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~i 175 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRI 175 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEE
Confidence 221 234668999999987765432 232 2445677889999999999999999999998555 899
Q ss_pred eecCCcc
Q 024336 143 CDFGYSK 149 (269)
Q Consensus 143 ~df~~~~ 149 (269)
.||+...
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9997554
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.90 E-value=4.4e-08 Score=76.00 Aligned_cols=72 Identities=17% Similarity=0.168 Sum_probs=54.7
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCC--cceeeEEEEeCCeEEEEEeecCCCc
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN--IIRFKEVLLTPTHLAIVMEYAAGGE 85 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (269)
..|++|..+.||+. .+..+++|...... ......+|.++++.+..-+ +.+++++....+...+||++++|.+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999973 24458889876533 4456789999999886433 4667777777778889999999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.7e-08 Score=90.39 Aligned_cols=201 Identities=19% Similarity=0.211 Sum_probs=143.5
Q ss_pred HHHHHHHHHhCCCCCcceeeEEEEeCCe----EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 024336 46 VQREIINHRSLRHPNIIRFKEVLLTPTH----LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121 (269)
Q Consensus 46 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 121 (269)
.+-|+..+..+.|+|++.++.+...... +.+..+++...++...++..+..+....+.+..++.+++.++|+....
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 4456677788899999999998766543 335567888889999999999999999999999999999999999766
Q ss_pred eecCCCC---cEEecCCCCCcEEEe--ecCCcccCCCCCCCCcccCCCcccCchhhccccCC-CccchhhhHHHHHHHHH
Q 024336 122 HRDLKLE---NTLLDGSPQPRLKIC--DFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD-GKISDVWSCGVTLYVML 195 (269)
Q Consensus 122 H~di~p~---ni~i~~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~~Di~slG~~l~~l~ 195 (269)
|.-+..+ +--++..+. +..+ ||+.+.................+.+||....+... ....|+|++|.....+.
T Consensus 309 ~v~L~~s~~~~~~~~~e~~--~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGV--VAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred eeEEecccccccccCccce--eecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 6665555 333333333 5555 88877765555555555566677888877654443 22369999999999998
Q ss_pred hCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 196 VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 196 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.|..+-.... ....... . .......+...+|+..++++|+++.+++.|+|...
T Consensus 387 ~~~~i~~~~~-------~~~~~l~------~--~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 387 QGEDISEKSA-------VPVSLLD------V--LSTSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred hcCccccccc-------chhhhhc------c--ccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 8765432211 1111111 0 11126778999999999999999999999998764
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.2e-07 Score=72.69 Aligned_cols=134 Identities=16% Similarity=0.147 Sum_probs=90.5
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCcccc--------------------HH-----HHHHHHHHHhCCC--CC
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--------------------EN-----VQREIINHRSLRH--PN 60 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--------------------~~-----~~~e~~~l~~l~h--~~ 60 (269)
...|+.|-.+.||+|... ++..+|+|++..+.... .. ...|+..|+++.. =.
T Consensus 53 ~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 346778888899998874 57889999985321110 01 2347777777743 33
Q ss_pred cceeeEEEEeCCeEEEEEeecCCCc-hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCC
Q 024336 61 IIRFKEVLLTPTHLAIVMEYAAGGE-LFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQP 138 (269)
Q Consensus 61 i~~~~~~~~~~~~~~~v~e~~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~~ 138 (269)
+.+.+++. .-.+||||++... -...+.. -++...+...+..++++.+.-|=. .++||+||+.-||++. ++.
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~- 204 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE- 204 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe-
Confidence 44455442 2369999996541 1222222 123444777888888888888776 8999999999999998 554
Q ss_pred cEEEeecCCccc
Q 024336 139 RLKICDFGYSKS 150 (269)
Q Consensus 139 ~~~l~df~~~~~ 150 (269)
+.++|++-+..
T Consensus 205 -p~iID~~QaV~ 215 (268)
T COG1718 205 -PYIIDVSQAVT 215 (268)
T ss_pred -EEEEECccccc
Confidence 99999997763
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.7e-07 Score=73.20 Aligned_cols=78 Identities=19% Similarity=0.194 Sum_probs=55.7
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCC--CcceeeEEEEe---CCeEEEEEeecC
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP--NIIRFKEVLLT---PTHLAIVMEYAA 82 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~---~~~~~~v~e~~~ 82 (269)
++.|+.|..+.||++...+ ..+++|..... .....+..|..+++.+... .+.+++..... ....+.++++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999999875 37999987654 3456677888888877433 34556654332 335799999999
Q ss_pred CCchHH
Q 024336 83 GGELFA 88 (269)
Q Consensus 83 ~~~l~~ 88 (269)
|..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 987766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.7e-07 Score=82.72 Aligned_cols=78 Identities=21% Similarity=0.244 Sum_probs=56.6
Q ss_pred cceecccCceEEEEEEEecCC--eEEEEEEeecCc--cccHHHHHHHHHHHhCC-CCCc--ceeeEEEEeC---CeEEEE
Q 024336 8 VKELGSGNFGVARLVRDKRTK--ELVAVKYIERGK--KIDENVQREIINHRSLR-HPNI--IRFKEVLLTP---THLAIV 77 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~--~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~~v 77 (269)
++.++.|.++.+|++.....+ ..+++|+.+... .....+.+|+.+++.+. |.++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 577889999999998875432 467888765432 22356889999999995 6654 6677776654 457899
Q ss_pred EeecCCCc
Q 024336 78 MEYAAGGE 85 (269)
Q Consensus 78 ~e~~~~~~ 85 (269)
||+++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4e-07 Score=66.13 Aligned_cols=127 Identities=21% Similarity=0.179 Sum_probs=92.0
Q ss_pred cccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcce-eeEEEEeCCeEEEEEeecCCC
Q 024336 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR-FKEVLLTPTHLAIVMEYAAGG 84 (269)
Q Consensus 6 ~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~~v~e~~~~~ 84 (269)
++.+.|++|.+|.||++.+. |..+|+|+-.. .....++..|.+++..+...++.+ ++.+..+ .+.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 45678999999999999996 66799996544 356688999999999988777654 4443222 3559999998
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCC--CcEEecCCCCCcEEEeecCCcc
Q 024336 85 ELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL--ENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p--~ni~i~~~~~~~~~l~df~~~~ 149 (269)
.|....... +.. -+..++++.-.|-..||-|+.|+- .||++. ++. +.|+||..++
T Consensus 98 ~L~~~~~~~---~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~~--~~iIDFd~At 154 (201)
T COG2112 98 PLGKLEIGG---DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DRD--VYIIDFDSAT 154 (201)
T ss_pred chhhhhhcc---cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEec-CCc--EEEEEccchh
Confidence 887765321 223 344556666668889999999975 355554 445 9999999886
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.5e-06 Score=65.56 Aligned_cols=129 Identities=22% Similarity=0.204 Sum_probs=92.5
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCc-----------------cccHHHHHHHHHHHhCC------CCCccee
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGK-----------------KIDENVQREIINHRSLR------HPNIIRF 64 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~~~~e~~~l~~l~------h~~i~~~ 64 (269)
...||+|+.-.||.--+ ....+||+..... .......+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 46789999999885433 3447889886654 22355666776665554 7899999
Q ss_pred eEEEEeCCeEEEEEeecCC------CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCC
Q 024336 65 KEVLLTPTHLAIVMEYAAG------GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP 138 (269)
Q Consensus 65 ~~~~~~~~~~~~v~e~~~~------~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~ 138 (269)
+|+.+++....+|+|.+.+ -+|.+++.+ +.+++ .. ...+-+...+|-+.+|+.+|++|.||++.....+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999998743 366777743 44555 33 3344455667789999999999999999765543
Q ss_pred --cEEEee
Q 024336 139 --RLKICD 144 (269)
Q Consensus 139 --~~~l~d 144 (269)
++.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 467777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.4e-09 Score=91.38 Aligned_cols=241 Identities=21% Similarity=0.181 Sum_probs=160.5
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCC-cceeeEEEEeCCeEEEEEeecC
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN-IIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
.|.....+++++++.+++.+...+...+ .+++... .+..-++++|.+++||| .+...+-+..+...+++++++.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 3455667788999999999887665544 5655433 55667899999999999 6777777777788999999998
Q ss_pred CC-chHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcc
Q 024336 83 GG-ELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST 160 (269)
Q Consensus 83 ~~-~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (269)
++ +..... ...-.+..-+...+.+.-+.+++++|+.--+|+| ||+..... .+..+|+..............
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~~t~ 390 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQLTRTMKPRTA 390 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc---cccccccCCcccCcccccccC
Confidence 77 221111 1111244555666777788899999998778888 77776533 799999987644333345667
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc--ccCCCcCCCCHHHH-HH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--YFLPDYVRVSADCR-HL 237 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-~l 237 (269)
.+++.++|||....+.+... .|.|++|.-..++.-|-+|-........ .+..+. ..+.+....++... ++
T Consensus 391 ~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~P~~~~~------~~g~~p~s~~L~~~~aw~~~~~~~~ 463 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSSPPAVLP------MIGNGPNSPMLTDKSAWSPVFHRDF 463 (829)
T ss_pred CCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCCCccccC------CCCCCCCccccchhhhcCcccccCC
Confidence 78999999998887777666 8999999877788877777543211000 000000 00000001111112 36
Q ss_pred HHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
-..|+...|.-|+.....+.+.+|+.
T Consensus 464 ~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 464 PAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred cccccCCCCCCCcchhhHHHHHHhcc
Confidence 67788888888888888888777765
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.4e-07 Score=78.71 Aligned_cols=135 Identities=19% Similarity=0.200 Sum_probs=89.0
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCccc-----------------------------------cHH------HH
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-----------------------------------DEN------VQ 47 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----------------------------------~~~------~~ 47 (269)
..|+.++-|.||+|...+ |+.||||+..++-.. .+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 567889999999999985 899999987542110 011 22
Q ss_pred HHHHHHHhC----C-CCCcceeeEEEEeCCeEEEEEeecCCCchHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 024336 48 REIINHRSL----R-HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARI--CSAGRFSEDEARFFFQQLISGVSYCHSMEI 120 (269)
Q Consensus 48 ~e~~~l~~l----~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 120 (269)
+|...+.++ . .+++.-..=++.-...-.++|||++|..+.+.. .. ..++...+...+.++. +..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 344444443 2 343332222333345568999999998887763 33 3456455444333332 234445899
Q ss_pred eeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 121 CHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 121 ~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
.|+|..|.||+++.++. +.+.|||+..
T Consensus 287 fHaDpHpGNi~v~~~g~--i~~lDfGi~g 313 (517)
T COG0661 287 FHADPHPGNILVRSDGR--IVLLDFGIVG 313 (517)
T ss_pred cccCCCccceEEecCCc--EEEEcCccee
Confidence 99999999999998877 9999999875
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.62 E-value=8.9e-07 Score=69.76 Aligned_cols=76 Identities=13% Similarity=0.055 Sum_probs=53.8
Q ss_pred ceecccCc-eEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEEeecCCCch
Q 024336 9 KELGSGNF-GVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 9 ~~l~~g~~-g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
..|..|.+ +.||++... +..+++|...... .....+|+.+++.+. +--+.+++++....+..++||++++|.++
T Consensus 4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 45556666 688999764 3568888775443 345778998888874 34455677777666678899999999776
Q ss_pred HH
Q 024336 87 FA 88 (269)
Q Consensus 87 ~~ 88 (269)
..
T Consensus 80 ~~ 81 (244)
T cd05150 80 AA 81 (244)
T ss_pred hH
Confidence 53
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.2e-06 Score=67.09 Aligned_cols=75 Identities=17% Similarity=0.271 Sum_probs=49.8
Q ss_pred cceecccCceEEEEEEEec-CCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCc-ceeeEEEEeCCeEEEEEeecCCCc
Q 024336 8 VKELGSGNFGVARLVRDKR-TKELVAVKYIERGKKIDENVQREIINHRSLRHPNI-IRFKEVLLTPTHLAIVMEYAAGGE 85 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~~~~~~ 85 (269)
++.|..|-...+|++.... .++.|++|+............+|+.+++.+...++ .+++..+. + .+++||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 4678888899999997653 35678899776543322344578888888854444 34444322 2 37999999866
Q ss_pred h
Q 024336 86 L 86 (269)
Q Consensus 86 l 86 (269)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.4e-06 Score=72.50 Aligned_cols=137 Identities=18% Similarity=0.175 Sum_probs=86.0
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCccc--------------------------------cHH------HHHHH
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKI--------------------------------DEN------VQREI 50 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------------------------------~~~------~~~e~ 50 (269)
+.|+..+.+.|++|+-.+ |+.||||+-++.-+. .+. +.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 578889999999999986 999999986432110 011 22333
Q ss_pred HHHHh----CCCCC---cceeeEEEEe-CCeEEEEEeecCCCchHH--HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 024336 51 INHRS----LRHPN---IIRFKEVLLT-PTHLAIVMEYAAGGELFA--RICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120 (269)
Q Consensus 51 ~~l~~----l~h~~---i~~~~~~~~~-~~~~~~v~e~~~~~~l~~--~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 120 (269)
+...+ +.|-+ -|.+=.++.+ ...-.++|||++|..+.+ .+.+. .++...+..-+.+... .-+-..|+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~--~qIf~~Gf 322 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYL--EQIFKTGF 322 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHH--HHHHhcCC
Confidence 33322 23434 1222222222 235689999999977644 44343 3566654443333332 33556789
Q ss_pred eeecCCCCcEEecCC--CCCcEEEeecCCcc
Q 024336 121 CHRDLKLENTLLDGS--PQPRLKICDFGYSK 149 (269)
Q Consensus 121 ~H~di~p~ni~i~~~--~~~~~~l~df~~~~ 149 (269)
+|+|-.|.||+++++ +..++.+.|||+..
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~ 353 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYA 353 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccc
Confidence 999999999999864 34569999999876
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.5e-06 Score=67.74 Aligned_cols=132 Identities=16% Similarity=0.116 Sum_probs=77.8
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCcccc-HHHHHHHHHHHhCCCCCc-ceeeEEEEeCCeEEEEEeecCCCch
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPNI-IRFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
..+..|-.+.+|++.. +++.+++|......... -...+|..+++.+...++ .+++... . -++|++|++|..+
T Consensus 2 ~~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~ 75 (256)
T TIGR02721 2 QTLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVI 75 (256)
T ss_pred CcCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccc
Confidence 3466788889999873 46678899765443222 245789999988864434 3344332 2 2689999998654
Q ss_pred HHH-----------------HHhcC----CCCHH-HHHHHHHHH---------HHHHHHHHh--------CCceeecCCC
Q 024336 87 FAR-----------------ICSAG----RFSED-EARFFFQQL---------ISGVSYCHS--------MEICHRDLKL 127 (269)
Q Consensus 87 ~~~-----------------~~~~~----~~~~~-~~~~~~~~i---------~~~l~~lh~--------~~i~H~di~p 127 (269)
... +++.. +++.. .+..+..++ ...+..+.+ ..++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 321 11111 11211 112221111 111222221 2489999999
Q ss_pred CcEEecCCCCCcEEEeecCCcc
Q 024336 128 ENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 128 ~ni~i~~~~~~~~~l~df~~~~ 149 (269)
.||+++.++ +.++||+.+.
T Consensus 156 ~Nil~~~~~---~~lIDwE~a~ 174 (256)
T TIGR02721 156 YNLVVTPQG---LKLIDWEYAS 174 (256)
T ss_pred CcEEEeCCC---CEEEeccccC
Confidence 999998765 6899999775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.2e-06 Score=67.11 Aligned_cols=74 Identities=11% Similarity=-0.017 Sum_probs=46.0
Q ss_pred cceecccCce-EEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCC---CcceeeEEEEeC---CeEEEEEee
Q 024336 8 VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP---NIIRFKEVLLTP---THLAIVMEY 80 (269)
Q Consensus 8 ~~~l~~g~~g-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~---~~~~~v~e~ 80 (269)
++.++.|+.. .||++. ..+++|.... ......+.+|..+++.+... .+.++++..... ...+++|++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 3567766666 589762 2478887554 23345788899999887532 233344433322 234789999
Q ss_pred cCCCchH
Q 024336 81 AAGGELF 87 (269)
Q Consensus 81 ~~~~~l~ 87 (269)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9986663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.3e-05 Score=65.01 Aligned_cols=78 Identities=13% Similarity=0.076 Sum_probs=56.7
Q ss_pred cccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCC---CCcceeeEEEEe---CCeEEEEEe
Q 024336 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH---PNIIRFKEVLLT---PTHLAIVME 79 (269)
Q Consensus 6 ~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~---~~~~~~v~e 79 (269)
.-.+.|+.|..+.||.....+ + .+++|.. +.......+..|...++.+.. -.+.++++++.. .+..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~-~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMA-RSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEe-cccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 446789999999999997643 3 3677764 332234678899999998853 357778877654 356899999
Q ss_pred ecCCCch
Q 024336 80 YAAGGEL 86 (269)
Q Consensus 80 ~~~~~~l 86 (269)
+++|.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.7e-05 Score=58.46 Aligned_cols=124 Identities=21% Similarity=0.252 Sum_probs=86.9
Q ss_pred ccccccceecccCc-eEEEEEEEecCCeEEEEEEeec---Cc-------------------cccHHHHHHHHHHHhC---
Q 024336 3 ERYEPVKELGSGNF-GVARLVRDKRTKELVAVKYIER---GK-------------------KIDENVQREIINHRSL--- 56 (269)
Q Consensus 3 ~~y~~~~~l~~g~~-g~v~~~~~~~~~~~vaiK~~~~---~~-------------------~~~~~~~~e~~~l~~l--- 56 (269)
.+++.++.||.|.. |.||+++.. |..||+|.+.. .. .....+..|-++.-+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 47889999999999 999999995 77999999321 00 0112356677766666
Q ss_pred CCCCc--ceeeEEEEeC------------------CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 024336 57 RHPNI--IRFKEVLLTP------------------THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116 (269)
Q Consensus 57 ~h~~i--~~~~~~~~~~------------------~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 116 (269)
.+.++ ++++|+..-. -...+|.||.+... .++...+. +|.+-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~~~----~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRDIP----QMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhHHH----HHHHHHHHHH
Confidence 45566 9999997422 12467788776543 23445544 4555566699
Q ss_pred hCCceeecCCCCcEEecCCCCCcEEEeecCCc
Q 024336 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYS 148 (269)
Q Consensus 117 ~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~ 148 (269)
+.||+-+|+++.|..= -+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~-------G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRG-------GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccC-------CEEEecccC
Confidence 9999999999999862 489999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.1e-05 Score=65.37 Aligned_cols=136 Identities=18% Similarity=0.132 Sum_probs=81.1
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCC--CcceeeEE------EEeCCeEEEEEe
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP--NIIRFKEV------LLTPTHLAIVME 79 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~------~~~~~~~~~v~e 79 (269)
.+.+..|....+|++... +..+++|+... ...+.+..|+.++..+... .+.+++.. ...++..+.+++
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 566777888899998753 34688898764 3345677788877777432 23444331 233456789999
Q ss_pred ecCCCchHH----H----------HHhc-CCCC--------HHHHHH------------HHHHHHHHHHHHHh-------
Q 024336 80 YAAGGELFA----R----------ICSA-GRFS--------EDEARF------------FFQQLISGVSYCHS------- 117 (269)
Q Consensus 80 ~~~~~~l~~----~----------~~~~-~~~~--------~~~~~~------------~~~~i~~~l~~lh~------- 117 (269)
+++|.++.. . ++.. ..+. ...... ....+..++..+.+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999865421 1 0100 0000 000000 11112233444443
Q ss_pred CCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 118 ~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
.+++|+|+.|.||+++.++. +.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDEL--SGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCce--EEEeehhhhc
Confidence 46999999999999987654 6899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.25 E-value=7.3e-05 Score=62.64 Aligned_cols=76 Identities=17% Similarity=0.095 Sum_probs=52.2
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecC--------ccccHHHHHHHHHHHhCC---CCCcceeeEEEEeCCeEEE
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERG--------KKIDENVQREIINHRSLR---HPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~ 76 (269)
.+.||.|....||++.....++.+++|.-.+. ....+....|...|+.+. ..++.+++.+ +++..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46789999999999999754457999975421 112345667888887762 2345666665 4455789
Q ss_pred EEeecCCCc
Q 024336 77 VMEYAAGGE 85 (269)
Q Consensus 77 v~e~~~~~~ 85 (269)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.9e-05 Score=62.45 Aligned_cols=76 Identities=13% Similarity=0.162 Sum_probs=51.5
Q ss_pred cceecccCceEEEEEEEec------CCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCc-ceeeEEEEeCCeEEEEEee
Q 024336 8 VKELGSGNFGVARLVRDKR------TKELVAVKYIERGKKIDENVQREIINHRSLRHPNI-IRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~ 80 (269)
++.+..|-...+|++.... .++.+++|+............+|..+++.+...++ .+++.++. + ..|++|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 4567778888999998653 25789999876654444567788888888854333 34555443 2 358999
Q ss_pred cCCCchH
Q 024336 81 AAGGELF 87 (269)
Q Consensus 81 ~~~~~l~ 87 (269)
++|.++.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9886653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.08 E-value=7.3e-05 Score=61.38 Aligned_cols=75 Identities=9% Similarity=0.004 Sum_probs=44.6
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCC--cceeeE------EEEeCCeEEEEEe
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN--IIRFKE------VLLTPTHLAIVME 79 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~------~~~~~~~~~~v~e 79 (269)
.+.|+.|....+|.+... +| .+++|++. ....+.+..|+..+..|...+ +.+++. +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 455667777899998764 33 58889875 223344455666665553211 233332 1223456789999
Q ss_pred ecCCCch
Q 024336 80 YAAGGEL 86 (269)
Q Consensus 80 ~~~~~~l 86 (269)
+++|..+
T Consensus 103 ~l~G~~~ 109 (319)
T PRK05231 103 FLEGKWP 109 (319)
T ss_pred ecCCCCC
Confidence 9998643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.9e-06 Score=67.69 Aligned_cols=131 Identities=15% Similarity=0.175 Sum_probs=91.6
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-------------------c----cHHHHHHHHHHHhCC-CC-
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------------------I----DENVQREIINHRSLR-HP- 59 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------------------~----~~~~~~e~~~l~~l~-h~- 59 (269)
+.++.+||-|--|.+|.+.+. .|.+.++|+=..... + .-....|...++.|. |-
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 567889999999999999986 577788885321100 0 012345777777774 32
Q ss_pred CcceeeEEEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCc
Q 024336 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR 139 (269)
Q Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~ 139 (269)
-+.+.++ .++.++||+++.|..|...-+ ...+..+...+...+-.|-+.|++|||+.-=||+++.++.
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~-- 240 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK-- 240 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC--
Confidence 2334443 356789999999877755431 1223345556666677789999999999999999998777
Q ss_pred EEEeecCCc
Q 024336 140 LKICDFGYS 148 (269)
Q Consensus 140 ~~l~df~~~ 148 (269)
++++||.-+
T Consensus 241 i~vIDFPQm 249 (465)
T KOG2268|consen 241 IVVIDFPQM 249 (465)
T ss_pred EEEeechHh
Confidence 999999744
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.8e-05 Score=58.48 Aligned_cols=97 Identities=14% Similarity=0.076 Sum_probs=77.1
Q ss_pred HHHHHHHHhCCC-CCcceeeEEEEeCCeEEEEEeecCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 024336 47 QREIINHRSLRH-PNIIRFKEVLLTPTHLAIVMEYAAGGELFAR---ICSAGRFSEDEARFFFQQLISGVSYCHS---ME 119 (269)
Q Consensus 47 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~ 119 (269)
.+|..+++.+++ +++.+++|+|-. .++.|+...+++... +......++..+..++.++++.+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888876 699999998843 578899887655421 1122235899999999999999999998 44
Q ss_pred ceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 120 i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
+.-+|++|+|+-++.++. ++++|.+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~--lk~iDld~v~ 110 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGR--LKLIDLDDVF 110 (188)
T ss_pred EEEeecchHHeEEeCCCc--EEEEechhcc
Confidence 888999999999998887 9999998664
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.03 E-value=9.9e-05 Score=60.26 Aligned_cols=137 Identities=18% Similarity=0.172 Sum_probs=78.5
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCC--cceeeEE------EEeCCeEEEEEe
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN--IIRFKEV------LLTPTHLAIVME 79 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~~v~e 79 (269)
.+.++.|....+|++... +| .+++|+..... ..+.+..|..++..|...+ +.+++.. ....+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeC-CC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 456777777899998753 34 58889775432 2345556777776663222 3343332 122456789999
Q ss_pred ecCCCchH----HH----------HHh-cCCCCH-------HHHH----------------HHHHHHHHHHHHHH-----
Q 024336 80 YAAGGELF----AR----------ICS-AGRFSE-------DEAR----------------FFFQQLISGVSYCH----- 116 (269)
Q Consensus 80 ~~~~~~l~----~~----------~~~-~~~~~~-------~~~~----------------~~~~~i~~~l~~lh----- 116 (269)
|++|..+. .. ++. ...++. ...+ .....+...++++.
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885431 10 111 000100 0000 00112233444443
Q ss_pred --hCCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 117 --SMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 117 --~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
..+++|+|+.+.||+++.++. +.+.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSV--KGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCce--EEEeeccccc
Confidence 267999999999999987764 6899999775
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.0001 Score=60.20 Aligned_cols=137 Identities=20% Similarity=0.213 Sum_probs=94.0
Q ss_pred ccceecccCceEEEEEEEecCCeEEEEEEeecC----------------------cc-ccH--H--HHHHHHHHHhCCCC
Q 024336 7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERG----------------------KK-IDE--N--VQREIINHRSLRHP 59 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----------------------~~-~~~--~--~~~e~~~l~~l~h~ 59 (269)
+-.+|+.|--+.||.|... +|+.+|||++..+ .. ..+ . ...|++.|+++...
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4567888999999998876 5777999987321 00 011 1 33578888888766
Q ss_pred CcceeeEEEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeecCCCCcEEecCCCCC
Q 024336 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-HSMEICHRDLKLENTLLDGSPQP 138 (269)
Q Consensus 60 ~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~H~di~p~ni~i~~~~~~ 138 (269)
+|.-..-+.. ..-.+||+|+....-..-.-+...++...+..+-.+++.-+.-| |..++||.||+--|+++. +|.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~- 302 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGK- 302 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCE-
Confidence 6433222222 23479999996533222222344578888888888888888776 457899999999999998 444
Q ss_pred cEEEeecCCcc
Q 024336 139 RLKICDFGYSK 149 (269)
Q Consensus 139 ~~~l~df~~~~ 149 (269)
+.++|.+-+.
T Consensus 303 -lyiIDVSQSV 312 (520)
T KOG2270|consen 303 -LYIIDVSQSV 312 (520)
T ss_pred -EEEEEccccc
Confidence 9999987665
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00016 Score=58.55 Aligned_cols=134 Identities=16% Similarity=0.129 Sum_probs=83.5
Q ss_pred ccceecccCceEEEEEEEecCCeEEEEEEeec---CccccHHHHHHHHHHHhCCCC--CcceeeEEEEeCC--eEEEEEe
Q 024336 7 PVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP--NIIRFKEVLLTPT--HLAIVME 79 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~--~~~~v~e 79 (269)
+++.+..|....+|..... ++.++++ .+. .........+|+..++.+.-- -+...++++.++. ..+.||+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 4455555555566666664 7778888 332 223345567788888776432 2333455555554 6699999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHH-HHHHHHHHHHHh-----------------------------------------
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFF-QQLISGVSYCHS----------------------------------------- 117 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~-~~i~~~l~~lh~----------------------------------------- 117 (269)
|++|..+.+..... ..-.+.+ ..++..|..||+
T Consensus 106 ~veGe~~~~~~~~~-----~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 106 WVEGEVVWSALPPE-----SLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred EecceeccCcCCcc-----cchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 99985443322110 0001222 255555555553
Q ss_pred -----------------CCceeecCCCCcEEecCCCCCcEEEeecCCccc
Q 024336 118 -----------------MEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 118 -----------------~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~ 150 (269)
..++|||+.+.|+++++++. +-+.||+++..
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~l 228 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP--TGVLDWELATL 228 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe--eEEEecccccc
Confidence 34899999999999998877 89999998864
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00016 Score=59.84 Aligned_cols=138 Identities=18% Similarity=0.210 Sum_probs=81.8
Q ss_pred ccceecccCceEEEEEEEec----CCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCc-ceeeEEEEeCCeEEEEEeec
Q 024336 7 PVKELGSGNFGVARLVRDKR----TKELVAVKYIERGKKIDENVQREIINHRSLRHPNI-IRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~~ 81 (269)
-...|..|-...+|++.... +++.|++|+........-...+|..+++.+...++ .++++.+... .|.+|+
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 34566678888999987532 24679999886544333344678888888865444 3456655332 578888
Q ss_pred CCCchHHH----------H-------HhcC------CCCHHHHHHHHHHHH-----------------HHHHHH----H-
Q 024336 82 AGGELFAR----------I-------CSAG------RFSEDEARFFFQQLI-----------------SGVSYC----H- 116 (269)
Q Consensus 82 ~~~~l~~~----------~-------~~~~------~~~~~~~~~~~~~i~-----------------~~l~~l----h- 116 (269)
++.++... + ++.. +.....+..+..++. ..+..| .
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87665311 0 1111 011223333332221 111111 1
Q ss_pred ---hCCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 117 ---SMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 117 ---~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
...++|+|+++.||+++.+. ..+.++||..+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence 23589999999999998532 239999999875
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00036 Score=57.54 Aligned_cols=75 Identities=15% Similarity=0.172 Sum_probs=49.4
Q ss_pred cceecccCceEEEEEEEecC---CeEEEEEEeecCccccHHHHHHHHHHHhCCCCCc-ceeeEEEEeCCeEEEEEeecCC
Q 024336 8 VKELGSGNFGVARLVRDKRT---KELVAVKYIERGKKIDENVQREIINHRSLRHPNI-IRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
.+.|..|-...+|++..... +..|++|+........-.-.+|..+++.+...++ .++++++. .+ +|.+|++|
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 45666688889999975432 3379999876544333345678888888865555 34565553 22 58889877
Q ss_pred Cch
Q 024336 84 GEL 86 (269)
Q Consensus 84 ~~l 86 (269)
.++
T Consensus 95 ~~l 97 (330)
T PLN02421 95 RTL 97 (330)
T ss_pred CCC
Confidence 654
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0016 Score=54.72 Aligned_cols=73 Identities=21% Similarity=0.189 Sum_probs=48.2
Q ss_pred ccceecccCceEEEEEEEecCCeEEEEEEeec-----Cc---cccHHHHHHHHHHHhCC---CCCcceeeEEEEeCCeEE
Q 024336 7 PVKELGSGNFGVARLVRDKRTKELVAVKYIER-----GK---KIDENVQREIINHRSLR---HPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~-----~~---~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~ 75 (269)
..+.||.|....||++.+. +..++||.-.. +. ........|...|+.+. ...+.+++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3567899999999999874 34588997652 11 12233444566666553 246777777665 4457
Q ss_pred EEEeecCC
Q 024336 76 IVMEYAAG 83 (269)
Q Consensus 76 ~v~e~~~~ 83 (269)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999976
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00051 Score=55.09 Aligned_cols=30 Identities=23% Similarity=0.355 Sum_probs=24.1
Q ss_pred CceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 119 ~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
.++|+|++|.||++++++. ..-|.||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC-EEEEECcHhcc
Confidence 4899999999999986443 24699999775
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0036 Score=51.68 Aligned_cols=72 Identities=19% Similarity=0.133 Sum_probs=46.4
Q ss_pred eecccCceEEEEEEEecCCeEEEEEEeecC--------ccccHHHHHHHHHHHhCC--CCC-cceeeEEEEeCCeEEEEE
Q 024336 10 ELGSGNFGVARLVRDKRTKELVAVKYIERG--------KKIDENVQREIINHRSLR--HPN-IIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 10 ~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~e~~~l~~l~--h~~-i~~~~~~~~~~~~~~~v~ 78 (269)
.||.|....||++.....++.++||.-.+. ....+...-|...|+... .|. +.+++. .++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 579999999999998644467999974321 122334556777776653 354 444443 4555667999
Q ss_pred eecCC
Q 024336 79 EYAAG 83 (269)
Q Consensus 79 e~~~~ 83 (269)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0015 Score=52.56 Aligned_cols=75 Identities=11% Similarity=0.065 Sum_probs=49.0
Q ss_pred cccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC---CCCcceeeEEEEeCCeEEEEEeecC
Q 024336 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR---HPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 6 ~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
+-.+.++.|....+|++. .+++.+.+|+-. ......+..|..-|+.|. .-.+.+++++...++.-++++||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 445678889999999988 457779999776 334567888998888883 3457788888877777799999997
Q ss_pred CC
Q 024336 83 GG 84 (269)
Q Consensus 83 ~~ 84 (269)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 65
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00037 Score=53.57 Aligned_cols=55 Identities=16% Similarity=0.103 Sum_probs=34.4
Q ss_pred CeEEEEEEeecCccccHHHHHHHHHHHhCCCCCc-ceeeEEEEeCCeEEEEEeecCCCch
Q 024336 28 KELVAVKYIERGKKIDENVQREIINHRSLRHPNI-IRFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 28 ~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
++.|++|+........-....|..+++.+...++ .++++.+.. + .|.+|++|.+|
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~-g---~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN-G---RVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT-E---EEEE--SSEE-
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC-C---cEEEEeccccc
Confidence 4568999887765555677789999988865554 455555432 2 56688877553
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0035 Score=51.23 Aligned_cols=30 Identities=20% Similarity=0.241 Sum_probs=26.5
Q ss_pred CCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 118 ~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
.+++|+|+.++|++++.++. +.++||..+.
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~ 225 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRG--GYFINFEKAS 225 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence 36999999999999987776 8999999775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0033 Score=52.58 Aligned_cols=74 Identities=22% Similarity=0.180 Sum_probs=48.4
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeec----C---ccccHHHHHHHHHHHhCC--CCC-cceeeEEEEeCCeEEEE
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIER----G---KKIDENVQREIINHRSLR--HPN-IIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~----~---~~~~~~~~~e~~~l~~l~--h~~-i~~~~~~~~~~~~~~~v 77 (269)
.+.||.|.-..||++.+...++.++||.-.+ . ....+...-|...|+... .|. +.+++. .++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 5688999999999999853356699987432 1 122344556777777663 354 444553 355566788
Q ss_pred EeecCC
Q 024336 78 MEYAAG 83 (269)
Q Consensus 78 ~e~~~~ 83 (269)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888854
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.005 Score=51.75 Aligned_cols=76 Identities=12% Similarity=0.077 Sum_probs=47.0
Q ss_pred ccceecccCceEEEEEEEecC-Ce-----EEEEEEeecCccccHHHHHHHHHHHhCCCCCc-ceeeEEEEeCCeEEEEEe
Q 024336 7 PVKELGSGNFGVARLVRDKRT-KE-----LVAVKYIERGKKIDENVQREIINHRSLRHPNI-IRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~~-~~-----~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e 79 (269)
..+.|..|-...+|++..... +. .|+++.........-.-.+|+.+++.+...++ .++++.+.. +++.|
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 355666788889999975432 12 24444432222222234678999998876555 456665542 59999
Q ss_pred ecCCCch
Q 024336 80 YAAGGEL 86 (269)
Q Consensus 80 ~~~~~~l 86 (269)
|++|.++
T Consensus 130 fIeGr~l 136 (383)
T PTZ00384 130 WVEGNTM 136 (383)
T ss_pred EeccccC
Confidence 9988665
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.02 Score=47.15 Aligned_cols=71 Identities=10% Similarity=0.004 Sum_probs=44.2
Q ss_pred cCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCC--Ccceee---E--EEEeCCeEEEEEeecCCCc
Q 024336 14 GNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP--NIIRFK---E--VLLTPTHLAIVMEYAAGGE 85 (269)
Q Consensus 14 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~---~--~~~~~~~~~~v~e~~~~~~ 85 (269)
+....||++... ++..+++|+..........+..|+..+..|... .++... + ....++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 445678988764 456699998865554566777788877766321 122211 1 1233456788999998753
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0018 Score=55.32 Aligned_cols=166 Identities=16% Similarity=0.157 Sum_probs=97.2
Q ss_pred HHHHHHHHHHHhCCCCCcceeeEEEEeC-CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 024336 44 ENVQREIINHRSLRHPNIIRFKEVLLTP-THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122 (269)
Q Consensus 44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 122 (269)
..+.-....++.+.|+|....+++-... .+..+|+|+++ .++.+...... +-..... +|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~------------------~~ 86 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDESLL------------------AH 86 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhhhc------------------cc
Confidence 3455677888999999999998876543 45889999995 58888875543 2111111 22
Q ss_pred ecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCC
Q 024336 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFE 202 (269)
Q Consensus 123 ~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~ 202 (269)
+- -+-|+ ++.+| .+... . |- ...+++||||+|.++.++.-|...+.
T Consensus 87 ~~-~~~~~---------~~~td-~~~t~----~-------------~~------~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 87 GV-LHLNI---------IYITD-HFLTK----Y-------------PS------PIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred cc-ceehh---------hhccc-ccccc----C-------------CC------CCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 21 11111 23333 11110 0 00 00125999999999999998876655
Q ss_pred CCCChhhHHHHHHHHhhccccCC-------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 203 DPEDPRNFRKTIDRIRNVQYFLP-------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
.....+.......- -..+.... -...++..+..+..+|+...|..||...++.++..+.+.
T Consensus 133 ~~~~s~~l~~i~k~-~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 133 ELTESEYLEILLKY-YTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHh-ccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 43332222111110 00000000 001345678889999999999999998998888877654
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.042 Score=44.87 Aligned_cols=29 Identities=31% Similarity=0.647 Sum_probs=24.7
Q ss_pred CCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 118 ~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
.+++|||+.+.||+++. +. +.+.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~--i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NE--VYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-Cc--EEEEECcccc
Confidence 57899999999999986 44 8999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.00015 Score=69.03 Aligned_cols=151 Identities=17% Similarity=0.117 Sum_probs=104.0
Q ss_pred HHHHHHhCCCCCcceeeEEEEe--CCeEEEEEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---
Q 024336 49 EIINHRSLRHPNIIRFKEVLLT--PTHLAIVMEYAAGGELFARICSA----GRFSEDEARFFFQQLISGVSYCHSME--- 119 (269)
Q Consensus 49 e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~--- 119 (269)
|....+...|+++.....-... ....+..++++.+|.+.+.+.++ .++....+.....+.+.+..-+|++.
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 4444455678877665543332 23468889999999999988653 33444444444444466666666432
Q ss_pred --ceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh
Q 024336 120 --ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV 196 (269)
Q Consensus 120 --i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t 196 (269)
-+|.++++-|.++..+.. +++.++|+.+...+ ........+++.|++|+....-..+.+ +|+|.+|+.+|...-
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~--v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYN--VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRSD 1435 (2724)
T ss_pred ccchhhhhhhhccceecCCc--ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHhc
Confidence 689999999999998887 99999999872222 222234456777888888765566555 999999999999887
Q ss_pred CCCCCC
Q 024336 197 GAYPFE 202 (269)
Q Consensus 197 g~~pf~ 202 (269)
|..+|.
T Consensus 1436 ~n~~fi 1441 (2724)
T KOG1826|consen 1436 GNAYFI 1441 (2724)
T ss_pred ccHHHH
Confidence 776663
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.012 Score=50.56 Aligned_cols=76 Identities=16% Similarity=0.064 Sum_probs=49.9
Q ss_pred ccceecccCceEEEEEEEecC--------CeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcc-eeeEEEEeCCeEEEE
Q 024336 7 PVKELGSGNFGVARLVRDKRT--------KELVAVKYIERGKKIDENVQREIINHRSLRHPNII-RFKEVLLTPTHLAIV 77 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~~v 77 (269)
-.+.|..|-.-.+|++..... ++.|++|+.-......-...+|..+++.+...++- ++++.+. -+.+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 456677788889999975421 46799998765544333456788888877655553 4555543 2467
Q ss_pred EeecCCCch
Q 024336 78 MEYAAGGEL 86 (269)
Q Consensus 78 ~e~~~~~~l 86 (269)
.+|++|.++
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 899987644
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.028 Score=46.20 Aligned_cols=135 Identities=18% Similarity=0.150 Sum_probs=78.3
Q ss_pred eecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCC---CCcce---eeEE--EEeCC--eEEEEEe
Q 024336 10 ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH---PNIIR---FKEV--LLTPT--HLAIVME 79 (269)
Q Consensus 10 ~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~---~~~~--~~~~~--~~~~v~e 79 (269)
.|.+ ....+|++...+ |+ +++|+.... .....+.-|+..+..|.- +-.++ .-|- ..-.. ....+++
T Consensus 33 ~l~s-~eN~~f~~~~~~-g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTED-GR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecC-CC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 556789888864 33 499988877 666777778888877732 11122 1111 11123 7788999
Q ss_pred ecCCCchHH-H--------------HHh----c---CC-----CCHHH-------------HHHHHHHHHHHHHHHHh--
Q 024336 80 YAAGGELFA-R--------------ICS----A---GR-----FSEDE-------------ARFFFQQLISGVSYCHS-- 117 (269)
Q Consensus 80 ~~~~~~l~~-~--------------~~~----~---~~-----~~~~~-------------~~~~~~~i~~~l~~lh~-- 117 (269)
|++|..+.. . ++. . .+ ..+.. -.....++...+..+.+
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999876662 1 000 0 00 11110 00022233334444442
Q ss_pred ------CC--ceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 118 ------ME--ICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 118 ------~~--i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
.+ ++|+|+.|.||+++.+.. .+.+.||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 33 999999999999997763 36899999665
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.025 Score=45.80 Aligned_cols=30 Identities=23% Similarity=0.478 Sum_probs=25.0
Q ss_pred ceeecCCCCcEEecCCCCC---cEEEeecCCcc
Q 024336 120 ICHRDLKLENTLLDGSPQP---RLKICDFGYSK 149 (269)
Q Consensus 120 i~H~di~p~ni~i~~~~~~---~~~l~df~~~~ 149 (269)
++|||+++.||++..++.+ .+++.||..+.
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeecccccc
Confidence 8999999999999766442 58999998775
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.022 Score=43.66 Aligned_cols=88 Identities=18% Similarity=0.144 Sum_probs=57.8
Q ss_pred ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--CC
Q 024336 42 IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS--ME 119 (269)
Q Consensus 42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~--~~ 119 (269)
....+.++.+++.++. +|+++..- ....+.++.|.|-.... .+.. ++..=+.+|...|+ .+
T Consensus 101 ~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------~~~N----~i~agi~~L~~fH~~~~~ 163 (308)
T PF07387_consen 101 NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------NFSN----FITAGIKDLMDFHSENQH 163 (308)
T ss_pred chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------chhH----HHHHhHHHHHHhhccCCC
Confidence 3455677888877654 45555521 33457889998853211 1111 11122456777884 46
Q ss_pred ceeecCCCCcEEecCCCCCcEEEeecCCc
Q 024336 120 ICHRDLKLENTLLDGSPQPRLKICDFGYS 148 (269)
Q Consensus 120 i~H~di~p~ni~i~~~~~~~~~l~df~~~ 148 (269)
.+|||-.|+|||.+..|. +||.|-++.
T Consensus 164 ~lHGD~np~NiM~D~~G~--lKlVDP~~L 190 (308)
T PF07387_consen 164 CLHGDCNPDNIMCDKFGY--LKLVDPVCL 190 (308)
T ss_pred eecCCCChhheeecCCCC--EEecChhhh
Confidence 899999999999999998 999997754
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.27 Score=47.03 Aligned_cols=32 Identities=28% Similarity=0.455 Sum_probs=25.6
Q ss_pred CCceeecCCCCcEEecCCCCCcEE-EeecCCcc
Q 024336 118 MEICHRDLKLENTLLDGSPQPRLK-ICDFGYSK 149 (269)
Q Consensus 118 ~~i~H~di~p~ni~i~~~~~~~~~-l~df~~~~ 149 (269)
.+++|+|+.+.||+++.++..++. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 569999999999999977532354 99999664
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.037 Score=43.65 Aligned_cols=79 Identities=15% Similarity=0.151 Sum_probs=53.0
Q ss_pred ccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec-CCCc
Q 024336 7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA-AGGE 85 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~-~~~~ 85 (269)
....+..|..+.|+.+... +|+++++|+..+......+.. ....|+.-+-.+.|++++. +...-.+++|.+ ++.+
T Consensus 6 ~~~~~~~g~~s~V~pv~~~-dG~~avLKl~~p~~~~~~E~~-g~~~L~~w~G~GaVrll~~--d~~~~AlLLErl~~g~~ 81 (253)
T PF04655_consen 6 PDGPPAHGSSSLVVPVRRA-DGTPAVLKLAPPHAEAEHEAR-GEAALRWWNGRGAVRLLAA--DPERGALLLERLDPGRS 81 (253)
T ss_pred cCCCCCCCcceEEEEEEcC-CCCeEEEEecCCcccchhhhh-HHhHhheeCCCCceeeecc--ccccchhhhhhccCCCc
Confidence 4455677999999999865 688999998765443223221 1244777778889999885 334556888888 4445
Q ss_pred hHHH
Q 024336 86 LFAR 89 (269)
Q Consensus 86 l~~~ 89 (269)
|.+.
T Consensus 82 L~~~ 85 (253)
T PF04655_consen 82 LASL 85 (253)
T ss_pred hhhc
Confidence 5444
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 269 | ||||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-128 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-127 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-127 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-127 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-124 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-124 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-48 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-46 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-46 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-46 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-46 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-46 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-46 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-45 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-45 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-45 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-45 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-45 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-44 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-43 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-42 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-42 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-41 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-41 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-38 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-38 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-37 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-37 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-37 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-37 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-37 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-37 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-37 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-37 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-37 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-37 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-37 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-37 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-36 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-36 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-36 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-36 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-36 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-36 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-36 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-36 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-36 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-36 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-35 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-35 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-35 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-35 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-35 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-35 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-35 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-35 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-35 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-35 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-35 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-35 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-35 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-35 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-35 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-35 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-35 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-35 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-35 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-35 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-35 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-35 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-35 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-35 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-35 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-35 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-35 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-35 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-35 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-35 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-35 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-35 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-34 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-34 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-34 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-34 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-34 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-34 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-34 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-34 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-34 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-34 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-34 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-34 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-34 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-34 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-34 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-34 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-34 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-34 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-34 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-34 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-34 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-34 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-34 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-34 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-34 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-34 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-34 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-34 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-34 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-33 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-33 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-33 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-33 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-32 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-32 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-32 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-32 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-32 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-32 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-32 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-32 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-32 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-31 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-31 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-31 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-31 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-31 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-31 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-31 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-31 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-31 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-31 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-31 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-31 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-31 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-31 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-31 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-31 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-31 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-31 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-31 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-31 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-31 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-31 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-31 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-31 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-31 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-31 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-31 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-31 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-31 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-31 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-31 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-31 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-31 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-31 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-31 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-31 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-31 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-31 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-31 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-30 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-30 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-30 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-30 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-30 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-30 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-30 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-30 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-30 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-30 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-30 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-30 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-30 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-30 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-30 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-30 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-30 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-30 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-30 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-30 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-30 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-30 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-30 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-30 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-30 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-30 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-30 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-30 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-30 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-30 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-30 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-30 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-30 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-30 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-30 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-30 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-30 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-30 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-30 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-29 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-29 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-29 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-29 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-29 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-29 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-29 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-29 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-29 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-29 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-29 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-29 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-29 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-29 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-29 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-28 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-28 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-28 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-28 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-28 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-28 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-28 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-28 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-28 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-28 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-28 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-28 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-28 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-28 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-28 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-28 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-28 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-28 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-28 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-28 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-28 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-27 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-27 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-27 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-27 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-27 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-27 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-27 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-27 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-27 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-26 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-26 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-26 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-26 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-26 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-26 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-26 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-26 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-25 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-25 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-25 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-25 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-25 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-25 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-25 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-25 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-25 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-24 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-24 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-24 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-24 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-24 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-24 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-24 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-24 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-24 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-24 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-23 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-23 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-23 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-23 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-23 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-23 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-23 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-23 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-23 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-23 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-23 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-23 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-23 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-23 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-23 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-23 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-23 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-23 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-23 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-23 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-23 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-23 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-23 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-23 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-22 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-22 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-22 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-22 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-21 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-21 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-21 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-21 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-21 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-21 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-21 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-21 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-21 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-21 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-21 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-21 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-21 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-21 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-21 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-21 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-21 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-21 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-21 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-21 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-21 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-21 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-21 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-21 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-21 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-21 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-21 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-21 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-21 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-20 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-20 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-20 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-20 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-20 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-20 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-20 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-20 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-20 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-20 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 9e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-19 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-19 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-19 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-19 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-19 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-19 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-19 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-19 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-19 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-19 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-19 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-19 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-19 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-19 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-19 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-19 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-19 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-19 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-19 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-19 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-19 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-19 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-19 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-19 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-19 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-19 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-19 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-19 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-19 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-19 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-19 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-19 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-18 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-18 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-18 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-18 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-18 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-18 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-18 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-18 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-18 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-18 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-18 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-17 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-17 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-17 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-17 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-17 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-17 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-17 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-17 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-17 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-16 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-16 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-16 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-16 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-16 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-16 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-16 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-16 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-16 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-16 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-16 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-15 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-15 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-15 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-15 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-15 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-15 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-14 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-13 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-12 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-12 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-11 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-11 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-08 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-07 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-07 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-07 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-07 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-07 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-07 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-07 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 2e-07 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 3e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-07 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-06 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-06 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-06 |
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 447 bits (1153), Expect = e-160
Identities = 203/246 (82%), Positives = 231/246 (93%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
+RY+ VK++GSGNFGVARL+RDK TKELVAVKYIERG IDENVQREIINHRSLRHPNI+
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
RFKEV+LTPTHLAI+MEYA+GGEL+ RIC+AGRFSEDEARFFFQQL+SGVSYCHSM+ICH
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL R+EYDGKI+
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIA 199
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
DVWSCGVTLYVMLVGAYPFEDPE+PR++RKTI RI +V+Y +PD +R+S +C HL+S+IF
Sbjct: 200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF 259
Query: 243 VADPSK 248
VADP+
Sbjct: 260 VADPAT 265
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 372 bits (957), Expect = e-131
Identities = 86/252 (34%), Positives = 140/252 (55%), Gaps = 12/252 (4%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
E ++ V+ LG G +G +L ++ T+E VAVK ++ + +D EN+++EI ++ L H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+++F + +EY +GGELF RI E +A+ FF QL++GV Y H + I
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYIAPEVLARKEY 177
HRD+K EN LLD + LKI DFG + +++ GT Y+APE+L R+E+
Sbjct: 127 THRDIKPENLLLDE--RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
+ DVWSCG+ L ML G P++ P D + + ++ + +L + ++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKKIDSAPLA 240
Query: 237 LLSQIFVADPSK 248
LL +I V +PS
Sbjct: 241 LLHKILVENPSA 252
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 368 bits (948), Expect = e-130
Identities = 86/252 (34%), Positives = 140/252 (55%), Gaps = 12/252 (4%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
E ++ V+ LG G +G +L ++ T+E VAVK ++ + +D EN+++EI ++ L H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+++F + +EY +GGELF RI E +A+ FF QL++GV Y H + I
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYIAPEVLARKEY 177
HRD+K EN LLD + LKI DFG + +++ GT Y+APE+L R+E+
Sbjct: 127 THRDIKPENLLLDE--RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
+ DVWSCG+ L ML G P++ P D + + ++ + +L + ++ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKKIDSAPLA 240
Query: 237 LLSQIFVADPSK 248
LL +I V +PS
Sbjct: 241 LLHKILVENPSA 252
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = e-101
Identities = 102/253 (40%), Positives = 136/253 (53%), Gaps = 20/253 (7%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHP 59
Y LG G FG ++ + T VAVK + R K + ++REI N + RHP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+II+ +V+ TPT +VMEY +GGELF IC GR E EAR FQQ++S V YCH
Sbjct: 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYS----KSGLLHSQPKSTVGTPAYIAPEVLARK 175
+ HRDLK EN LLD KI DFG S L ++ G+P Y APEV++ +
Sbjct: 132 VVHRDLKPENVLLDA--HMNAKIADFGLSNMMSDGEFLR----TSCGSPNYAAPEVISGR 185
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
Y G D+WSCGV LY +L G PF+D P F+K IR +++P+Y ++
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPEY--LNRSVA 239
Query: 236 HLLSQIFVADPSK 248
LL + DP K
Sbjct: 240 TLLMHMLQVDPLK 252
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = e-100
Identities = 94/248 (37%), Positives = 136/248 (54%), Gaps = 11/248 (4%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---VQREIINHRSLRHPN 60
Y +K +G GNF +L R T VA+K I++ + + + RE+ + L HPN
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
I++ EV+ T L ++MEYA+GGE+F + + GR E EAR F+Q++S V YCH I
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRI 135
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
HRDLK EN LLD +KI DFG+S + + + G P Y APE+ K+YDG
Sbjct: 136 VHRDLKAENLLLDA--DMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGP 193
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
DVWS GV LY ++ G+ PF+ + + +Y +P Y +S DC +LL +
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VLRGKYRIPFY--MSTDCENLLKR 247
Query: 241 IFVADPSK 248
V +P K
Sbjct: 248 FLVLNPIK 255
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 8e-99
Identities = 77/251 (30%), Positives = 119/251 (47%), Gaps = 14/251 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
RY + LG G F + D TKE+ A K + + E + EI HRSL H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
+++ F + +V+E L +E EAR++ +Q++ G Y H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEY 177
+ HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL++K +
Sbjct: 135 RVIHRDLKLGNLFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
+ DVWS G +Y +LVG PFE ++T RI+ +Y +P + ++ L
Sbjct: 193 SFE-VDVWSIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPKH--INPVAASL 245
Query: 238 LSQIFVADPSK 248
+ ++ DP+
Sbjct: 246 IQKMLQTDPTA 256
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = 1e-98
Identities = 99/253 (39%), Positives = 136/253 (53%), Gaps = 20/253 (7%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHP 59
Y LG G FG ++ + + T VAVK + R K + ++REI N + RHP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+II+ +V+ TP+ + +VMEY +GGELF IC GR E E+R FQQ++SGV YCH
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYS----KSGLLHSQPKSTVGTPAYIAPEVLARK 175
+ HRDLK EN LLD KI DFG S L ++ G+P Y APEV++ +
Sbjct: 137 VVHRDLKPENVLLDA--HMNAKIADFGLSNMMSDGEFLR----TSCGSPNYAAPEVISGR 190
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
Y G D+WS GV LY +L G PF+D P F+K I + ++ P Y ++
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICDGIFYTPQY--LNPSVI 244
Query: 236 HLLSQIFVADPSK 248
LL + DP K
Sbjct: 245 SLLKHMLQVDPMK 257
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 1e-98
Identities = 106/253 (41%), Positives = 147/253 (58%), Gaps = 21/253 (8%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHP 59
Y + LG G+FG +L +T++ VA+K+I R + V+REI + LRHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+II+ +V+ TPT + +V+EYA GGELF I R +EDE R FFQQ+I + YCH +
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYS----KSGLLHSQPKSTVGTPAYIAPEVLARK 175
I HRDLK EN LLD + +KI DFG S L ++ G+P Y APEV+ K
Sbjct: 129 IVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFLK----TSCGSPNYAAPEVINGK 182
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
Y G DVWSCG+ LYVMLVG PF+D P F+K + + Y +PD+ +S +
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPDF--LSPGAQ 236
Query: 236 HLLSQIFVADPSK 248
L+ ++ VADP +
Sbjct: 237 SLIRRMIVADPMQ 249
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 3e-97
Identities = 77/251 (30%), Positives = 119/251 (47%), Gaps = 14/251 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
RY + LG G F + D TKE+ A K + + E + EI HRSL H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
+++ F + +V+E L +E EAR++ +Q++ G Y H
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEY 177
+ HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL++K +
Sbjct: 161 RVIHRDLKLGNLFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
+ DVWS G +Y +LVG PFE ++T RI+ +Y +P + ++ L
Sbjct: 219 SFE-VDVWSIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPKH--INPVAASL 271
Query: 238 LSQIFVADPSK 248
+ ++ DP+
Sbjct: 272 IQKMLQTDPTA 282
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 7e-97
Identities = 80/262 (30%), Positives = 116/262 (44%), Gaps = 30/262 (11%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-----KIDENVQREIINHRSLRH 58
+Y LG G++G + V D T AVK +++ K + NV++EI R LRH
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 59 PNIIRFKEVLL--TPTHLAIVMEYAAGG--ELFARICSAGRFSEDEARFFFQQLISGVSY 114
N+I+ +VL + +VMEY G E+ + RF +A +F QLI G+ Y
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEY 124
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS-------KSGLLHSQPKSTVGTPAYI 167
HS I H+D+K N LL LKI G + ++ G+PA+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTT--GGTLKISALGVAEALHPFAADDTCR----TSQGSPAFQ 178
Query: 168 APEVLA-RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
PE+ + G D+WS GVTLY + G YPFE N K + I Y +P
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYKLFENIGKGSYAIPG 234
Query: 227 YVRVSADCRHLLSQIFVADPSK 248
LL + +P+K
Sbjct: 235 D--CGPPLSDLLKGMLEYEPAK 254
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 2e-96
Identities = 88/281 (31%), Positives = 132/281 (46%), Gaps = 47/281 (16%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------------------- 43
+Y E+G G++GV +L ++ A+K + + K I
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 44 -------ENVQREIINHRSLRHPNIIRFKEVLLTPT--HLAIVMEYAAGGELFARICSAG 94
E V +EI + L HPN+++ EVL P HL +V E G + + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132
Query: 95 RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS-----K 149
SED+ARF+FQ LI G+ Y H +I HRD+K N L+ +KI DFG S
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE--DGHIKIADFGVSNEFKGS 190
Query: 150 SGLLHSQPKSTVGTPAYIAPEVLA--RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP 207
LL +TVGTPA++APE L+ RK + GK DVW+ GVTLY + G PF D
Sbjct: 191 DALLS----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE--- 243
Query: 208 RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK 248
+I++ PD ++ D + L++++ +P
Sbjct: 244 -RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPES 283
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 1e-95
Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 15/252 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
E ++ LG G+F T VA+K I++ + + VQ E+ H L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHS 117
P+I+ ++ +V+E GE+ + + FSE+EAR F Q+I+G+ Y HS
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKE 176
I HRDL L N LL + +KI DFG + + + T+ GTP YI+PE+ R
Sbjct: 131 HGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
+ + SDVWS G Y +L+G PF+ + T++++ Y +P + +S + +
Sbjct: 189 HGLE-SDVWSLGCMFYTLLIGRPPFDTD----TVKNTLNKVVLADYEMPSF--LSIEAKD 241
Query: 237 LLSQIFVADPSK 248
L+ Q+ +P+
Sbjct: 242 LIHQLLRRNPAD 253
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 4e-95
Identities = 82/251 (32%), Positives = 136/251 (54%), Gaps = 16/251 (6%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
E +E + LG G FG L R+K++K ++A+K + + + ++ ++RE+ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
PNI+R T + +++EYA G ++ + +F E + +L + +SYCHS
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEY 177
+ HRD+K EN LL LKI DFG+S S ++ + GT Y+ PE++ + +
Sbjct: 129 RVIHRDIKPENLLLGS--AGELKIADFGWSV--HAPSSRRTDLCGTLDYLPPEMIEGRMH 184
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
D K+ D+WS GV Y LVG PFE +++T RI V++ PD+ V+ R L
Sbjct: 185 DEKV-DLWSLGVLCYEFLVGKPPFEAN----TYQETYKRISRVEFTFPDF--VTEGARDL 237
Query: 238 LSQIFVADPSK 248
+S++ +PS+
Sbjct: 238 ISRLLKHNPSQ 248
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 7e-95
Identities = 80/251 (31%), Positives = 132/251 (52%), Gaps = 16/251 (6%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
+ ++ + LG G FG L R+K+ K ++A+K + + + ++ ++REI LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
PNI+R + +++E+A GEL+ + GRF E + F ++L + YCH
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEY 177
++ HRD+K EN L+ + LKI DFG+S S + T+ GT Y+ PE++ K +
Sbjct: 134 KVIHRDIKPENLLMGY--KGELKIADFGWSV--HAPSLRRRTMCGTLDYLPPEMIEGKTH 189
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
D K+ D+W GV Y LVG PF+ P + +T RI NV P + +S + L
Sbjct: 190 DEKV-DLWCAGVLCYEFLVGMPPFDSP----SHTETHRRIVNVDLKFPPF--LSDGSKDL 242
Query: 238 LSQIFVADPSK 248
+S++ P +
Sbjct: 243 ISKLLRYHPPQ 253
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 6e-93
Identities = 73/258 (28%), Positives = 111/258 (43%), Gaps = 30/258 (11%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINHRSL 56
+Y+ LGSG FG VA+K++E+ + D V E++ + +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 57 RH--PNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLISGVS 113
+IR + P +++E +LF I G E+ AR FF Q++ V
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTVGTPAYIAPE 170
+CH+ + HRD+K EN L+D + LK+ DFG K + GT Y PE
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSPPE 218
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
+ Y G+ + VWS G+ LY M+ G PFE + I Q F V
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----------EEIIRGQVFFRQR--V 266
Query: 231 SADCRHLLSQIFVADPSK 248
S++C+HL+ PS
Sbjct: 267 SSECQHLIRWCLALRPSD 284
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 2e-92
Identities = 75/259 (28%), Positives = 111/259 (42%), Gaps = 32/259 (12%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---------KIDENVQREIINHR 54
+Y + LGSG FG DK + V VK+I++ K V EI
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 55 SLRHPNIIRFKEVLLTPTHLAIVMEYAA-GGELFARICSAGRFSEDEARFFFQQLISGVS 113
+ H NII+ ++ +VME G +LFA I R E A + F+QL+S V
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS----KSGLLHSQPKSTVGTPAYIAP 169
Y +I HRD+K EN ++ +K+ DFG + + L + + GT Y AP
Sbjct: 145 YLRLKDIIHRDIKDENIVIAE--DFTIKLIDFGSAAYLERGKLFY----TFCGTIEYCAP 198
Query: 170 EVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
EVL Y G ++WS GVTLY ++ PF + ++ P
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE----------LEETVEAAIHPPYL-- 246
Query: 230 VSADCRHLLSQIFVADPSK 248
VS + L+S + P +
Sbjct: 247 VSKELMSLVSGLLQPVPER 265
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 273 bits (701), Expect = 4e-92
Identities = 70/260 (26%), Positives = 101/260 (38%), Gaps = 32/260 (12%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINHRSL 56
Y LG G FG + VA+K I R + + E+ +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 57 R----HPNIIRFKEVLLTPTHLAIVMEYAA-GGELFARICSAGRFSEDEARFFFQQLISG 111
HP +IR + T +V+E +LF I G E +R FF Q+++
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTVGTPAYIA 168
+ +CHS + HRD+K EN L+D K+ DFG GT Y
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVYSP 206
Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228
PE ++R +Y + VWS G+ LY M+ G PFE I + P +
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFER----------DQEILEAELHFPAH- 255
Query: 229 RVSADCRHLLSQIFVADPSK 248
VS DC L+ + PS
Sbjct: 256 -VSPDCCALIRRCLAPKPSS 274
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 8e-85
Identities = 84/251 (33%), Positives = 122/251 (48%), Gaps = 10/251 (3%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
+ Y +G G++G ++ K T+ A K I + D + ++EI +SL HPN
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
IIR E T + +VME GGELF R+ F E +A + ++S V+YCH + +
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 121 CHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
HRDLK EN L SP LK+ DFG + ++ VGTP Y++P+VL Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLYGP 186
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRHL 237
+ D WS GV +YV+L G PF P D K IR + F + VS L
Sbjct: 187 EC-DEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAESL 241
Query: 238 LSQIFVADPSK 248
+ ++ P +
Sbjct: 242 IRRLLTKSPKQ 252
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 8e-85
Identities = 83/252 (32%), Positives = 133/252 (52%), Gaps = 12/252 (4%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE-NVQREIINHRSLRHPN 60
+ + ++ LGSG F LV+ + T +L A+K I++ + +++ EI + ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
I+ +++ + TH +VM+ +GGELF RI G ++E +A QQ++S V Y H I
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 121 CHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLARKEYD 178
HRDLK EN L ++ I DFG SK + + + GTP Y+APEVLA+K Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY- 184
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRH 236
K D WS GV Y++L G PF + + + F K I+ Y F + +S +
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKD 240
Query: 237 LLSQIFVADPSK 248
+ + DP++
Sbjct: 241 FICHLLEKDPNE 252
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 1e-84
Identities = 64/287 (22%), Positives = 108/287 (37%), Gaps = 41/287 (14%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHP 59
+ LG G R K+T +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 60 NIIRFKEVL--LTPTHLAIVMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSY 114
NI++ + T H ++ME+ G L+ + E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 115 CHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
I HR++K N + Q K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 173 AR--------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF- 223
R K+Y + D+WS GVT Y G+ PF E PR ++ + +I +
Sbjct: 188 ERAVLRKDHQKKYGATV-DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 224 ------------------LPDYVRVSADCR----HLLSQIFVADPSK 248
+P +S + +L+ I AD K
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 1e-84
Identities = 82/253 (32%), Positives = 126/253 (49%), Gaps = 11/253 (4%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRH 58
+ Y+ +ELG G F V R K T A K I K + + ++RE R L+H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
PNI+R + + + +V + GGELF I + +SE +A QQ++ ++YCHS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 119 EICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
I HR+LK EN LL + +K+ DFG + GTP Y++PEVL + Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 235
K D+W+CGV LY++LVG PF D + R + + I+ Y + V+ + +
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAK 239
Query: 236 HLLSQIFVADPSK 248
L+ + +P K
Sbjct: 240 SLIDSMLTVNPKK 252
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 2e-84
Identities = 52/294 (17%), Positives = 99/294 (33%), Gaps = 59/294 (20%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK------------------KIDE 44
Y ++ L G F L + A+K E+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 45 NVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG--------RF 96
+ + E+ +++ + + ++ + I+ EY +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 97 SEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGL 152
+ + +++ SY H+ ICHRD+K N L+D R+K+ DFG S+
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK--NGRVKLSDFGESEYMVDKK 206
Query: 153 LHSQPKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFR 211
+ + GT ++ PE + + Y+G D+WS G+ LYVM PF +
Sbjct: 207 IK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF---SLKISLV 259
Query: 212 KTIDRIRNVQYFLPDYVR-----------------VSADCRHLLSQIFVADPSK 248
+ + IR P +S + L +P++
Sbjct: 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 3e-84
Identities = 87/261 (33%), Positives = 124/261 (47%), Gaps = 18/261 (6%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---------KIDENVQREIIN 52
+ Y K LGSG G +L +++T + VA+K I + K NV+ EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 53 HRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
+ L HP II+ K + IV+E GGELF ++ R E + +F Q++ V
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 113 SYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
Y H I HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 172 LARKEYD--GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY- 227
L + D WS GV L++ L G PF + + D+I + +Y F+P+
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQITSGKYNFIPEVW 244
Query: 228 VRVSADCRHLLSQIFVADPSK 248
VS L+ ++ V DP
Sbjct: 245 AEVSEKALDLVKKLLVVDPKA 265
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 1e-83
Identities = 77/255 (30%), Positives = 123/255 (48%), Gaps = 14/255 (5%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KID-ENVQREIINHRSLRHP 59
++ + ++LGSG FG LV ++ + +K I + + ++ E ++ EI +SL HP
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYC 115
NII+ EV ++ IVME GGEL RI S SE +Q+++ ++Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 116 HSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
HS + H+DLK EN L SP +KI DFG ++ + GT Y+APEV +
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-K 199
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSAD 233
++ K D+WS GV +Y +L G PF +K + + + ++
Sbjct: 200 RDVTFKC-DIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQ 254
Query: 234 CRHLLSQIFVADPSK 248
LL Q+ DP +
Sbjct: 255 AVDLLKQMLTKDPER 269
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 2e-83
Identities = 63/287 (21%), Positives = 108/287 (37%), Gaps = 41/287 (14%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHP 59
+ LG G R K+T +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 60 NIIRFKEVL--LTPTHLAIVMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSY 114
NI++ + T H ++ME+ G L+ + E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 115 CHSMEICHRDLKLENTLLDGSPQPR--LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
I HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 173 AR--------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF- 223
R K+Y + D+WS GVT Y G+ PF E PR ++ + +I +
Sbjct: 188 ERAVLRKDHQKKYGATV-DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 224 ------------------LPDYVRVSADCR----HLLSQIFVADPSK 248
+P +S + +L+ I AD K
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 2e-83
Identities = 87/262 (33%), Positives = 127/262 (48%), Gaps = 20/262 (7%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---------KIDENVQREIIN 52
+ Y K LGSG G +L +++T + VA++ I + K NV+ EI
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 53 HRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
+ L HP II+ K + IV+E GGELF ++ R E + +F Q++ V
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 113 SYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
Y H I HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312
Query: 172 LA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY 227
L Y+ + D WS GV L++ L G PF + + + D+I + +Y F+P+
Sbjct: 313 LVSVGTAGYNRAV-DCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEV 368
Query: 228 -VRVSADCRHLLSQIFVADPSK 248
VS L+ ++ V DP
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKA 390
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 2e-82
Identities = 88/258 (34%), Positives = 137/258 (53%), Gaps = 16/258 (6%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINHR 54
E+ YE +ELGSG F + R R K T + A K+I++ + E ++RE+ R
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 55 SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
+RHPNII ++ T + +++E +GGELF + +EDEA F +Q++ GV Y
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 115 CHSMEICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
HS I H DLK EN +L P PR+K+ DFG + ++ K+ GTP ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRV 230
+ G +D+WS GV Y++L GA PF ++T+ I V Y F +Y
Sbjct: 184 NYEPL-GLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNYDFDEEYFSNT 238
Query: 231 SADCRHLLSQIFVADPSK 248
S + + ++ V DP +
Sbjct: 239 SELAKDFIRRLLVKDPKR 256
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 6e-82
Identities = 93/253 (36%), Positives = 129/253 (50%), Gaps = 12/253 (4%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRH 58
ERY V LG G+FG +D+ T++ AVK I + K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
PNI++ E+L + IV E GGELF I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 119 EICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
I HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEVL R Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 235
D K DVWS GV LY++L G PF + ++ + +Y F +S D +
Sbjct: 200 DEKC-DVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAK 254
Query: 236 HLLSQIFVADPSK 248
L+ ++ PS
Sbjct: 255 DLIRKMLTFHPSL 267
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 1e-81
Identities = 83/253 (32%), Positives = 126/253 (49%), Gaps = 11/253 (4%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KID-ENVQREIINHRSLRH 58
+ Y+ +ELG G F V R K T A K I K D + ++RE R L+H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
PNI+R + + + +V + GGELF I + +SE +A QQ++ ++YCHS
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 119 EICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
I HR+LK EN LL + +K+ DFG + GTP Y++PEVL + Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 235
K D+W+CGV LY++LVG PF D + R + + I+ Y + V+ + +
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAK 262
Query: 236 HLLSQIFVADPSK 248
L+ + +P K
Sbjct: 263 SLIDSMLTVNPKK 275
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 1e-81
Identities = 85/254 (33%), Positives = 126/254 (49%), Gaps = 13/254 (5%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHPN 60
+ YE +++G G++ V + K T AVK I++ K + EI I R +HPN
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---RDPTEEIEILLRYGQHPN 77
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
II K+V ++ +V E GGEL +I FSE EA + V Y H+ +
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 121 CHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKE 176
HRDLK N L G+P+ ++ICDFG++K + T T ++APEVL R+
Sbjct: 138 VHRDLKPSNILYVDESGNPES-IRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG 196
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADC 234
YD D+WS GV LY ML G PF + D + + RI + ++ Y VS
Sbjct: 197 YDAAC-DIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTA 254
Query: 235 RHLLSQIFVADPSK 248
+ L+S++ DP +
Sbjct: 255 KDLVSKMLHVDPHQ 268
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 2e-81
Identities = 92/250 (36%), Positives = 132/250 (52%), Gaps = 8/250 (3%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
+ +E ELG G + + K T++ A+K +++ + V+ EI L HPNI
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-TVDKKIVRTEIGVLLRLSHPNI 110
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
I+ KE+ TPT +++V+E GGELF RI G +SE +A +Q++ V+Y H I
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 122 HRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
HRDLK EN L +P LKI DFG SK K+ GTP Y APE+L Y G
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GP 229
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRHLL 238
D+WS G+ Y++L G PF D R + RI N +Y F+ + VS + + L+
Sbjct: 230 EVDMWSVGIITYILLCGFEPF---YDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV 286
Query: 239 SQIFVADPSK 248
++ V DP K
Sbjct: 287 RKLIVLDPKK 296
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 3e-81
Identities = 83/265 (31%), Positives = 118/265 (44%), Gaps = 24/265 (9%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----------KIDENVQREI- 50
E YEP + LG G V R K T + AVK I+ ++ E +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 51 INHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLIS 110
I + HPNII+ K+ T T +V + GELF + SE E R + L+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
+ H + I HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 171 VLARKEYD-----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FL 224
++ D GK D+WS GV +Y +L G+ PF + R I + Y F
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQFG 249
Query: 225 PDY-VRVSADCRHLLSQIFVADPSK 248
S + L+S+ V P K
Sbjct: 250 SPEWDDYSDTVKDLVSRFLVVQPQK 274
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 3e-81
Identities = 61/264 (23%), Positives = 104/264 (39%), Gaps = 26/264 (9%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHP 59
Y +K++GSG V ++ K++ A+KY+ + + ++ + EI L+
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 60 N--IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
+ IIR + +T ++ +VME +L + + E + +++ ++ V H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLAR 174
I H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 146 HGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 175 KEYD----------GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 224
SDVWS G LY M G PF+ N + I + + +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---NQISKLHAIIDPNHEI 259
Query: 225 PDYVRVSADCRHLLSQIFVADPSK 248
D + +L DP +
Sbjct: 260 EFPDIPEKDLQDVLKCCLKRDPKQ 283
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 4e-81
Identities = 68/277 (24%), Positives = 109/277 (39%), Gaps = 39/277 (14%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
+E + LG G FG R+ A+K I ++ + E++ SL H ++
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 63 RFKEV-------------LLTPTHLAIVMEYAAGGELFARICSAGRF-SEDEARFFFQQL 108
R+ + + L I MEY G L+ I S DE F+Q+
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----------- 157
+ +SY HS I HRDLK N +D S +KI DFG +K+
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 158 ----KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT 213
S +GT Y+A EVL + + D++S G+ + M+ YPF
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGM---ERVNI 237
Query: 214 IDRIRNVQYFLPDYV--RVSADCRHLLSQIFVADPSK 248
+ ++R+V P + ++ + DP+K
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNK 274
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 7e-81
Identities = 87/258 (33%), Positives = 143/258 (55%), Gaps = 16/258 (6%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINHR 54
++ Y+ +ELGSG F V + R+K T A K+I++ + E+++RE+ +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 55 SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
++HPN+I EV T + +++E AGGELF + +E+EA F +Q+++GV Y
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 115 CHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
HS++I H DLK EN +L P+PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRV 230
+ G +D+WS GV Y++L GA PF ++T+ + V Y F +Y
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNT 244
Query: 231 SADCRHLLSQIFVADPSK 248
SA + + ++ V DP K
Sbjct: 245 SALAKDFIRRLLVKDPKK 262
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 2e-80
Identities = 82/258 (31%), Positives = 136/258 (52%), Gaps = 16/258 (6%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINHR 54
E+ Y+ +ELGSG F + + R+K T A K+I++ + E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 55 SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
+ HPNII +V T + +++E +GGELF + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 115 CHSMEICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
H+ +I H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRV 230
+ G +D+WS GV Y++L GA PF ++T+ I V Y F ++ +
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTK----QETLANITAVSYDFDEEFFSQT 245
Query: 231 SADCRHLLSQIFVADPSK 248
S + + ++ V + K
Sbjct: 246 SELAKDFIRKLLVKETRK 263
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 2e-80
Identities = 80/258 (31%), Positives = 135/258 (52%), Gaps = 16/258 (6%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINHR 54
E+ Y+ +ELGSG F + + R+K T A K+I++ + E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 55 SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
+ H N+I +V T + +++E +GGELF + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 115 CHSMEICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
H+ +I H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRV 230
+ G +D+WS GV Y++L GA PF ++T+ I +V Y F ++
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTK----QETLANITSVSYDFDEEFFSHT 245
Query: 231 SADCRHLLSQIFVADPSK 248
S + + ++ V + K
Sbjct: 246 SELAKDFIRKLLVKETRK 263
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 2e-80
Identities = 94/253 (37%), Positives = 130/253 (51%), Gaps = 12/253 (4%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRH 58
ERY V LG G+FG +D+ T++ AVK I + + + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
PNI++ E+L + IV E GGELF I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 119 EICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
I HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEVL R Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 235
D K DVWS GV LY++L G PF +N + R+ +Y F +S D +
Sbjct: 200 DEKC-DVWSAGVILYILLSGTPPFYG----KNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 236 HLLSQIFVADPSK 248
L+ ++ PS
Sbjct: 255 DLIRKMLTFHPSL 267
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 4e-80
Identities = 61/264 (23%), Positives = 104/264 (39%), Gaps = 26/264 (9%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHP 59
Y +K++GSG V ++ K++ A+KY+ + + ++ + EI L+
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 60 N--IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
+ IIR + +T ++ +VME +L + + E + +++ ++ V H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLAR 174
I H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 127 HGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 175 KEYD----------GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 224
SDVWS G LY M G PF+ N + I + + +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---NQISKLHAIIDPNHEI 240
Query: 225 PDYVRVSADCRHLLSQIFVADPSK 248
D + +L DP +
Sbjct: 241 EFPDIPEKDLQDVLKCCLKRDPKQ 264
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 6e-80
Identities = 89/258 (34%), Positives = 132/258 (51%), Gaps = 14/258 (5%)
Query: 2 EERYE---PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLR 57
+ Y+ K LG G+F + R K++ + AVK I K+++ N Q+EI
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--KRMEANTQKEITALKLCEG 64
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
HPNI++ EV H +VME GGELF RI FSE EA + ++L+S VS+ H
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 118 MEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLARK 175
+ + HRDLK EN L D + +KI DFG+++ +QP K+ T Y APE+L +
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI---DRIRNVQY-FLPDY-VRV 230
YD D+WS GV LY ML G PF+ + + +I+ + F + V
Sbjct: 185 GYDESC-DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243
Query: 231 SADCRHLLSQIFVADPSK 248
S + + L+ + DP+K
Sbjct: 244 SQEAKDLIQGLLTVDPNK 261
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 6e-80
Identities = 92/254 (36%), Positives = 131/254 (51%), Gaps = 13/254 (5%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLR 57
+RY+ + LG G+FG L +DK T + AVK I + + E++ RE+ + L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
HPNI++ E + +V E GGELF I S RFSE +A +Q++SG++Y H
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 118 MEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
+I HRDLK EN LL+ S ++I DFG S + K +GT YIAPEVL
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGT 203
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADC 234
YD K DVWS GV LY++L G PF N + ++ +Y F +VS
Sbjct: 204 YDEKC-DVWSTGVILYILLSGCPPFNG----ANEYDILKKVEKGKYTFELPQWKKVSESA 258
Query: 235 RHLLSQIFVADPSK 248
+ L+ ++ PS
Sbjct: 259 KDLIRKMLTYVPSM 272
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 7e-80
Identities = 78/264 (29%), Positives = 120/264 (45%), Gaps = 23/264 (8%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---------KIDENVQREI-I 51
++Y+P +G G V R + T AVK +E ++ E +RE I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 52 NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
+ HP+II + + + + +V + GELF + SE E R + L+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
VS+ H+ I HRDLK EN LLD + Q +++ DFG+S + + GTP Y+APE+
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 172 LARKEYD-----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLP 225
L + GK D+W+CGV L+ +L G+ PF R I QY F
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSS 326
Query: 226 DY-VRVSADCRHLLSQIFVADPSK 248
S+ + L+S++ DP
Sbjct: 327 PEWDDRSSTVKDLISRLLQVDPEA 350
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 7e-80
Identities = 90/253 (35%), Positives = 129/253 (50%), Gaps = 12/253 (4%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRH 58
E Y+ VK+LGSG +G L RDK T A+K I + + + E+ + L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
PNI++ + + +VME GGELF I +F+E +A +Q++SGV+Y H
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 119 EICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
I HRDLK EN LL +KI DFG S + K +GT YIAPEVL RK+Y
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKY 214
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 235
D K DVWS GV L+++L G PF + ++ + ++ +Y F VS +
Sbjct: 215 DEKC-DVWSIGVILFILLAGYPPFGG----QTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269
Query: 236 HLLSQIFVADPSK 248
L+ Q+ D +
Sbjct: 270 DLIKQMLQFDSQR 282
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 253 bits (646), Expect = 7e-80
Identities = 74/276 (26%), Positives = 103/276 (37%), Gaps = 27/276 (9%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNI 61
+E + LG+G FG + T E VA+K + K E EI + L HPN+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 62 IRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGV 112
+ +EV LA + MEY GG+L + E R + S +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 113 SYCHSMEICHRDLKLENTLLD-GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
Y H I HRDLK EN +L G + KI D GY+K VGT Y+APE+
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-------- 223
L +K+Y + D WS G + + G PF P + + N
Sbjct: 195 LEQKKYTVTV-DYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253
Query: 224 ------LPDYVRVSADCRHLLSQIFVADPSKDPHSR 253
LP +S L + R
Sbjct: 254 VKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR 289
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 3e-79
Identities = 83/254 (32%), Positives = 127/254 (50%), Gaps = 12/254 (4%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRH 58
E Y+ +ELG G F V R + A I K + ++RE R L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
PNI+R + + H ++ + GGELF I + +SE +A QQ++ V +CH M
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 119 EICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLARKE 176
+ HR+LK EN LL +K+ DFG + Q GTP Y++PEVL +
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADC 234
Y GK D+W+CGV LY++LVG PF D + R +++ I+ Y F V+ +
Sbjct: 190 Y-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVTPEA 244
Query: 235 RHLLSQIFVADPSK 248
+ L++++ +PSK
Sbjct: 245 KDLINKMLTINPSK 258
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 240 bits (616), Expect = 3e-79
Identities = 60/250 (24%), Positives = 111/250 (44%), Gaps = 8/250 (3%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
E+Y ++LG G FG+ + +K+ K+++ V++EI RH NI
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEI 120
+ E + L ++ E+ +G ++F RI ++ +E E + Q+ + + HS I
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
H D++ EN + +KI +FG ++ + P Y APEV
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-ST 182
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRHLL 238
+D+WS G +YV+L G PF + ++ I+ I N +Y F + +S + +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDFV 238
Query: 239 SQIFVADPSK 248
++ V +
Sbjct: 239 DRLLVKERKS 248
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 242 bits (618), Expect = 4e-79
Identities = 76/302 (25%), Positives = 124/302 (41%), Gaps = 60/302 (19%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID------ENVQREIINHRS 55
+++Y +G G++GV R+ + +T+ + A+K + + K E ++ E+ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-------------------- 95
L HPNI R EV ++ +VME GG L ++
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 96 --------------------FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS 135
E +Q+ S + Y H+ ICHRD+K EN L +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 136 PQPRLKICDFGYSKSGLLHSQP-----KSTVGTPAYIAPEVL--ARKEYDGKISDVWSCG 188
+K+ DFG SK + + GTP ++APEVL + Y K D WS G
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC-DAWSAG 263
Query: 189 VTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLLSQIFVADP 246
V L+++L+GA PF D + + N + P+Y +S R LLS + +
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQ----VLNKKLCFENPNYNVLSPLARDLLSNLLNRNV 319
Query: 247 SK 248
+
Sbjct: 320 DE 321
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 5e-79
Identities = 88/264 (33%), Positives = 137/264 (51%), Gaps = 23/264 (8%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--------------KIDENVQ 47
E Y V++LGSG +G L ++K A+K I++ + K E +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 48 REIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQ 107
EI +SL HPNII+ +V + +V E+ GGELF +I + +F E +A +Q
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 108 LISGVSYCHSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 166
++SG+ Y H I HRD+K EN LL + + +KI DFG S + + +GT Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLP 225
IAPEVL +K+Y+ K DVWSCGV +Y++L G PF +N + I ++ +Y F
Sbjct: 215 IAPEVL-KKKYNEK-CDVWSCGVIMYILLCGYPPFGG----QNDQDIIKKVEKGKYYFDF 268
Query: 226 DY-VRVSADCRHLLSQIFVADPSK 248
+ +S + + L+ + D +K
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNK 292
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 2e-78
Identities = 62/264 (23%), Positives = 104/264 (39%), Gaps = 26/264 (9%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHP 59
Y +K++GSG V ++ K++ A+KY+ + + ++ + EI L+
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 60 N--IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
+ IIR + +T ++ +VME +L + + E + +++ ++ V H
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLAR 174
I H DLK N L+ LK+ DFG + S VG Y+ PE +
Sbjct: 174 HGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 175 KEYD----------GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 224
SDVWS G LY M G PF+ + + I N +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-PNHEIEF 289
Query: 225 PDYVRVSADCRHLLSQIFVADPSK 248
PD D + +L DP +
Sbjct: 290 PDI--PEKDLQDVLKCCLKRDPKQ 311
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 5e-78
Identities = 72/251 (28%), Positives = 119/251 (47%), Gaps = 9/251 (3%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
+ Y+ ++ELGSG FGV +K T + K+I +D V+ EI L HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSME 119
+I + + +++E+ +GGELF RI + + SE E + +Q G+ + H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
I H D+K EN + + +KI DFG + K T T + APE++ R+ G
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-G 228
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRHL 237
+D+W+ GV YV+L G PF +D +T+ ++ + F D VS + +
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 238 LSQIFVADPSK 248
+ + +P K
Sbjct: 285 IKNLLQKEPRK 295
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-77
Identities = 74/257 (28%), Positives = 117/257 (45%), Gaps = 15/257 (5%)
Query: 2 EERYE-PVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREI-INHRSL 56
Y KELG G F V R K T + A K+++ RG+ + EI + +
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS--AGRFSEDEARFFFQQLISGVSY 114
P +I EV + + +++EYAAGGE+F+ A SE++ +Q++ GV Y
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 115 CHSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
H I H DLK +N LL P +KI DFG S+ + + +GTP Y+APE+L
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVS 231
+D+W+ G+ Y++L PF ++ + I V + + VS
Sbjct: 207 YDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----ISQVNVDYSEETFSSVS 261
Query: 232 ADCRHLLSQIFVADPSK 248
+ + V +P K
Sbjct: 262 QLATDFIQSLLVKNPEK 278
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 4e-77
Identities = 74/261 (28%), Positives = 122/261 (46%), Gaps = 20/261 (7%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID------ENVQREIINHRS 55
E+ YE + +G G F V R ++ T + AVK ++ K E+++RE
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISG 111
L+HP+I+ E + L +V E+ G +L I +SE A + +Q++
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 112 VSYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAP 169
+ YCH I HRD+K LL +K+ FG + VGTP ++AP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 170 EVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY- 227
EV+ R+ Y GK DVW CGV L+++L G PF ++ + + I +Y P
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQW 256
Query: 228 VRVSADCRHLLSQIFVADPSK 248
+S + L+ ++ + DP++
Sbjct: 257 SHISESAKDLVRRMLMLDPAE 277
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 1e-76
Identities = 73/253 (28%), Positives = 117/253 (46%), Gaps = 11/253 (4%)
Query: 2 EERYE--PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRH 58
Y + LG G FG + T +A K I+ D E V+ EI L H
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHS 117
N+I+ + + + +VMEY GGELF RI +E + F +Q+ G+ + H
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
M I H DLK EN L ++KI DFG ++ + K GTP ++APEV+ +
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYD-F 264
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 235
+D+WS GV Y++L G PF D +T++ I ++ + +S + +
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDND----AETLNNILACRWDLEDEEFQDISEEAK 320
Query: 236 HLLSQIFVADPSK 248
+S++ + + S
Sbjct: 321 EFISKLLIKEKSW 333
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 240 bits (613), Expect = 8e-76
Identities = 74/251 (29%), Positives = 124/251 (49%), Gaps = 9/251 (3%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
+ Y+ +ELG+G FGV V ++ T A K++ + D E V++EI LRHP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSME 119
++ + + ++ E+ +GGELF ++ + SEDEA + +Q+ G+ + H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
H DLK EN + LK+ DFG + K T GT + APEV K G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHL 237
+D+WS GV Y++L G PF D +T+ +++ + + D + +S D +
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 238 LSQIFVADPSK 248
+ ++ +ADP+
Sbjct: 391 IRKLLLADPNT 401
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 1e-75
Identities = 79/259 (30%), Positives = 121/259 (46%), Gaps = 19/259 (7%)
Query: 2 EERYEPVKE-LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHP 59
+ Y+ K+ LG G G +RT + A+K + K ++E+ + ++ P
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGP 82
Query: 60 NIIRFKEVLLTPTHLA----IVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVS 113
+I+ +V H I+ME GGELF+RI G F+E EA + + + +
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 114 YCHSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEV 171
+ HS I HRD+K EN L LK+ DFG++K ++ TP Y+APEV
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEV 200
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VR 229
L ++YD D+WS GV +Y++L G PF RIR QY F
Sbjct: 201 LGPEKYDKSC-DMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259
Query: 230 VSADCRHLLSQIFVADPSK 248
VS D + L+ + DP++
Sbjct: 260 VSEDAKQLIRLLLKTDPTE 278
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-75
Identities = 76/265 (28%), Positives = 127/265 (47%), Gaps = 27/265 (10%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHP 59
E YE + +G+G++G + +R K +++ K ++ G + + + E+ R L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 60 NIIRFKE--VLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVS 113
NI+R+ + + T T L IVMEY GG+L + I + E+ QL +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 114 YCHSM-----EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAY 166
CH + HRDLK N LDG +K+ DFG ++ L H K+ VGTP Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARI-LNHDTSFAKTFVGTPYY 182
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLP 225
++PE + R Y+ K SD+WS G LY + PF + ++ +IR ++ +P
Sbjct: 183 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIP 237
Query: 226 DYVRVSADCRHLLSQIFVADPSKDP 250
R S + +++++ P
Sbjct: 238 Y--RYSDELNEIITRMLNLKDYHRP 260
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 5e-75
Identities = 84/257 (32%), Positives = 129/257 (50%), Gaps = 15/257 (5%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHPN 60
++ + LG G G + +KRT+E A+K ++ K +RE+ ++ R+ + P+
Sbjct: 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPH 116
Query: 61 IIRFKEV----LLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSY 114
I+R +V L IVME GGELF+RI G F+E EA + + + Y
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 115 CHSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
HS+ I HRD+K EN L P LK+ DFG++K H+ + TP Y+APEVL
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 236
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV--RVS 231
++YD D+WS GV +Y++L G PF RIR QY P+ VS
Sbjct: 237 PEKYDKSC-DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295
Query: 232 ADCRHLLSQIFVADPSK 248
+ + L+ + +P++
Sbjct: 296 EEVKMLIRNLLKTEPTQ 312
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 5e-75
Identities = 73/258 (28%), Positives = 129/258 (50%), Gaps = 20/258 (7%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHP 59
E+Y ++++G G+FG A LV+ +K I + E +RE+ +++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHS 117
NI++++E L IVM+Y GG+LF RI + F ED+ +F Q+ + + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKE 176
+I HRD+K +N L +++ DFG ++ ++ +GTP Y++PE+ K
Sbjct: 144 RKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSADCR 235
Y+ K SD+W+ G LY + + FE + + + +I + + + S D R
Sbjct: 202 YNNK-SDIWALGCVLYELCTLKHAFEA----GSMKNLVLKIISGSFPPVSL--HYSYDLR 254
Query: 236 HLLSQIFVADPSKDPHSR 253
L+SQ+F ++P R
Sbjct: 255 SLVSQLF----KRNPRDR 268
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 7e-74
Identities = 72/277 (25%), Positives = 114/277 (41%), Gaps = 31/277 (11%)
Query: 2 EERYEPVKE-LGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREI-INHRSLRH 58
E+ Y+ ++ LG G + + T + AVK IE+ V RE+ + ++ H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
N++ E +V E GG + + I F+E EA Q + S + + H+
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 119 EICHRDLKLENTLL-DGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAP 169
I HRDLK EN L + +KICDF S + + + G+ Y+AP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 170 EVL-----ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI---------- 214
EV+ YD K D+WS GV LY++L G PF
Sbjct: 191 EVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 215 -DRIRNVQY-FLPDY-VRVSADCRHLLSQIFVADPSK 248
+ I+ +Y F +S + L+S++ V D +
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQ 286
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 1e-73
Identities = 67/271 (24%), Positives = 105/271 (38%), Gaps = 26/271 (9%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
+ Y +++LG G F LV A+K I ++ D E QRE HR HPN
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPN 87
Query: 61 IIRFKEVLLTPT----HLAIVMEYAAGGELF----ARICSAGRFSEDEARFFFQQLISGV 112
I+R L +++ + G L+ +ED+ + + G+
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----------VG 162
H+ HRDLK N LL QP + D G +H +
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQP--VLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 163 TPAYIAPEVLARKEYD--GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 220
T +Y APE+ + + + + +DVWS G LY M+ G P++ +
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA---LAVQN 262
Query: 221 QYFLPDYVRVSADCRHLLSQIFVADPSKDPH 251
Q +P R S+ LL+ + DP + PH
Sbjct: 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPH 293
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-72
Identities = 58/266 (21%), Positives = 104/266 (39%), Gaps = 34/266 (12%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
++ ++ +GSG FG + + + +K ++ E +RE+ L H NI+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIV 67
Query: 63 RFKE----------------VLLTPTHLAIVMEYAAGGELFARI--CSAGRFSEDEARFF 104
+ L I ME+ G L I + + A
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 105 FQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP 164
F+Q+ GV Y HS ++ +RDLK N L + Q +KI DFG S + + GT
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 165 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 224
Y++PE ++ ++Y + D+++ G+ L +L + K +R+ +
Sbjct: 186 RYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFETS------KFFTDLRDGI--I 236
Query: 225 PDYVRVSADCRHLLSQIFVADPSKDP 250
D + LL ++ P P
Sbjct: 237 SD--IFDKKEKTLLQKLLSKKPEDRP 260
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 9e-70
Identities = 70/261 (26%), Positives = 108/261 (41%), Gaps = 20/261 (7%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRH 58
+ K++G G F VA+K ++ +D + +EI + L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVSY 114
PN+I++ + L IV+E A G+L I + E +F QL S + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLA 173
HS + HRD+K N + + +K+ D G + + S VGTP Y++PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSA 232
Y+ K SD+WS G LY M PF D N +I Y LP S
Sbjct: 210 ENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPS-DHYSE 265
Query: 233 DCRHLLSQIFVADPSKDPHSR 253
+ R L++ + DP R
Sbjct: 266 ELRQLVNMCI----NPDPEKR 282
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 2e-68
Identities = 77/257 (29%), Positives = 115/257 (44%), Gaps = 36/257 (14%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHPN 60
++ + LG G G + +KRT+E A+K ++ K +RE+ ++ R+ + P+
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPH 72
Query: 61 IIRFKEV----LLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSY 114
I+R +V L IVME GGELF+RI G F+E EA + + + Y
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 115 CHSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
HS+ I HRD+K EN L P LK+ DFG A E
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETTG 172
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV--RVS 231
K YD D+WS GV +Y++L G PF RIR QY P+ VS
Sbjct: 173 EK-YDKSC-DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 230
Query: 232 ADCRHLLSQIFVADPSK 248
+ + L+ + +P++
Sbjct: 231 EEVKMLIRNLLKTEPTQ 247
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-68
Identities = 66/278 (23%), Positives = 107/278 (38%), Gaps = 39/278 (14%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSLR-HP 59
E R + L G F +D + A+K + ++ + +E+ + L HP
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 60 NIIRF-------KEVLLTPTHLAIVMEYAAGGELFA---RICSAGRFSEDEARFFFQQLI 109
NI++F KE T +++ G+L ++ S G S D F Q
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 110 SGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST------- 160
V + H + I HRDLK+EN LL K+CDFG + + + +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTI--KLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 161 ------VGTPAYIAPEV--LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK 212
TP Y PE+ L G+ D+W+ G LY++ +PFED
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG-------- 256
Query: 213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDP 250
RI N +Y +P + L+ + +P +
Sbjct: 257 AKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL 294
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 6e-68
Identities = 58/254 (22%), Positives = 101/254 (39%), Gaps = 17/254 (6%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSL-R 57
++ ++ + LG G++G VR K L AVK RG K E+ +H + +
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCH 116
HP +R ++ L + E G L + G E + + + + +++ H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
S + H D+K N L P+ R K+ DFG + G P Y+APE+L +
Sbjct: 175 SQGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL-QGS 231
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
Y +DV+S G+T+ + E + R+ +S++ R
Sbjct: 232 YGTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPE-----FTAG--LSSELRS 283
Query: 237 LLSQIFVADPSKDP 250
+L + DP
Sbjct: 284 VLVMMLEPDPKLRA 297
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-65
Identities = 73/253 (28%), Positives = 115/253 (45%), Gaps = 20/253 (7%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVK-----YIERGKKIDE-NVQREIINHRSLRH 58
++ K LG G+F L R+ T A+K +I + K+ +R++++ L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS--RLDH 89
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
P ++ L + YA GEL I G F E RF+ +++S + Y H
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST---VGTPAYIAPEVLARK 175
I HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L K
Sbjct: 150 GIIHRDLKPENILLNE--DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
K SD+W+ G +Y ++ G PF N +I ++Y P+ R
Sbjct: 208 SA-CKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEYDFPEK--FFPKAR 260
Query: 236 HLLSQIFVADPSK 248
L+ ++ V D +K
Sbjct: 261 DLVEKLLVLDATK 273
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-65
Identities = 65/278 (23%), Positives = 105/278 (37%), Gaps = 40/278 (14%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPN 60
+EP++ LG G FGV ++K A+K I + E V RE+ L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 61 IIRFKEVLLT------------PTHLAIVMEYAAGGELFARI---CSAGRFSEDEARFFF 105
I+R+ L +L I M+ L + C+ F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 106 QQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK-------------SGL 152
Q+ V + HS + HRDLK N +K+ DFG
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK 212
+++ VGT Y++PE + Y K D++S G+ L+ +L YPF + +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMER---VR 235
Query: 213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDP 250
T+ +RN F P + + ++ + P + P
Sbjct: 236 TLTDVRN-LKFPPLFTQKYPCEYVMVQDMLSPSPMERP 272
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 6e-62
Identities = 69/285 (24%), Positives = 106/285 (37%), Gaps = 48/285 (16%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHP 59
++ K LG G+ G + VAVK + + EI + S HP
Sbjct: 13 LKNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRML--IDFCDIALMEIKLLTESDDHP 69
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSED-------EARFFFQQLISGV 112
N+IR+ T L I +E L + S E+ +Q+ SGV
Sbjct: 70 NVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQP-----------RLKICDFGYSK-----SGLLHSQ 156
++ HS++I HRDLK +N L+ S + R+ I DFG K +
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 157 PKSTVGTPAYIAPEVL-------ARKEYDGKISDVWSCGVTLYVMLVGAY-PFEDPEDPR 208
+ GT + APE+L ++ I D++S G Y +L PF D
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSI-DIFSMGCVFYYILSKGKHPFGDKYS-- 245
Query: 209 NFRKTIDRIRNVQYFLPDYVR-----VSADCRHLLSQIFVADPSK 248
I + L + + A+ L+SQ+ DP K
Sbjct: 246 ----RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK 286
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-61
Identities = 50/303 (16%), Positives = 100/303 (33%), Gaps = 42/303 (13%)
Query: 2 EERYEPVKELGSGNFGVARLVR-----DKRTKELVAVKYIERGKKIDENVQREIIN-HRS 55
+ LG G F D + K+ +K + + + +++ +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-----FSEDEARFFFQQLIS 110
++F L +V E + G L I + F +++
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPR---------LKICDFGYSKSGLLHSQPKSTV 161
+ H EI H D+K +N +L + L + D G S + PK T+
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGTI 241
Query: 162 -----GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF-EDPEDPRNFRKTID 215
T + E+L+ K ++ +I D + T+Y ML G Y ++
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
Query: 216 RIRNVQYF---------LPDYVRVSA--DCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264
R+ ++ + +PD + + R L ++F + R + L+
Sbjct: 301 RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN--KIRALRNRLIVLLL 358
Query: 265 AER 267
+
Sbjct: 359 ECK 361
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 3e-61
Identities = 62/259 (23%), Positives = 93/259 (35%), Gaps = 19/259 (7%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHPN 60
+ + P LG G G R VAVK I + RE+ + S HPN
Sbjct: 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRIL--PECFSFADREVQLLRESDEHPN 79
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSME 119
+IR+ I +E L + E QQ SG+++ HS+
Sbjct: 80 VIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 120 ICHRDLKLENTLL---DGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIAPEVL 172
I HRDLK N L+ + + + I DFG K S+ GT +IAPE+L
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 173 ARKEYD--GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVR 229
+ + D++S G Y ++ P R+ + L
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH---PFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 230 VSADCRHLLSQIFVADPSK 248
R L+ ++ DP K
Sbjct: 256 EDVIARELIEKMIAMDPQK 274
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-58
Identities = 61/277 (22%), Positives = 105/277 (37%), Gaps = 40/277 (14%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSL- 56
+ ++++GSG FG + + A+K + G ++N RE+ H L
Sbjct: 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGV 112
+H +++R+ H+ I EY GG L I R F E E + Q+ G+
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 113 SYCHSMEICHRDLKLENTLLD-----------------GSPQPRLKICDFGYSKSGLLHS 155
Y HSM + H D+K N + S + KI D G+ S
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---IS 185
Query: 156 QPKSTVGTPAYIAPEVLA-RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
P+ G ++A EVL + K +D+++ +T+ + +
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQ-------W 237
Query: 215 DRIRNVQY-FLPDYVRVSADCRHLLSQIFVADPSKDP 250
IR + +P +S + LL + DP + P
Sbjct: 238 HEIRQGRLPRIPQ--VLSQEFTELLKVMIHPDPERRP 272
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-57
Identities = 70/251 (27%), Positives = 131/251 (52%), Gaps = 18/251 (7%)
Query: 6 EPVKELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
E +K LG G+FG + + + ++L A+K + + + + R + H
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVEVNH 85
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
P I++ T L +++++ GG+LF R+ F+E++ +F+ +L + + HS+
Sbjct: 86 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEY 177
I +RDLK EN LLD + +K+ DFG SK + H + + GT Y+APEV+ R+ +
Sbjct: 146 GIIYRDLKPENILLDE--EGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
+ +D WS GV ++ ML G PF+ ++ ++T+ I + +P + +S + + L
Sbjct: 204 -TQSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSL 256
Query: 238 LSQIFVADPSK 248
L +F +P+
Sbjct: 257 LRMLFKRNPAN 267
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 2e-57
Identities = 83/248 (33%), Positives = 120/248 (48%), Gaps = 23/248 (9%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH---------RSLRHPNI 61
LG G+FG L K+T + A+K + KK D + + + + HP +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKAL---KK-DVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
T +L VMEY GG+L I S +F A F+ ++I G+ + HS I
Sbjct: 81 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIV 140
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYDGK 180
+RDLKL+N LLD +KI DFG K +L +T GTP YIAPE+L ++Y
Sbjct: 141 YRDLKLDNILLD--KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NH 197
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
D WS GV LY ML+G PF ++ + IR F P + + + + LL +
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMDNPFYPRW--LEKEAKDLLVK 251
Query: 241 IFVADPSK 248
+FV +P K
Sbjct: 252 LFVREPEK 259
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-57
Identities = 83/249 (33%), Positives = 127/249 (51%), Gaps = 22/249 (8%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH--------RSLRHPN 60
K LG G FG LVR+K T A+K + +K + + ++ + H ++ RHP
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKIL---RK-EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+ K T L VMEYA GGELF + F+E+ ARF+ +++S + Y HS ++
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYDG 179
+RD+KLEN +LD +KI DFG K G+ T GTP Y+APEVL +Y G
Sbjct: 127 VYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-G 183
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
+ D W GV +Y M+ G PF + ++ + + I + P +S + + LL+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEEIRFPRT--LSPEAKSLLA 237
Query: 240 QIFVADPSK 248
+ DP +
Sbjct: 238 GLLKKDPKQ 246
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-57
Identities = 82/252 (32%), Positives = 129/252 (51%), Gaps = 23/252 (9%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH--------RSL 56
++ ++ LG+G+FG L+R + A+K + K + V+ + + H +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLMLSIV 63
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
HP IIR + ++M+Y GGELF+ + + RF A+F+ ++ + Y H
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
S +I +RDLK EN LLD +KI DFG++K + + GTP YIAPEV++ K
Sbjct: 124 SKDIIYRDLKPENILLDK--NGHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKP 179
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
Y K D WS G+ +Y ML G PF D N KT ++I N + P + + D +
Sbjct: 180 Y-NKSIDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRFPPF--FNEDVKD 232
Query: 237 LLSQIFVADPSK 248
LLS++ D S+
Sbjct: 233 LLSRLITRDLSQ 244
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-57
Identities = 85/250 (34%), Positives = 119/250 (47%), Gaps = 23/250 (9%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH---------RSLRHP 59
+ LG G+FG L R K T +L AVK + KK D +Q + + + HP
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVL---KK-DVILQDDDVECTMTEKRILSLARNHP 84
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+ + TP L VME+ GG+L I + RF E ARF+ ++IS + + H
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 178
I +RDLKL+N LLD + K+ DFG K G+ + +T GTP YIAPE+L Y
Sbjct: 145 IIYRDLKLDNVLLD--HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY- 201
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
G D W+ GV LY ML G PFE N + I N + P + + D +L
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPFEA----ENEDDLFEAILNDEVVYPTW--LHEDATGIL 255
Query: 239 SQIFVADPSK 248
+P+
Sbjct: 256 KSFMTKNPTM 265
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 5e-57
Identities = 60/246 (24%), Positives = 109/246 (44%), Gaps = 11/246 (4%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRHPNIIRF 64
+ +G G+FG +V+ TK++ A+KY+ + K ++ N R + L HP ++
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 65 KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
+ +V++ GG+L + F E+ + F +L+ + Y + I HRD
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG--KIS 182
+K +N LLD + I DF + +Q + GT Y+APE+ + ++ G
Sbjct: 141 MKPDNILLDE--HGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAV 198
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
D WS GVT Y +L G P+ + ++ + P S + LL ++
Sbjct: 199 DWWSLGVTAYELLRGRRPYHI-RSSTSSKEIVHTFETTVVTYPSA--WSQEMVSLLKKLL 255
Query: 243 VADPSK 248
+P +
Sbjct: 256 EPNPDQ 261
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 8e-57
Identities = 83/250 (33%), Positives = 120/250 (48%), Gaps = 23/250 (9%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH---------RSLRHP 59
K +G G+FG L R K + AVK + +K ++++ H ++++HP
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVL---QK-KAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
++ T L V++Y GGELF + F E ARF+ ++ S + Y HS+
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 159
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYD 178
I +RDLK EN LLD Q + + DFG K + H+ ST GTP Y+APEVL ++ Y
Sbjct: 160 IVYRDLKPENILLDS--QGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY- 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
+ D W G LY ML G PF RN + D I N L ++ RHLL
Sbjct: 217 DRTVDWWCLGAVLYEMLYGLPPFYS----RNTAEMYDNILNKPLQLKPN--ITNSARHLL 270
Query: 239 SQIFVADPSK 248
+ D +K
Sbjct: 271 EGLLQKDRTK 280
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 9e-57
Identities = 81/250 (32%), Positives = 111/250 (44%), Gaps = 23/250 (9%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH---------RSLRHP 59
LG G+FG L K T EL AVK + KK D +Q + + + P
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKIL---KK-DVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+ + T L VMEY GG+L I GRF E A F+ ++ G+ + S
Sbjct: 82 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 141
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYD 178
I +RDLKL+N +LD + +KI DFG K + T GTP YIAPE++A + Y
Sbjct: 142 IIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY- 198
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
GK D W+ GV LY ML G PFE + + I P +S + +
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEG----EDEDELFQSIMEHNVAYPKS--MSKEAVAIC 252
Query: 239 SQIFVADPSK 248
+ P K
Sbjct: 253 KGLMTKHPGK 262
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 1e-56
Identities = 37/287 (12%), Positives = 73/287 (25%), Gaps = 62/287 (21%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLR------- 57
LG + D+ T E V ++ + ++ E++ R LR
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 58 ------------------HPNIIRFKEVLLTPTHLAIVMEYAA--------GGELFARIC 91
+IR + L+ Y G L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 92 SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151
+ Q+I ++ H + H L+ + +LD + + + F +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFEHLVRD 256
Query: 152 LLHSQPKSTVGTPAYIAPEVLA----------RKEYDGKISDVWSCGVTLYVMLVGAYPF 201
+ + + PE+ A R+ D W+ G+ +Y + P
Sbjct: 257 ---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313
Query: 202 EDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK 248
+N + R LL
Sbjct: 314 TKDAALGGSEWIFRSCKN----------IPQPVRALLEGFLRYPKED 350
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-56
Identities = 76/248 (30%), Positives = 134/248 (54%), Gaps = 15/248 (6%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRHPN 60
++ +K LG+G+FG LV+ K + A+K +++ K + +N + ++ P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+++ + ++L +VMEY AGGE+F+ + GRFSE ARF+ Q++ Y HS+++
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
+RDLK EN L+D Q +++ DFG++K + + + GTP +APE++ K Y K
Sbjct: 163 IYRDLKPENLLIDQ--QGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPEIILSKGY-NK 217
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
D W+ GV +Y M G PF + P + ++I + + P + S+D + LL
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFA-DQP---IQIYEKIVSGKVRFPSH--FSSDLKDLLRN 271
Query: 241 IFVADPSK 248
+ D +K
Sbjct: 272 LLQVDLTK 279
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 1e-56
Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 24/255 (9%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH---------RSLRHP 59
+ +G G++ LVR K+T + A+K + KK + E I+ ++ HP
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVV---KK-ELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
++ T + L V+EY GG+L + + E+ ARF+ ++ ++Y H
Sbjct: 71 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYD 178
I +RDLKL+N LLD + +K+ D+G K GL ST GTP YIAPE+L ++Y
Sbjct: 131 IIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY- 187
Query: 179 GKISDVWSCGVTLYVMLVGAYPF-----EDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
G D W+ GV ++ M+ G PF D D I Q +P +S
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVK 245
Query: 234 CRHLLSQIFVADPSK 248
+L DP +
Sbjct: 246 AASVLKSFLNKDPKE 260
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 8e-56
Identities = 76/252 (30%), Positives = 121/252 (48%), Gaps = 18/252 (7%)
Query: 6 EPVKELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQRE-IINHR----SLR 57
E ++ LG G +G R V T ++ A+K +++ + R ++
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
HP I+ T L +++EY +GGELF ++ G F ED A F+ ++ + + H
Sbjct: 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKE 176
I +RDLK EN +L+ Q +K+ DFG K + T GT Y+APE+L R
Sbjct: 140 KGIIYRDLKPENIMLNH--QGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG 197
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
+ + D WS G +Y ML GA PF N +KTID+I + LP Y ++ + R
Sbjct: 198 H-NRAVDWWSLGALMYDMLTGAPPFTG----ENRKKTIDKILKCKLNLPPY--LTQEARD 250
Query: 237 LLSQIFVADPSK 248
LL ++ + +
Sbjct: 251 LLKKLLKRNAAS 262
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 9e-56
Identities = 74/255 (29%), Positives = 117/255 (45%), Gaps = 24/255 (9%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH---------RSLRHP 59
+ +G G++ LVR K+T + A++ + KK + E I+ ++ HP
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVV---KK-ELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
++ T + L V+EY GG+L + + E+ ARF+ ++ ++Y H
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYD 178
I +RDLKL+N LLD + +K+ D+G K GL ST GTP YIAPE+L ++Y
Sbjct: 174 IIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY- 230
Query: 179 GKISDVWSCGVTLYVMLVGAYPF-----EDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
G D W+ GV ++ M+ G PF D D I Q +P +S
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVK 288
Query: 234 CRHLLSQIFVADPSK 248
+L DP +
Sbjct: 289 AASVLKSFLNKDPKE 303
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-54
Identities = 89/254 (35%), Positives = 128/254 (50%), Gaps = 23/254 (9%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH--------RSL 56
+E +K LG G FG LV++K T A+K + KK + V ++ + H ++
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKIL---KK-EVIVAKDEVAHTLTENRVLQNS 205
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
RHP + K T L VMEYA GGELF + FSED ARF+ +++S + Y H
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 265
Query: 117 S-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLAR 174
S + +RDLKLEN +LD +KI DFG K G+ T GTP Y+APEVL
Sbjct: 266 SEKNVVYRDLKLENLMLDK--DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 323
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
+Y G+ D W GV +Y M+ G PF + ++ K + I + P + +
Sbjct: 324 NDY-GRAVDWWGLGVVMYEMMCGRLPFYN----QDHEKLFELILMEEIRFPRT--LGPEA 376
Query: 235 RHLLSQIFVADPSK 248
+ LLS + DP +
Sbjct: 377 KSLLSGLLKKDPKQ 390
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 8e-54
Identities = 81/254 (31%), Positives = 113/254 (44%), Gaps = 23/254 (9%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH---------RS 55
+ + LG G+FG L K T EL AVK + KK D +Q + +
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKIL---KK-DVVIQDDDVECTMVEKRVLALP 398
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
+ P + + T L VMEY GG+L I GRF E A F+ ++ G+ +
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLAR 174
S I +RDLKL+N +LD + +KI DFG K + T GTP YIAPE++A
Sbjct: 459 QSKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY 516
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
+ Y GK D W+ GV LY ML G PFE + + I P +S +
Sbjct: 517 QPY-GKSVDWWAFGVLLYEMLAGQAPFEG----EDEDELFQSIMEHNVAYPKS--MSKEA 569
Query: 235 RHLLSQIFVADPSK 248
+ + P K
Sbjct: 570 VAICKGLMTKHPGK 583
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 177 bits (449), Expect = 1e-53
Identities = 39/285 (13%), Positives = 75/285 (26%), Gaps = 44/285 (15%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRHP 59
+ + V+ L G+ V LVRD E A+K G + E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 60 NIIRFKEVL--------------------------LTPTHLAIVMEYAAG------GELF 87
+ ++ + ++M A+ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 88 ARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY 147
G QLI + S + H +N + P RL + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM--PDGRLMLGDVSA 240
Query: 148 SKSGLLHSQPKSTVGTPAYIAPEVLARKEYD-GKISDVWSCGVTLYVMLVGAYPFEDPED 206
+ ++ ++ Y E L + W G+++Y + PF
Sbjct: 241 LWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 207 PRNF---RKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK 248
R ++ + + L+ + D +
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRR 343
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-53
Identities = 70/258 (27%), Positives = 121/258 (46%), Gaps = 22/258 (8%)
Query: 6 EPVKELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINH--------- 53
E +K LG+G +G + R + T +L A+K + KK + + H
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL---KKATIVQKAKTTEHTRTERQVLE 113
Query: 54 RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
+ P ++ T T L ++++Y GGELF + RF+E E + + +++ +
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 173
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV 171
+ H + I +RD+KLEN LLD + + DFG SK + ++ GT Y+AP++
Sbjct: 174 HLHKLGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 172 LARKEY-DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
+ + K D WS GV +Y +L GA PF + + + RI + P +
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE--M 289
Query: 231 SADCRHLLSQIFVADPSK 248
SA + L+ ++ + DP K
Sbjct: 290 SALAKDLIQRLLMKDPKK 307
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-53
Identities = 82/259 (31%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH--------RSL 56
YE VK +G G FG +LVR K T+++ A+K + E ++R
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIMAFA 126
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
P +++ +L +VMEY GG+L + S E ARF+ +++ + H
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLAR 174
SM HRD+K +N LLD LK+ DFG + VGTP YI+PEVL
Sbjct: 186 SMGFIHRDVKPDNMLLDK--SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 175 KEYD---GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVR 229
+ D G+ D WS GV LY MLVG PF + T +I N + L PD
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA----DSLVGTYSKIMNHKNSLTFPDDND 299
Query: 230 VSADCRHLLSQIFVADPSK 248
+S + ++L+ F+ D
Sbjct: 300 ISKEAKNLICA-FLTDREV 317
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-52
Identities = 64/247 (25%), Positives = 113/247 (45%), Gaps = 13/247 (5%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR-------SLRHPNI 61
+ +G G FG R T ++ A+K +++ + + + +N R + P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
+ TP L+ +++ GG+L + G FSE + RF+ ++I G+ + H+ +
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
+RDLK N LLD ++I D G + +P ++VGT Y+APEVL +
Sbjct: 315 YRDLKPANILLDE--HGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
+D +S G L+ +L G PF ++ + + LPD S + R LL +
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRSLLEGL 428
Query: 242 FVADPSK 248
D ++
Sbjct: 429 LQRDVNR 435
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 8e-52
Identities = 66/260 (25%), Positives = 112/260 (43%), Gaps = 28/260 (10%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH--------RSL 56
+E +K +G G FG +V+ K ++ A+K + K E ++R +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL---NK-WEMLKRAETACFREERDVLVNG 131
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYC 115
I +L +VM+Y GG+L + R E+ ARF+ +++ +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLA 173
H + HRD+K +N L+D +++ DFG + +S+ VGTP YI+PE+L
Sbjct: 192 HQLHYVHRDIKPDNILMDM--NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 174 RKEYD----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP---D 226
E G D WS GV +Y ML G PF + +T +I N +
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA----ESLVETYGKIMNHKERFQFPTQ 305
Query: 227 YVRVSADCRHLLSQIFVADP 246
VS + + L+ ++ +
Sbjct: 306 VTDVSENAKDLIRRLICSRE 325
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-51
Identities = 63/264 (23%), Positives = 110/264 (41%), Gaps = 31/264 (11%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH--------RSL 56
+E +K +G G F +V+ K+T ++ A+K + K + ++R ++ +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM---NK-WDMLKRGEVSCFREERDVLVNG 118
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYC 115
I + +L +VMEY GG+L + G R + ARF+ +++ +
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLA 173
H + HRD+K +N LLD +++ DFG +S VGTP Y++PE+L
Sbjct: 179 HRLGYVHRDIKPDNILLDR--CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 174 RKEYD------GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP-- 225
G D W+ GV Y M G PF + +T +I + + L
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA----DSTAETYGKIVHYKEHLSLP 292
Query: 226 -DYVRVSADCRHLLSQIFVADPSK 248
V + R + + + P
Sbjct: 293 LVDEGVPEEARDFIQR-LLCPPET 315
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-51
Identities = 64/257 (24%), Positives = 99/257 (38%), Gaps = 19/257 (7%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
+G G+FG ++DK+T AVK + ++ E++ L P I
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPRI 112
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
+ + + I ME GG L I G ED A ++ Q + G+ Y H+ I
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172
Query: 122 HRDLKLENTLLD--GSPQPRLKICDFGYSK------SGLLHSQPKSTVGTPAYIAPEVLA 173
H D+K +N LL GS R +CDFG++ G GT ++APEV+
Sbjct: 173 HGDVKADNVLLSSDGS---RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
K D K D+WS + ML G +P+ K I +P +
Sbjct: 230 GKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK-IASEPPPIREIPP--SCAPL 285
Query: 234 CRHLLSQIFVADPSKDP 250
+ + +P
Sbjct: 286 TAQAIQEGLRKEPVHRA 302
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-50
Identities = 65/247 (26%), Positives = 101/247 (40%), Gaps = 14/247 (5%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRHPNIIRFKE 66
LG G FG + K T +L A K + + + + + + + I+
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 67 VLLTPTHLAIVMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICH 122
T T L +VM GG++ I + F E A F+ Q++SG+ + H I +
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKI 181
RDLK EN LLD ++I D G + GTP ++APE+L +EY
Sbjct: 313 RDLKPENVLLDD--DGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DFS 369
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
D ++ GVTLY M+ PF + ++ R+ PD S + +
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPASKDFCEAL 427
Query: 242 FVADPSK 248
DP K
Sbjct: 428 LQKDPEK 434
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 6e-50
Identities = 64/244 (26%), Positives = 103/244 (42%), Gaps = 11/244 (4%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS----LRHPNIIRFKE 66
LG G FG + + T ++ A K +E+ + + +N + + ++
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 67 VLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
T L +V+ GG+L I G+ F E A F+ ++ G+ H I +RD
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 184
LK EN LLD ++I D G + K VGT Y+APEV+ + Y D
Sbjct: 312 LKPENILLDD--HGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY-TFSPDW 368
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
W+ G LY M+ G PF+ + + ++ V + S R L SQ+
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQARSLCSQLLCK 426
Query: 245 DPSK 248
DP++
Sbjct: 427 DPAE 430
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 3e-49
Identities = 71/232 (30%), Positives = 109/232 (46%), Gaps = 9/232 (3%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN--VQREI-INHRSLRH 58
++ +E + ELG+GN GV V K + ++A K I K + RE+ + H
Sbjct: 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NS 90
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS- 117
P I+ F + ++I ME+ GG L + AGR E +I G++Y
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
+I HRD+K N L++ + +K+CDFG S L+ S S VGT +Y++PE L Y
Sbjct: 151 HKIMHRDVKPSNILVNSRGE--IKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 207
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
+ SD+WS G++L M VG YP P+ ++ P R
Sbjct: 208 SVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-47
Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 16/217 (7%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN--VQREI-INHRSLRHP 59
+ EP+ ELG G +GV +R + +++AVK I E + ++ I+ R++ P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGG--ELFARICS-AGRFSEDEARFFFQQLISGVSYCH 116
+ F L + I ME + + ++ ED ++ + + H
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 117 S-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLA- 173
S + + HRD+K N L++ Q K+CDFG S L+ K G Y+APE +
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQV--KMCDFGISGY-LVDDVAKDIDAGCKPYMAPERINP 183
Query: 174 ---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP 207
+K Y K SD+WS G+T+ + + +P++ P
Sbjct: 184 ELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP 219
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-47
Identities = 69/250 (27%), Positives = 124/250 (49%), Gaps = 18/250 (7%)
Query: 11 LGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
LG G +G+ RD + +A+K I R + + + EI H+ L+H NI+++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 70 TPTHLAIVMEYAAGGELFARICSA--GRFSEDEA--RFFFQQLISGVSYCHSMEICHRDL 125
+ I ME GG L + + + G ++E F+ +Q++ G+ Y H +I HRD+
Sbjct: 90 ENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148
Query: 126 KLENTLLDGSPQPRLKICDFGYSK-SGLLHSQPKSTVGTPAYIAPEVL--ARKEYDGKIS 182
K +N L++ + LKI DFG SK ++ ++ GT Y+APE++ + Y +
Sbjct: 149 KGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-A 206
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSADCRHLLSQ 240
D+WS G T+ M G PF + +P + + ++ + +P+ +SA+ + + +
Sbjct: 207 DIWSLGCTIIEMATGKPPFYELGEP---QAAMFKVGMFKVHPEIPE--SMSAEAKAFILK 261
Query: 241 IFVADPSKDP 250
F DP K
Sbjct: 262 CFEPDPDKRA 271
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-47
Identities = 35/283 (12%), Positives = 73/283 (25%), Gaps = 55/283 (19%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLR------- 57
LG + D+ T E V ++ + ++ E++ R LR
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 58 ---------------HPNIIRFKEVLLTPTHLAIVMEYAA-----------GGELFARIC 91
P + V L + ++ + G L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 92 SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151
+ Q+I ++ H + H L+ + +LD + + + F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFEHLVRD 261
Query: 152 LLHSQPKST--VGTPAYIAPEVLARKEYDGKI----SDVWSCGVTLYVMLVGAYPFEDPE 205
+ P A +L ++ + D W+ G+ +Y + P D
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321
Query: 206 DPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK 248
+ + R LL
Sbjct: 322 ALGGSEWIFRSCK----------NIPQPVRALLEGFLRYPKED 354
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-47
Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 14/215 (6%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREI-INHRSLRHP 59
E + E+GSG G +R ++T ++AVK + K+ ++ + ++ + +S P
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-M 118
I++ +T T + I ME + G E ++ + Y
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKE- 176
+ HRD+K N LLD Q +K+CDFG S L+ + K G AY+APE + +
Sbjct: 145 GVIHRDVKPSNILLDERGQ--IKLCDFGISGR-LVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 177 ----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDP 207
YD + +DVWS G++L + G +P+++ +
Sbjct: 202 TKPDYDIR-ADVWSLGISLVELATGQFPYKNCKTD 235
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-46
Identities = 66/206 (32%), Positives = 108/206 (52%), Gaps = 9/206 (4%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHP 59
EE + ++++G G+FG D RT+++VA+K I E + E++Q+EI P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+ ++ L T L I+MEY GG + G E + ++++ G+ Y HS +
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEY 177
HRD+K N LL + +K+ DFG + L +Q K + VGTP ++APEV+ + Y
Sbjct: 140 KIHRDIKAANVLLSEHGE--VKLADFGVAGQ-LTDTQIKRNTFVGTPFWMAPEVIKQSAY 196
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFED 203
D K +D+WS G+T + G P +
Sbjct: 197 DSK-ADIWSLGITAIELARGEPPHSE 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-46
Identities = 60/205 (29%), Positives = 106/205 (51%), Gaps = 8/205 (3%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
+++Y +++G G G D T + VA++ + ++ E + EI+ R ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
I+ + + L L +VMEY AGG L + + E + ++ + + + HS ++
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEYD 178
HRD+K +N LL +K+ DFG+ + Q K + VGTP ++APEV+ RK Y
Sbjct: 138 IHRDIKSDNILL--GMDGSVKLTDFGFCAQ-ITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 179 GKISDVWSCGVTLYVMLVGAYPFED 203
K+ D+WS G+ M+ G P+ +
Sbjct: 195 PKV-DIWSLGIMAIEMIEGEPPYLN 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-45
Identities = 60/205 (29%), Positives = 109/205 (53%), Gaps = 8/205 (3%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
+ ++G G+ G+ L R+K + VAVK ++ K+ E + E++ R +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
++ + L L ++ME+ GG L I S R +E++ + ++ ++Y H+ +
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEYD 178
HRD+K ++ LL + R+K+ DFG+ + PK S VGTP ++APEV++R Y
Sbjct: 163 IHRDIKSDSILL--TLDGRVKLSDFGFCAQ-ISKDVPKRKSLVGTPYWMAPEVISRSLYA 219
Query: 179 GKISDVWSCGVTLYVMLVGAYPFED 203
++ D+WS G+ + M+ G P+
Sbjct: 220 TEV-DIWSLGIMVIEMVDGEPPYFS 243
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-45
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN--VQREI-INHRSLRHP 59
E + + E+G G +G + K + +++AVK I E + ++ + RS P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGEL----FARICSAGRFSEDEARFFFQQLISGVSYC 115
I++F L I ME + + E+ + +++
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 116 HS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYIAPEVLA 173
++I HRD+K N LLD S +K+CDFG S L+ S K+ G Y+APE +
Sbjct: 142 KENLKIIHRDIKPSNILLDRSGN--IKLCDFGISG-QLVDSIAKTRDAGCRPYMAPERID 198
Query: 174 ----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP 207
R+ YD + SDVWS G+TLY + G +P+
Sbjct: 199 PSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSV 235
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-45
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 8/205 (3%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
EE ++ +++LG G++G K T ++VA+K + + E + +EI + P++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHV 86
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+++ T L IVMEY G + I +EDE Q + G+ Y H M
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEYD 178
HRD+K N LL + + K+ DFG + L + K + +GTP ++APEV+ Y+
Sbjct: 147 IHRDIKAGNILL--NTEGHAKLADFGVAGQ-LTDTMAKRNTVIGTPFWMAPEVIQEIGYN 203
Query: 179 GKISDVWSCGVTLYVMLVGAYPFED 203
+D+WS G+T M G P+ D
Sbjct: 204 CV-ADIWSLGITAIEMAEGKPPYAD 227
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-44
Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
+ +G G FGV + + K + VA+K I + + E+ + HPNI++
Sbjct: 14 EVVGRGAFGV--VCKAKWRAKDVAIKQI-ESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 69 LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI---SGVSYCHSME---ICH 122
L P + +VMEYA GG L+ + A A + GV+Y HSM+ + H
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
RDLK N LL LKICDFG + + + + G+ A++APEV Y K
Sbjct: 129 RDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEGSNYSEK-C 184
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDP 207
DV+S G+ L+ ++ PF++ P
Sbjct: 185 DVFSWGIILWEVITRRKPFDEIGGP 209
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-44
Identities = 58/252 (23%), Positives = 104/252 (41%), Gaps = 18/252 (7%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQR---EIINHRSLRHPNIIRF- 64
E+G G+F D T VA ++ K QR E + L+HPNI+RF
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 65 ---KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME-- 119
+ + + +V E G L + R + +Q++ G+ + H+
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
I HRDLK +N + G P +KI D G + S K+ +GTP ++APE+ K YD
Sbjct: 152 IIHRDLKCDNIFITG-PTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMYEEK-YDE 208
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRN-FRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
DV++ G+ + M YP+ + ++ +R+ ++ + + ++
Sbjct: 209 S-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDK--VAIPEVKEII 263
Query: 239 SQIFVADPSKDP 250
+ +
Sbjct: 264 EGCIRQNKDERY 275
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-42
Identities = 71/209 (33%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-----ENVQREIINHRSLRHPNIIR 63
+ +G G FG ++ R + VAVK D ENV++E L+HPNII
Sbjct: 13 EIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM---EI 120
+ V L +L +VME+A GG L R+ S R D + Q+ G++Y H I
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLN-RVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 121 CHRDLKLENTLLDGS------PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
HRDLK N L+ LKI DFG ++ + S G A++APEV+
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-WHRTTKMSAAGAYAWMAPEVIRA 188
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFED 203
+ SDVWS GV L+ +L G PF
Sbjct: 189 SMFSKG-SDVWSYGVLLWELLTGEVPFRG 216
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-42
Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 20/218 (9%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPN 60
+E V+ +G+G +G R +T +L A+K ++ +E +++EI + H N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 61 IIRF------KEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGV 112
I + K L +VME+ G + + E+ + ++++ G+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPE 170
S+ H ++ HRD+K +N LL + +K+ DFG S L + + + +GTP ++APE
Sbjct: 143 SHLHQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQ-LDRTVGRRNTFIGTPYWMAPE 199
Query: 171 VLARKE-----YDGKISDVWSCGVTLYVMLVGAYPFED 203
V+A E YD K SD+WS G+T M GA P D
Sbjct: 200 VIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 6e-42
Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI----ERGKKIDENVQREIINHRSLR 57
E+ + ++E+G G+FG RD R E+VA+K + ++ + +++ +E+ + LR
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
HPN I+++ L +VMEY G E E + G++Y HS
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA---R 174
+ HRD+K N LL S +K+ DFG + ++ + S VGTP ++APEV+
Sbjct: 173 HNMIHRDVKAGNILL--SEPGLVKLGDFGS--ASIM-APANSFVGTPYWMAPEVILAMDE 227
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFED 203
+YDGK DVWS G+T + P +
Sbjct: 228 GQYDGK-VDVWSLGITCIELAERKPPLFN 255
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-42
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 13/211 (6%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
E +E V ELG G FG ++K T L A K IE + + E+ EI + HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSME 119
I++ L I++E+ GG + A + +E + + +Q++ +++ HS
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKE- 176
I HRDLK N L+ + + +++ DFG S + L + K S +GTP ++APEV+ +
Sbjct: 138 IIHRDLKAGNVLM--TLEGDIRLADFGVS-AKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 177 ----YDGKISDVWSCGVTLYVMLVGAYPFED 203
YD K +D+WS G+TL M P +
Sbjct: 195 KDTPYDYK-ADIWSLGITLIEMAQIEPPHHE 224
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-41
Identities = 45/231 (19%), Positives = 81/231 (35%), Gaps = 26/231 (11%)
Query: 40 KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARI---CSAGRF 96
+ +I N + + +L I M+ L + CS
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 97 SEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
F Q+ V + HS + HRDLK N +K+ DFG + +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEE 219
Query: 157 PKST-------------VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFED 203
++ VGT Y++PE + Y K D++S G+ L+ +L Y F
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFST 275
Query: 204 PEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRD 254
+ I +RN++ F + + ++ + P++ P + D
Sbjct: 276 QM---ERVRIITDVRNLK-FPLLFTQKYPQEHMMVQDMLSPSPTERPEATD 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-41
Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 18/206 (8%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
+++G+G+FG + R + VAVK + E V RE+ + LRHPNI+ F
Sbjct: 43 EKIGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 66 EVLLTPTHLAIVMEYAAGGELFA---RICSAGRFSEDEARFFFQQLISGVSYCHSME--I 120
+ P +L+IV EY + G L+ + + + E + G++Y H+ I
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYIAPEVLARKEY 177
HR+LK N L+D +K+CDFG S+ L S KS GTP ++APEVL +
Sbjct: 161 VHRNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFED 203
+ K SDV+S GV L+ + P+ +
Sbjct: 217 NEK-SDVYSFGVILWELATLQQPWGN 241
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-41
Identities = 69/271 (25%), Positives = 113/271 (41%), Gaps = 26/271 (9%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHP 59
+ YE + +GSG V + KE VA+K I E+ + + + +EI HP
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELF--------ARICSAGRFSEDEARFFFQQLISG 111
NI+ + + L +VM+ +GG + +G E ++++ G
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS------KSGLLHSQPKSTVGTPA 165
+ Y H HRD+K N LL ++I DFG S + K+ VGTP
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 166 YIAPEVLAR-KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTID----RIRN 219
++APEV+ + + YD K +D+WS G+T + GA P+ P + T+ +
Sbjct: 192 WMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHK-YPPMKVLMLTLQNDPPSLET 249
Query: 220 VQYFLPDYVRVSADCRHLLSQIFVADPSKDP 250
+ R ++S DP K P
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-41
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV--------QREIINHRSLRHPN 60
K++G G FG+ R + K +VA+K + G E QRE+ +L HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
I++ ++ P +VME+ G+L+ R+ + G+ Y +
Sbjct: 85 IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 120 --ICHRDLKLENTLLDGSPQPR---LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA- 173
I HRDL+ N L + K+ DFG S+ +G ++APE +
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPETIGA 200
Query: 174 -RKEYDGKISDVWSCGVTLYVMLVGAYPFED 203
+ Y K +D +S + LY +L G PF++
Sbjct: 201 EEESYTEK-ADTYSFAMILYTILTGEGPFDE 230
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 20/219 (9%)
Query: 2 EERYEPVKELGSG--NFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSL 56
YE + +G G + L R K T E V V+ I ++ +Q E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELF--ARICSAGRFSEDEARFFFQQLISGVSY 114
HPNI+ ++ + L +V + A G +E + Q ++ + Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS--------KSGLLHSQPKSTVGTPAY 166
H M HR +K + L+ + + + + + ++H PK +V +
Sbjct: 144 IHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 167 IAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFED 203
++PEVL + + YD K SD++S G+T + G PF+D
Sbjct: 202 LSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 239
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-39
Identities = 66/255 (25%), Positives = 110/255 (43%), Gaps = 21/255 (8%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
+ +GSG+FG V + VAVK + + +Q E+ R RH NI+ F
Sbjct: 30 QRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 66 EVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
T LAIV ++ G L+ + S +F + +Q G+ Y H+ I HRD
Sbjct: 87 GYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145
Query: 125 LKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARKE---YD 178
LK N L +KI DFG + Q + G+ ++APEV+ ++ Y
Sbjct: 146 LKSNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
+ SDV++ G+ LY ++ G P+ + + + + R PD +V ++C +
Sbjct: 204 FQ-SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR----GSLSPDLSKVRSNCPKRM 258
Query: 239 SQIFVADPSKDPHSR 253
++ K R
Sbjct: 259 KRLMAECLKKKRDER 273
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-39
Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
+ +G G FG V R VA++ I+ + ++ ++ RE++ +R RH N++ F
Sbjct: 39 ELIGKGRFGQ---VYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 66 EVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEICHRD 124
++P HLAI+ G L++ + A ++ R Q+++ G+ Y H+ I H+D
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKD 155
Query: 125 LKLENTLLDGSPQPRLKICDFGYSK------SGLLHSQPKSTVGTPAYIAPEVL------ 172
LK +N D ++ I DFG +G + + G ++APE++
Sbjct: 156 LKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 173 ---ARKEYDGKISDVWSCGVTLYVMLVGAYPFED 203
+ + SDV++ G Y + +PF+
Sbjct: 213 TEEDKLPFSKH-SDVFALGTIWYELHAREWPFKT 245
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-38
Identities = 42/206 (20%), Positives = 81/206 (39%), Gaps = 19/206 (9%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFK 65
+L + G L + + + VK ++ + + E R HPN++
Sbjct: 16 TKLNENHSG--ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 66 EVLLTP--THLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVSYCHSME-- 119
+P H ++ + G L+ + F D+++ F + G+++ H++E
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
I L + ++D +I S Q + PA++APE L +K D
Sbjct: 134 IPRHALNSRSVMIDEDM--TARISMADVKFS----FQSPGRMYAPAWVAPEALQKKPEDT 187
Query: 180 KI--SDVWSCGVTLYVMLVGAYPFED 203
+D+WS V L+ ++ PF D
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFAD 213
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-37
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIER-GKKIDENVQREIINHRSLRHPNIIRFKEV 67
+ LG G FG A V + T E++ +K + R ++ +E+ R L HPN+++F V
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 68 LLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
L L + EY GG L I S + + F + + SG++Y HSM I HRDL
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLN 135
Query: 127 LENTLLDGSPQPRLKICDFGYSK---------------SGLLHSQPKSTVGTPAYIAPEV 171
N L+ + + + DFG ++ + + VG P ++APE+
Sbjct: 136 SHNCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN 209
+ + YD K DV+S G+ L ++ D PR
Sbjct: 194 INGRSYDEK-VDVFSFGIVLCEIIGRVNADPDY-LPRT 229
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-37
Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 19/200 (9%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
E Y K +G+G+FGV + + ELVA+K + + K+ +N RE+ R L H N
Sbjct: 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKN--RELQIMRKLDHCN 108
Query: 61 IIRFKEVLLTPT------HLAIVMEYAAGGELFARI----CSAGRFSEDEARFFFQQLIS 110
I+R + + +L +V++Y ++ + + + QL
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAP 169
++Y HS ICHRD+K +N LLD LK+CDFG +K L+ +P S + + Y AP
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAP 225
Query: 170 EVLAR-KEYDGKISDVWSCG 188
E++ +Y I DVWS G
Sbjct: 226 ELIFGATDYTSSI-DVWSAG 244
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-35
Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSL 56
M E+YE + ++G G++GV R++ T ++VA+K + D ++ REI + L
Sbjct: 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQL 59
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYC 115
+HPN++ EV L +V EY + + R E + Q + V++C
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-T--VGTPAYIAPEVL 172
H HRD+K EN L+ +K+CDFG+++ L V T Y +PE+L
Sbjct: 119 HKHNCIHRDVKPENILITKHSV--IKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELL 174
Query: 173 AR-KEYDGKISDVWSCG 188
+Y + DVW+ G
Sbjct: 175 VGDTQYGPPV-DVWAIG 190
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 67/207 (32%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
+RY + +LG G +G D T E VA+K I R + +E V RE+ + L+H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
NII K V+ L ++ EYA +L + S + F QLI+GV++CHS
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 119 EICHRDLKLENTLLDGSPQPR---LKICDFGYSKSGLLHSQPKST----VGTPAYIAPEV 171
HRDLK +N LL S LKI DFG +++ P + T Y PE+
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA---FGIPIRQFTHEIITLWYRPPEI 208
Query: 172 L-ARKEYDGKISDVWSCGVTLYVMLVG 197
L + Y + D+WS ML+
Sbjct: 209 LLGSRHYSTSV-DIWSIACIWAEMLMK 234
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-35
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLR-HP 59
+ Y+ V++LG G + + E V VK + + KKI +REI +LR P
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI----KREIKILENLRGGP 91
Query: 60 NIIRFKEVLLTPTH--LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
NII +++ P A+V E+ + ++ + RF+ +++ + YCHS
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS 148
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL-AR 174
M I HRD+K N ++D +L++ D+G ++ H + V + + PE+L
Sbjct: 149 MGIMHRDVKPHNVMIDHE-HRKLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDY 205
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPF 201
+ YD + D+WS G L M+ PF
Sbjct: 206 QMYDYSL-DMWSLGCMLASMIFRKEPF 231
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 72/286 (25%), Positives = 119/286 (41%), Gaps = 51/286 (17%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
E Y K +G+G+FGV + + E VA+K + + K+ +N RE+ R ++HPN+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-FKN--RELQIMRIVKHPNV 94
Query: 62 IRFKEVLLTPTH------LAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISG 111
+ K + L +V+EY ++ + + + QL+
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAP 169
++Y HS+ ICHRD+K +N LLD LK+ DFG +K L + + + + Y AP
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKI--LIAGEPNVSYICSRYYRAP 210
Query: 170 EVLAR-KEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------------- 206
E++ Y I D+WS G + ++ G +P E D
Sbjct: 211 ELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269
Query: 207 -PRNFRKTIDRIRNV---QYFLPDYVRVSADCRHLLSQIFVADPSK 248
P +IR + F P R D L+S++ PS
Sbjct: 270 NPNYMEHKFPQIRPHPFSKVFRP---RTPPDAIDLISRLLEYTPSA 312
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 20/197 (10%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSLRH 58
E+YE + +G G++G+ R+K T +VA+K D+ V REI + LRH
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRH 83
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAG---GELFARICSAGRFSEDEARFFFQQLISGVSYC 115
N++ EV +V E+ +L + + Q+I+G+ +C
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFC 140
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS---TVGTPAYIAPEVL 172
HS I HRD+K EN L+ S +K+CDFG++++ L + + V T Y APE+L
Sbjct: 141 HSHNIIHRDIKPENILVSQSGV--VKLCDFGFART--LAAPGEVYDDEVATRWYRAPELL 196
Query: 173 AR-KEYDGKISDVWSCG 188
+Y + DVW+ G
Sbjct: 197 VGDVKYGKAV-DVWAIG 212
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-33
Identities = 74/208 (35%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSLRH 58
ERY+ V +LG G L D VA+K I + E +RE+ N L H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
NI+ +V +VMEY G L I S G S D A F Q++ G+ + H M
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
I HRD+K +N L+D LKI DFG S++ L +Q +GT Y +PE A+
Sbjct: 131 RIVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSL--TQTNHVLGTVQYFSPE-QAK 185
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFE 202
E + +D++S G+ LY MLVG PF
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-33
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 36/218 (16%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
++YE ++++G G +G +++ T E+VA+K + R DE V REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS----------AGRFSEDEARFFFQQL 108
NI+R +VL + L +V E+ C G + + F QL
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEF----------CDQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTP 164
+ G+ +CHS + HRDLK +N L++ + + LK+ +FG +++ P V T
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARA---FGIPVRCYSAEVVTL 165
Query: 165 AYIAPEVL-ARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
Y P+VL K Y I D+WS G + P
Sbjct: 166 WYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPL 202
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-33
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI----ERGKKIDENVQREIINHRSLRH 58
+++ +++LG+G + +K T VA+K + E G REI + L+H
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKH 62
Query: 59 PNIIRFKEVLLTPTHLAIVMEY-----AAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
NI+R +V+ T L +V E+ + + + ++F QL+ G++
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAP 169
+CH +I HRDLK +N L++ + +LK+ DFG +++ P +T V T Y AP
Sbjct: 123 FCHENKILHRDLKPQNLLIN--KRGQLKLGDFGLARA---FGIPVNTFSSEVVTLWYRAP 177
Query: 170 EVL-ARKEYDGKISDVWSCGVTLYVMLVG 197
+VL + Y I D+WSCG L M+ G
Sbjct: 178 DVLMGSRTYSTSI-DIWSCGCILAEMITG 205
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-32
Identities = 65/215 (30%), Positives = 91/215 (42%), Gaps = 24/215 (11%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPNI 61
RY +K LG G G+ D + VA+K I ++ REI R L H NI
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 62 IRFKEVLLTPTHLA--------------IVMEYAAGGELFARICSAGRFSEDEARFFFQQ 107
++ E+L IV EY +L A + G E+ AR F Q
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLLEEHARLFMYQ 128
Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGT 163
L+ G+ Y HS + HRDLK N ++ + LKI DFG ++ H K + T
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 164 PAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVG 197
Y +P + L+ Y I D+W+ G ML G
Sbjct: 188 KWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTG 221
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-32
Identities = 52/224 (23%), Positives = 86/224 (38%), Gaps = 29/224 (12%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF--- 64
++ +G G +G + R E VAVK + + E+ N LRH NI+ F
Sbjct: 13 LECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 65 -KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME---- 119
+ T L ++ Y G L+ + + SG+++ H
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 120 ----ICHRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPE 170
I HRDLK +N L+ + + I D G + + L VGT Y+APE
Sbjct: 130 GKPAIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 171 VLARK------EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR 208
VL + ++ D+W+ G+ L+ + ED +
Sbjct: 188 VLDETIQVDCFDSYKRV-DIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-32
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ------REIINHRS 55
+R++ + G G FG +L ++K T VA+ KK+ ++ + + + +
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAI------KKVIQDPRFRNRELQIMQDLAV 75
Query: 56 LRHPNIIRFKEVLLTPTH-------LAIVMEYAAGGELFARICSAGR----FSEDEARFF 104
L HPNI++ + T L +VMEY L + R + F
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY-VPDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 105 FQQLISGVSYCH--SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-- 160
QLI + H S+ +CHRD+K N L++ + LK+CDFG +K L +
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKK--LSPSEPNVAY 191
Query: 161 VGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVG 197
+ + Y APE+ + Y + D+WS G M++G
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLG 228
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-32
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPN 60
E Y + +LG G + + K T LVA+K I E + RE+ + L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
I+ +++ T L +V EY +L + G + + F QL+ G++YCH +
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEVL-AR 174
+ HRDLK +N L++ + LK+ DFG +++ S P T V T Y P++L
Sbjct: 121 VLHRDLKPQNLLINERGE--LKLADFGLARA---KSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 175 KEYDGKISDVWSCGVTLYVMLVG 197
+Y +I D+W G Y M G
Sbjct: 176 TDYSTQI-DMWGVGCIFYEMATG 197
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-32
Identities = 54/232 (23%), Positives = 89/232 (38%), Gaps = 26/232 (11%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSLRHP 59
Y + +G G G D + +VA+K + D QRE L+ P
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+++ + L + M G +L A + G + A +Q+ S + H+
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
HRD+K EN L+ S + DFG + L +Q +TVGT Y+APE +
Sbjct: 155 ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKL--TQLGNTVGTLYYMAPERFSES 210
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF-------------EDPEDPRNFRKTI 214
+ +D+++ LY L G+ P+ + P R I
Sbjct: 211 HATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGI 261
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 117 bits (297), Expect = 6e-32
Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 13/202 (6%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
E+Y ++++G G +GV ++ E A+K I R +K DE + REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHS 117
NI++ +V+ T L +V E+ +L + G A+ F QL++G++YCH
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL-ARK 175
+ HRDLK +N L++ + LKI DFG +++ + + + + T Y AP+VL K
Sbjct: 119 RRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 176 EYDGKISDVWSCGVTLYVMLVG 197
+Y I D+WS G M+ G
Sbjct: 177 KYSTTI-DIWSVGCIFAEMVNG 197
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-32
Identities = 63/220 (28%), Positives = 93/220 (42%), Gaps = 36/220 (16%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQ------REIINHR 54
++ LG G +GV K T E+VA+K KI+ + REI +
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIKILK 64
Query: 55 SLRHPNIIRFKEVLLTPTHLA-----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLI 109
+H NII + + I+ E +L R+ S S+D ++F Q +
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTL 122
Query: 110 SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKST----- 160
V H + HRDLK N L++ + LK+CDFG +S +S+P
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 161 --VGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVG 197
V T Y APEV L +Y + DVWSCG L + +
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLR 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-31
Identities = 70/238 (29%), Positives = 99/238 (41%), Gaps = 29/238 (12%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSLRH 58
+RYE + LG G L RD R VAVK + D + +RE N +L H
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 59 PNIIR---FKEVLLTPTHLA-IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
P I+ E L IVMEY G L + + G + A +++
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPE 170
H I HRD+K N ++ S +K+ DFG + SG +Q + +GT Y++PE
Sbjct: 132 SHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPF--------------EDPEDPRNFRKTI 214
AR + SDV+S G LY +L G PF EDP P + +
Sbjct: 190 -QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 74/285 (25%), Positives = 118/285 (41%), Gaps = 46/285 (16%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKID-ENVQREIINHRSLR 57
+ ERY+ + +GSG +G D +T VAVK + R I + RE+ + ++
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 58 HPNIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
H N+I +V L +V G +L I + ++D +F Q++ G
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 144
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAP 169
+ Y HS +I HRDLK N ++ + LKI DFG ++ + + T V T Y AP
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARH----TADEMTGYVATRWYRAP 198
Query: 170 EV-LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKTI 214
E+ L Y+ + D+WS G + +L G +P D D K I
Sbjct: 199 EIMLNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 215 --DRIRNVQYFLPDYVRV---------SADCRHLLSQIFVADPSK 248
+ RN L ++ + LL ++ V D K
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 302
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 72/283 (25%), Positives = 121/283 (42%), Gaps = 47/283 (16%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKID-ENVQREIINHRSLRHP 59
+ Y +GSG +G DKR+ E VA+K + R +I + RE++ + ++H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 60 NIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
N+I +V + L +VM + +L + +FSE++ ++ Q++ G+
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGL--KFSEEKIQYLVYQMLKGLK 140
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV 171
Y HS + HRDLK N ++ + LKI DFG ++ + + T V T Y APEV
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARH----ADAEMTGYVVTRWYRAPEV 194
Query: 172 -LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKTI-- 214
L+ Y+ + D+WS G + ML G + +D D F + +
Sbjct: 195 ILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 215 DRIRNVQYFLPDYVRV---------SADCRHLLSQIFVADPSK 248
++ LP R S LL ++ D K
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDK 296
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKID-ENVQREIINHRSLR 57
+ Y ++ +GSG +G D RT VA+K + R ++ + RE+ + +R
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 58 HPNIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
H N+I +V L +VM + G +L ++ + ED +F Q++ G
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKG 140
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAP 169
+ Y H+ I HRDLK N ++ + LKI DFG ++ + + T V T Y AP
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQ----ADSEMTGYVVTRWYRAP 194
Query: 170 EV-LARKEYDGKISDVWSCGVTLYVMLVG 197
EV L Y + D+WS G + M+ G
Sbjct: 195 EVILNWMRYTQTV-DIWSVGCIMAEMITG 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENV----QREIINHRSL 56
+RYE + LG G F RDK T ++VA+K I + + + REI + L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYC 115
HPNII + +++++V ++ E+ + S + + + + G+ Y
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYL 128
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEV 171
H I HRDLK N LLD + LK+ DFG +KS P V T Y APE+
Sbjct: 129 HQHWILHRDLKPNNLLLDENGV--LKLADFGLAKS---FGSPNRAYTHQVVTRWYRAPEL 183
Query: 172 L-ARKEYDGKISDVWSCGVTLYVMLVG 197
L + Y + D+W+ G L +L+
Sbjct: 184 LFGARMYGVGV-DMWAVGCILAELLLR 209
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-31
Identities = 56/222 (25%), Positives = 86/222 (38%), Gaps = 29/222 (13%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF--- 64
+ +G G FG + R K E VAVK ++ + EI LRH NI+ F
Sbjct: 47 QESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 65 -KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS------ 117
+ T T L +V +Y G LF + + + SG+++ H
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 118 --MEICHRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPE 170
I HRDLK +N L+ + I D G + + + P VGT Y+APE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 171 VL------ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED 206
VL E + D+++ G+ + + ED
Sbjct: 222 VLDDSINMKHFESFKRA-DIYAMGLVFWEIARRCSIGGIHED 262
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-31
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 37/214 (17%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
E+Y+ ++++G G +GV +D +VA+K I R DE + REI + L H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAEDEGIPSTAIREISLLKELHH 78
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARIC----------SAGRFSEDEARFFFQQL 108
PNI+ +V+ + L +V E+ + + + + + QL
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEF----------MEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTP 164
+ GV++CH I HRDLK +N L++ LK+ DFG +++ P + V T
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARA---FGIPVRSYTHEVVTL 183
Query: 165 AYIAPEVL-ARKEYDGKISDVWSCGVTLYVMLVG 197
Y AP+VL K+Y + D+WS G M+ G
Sbjct: 184 WYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITG 216
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-31
Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 30/207 (14%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ------REIINHRSL 56
RYEPV E+G G +G RD + VA+K + RE+ R L
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 57 R---HPNIIRFKEVLLTPTH-----LAIVMEYAAGGEL----FARICSAGRFSEDEARFF 104
HPN++R +V T + +V E+ + + + +
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDL 125
Query: 105 FQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STV 161
+Q + G+ + H+ I HRDLK EN L+ +K+ DFG ++ +S V
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARI---YSYQMALTPVV 180
Query: 162 GTPAYIAPEVLARKEYDGKISDVWSCG 188
T Y APEVL + Y + D+WS G
Sbjct: 181 VTLWYRAPEVLLQSTYATPV-DMWSVG 206
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-31
Identities = 52/222 (23%), Positives = 87/222 (39%), Gaps = 29/222 (13%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF--- 64
VK++G G +G + K E VAVK ++ + EI +RH NI+ F
Sbjct: 42 VKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 65 -KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS------ 117
+ + T L ++ +Y G L+ + S +SG+ + H+
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 118 --MEICHRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPE 170
I HRDLK +N L+ + I D G + + + P + VGT Y+ PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 171 VLA------RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED 206
VL + D++S G+ L+ + E+
Sbjct: 217 VLDESLNRNHFQSYIMA-DMYSFGLILWEVARRCVSGGIVEE 257
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 66/213 (30%), Positives = 91/213 (42%), Gaps = 29/213 (13%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQ------REIINHR 54
RY + +G G +G+ D K VA+K KI E+ REI
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKILL 80
Query: 55 SLRHPNIIRFKEVLLTPTH-----LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI 109
RH NII +++ PT + IV + +L ++ S D +F Q++
Sbjct: 81 RFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQIL 138
Query: 110 SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPA 165
G+ Y HS + HRDLK N LL+ + LKICDFG ++ V T
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 166 YIAPEV-LARKEYDGKISDVWSCGVTLYVMLVG 197
Y APE+ L K Y I D+WS G L ML
Sbjct: 197 YRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSN 228
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 67/280 (23%), Positives = 108/280 (38%), Gaps = 44/280 (15%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKID-ENVQREIINHRSLRHP 59
+RYE +G+G++G DK K +VA+K I R ID + + REI L H
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 60 NIIRFKEVLLTPT-----HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
++++ ++++ L +V+E A + + +E + L+ GV Y
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--------- 165
HS I HRDLK N L++ +K+CDFG +++ S +
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 166 -------------------YIAPEV-LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE 205
Y APE+ L ++ Y I DVWS G +L
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIGCIFAELLNMIKENVAYH 288
Query: 206 DPRN--FR-KTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
R F + + Q D+ + R L+ IF
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIF 328
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 60/241 (24%), Positives = 95/241 (39%), Gaps = 53/241 (21%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
++Y K LG+G+FG+ V D + + A+K + + + RE+ + L H NI
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK---NRELDIMKVLDHVNI 62
Query: 62 IRFKEVLLTPTH--------------------------------------LAIVMEYAAG 83
I+ + T L ++MEY
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-P 121
Query: 84 GELFARI----CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR 139
L + S + + QL V + HS+ ICHRD+K +N L++
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-T 180
Query: 140 LKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLV 196
LK+CDFG +K L S + + Y APE+ L EY I D+WS G +++
Sbjct: 181 LKLCDFGSAKK--LIPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELIL 237
Query: 197 G 197
G
Sbjct: 238 G 238
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-30
Identities = 61/238 (25%), Positives = 97/238 (40%), Gaps = 36/238 (15%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKID-ENVQREIINHRSLRHP 59
+ Y +G G++G L DK T++ VA+K + R ID + + REI L+
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 60 NIIRFKEVLLTPTHLA-----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
IIR ++++ L IV+E A +L + +E+ + L+ G ++
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFG---------------------YSKSGLL 153
H I HRDLK N LL+ +K+CDFG
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 154 HSQPKST--VGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR 208
+ + + T V T Y APE+ L ++ Y I D+WS G +L + R
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTNR 259
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 19/206 (9%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKID-ENVQREIINHRSLRHP 59
+RY+ +K +GSG G+ D + VA+K + R + + RE++ + + H
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 60 NIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
NII V L IVME L I + + Q++ G+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIK 141
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV 171
+ HS I HRDLK N ++ LKI DFG +++ + T V T Y APEV
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 197
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVG 197
+ Y + D+WS G + M+ G
Sbjct: 198 ILGMGYKENV-DIWSVGCIMGEMIKG 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-30
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSLRH 58
+YE + ++G G FG R ++T + VA+K + + E REI + L+H
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKH 75
Query: 59 PNIIRFKEVLLTPTHLA--------IVMEYA----AGGELFARICSAGRFSEDEARFFFQ 106
N++ E+ T +V ++ AG L + + +F+ E + Q
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSEIKRVMQ 131
Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQP-KSTV 161
L++G+ Y H +I HRD+K N L+ LK+ DFG +S + + V
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 162 GTPAYIAPEVL-ARKEYDGKISDVWSCG 188
T Y PE+L ++Y I D+W G
Sbjct: 190 VTLWYRPPELLLGERDYGPPI-DLWGAG 216
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-30
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 19/206 (9%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKID-ENVQREIINHRSLRHP 59
+RY+ +K +GSG G+ D VA+K + R + + RE++ + + H
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 60 NIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
NII V L +VME L I + + Q++ G+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIK 178
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV 171
+ HS I HRDLK N ++ LKI DFG +++ + T V T Y APEV
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 234
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVG 197
+ Y + D+WS G + M+
Sbjct: 235 ILGMGYKENV-DIWSVGCIMGEMVRH 259
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-29
Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 1 MEERYEPVKE-LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL 56
+E+ +E +G G +G A+ +D + + A+K IE I + REI R L
Sbjct: 18 VEDLFEYEGCKVGRGTYGHVYKAK-RKDGKDDKDYALKQIEG-TGISMSACREIALLREL 75
Query: 57 RHPNIIRFKEVLLTPTHLAI--VMEYA--------AGGELFARICSAGRFSEDEARFFFQ 106
+HPN+I ++V L+ + + +YA + +
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPR--LKICDFG----YSKSGLLHSQPKST 160
Q++ G+ Y H+ + HRDLK N L+ G R +KI D G ++ +
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 161 VGTPAYIAPEVL-ARKEYDGKISDVWSCG 188
V T Y APE+L + Y I D+W+ G
Sbjct: 196 VVTFWYRAPELLLGARHYTKAI-DIWAIG 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 51/293 (17%), Positives = 96/293 (32%), Gaps = 54/293 (18%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ------------REI 50
Y + + SG++G D VA+K + V REI
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 51 INHRSLRHPNIIRFKEVLLTPTH-----LAIVMEYAAGGELFARI-CSAGRFSEDEARFF 104
HPNI+ +++ + L +V E +L I S ++F
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 105 FQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP 164
++ G+ H + HRDL N LL + + ICDF ++ + V
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITICDFNLAREDTADANKTHYVTHR 197
Query: 165 AYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED-----------PRNF 210
Y APE+ + K + + D+WS G + M + + P+
Sbjct: 198 WYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK-- 254
Query: 211 RKTIDRIRN------VQYFLPDYVRV---------SADCRHLLSQIFVADPSK 248
+ + + ++ L + L++++ +P +
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 51/229 (22%), Positives = 81/229 (35%), Gaps = 38/229 (16%)
Query: 4 RYEPVKELGSGNFGVARLVRDKR-TKELVAVK---------YIERGKKIDENVQREIINH 53
+YE + G G L D+ V +K E
Sbjct: 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM-------AMAERQFL 133
Query: 54 RSLRHPNIIR---FKEVLLTPTHLA--IVMEYAAGGELFARICSAGRFSEDEARFFFQQL 108
+ HP+I++ F E IVMEY G L + EA + ++
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEI 191
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIA 168
+ +SY HS+ + + DLK EN +L +LK+ D G + GTP + A
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQA 245
Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFED------PEDPRNFR 211
PE+ R +D+++ G TL + + PED +
Sbjct: 246 PEI-VRTGPTVA-TDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK 292
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 34/208 (16%)
Query: 3 ERYEPVKELGSGNFGVARLVRD-KRTKELVAVKYIERGKKIDENVQ-------REI---I 51
++YE V E+G G +G RD K VA+K + ++ + RE+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREVAVLR 66
Query: 52 NHRSLRHPNIIRFKEVLLTP-----THLAIVMEYAAGGEL----FARICSAGRFSEDEAR 102
+ + HPN++R +V T L +V E+ + + + +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIK 123
Query: 103 FFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-- 160
QL+ G+ + HS + HRDLK +N L+ S Q +K+ DFG ++ Q T
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARI--YSFQMALTSV 179
Query: 161 VGTPAYIAPEVLARKEYDGKISDVWSCG 188
V T Y APEVL + Y + D+WS G
Sbjct: 180 VVTLWYRAPEVLLQSSYATPV-DLWSVG 206
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 66/224 (29%), Positives = 96/224 (42%), Gaps = 34/224 (15%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKID-ENVQREIINHRSLR-H 58
+YE VK+LG G +G+ D+RT E+VAVK I D + REI+ L H
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 59 PNIIRFKEVLLTPT--HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
NI+ VL + +V +Y +L + A ++ QLI + Y H
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYLH 126
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST---------------- 160
S + HRD+K N LL+ +K+ DFG S+S + + +
Sbjct: 127 SGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 161 ------VGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVG 197
V T Y APE+ L +Y I D+WS G L +L G
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCG 227
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 30/223 (13%)
Query: 8 VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF-- 64
++ G FG V + VAVK K + E+ + ++H NI++F
Sbjct: 29 LEVKARGRFGCVWKAQLLNEY---VAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIG 85
Query: 65 --KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME--- 119
K L ++ + G L + A S +E + + G++Y H
Sbjct: 86 AEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 120 -------ICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAP 169
I HRD+K +N LL + I DFG + +G VGT Y+AP
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202
Query: 170 EVL-----ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP 207
EVL +++ + D+++ G+ L+ + + P D
Sbjct: 203 EVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDE 244
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 5e-27
Identities = 53/234 (22%), Positives = 82/234 (35%), Gaps = 43/234 (18%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF 64
++ +G G +G L + VAVK + + ++ I + H NI RF
Sbjct: 18 LELIGRGRYGAVYKGSL-----DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARF 72
Query: 65 -----KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+ +VMEY G L + S + + G++Y H+
Sbjct: 73 IVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYLHTEL 131
Query: 120 ---------ICHRDLKLENTLLDGSPQPRLKICDFGYSK---------SGLLHSQPKSTV 161
I HRDL N L+ I DFG S G + S V
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKN--DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 162 GTPAYIAPEVL------ARKEYDGKISDVWSCGVTLYVML---VGAYPFEDPED 206
GT Y+APEVL E K D+++ G+ + + +P E +
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-26
Identities = 55/237 (23%), Positives = 95/237 (40%), Gaps = 27/237 (11%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHRSLRH 58
RY V++LG G+F L +D VA+K + K E + EI +N
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 59 P------NIIRFKEVL----LTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQ 106
+I++ + H+ +V E G L + + +
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 107 QLISGVSYCHSME-ICHRDLKLENTLLDGSPQPR----LKICDFGYSKSGLLHSQPKSTV 161
QL+ G+ Y H I H D+K EN L++ P +KI D G + +++
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNSI 196
Query: 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR 218
T Y +PEVL + D+WS ++ ++ G + F +P++ ++ K D I
Sbjct: 197 QTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLF-EPDEGHSYTKDDDHIA 251
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 61/207 (29%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 4 RYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH---- 58
RYE +K +G G+FG V + D + + VA+K + K+ EI R L H
Sbjct: 98 RYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEHLRKQ 153
Query: 59 -----PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISG 111
N+I E H+ + E L+ I FS R F ++
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPE 170
+ H I H DLK EN LL + +K+ DFG S Q T + + Y APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFYRAPE 269
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG 197
V+ Y I D+WS G L +L G
Sbjct: 270 VILGARYGMPI-DMWSLGCILAELLTG 295
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-25
Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 8 VKELGSGNFGVARL----VRDKRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNII 62
+++LG GNFG + T E+VAVK + ++ + +REI +SL+H NI+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 63 RFKEVLLTPTH--LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
++K V + L ++MEY G L + + R + + Q+ G+ Y +
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLA 173
HRDL N L+ + R+KI DFG +K L + V P APE L
Sbjct: 134 RYIHRDLATRNILV-ENEN-RVKIGDFGLTKV-LPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 174 RKEYDGKISDVWSCGVTLY 192
++ SDVWS GV LY
Sbjct: 191 ESKFSVA-SDVWSFGVVLY 208
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 9e-25
Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 8 VKELGSGNFGVARL----VRDKRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNII 62
+++LG GNFG + T E+VAVK + ++ + +REI +SL+H NI+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 63 RFKEVLLTPTH--LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
++K V + L ++MEY G L + + R + + Q+ G+ Y +
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLA 173
HRDL N L+ + R+KI DFG +K L + V P APE L
Sbjct: 165 RYIHRDLATRNILV--ENENRVKIGDFGLTKV-LPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 174 RKEYDGKISDVWSCGVTLY 192
++ SDVWS GV LY
Sbjct: 222 ESKFSVA-SDVWSFGVVLY 239
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-24
Identities = 59/211 (27%), Positives = 82/211 (38%), Gaps = 21/211 (9%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPN 60
+++LG G+FGV VAVK ++ + I SL H N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSME 119
+IR V+LTP + +V E A G L R+ G F + Q+ G+ Y S
Sbjct: 83 LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYI---APEVLA 173
HRDL N LL + +KI DFG + L APE L
Sbjct: 142 FIHRDLAARNLLL-ATRD-LVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
+ + SD W GVTL+ + G P+
Sbjct: 198 TRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 58/205 (28%), Positives = 84/205 (40%), Gaps = 14/205 (6%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
+++G GNFG R + LVAVK D + +E + HPNI+R
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 66 EVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEICHRD 124
V + IVME GG+ + + G +G+ Y S HRD
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLARKEYDG 179
L N L+ + + LKI DFG S+ + G + APE L Y
Sbjct: 239 LAARNCLV--TEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 180 KISDVWSCGVTLY-VMLVGAYPFED 203
+ SDVWS G+ L+ +GA P+ +
Sbjct: 295 E-SDVWSFGILLWETFSLGASPYPN 318
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-24
Identities = 64/214 (29%), Positives = 88/214 (41%), Gaps = 20/214 (9%)
Query: 8 VKELGSGNFGV---ARLVRD-KRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNII 62
+ +LG GNFG R T LVAVK + G + QREI ++L I+
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 63 RFKEVLLTPTH--LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
+++ V P L +VMEY G L F + R + Q+ G+ Y S
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR 146
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLA 173
HRDL N L+ S +KI DFG +K L + V P APE L+
Sbjct: 147 RCVHRDLAARNILV-ESEA-HVKIADFGLAKL-LPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPED 206
+ + SDVWS GV LY + +
Sbjct: 204 DNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAE 236
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-24
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKEL-VAVKYIERGKKIDENVQREIINH----RSLRHP 59
+K LGSG FG + + ++ VA+K + +EI++ S+ +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNP 77
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHS 117
++ R + LT T + ++ + G L + R + Q+ G++Y
Sbjct: 78 HVCRLLGICLTST-VQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVL 172
+ HRDL N L+ +PQ +KI DFG +K LL ++ K + A E +
Sbjct: 136 RRLVHRDLAARNVLV-KTPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 173 ARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
+ Y + SDVWS GVT++ +M G+ P++
Sbjct: 192 LHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-24
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 22/201 (10%)
Query: 8 VKELGSGNFGV---ARLVRD-KRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPNI 61
+++LG G+FG R + T E VAVK + E G ++++EI R+L H NI
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 62 IRFKEVLLTPTH--LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHS 117
+++K + + ++ME+ G L + + + + + Q+ G+ Y S
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGS 144
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYI-----APEV 171
+ HRDL N L++ + ++KI DFG +K + + + TV APE
Sbjct: 145 RQYVHRDLAARNVLVES--EHQVKIGDFGLTK--AIETDKEYYTVKDDRDSPVFWYAPEC 200
Query: 172 LARKEYDGKISDVWSCGVTLY 192
L + ++ SDVWS GVTL+
Sbjct: 201 LMQSKFYIA-SDVWSFGVTLH 220
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 50/201 (24%), Positives = 81/201 (40%), Gaps = 8/201 (3%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
+LG G +G K+ VAVK ++ E +E + ++HPN+++ V
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 68 LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
I+ E+ G L + R C+ S + Q+ S + Y HR+L
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNL 344
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY--IAPEVLARKEYDGKISD 183
N L+ +K+ DFG S+ + APE LA ++ K SD
Sbjct: 345 AARNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SD 401
Query: 184 VWSCGVTLY-VMLVGAYPFED 203
VW+ GV L+ + G P+
Sbjct: 402 VWAFGVLLWEIATYGMSPYPG 422
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-23
Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 22/200 (11%)
Query: 8 VKELGSGNFGVARL----VRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPNI 61
+++LG G+FG L + T E+VAVK + + G + ++EI R+L H +I
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 62 IRFKEVLLTPTH--LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHS 117
I++K L +VMEY G L + + F QQ+ G++Y H+
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVL 172
HRDL N LL + + +KI DFG +K+ + V APE L
Sbjct: 153 QHYIHRDLAARNVLL-DNDR-LVKIGDFGLAKA-VPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 173 ARKEYDGKISDVWSCGVTLY 192
++ SDVWS GVTLY
Sbjct: 210 KEYKFYYA-SDVWSFGVTLY 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-23
Identities = 60/206 (29%), Positives = 87/206 (42%), Gaps = 16/206 (7%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP--- 59
+RYE +G G+FG D+ +E VA+K I+ K Q E+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 60 ---NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSY 114
I+ K + HL +V E L+ + + S + R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEM-LSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 115 CHSME--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV 171
+ E I H DLK EN LL + +KI DFG S Q + + Y +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEV 229
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVG 197
L YD I D+WS G L M G
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTG 254
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-22
Identities = 53/202 (26%), Positives = 85/202 (42%), Gaps = 10/202 (4%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
+LG G +G K+ VAVK ++ E +E + ++HPN+++ V
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 68 LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
I+ E+ G L + R C+ S + Q+ S + Y HRDL
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT--PA-YIAPEVLARKEYDGKIS 182
N L+ +K+ DFG S+ + + G P + APE LA ++ K S
Sbjct: 138 AARNCLV--GENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-S 193
Query: 183 DVWSCGVTLY-VMLVGAYPFED 203
DVW+ GV L+ + G P+
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPG 215
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-22
Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 18/207 (8%)
Query: 9 KELGSGNFGVAR--LVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIR 63
KELGSGNFG + + K+ + VAVK ++ + + + E + L +P I+R
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
+ + + +VME A G L + + Q+ G+ Y HR
Sbjct: 83 MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGT--P-AYIAPEVLARKEY 177
DL N LL + KI DFG SK L + K+ P + APE + ++
Sbjct: 142 DLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFED 203
K SDVWS GV ++ G P+
Sbjct: 198 SSK-SDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-22
Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKEL-VAVKYIERGKKIDENVQREIINH----RSLRHP 59
+K LGSG FG + + ++ VA+K + +EI++ S+ +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNP 77
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSM 118
++ R + LT T + ++ + G L + + Q+ G++Y
Sbjct: 78 HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLA 173
+ HRDL N L+ +PQ +KI DFG +K LL ++ K + A E +
Sbjct: 137 RLVHRDLAARNVLV-KTPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
+ Y + SDVWS GVT++ +M G+ P++
Sbjct: 193 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-22
Identities = 30/208 (14%), Positives = 54/208 (25%), Gaps = 35/208 (16%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHP 59
RY + G D VA+ +++ + ++ + + P
Sbjct: 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP 91
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+ R +V+ T +V E+ GG L S A Q L + H
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
+ + L PA +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVL---------------------AYPATMPDANPQ------ 182
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDP 207
D+ G +LY +LV +P +
Sbjct: 183 --DDIRGIGASLYALLVNRWPLPEAGVR 208
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-22
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKEL-VAVKYI--ERGKKIDENVQREIINHRSLRHPNI 61
+K LGSG FG + + + ++ V +K I + G++ + V ++ SL H +I
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+R + + L +V +Y G L R G + Q+ G+ Y
Sbjct: 78 VRLLGLCPGSS-LQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLAR 174
+ HR+L N LL SP ++++ DFG + LL K + + A A E +
Sbjct: 136 MVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 175 KEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
+Y + SDVWS GVT++ +M GA P+
Sbjct: 192 GKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-21
Identities = 51/201 (25%), Positives = 81/201 (40%), Gaps = 10/201 (4%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
+LG G FG + T VA+K ++ G E +E + LRH +++ V
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 68 LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
++ + IV EY + G L F + + + Q+ SG++Y M HRDL
Sbjct: 248 -VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 306
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY--IAPEVLARKEYDGKISD 183
+ N L+ K+ DFG ++ + APE + K SD
Sbjct: 307 RAANILV--GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SD 363
Query: 184 VWSCGVTLY-VMLVGAYPFED 203
VWS G+ L + G P+
Sbjct: 364 VWSFGILLTELTTKGRVPYPG 384
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-21
Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 16/208 (7%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNII 62
K +GSG+ G RL + VA+K ++ G + E HPNII
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 63 RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
R + V+ IV EY G L F R G+F+ + + + +G+ Y +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYI---APEVLARKE 176
HRDL N L+ K+ DFG S+ +T G I APE +A +
Sbjct: 173 VHRDLAARNVLV--DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFED 203
+ SDVWS GV ++ V+ G P+ +
Sbjct: 231 FSSA-SDVWSFGVVMWEVLAYGERPYWN 257
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-21
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF 64
V+E+GSG FG+ K+ VA+K I G +E+ E L HP +++
Sbjct: 13 VQEIGSGQFGLVHLGYW----LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 68
Query: 65 KEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
V L + +V E+ G L + R G F+ + + G++Y + H
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYDG 179
RDL N L+ +K+ DFG ++ +L Q S+ GT + +PEV + Y
Sbjct: 128 RDLAARNCLV--GENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 180 KISDVWSCGVTLY-VMLVGAYPFED 203
K SDVWS GV ++ V G P+E+
Sbjct: 185 K-SDVWSFGVLMWEVFSEGKIPYEN 208
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-21
Identities = 51/201 (25%), Positives = 81/201 (40%), Gaps = 10/201 (4%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
+LG G FG + T VA+K ++ G E +E + LRH +++ V
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 68 LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
++ + IV EY + G L F + + + Q+ SG++Y M HRDL
Sbjct: 331 -VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 389
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY--IAPEVLARKEYDGKISD 183
+ N L+ K+ DFG ++ + APE + K SD
Sbjct: 390 RAANILV--GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SD 446
Query: 184 VWSCGVTLY-VMLVGAYPFED 203
VWS G+ L + G P+
Sbjct: 447 VWSFGILLTELTTKGRVPYPG 467
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
K+LG+G FG + + + VAVK ++ G E E ++L+H +++ V
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 68 LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
+T + I+ E+ A G L F + + + F Q+ G+++ HRDL
Sbjct: 252 -VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYDGKIS 182
+ N L+ S KI DFG ++ + ++ + G I APE + + K S
Sbjct: 311 RAANILV--SASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-S 366
Query: 183 DVWSCGVTLY-VMLVGAYPFED 203
DVWS G+ L ++ G P+
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPG 388
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-21
Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENV--QREIINHRSLRHPNII 62
K +G+G FG RL + + VA+K ++ G + E HPNII
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 63 RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
R + V+ + IV EY G L F R +F+ + + + SG+ Y M
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYI---APEVLAR 174
HRDL N L+ + K+ DFG + +L P +T G I +PE +A
Sbjct: 169 VHRDLAARNILI--NSNLVCKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 175 KEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
+++ SDVWS G+ L+ VM G P+ +
Sbjct: 225 RKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-21
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 18/206 (8%)
Query: 10 ELGSGNFG-VAR-LVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFK 65
ELG GNFG V + + R ++ + VA+K +++G K E + RE L +P I+R
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 66 EVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
V + +VME A GG L F Q+ G+ Y HR
Sbjct: 77 GVCQAEALM-LVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLARKEYD 178
DL N LL + KI DFG SK+ L T + APE + +++
Sbjct: 135 DLAARNVLL-VNRH-YAKISDFGLSKA-LGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 179 GKISDVWSCGVTLY-VMLVGAYPFED 203
+ SDVWS GVT++ + G P++
Sbjct: 192 SR-SDVWSYGVTMWEALSYGQKPYKK 216
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 7e-21
Identities = 58/277 (20%), Positives = 97/277 (35%), Gaps = 67/277 (24%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHRSLR 57
RY +++LG G+F L D + K+ VA+K ++ + E EI + +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 58 HPN--IIR-----FKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQL 108
PN ++ FK + TH+ +V E G L + + + QQ+
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQV 155
Query: 109 ISGVSYCHS-MEICHRDLKLENTLLD---------------------------------- 133
+ G+ Y H+ I H D+K EN LL
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 134 -------------GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
+ + ++KI D G + H + T Y + EVL Y+
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI 217
D+WS + + G Y F +P + + D I
Sbjct: 274 A-DIWSTACMAFELATGDYLF-EPHSGEEYTRDEDHI 308
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-21
Identities = 56/203 (27%), Positives = 80/203 (39%), Gaps = 18/203 (8%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
++ +G G FG L + K VAVK I+ + E LRH N+++ V
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 68 -LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
+ L IV EY A G L + R D F + + Y HRD
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 314
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYDGKI 181
L N L+ S K+ DFG +K + + APE L K++ K
Sbjct: 315 LAARNVLV--SEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPEALREKKFSTK- 366
Query: 182 SDVWSCGVTLY-VMLVGAYPFED 203
SDVWS G+ L+ + G P+
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPR 389
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 1e-20
Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 20/208 (9%)
Query: 9 KELGSGNFGV---ARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIR 63
ELG GNFG K+ + VA+K +++G K E + RE L +P I+R
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
V + +VME A GG L + Q+ G+ Y H
Sbjct: 401 LIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYI---APEVLARKE 176
R+L N LL + KI DFG SK L + + + APE + ++
Sbjct: 460 RNLAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFED 203
+ + SDVWS GVT++ + G P++
Sbjct: 516 FSSR-SDVWSYGVTMWEALSYGQKPYKK 542
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-20
Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
V+ LG+G FG + + VAVK +++G + E + L+H ++R V
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 68 LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
+T + I+ EY G L F + S + + ++ Q+ G+++ HRDL
Sbjct: 77 -VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYDGKIS 182
+ N L+ S KI DFG ++ + ++ + G I APE + + K S
Sbjct: 136 RAANILV--SDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-S 191
Query: 183 DVWSCGVTLY-VMLVGAYPFED 203
DVWS G+ L ++ G P+
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPG 213
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-20
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF 64
+KELGSG FGV + + + VAVK I+ G ++ +E L HP +++F
Sbjct: 13 LKELGSGQFGVVKLGKW----KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF 68
Query: 65 KEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
V + IV EY + G L + R + + G+++ S + H
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYDG 179
RDL N L+ +K+ DFG ++ +L Q S+VGT + APEV +Y
Sbjct: 128 RDLAARNCLV--DRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 180 KISDVWSCGVTLY-VMLVGAYPFED 203
K SDVW+ G+ ++ V +G P++
Sbjct: 185 K-SDVWAFGILMWEVFSLGKMPYDL 208
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-20
Identities = 56/203 (27%), Positives = 80/203 (39%), Gaps = 18/203 (8%)
Query: 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
++ +G G FG L + K VAVK I+ + E LRH N+++ V
Sbjct: 26 LQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 68 -LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
+ L IV EY A G L + R D F + + Y HRD
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 142
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYDGKI 181
L N L+ S K+ DFG +K + + APE L K++ K
Sbjct: 143 LAARNVLV--SEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPEALREKKFSTK- 194
Query: 182 SDVWSCGVTLY-VMLVGAYPFED 203
SDVWS G+ L+ + G P+
Sbjct: 195 SDVWSFGILLWEIYSFGRVPYPR 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-20
Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 35/221 (15%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNI 61
+ LG G FG A+L ++ + VAVK ++ +++ RE + HP++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 62 IRF------KEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLI---- 109
+ +++ + G+L F A R E+ Q L+
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQTLVRFMV 144
Query: 110 ---SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 166
G+ Y S HRDL N +L + + DFG S+ ++S G +
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYYRQGCASK 200
Query: 167 I-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
+ A E LA Y SDVW+ GVT++ +M G P+
Sbjct: 201 LPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPY 240
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-20
Identities = 50/227 (22%), Positives = 89/227 (39%), Gaps = 38/227 (16%)
Query: 3 ERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHRSL 56
+ ++++G G FG V + K+ AVK + KK + + E I + +
Sbjct: 35 NAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSY 114
+ NI+++ + H+ ++ E G L+ I F ++ + + +++ ++Y
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 115 CHSMEICHRDLKLENTLLDGSP-----------------------QPRLKICDFGYSKSG 151
M + H DLK EN LLD +K+ DFG
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA 209
Query: 152 LLHSQPKST-VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVG 197
S + + T Y APEV+ +D D+WS G L + G
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTG 255
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-20
Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKEL-VAVKYIERGKKIDENV--QREIINHRSLRHPNI 61
K +G+G FG L KE+ VA+K ++ G + V E H NI
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
IR + V+ + I+ EY G L F R G FS + + + +G+ Y +M
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYI---APEVLARK 175
HRDL N L+ + K+ DFG S+ + +T G I APE ++ +
Sbjct: 168 YVHRDLAARNILV--NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 176 EYDGKISDVWSCGVTLY-VMLVGAYPFED 203
++ SDVWS G+ ++ VM G P+ +
Sbjct: 226 KFTSA-SDVWSFGIVMWEVMTYGERPYWE 253
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 7e-20
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF 64
+KELG+G FGV + R + VA+K I+ G ++ E +L H +++
Sbjct: 29 LKELGTGQFGVVKYGKW----RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 84
Query: 65 KEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
V + I+ EY A G L + R RF + + + + Y S + H
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYDG 179
RDL N L+ + Q +K+ DFG S+ +L + S+VG+ + PEVL ++
Sbjct: 144 RDLAARNCLV--NDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 180 KISDVWSCGVTLY-VMLVGAYPFED 203
K SD+W+ GV ++ + +G P+E
Sbjct: 201 K-SDIWAFGVLMWEIYSLGKMPYER 224
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-20
Identities = 56/222 (25%), Positives = 79/222 (35%), Gaps = 32/222 (14%)
Query: 3 ERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP-- 59
ERYE V LG G FG V + R K VA+K I K E + EI + ++
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 60 ----NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVS 113
+ + H+ I E G F + + R QL +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 114 YCHSMEICHRDLKLENTLLDGSP-----------------QPRLKICDFGYSKSGLLHSQ 156
+ H ++ H DLK EN L S +++ DFG S +
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHE 194
Query: 157 PKST-VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVG 197
+T V T Y PEV+ + DVWS G L+ G
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRG 235
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-19
Identities = 54/220 (24%), Positives = 84/220 (38%), Gaps = 34/220 (15%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNI 61
K LG G FG L ++ T VAVK ++ ++ E + HPN+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 62 IR-----FKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLI----- 109
IR + +++ + G+L + R Q L+
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS---RLETGPKHIPLQTLLKFMVD 155
Query: 110 --SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI 167
G+ Y + HRDL N +L + + DFG SK ++S G A +
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSK--KIYSGDYYRQGRIAKM 211
Query: 168 -----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
A E LA + Y K SDVW+ GVT++ + G P+
Sbjct: 212 PVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPY 250
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-19
Identities = 53/217 (24%), Positives = 80/217 (36%), Gaps = 28/217 (12%)
Query: 8 VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENV--QREIINHRSLRHPN 60
++ LG G FG + + + VAVK + + + E + H N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLI-------SG 111
I+R V L I+ME AGG+L F R + L+ G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPR--PSQPSSLAMLDLLHVARDIACG 152
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYI--- 167
Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVK 210
Query: 168 --APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
PE + K +D WS GV L+ + +G P+
Sbjct: 211 WMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-19
Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 17/207 (8%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNII 62
+ LG G FG K K VAVK ++ +D + E + ++L HP+I+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 63 RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+ ++ I+ME GEL + + + Q+ ++Y S+
Sbjct: 77 KLIGIIEEEPTW-IIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEY 177
HRD+ + N L+ +K+ DFG S+ + T I +PE + + +
Sbjct: 135 VHRDIAVRNILVASPEC--VKLGDFGLSRY-IEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFED 203
SDVW V ++ ++ G PF
Sbjct: 192 TTA-SDVWMFAVCMWEILSFGKQPFFW 217
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 52/217 (23%), Positives = 80/217 (36%), Gaps = 28/217 (12%)
Query: 8 VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENV--QREIINHRSLRHPN 60
++ LG G FG + + + VAVK + + + E + H N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLI-------SG 111
I+R V L I++E AGG+L F R + L+ G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR--PSQPSSLAMLDLLHVARDIACG 193
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYI--- 167
Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAGYYRKGGCAMLPVK 251
Query: 168 --APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
PE + K +D WS GV L+ + +G P+
Sbjct: 252 WMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 287
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-19
Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 17/207 (8%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNII 62
+ +G G FG + + VA+K + + E +E + R HP+I+
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 63 RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+ V+ I+ME GEL F + + QL + ++Y S
Sbjct: 80 KLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKRF 137
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT--PA-YIAPEVLARKEY 177
HRD+ N L+ S +K+ DFG S+ + S P ++APE + + +
Sbjct: 138 VHRDIAARNVLV--SSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFED 203
SDVW GV ++ +++ G PF+
Sbjct: 195 TSA-SDVWMFGVCMWEILMHGVKPFQG 220
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-19
Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 32/212 (15%)
Query: 8 VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSLRHPNI 61
+ELG G FG + + K LVAVK ++ QRE +L+H +I
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGEL--FARICS-------AGRFSEDEARFFFQQLI--- 109
++F V L +V EY G+L F R G+ + + Q++
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 110 ----SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA 165
SG+ Y S HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYRVGGHT 195
Query: 166 YI-----APEVLARKEYDGKISDVWSCGVTLY 192
+ PE + +++ + SDVWS GV L+
Sbjct: 196 MLPIRWMPPESIMYRKFTTE-SDVWSFGVILW 226
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-19
Identities = 64/223 (28%), Positives = 86/223 (38%), Gaps = 34/223 (15%)
Query: 3 ERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHR-- 54
RYE V LG G FG V + K VAVK ++ + E + EI +N
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 55 SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGV 112
+ ++ E H+ IV E G + I G F D R Q+ V
Sbjct: 74 NSTF-RCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 113 SYCHSMEICHRDLKLENTLLDGS-----------------PQPRLKICDFGYSKSGLLHS 155
++ HS ++ H DLK EN L S P +K+ DFG S
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188
Query: 156 QPKST-VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVG 197
+ ST V T Y APEV+ + DVWS G L +G
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLG 230
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 1e-18
Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNII 62
+ +G G FG + + VA+K + + E +E + R HP+I+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 63 RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+ V+ I+ME GEL F + + QL + ++Y S
Sbjct: 455 KLIGVITENPVW-IIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVG-TPA-YIAPEVLARKE 176
HRD+ N L+ S +K+ DFG S+ + K++ G P ++APE + +
Sbjct: 513 VHRDIAARNVLV--SSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFED 203
+ SDVW GV ++ +++ G PF+
Sbjct: 569 FTSA-SDVWMFGVCMWEILMHGVKPFQG 595
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-18
Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 32/221 (14%)
Query: 8 VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSLRHPNI 61
ELG G FG + ++ K LVAVK ++ + QRE L+H +I
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGEL--FARICS------AGRFSEDEARFFFQQLI---- 109
+RF V L +V EY G+L F R AG QL+
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 110 ---SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 166
+G+ Y + HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSRD--IYSTDYYRVGGRTM 221
Query: 167 I-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
+ PE + +++ + SDVWS GV L+ + G P+
Sbjct: 222 LPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-18
Identities = 46/217 (21%), Positives = 86/217 (39%), Gaps = 28/217 (12%)
Query: 8 VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENV--QREIINHRSLRHPN 60
+ELG G+FG VA+ V + VA+K + + E + E + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEAR--------FFFQQLIS 110
++R V+ ++ME G+L + R + ++
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI--- 167
G++Y ++ + HRDL N ++ + +KI DFG ++ ++ G +
Sbjct: 150 GMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVR 205
Query: 168 --APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
+PE L + SDVWS GV L+ + + P+
Sbjct: 206 WMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY 241
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 18/207 (8%)
Query: 9 KELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIR 63
+ +G G+FG L+ + K AVK + R I E Q E I + HPN++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 64 FKEVLLTPTH-LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+ L +V+ Y G+L F R + + F Q+ G+ + S +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLASKKF 213
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLARK 175
HRDL N +LD +K+ DFG ++ T A + A E L +
Sbjct: 214 VHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 176 EYDGKISDVWSCGVTLY-VMLVGAYPF 201
++ K SDVWS GV L+ +M GA P+
Sbjct: 272 KFTTK-SDVWSFGVLLWELMTRGAPPY 297
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-17
Identities = 37/217 (17%), Positives = 72/217 (33%), Gaps = 29/217 (13%)
Query: 8 VKELGSGNFGV-------ARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSL 56
+ LG G F + + V +K + K N L
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAASMMSKL 69
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSY 114
H +++ V + +V E+ G L + + + + +QL + + +
Sbjct: 70 SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHF 128
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRL------KICDFGYSKSGLLHSQPKSTVGTPAYIA 168
+ H ++ +N LL + K+ D G S + L + + ++
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI---PWVP 185
Query: 169 PEVLA-RKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
PE + K + +D WS G TL+ + G P
Sbjct: 186 PECIENPKNLNLA-TDKWSFGTTLWEICSGGDKPLSA 221
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-17
Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNII 62
+ +G G+FG L+ + K AVK + R I E Q E I + HPN++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 63 RFKEVLLTPTH-LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
+ L +V+ Y G+L F R + + F Q+ G+ Y S +
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLAR 174
HRDL N +LD +K+ DFG ++ T A + A E L
Sbjct: 149 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 175 KEYDGKISDVWSCGVTLY-VMLVGAYPF 201
+++ K SDVWS GV L+ +M GA P+
Sbjct: 207 QKFTTK-SDVWSFGVLLWELMTRGAPPY 233
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 7e-17
Identities = 45/223 (20%), Positives = 88/223 (39%), Gaps = 34/223 (15%)
Query: 8 VKELGSGNFG-----VARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPN 60
++ELG FG + VA+K ++ + E + E + L+HPN
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGEL---------FARICSAGRFSEDEARFFFQQLI-- 109
++ V+ L+++ Y + G+L + + S ++ +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 110 -----SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP 164
+G+ Y S + H+DL N L+ + +KI D G + +++ +
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR--EVYAADYYKLLGN 189
Query: 165 AYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
+ + APE + ++ SD+WS GV L+ V G P+
Sbjct: 190 SLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-16
Identities = 53/231 (22%), Positives = 85/231 (36%), Gaps = 42/231 (18%)
Query: 8 VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENV--QREIINHRSLRHPN 60
V+++G G FG A + +VAVK ++ D QRE +PN
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGEL-----------------FARICSAGRFSEDEARF 103
I++ V + ++ EY A G+L A S
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 104 FFQQLI-------SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
+ + +G++Y + HRDL N L+ +KI DFG S++ ++S
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN--IYSA 227
Query: 157 PKSTVGTPAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
I PE + Y + SDVW+ GV L+ + G P+
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-16
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 34/215 (15%)
Query: 9 KELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIR 63
+ +G G+FGV + + + A+K + R ++ + RE + R L HPN++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 64 FKEVLLT--PTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLI-------SGV 112
++L +++ Y G+L F R + + LI G+
Sbjct: 87 LIGIMLPPEGLPH-VLLPYMCHGDLLQFIR--------SPQRNPTVKDLISFGLQVARGM 137
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI----- 167
Y + HRDL N +LD S +K+ DFG ++ L A +
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 168 APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
A E L + K SDVWS GV L+ ++ GA P+
Sbjct: 196 ALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPY 229
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-16
Identities = 55/225 (24%), Positives = 85/225 (37%), Gaps = 37/225 (16%)
Query: 8 VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENV--QREI-INHRSLRHP 59
K LG+G FG A + VAVK ++ + E E+ + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGEL-----------FARICSAGRFSEDEARFFFQQL 108
NI+ ++ EY G+L S +DE + L
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 109 IS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 161
+S G+++ S HRDL N LL + KICDFG ++ + + V
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILL--THGRITKICDFGLAR--DIKNDSNYVV 203
Query: 162 GTPAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYP 200
A + APE + Y + SDVWS G+ L+ + +G+ P
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-16
Identities = 56/223 (25%), Positives = 85/223 (38%), Gaps = 41/223 (18%)
Query: 8 VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RHP 59
+G GNFG AR+ +D + A+K ++ ++ R+ + HP
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHP 86
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGEL--FARIC-------SAGRFSEDEARFFFQQLI- 109
NII +L + +EYA G L F R + + + QQL+
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 110 ------SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT 163
G+ Y + HRDL N L+ KI DFG S+ ++ T
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILV--GENYVAKIADFGLSRGQEVY-----VKKT 199
Query: 164 PAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYP 200
+ A E L Y SDVWS GV L+ ++ +G P
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-16
Identities = 58/231 (25%), Positives = 90/231 (38%), Gaps = 42/231 (18%)
Query: 8 VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENV--QREIINHRSLRHPN 60
K LG G FG A ++ + VAVK ++ E E + + HP+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGEL-----------------FARICSAGRFSEDEARF 103
+I+ L +++EYA G L S+ DE
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 104 FFQQLIS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
LIS G+ Y M++ HRDL N L+ + ++KI DFG S+ ++ +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV--AEGRKMKISDFGLSR--DVYEE 203
Query: 157 PKSTVGTPAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
+ I A E L Y + SDVWS GV L+ ++ +G P+
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 37/223 (16%)
Query: 8 VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----R 57
K LG+G FG A + + VAVK ++ DE + +++ + +
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE--KEALMSELKIMSHLGQ 108
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGEL--FAR-----ICSAGRFSEDEARFFFQQLIS 110
H NI+ + ++ EY G+L F R + + F+ + + L+
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 111 -------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT 163
G+++ S HRD+ N LL + KI DFG ++ + + V
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLAR--DIMNDSNYIVKG 224
Query: 164 PAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYP 200
A + APE + Y + SDVWS G+ L+ + +G P
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNP 266
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-15
Identities = 58/225 (25%), Positives = 91/225 (40%), Gaps = 37/225 (16%)
Query: 8 VKELGSGNFG-----VARLVRDKRTKE--LVAVKYIERGKKIDENV--QREIINHRSL-R 57
K LG G FG A + + KE VAVK ++ + E+ + + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGEL---------FARICSAGRFSEDEARFFFQQL 108
H NII L +++EYA+ G L S E + F+ L
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 109 IS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 161
+S G+ Y S + HRDL N L+ + +KI DFG ++ +++
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNIDYYKK 215
Query: 162 GTPAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYP 200
T + APE L + Y + SDVWS GV ++ + +G P
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSP 259
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-15
Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 37/226 (16%)
Query: 8 VKELGSGNFG-----VARLVRDKRTKE--LVAVKYIERGKKIDENV--QREIINHRSL-R 57
K LG G FG A + + KE VAVK ++ + E+ + + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGEL---------FARICSAGRFSEDEARFFFQQL 108
H NII L +++EYA+ G L S E + F+ L
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 109 IS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 161
+S G+ Y S + HRDL N L+ + +KI DFG ++ +++
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNIDYYKK 261
Query: 162 GTPAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
T + APE L + Y + SDVWS GV ++ + +G P+
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 306
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-15
Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 40/227 (17%)
Query: 8 VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----R 57
K LG G FG A + T VAVK ++ G E R +++ +
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGH 89
Query: 58 HPNIIRFKEV-LLTPTHLAIVMEYAAGGEL--FARIC-------SAGRFSEDEARFFFQQ 107
H N++ L +++E+ G L + R + +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 108 LIS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST 160
LI G+ + S + HRDL N LL S + +KICDFG ++ ++ P
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKDPDYV 205
Query: 161 VGTPAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
A + APE + + Y + SDVWS GV L+ + +GA P+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 251
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-15
Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 40/218 (18%)
Query: 8 VKELGSGNFG-----VARLVRDKRTKE--LVAVKYIERGKKIDENVQREIINHRSL---- 56
K LG G FG A + + VAVK ++ + ++I+ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMI 131
Query: 57 -RHPNIIRFKEVLLTPTHLAIVMEYAAGGEL--FARIC-------SAGRFSEDEARFFFQ 106
+H NII L +++EYA+ G L + + S E + +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 107 QLIS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159
L+S G+ Y S + HRDL N L+ + +KI DFG ++ +H
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLAR--DIHHIDYY 247
Query: 160 TVGTPAYI-----APEVLARKEYDGKISDVWSCGVTLY 192
T + APE L + Y + SDVWS GV L+
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLW 284
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-13
Identities = 50/182 (27%), Positives = 75/182 (41%), Gaps = 27/182 (14%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH----P 59
+ K++G GNFG RL ++ T E VA+K +E K + E ++ L P
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGG----ELFARICSAGRFSEDEARFFFQQLISGVSYC 115
+ F + A+V+E G +LF +C FS QLIS + Y
Sbjct: 69 QVYYFGP---CGKYNAMVLELL--GPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYV 121
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKIC---DFGYSK-----SGLLH---SQPKSTVGTP 164
HS + +RD+K EN L+ ++ DF +K H + KS GT
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181
Query: 165 AY 166
Y
Sbjct: 182 RY 183
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-13
Identities = 55/232 (23%), Positives = 83/232 (35%), Gaps = 46/232 (19%)
Query: 8 VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----R 57
K LGSG FG A + VAVK ++ E + +++ +
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE--REALMSELKMMTQLGS 107
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGEL----------------FARICSAGRFSEDEA 101
H NI+ + ++ EY G+L ED
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 102 RFFFQQLIS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154
F+ L+ G+ + HRDL N L+ + +KICDFG ++ +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV--THGKVVKICDFGLARD--IM 223
Query: 155 SQPKSTVGTPAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYP 200
S V A + APE L Y K SDVWS G+ L+ + +G P
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNP 274
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 39/182 (21%), Positives = 72/182 (39%), Gaps = 25/182 (13%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH---- 58
Y+ + +G G+FGV + + VA+K+ E + ++ E ++ L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAG---GELFARICSAGRFSEDEARFFFQQLISGVSYC 115
PN+ F + H +V++ G +L +C +FS +Q+++ V
Sbjct: 69 PNVYYFGQ---EGLHNVLVIDL-LGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSI 122
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLK---ICDFGYSK-----SGLLH---SQPKSTVGTP 164
H + +RD+K +N L+ + DFG K H + K+ GT
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 165 AY 166
Y
Sbjct: 183 RY 184
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 50/180 (27%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH---- 58
++ +++GSG+FG L + +T E VA+K E K + E +R L+
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAG---GELFARICSAGRFSEDEARFFFQQLISGVSYC 115
PN+ F + +VM+ G +LF CS + S Q+I+ V +
Sbjct: 66 PNVRWFGV---EGDYNVLVMDL-LGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFV 119
Query: 116 HSMEICHRDLKLENTLLD-GSPQPRLKICDFGYSK-----SGLLH---SQPKSTVGTPAY 166
HS HRD+K +N L+ G ++ I DFG +K S H + K+ GT Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-13
Identities = 51/180 (28%), Positives = 74/180 (41%), Gaps = 23/180 (12%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH---- 58
RY +++GSG+FG L D E VA+K E K + E ++ ++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAG---GELFARICSAGRFSEDEARFFFQQLISGVSYC 115
P I + +VME G +LF CS +FS Q+IS + Y
Sbjct: 68 PTIRWCGA---EGDYNVMVMEL-LGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYI 121
Query: 116 HSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSK-----SGLLH---SQPKSTVGTPAY 166
HS HRD+K +N L+ G + I DFG +K H + K+ GT Y
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.0 bits (152), Expect = 1e-11
Identities = 48/290 (16%), Positives = 77/290 (26%), Gaps = 76/290 (26%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREIIN 52
E+ + +++G G FG T VA+K I N + EII
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 53 HRSL---------RHPNIIRFKEV------------------------------LLTPTH 73
+ L R I V
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH-SMEICHRDLKLENTLL 132
L IV+E+ GG ++ + S A+ QL + ++ S+ HRDL N LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 133 DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY 192
K+ K ST+ + I D +
Sbjct: 196 K--KTSLKKLHYTLNGK--------SSTIPSCGLQVS-----------IIDYTLSRLERD 234
Query: 193 VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
++V D + F D ++ + H S +
Sbjct: 235 GIVVFCDVSMDEDL---FTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVL 281
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 6e-11
Identities = 40/149 (26%), Positives = 58/149 (38%), Gaps = 41/149 (27%)
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK------ST--VG 162
G+++ H HRD+K N LLD + KI DFG +++ K ++ VG
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARAS-----EKFAQTVMTSRIVG 197
Query: 163 TPAYIAPEVLARKEY-DGKI---SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR 218
T AY+AP E G+I SD++S GV L ++ G +D R
Sbjct: 198 TTAYMAP------EALRGEITPKSDIYSFGVVLLEIITG-------------LPAVDEHR 238
Query: 219 NVQYFLPDYVRVSADCRHLLSQIFVADPS 247
Q L D D + D
Sbjct: 239 EPQL-LLDIKEEIEDEEKTIEDY--IDKK 264
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 6e-10
Identities = 42/105 (40%), Positives = 52/105 (49%), Gaps = 13/105 (12%)
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STV--GTPAYI 167
G+ Y H+ I HRD+K N LLD + P KI DFG SK G Q STV GT YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYI 208
Query: 168 APEVLARKEYDGKI---SDVWSCGVTLYVMLVGAYPFEDPEDPRN 209
PE + G++ SDV+S GV L+ +L PR
Sbjct: 209 DPEYFIK----GRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPRE 248
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-09
Identities = 32/165 (19%), Positives = 60/165 (36%), Gaps = 20/165 (12%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR 63
++ K++GSG FG+ L E A ++ + + + E+ ++ + + I+
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 64 FKEVLLTPTHLAI-------------------VMEYAAGGELFARICSAGRFSEDEARFF 104
+L I VME G +L G F +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQL 156
Query: 105 FQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149
+++ + Y H E H D+K N LL ++ + D+G S
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 24/173 (13%), Positives = 57/173 (32%), Gaps = 31/173 (17%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRT--------KELVAVKYIERGKKIDENVQREIINHR 54
+++ N G+ T K+ ++K ++ N Q R
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQN--FFQR 98
Query: 55 SLRHPNIIRFKEVLLTPT---------------HLAIVMEYAAG---GELFARICSAGRF 96
+ + + ++K++ TP + +V+ G +
Sbjct: 99 AAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSAL-DVSPKHVL 156
Query: 97 SEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149
SE +L+ + + H E H ++ EN +D Q ++ + +G++
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-08
Identities = 34/117 (29%), Positives = 55/117 (47%), Gaps = 11/117 (9%)
Query: 104 FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT 163
+ Q+ G+ + S + HRDL N LL +KICDFG ++ ++ P
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKG 253
Query: 164 PAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTI 214
A + APE + + Y + SDVWS GV L+ + +GA P+ + F + +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 3e-08
Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 53/211 (25%)
Query: 11 LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQRE------IINHRSLRHPNI 61
LG G FG RL D LVAVK ++ + + + + +I+ H N+
Sbjct: 38 LGRGGFGKVYKGRL-ADGT---LVAVKRLKEERT--QGGELQFQTEVEMISM--AVHRNL 89
Query: 62 IRFKEVLL----TPTHLAIVMEYAAGGELFARI--CSAGRFSED-EARFFFQQLISGV-- 112
+R L TPT +V Y A G + + + + D R ++ G
Sbjct: 90 LR----LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ---RIALGSAR 142
Query: 113 --SYCHSMEIC-----HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGT 163
+Y H + C HRD+K N LLD + + DFG +K +T GT
Sbjct: 143 GLAYLH--DHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAKLMDYKDTHVTTAVRGT 198
Query: 164 PAYIAPEVLARKEYDGKI---SDVWSCGVTL 191
+IAPE L+ GK +DV+ GV L
Sbjct: 199 IGHIAPEYLST----GKSSEKTDVFGYGVML 225
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 6e-07
Identities = 32/201 (15%), Positives = 74/201 (36%), Gaps = 37/201 (18%)
Query: 2 EERYEP-VKELGSGNFG--VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH 58
EE + V+E+ N+ ++ + ++R ++ YIE+ ++ + Q + S R
Sbjct: 76 EEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RL 134
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSEDEARFFFQQL-ISGVS 113
++ ++ LL V+ G + +C + + + + F+ ++ +
Sbjct: 135 QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKV---QCKMDFKIFWLN-LK 190
Query: 114 YCHSME--------ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA 165
C+S E + ++ + D S +L+I LL S+P
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN----C 246
Query: 166 YIAPEVLARKEYDGKISDVWS 186
+ VL +V +
Sbjct: 247 LL---VL-----L----NVQN 255
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-07
Identities = 27/170 (15%), Positives = 52/170 (30%), Gaps = 27/170 (15%)
Query: 4 RYEPVKELGSGNFGVARLVRDK-----RTKELVAVK---------------YIERGKKID 43
++ +G G FG L + VK Y K
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 44 ENVQREIINHRSLRHPNIIRF-KEVLLTPTHLAIVMEYAAG---GELFARICSAGRFSED 99
+ L P ++ ++M+ G +++ + RFS
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIY-EANA-KRFSRK 152
Query: 100 EARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149
+++ + Y H E H D+K N LL+ ++ + D+G +
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 269 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.57 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.37 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.18 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.05 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 99.01 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.88 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.74 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.64 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.61 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.53 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.38 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.35 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.32 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.23 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 98.13 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.07 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.02 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.9 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.87 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.86 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.81 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.7 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.68 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.42 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.38 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.24 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.64 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 94.86 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 94.57 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.88 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-67 Score=415.25 Aligned_cols=252 Identities=40% Similarity=0.628 Sum_probs=211.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||+||+|.+..+|+.||+|++.+.. ...+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999999999999999987542 23356889999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||+ +|+|.+.+.+.+++++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+|..........
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~~~ 169 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDGNFLK 169 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC----------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCCCccC
Confidence 999 5799999999999999999999999999999999999999999999999998887 9999999997655455556
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...||+.|+|||++.+..+++.++|||||||++|+|+||..||...+. ......+......++. .+|+++.+||
T Consensus 170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~li 243 (275)
T 3hyh_A 170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI----PVLFKNISNGVYTLPK--FLSPGAAGLI 243 (275)
T ss_dssp -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCT--TSCHHHHHHH
T ss_pred CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHcCCCCCCC--CCCHHHHHHH
Confidence 678999999999999888777779999999999999999999986443 3445556666666665 7999999999
Q ss_pred HHHhhhCCCCCCCcHHHhhccChhh
Q 024336 239 SQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.+||++||++|||++|+++|+|++.
T Consensus 244 ~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHccCChhHCcCHHHHHcCccccc
Confidence 9999999999999999999999963
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-67 Score=419.37 Aligned_cols=253 Identities=30% Similarity=0.478 Sum_probs=225.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++++.||+|+||+||+|++..+|+.||+|++.+. ....+.+.+|+.++++++|||||+++++|.+++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999999999999999999753 234467899999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC---C
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---S 155 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~---~ 155 (269)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+|...... .
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTTTCC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCCCcc
Confidence 99999999999999999999999999999999999999999999999999999998888 999999999753322 2
Q ss_pred CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
...+.+||+.|+|||++.+..++ .++|||||||++|+|+||.+||...+. ..+...+....+.+|. .+++++.
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~ 262 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNE----GLIFAKIIKLEYDFPE--KFFPKAR 262 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCT--TCCHHHH
T ss_pred cccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCc--ccCHHHH
Confidence 23456899999999999887774 459999999999999999999987543 4455666667777776 7999999
Q ss_pred HHHHHHhhhCCCCCCCcHH------HhhccChhhh
Q 024336 236 HLLSQIFVADPSKDPHSRD------QKASLVPEEF 264 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~------~l~~~~~~~~ 264 (269)
+||.+||.+||++|||++| +++||||+.+
T Consensus 263 dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 9999999999999999998 5889999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-65 Score=415.41 Aligned_cols=253 Identities=25% Similarity=0.432 Sum_probs=219.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
+.|++++.||+|+||+||+|.+..+|+.||||++.... ...+.+.+|+.+++.++|||||+++++|.+++.+|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999997543 33456889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCcc
Q 024336 82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKST 160 (269)
Q Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~ 160 (269)
+||+|.+++.+ +++++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|...... ......
T Consensus 154 ~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 154 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCC
T ss_pred CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCccccc
Confidence 99999998865 56999999999999999999999999999999999999998888 999999999754333 234566
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc-cccCCCcCCCCHHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 239 (269)
+||+.|+|||++.+..++. ++|||||||++|+|++|.+||.+.+... ....+... ....+.+..+|+++.+||.
T Consensus 231 ~GTp~YmAPEvl~~~~y~~-~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~~~~~~~~~~~~~~s~~~~dli~ 305 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGP-EVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIRDNLPPRLKNLHKVSPSLKGFLD 305 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred ccCcCcCCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence 8999999999998777755 4999999999999999999998755433 22333332 2334445579999999999
Q ss_pred HHhhhCCCCCCCcHHHhhccChhh
Q 024336 240 QIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+||.+||++|||++|+++|+|+..
T Consensus 306 ~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 306 RLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHcCCChhHCcCHHHHhcCHhhcC
Confidence 999999999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-65 Score=410.34 Aligned_cols=253 Identities=29% Similarity=0.514 Sum_probs=215.5
Q ss_pred ccccccceecccCceEEEEEEEe---cCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
++|++++.||+|+||+||+|++. .+++.||+|++.+.. .....+.+|+.++++++|||||++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999984 467899999986532 233467889999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CC
Q 024336 77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HS 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~ 155 (269)
||||++||+|.+++.+.+.+++..+..++.|++.||+|||++||+||||||+||+++.++. +||+|||+|+.... ..
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEK 181 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC-----C
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCCCc
Confidence 9999999999999999999999999999999999999999999999999999999998888 99999999975332 33
Q ss_pred CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
......||+.|+|||++.+..++.+ +|||||||++|+|+||.+||.+.+. .+....+......+|. .+|+++.
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~ 254 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDR----KETMTMILKAKLGMPQ--FLSPEAQ 254 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred cccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCH----HHHHHHHHcCCCCCCC--cCCHHHH
Confidence 3456689999999999988777655 9999999999999999999987544 3444555566666665 7999999
Q ss_pred HHHHHHhhhCCCCCCCc-----HHHhhccChhhh
Q 024336 236 HLLSQIFVADPSKDPHS-----RDQKASLVPEEF 264 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~-----~~~l~~~~~~~~ 264 (269)
+||.+||++||++|||+ +|+++|+||+.+
T Consensus 255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 99999999999999995 799999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-65 Score=416.19 Aligned_cols=254 Identities=29% Similarity=0.484 Sum_probs=212.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|++++.||+|+||+||+|++..+|+.||||++..... ..+.+.+|+.++++++|||||++++++.+++.+|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 689999999999999999999999999999999976432 23568899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-C
Q 024336 80 YAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-Q 156 (269)
Q Consensus 80 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~ 156 (269)
||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...... .
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCHHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecCCccc
Confidence 99999999999654 35799999999999999999999999999999999999998887 9999999997533221 1
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....||+.|+|||++.+..++. ++|||||||++|+|+||.+||...+. ......+...... +.+..+|+++.+
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~-~~DiwSlGvilyemltG~~PF~~~~~----~~~~~~i~~~~~~-~~~~~~s~~~~~ 255 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNN-KSDIWALGCVLYELCTLKHAFEAGSM----KNLVLKIISGSFP-PVSLHYSYDLRS 255 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHTCCC-CCCTTSCHHHHH
T ss_pred ccccCCCccccCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcCH----HHHHHHHHcCCCC-CCCccCCHHHHH
Confidence 23456999999999998877754 59999999999999999999987544 3334444444432 223478999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
||.+||++||++|||++|+|+|+|+..-
T Consensus 256 li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999999999999999999999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-64 Score=415.98 Aligned_cols=253 Identities=25% Similarity=0.437 Sum_probs=219.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
++|++++.||+|+||.||+|.+..+|+.||||++.... ...+.+.+|+.+++.++|||||+++++|.+++.+|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 57999999999999999999999999999999997543 33456889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCcc
Q 024336 82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKST 160 (269)
Q Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~ 160 (269)
+||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|...... ......
T Consensus 231 ~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 231 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCCC
T ss_pred CCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCcccccc
Confidence 99999998854 56999999999999999999999999999999999999998888 999999999754333 234456
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc-cccCCCcCCCCHHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 239 (269)
+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||.+.+... ....+... ...++.+..+|+++.+||.
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~~~~~~~~~~~~~~s~~~~dli~ 382 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIRDNLPPRLKNLHKVSPSLKGFLD 382 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred ccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence 89999999999988777554 999999999999999999998755433 22333332 2334445579999999999
Q ss_pred HHhhhCCCCCCCcHHHhhccChhh
Q 024336 240 QIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+||..||++|||+.|+|+|+|+..
T Consensus 383 ~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 383 RLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHcCCChhHCcCHHHHhcCHHhcC
Confidence 999999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-64 Score=398.66 Aligned_cols=253 Identities=22% Similarity=0.341 Sum_probs=211.6
Q ss_pred ccc-cccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEe----CCeE
Q 024336 3 ERY-EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLT----PTHL 74 (269)
Q Consensus 3 ~~y-~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 74 (269)
.+| ++.+.||+|+||+||+|.+..++..||+|.+..... ..+.+.+|+.++++++|||||+++++|.+ +..+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 344 677889999999999999999999999999875432 23568899999999999999999999875 3568
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecC-CCCCcEEEeecCCcccC
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDG-SPQPRLKICDFGYSKSG 151 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~p~ni~i~~-~~~~~~~l~df~~~~~~ 151 (269)
|+||||++||+|.+++.+.+.+++..+..++.||+.||+|||++| |+||||||+|||++. ++. +||+|||+|+..
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~--vKl~DFGla~~~ 182 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLK 182 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC--EEECCTTGGGGC
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC--EEEEeCcCCEeC
Confidence 999999999999999999999999999999999999999999999 999999999999974 566 999999999742
Q ss_pred CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
.........||+.|+|||++.+ .+ +.++|||||||++|+|+||..||........+ ...+.........+...+
T Consensus 183 -~~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~---~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 183 -RASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQI---YRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp -CTTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH---HHHHTTTCCCGGGGGCCC
T ss_pred -CCCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH---HHHHHcCCCCCCCCccCC
Confidence 2233445689999999998864 45 45599999999999999999999876554333 333333322222233678
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+++.+||.+||++||++|||++|+++|||++.
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-63 Score=404.01 Aligned_cols=253 Identities=24% Similarity=0.314 Sum_probs=212.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
+.|++.+.||+|+||.||+|++..+|+.||||++..... ..+|+.+++.++|||||++++++.+++.+|+||||++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 457888999999999999999999999999999976533 2469999999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC------
Q 024336 83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ------ 156 (269)
Q Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~------ 156 (269)
||+|.+++.+.+++++..+..++.||+.||+|||++||+||||||+|||++.++. ++||+|||+|........
T Consensus 134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC-----------
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccceec
Confidence 9999999999899999999999999999999999999999999999999987762 399999999974332221
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC-CCcCCCCHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL-PDYVRVSADCR 235 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (269)
.....||+.|+|||++.+..++.+ +|||||||++|+|+||.+||............. ...... .-+..+|+++.
T Consensus 213 ~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~----~~~~~~~~~~~~~s~~~~ 287 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA----SEPPPIREIPPSCAPLTA 287 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH----HSCCGGGGSCTTSCHHHH
T ss_pred CCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH----cCCCCchhcCccCCHHHH
Confidence 223469999999999988777555 999999999999999999998766544433332 222211 11237899999
Q ss_pred HHHHHHhhhCCCCCCCcHHH-------------hhccChhhhh
Q 024336 236 HLLSQIFVADPSKDPHSRDQ-------------KASLVPEEFA 265 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~-------------l~~~~~~~~~ 265 (269)
+||.+||++||.+|||+.|+ ++|||+..+.
T Consensus 288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 99999999999999999998 4688877654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-61 Score=399.96 Aligned_cols=261 Identities=25% Similarity=0.383 Sum_probs=218.3
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEe------C
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLT------P 71 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 71 (269)
+.++|++++.||+|+||+||+|.+..+|+.||||++...... .+.+.+|+.+++.++|||||++++++.. .
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 357899999999999999999999999999999999754332 2457789999999999999999998764 3
Q ss_pred CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 72 THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 72 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
+.+|+||||++ |+|.+++.+.+++++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||+++..
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~ 208 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGL 208 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeec
Confidence 57999999996 579999988899999999999999999999999999999999999999998887 999999999743
Q ss_pred CC-----CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcccc---
Q 024336 152 LL-----HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--- 223 (269)
Q Consensus 152 ~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~--- 223 (269)
.. ........||+.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.+....+.............
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 22 2233456899999999999887776777999999999999999999998876655554443332211100
Q ss_pred -------------CCC---------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 224 -------------LPD---------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 224 -------------~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
++. ...+++++.+||.+||..||.+|||++|+|+|||+..+
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 010 12468899999999999999999999999999999865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-60 Score=388.51 Aligned_cols=258 Identities=22% Similarity=0.354 Sum_probs=208.7
Q ss_pred CcccccccceecccCceEEEEEEEe---cCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 76 (269)
+.++|++.+.||+|+||+||+|++. .+++.||+|.+.... ....+.+|+.+++.+ +||||++++++|.+++.+|+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 3578999999999999999999985 457889999886543 345678899999988 69999999999999999999
Q ss_pred EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC-CCCcEEEeecCCcccCCCCC
Q 024336 77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~-~~~~~~l~df~~~~~~~~~~ 155 (269)
||||++|++|.+++. .+++.+++.++.||+.||+|||++||+||||||+||+++.+ +. +||+|||+|+......
T Consensus 98 vmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~--~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 98 AMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKK--YALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE--EEECCCTTCEECTTCS
T ss_pred EEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCe--EEECcCCCCcccCCcc
Confidence 999999999999883 58999999999999999999999999999999999999865 44 9999999986322111
Q ss_pred -----------------------------CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Q 024336 156 -----------------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED 206 (269)
Q Consensus 156 -----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~ 206 (269)
......||+.|+|||++.+....+.++||||+||++|+|+||..||....+
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 122346999999999998776556669999999999999999999976555
Q ss_pred hhhHHHHHHHH-----------------------------------hhcc--------------ccCCCcCCCCHHHHHH
Q 024336 207 PRNFRKTIDRI-----------------------------------RNVQ--------------YFLPDYVRVSADCRHL 237 (269)
Q Consensus 207 ~~~~~~~~~~~-----------------------------------~~~~--------------~~~~~~~~~~~~~~~l 237 (269)
.......+..+ .... .....+..+|+++.+|
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 43222211110 0000 0112234688999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
|.+||..||++|||++|+|+||||+.+
T Consensus 333 l~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-60 Score=381.44 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=198.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCC--------
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPT-------- 72 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 72 (269)
++|++++.||+|+||+||+|++..+|+.||+|.+..... ..+.+.+|+.++++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 469999999999999999999999999999999875432 2356889999999999999999999987544
Q ss_pred ----eEEEEEeecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeec
Q 024336 73 ----HLAIVMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDF 145 (269)
Q Consensus 73 ----~~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df 145 (269)
.+|+|||||++|+|.+++..... .+...++.++.||+.||+|||++||+||||||+||+++.++. +||+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DF 162 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDF 162 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccC
Confidence 37999999999999999987654 445678899999999999999999999999999999998887 999999
Q ss_pred CCcccCCCCCC-------------CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHH
Q 024336 146 GYSKSGLLHSQ-------------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK 212 (269)
Q Consensus 146 ~~~~~~~~~~~-------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~ 212 (269)
|+|+....... .....||+.|+|||++.+..++. ++|||||||++|+|++ ||... .....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~-~~DiwSlGvilyell~---Pf~~~---~~~~~ 235 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSH-KVDIFSLGLILFELLY---PFSTQ---MERVR 235 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCT-HHHHHHHHHHHHHHHS---CCSSH---HHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCC-HHHHHHHHHHHHHHcc---CCCCc---cHHHH
Confidence 99874322211 12346999999999998877755 4999999999999996 77542 12222
Q ss_pred HHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
....+...... +.+...++...+||.+||++||.+|||+.|+++|+|++.+.
T Consensus 236 ~~~~~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 236 TLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 23333332211 11224567788999999999999999999999999998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-60 Score=382.44 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=206.0
Q ss_pred cccccccceecccCceEEEEEEEe-----cCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
.++|.+.+.||+|+||+||++++. .++..||||.+.... ...+.+.+|+.++++++|||||++++++.+++.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 367999999999999999999874 358899999987543 23456899999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEE
Q 024336 76 IVMEYAAGGELFARICSA-------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKI 142 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l 142 (269)
+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++. +||
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~Ki 169 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKI 169 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--EEE
Confidence 999999999999999764 35899999999999999999999999999999999999998887 999
Q ss_pred eecCCcccCCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHh
Q 024336 143 CDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIR 218 (269)
Q Consensus 143 ~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~ 218 (269)
+|||+++...... ......+|+.|+|||.+.+..++.+ +||||||+++|||+| |..||...+.. +....+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~~i~ 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIECIT 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHH
Confidence 9999997432222 2233458999999999988877555 999999999999999 89999876543 3333344
Q ss_pred hccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhh
Q 024336 219 NVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKA 257 (269)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 257 (269)
.+.. .+.+..+|+++.+||.+||+.||++|||++|+..
T Consensus 245 ~~~~-~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 245 QGRV-LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp HTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCC-CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3332 2233479999999999999999999999999965
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-59 Score=407.80 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=220.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHH---HHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQRE---IINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e---~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
++|++++.||+|+||.||+|++..+|+.||+|++.+.. .......+| +.+++.++|||||+++++|.+++.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 68999999999999999999999999999999997532 222233333 56667789999999999999999999
Q ss_pred EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.+++ +||+|||+|.... ..
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~-~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFS-KK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECS-SC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeecC-CC
Confidence 99999999999999999999999999999999999999999999999999999999999988 9999999997533 33
Q ss_pred CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
...+.+||+.|+|||++..+..++.++|+|||||++|+|++|.+||....... .......+......+|. .+|+++.
T Consensus 346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~~~~~p~--~~S~~a~ 422 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPD--SFSPELR 422 (689)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCCCCCc--cCCHHHH
Confidence 34567899999999999765545666999999999999999999997644322 23445555566666665 7999999
Q ss_pred HHHHHHhhhCCCCCCC-----cHHHhhccChhhh
Q 024336 236 HLLSQIFVADPSKDPH-----SRDQKASLVPEEF 264 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps-----~~~~l~~~~~~~~ 264 (269)
+||.+||.+||.+|++ ++|+++|+||+.+
T Consensus 423 dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 9999999999999998 6999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-60 Score=378.42 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=200.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
+++++.+.||+|+||+||++++.. .||||++.... ...+.+.+|+.++++++|||||++++++.+ +.+++|||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 578899999999999999998753 48999986433 233568899999999999999999998764 56899999
Q ss_pred ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC---C
Q 024336 80 YAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---S 155 (269)
Q Consensus 80 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~---~ 155 (269)
|+++|+|.+++... .++++..+..++.|++.||+|||+++|+||||||+|||++.++. +||+|||+|...... .
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC--------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceecccCCcce
Confidence 99999999999654 57999999999999999999999999999999999999998887 999999999743221 2
Q ss_pred CCCcccCCCcccCchhhccc--cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 156 QPKSTVGTPAYIAPEVLARK--EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
......||+.|+|||++.+. ...+.++||||||+++|||+||..||...+....+................+..+|++
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 269 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA 269 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence 23455799999999998643 2345569999999999999999999987766544443332211111111123468999
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+.+||.+||+.||++|||+.|+++++
T Consensus 270 l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 270 MKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp HHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 99999999999999999999988764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-59 Score=381.42 Aligned_cols=249 Identities=27% Similarity=0.373 Sum_probs=202.9
Q ss_pred ccccccceecccCceEEEEEEEe-----cCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
++|.+.+.||+|+||+||++++. .++..||||++.... ...+.+.+|+.++++++|||||++++++.+++.+++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56788899999999999999864 468899999987543 234578999999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEE
Q 024336 77 VMEYAAGGELFARICSA---------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLK 141 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~ 141 (269)
||||+++|+|.+++.+. +++++.++..++.|++.||.|||+.+|+||||||+||+++.++. +|
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~--~K 198 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VK 198 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--EE
Confidence 99999999999998653 35899999999999999999999999999999999999998887 99
Q ss_pred EeecCCcccCCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHH
Q 024336 142 ICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRI 217 (269)
Q Consensus 142 l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~ 217 (269)
|+|||+++...... ......+|+.|+|||.+.+..++.+ +||||||+++|||+| |..||......+ ....+
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~----~~~~i 273 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTE----AIDCI 273 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSCHHH----HHHHH
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCCHHH----HHHHH
Confidence 99999997432222 2234568999999999988877554 999999999999999 899998765433 23333
Q ss_pred hhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
..+. ..+.+..+|+++.+||.+||+.||++|||+.|+++++
T Consensus 274 ~~g~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L 314 (329)
T 4aoj_A 274 TQGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314 (329)
T ss_dssp HHTC-CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHH
T ss_pred HcCC-CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 3322 2233347999999999999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=377.90 Aligned_cols=249 Identities=23% Similarity=0.371 Sum_probs=208.0
Q ss_pred ccccccceecccCceEEEEEEEe-----cCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
.++++.+.||+|+||+||++... .+++.||||.+.... ...+.+.+|+.++++++|||||++++++.+++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 46788899999999999999863 467899999986432 33467999999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCc
Q 024336 76 IVMEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR 139 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~ 139 (269)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+++||||||+||+++.++.
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~-- 183 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN-- 183 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC--
Confidence 999999999999999643 35899999999999999999999999999999999999998887
Q ss_pred EEEeecCCcccCCCC---CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHH
Q 024336 140 LKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTID 215 (269)
Q Consensus 140 ~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~ 215 (269)
+||+|||+++..... .......+|+.|+|||.+.+..++.+ +||||||+++|||+| |..||.+.+.. ....
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~~~~----~~~~ 258 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQ----DVVE 258 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTCCHH----HHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCHH----HHHH
Confidence 999999998743222 22344578999999999988877555 999999999999998 89999876543 2333
Q ss_pred HHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 216 RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+.... ..+.+..+|+.+.+||.+||+.||++|||+.|+++++
T Consensus 259 ~i~~~~-~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 259 MIRNRQ-VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 333332 2333448999999999999999999999999998874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-59 Score=405.13 Aligned_cols=257 Identities=28% Similarity=0.496 Sum_probs=223.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
++|++++.||+|+||.||+|.+..+|+.||+|++.... ...+.+.+|+.+++.++||||++++++|.+++.+|+||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 68999999999999999999999999999999987543 23456889999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcc
Q 024336 82 AGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST 160 (269)
Q Consensus 82 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (269)
+||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+||+++.+..+.+||+|||++............
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~ 316 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 316 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEE
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeee
Confidence 99999999864 45799999999999999999999999999999999999998764445999999999865555555566
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC--CcCCCCHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLL 238 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li 238 (269)
.||+.|+|||++.+..+. .++|||||||++|+|++|.+||.+.+. ......+....+.++ .+..+|+++.+||
T Consensus 317 ~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~dli 391 (573)
T 3uto_A 317 TGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSGISEDGKDFI 391 (573)
T ss_dssp CSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred EECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 899999999999887774 459999999999999999999987654 334445555544433 3457899999999
Q ss_pred HHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 239 SQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
.+||..||.+|||+.|+|+|+|+...
T Consensus 392 ~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 392 RKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp HTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHccCChhHCcCHHHHhcCcCcCCC
Confidence 99999999999999999999999753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=376.00 Aligned_cols=262 Identities=78% Similarity=1.275 Sum_probs=226.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++++.||+|+||+||++++..+++.||+|++.......+.+.+|+.+++.++||||+++++++.+.+.+++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 47899999999999999999999999999999999887777788999999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCccc
Q 024336 82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 161 (269)
Q Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 161 (269)
++++|.+++...+++++..++.++.|++.||.|||+.|++||||||+||+++.++.++++|+|||++.............
T Consensus 99 ~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 178 (361)
T 3uc3_A 99 SGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 178 (361)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCc
Confidence 99999999988889999999999999999999999999999999999999987776679999999987544445555667
Q ss_pred CCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHH
Q 024336 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241 (269)
Q Consensus 162 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 241 (269)
+++.|+|||.+.+..+.++++||||||+++|+|++|..||...............+.......+....+++++.+||.+|
T Consensus 179 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 258 (361)
T 3uc3_A 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRI 258 (361)
T ss_dssp --CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHH
T ss_pred CCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHH
Confidence 99999999999888877777999999999999999999999877766777777777777777777778999999999999
Q ss_pred hhhCCCCCCCcHHHhhccChhh
Q 024336 242 FVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 242 l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
|..||.+|||+.|+++|+|+..
T Consensus 259 L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 259 FVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp SCSCTTTSCCHHHHHTSHHHHT
T ss_pred ccCChhHCcCHHHHHhCcchhc
Confidence 9999999999999999999954
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-57 Score=367.60 Aligned_cols=254 Identities=37% Similarity=0.620 Sum_probs=226.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|++.+.||+|+||.||++.+..+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++.+++.+++|||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 689999999999999999999999999999999876432 23457789999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCc
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 159 (269)
|+++++|.+++...+++++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++...........
T Consensus 95 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~ 172 (328)
T 3fe3_A 95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLDA 172 (328)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGGGT
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCcccc
Confidence 9999999999988889999999999999999999999999999999999999998887 99999999975544444556
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
..+++.|+|||.+.+..+.+.++||||||+++|+|++|..||.+.+. ......+.......|. .+++++.+||.
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~li~ 246 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL----KELRERVLRGKYRIPF--YMSTDCENLLK 246 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHHHHHH
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCC--CCCHHHHHHHH
Confidence 67999999999999888877779999999999999999999987543 3444555555555555 68999999999
Q ss_pred HHhhhCCCCCCCcHHHhhccChhhh
Q 024336 240 QIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+||..||.+|||++|+++|+|+...
T Consensus 247 ~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 247 RFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HHCCCChhHCcCHHHHhcCHhhcCC
Confidence 9999999999999999999999764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-58 Score=373.97 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=207.2
Q ss_pred cccccccceecccCceEEEEEEEecC-----CeEEEEEEeecCcc--ccHHHHHHHHHHHhCCC-CCcceeeEEEEeC-C
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRT-----KELVAVKYIERGKK--IDENVQREIINHRSLRH-PNIIRFKEVLLTP-T 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~-~ 72 (269)
.++|++.+.||+|+||+||+|.+..+ ++.||+|.+..... ..+.+.+|+.+++++.| ||||+++++|.++ +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 36899999999999999999998754 36799999875432 23468899999999965 9999999998765 5
Q ss_pred eEEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC
Q 024336 73 HLAIVMEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP 136 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~ 136 (269)
.+++|||||++|+|.+++.+. ..+++..+..++.||+.||.|||+++++||||||+||+++.++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence 689999999999999999653 3489999999999999999999999999999999999999888
Q ss_pred CCcEEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 024336 137 QPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRK 212 (269)
Q Consensus 137 ~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~ 212 (269)
. +||+|||+|+....... .....+|+.|+|||.+.+..++.+ +|||||||++|||+| |..||.+......+..
T Consensus 223 ~--vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 223 V--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp C--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred C--EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 7 99999999975433222 223467899999999988877554 999999999999998 8999987665444333
Q ss_pred HHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+ ..+ ..++.+..+++++.++|.+||+.||++|||+.|+++|+
T Consensus 300 ~i---~~g-~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L 342 (353)
T 4ase_A 300 RL---KEG-TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342 (353)
T ss_dssp HH---HHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HH---HcC-CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 32 222 22233337899999999999999999999999999985
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-56 Score=365.97 Aligned_cols=259 Identities=31% Similarity=0.521 Sum_probs=223.9
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-------ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSLRHPNIIRFKEVLLTPTH 73 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (269)
+.++|++.+.||+|+||.||++.+..+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 35789999999999999999999999999999999976432 23678899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC--CcEEEeecCCcccC
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ--PRLKICDFGYSKSG 151 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~--~~~~l~df~~~~~~ 151 (269)
+++||||++|++|.+++...+.+++..+..++.||+.||.|||+.|++|+||||+||+++.++. ..++|+|||++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 9999999999999999988888999999999999999999999999999999999999987662 24999999999765
Q ss_pred CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC--cCC
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 229 (269)
..........+++.|+|||.+.+..++. ++|+||||+++|+|++|..||.+.... .....+......++. +..
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~ 244 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQ----ETLANITAVSYDFDEEFFSQ 244 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHTTCCCCCHHHHTT
T ss_pred CCCCccccCCCCccEECchHHcCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCCCCCchhccC
Confidence 5444555667999999999998776654 499999999999999999999875543 334444444444332 247
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 230 VSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+++.+.+||.+||..||.+|||+.|+++|||+...
T Consensus 245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 89999999999999999999999999999999854
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=357.52 Aligned_cols=253 Identities=32% Similarity=0.557 Sum_probs=221.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++++.||+|+||.||++++..+|+.||+|++.+. ......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 6899999999999999999999999999999999753 234456889999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~ 157 (269)
||++|++|.+.+.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++. ++|+|||++..... ....
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~~ 162 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATM 162 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCCB
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCCcc
Confidence 99999999999998889999999999999999999999999999999999999998887 99999999875322 2234
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....+|+.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+. ......+......++. .+++++.++
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~l 235 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFPR--TLSPEAKSL 235 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred cccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCCCCC--CCCHHHHHH
Confidence 45678999999999987776554 9999999999999999999987543 2334444445555555 789999999
Q ss_pred HHHHhhhCCCCCC-----CcHHHhhccChhhh
Q 024336 238 LSQIFVADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 238 i~~~l~~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
|.+||+.||.+|| +++|+++|+|+..+
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999 89999999999764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-56 Score=358.86 Aligned_cols=254 Identities=22% Similarity=0.243 Sum_probs=195.4
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCC----eEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT----HLAI 76 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~ 76 (269)
|.++|.+.+.||+|+||+||++++ +|+.||||++..........+.|+..+.+++|||||++++++.+++ .+++
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 578899999999999999999987 5889999998765433334456777778899999999999998654 5899
Q ss_pred EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeecCCCCcEEecCCCCCcEEEeecCCc
Q 024336 77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM--------EICHRDLKLENTLLDGSPQPRLKICDFGYS 148 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------~i~H~di~p~ni~i~~~~~~~~~l~df~~~ 148 (269)
||||+++|+|.+++.. .++++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++
T Consensus 79 V~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla 155 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTC
T ss_pred EecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCC
Confidence 9999999999999965 4689999999999999999999987 9999999999999998887 999999998
Q ss_pred ccCCCCC-----CCCcccCCCcccCchhhcccc-----CCCccchhhhHHHHHHHHHhCCCCCCCCCCh-----------
Q 024336 149 KSGLLHS-----QPKSTVGTPAYIAPEVLARKE-----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDP----------- 207 (269)
Q Consensus 149 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~----------- 207 (269)
+...... ......||+.|+|||.+.+.. ..+.++|||||||++|||+||.+||......
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 6432222 122456999999999987542 1244599999999999999998776432211
Q ss_pred hhHHHHHHHHhhccc--cCCCc---CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 208 RNFRKTIDRIRNVQY--FLPDY---VRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 208 ~~~~~~~~~~~~~~~--~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.........+..... ..|.. ...++.+.+|+.+||+.||++|||+.|+++.+
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 292 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 112222222222221 22221 11235688999999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-56 Score=361.48 Aligned_cols=260 Identities=23% Similarity=0.415 Sum_probs=222.9
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+.++|++.+.||+|+||.||++.+..+++.||+|.+.........+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 46899999999999999999999999999999999876655556788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCc
Q 024336 81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 159 (269)
+++++|.+.+...+ .+++..++.++.|++.||.|||+.|++|+||||+||+++.+..+.++|+|||++...........
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 162 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccc
Confidence 99999999997654 69999999999999999999999999999999999999874344599999999975444444445
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC--cCCCCHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHL 237 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 237 (269)
..+++.|+|||.+.+..++ .++||||||+++|+|++|..||...... .....+......++. +..+++++.+|
T Consensus 163 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 163 LFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQ----QIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp EESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred ccCChhhcCcHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcCCCHH----HHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 5689999999999876654 4599999999999999999999876543 333444444433332 34689999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
|.+||..||.+|||+.|+++|+|+....
T Consensus 238 i~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 238 VDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 9999999999999999999999997643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-55 Score=359.96 Aligned_cols=253 Identities=33% Similarity=0.512 Sum_probs=218.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++++.||+|+||.||++++..+|+.||+|++.+. ....+.+.+|..+++.+ +||||+++++++.+.+.+|+|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 6899999999999999999999999999999998753 23345677899999888 799999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~ 156 (269)
|||++|++|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++..... ...
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~~~~ 180 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICNGVT 180 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC----
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecccCCcc
Confidence 999999999999999899999999999999999999999999999999999999998888 99999999874322 233
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+|+.|+|||.+.+..++.. +|+||||+++|+|++|..||...+. ......+......++. .+++++.+
T Consensus 181 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~~~~~~~ 253 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENE----DDLFEAILNDEVVYPT--WLHEDATG 253 (353)
T ss_dssp -----CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHHH
T ss_pred ccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCC--CCCHHHHH
Confidence 445679999999999987777554 9999999999999999999987554 3444555556666665 68999999
Q ss_pred HHHHHhhhCCCCCCCc------HHHhhccChhhh
Q 024336 237 LLSQIFVADPSKDPHS------RDQKASLVPEEF 264 (269)
Q Consensus 237 li~~~l~~~p~~Rps~------~~~l~~~~~~~~ 264 (269)
+|.+||..||.+||++ +|+++|+|+..+
T Consensus 254 li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 9999999999999999 899999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=360.12 Aligned_cols=257 Identities=26% Similarity=0.457 Sum_probs=221.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++++.||+|+||.||++++..+++.||+|++.+.. ...+.+.+|..+++++ +||||+++++++.+++.+++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 58999999999999999999999999999999997642 2234577899988776 899999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC-CCCCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG-LLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~-~~~~~ 156 (269)
|||++|++|...+.+.+.+++..++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++... .....
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~~ 209 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDT 209 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecccCCCc
Confidence 999999999999998889999999999999999999999999999999999999998888 999999999752 23334
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh-----hhHHHHHHHHhhccccCCCcCCCC
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----RNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
.....+|+.|+|||.+.+..++. ++|+||||+++|+|++|..||...... .........+......+|. .++
T Consensus 210 ~~~~~gt~~Y~aPE~l~~~~~~~-~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s 286 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLS 286 (396)
T ss_dssp BCCCCBCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--TSC
T ss_pred cccccCCcccCCchhhcCCCCCh-HHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--cCC
Confidence 45667999999999998877754 499999999999999999999643321 1223344555556666666 799
Q ss_pred HHHHHHHHHHhhhCCCCCCCc------HHHhhccChhhh
Q 024336 232 ADCRHLLSQIFVADPSKDPHS------RDQKASLVPEEF 264 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~------~~~l~~~~~~~~ 264 (269)
+++.+||.+||+.||.+||++ +|+++|+||..+
T Consensus 287 ~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 999999999999999999996 799999999865
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=351.09 Aligned_cols=251 Identities=33% Similarity=0.550 Sum_probs=221.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++++..+|+.||+|++.+.. ...+.+.+|..+++.++||||+++++++.+...+++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 68999999999999999999999999999999987532 34456788999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||++|++|.+++.+.+.+++..++.++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++... .....
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~--~~~~~ 161 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYV--PDVTY 161 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEEC--SSCBC
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceec--CCccc
Confidence 99999999999998889999999999999999999999999999999999999998887 999999999743 22334
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...+|+.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.. .....+......++. .+++++.++|
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~p~--~~~~~~~~li 234 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTM----KTYEKILNAELRFPP--FFNEDVKDLL 234 (318)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHCCCCCCT--TSCHHHHHHH
T ss_pred cccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCC--CCCHHHHHHH
Confidence 5678999999999987776555 99999999999999999999875442 334444455555555 7899999999
Q ss_pred HHHhhhCCCCCC-----CcHHHhhccChhhh
Q 024336 239 SQIFVADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 239 ~~~l~~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
.+||..||++|| +++++++|+|+..+
T Consensus 235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 999999999999 99999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-55 Score=356.12 Aligned_cols=258 Identities=33% Similarity=0.571 Sum_probs=220.8
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-------ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
.++|++.+.||+|+||.||++.+..+|..||+|++..... ..+.+.+|+.+++.++||||+++++++.++...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4689999999999999999999999999999999875432 246788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC--CcEEEeecCCcccCC
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ--PRLKICDFGYSKSGL 152 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~--~~~~l~df~~~~~~~ 152 (269)
++||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ..++|+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 999999999999999988888999999999999999999999999999999999999987761 249999999997654
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC--cCCC
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRV 230 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 230 (269)
.........+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||........ ...+......++. +..+
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 244 (326)
T 2y0a_A 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQET----LANVSAVNYEFEDEYFSNT 244 (326)
T ss_dssp TTSCCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHHTCCCCCHHHHTTS
T ss_pred CCCccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHH----HHHHHhcCCCcCccccccC
Confidence 4444556679999999999987766554 9999999999999999999987554332 2333333333321 2368
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
++.+.+||.+||..||.+|||+.|+++|+|+...
T Consensus 245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 8999999999999999999999999999999753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=360.11 Aligned_cols=252 Identities=41% Similarity=0.701 Sum_probs=219.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+++.||+|++... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6899999999999999999999999999999998643 233467889999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||+ +|+|.+.+...+.+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..........
T Consensus 89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~~~ 165 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFLK 165 (336)
T ss_dssp CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBTTC
T ss_pred ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCcccc
Confidence 999 6799999988889999999999999999999999999999999999999998887 9999999997655555556
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...+++.|+|||.+.+..+.+.++||||||+++|+|++|..||........ ...+.......+. .+++++.+||
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~li 239 (336)
T 3h4j_B 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----FKKVNSCVYVMPD--FLSPGAQSLI 239 (336)
T ss_dssp CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----BCCCCSSCCCCCT--TSCHHHHHHH
T ss_pred cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----HHHHHcCCCCCcc--cCCHHHHHHH
Confidence 678999999999998877767779999999999999999999976543221 1122222333343 6899999999
Q ss_pred HHHhhhCCCCCCCcHHHhhccChhh
Q 024336 239 SQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.+||..||.+|||++|+++|+|++.
T Consensus 240 ~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp HTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred HHHcCCChhHCcCHHHHHhChhhcc
Confidence 9999999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-54 Score=345.86 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=218.1
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++|++.+.||+|+||+||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 468999999999999999999999999999999987543 3345688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 159 (269)
+++++|.+++... .+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++....... ....
T Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~ 175 (297)
T 3fxz_A 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 175 (297)
T ss_dssp CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCC
T ss_pred CCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCcccccCC
Confidence 9999999999664 6899999999999999999999999999999999999998887 9999999986433322 2334
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
..+++.|+|||.+.+..++.+ +||||||+++|+|+||..||............ .............+++.+.+||.
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~ 251 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFLN 251 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHHCSCCCSCGGGSCHHHHHHHH
T ss_pred ccCCcCccChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhCCCCCCCCccccCHHHHHHHH
Confidence 578999999999988777554 99999999999999999999876543332222 22222233334478999999999
Q ss_pred HHhhhCCCCCCCcHHHhhccChhhh
Q 024336 240 QIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+||+.||.+|||+.|+++|+|++..
T Consensus 252 ~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 252 RCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHccCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=354.93 Aligned_cols=253 Identities=34% Similarity=0.547 Sum_probs=220.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++.+.||+|+||.||++++..+|+.||+|++.+. ....+....|..+++.+ +||||+++++++.+.+.+|+|
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 6899999999999999999999999999999999753 23445677888888876 899999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~ 156 (269)
|||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++..... ...
T Consensus 97 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~ 174 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAK 174 (345)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhcccCCCc
Confidence 999999999999998888999999999999999999999999999999999999998887 99999999874322 223
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+|+.|+|||.+.+..++. ++|+||||+++|+|++|..||...+. ......+......++. .+++++.+
T Consensus 175 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~ 247 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILLGQKYNH-SVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIRMDNPFYPR--WLEKEAKD 247 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHHH
T ss_pred ccCCCCCcccCChhhhcCCCCCC-hhhhHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHhCCCCCCc--ccCHHHHH
Confidence 44567899999999998877654 49999999999999999999987544 3344445555555555 68999999
Q ss_pred HHHHHhhhCCCCCCCcH-HHhhccChhhh
Q 024336 237 LLSQIFVADPSKDPHSR-DQKASLVPEEF 264 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~-~~l~~~~~~~~ 264 (269)
+|.+||..||.+||++. ++++|+|+..+
T Consensus 248 li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 99999999999999998 99999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=350.78 Aligned_cols=257 Identities=27% Similarity=0.463 Sum_probs=219.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc----cHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++++.||+|+||.||++++..+++.||+|++.+.... .+.+.+|..+++++ +||||+++++++.+++.+++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 6899999999999999999999999999999999864322 23477899999887 899999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC-CCCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~-~~~~ 156 (269)
|||+++++|.+++.+.+.+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++.... ....
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~~~~ 166 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDT 166 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCTTCC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCCCCc
Confidence 999999999999988888999999999999999999999999999999999999998887 9999999987432 2233
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh-----hhHHHHHHHHhhccccCCCcCCCC
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----RNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
.....+++.|+|||.+.+..++. ++|+||||+++|+|++|..||...... .........+......++. .++
T Consensus 167 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s 243 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLS 243 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--TSC
T ss_pred ccccCCCccccCccccCCCCCCh-HHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--CCC
Confidence 44567899999999998877644 599999999999999999999753221 1223344445555555555 789
Q ss_pred HHHHHHHHHHhhhCCCCCCCc------HHHhhccChhhh
Q 024336 232 ADCRHLLSQIFVADPSKDPHS------RDQKASLVPEEF 264 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~------~~~l~~~~~~~~ 264 (269)
.++.++|.+||..||.+||++ .|+++|+|+..+
T Consensus 244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 999999999999999999996 799999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-54 Score=353.61 Aligned_cols=251 Identities=31% Similarity=0.513 Sum_probs=221.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++++.||+|+||.||++++..+|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999986532 34456888999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||++|++|.+++.+.+.+++..++.++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++.... ....
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~--~~~~ 196 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVK--GRTW 196 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECS--SCBC
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceecc--CCcc
Confidence 99999999999998889999999999999999999999999999999999999998887 9999999997432 2334
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...+++.|+|||.+.+..++. ++|+||||+++|+|++|..||..... ......+......++. .+++++.++|
T Consensus 197 ~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~~~~~~~li 269 (350)
T 1rdq_E 197 TLCGTPEALAPEIILSKGYNK-AVDWWALGVLIYEMAAGYPPFFADQP----IQIYEKIVSGKVRFPS--HFSSDLKDLL 269 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TCCHHHHHHH
T ss_pred cccCCccccCHHHhcCCCCCC-cCCEecccHhHhHHhhCCCCCCCCCH----HHHHHHHHcCCCCCCC--CCCHHHHHHH
Confidence 567899999999998777654 49999999999999999999987543 3344455555555555 7899999999
Q ss_pred HHHhhhCCCCCCC-----cHHHhhccChhhh
Q 024336 239 SQIFVADPSKDPH-----SRDQKASLVPEEF 264 (269)
Q Consensus 239 ~~~l~~~p~~Rps-----~~~~l~~~~~~~~ 264 (269)
.+||+.||.+||+ ++++++|+|+..+
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 9999999999999 9999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-54 Score=363.28 Aligned_cols=258 Identities=31% Similarity=0.530 Sum_probs=218.7
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.++|++.+.||+|+||+||++.+..+|+.+|+|++..... ..+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 4789999999999999999999999999999999876432 2345789999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC-CCCcEEEeecCCcccCCCCC-C
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHS-Q 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~-~~~~~~l~df~~~~~~~~~~-~ 156 (269)
||++|++|.+.+...+.+++..+..++.||+.||.|||+.|++||||||+||+++.+ ..+.++|+|||++....... .
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~ 169 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence 999999999999998899999999999999999999999999999999999999843 22349999999997433322 2
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC--CCcCCCCHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADC 234 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 234 (269)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++|.+||..... ......+......+ +.+..+++++
T Consensus 170 ~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQ----HRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred eecccCCcccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHhCCCCCCccccccCCHHH
Confidence 234578999999999987777554 9999999999999999999987554 33334444444433 3445789999
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
.+||.+||+.||.+|||+.|+++|+|+...
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999999999999999999999999999754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-54 Score=355.35 Aligned_cols=258 Identities=31% Similarity=0.537 Sum_probs=221.7
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.++|++.+.||+|+||.||++.+..+|..||+|++..... ..+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3679999999999999999999999999999999975432 2346788999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC-CcEEEeecCCcccCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~-~~~~l~df~~~~~~~~~~~~ 157 (269)
||+++++|.+.+.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ..++|+|||++.........
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 99999999999988888999999999999999999999999999999999999986543 45999999999765444444
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC--CCcCCCCHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCR 235 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (269)
....+++.|+|||.+.+..++. ++||||||+++|+|++|.+||..... ......+......+ +.+..+++++.
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKKDPYSK-PVDIWACGVILYILLVGYPPFWDEDQ----HRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp CCSCSCTTTCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred ccCCCCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 5567999999999998776655 49999999999999999999987544 23334444444433 33457899999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+||.+||..||.+|||+.|+++|+|+...
T Consensus 263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=347.35 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=214.6
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
+.++|++++.||+|+||+||++.+. +|+.||+|.+...... ...+.+|+.++++++||||+++++++.+++.+++|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 4689999999999999999999985 5889999998754322 35678999999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-C
Q 024336 78 MEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-S 155 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~ 155 (269)
|||+++ +|.+.+... ..+++..++.++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++...... .
T Consensus 98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVR 174 (311)
T ss_dssp EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSCCC
T ss_pred EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecCCCcc
Confidence 999986 777777654 45999999999999999999999999999999999999998887 999999998743322 2
Q ss_pred CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcccc-CC---------
Q 024336 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LP--------- 225 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~--------- 225 (269)
......+++.|+|||.+.+....+.++||||||+++|+|++|..||...................... ++
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 33345689999999999876555666999999999999999999998877766665555433321110 00
Q ss_pred --------------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 226 --------------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 226 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
....+++++.+||.+||+.||++|||++|+++|+|++.+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 01246789999999999999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-54 Score=355.70 Aligned_cols=257 Identities=24% Similarity=0.419 Sum_probs=223.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++++.||+|+||.||++.+..+++.||+|++... ......+.+|+.+++.++||||+++++++.+.+.+++|+
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 6899999999999999999999999999999998653 233457889999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||+.|++|..++...+.+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..........
T Consensus 95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~~ 172 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRETQIT 172 (384)
T ss_dssp CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTCCBC
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccCCCcee
Confidence 99999999999998889999999999999999999999999999999999999998887 9999999997655455556
Q ss_pred cccCCCcccCchhhccc--cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 159 STVGTPAYIAPEVLARK--EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
...+|+.|+|||.+... ...+.++|+||||+++|+|++|..||...... ........+......++. .+++.+.+
T Consensus 173 ~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~p~--~~s~~~~~ 249 (384)
T 4fr4_A 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-SSKEIVHTFETTVVTYPS--AWSQEMVS 249 (384)
T ss_dssp CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-CHHHHHHHHHHCCCCCCT--TSCHHHHH
T ss_pred ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhhcccCCCC--cCCHHHHH
Confidence 67899999999998743 22345599999999999999999999754432 233444455555555555 78999999
Q ss_pred HHHHHhhhCCCCCCC-cHHHhhccChhhh
Q 024336 237 LLSQIFVADPSKDPH-SRDQKASLVPEEF 264 (269)
Q Consensus 237 li~~~l~~~p~~Rps-~~~~l~~~~~~~~ 264 (269)
||.+||..||.+||+ +++++.|+|+..+
T Consensus 250 li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 250 LLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp HHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred HHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 999999999999999 8999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=342.82 Aligned_cols=261 Identities=23% Similarity=0.387 Sum_probs=211.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|++++.||+|+||+||++.+..+++.||+|++...... ...+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999999999999999999754332 3567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCCC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPK 158 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~ 158 (269)
|++++.+..+....+.+++..++.++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++..... .....
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSCCC
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCcccccc
Confidence 9987444444444678999999999999999999999999999999999999998887 99999999874322 22334
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChh-hHHHHHHHHhhccc-cC------------
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR-NFRKTIDRIRNVQY-FL------------ 224 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~-~~------------ 224 (269)
...+++.|+|||.+.+....+.++||||||+++|+|++|..||....+.. .............. .+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence 55789999999999877755666999999999999999888754444333 33332222211100 00
Q ss_pred ----------CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 225 ----------PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 225 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.....+++++.+||.+||+.||++|||++|+++|+|+..+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 01124788999999999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-54 Score=351.59 Aligned_cols=258 Identities=34% Similarity=0.555 Sum_probs=219.2
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 5799999999999999999999999999999999864432 23568899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC---CCC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---HSQ 156 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~---~~~ 156 (269)
|+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++..... ...
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCcccc
Confidence 9999999999988888999999999999999999999999999999999999998887 99999999863221 122
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+++.|+|||.+.+..+.+.++||||||+++|+|++|..||.......... ..........+.+..+++.+.+
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 240 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---SDWKEKKTYLNPWKKIDSAPLA 240 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH---HHHHTTCTTSTTGGGSCHHHHH
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHHhcccccCCccccCCHHHHH
Confidence 2345789999999999887776667999999999999999999998765532222 1222223334445578999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
||.+||..||.+|||+.|+++|+|+...
T Consensus 241 li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 241 LLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHccCChhhCcCHHHHhhChhhccc
Confidence 9999999999999999999999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=351.85 Aligned_cols=253 Identities=32% Similarity=0.488 Sum_probs=220.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++++.||+|+||.||++++..+++.||+|++.+. ....+.+..|..+++.+ +||+|+++++++.+.+.+|+|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 6899999999999999999999999999999998753 23445678899999887 799999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~ 156 (269)
|||++|++|.+++.+.+.+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..... ...
T Consensus 100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~ 177 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGVT 177 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCcccccccCCcc
Confidence 999999999999998888999999999999999999999999999999999999998887 99999999975322 233
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+++.|+|||.+.+..++. ++|+||||+++|+|++|..||...+. ......+......++. .+++++.+
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~ 250 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAYQPYGK-SVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYPK--SMSKEAVA 250 (353)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBST-HHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHHH
T ss_pred cccccCCccccChhhhcCCCcCC-cccccchHHHHHHHHcCCCCCCCCCH----HHHHHHHHhCCCCCCC--CCCHHHHH
Confidence 44567899999999998777654 49999999999999999999987544 3344455555556665 79999999
Q ss_pred HHHHHhhhCCCCCCC-----cHHHhhccChhhh
Q 024336 237 LLSQIFVADPSKDPH-----SRDQKASLVPEEF 264 (269)
Q Consensus 237 li~~~l~~~p~~Rps-----~~~~l~~~~~~~~ 264 (269)
||.+||..||.+||+ ++++++|+|+..+
T Consensus 251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 999999999999995 5999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-54 Score=364.69 Aligned_cols=253 Identities=38% Similarity=0.666 Sum_probs=223.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+.+++|+
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 68999999999999999999999999999999987532 23457889999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||+++++|.+++.+.+.+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..........
T Consensus 96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~~~ 173 (476)
T 2y94_A 96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLR 173 (476)
T ss_dssp ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTCCBC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhcccccccc
Confidence 99999999999988888999999999999999999999999999999999999998887 9999999997654444455
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...+++.|+|||.+.+..+.+.++||||||+++|+|++|..||...... .....+.......+. .+++++.+||
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~~Li 247 (476)
T 2y94_A 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP----TLFKKICDGIFYTPQ--YLNPSVISLL 247 (476)
T ss_dssp CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH----HHHHHHHTTCCCCCT--TCCHHHHHHH
T ss_pred ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH----HHHHHHhcCCcCCCc--cCCHHHHHHH
Confidence 6679999999999988777677799999999999999999999876553 333444444444444 6899999999
Q ss_pred HHHhhhCCCCCCCcHHHhhccChhh
Q 024336 239 SQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.+||..||.+|||+.|+++|+|+..
T Consensus 248 ~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 248 KHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp HHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred HHHcCCCchhCcCHHHHHhCHHhhh
Confidence 9999999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-54 Score=357.29 Aligned_cols=257 Identities=26% Similarity=0.467 Sum_probs=218.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++|++.+.||+|+||.||++.+..+|+.||+|++..... ....+.+|+.+++.++||||+++++++.++..+++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 3689999999999999999999999999999999875432 334688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCc
Q 024336 81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 159 (269)
+++++|.+.+.... .+++..++.++.|++.||.|||+.|++||||||+||+++.+..+.++|+|||++...........
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~ 209 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 209 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceee
Confidence 99999999987554 69999999999999999999999999999999999999865445599999999975444444445
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC--CCcCCCCHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHL 237 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l 237 (269)
..+++.|+|||.+.+..++ .++||||||+++|+|++|..||........ ...+......+ ..+..+++++.+|
T Consensus 210 ~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~l 284 (387)
T 1kob_A 210 TTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLET----LQNVKRCDWEFDEDAFSSVSPEAKDF 284 (387)
T ss_dssp ECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred eccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCccccccCCHHHHHH
Confidence 5789999999999877664 459999999999999999999987654332 33333333322 2234789999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
|.+||..||.+|||+.|+++|+|+..
T Consensus 285 i~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (387)
T 1kob_A 285 IKNLLQKEPRKRLTVHDALEHPWLKG 310 (387)
T ss_dssp HHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHHHcCCChhHCcCHHHHhhCccccC
Confidence 99999999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-53 Score=339.28 Aligned_cols=259 Identities=32% Similarity=0.538 Sum_probs=222.2
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
+.++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 46899999999999999999999999999999999875432 234577899999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC-CcEEEeecCCcccCCCCCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~-~~~~l~df~~~~~~~~~~~ 156 (269)
+|++++++|.+.+.....+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ..++|+|||++........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999999999988888999999999999999999999999999999999999976543 4599999999975554444
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc--cCCCcCCCCHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRVSADC 234 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 234 (269)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||....... ....+..... ..+.+..+++++
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHR----LYAQIKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred ccCCCCCcCCcCchhhcCCCCCcc-cchHHHHHHHHHHHHCCCCCCCCchhH----HHHHHHhccccCCchhhcccCHHH
Confidence 455678999999999988777554 999999999999999999998765432 2333333333 333345789999
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
.++|.+||+.||.+|||+.|+++|+|+...
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred HHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 999999999999999999999999999764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=343.54 Aligned_cols=253 Identities=33% Similarity=0.527 Sum_probs=211.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---------------------------ccHHHHHHHHHHHh
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---------------------------IDENVQREIINHRS 55 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---------------------------~~~~~~~e~~~l~~ 55 (269)
++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 689999999999999999999999999999999865421 12457899999999
Q ss_pred CCCCCcceeeEEEEe--CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec
Q 024336 56 LRHPNIIRFKEVLLT--PTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLD 133 (269)
Q Consensus 56 l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~ 133 (269)
++||||+++++++.+ ...+++||||+++++|.+++ ..+++++..++.++.|++.||.+||+.|++|+||||+||+++
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence 999999999999987 56899999999999998865 445799999999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCcccCCCCC-CCCcccCCCcccCchhhccccC--CCccchhhhHHHHHHHHHhCCCCCCCCCChhhH
Q 024336 134 GSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEY--DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF 210 (269)
Q Consensus 134 ~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~ 210 (269)
.++. ++|+|||++....... ......+++.|+|||.+.+... .+.++||||||+++|+|++|..||.....
T Consensus 172 ~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---- 245 (298)
T 2zv2_A 172 EDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI---- 245 (298)
T ss_dssp TTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred CCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH----
Confidence 8887 9999999987433222 2234568999999999876543 35669999999999999999999976543
Q ss_pred HHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChh
Q 024336 211 RKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
......+......++....+++++.++|.+||+.||++|||+.|+++|+|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 2333444445555565567999999999999999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=349.22 Aligned_cols=258 Identities=30% Similarity=0.507 Sum_probs=220.8
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-------ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
.++|++.+.||+|+||.||++.+..+|+.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4689999999999999999999999999999999875432 245688999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC--CcEEEeecCCcccCC
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ--PRLKICDFGYSKSGL 152 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~--~~~~l~df~~~~~~~ 152 (269)
++|+||+++++|.+++...+.+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ..++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 999999999999999988888999999999999999999999999999999999999987762 149999999997554
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC--cCCC
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRV 230 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 230 (269)
.........+++.|+|||.+.+..++. ++|+||||+++|+|++|..||....... ....+......++. ...+
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~ 245 (321)
T 2a2a_A 171 DGVEFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQE----TLANITSVSYDFDEEFFSHT 245 (321)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHTTCCCCCHHHHTTC
T ss_pred ccccccccCCCCCccCcccccCCCCCC-ccccHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhcccccChhhhccc
Confidence 444445567899999999998776654 4999999999999999999998755432 33333333333221 1368
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
++.+.++|.+||..||.+|||+.|+++|+|+...
T Consensus 246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 8999999999999999999999999999999764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-53 Score=343.02 Aligned_cols=264 Identities=25% Similarity=0.385 Sum_probs=214.0
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
+-++|++++.||+|+||+||++.+..+|+.||+|.+...... .+.+.+|+.++++++||||+++++++...+..++|
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 457999999999999999999999999999999988654332 34577899999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~ 156 (269)
|||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++..... ...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCcccc
Confidence 999999999999888888999999999999999999999999999999999999998887 99999999874332 222
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc---------------c
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------Q 221 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------------~ 221 (269)
.....+++.|+|||.+.+....+.++|+||||+++|+|++|..||................... .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 3445688999999999875555666999999999999999999998876654444333221110 0
Q ss_pred ccCCC----------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 222 YFLPD----------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 222 ~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
...+. ...+++.+.+||.+||+.||.+|||++|+++|+|++.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 01111 1357889999999999999999999999999999998653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=339.75 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=210.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|++++.||+|+||+||++.+ .+|+.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 6899999999999999999998 578899999986543 234678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCC
Q 024336 80 YAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQP 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~ 157 (269)
++++ +|.+.+... +.+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++..... ....
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCcccccc
Confidence 9986 888888654 67999999999999999999999999999999999999998887 99999998864322 1223
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cCC-----------
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLP----------- 225 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~----------- 225 (269)
....+++.|+|||.+.+....+.++||||||+++|+|++|..||..................... .++
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 34567999999999977655566699999999999999999999887655554444433221100 000
Q ss_pred -----------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 226 -----------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 226 -----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
....+++++.+||.+||+.||++|||++|+++|+|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 01357899999999999999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-53 Score=343.05 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=203.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.++|++++.||+|+||.||++.+..+|+.||+|.+.... ...+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 368999999999999999999999999999999987543 334678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 80 YAAGGELFARICSA------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 80 ~~~~~~l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
|+++ +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++.....
T Consensus 84 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 84 FMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFGI 160 (317)
T ss_dssp CCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETTS
T ss_pred ecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecCC
Confidence 9985 898888653 35899999999999999999999999999999999999998887 99999999874332
Q ss_pred C-CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcccc---------
Q 024336 154 H-SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--------- 223 (269)
Q Consensus 154 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~--------- 223 (269)
. .......+++.|+|||.+.+....+.++||||||+++|+|++|..||......................
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 2 223445789999999999876555666999999999999999999998876655554444332211000
Q ss_pred -------------------CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 224 -------------------LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 224 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
......+++++.+||.+||+.||.+|||+.|+++|+|+..+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 000125788999999999999999999999999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=337.90 Aligned_cols=256 Identities=32% Similarity=0.547 Sum_probs=220.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++|++.+.||+|+||.||++.+..++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 468999999999999999999999999999999987643 3456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe---cCCCCCcEEEeecCCcccCCCCCCC
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i---~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
+++++|.+.+...+.+++..++.++.|++.||.+||+.|++|+||||+||++ +.++. ++|+|||++.........
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~--~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP--LKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCC--EEECCCTTCEECCTTSCB
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCc--EEEEecccceeccCccch
Confidence 9999999999888889999999999999999999999999999999999999 55555 999999998765555555
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC--cCCCCHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCR 235 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 235 (269)
....+++.|+|||.+.+. + +.++|+||||+++|+|++|..||....... ....+.......+. +..+++.+.
T Consensus 166 ~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSE----VMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred hccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhCCCCCCchhhhcCCHHHH
Confidence 566789999999998654 4 455999999999999999999998765432 33333444333332 236899999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
++|.+||+.||.+|||+.++++|+|++...
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 999999999999999999999999998744
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=349.97 Aligned_cols=259 Identities=35% Similarity=0.536 Sum_probs=204.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 467999999999999999999999999999999987643 3456788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCCcEEEeecCCcccCCCCCCCCcc
Q 024336 82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKST 160 (269)
Q Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~-~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (269)
++++|.+.+...+.+++..++.++.|++.||.+||+.|++||||||+||+++. +..+.++|+|||++............
T Consensus 131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 210 (349)
T 2w4o_A 131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210 (349)
T ss_dssp CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccc
Confidence 99999999988888999999999999999999999999999999999999975 22234999999998754444344456
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC--CCcCCCCHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLL 238 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li 238 (269)
.+++.|+|||.+.+..++. ++||||||+++|+|++|..||......... ...+....... +.+..++.++.+||
T Consensus 211 ~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~li 286 (349)
T 2w4o_A 211 CGTPGYCAPEILRGCAYGP-EVDMWSVGIITYILLCGFEPFYDERGDQFM---FRRILNCEYYFISPWWDEVSLNAKDLV 286 (349)
T ss_dssp --CGGGSCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCTTCCTTCHHHH---HHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred cCCCCccCHHHhcCCCCCc-ccchHHHHHHHHHHHhCCCCCCCCcccHHH---HHHHHhCCCccCCchhhhCCHHHHHHH
Confidence 7899999999998776655 499999999999999999999876654322 23333333322 22347899999999
Q ss_pred HHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 239 SQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.+||..||++|||+.|+++|+|+....
T Consensus 287 ~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 287 RKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999999999999999999999997643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=340.39 Aligned_cols=261 Identities=26% Similarity=0.369 Sum_probs=212.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc------cccHHHHHHHHHHHhC---CCCCcceeeEEEEeCC
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK------KIDENVQREIINHRSL---RHPNIIRFKEVLLTPT 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~ 72 (269)
.++|++.+.||+|+||+||++.+..+++.||+|++.... .......+|+..++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 579999999999999999999999999999999987432 2235677888877776 4999999999998765
Q ss_pred -----eEEEEEeecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeec
Q 024336 73 -----HLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDF 145 (269)
Q Consensus 73 -----~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df 145 (269)
.+++++|++++ +|.+++..... +++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+||
T Consensus 88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Df 164 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADF 164 (308)
T ss_dssp SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECSC
T ss_pred CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEeeC
Confidence 58999999975 99999977654 899999999999999999999999999999999999998887 999999
Q ss_pred CCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cC
Q 024336 146 GYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FL 224 (269)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 224 (269)
|++.............+++.|+|||.+.+..++.+ +||||||+++|+|++|.+||..................... .+
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 99976544445556678999999999987777555 99999999999999999999887765555554443322111 11
Q ss_pred CC--------------------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 225 PD--------------------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 225 ~~--------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
+. ...+++.+.+||.+||+.||.+|||+.|+++|+|++.-.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305 (308)
T ss_dssp CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence 10 1257889999999999999999999999999999987554
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=355.62 Aligned_cols=257 Identities=30% Similarity=0.439 Sum_probs=217.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++++.||+|+||.||++++..+++.||+|++.+. ....+.+.+|..+++.++||||+++++++.+++.+|+||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999999999999999998752 233455788999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--C
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--Q 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~ 156 (269)
||++||+|.+++.+ ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++....... .
T Consensus 149 E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~~~~ 225 (410)
T 3v8s_A 149 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVR 225 (410)
T ss_dssp CCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSEEE
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCCccc
Confidence 99999999999865 56899999999999999999999999999999999999998888 9999999997433222 2
Q ss_pred CCcccCCCcccCchhhccccC---CCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEY---DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~---~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
.....+|+.|+|||.+.+... .+.++|+||||+++|+|++|..||...+............ ....++....++++
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~s~~ 303 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--NSLTFPDDNDISKE 303 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCCTTCCCCHH
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc--ccccCCCcccccHH
Confidence 335679999999999976541 3455999999999999999999998765443333332221 12345555579999
Q ss_pred HHHHHHHHhhhCCCC--CCCcHHHhhccChhhh
Q 024336 234 CRHLLSQIFVADPSK--DPHSRDQKASLVPEEF 264 (269)
Q Consensus 234 ~~~li~~~l~~~p~~--Rps~~~~l~~~~~~~~ 264 (269)
+.+||.+||..+|.+ ||+++|+++|+||+.+
T Consensus 304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 999999999999988 9999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-53 Score=344.24 Aligned_cols=254 Identities=30% Similarity=0.485 Sum_probs=210.6
Q ss_pred cccccccceecccCceEEEEEEEe---cCCeEEEEEEeecCc-----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK-----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTH 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (269)
.++|++.+.||+|+||.||++++. .+++.||+|++.... .....+.+|+.+++.++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 478999999999999999999985 689999999987542 233457789999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
+++||||+++++|.+++...+.+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++.....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC-----
T ss_pred EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCccccccc
Confidence 9999999999999999988888999999999999999999999999999999999999998887 99999999864322
Q ss_pred C-CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCH
Q 024336 154 H-SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232 (269)
Q Consensus 154 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
. .......+++.|+|||.+.+..++. ++|+||||+++|+|++|..||...... .....+......++. .+++
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~~~~~~~p~--~~~~ 246 (327)
T 3a62_A 174 DGTVTHTFCGTIEYMAPEILMRSGHNR-AVDWWSLGALMYDMLTGAPPFTGENRK----KTIDKILKCKLNLPP--YLTQ 246 (327)
T ss_dssp -----CTTSSCCTTSCHHHHTTSCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHTCCCCCT--TSCH
T ss_pred CCccccccCCCcCccCHhhCcCCCCCC-cccchhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhCCCCCCC--CCCH
Confidence 2 2234457899999999998776644 599999999999999999999876543 333444444455554 7899
Q ss_pred HHHHHHHHHhhhCCCCCC-----CcHHHhhccChhhh
Q 024336 233 DCRHLLSQIFVADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
++.++|.+||..||.+|| ++.++++|+|+..+
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 999999999999999999 78899999999764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=365.05 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=224.1
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
.++|++.+.||+|+||.||++.+..+|+.||+|++.+. ......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 36799999999999999999999999999999998653 23345678999999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 78 MEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
|||++|++|.+++...+. +++..++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQ 340 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTTC
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceecccCc
Confidence 999999999999976543 999999999999999999999999999999999999998887 9999999997544444
Q ss_pred CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
......+|+.|+|||.+.+..++.. +|+||||+++|+|++|..||...............+......++. .+++++.
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~--~~s~~~~ 417 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE--RFSPQAR 417 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred cccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCc--cCCHHHH
Confidence 4445689999999999987776544 999999999999999999998765444444455555555555554 7899999
Q ss_pred HHHHHHhhhCCCCCC-----CcHHHhhccChhhh
Q 024336 236 HLLSQIFVADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 236 ~li~~~l~~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
+||.+||..||.+|| +++|+++|+|+..+
T Consensus 418 dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 999999999999999 78999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-53 Score=337.93 Aligned_cols=256 Identities=29% Similarity=0.472 Sum_probs=208.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.++|++.+.||+|+||.||++.+..++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 478999999999999999999999999999999987643 234678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CCcEEEeecCCcccCCCC
Q 024336 80 YAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 80 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~~~~ 154 (269)
|+++++|.+.+.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++.+. .+.++|+|||++......
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 9999999998854 36799999999999999999999999999999999999995422 234999999999754444
Q ss_pred CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC-CCcCCCCHH
Q 024336 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL-PDYVRVSAD 233 (269)
Q Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 233 (269)
.......+++.|+|||.+.. .+ +.++|+||||+++|+|++|..||........ ........... .....++++
T Consensus 181 ~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 254 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV----QQKATYKEPNYAVECRPLTPQ 254 (285)
T ss_dssp ------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCC--CCCCHH
T ss_pred ccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHH----HhhhccCCcccccccCcCCHH
Confidence 44556678999999999853 33 5569999999999999999999987553222 22222222211 222357899
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+.++|.+||+.||++|||+.|+++|+|++.
T Consensus 255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-53 Score=346.46 Aligned_cols=259 Identities=31% Similarity=0.473 Sum_probs=218.1
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++|++.+.||+|+||.||++.+..+|+.||+|++...... ..+|+.++.++ +||||+++++++.+++.+|+||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 46899999999999999999999999999999999765432 34688888777 799999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-C-CcEEEeecCCcccCCCC-CCC
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-Q-PRLKICDFGYSKSGLLH-SQP 157 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~-~~~~l~df~~~~~~~~~-~~~ 157 (269)
++|++|.+.+.+.+.+++..+..++.|++.||.|||+.|++||||||+||++..+. . ..++|+|||++...... ...
T Consensus 98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 177 (342)
T 2qr7_A 98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177 (342)
T ss_dssp CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence 99999999998888899999999999999999999999999999999999985432 2 34999999998743322 233
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC--cCCCCHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCR 235 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 235 (269)
....+++.|+|||.+.+..++. ++|+||||+++|+|++|..||..... .........+......++. +..+++++.
T Consensus 178 ~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 255 (342)
T 2qr7_A 178 MTPCYTANFVAPEVLERQGYDA-ACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTAK 255 (342)
T ss_dssp CCSSCCSSCCCHHHHHHHHHHH-HHHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTTTTSCHHHH
T ss_pred eccCCCccccCHHHhcCCCCCC-ccCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcccCccccccCCHHHH
Confidence 4557899999999998766644 49999999999999999999986432 2334455555555554432 347899999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
+||.+||..||.+|||+.++++|+|+..+.
T Consensus 256 ~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 256 DLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred HHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 999999999999999999999999997654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-53 Score=349.45 Aligned_cols=253 Identities=31% Similarity=0.516 Sum_probs=212.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHH-HHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIIN-HRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++++.||+|+||.||++++..+++.||+|++.+... ....+..|..+ ++.++||||+++++++.+.+.+|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 689999999999999999999999999999999976432 22345556665 4678999999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC-CCCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~-~~~~ 156 (269)
|||++|++|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+++.+++ ++|+|||++.... ....
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~~~~~ 195 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNST 195 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBCCCCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCccccccccCCCc
Confidence 999999999999998888999999999999999999999999999999999999998887 9999999987422 2334
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+|+.|+|||.+.+..++. ++|+||||+++|+|++|..||...+. ......+......++. .++..+.+
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~~~~~~~--~~~~~~~~ 268 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQPYDR-TVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYDNILNKPLQLKP--NITNSARH 268 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCTTCCSBH----HHHHHHHHHSCCCCCS--SSCHHHHH
T ss_pred cccccCCccccCHHHhCCCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhcccCCCC--CCCHHHHH
Confidence 45667999999999998777654 49999999999999999999987544 3344444555555554 78999999
Q ss_pred HHHHHhhhCCCCCCCc----HHHhhccChhhh
Q 024336 237 LLSQIFVADPSKDPHS----RDQKASLVPEEF 264 (269)
Q Consensus 237 li~~~l~~~p~~Rps~----~~~l~~~~~~~~ 264 (269)
||.+||+.||.+||++ .++++|+|+..+
T Consensus 269 li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 9999999999999998 599999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=359.55 Aligned_cols=253 Identities=34% Similarity=0.557 Sum_probs=211.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++++.||+|+||.||++.+..+|+.||+|++... ......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 6799999999999999999999999999999998753 223345678999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQ 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~ 156 (269)
||+++++|.+.+...+.+++..+..++.|++.||+|||+ .||+||||||+||+++.++. ++|+|||++..... ...
T Consensus 228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 305 (446)
T 4ejn_A 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGAT 305 (446)
T ss_dssp CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC----
T ss_pred eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCCCcc
Confidence 999999999999888899999999999999999999998 99999999999999998887 99999999874322 233
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+|+.|+|||.+.+..++. ++||||||+++|+|++|..||...... .....+......++. .+++++.+
T Consensus 306 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~~~~~~~ 378 (446)
T 4ejn_A 306 MKTFCGTPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEEIRFPR--TLGPEAKS 378 (446)
T ss_dssp -CCSSSCGGGCCHHHHHTSCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCT--TSCHHHHH
T ss_pred cccccCCccccCHhhcCCCCCCC-ccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHHHhCCCCCCc--cCCHHHHH
Confidence 44567899999999998777755 499999999999999999999875542 333444445555555 78999999
Q ss_pred HHHHHhhhCCCCCC-----CcHHHhhccChhhh
Q 024336 237 LLSQIFVADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 237 li~~~l~~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
||.+||+.||.+|| +++|+++|+|+..+
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 99999999999999 99999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-53 Score=364.37 Aligned_cols=259 Identities=34% Similarity=0.598 Sum_probs=220.6
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--------------cccHHHHHHHHHHHhCCCCCcceeeE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--------------KIDENVQREIINHRSLRHPNIIRFKE 66 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 66 (269)
+.++|++++.||+|+||+||+|.+..++..||+|++.... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999999999999999987543 23456889999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC-CcEEEeec
Q 024336 67 VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDF 145 (269)
Q Consensus 67 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~-~~~~l~df 145 (269)
++.+...+++||||+++++|.+.+...+.+++..++.++.|++.||.|||+.|++||||||+||+++.++. ..++|+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 99999999999999999999999988889999999999999999999999999999999999999987653 25999999
Q ss_pred CCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC
Q 024336 146 GYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225 (269)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (269)
|++.............+++.|+|||.+.+ .+ +.++||||||+++|+|++|.+||...... .....+......++
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQ----DIIKKVEKGKYYFD 267 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCC
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCC
Confidence 99976554445556679999999999864 44 45599999999999999999999876543 33444444443332
Q ss_pred --CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 226 --DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 226 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.+..+|+++.+||.+||..||.+|||++|+++|+|++...
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 3457899999999999999999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=336.42 Aligned_cols=255 Identities=33% Similarity=0.587 Sum_probs=218.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..++..||+|++.... .....+.+|+.+++.++||||+++++++.+....++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 68999999999999999999999999999999986432 23456889999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||+++++|.+.+.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.... .....
T Consensus 89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~-~~~~~ 165 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SSRRT 165 (279)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC-------
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCC-ccccc
Confidence 99999999999988888999999999999999999999999999999999999998887 9999999885432 22234
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...+++.|+|||.+.+...+.+ +|+||||+++|+|++|..||..... ......+......++. .+++.+.+||
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~--~~~~~~~~li 238 (279)
T 3fdn_A 166 DLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTY----QETYKRISRVEFTFPD--FVTEGARDLI 238 (279)
T ss_dssp --CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHTCCCCCT--TSCHHHHHHH
T ss_pred ccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCcH----HHHHHHHHhCCCCCCC--cCCHHHHHHH
Confidence 4568999999999987766544 9999999999999999999986543 3333444444555555 6899999999
Q ss_pred HHHhhhCCCCCCCcHHHhhccChhhhhhc
Q 024336 239 SQIFVADPSKDPHSRDQKASLVPEEFAER 267 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~~~~~~~~~ 267 (269)
.+||+.||.+|||+.|+++|+|+......
T Consensus 239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp HHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred HHHhccChhhCCCHHHHhhCccccCCccC
Confidence 99999999999999999999999876543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-53 Score=347.82 Aligned_cols=257 Identities=28% Similarity=0.497 Sum_probs=215.3
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc------cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK------KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
.++|++.+.||+|+||+||++.+..+|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++.++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 468999999999999999999999999999999986421 23467899999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC-CcEEEeecCCccc
Q 024336 76 IVMEYAAGGELFARICSA----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKS 150 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~-~~~~l~df~~~~~ 150 (269)
+||||+++++|.+.+... ..+++..++.++.|++.||.|||++|++||||||+||+++.++. ..++|+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998877543 35899999999999999999999999999999999999986543 4599999999875
Q ss_pred CCCCCC-CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC--Cc
Q 024336 151 GLLHSQ-PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DY 227 (269)
Q Consensus 151 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~ 227 (269)
...... .....+++.|+|||.+.+..++. ++||||||+++|+|++|..||.... ......+.......+ .+
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~i~~~~~~~~~~~~ 256 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGK-PVDVWGCGVILFILLSGCLPFYGTK-----ERLFEGIIKGKYKMNPRQW 256 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCSSH-----HHHHHHHHHTCCCCCHHHH
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCc-hHhhHHHHHHHHHHHHCCCCCCCcH-----HHHHHHHHcCCCCCCcccc
Confidence 433222 34457899999999998777654 4999999999999999999998642 223333333333222 22
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 228 VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
..+++++.+||.+||..||.+|||+.|+++|+|+...
T Consensus 257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 4689999999999999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=340.91 Aligned_cols=261 Identities=33% Similarity=0.561 Sum_probs=218.1
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-------ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 5789999999999999999999999999999999875421 246788999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC--CcEEEeecCCcccCC
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ--PRLKICDFGYSKSGL 152 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~--~~~~l~df~~~~~~~ 152 (269)
++|+|++++++|.+++.+...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ..++|+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 999999999999999988888999999999999999999999999999999999999987662 249999999987544
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC--CcCCC
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRV 230 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 230 (269)
.........+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||....... ....+.......+ ....+
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQE----TLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTTCCCCCHHHHTTC
T ss_pred CCCcccccCCCcCccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCCCCcchHH----HHHHhHhcccCCcchhcccC
Confidence 4444445568999999999987766554 999999999999999999998755432 2233333332222 12367
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhhc
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAER 267 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~~ 267 (269)
++.+.++|.+||..||.+|||+.++++|+|++.+..+
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 8999999999999999999999999999999987654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=363.16 Aligned_cols=258 Identities=36% Similarity=0.570 Sum_probs=220.0
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecC---ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.++|++++.||+|+||+||++.+..+++.||+|++... ......+.+|+.++++++||||+++++++.+...+++|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 47899999999999999999999999999999998642 334567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CCcEEEeecCCcccCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~~~~~~~ 157 (269)
||+.+++|.+.+...+.+++..++.++.|++.||.|||+.|++||||||+||+++..+ .+.++|+|||++.........
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 180 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence 9999999999998888999999999999999999999999999999999999996432 234999999999765545555
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc--cCCCcCCCCHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRVSADCR 235 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 235 (269)
....+++.|+|||.+.+. + +.++||||||+++|+|++|.+||....... ....+..... ..+.+..+|+++.
T Consensus 181 ~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~ 254 (486)
T 3mwu_A 181 KDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVETGKYAFDLPQWRTISDDAK 254 (486)
T ss_dssp -CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred CCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCCcccCCCCHHHH
Confidence 566799999999998753 4 556999999999999999999998765433 3333444333 3445567899999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
+||.+||..||.+|||+.|+++|+|++...
T Consensus 255 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred HHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 999999999999999999999999998754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=361.51 Aligned_cols=258 Identities=34% Similarity=0.556 Sum_probs=218.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecC---ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.++|++++.||+|+||+||++.+..++..||+|++... ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 35799999999999999999999999999999998753 234567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CCcEEEeecCCcccCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~~~~~~~ 157 (269)
||+++++|.+.+....++++..++.++.|++.||.|||+.|++||||||+||+++..+ ...++|+|||++.........
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~ 195 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence 9999999999998888999999999999999999999999999999999999997643 245999999998765544555
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcccc--CCCcCCCCHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSADCR 235 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (269)
....+++.|+|||.+.+ .+ +.++||||||+++|+|++|.+||...... .....+...... .+.+..+++.+.
T Consensus 196 ~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 196 KERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQ----EILRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp CCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred cccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCchhcccCCHHHH
Confidence 56679999999999863 44 45599999999999999999999876543 333444444333 334457899999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
+||.+||+.||.+|||+.|+++|||+....
T Consensus 270 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred HHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 999999999999999999999999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=335.00 Aligned_cols=254 Identities=39% Similarity=0.663 Sum_probs=212.7
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
.++|++.+.||+|++|.||++.+..+|+.||+|.+.... ...+.+.+|+..++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999999899999999986532 3345788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
+|++++++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~ 167 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFL 167 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC----
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCCCcce
Confidence 999999999999988888999999999999999999999999999999999999998887 999999998754444444
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....+++.|+|||.+.+....+.++|+||||+++|+|++|..||..... ......+.......+. .++..+.++
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~--~~~~~l~~l 241 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV----PTLFKKIRGGVFYIPE--YLNRSVATL 241 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHhhcCcccCch--hcCHHHHHH
Confidence 4567889999999998776656679999999999999999999976543 2333444444444444 689999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
|.+||+.||.+|||+.++++|+|+..
T Consensus 242 i~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 242 LMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHccCChhhCCCHHHHHhChhhcc
Confidence 99999999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=346.74 Aligned_cols=248 Identities=30% Similarity=0.427 Sum_probs=215.7
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---------ccHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---------IDENVQREIINHRSLRHPNIIRFKEVLLTPT 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ....+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 3689999999999999999999999999999999876432 2235678999999999999999999999999
Q ss_pred eEEEEEeecCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 73 HLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 73 ~~~~v~e~~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
..++|+|++.++ +|.+++...+.+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++...
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~ 180 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEEC
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceEC
Confidence 999999998766 99999988888999999999999999999999999999999999999998887 999999999755
Q ss_pred CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
..........+++.|+|||.+.+..+.+.++||||||+++|+|++|..||..... ..... ......++
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~~--~~~~~~~~ 248 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAA--IHPPYLVS 248 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTTC--CCCSSCCC
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhhc--cCCCcccC
Confidence 4444445567899999999998888767779999999999999999999975321 11111 22233689
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+++.+||.+||+.||.+|||+.++++|+|+..
T Consensus 249 ~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 99999999999999999999999999999865
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-52 Score=348.00 Aligned_cols=263 Identities=22% Similarity=0.331 Sum_probs=211.9
Q ss_pred cccccccceeccc--CceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 2 EERYEPVKELGSG--NFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 2 ~~~y~~~~~l~~g--~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
.++|++.+.||+| +||.||++.+..+|+.||+|++...... .+.+.+|+.+++.++||||+++++++.+++.+++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4789999999999 9999999999999999999999764322 3457789999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-
Q 024336 77 VMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL- 153 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~- 153 (269)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISH 181 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCGGGCEECEET
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccccceeeccc
Confidence 99999999999999775 67999999999999999999999999999999999999998887 99999998742211
Q ss_pred -------CCCCCcccCCCcccCchhhccc-cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc-----
Q 024336 154 -------HSQPKSTVGTPAYIAPEVLARK-EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV----- 220 (269)
Q Consensus 154 -------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----- 220 (269)
........+++.|+|||.+.+. ...+.++||||||+++|+|++|..||...................
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 1222334678899999999873 233455999999999999999999998765544333222111000
Q ss_pred -----------------------------------cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 221 -----------------------------------QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 221 -----------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
....+....+++.+.+||.+||+.||++|||+.|+++|+|++.+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 000111235788999999999999999999999999999998765
Q ss_pred h
Q 024336 266 E 266 (269)
Q Consensus 266 ~ 266 (269)
.
T Consensus 342 ~ 342 (389)
T 3gni_B 342 R 342 (389)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=358.69 Aligned_cols=257 Identities=27% Similarity=0.390 Sum_probs=222.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++++..+|+.||+|++.+.. .....+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999987532 33456888999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 79 EYAAGGELFARICSA----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 79 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
||++|++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELKAG 342 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeeccCC
Confidence 999999999998764 36999999999999999999999999999999999999998887 999999999754333
Q ss_pred CC-CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 155 SQ-PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 155 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
.. .....+|+.|+|||.+.+..++.. +|+||||+++|+|+||..||...............+......++. .+++.
T Consensus 343 ~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~ 419 (543)
T 3c4z_A 343 QTKTKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSPA 419 (543)
T ss_dssp CCCBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT--TSCHH
T ss_pred CcccccccCCccccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc--ccCHH
Confidence 32 233479999999999988776554 999999999999999999998765444445555556655555555 79999
Q ss_pred HHHHHHHHhhhCCCCCCC-----cHHHhhccChhhh
Q 024336 234 CRHLLSQIFVADPSKDPH-----SRDQKASLVPEEF 264 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps-----~~~~l~~~~~~~~ 264 (269)
+.+||.+||..||.+||+ ++++++|+|+..+
T Consensus 420 ~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 420 SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred HHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 999999999999999996 4899999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=344.68 Aligned_cols=262 Identities=24% Similarity=0.388 Sum_probs=210.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc--cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI--DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++|++++.||+|+||+||++.+..+++.||+|++...... ...+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 6899999999999999999999999999999998643321 12345799999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCC
Q 024336 81 AAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPK 158 (269)
Q Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~ 158 (269)
+++ +|.+++... ..+++..++.++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++...... ....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC--------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCccccc
Confidence 985 888888664 45899999999999999999999999999999999999998887 999999998643322 2233
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cCC------------
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLP------------ 225 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~------------ 225 (269)
...+++.|+|||.+.+....+.++||||||+++|+|++|..||..................... .++
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence 4567999999999987555566699999999999999999999887665554444433221110 000
Q ss_pred -----------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhhc
Q 024336 226 -----------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAER 267 (269)
Q Consensus 226 -----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~~ 267 (269)
....+++++.+||.+||+.||.+|||++|+++|+|+..+.++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 012578899999999999999999999999999999987654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=337.35 Aligned_cols=264 Identities=28% Similarity=0.437 Sum_probs=213.6
Q ss_pred Cccccccc-ceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 1 MEERYEPV-KELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 1 i~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
+.++|++. +.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++++ +||||+++++++.+++.+++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 35789985 78999999999999999999999999997643 3346788999999885 799999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC-CcEEEeecCCcccCCCCC-
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHS- 155 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~-~~~~l~df~~~~~~~~~~- 155 (269)
|||+++++|.+++...+.+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ..++|+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 999999999999988888999999999999999999999999999999999999987654 358999999886432111
Q ss_pred -------CCCcccCCCcccCchhhcc-----ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChh-----------hHHH
Q 024336 156 -------QPKSTVGTPAYIAPEVLAR-----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR-----------NFRK 212 (269)
Q Consensus 156 -------~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~-----------~~~~ 212 (269)
......+++.|+|||.+.. ..+ +.++||||||+++|+|++|..||....... ....
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 1223458899999999875 334 445999999999999999999997654321 1233
Q ss_pred HHHHHhhccccCCC--cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 213 TIDRIRNVQYFLPD--YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 213 ~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
....+......++. +..+++.+.+||.+||..||.+|||+.|+++|+|++...
T Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 34445555444442 246899999999999999999999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=353.65 Aligned_cols=258 Identities=25% Similarity=0.461 Sum_probs=216.3
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
.++|++.+.||+|+||+||++++..+++.||+|++.+. ......+.+|..+++.++||||+++++++.+++.+++|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999998752 12233478899999999999999999999999999999
Q ss_pred EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 78 MEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
|||+++|+|.+++.+ .+.+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+|||++........
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGT 230 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSC
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccCCC
Confidence 999999999999987 567999999999999999999999999999999999999998887 99999999864333222
Q ss_pred --CCcccCCCcccCchhhc-----cccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCc-C
Q 024336 157 --PKSTVGTPAYIAPEVLA-----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY-V 228 (269)
Q Consensus 157 --~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 228 (269)
.....+|+.|+|||.+. ...+ +.++|+||||+++|+|++|..||...+............. ...+|.. .
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~ 307 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--RFQFPTQVT 307 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCCCCSSCC
T ss_pred cccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc--cccCCcccc
Confidence 23357999999999987 2334 5559999999999999999999987655444433332211 2233332 4
Q ss_pred CCCHHHHHHHHHHhhhCCCC--CCCcHHHhhccChhhh
Q 024336 229 RVSADCRHLLSQIFVADPSK--DPHSRDQKASLVPEEF 264 (269)
Q Consensus 229 ~~~~~~~~li~~~l~~~p~~--Rps~~~~l~~~~~~~~ 264 (269)
.+++++.+||++||..+|.+ ||+++|+++|+||..+
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 68999999999999888888 9999999999999865
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=364.48 Aligned_cols=258 Identities=36% Similarity=0.573 Sum_probs=220.9
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
.++|++.+.||+|+||.||++.+..+|+.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 46899999999999999999999999999999998653 23456788999999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC-CCCcEEEeecCCcccCCCCCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~-~~~~~~l~df~~~~~~~~~~~ 156 (269)
+|++.+++|.+.+...+.+++..++.++.|++.||.|||+.|++||||||+||+++.. ..+.++|+|||++........
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 9999999999999888899999999999999999999999999999999999999532 223499999999875444444
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc--cCCCcCCCCHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRVSADC 234 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 234 (269)
.....+++.|+|||.+.+ .+ +.++||||||+++|+|++|.+||....... ....+..... ..+.+..+|+++
T Consensus 185 ~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 185 MKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYD----ILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp HHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred cccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHcCCCCCCCcccccCCHHH
Confidence 445678999999999865 44 455999999999999999999998765433 3333444433 334556799999
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.+||.+||+.||.+|||+.|+++|+|++...
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 9999999999999999999999999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=343.40 Aligned_cols=262 Identities=27% Similarity=0.354 Sum_probs=209.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
-++|++.+.||+|+||+||++.+..+++.||+|++...... ...+.+|+.++++++||||+++++++.+++.+++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 46899999999999999999999999999999998654322 345678999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC---CCcEEEeecCCcccCCC-C
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP---QPRLKICDFGYSKSGLL-H 154 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~---~~~~~l~df~~~~~~~~-~ 154 (269)
||+++ +|.+++...+.+++..++.++.|++.||.+||+.|++|+||||+||+++.++ ...++|+|||++..... .
T Consensus 113 e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~ 191 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191 (329)
T ss_dssp ECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred ecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence 99985 9999999888899999999999999999999999999999999999995432 23499999999864322 2
Q ss_pred CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cCC--------
Q 024336 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLP-------- 225 (269)
Q Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~-------- 225 (269)
.......+++.|+|||.+.+....+.++||||||+++|+|++|..||..................... .++
T Consensus 192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (329)
T 3gbz_A 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271 (329)
T ss_dssp --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence 22334567999999999987665566699999999999999999999887665555444433221110 000
Q ss_pred -----C----------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 226 -----D----------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 226 -----~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
. ...+++++.+||.+||+.||.+|||++|+++|+|+...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 272 KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 0 01267899999999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=332.91 Aligned_cols=255 Identities=31% Similarity=0.554 Sum_probs=220.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
.++|++.+.||+|+||.||++.+..++..||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 36899999999999999999999999999999998643 22345688999999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
+|++++++|.+.+...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~ 169 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS-LRR 169 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-SCB
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-ccc
Confidence 999999999999988888999999999999999999999999999999999999998887 99999998864322 223
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||....... ....+......++. .++.++.++
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~l 242 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTE----THRRIVNVDLKFPP--FLSDGSKDL 242 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTTCCCCCT--TSCHHHHHH
T ss_pred ccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHhH----HHHHHhccccCCCC--cCCHHHHHH
Confidence 44568999999999987776555 999999999999999999998755432 23334444444444 789999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
|.+||+.||.+|||+.++++|+|+.....
T Consensus 243 i~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 99999999999999999999999987553
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=341.86 Aligned_cols=259 Identities=32% Similarity=0.549 Sum_probs=199.5
Q ss_pred cccccc---ceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPV---KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~---~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|.+. +.||+|+||.||++.+..+++.||+|++... ......+|+..++.+. ||||+++++++.++...++||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 356654 7899999999999999999999999998753 3467788999999997 999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC-CcEEEeecCCcccCCCC-CC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLH-SQ 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~-~~~~l~df~~~~~~~~~-~~ 156 (269)
||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++. ..++|+|||++...... ..
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 99999999999999889999999999999999999999999999999999999986552 24999999998743322 22
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh---hhHHHHHHHHhhccccCCC--cCCCC
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---RNFRKTIDRIRNVQYFLPD--YVRVS 231 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~~ 231 (269)
.....+++.|+|||.+.+..++. ++||||||+++|+|++|..||...... .........+......++. +..++
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDE-SCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp ------------------CCCCH-HHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred ccccCCCcCccCHHHhcCCCCCC-ccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence 34456799999999998777644 599999999999999999999865432 2234455555555554432 24689
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+++.+||.+||..||.+|||+.|+++|+|++.-
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 999999999999999999999999999999764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-52 Score=332.47 Aligned_cols=260 Identities=33% Similarity=0.553 Sum_probs=220.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 368999999999999999999999999999999987543 234678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC---CC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQ 156 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~---~~ 156 (269)
++++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchhc
Confidence 9999999999987778999999999999999999999999999999999999998887 999999988642211 12
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+++.|+|||.+.+..+.+.++|+||||+++|+|++|..||........... .........+.+..+++.+.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH---HHHTTCTTSTTGGGSCHHHHH
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HhhhcccccCchhhcCHHHHH
Confidence 33456889999999998777666679999999999999999999987655322221 222222233444578999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
+|.+||+.||.+|||+.|+++|+|++...+
T Consensus 241 li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 999999999999999999999999987543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=348.76 Aligned_cols=262 Identities=29% Similarity=0.476 Sum_probs=214.2
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecC------ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG------KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 57899999999999999999999999999999998643 233467889999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 024336 76 IVMEYAAGGELFARICS----------------------------------------AGRFSEDEARFFFQQLISGVSYC 115 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~----------------------------------------~~~~~~~~~~~~~~~i~~~l~~l 115 (269)
+||||+++++|.+++.. ...+++..++.++.|++.||.+|
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999998842 11236788999999999999999
Q ss_pred HhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-----CCCcccCCCcccCchhhccc-cCCCccchhhhHHH
Q 024336 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----QPKSTVGTPAYIAPEVLARK-EYDGKISDVWSCGV 189 (269)
Q Consensus 116 h~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ 189 (269)
|+.|++|+||||+||+++.++...++|+|||++....... ......+++.|+|||.+.+. ...+.++||||||+
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 9999999999999999987774459999999986422211 22355689999999998752 33455699999999
Q ss_pred HHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc--cCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhhc
Q 024336 190 TLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAER 267 (269)
Q Consensus 190 ~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~~ 267 (269)
++|+|++|..||............ ..... ..+....+++.+.++|.+||+.||.+||++.++++|+|+..+..+
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQV----LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK 340 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHH----HHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred HHHHHHHCCCCCCCCChHHHHHHH----HhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence 999999999999876654433332 22222 223334589999999999999999999999999999999987654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=338.20 Aligned_cols=255 Identities=32% Similarity=0.566 Sum_probs=214.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++|++.+.||+|+||.||++.+..+|+.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+....++|+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 4689999999999999999999999999999999876432 345688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe---cCCCCCcEEEeecCCcccCCCCCCC
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i---~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
+++++|.+.+...+.+++..++.++.|++.||.+||+.|++|+||+|+||++ +.++. ++|+|||++.... ....
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~--~kl~Dfg~~~~~~-~~~~ 164 (304)
T 2jam_A 88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSK--IMITDFGLSKMEQ-NGIM 164 (304)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCC--EEBCSCSTTCCCC-CBTT
T ss_pred CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCC--EEEccCCcceecC-CCcc
Confidence 9999999999888889999999999999999999999999999999999999 44555 9999999886432 2223
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC--CCcCCCCHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCR 235 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (269)
....+++.|+|||.+.+..++ .++|+||||+++|+|++|..||....... ....+......+ +.+..+++.+.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESK----LFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp HHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred ccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHcCCCCCCccccccCCHHHH
Confidence 344689999999999876664 55999999999999999999998755432 233333333322 22347899999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
++|.+||..||.+|||+.|+++|+|+...
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999999753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=349.18 Aligned_cols=253 Identities=28% Similarity=0.461 Sum_probs=208.4
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCch
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
.+.||+|+||.||++.+..+|..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+.+++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999999999999999987643 3345788999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccCCCc
Q 024336 87 FARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA 165 (269)
Q Consensus 87 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 165 (269)
.+.+... ..+++..++.++.|++.||.|||+.|++||||||+||++..+...+++|+|||++.............+++.
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~ 253 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPE 253 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCT
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCc
Confidence 9888654 468999999999999999999999999999999999999544434599999999975544444455678999
Q ss_pred ccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC--CcCCCCHHHHHHHHHHhh
Q 024336 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQIFV 243 (269)
Q Consensus 166 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~ 243 (269)
|+|||.+.+..+ +.++||||||+++|+|++|..||.......... .+......++ .+..+++++.+||.+||.
T Consensus 254 y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 328 (373)
T 2x4f_A 254 FLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN----NILACRWDLEDEEFQDISEEAKEFISKLLI 328 (373)
T ss_dssp TCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHHTCCCSCSGGGTTSCHHHHHHHHTTSC
T ss_pred EeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhccCCCChhhhccCCHHHHHHHHHHcC
Confidence 999999976665 445999999999999999999998765543333 3333333222 234689999999999999
Q ss_pred hCCCCCCCcHHHhhccChhhhh
Q 024336 244 ADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 244 ~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.||.+|||+.|+++|+|+....
T Consensus 329 ~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 329 KEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp SSGGGSCCHHHHHHSHHHHCHH
T ss_pred CChhhCCCHHHHhcCcCcCCCc
Confidence 9999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=344.37 Aligned_cols=258 Identities=23% Similarity=0.398 Sum_probs=211.5
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC-----CCCcceeeEEEEeCCeEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-----HPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~ 75 (269)
+.++|++.+.||+|+||+||++.+..+++.||+|++............|+.+++.+. ||||+++++++...+..+
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~ 112 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC 112 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence 357999999999999999999999999999999999765555667788999999986 999999999999999999
Q ss_pred EEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC------------------
Q 024336 76 IVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS------------------ 135 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~------------------ 135 (269)
+|||++ +++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+||+++.+
T Consensus 113 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp EEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 999999 889999997654 48999999999999999999999999999999999999751
Q ss_pred -----CCCcEEEeecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhH
Q 024336 136 -----PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF 210 (269)
Q Consensus 136 -----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~ 210 (269)
....++|+|||++... ........+++.|+|||.+.+..++.+ +||||||+++|+|+||..||.........
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~ 268 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHMEHL 268 (360)
T ss_dssp EEEEESCCCEEECCCTTCEET--TSCCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccccCCCCEEEEeccCceec--CCCCcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence 1234999999999742 333445678999999999988777555 99999999999999999999876654443
Q ss_pred HHHHHHHhhcc----------------------ccCCCc------------------CCCCHHHHHHHHHHhhhCCCCCC
Q 024336 211 RKTIDRIRNVQ----------------------YFLPDY------------------VRVSADCRHLLSQIFVADPSKDP 250 (269)
Q Consensus 211 ~~~~~~~~~~~----------------------~~~~~~------------------~~~~~~~~~li~~~l~~~p~~Rp 250 (269)
........... ..++.. ...++.+.+||.+||+.||.+||
T Consensus 269 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 348 (360)
T 3llt_A 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP 348 (360)
T ss_dssp HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC
Confidence 33222111000 000100 01236788999999999999999
Q ss_pred CcHHHhhccChh
Q 024336 251 HSRDQKASLVPE 262 (269)
Q Consensus 251 s~~~~l~~~~~~ 262 (269)
|+.|+|+|+|++
T Consensus 349 ta~elL~hp~f~ 360 (360)
T 3llt_A 349 SPAELLKHKFLE 360 (360)
T ss_dssp CHHHHTTSGGGC
T ss_pred CHHHHhcCcccC
Confidence 999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=349.36 Aligned_cols=258 Identities=24% Similarity=0.396 Sum_probs=213.8
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
.++|++.+.||+|+||.||++++..+|+.||+|++.+.. ...+.+.+|..++..++||||+++++++.+++.+|+|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 368999999999999999999999999999999987532 2234578899999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 78 MEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
|||++|++|.+++.+.+ .+++..++.++.|++.||.|||+.||+||||||+||+++.+++ ++|+|||++........
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADGT 217 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSC
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCCCc
Confidence 99999999999998754 7999999999999999999999999999999999999998888 99999999875333222
Q ss_pred --CCcccCCCcccCchhhcc------ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC-c
Q 024336 157 --PKSTVGTPAYIAPEVLAR------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-Y 227 (269)
Q Consensus 157 --~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~ 227 (269)
.....+|+.|+|||.+.. ....+.++|+||||+++|+|++|..||...+............. ...++. .
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~ 295 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE--HLSLPLVD 295 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCCCC---
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--CcCCCccc
Confidence 234578999999999873 22235559999999999999999999987655433333322111 122232 2
Q ss_pred CCCCHHHHHHHHHHhhhCCCCC---CCcHHHhhccChhhh
Q 024336 228 VRVSADCRHLLSQIFVADPSKD---PHSRDQKASLVPEEF 264 (269)
Q Consensus 228 ~~~~~~~~~li~~~l~~~p~~R---ps~~~~l~~~~~~~~ 264 (269)
..+|+++.+||.+||. +|.+| |+++|+++|+||..+
T Consensus 296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 3689999999999999 99998 599999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-52 Score=334.52 Aligned_cols=258 Identities=32% Similarity=0.478 Sum_probs=218.9
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----------cccHHHHHHHHHHHhCC-CCCcceeeEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----------KIDENVQREIINHRSLR-HPNIIRFKEVLLT 70 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 70 (269)
.++|++.+.||+|++|.||++.+..+|+.||+|++.... ...+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 578999999999999999999999999999999987543 11245678999999995 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCccc
Q 024336 71 PTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 71 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~ 150 (269)
++..++|+|++++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchhh
Confidence 9999999999999999999988888999999999999999999999999999999999999998887 99999999875
Q ss_pred CCCCCCCCcccCCCcccCchhhcc-----ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcccc--
Q 024336 151 GLLHSQPKSTVGTPAYIAPEVLAR-----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-- 223 (269)
Q Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 223 (269)
...........+++.|+|||.+.+ ....+.++|+||||+++|+|++|..||....... ....+......
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~ 249 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----MLRMIMSGNYQFG 249 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCC
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH----HHHHHhcCCcccC
Confidence 444444455678999999999862 2223555999999999999999999998755432 22333333332
Q ss_pred CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 224 LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.+.+..+++.+.++|.+||+.||.+|||+.|+++|+|++...
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 233457899999999999999999999999999999998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-52 Score=346.13 Aligned_cols=258 Identities=24% Similarity=0.378 Sum_probs=211.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeC----------
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTP---------- 71 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---------- 71 (269)
.++|++.+.||+|+||+||+|.+..+|+.||+|++..+... ..+|+.+++.++||||+++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 47899999999999999999999999999999998755332 34799999999999999999998543
Q ss_pred ----------------------------CeEEEEEeecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 024336 72 ----------------------------THLAIVMEYAAGGELFARIC----SAGRFSEDEARFFFQQLISGVSYCHSME 119 (269)
Q Consensus 72 ----------------------------~~~~~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 119 (269)
..+++||||+++ +|.+.+. ....+++..++.++.|++.||.|||+.|
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ---------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 348999999985 6665553 4567999999999999999999999999
Q ss_pred ceeecCCCCcEEec-CCCCCcEEEeecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCC
Q 024336 120 ICHRDLKLENTLLD-GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA 198 (269)
Q Consensus 120 i~H~di~p~ni~i~-~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~ 198 (269)
++||||||+||+++ .++. ++|+|||++.............+++.|+|||.+.+....+.++||||||+++|+|++|.
T Consensus 162 i~H~Dikp~Nil~~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 239 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239 (383)
T ss_dssp EECSCCCGGGEEEETTTTE--EEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CccCccCHHHEEEcCCCCc--EEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCC
Confidence 99999999999997 4555 99999999986555555566778999999999887665566699999999999999999
Q ss_pred CCCCCCCChhhHHHHHHHHhhc-------------cccCCC----------cCCCCHHHHHHHHHHhhhCCCCCCCcHHH
Q 024336 199 YPFEDPEDPRNFRKTIDRIRNV-------------QYFLPD----------YVRVSADCRHLLSQIFVADPSKDPHSRDQ 255 (269)
Q Consensus 199 ~pf~~~~~~~~~~~~~~~~~~~-------------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 255 (269)
.||.+....+.+.......... ...++. ...+++++.+||.+||..||.+|||+.|+
T Consensus 240 ~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (383)
T 3eb0_A 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319 (383)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 9999877655555444322111 001111 12578899999999999999999999999
Q ss_pred hhccChhhhh
Q 024336 256 KASLVPEEFA 265 (269)
Q Consensus 256 l~~~~~~~~~ 265 (269)
++|+|++.+.
T Consensus 320 l~hp~f~~~~ 329 (383)
T 3eb0_A 320 MAHPFFDHLR 329 (383)
T ss_dssp HTSGGGHHHH
T ss_pred hcCHHHHHHH
Confidence 9999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=339.60 Aligned_cols=261 Identities=25% Similarity=0.323 Sum_probs=213.6
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCC--eEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPT--HLAI 76 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 76 (269)
+.++|++.+.||+|+||+||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.... ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3578999999999999999999999999999999987533 33466789999999999999999999998765 7899
Q ss_pred EEeecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe----cCCCCCcEEEeecCCcc
Q 024336 77 VMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL----DGSPQPRLKICDFGYSK 149 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i----~~~~~~~~~l~df~~~~ 149 (269)
||||+++++|.+++..... +++..++.++.|++.||.+||+.|++|+||||+||++ +.++ .++|+|||++.
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~Dfg~a~ 164 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAAR 164 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE--EEEECCCTTCE
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc--eEEEccCCCce
Confidence 9999999999999976443 8999999999999999999999999999999999998 4444 49999999997
Q ss_pred cCCCCCCCCcccCCCcccCchhhcc-------ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc
Q 024336 150 SGLLHSQPKSTVGTPAYIAPEVLAR-------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY 222 (269)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 222 (269)
............+++.|+|||.+.. ....+.++||||||+++|+|+||..||...............+.....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 6544444455678999999999863 223345599999999999999999999876665554555544443322
Q ss_pred -------------------cCCCc----CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 223 -------------------FLPDY----VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 223 -------------------~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
..+.. ..+++.+.++|.+||+.||++|||++|+++|+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11111 123457889999999999999999999999987554
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=332.38 Aligned_cols=253 Identities=31% Similarity=0.488 Sum_probs=218.7
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 578999999999999999999999999999999987543 2235678899999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~ 156 (269)
+|++++++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGER 171 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTTCC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCccc
Confidence 999999999999988888999999999999999999999999999999999999998887 999999998753322 22
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+++.|+|||.+.+..++. ++|+||||+++|+|++|..||...... .....+.......+. .+++.+.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~ 244 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRIKKNEYSIPK--HINPVAAS 244 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCT-HHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHTTCCCCCT--TSCHHHHH
T ss_pred cccccCCCCcCCcchhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhhccCCCcc--ccCHHHHH
Confidence 33456889999999998776644 499999999999999999999875542 233334444444444 78999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+|.+||+.||++|||++|+++|+|+..
T Consensus 245 li~~~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 245 LIQKMLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred HHHHHcccChhhCcCHHHHhhChheec
Confidence 999999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=356.59 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=204.9
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeC------C
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP------T 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 72 (269)
.++|++++.||+|+||+||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999999999999999997532 2345677899999999999999999999754 3
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
.+|+||||+++ ++.+.+.. .+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++....
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 215 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC----
T ss_pred eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecC
Confidence 57999999986 46666533 4899999999999999999999999999999999999998887 9999999998655
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc----------
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY---------- 222 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~---------- 222 (269)
.........+|+.|+|||.+.+..++.+ +||||||+++|+|++|.+||.+.+..+..............
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred CCcccCCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 4444556788999999999988777554 99999999999999999999887655554444332211100
Q ss_pred -----cCCCcCC---------------------CCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 223 -----FLPDYVR---------------------VSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 223 -----~~~~~~~---------------------~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
..+.... .++++.+||.+||..||.+|||++|+++|+|+..+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 0000000 14578999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-52 Score=343.62 Aligned_cols=254 Identities=31% Similarity=0.493 Sum_probs=216.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---------cHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---------DENVQREIINHRSL-RHPNIIRFKEVLLTPT 72 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 72 (269)
++|++.+.||+|++|.||++.+..+|+.||+|++...... .+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999999989999999998764321 34577899999998 7999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
..++||||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccC
Confidence 99999999999999999988888999999999999999999999999999999999999998887 9999999987554
Q ss_pred CCCCCCcccCCCcccCchhhccc-----cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC--C
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARK-----EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--P 225 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~ 225 (269)
.........+++.|+|||.+.+. ...+.++||||||+++|+|++|..||....... ....+....... +
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~~~ 327 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL----MLRMIMEGQYQFSSP 327 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCCHH
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhCCCCCCCc
Confidence 44444566789999999998643 123455999999999999999999998754422 223333333222 2
Q ss_pred CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChh
Q 024336 226 DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
.+..++..+.++|.+||..||.+|||+.++++|+|++
T Consensus 328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 2347889999999999999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=349.59 Aligned_cols=256 Identities=33% Similarity=0.517 Sum_probs=204.0
Q ss_pred cccccc-ceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHH-HhCCCCCcceeeEEEEe----CCeEEE
Q 024336 3 ERYEPV-KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH-RSLRHPNIIRFKEVLLT----PTHLAI 76 (269)
Q Consensus 3 ~~y~~~-~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~~ 76 (269)
++|.+. +.||+|+||+||++.+..+|+.||+|++.. ...+.+|+.++ +..+||||+++++++.. ...+++
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 567776 689999999999999999999999999863 35677888877 44589999999999876 567999
Q ss_pred EEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CCcEEEeecCCcccCCC
Q 024336 77 VMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLL 153 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~~~ 153 (269)
||||++|++|.+++...+ .+++..++.++.|++.||.|||+.|++||||||+||+++.++ .+.++|+|||++.....
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 999999999999997653 599999999999999999999999999999999999998732 23499999999975444
Q ss_pred CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC--CCcCCCC
Q 024336 154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVS 231 (269)
Q Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 231 (269)
........+|+.|+|||.+.+..++. ++||||||+++|+|++|..||...............+......+ +.+..++
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 295 (400)
T 1nxk_A 217 HNSLTTPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSS-HHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSC
T ss_pred CCccccCCCCCCccCHhhcCCCCCCC-cccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCC
Confidence 44445667899999999998777655 49999999999999999999986554322112233333443333 3345789
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+++.+||.+||..||.+|||+.|+++|+|+..
T Consensus 296 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=338.13 Aligned_cols=253 Identities=31% Similarity=0.488 Sum_probs=219.0
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999999999999999987543 2335678899999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~ 156 (269)
|||+++++|.+++...+.+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++...... ..
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGER 197 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTTCC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCccc
Confidence 999999999999988888999999999999999999999999999999999999998887 999999998753322 22
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+++.|+|||.+.+..++. ++||||||+++|+|++|..||...... .....+......++. .+++.+.+
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~ 270 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRIKKNEYSIPK--HINPVAAS 270 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCT-HHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHTCCCCCT--TSCHHHHH
T ss_pred ccccCCCccccCHHHhccCCCCc-hhhHHHHHHHHHHHHHCcCCCCCCCHH----HHHHHHhcCCCCCCc--cCCHHHHH
Confidence 33456899999999998776644 499999999999999999999875432 233334444444444 78999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+|.+||+.||.+|||+.|+++|+|+..
T Consensus 271 li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 271 LIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred HHHHHccCChhHCcCHHHHhcCccccC
Confidence 999999999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=347.28 Aligned_cols=260 Identities=28% Similarity=0.370 Sum_probs=202.8
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCC-CCCcceeeEEEEeCC--eEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLR-HPNIIRFKEVLLTPT--HLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~ 75 (269)
.++|++++.||+|+||.||++.+..+|+.||+|.+.... .......+|+.+++.+. ||||+++++++..++ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 468999999999999999999999999999999986432 23345678999999997 999999999998654 789
Q ss_pred EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC--
Q 024336 76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-- 153 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-- 153 (269)
+||||+++ +|...+.. +.+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++.....
T Consensus 88 lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 88 LVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCC
T ss_pred EEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCcccccccccc
Confidence 99999985 88888865 57899999999999999999999999999999999999998887 99999999864321
Q ss_pred --------------------CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHH
Q 024336 154 --------------------HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT 213 (269)
Q Consensus 154 --------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~ 213 (269)
........+|+.|+|||.+.+....+.++|||||||++|+|++|.+||.+.+....+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 111223468899999999987555566699999999999999999999887665544444
Q ss_pred HHHHhhccc-----------------------------------------cCCCcCCCCHHHHHHHHHHhhhCCCCCCCc
Q 024336 214 IDRIRNVQY-----------------------------------------FLPDYVRVSADCRHLLSQIFVADPSKDPHS 252 (269)
Q Consensus 214 ~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 252 (269)
......... .......+++++.+||.+||..||.+|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 322111000 000112678899999999999999999999
Q ss_pred HHHhhccChhhhh
Q 024336 253 RDQKASLVPEEFA 265 (269)
Q Consensus 253 ~~~l~~~~~~~~~ 265 (269)
+|+++|||+..+.
T Consensus 324 ~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 324 NDALKHPFVSIFH 336 (388)
T ss_dssp HHHTTSTTTTTTC
T ss_pred HHHhCCHHHHHhc
Confidence 9999999987654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-52 Score=334.25 Aligned_cols=258 Identities=29% Similarity=0.386 Sum_probs=209.1
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc----cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
+.++|++.+.||+|+||.||++.+..++..||+|.+...... .+.+.+|+..+++++||||+++++++.+++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 357999999999999999999999999999999998654332 2457889999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-
Q 024336 77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS- 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~- 155 (269)
||||+++++|.+++.+.+++++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC-----
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCccccccccc
Confidence 9999999999999998889999999999999999999999999999999999999998887 9999999987433222
Q ss_pred -CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC--CCcCCCCH
Q 024336 156 -QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSA 232 (269)
Q Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 232 (269)
......+++.|+|||.+.+..++.+ +|+||||+++|+|+||..||........... .+....... .....+|+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIK---HIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH---HHSSCCCCHHHHSCTTSCH
T ss_pred cccCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HhhccCCCcchhcccCCCH
Confidence 2233468999999999987776544 9999999999999999999987654332222 111111111 11236899
Q ss_pred HHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 233 DCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
.+.++|.+||+.||.+||+..+.+.+.|...+
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 99999999999999999977776666655443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=337.48 Aligned_cols=261 Identities=27% Similarity=0.397 Sum_probs=213.9
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
-++|++.+.||+|+||.||++.+..+|+.||+|.+...... .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 36899999999999999999999999999999998654332 234678999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~ 157 (269)
||+++++|.++....+.+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++..... ....
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 181 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVY 181 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC----------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCceeecCCcccc
Confidence 99999999888877788999999999999999999999999999999999999998887 99999999864322 2233
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc---------------cc
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QY 222 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------------~~ 222 (269)
....+++.|+|||.+.+....+.++||||||+++|+|++|..||................... ..
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 455689999999999876555666999999999999999999998876655444333221110 01
Q ss_pred cCCC----------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 223 FLPD----------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 223 ~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
..+. ...+++.+.+||.+||+.||.+|||+.|+++|+|++.-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 1111 12578999999999999999999999999999999763
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=352.61 Aligned_cols=260 Identities=32% Similarity=0.485 Sum_probs=207.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---------ccHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---------IDENVQREIINHRSLRHPNIIRFKEVLLTPT 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ....+.+|+.++++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 4689999999999999999999999999999999875321 11247889999999999999999999754 5
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CCcEEEeecCCcccC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSG 151 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~ 151 (269)
..++||||+++++|.+.+...+.+++..++.++.|++.||.|||+.|++||||||+||+++.++ ...++|+|||++...
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5899999999999999998888899999999999999999999999999999999999997543 235999999999865
Q ss_pred CCCCCCCcccCCCcccCchhhcc--ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC--Cc
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DY 227 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~ 227 (269)
..........+++.|+|||.+.+ ....+.++||||||+++|+|+||..||............. ......+. .+
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i---~~~~~~~~~~~~ 369 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI---TSGKYNFIPEVW 369 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH---HTTCCCCCHHHH
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH---hcCCCCCCchhh
Confidence 44444456678999999999864 2333556999999999999999999998765544433332 22222221 12
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 228 VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
..+++.+.+||.+||+.||.+|||++|+++|+|++...
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 46899999999999999999999999999999998643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=344.20 Aligned_cols=259 Identities=25% Similarity=0.367 Sum_probs=207.6
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPT----- 72 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 72 (269)
+.++|++.+.||+|+||.||++.+..+|+.||+|.+..... ..+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 35789999999999999999999999999999999865322 2345778999999999999999999998763
Q ss_pred -eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 73 -HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 73 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
.+|+|||++ +++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++...
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeeccccc
Confidence 469999999 7799998865 67899999999999999999999999999999999999998887 999999999743
Q ss_pred CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc----------
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ---------- 221 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---------- 221 (269)
. .......+++.|+|||.+.+....+.++|+|||||++++|++|..||.+.+....+...........
T Consensus 179 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 179 D--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp C--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred c--cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 2 2334557899999999998744445669999999999999999999988765544443332211100
Q ss_pred ---------c-----cC-CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 222 ---------Y-----FL-PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 222 ---------~-----~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
. .+ .-....++.+.+||.+||..||.+|||++|+++|+|+..+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0 00 01135689999999999999999999999999999998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=339.99 Aligned_cols=258 Identities=23% Similarity=0.331 Sum_probs=209.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeC--------
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP-------- 71 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------- 71 (269)
++|++++.||+|+||.||++.+..+|+.||+|++.... .....+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 68999999999999999999999999999999986433 2345678999999999999999999999873
Q ss_pred CeEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCccc
Q 024336 72 THLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 72 ~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~ 150 (269)
+.+++||||+++ +|.+.+.. ...+++..++.++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++..
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~ 173 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARA 173 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEccchhccc
Confidence 468999999986 66666654 357999999999999999999999999999999999999998887 99999999864
Q ss_pred CCC-----CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcccc-C
Q 024336 151 GLL-----HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-L 224 (269)
Q Consensus 151 ~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-~ 224 (269)
... ........+++.|+|||.+.+....+.++||||||+++|+|+||.+||...................... +
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 321 1222345678999999999876655666999999999999999999998866554444433332222111 1
Q ss_pred CCcC-------------------------CCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 225 PDYV-------------------------RVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 225 ~~~~-------------------------~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+... ..++.+.+||.+||+.||++|||++|+++|+|+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 317 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317 (351)
T ss_dssp TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence 1100 02677999999999999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=364.15 Aligned_cols=253 Identities=32% Similarity=0.486 Sum_probs=222.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++++.||+|+||.||++.+..+++.||+|++.+. ....+.+..|..++..+ +||+|+++++++.+.+.+|+|
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 5799999999999999999999999999999998753 23456678899999887 799999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC-CCCC
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~-~~~~ 156 (269)
|||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++.... ....
T Consensus 421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~~ 498 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGVT 498 (674)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTTCC
T ss_pred EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCCcc
Confidence 999999999999998889999999999999999999999999999999999999998888 9999999987432 2233
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+|+.|+|||++.+..++.. +|+||||+++|+|++|..||...+. ..+...+......++. .+++++.+
T Consensus 499 ~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~ 571 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYPK--SMSKEAVA 571 (674)
T ss_dssp BCCCCSCSSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHSSCCCCCT--TSCHHHHH
T ss_pred cccccCCCcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCCH----HHHHHHHHhCCCCCCc--cCCHHHHH
Confidence 445679999999999987777554 9999999999999999999987544 3445556666666666 79999999
Q ss_pred HHHHHhhhCCCCCCCc-----HHHhhccChhhh
Q 024336 237 LLSQIFVADPSKDPHS-----RDQKASLVPEEF 264 (269)
Q Consensus 237 li~~~l~~~p~~Rps~-----~~~l~~~~~~~~ 264 (269)
||.+||+.||.+||++ +|+++|+||..+
T Consensus 572 li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 572 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 9999999999999998 999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=331.47 Aligned_cols=254 Identities=29% Similarity=0.476 Sum_probs=194.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+|+.||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++|+
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 67999999999999999999999899999999986432 22367889999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CC
Q 024336 79 EYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQ 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~ 156 (269)
||+++++|.+++... .++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHEK 168 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC-----
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCCCc
Confidence 999999999999765 57999999999999999999999999999999999999998887 999999998743322 22
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||......... ..+.......+. .++.++.+
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~ 241 (278)
T 3cok_A 169 HYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTL----NKVVLADYEMPS--FLSIEAKD 241 (278)
T ss_dssp -----------------------C-THHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCCCCT--TSCHHHHH
T ss_pred ceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHHHHH----HHHhhcccCCcc--ccCHHHHH
Confidence 234568899999999887666444 99999999999999999999875543222 222222333333 68999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
+|.+||..||.+|||+.++++|+|+..-.
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 99999999999999999999999997644
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-52 Score=333.61 Aligned_cols=259 Identities=36% Similarity=0.567 Sum_probs=220.0
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 468999999999999999999999899999999986532 34567889999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CCcEEEeecCCcccCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~~~~~~~ 157 (269)
|++++++|.+.+...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ ...++|+|||++.........
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 9999999999998888899999999999999999999999999999999999997644 235999999998754444444
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc--cCCCcCCCCHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRVSADCR 235 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 235 (269)
....+++.|+|||.+.+. + +.++|+||||+++|+|++|..||....... ....+..... ..+.+..+++++.
T Consensus 181 ~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVETGKYAFDLPQWRTISDDAK 254 (287)
T ss_dssp SCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred ccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCchhhhhcCHHHH
Confidence 445678899999998754 4 455999999999999999999998765432 2333333332 3334457899999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
++|.+||..||.+|||+.++++|+|++.+..
T Consensus 255 ~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred HHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 9999999999999999999999999987653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=341.47 Aligned_cols=258 Identities=26% Similarity=0.350 Sum_probs=208.8
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCcccc----HHHHHHHHHHHhCCCCCcceeeEEEEeCC----
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRHPNIIRFKEVLLTPT---- 72 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 72 (269)
+.++|++.+.||+|+||.||++.+..+++.||+|++....... ..+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3679999999999999999999999999999999997643322 35778999999999999999999987654
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
..++||||+++++|.+++...+++++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++....
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC----
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCccccc
Confidence 35999999999999999998889999999999999999999999999999999999999998887 9999999986432
Q ss_pred CCC----CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC--C
Q 024336 153 LHS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--D 226 (269)
Q Consensus 153 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~ 226 (269)
... ......+++.|+|||.+.+..++. ++||||||+++|+|+||..||............ .......+ .
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~ 242 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDA-RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH----VREDPIPPSAR 242 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----HHCCCCCHHHH
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----hcCCCCCcccc
Confidence 221 222345899999999998776644 599999999999999999999875543322222 11111111 1
Q ss_pred cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 227 YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
...+++++.++|.+||+.||.+||++.+++.++|+....
T Consensus 243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 236899999999999999999999999999999987654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=331.96 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=213.6
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
.|...+.||+|+||.||++.+..+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 37778899999999999999998999999999875443 34568899999999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCccc
Q 024336 83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTV 161 (269)
Q Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~~~ 161 (269)
+++|.+++.. ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++....... ......
T Consensus 126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCcccccccc
Confidence 9999998854 56899999999999999999999999999999999999998887 9999999886433222 233457
Q ss_pred CCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-ccCCCcCCCCHHHHHHHHH
Q 024336 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRVSADCRHLLSQ 240 (269)
Q Consensus 162 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 240 (269)
+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||........ ...+.... ........+++.+.++|.+
T Consensus 203 gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~ 277 (321)
T 2c30_A 203 GTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQA----MKRLRDSPPPKLKNSHKVSPVLRDFLER 277 (321)
T ss_dssp SCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSSCCCCTTGGGSCHHHHHHHHH
T ss_pred CCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCCCCcCccccCCHHHHHHHHH
Confidence 8999999999987776554 9999999999999999999986544322 22222222 2233334688999999999
Q ss_pred HhhhCCCCCCCcHHHhhccChhhh
Q 024336 241 IFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 241 ~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
||+.||++|||+.++++|+|+...
T Consensus 278 ~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 278 MLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HccCChhhCcCHHHHhcChhhccC
Confidence 999999999999999999999753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=342.34 Aligned_cols=260 Identities=28% Similarity=0.414 Sum_probs=215.9
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.++|++.+.||+|+||.||++.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 578999999999999999999999999999999987642 223568899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
|+++++|.+++...+.+++..+..++.|++.||.+||+. |++|+||||+||+++.++. ++|+|||++.... .....
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~-~~~~~ 188 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI-DSMAN 188 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHH-HHC--
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCcccc-ccccc
Confidence 999999999999888899999999999999999999996 9999999999999998887 9999999885321 12233
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhH----------------------------
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF---------------------------- 210 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~---------------------------- 210 (269)
...+++.|+|||.+.+..++ .++||||||+++|+|++|..||.........
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp --CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred CCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 45789999999999877664 4599999999999999999999765432211
Q ss_pred ----------HHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 211 ----------RKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 211 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
......+............++.++.+||.+||+.||++|||++|+++|+|++...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 1111222222222222235789999999999999999999999999999998765
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=349.74 Aligned_cols=262 Identities=26% Similarity=0.343 Sum_probs=207.0
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeC-----C
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTP-----T 72 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 72 (269)
+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 46899999999999999999999999999999999875322 235678999999999999999999999876 5
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
.+|+|||++++ +|.+.+.....+++..++.++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++....
T Consensus 104 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~DFGla~~~~ 180 (432)
T 3n9x_A 104 ELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCDFGLARTIN 180 (432)
T ss_dssp CEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC-
T ss_pred eEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEccCCCccccc
Confidence 69999999975 99999988888999999999999999999999999999999999999998887 9999999987433
Q ss_pred CCC-----------------------CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCC-----------
Q 024336 153 LHS-----------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA----------- 198 (269)
Q Consensus 153 ~~~-----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~----------- 198 (269)
... ......+|+.|+|||.+......+.++|||||||++|+|++|.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 221 1245568999999999765555566699999999999999844
Q ss_pred CCCCCCCC-----------------hhhHHHHHH--------------------HHhhccccCC-----CcCCCCHHHHH
Q 024336 199 YPFEDPED-----------------PRNFRKTID--------------------RIRNVQYFLP-----DYVRVSADCRH 236 (269)
Q Consensus 199 ~pf~~~~~-----------------~~~~~~~~~--------------------~~~~~~~~~~-----~~~~~~~~~~~ 236 (269)
++|.+... ...+..... .+.......+ ....+++++.+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 340 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence 44433221 011111111 0111111000 01357899999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
||.+||..||.+|||++|+|+|+|+..+.
T Consensus 341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 341 LLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999998864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=346.93 Aligned_cols=261 Identities=24% Similarity=0.287 Sum_probs=213.7
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC------CCCCcceeeEEEEeCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL------RHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~ 75 (269)
..+|++++.||+|+||.||++.+..+++.||+|++.........+.+|+.+++.+ +|+||+++++.+.....++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 4689999999999999999999999999999999987655556777888888776 5779999999999999999
Q ss_pred EEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 76 IVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
+|+|+++ ++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+||+++.++...++|+|||++.. .
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~--~ 252 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--E 252 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE--T
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee--c
Confidence 9999996 58988887654 48999999999999999999999999999999999999988765699999999863 2
Q ss_pred CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcccc----------
Q 024336 154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF---------- 223 (269)
Q Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~---------- 223 (269)
........+++.|+|||.+.+..++.+ +|||||||++|+|+||.+||........+.............
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~ 331 (429)
T 3kvw_A 253 HQRVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331 (429)
T ss_dssp TCCCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHH
T ss_pred CCcccccCCCCCccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhh
Confidence 333445678999999999988777555 999999999999999999998876655554444322110000
Q ss_pred ------C-----------------------------CC--------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 224 ------L-----------------------------PD--------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 224 ------~-----------------------------~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
. +. ....++.+.+||.+||+.||++|||++|+|+|+|
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw 411 (429)
T 3kvw_A 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPW 411 (429)
T ss_dssp HBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred ccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChh
Confidence 0 00 0123678999999999999999999999999999
Q ss_pred hhhhhh
Q 024336 261 PEEFAE 266 (269)
Q Consensus 261 ~~~~~~ 266 (269)
++....
T Consensus 412 ~~~~~~ 417 (429)
T 3kvw_A 412 LRRRLP 417 (429)
T ss_dssp TC----
T ss_pred hccCCC
Confidence 987543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-52 Score=338.91 Aligned_cols=258 Identities=28% Similarity=0.481 Sum_probs=211.8
Q ss_pred ccccccc-ceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEE
Q 024336 2 EERYEPV-KELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 2 ~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 76 (269)
.++|.+. +.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.+ .||||+++++++.+.+..++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 4678887 89999999999999999999999999987532 2346788999999999 46999999999999999999
Q ss_pred EEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC---CCCCcEEEeecCCcccC
Q 024336 77 VMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG---SPQPRLKICDFGYSKSG 151 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~---~~~~~~~l~df~~~~~~ 151 (269)
||||+++++|.+++... +.+++..++.++.|++.||.+||+.|++||||||+||+++. ++. ++|+|||++...
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~--~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGD--IKIVDFGMSRKI 184 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCC--EEECCGGGCEEC
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCc--EEEeeCcccccc
Confidence 99999999999998543 56999999999999999999999999999999999999987 444 999999999755
Q ss_pred CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
..........+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||............... ......+....++
T Consensus 185 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 261 (327)
T 3lm5_A 185 GHACELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV--NVDYSEETFSSVS 261 (327)
T ss_dssp ---------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTTTTSC
T ss_pred CCccccccccCCcCccCCeeecCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc--ccccCchhhcccC
Confidence 44444455678999999999987776554 99999999999999999999876553333222211 1222233345789
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+.+.++|.+||+.||.+|||++++++|+|++.+
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 999999999999999999999999999999865
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=351.82 Aligned_cols=262 Identities=26% Similarity=0.368 Sum_probs=195.6
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeC-----C
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTP-----T 72 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 72 (269)
+.++|++++.||+|+||+||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 35789999999999999999999999999999999865322 235678899999999999999999998543 5
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
.+|+|||+++ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||++....
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTT
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--Eeecccccchhcc
Confidence 6999999985 589999988888999999999999999999999999999999999999998887 9999999997432
Q ss_pred CCC----------------------------CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh--------
Q 024336 153 LHS----------------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-------- 196 (269)
Q Consensus 153 ~~~----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-------- 196 (269)
... ......+|+.|+|||++......+.++|||||||++|+|+|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 211 12234579999999987655545666999999999999999
Q ss_pred ---CCCCCCCCCC--------------------hhhHHHHHHHHhhcc----------------ccC---------CCcC
Q 024336 197 ---GAYPFEDPED--------------------PRNFRKTIDRIRNVQ----------------YFL---------PDYV 228 (269)
Q Consensus 197 ---g~~pf~~~~~--------------------~~~~~~~~~~~~~~~----------------~~~---------~~~~ 228 (269)
|.++|.+... ...+........... ..+ ..+.
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 6677755331 011111111000000 000 0123
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 229 RVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
..++++.+||.+||..||++|||++|+|+|+|+..+.
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 4689999999999999999999999999999998763
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=341.49 Aligned_cols=258 Identities=29% Similarity=0.500 Sum_probs=218.4
Q ss_pred ccccccceecccCceEEEEEEEe---cCCeEEEEEEeecCc-----cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK-----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTH 73 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 73 (269)
++|++.+.||+|+||.||++++. .+++.||+|++.... ...+.+.+|+.+++.+ +||||+++++++..+..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 68999999999999999999984 578999999986432 2345577899999999 69999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
+++||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++.....
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVA 211 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCG
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeeccc
Confidence 9999999999999999988888999999999999999999999999999999999999998887 99999999864322
Q ss_pred C--CCCCcccCCCcccCchhhcccc-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 154 H--SQPKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 154 ~--~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
. .......+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||...............+.......+. .+
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 289 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EM 289 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--TS
T ss_pred CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc--cc
Confidence 1 1223456899999999998533 33556999999999999999999998655544445555555555544444 78
Q ss_pred CHHHHHHHHHHhhhCCCCCC-----CcHHHhhccChhhh
Q 024336 231 SADCRHLLSQIFVADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
+..+.+||.+||..||.+|| +++|+++|+|+..+
T Consensus 290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 99999999999999999999 99999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=339.09 Aligned_cols=260 Identities=27% Similarity=0.410 Sum_probs=214.3
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeC-----Ce
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTP-----TH 73 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 73 (269)
+.++|++++.||+|+||.||++.+..++..||+|.+..... ..+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 35799999999999999999999999999999999875332 235678999999999999999999998765 36
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
.++|+|++++ +|.+++.. +.+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++.....
T Consensus 105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADP 180 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCG
T ss_pred EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCC
Confidence 8999999975 89888855 56899999999999999999999999999999999999998887 99999999874332
Q ss_pred CCC----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-------
Q 024336 154 HSQ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY------- 222 (269)
Q Consensus 154 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~------- 222 (269)
... .....+++.|+|||.+.+....+.++||||||+++|+|++|..||.....................
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 221 234578999999999876665566699999999999999999999887766555544332211100
Q ss_pred ---------cCCC---------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 223 ---------FLPD---------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 223 ---------~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
..+. ...+++++.+||.+||+.||.+|||+.|+++|+|+..+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0000 13578899999999999999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=333.92 Aligned_cols=259 Identities=22% Similarity=0.355 Sum_probs=213.0
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC-CCCcceeeEEEEe--CCeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEVLLT--PTHLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~~v~ 78 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++... ..+.+.+|+.+++++. ||||+++++++.+ ....++||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 46899999999999999999999999999999998743 3477889999999997 9999999999988 56789999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
|++++++|.+++.. +++..+..++.|++.||.+||+.|++||||||+||+++.++. .++|+|||++..........
T Consensus 113 e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~~~ 188 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYN 188 (330)
T ss_dssp ECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCC
T ss_pred eccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCccc
Confidence 99999999988853 899999999999999999999999999999999999986662 39999999997555555555
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhH-HHHHHH---------HhhccccC----
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF-RKTIDR---------IRNVQYFL---- 224 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~-~~~~~~---------~~~~~~~~---- 224 (269)
...+++.|+|||.+.+....+.++||||||+++|+|++|..||......... ...... +.......
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (330)
T 3nsz_A 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 268 (330)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence 6678999999999987555566699999999999999999999655443222 111111 11111000
Q ss_pred ------------------CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 225 ------------------PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 225 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
.....+++++.+||.+||+.||.+|||++|+++|+|+..+.+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 111237899999999999999999999999999999998653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=329.15 Aligned_cols=260 Identities=22% Similarity=0.303 Sum_probs=199.3
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcccc---HHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.++|++.+.||+|+||+||++.+..+|+.||+|++....... ..+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 478999999999999999999999999999999987543222 22334455578889999999999999999999999
Q ss_pred eecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 79 EYAAGGELFARIC----SAGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 79 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
||+++ +|.+.+. ....+++..++.++.|++.||.+||++ |++|+||||+||+++.++. ++|+|||++.....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC--EEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecCCcccccc
Confidence 99985 7766664 356799999999999999999999998 9999999999999998887 99999999875444
Q ss_pred CCCCCcccCCCcccCchhhc---cccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 154 HSQPKSTVGTPAYIAPEVLA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 154 ~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
........+++.|+|||.+. .....+.++|+||||+++|+|+||..||........ ........... ......+
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~-~~~~~~~ 239 (290)
T 3fme_A 163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ--QLKQVVEEPSP-QLPADKF 239 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH--HHHHHHHSCCC-CCCTTTS
T ss_pred cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH--HHHHHhccCCC-CcccccC
Confidence 44445557899999999973 333345569999999999999999999986544322 22222222222 2222368
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhhc
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAER 267 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~~ 267 (269)
++++.++|.+||+.||++|||+.|+++|+|+.....+
T Consensus 240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~ 276 (290)
T 3fme_A 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESK 276 (290)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCccc
Confidence 9999999999999999999999999999999876543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=337.99 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=203.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCC--------
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPT-------- 72 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------- 72 (269)
++|++.+.||+|+||.||++.+..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 68999999999999999999999999999999987533 23467889999999999999999999986543
Q ss_pred -------------------------------------------------eEEEEEeecCCCchHHHHHhcCC---CCHHH
Q 024336 73 -------------------------------------------------HLAIVMEYAAGGELFARICSAGR---FSEDE 100 (269)
Q Consensus 73 -------------------------------------------------~~~~v~e~~~~~~l~~~~~~~~~---~~~~~ 100 (269)
..++||||+++++|.+++..... .++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 38999999999999999977543 56667
Q ss_pred HHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-------------CCCcccCCCccc
Q 024336 101 ARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-------------QPKSTVGTPAYI 167 (269)
Q Consensus 101 ~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-------------~~~~~~~~~~~~ 167 (269)
++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++....... ......+++.|+
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 9999999999999999999999999999999998887 9999999987433321 223346899999
Q ss_pred CchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCC
Q 024336 168 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPS 247 (269)
Q Consensus 168 aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 247 (269)
|||.+.+..++. ++||||||+++|+|++|..|+. ............... ......++++.++|.+||+.||.
T Consensus 244 aPE~~~~~~~~~-~~Di~slG~il~el~~~~~~~~------~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~ 315 (332)
T 3qd2_B 244 SPEQIHGNNYSH-KVDIFSLGLILFELLYSFSTQM------ERVRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPT 315 (332)
T ss_dssp CHHHHHCCCCCT-HHHHHHHHHHHHHHHSCCCCHH------HHHHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHHCSSGG
T ss_pred ChHHhcCCCCcc-hhhHHHHHHHHHHHHHcCCChh------HHHHHHHHhhccCCC-cccccCChhHHHHHHHHccCCCC
Confidence 999998777655 4999999999999999876542 122222222222111 11124567889999999999999
Q ss_pred CCCCcHHHhhccChhhh
Q 024336 248 KDPHSRDQKASLVPEEF 264 (269)
Q Consensus 248 ~Rps~~~~l~~~~~~~~ 264 (269)
+|||+.|+++|+|++.+
T Consensus 316 ~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 316 ERPEATDIIENAIFENL 332 (332)
T ss_dssp GSCCHHHHHHSTTCCCC
T ss_pred cCCCHHHHhhchhhhcC
Confidence 99999999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=337.43 Aligned_cols=259 Identities=27% Similarity=0.387 Sum_probs=210.3
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc------ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
.++|++.+.||+|+||.||++.+..+|+.||+|.+..... ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 4689999999999999999999999999999999864321 1346788999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-
Q 024336 76 IVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL- 153 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~- 153 (269)
+|+||+++ +|.+.+... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccceeccCC
Confidence 99999986 788887654 36899999999999999999999999999999999999998887 99999999875322
Q ss_pred CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cCCC------
Q 024336 154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPD------ 226 (269)
Q Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~------ 226 (269)
........+++.|+|||.+.+....+.++||||||+++|+|++|.+||........+............ .++.
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 223345578999999999977665566799999999999999999999887665555544443322110 1110
Q ss_pred ---------------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 227 ---------------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 227 ---------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
...+++++.+||.+||..||.+|||+.|+++|+|+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 1356789999999999999999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=332.54 Aligned_cols=248 Identities=22% Similarity=0.274 Sum_probs=198.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcccc---HHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||+||++.+..+|+.||+|++....... .....|+..+..+ +||||+++++++.+++.+++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999999999999999876543222 2344455555444 8999999999999999999999
Q ss_pred eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 79 EYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
|++ +++|.+.+... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++.........
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCC
Confidence 999 55888877654 46999999999999999999999999999999999999998887 999999998755444445
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....+++.|+|||.+.+ .+ +.++||||||+++|+|++|..|+.... ....+............+++++.++
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~l 284 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGE-------GWQQLRQGYLPPEFTAGLSSELRSV 284 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHH-------HHHHHTTTCCCHHHHTTSCHHHHHH
T ss_pred cccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHhccCCCcccccCCCHHHHHH
Confidence 55678999999999875 44 455999999999999999977665421 1122222211111123688999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccChh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
|.+||+.||++|||++|+++|+|++
T Consensus 285 i~~~L~~dP~~Rpt~~ell~hp~~~ 309 (311)
T 3p1a_A 285 LVMMLEPDPKLRATAEALLALPVLR 309 (311)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred HHHHcCCChhhCcCHHHHHhCcccc
Confidence 9999999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-51 Score=326.52 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=206.9
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
.++|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+..+..+ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 468999999999999999999999999999999987542 2335677899999998 899999999999999999999
Q ss_pred EeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-----------------
Q 024336 78 MEYAAGGELFARICSA----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP----------------- 136 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~----------------- 136 (269)
+||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999999765 6689999999999999999999999999999999999998543
Q ss_pred CCcEEEeecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHH
Q 024336 137 QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR 216 (269)
Q Consensus 137 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~ 216 (269)
...++|+|||.+..... .....+++.|+|||.+.+....+.++||||||+++|+|++|.+++.... . ...
T Consensus 170 ~~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~----~~~ 239 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---Q----WHE 239 (289)
T ss_dssp CCCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---H----HHH
T ss_pred ceEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---H----HHH
Confidence 22489999998874322 2334589999999999876555566999999999999999988765432 1 122
Q ss_pred Hhhccc-cCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 217 IRNVQY-FLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 217 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
+..... ..+ ..+++++.++|.+||+.||.+|||+.|+++|+|+.....
T Consensus 240 ~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 288 (289)
T 1x8b_A 240 IRQGRLPRIP--QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288 (289)
T ss_dssp HHTTCCCCCS--SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-----
T ss_pred HHcCCCCCCC--cccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhcc
Confidence 222221 223 378999999999999999999999999999999987544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=326.02 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=210.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEe----CCeEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLT----PTHLA 75 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 75 (269)
+.|++.+.||+|+||.||++.+..++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 46899999999999999999999999999999987543 233467889999999999999999999875 45689
Q ss_pred EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEec-CCCCCcEEEeecCCcccCC
Q 024336 76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLD-GSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~p~ni~i~-~~~~~~~~l~df~~~~~~~ 152 (269)
+||||+++++|.+++...+.+++..++.++.|++.||.+||+.| ++|+||||+||+++ .++. ++|+|||++....
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~--~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKR 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGCC
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC--EEEeeCCCccccc
Confidence 99999999999999988888999999999999999999999999 99999999999997 5666 9999999986322
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCH
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
........+++.|+|||.+.+ .+ +.++|+||||+++|+|++|..||.......... ..+.............++
T Consensus 184 -~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 184 -ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIY---RRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp -TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---HHHTTTCCCGGGGGCCCH
T ss_pred -ccccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH---HHHhccCCccccCCCCCH
Confidence 222334568999999998864 34 555999999999999999999998766543332 222222222222235778
Q ss_pred HHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 233 DCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
++.++|.+||+.||.+|||+.|+++|+|++.
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=334.75 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=208.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc----cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++++.||+|+||+||++.+..+|+.||+|.+...... .+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4689999999999999999999999999999998754322 245788999999999999999999999999999999
Q ss_pred eecCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 79 EYAAGGELFARIC-SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
||+.| ++.+.+. ...++++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++.... ..
T Consensus 134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~---~~ 207 (348)
T 1u5q_A 134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMA---PA 207 (348)
T ss_dssp ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSS---SB
T ss_pred ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEeeccCceecC---CC
Confidence 99975 7777774 4567999999999999999999999999999999999999998877 9999999987432 22
Q ss_pred CcccCCCcccCchhhc---cccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHH
Q 024336 158 KSTVGTPAYIAPEVLA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
....+++.|+|||.+. ...+ +.++||||||+++|+|++|..||.......... .+............+++.+
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l 282 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALY----HIAQNESPALQSGHWSEYF 282 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSCCCCCCCTTSCHHH
T ss_pred CcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH----HHHhcCCCCCCCCCCCHHH
Confidence 3457899999999985 3344 455999999999999999999998765433322 2222222222234689999
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.++|.+||+.||.+|||++++++|+|+..
T Consensus 283 ~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 99999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=336.97 Aligned_cols=260 Identities=32% Similarity=0.490 Sum_probs=211.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---------cccHHHHHHHHHHHhCCCCCcceeeEEEEeCC
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---------KIDENVQREIINHRSLRHPNIIRFKEVLLTPT 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 478999999999999999999999999999999986432 11234788999999999999999999987665
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC-CcEEEeecCCcccC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSG 151 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~-~~~~l~df~~~~~~ 151 (269)
.++|+||+++++|.+.+.....+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ..++|+|||++...
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999988888999999999999999999999999999999999999986542 35999999998743
Q ss_pred CCCCCCCcccCCCcccCchhhcc--ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC--Cc
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DY 227 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~ 227 (269)
..........+++.|+|||.+.+ ....+.++||||||+++|+|++|..||.............. ....... .+
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~ 244 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---SGKYNFIPEVW 244 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH---HTCCCCCHHHH
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH---hCccccCchhh
Confidence 32222234468999999999752 33335569999999999999999999987655433333322 2222111 12
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 228 VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
..+++.+.++|.+||..||.+|||+.++++|+|+....
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 36889999999999999999999999999999997643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=337.34 Aligned_cols=261 Identities=23% Similarity=0.353 Sum_probs=203.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCC-------eEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT-------HLA 75 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-------~~~ 75 (269)
++|++.+.||+|+||.||++.+..+|+.||+|.+...........+++..++.++||||+++++++.... .++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence 6899999999999999999999999999999998776666667788888899999999999999987633 389
Q ss_pred EEEeecCCCchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--hCCceeecCCCCcEEecC-CCCCcEEEeecCCc
Q 024336 76 IVMEYAAGGELFARI----CSAGRFSEDEARFFFQQLISGVSYCH--SMEICHRDLKLENTLLDG-SPQPRLKICDFGYS 148 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lh--~~~i~H~di~p~ni~i~~-~~~~~~~l~df~~~ 148 (269)
+||||++++ |...+ .....+++..++.++.|++.||.+|| +.|++|+||||+||+++. ++. ++|+|||++
T Consensus 103 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~--~kl~Dfg~a 179 (360)
T 3e3p_A 103 VVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKLCDFGSA 179 (360)
T ss_dssp EEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE--EEECCCTTC
T ss_pred EEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc--EEEeeCCCc
Confidence 999999874 44333 34567899999999999999999999 999999999999999986 565 999999999
Q ss_pred ccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-------
Q 024336 149 KSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ------- 221 (269)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~------- 221 (269)
.............+++.|+|||.+.+....+.++||||||+++|+|++|..||....................
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence 8655555555667899999999997766556669999999999999999999988766555544433221100
Q ss_pred ------cc-------------CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 222 ------YF-------------LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 222 ------~~-------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
.. .......++++.+||.+||+.||.+|||+.|+++|+|+..+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 00 0001125678999999999999999999999999999998753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=330.97 Aligned_cols=257 Identities=25% Similarity=0.361 Sum_probs=210.0
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEEe------CCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLT------PTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~ 74 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++.......+.+.+|+.+++++ +||||+++++++.. ....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 102 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 102 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence 5789999999999999999999999999999999987766778899999999998 79999999999987 4689
Q ss_pred EEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 75 AIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 103 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLD 180 (326)
T ss_dssp EEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTTC---
T ss_pred EEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCceecC
Confidence 9999999999999999764 46899999999999999999999999999999999999998887 9999999886432
Q ss_pred CC-CCCCcccCCCcccCchhhcc----ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCc
Q 024336 153 LH-SQPKSTVGTPAYIAPEVLAR----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227 (269)
Q Consensus 153 ~~-~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (269)
.. .......+++.|+|||.+.. ....+.++||||||+++|+|++|..||.......... .+..........
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~ 256 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF----LIPRNPAPRLKS 256 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSCCCCCSC
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH----HhhcCccccCCc
Confidence 22 12334568899999999862 2223455999999999999999999997655432222 222222222223
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 228 VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
..+++.+.++|.+||..||.+||++.++++|+|+...
T Consensus 257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 4689999999999999999999999999999999764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=342.15 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=196.3
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeC------C
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTP------T 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~ 72 (269)
.++|++++.||+|+||.||++.+..+|+.||+|++..... ....+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 5789999999999999999999999999999999865322 234677899999999999999999998754 5
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
.++++++++ +++|.+++.. +.+++..++.++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++....
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~ 183 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTA 183 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC--------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeecccccccc
Confidence 589999999 5799888855 67999999999999999999999999999999999999998887 9999999987432
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-----------
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ----------- 221 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~----------- 221 (269)
.......+++.|+|||.+.+....+.++|||||||++|+|++|..||.+.+....+...........
T Consensus 184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 184 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred --ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 2234557899999999998755456669999999999999999999988766554444333221100
Q ss_pred --------ccCCC------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 222 --------YFLPD------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 222 --------~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
...+. ....++.+.+||.+||..||.+|||+.|+++|+|+..+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 00000 124678999999999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=328.59 Aligned_cols=249 Identities=27% Similarity=0.396 Sum_probs=200.3
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.++|++.+.||+|+||+||++.+ +|+.||+|++...... .+.+.+|+.++++++||||+++++++.+...+++||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 36899999999999999999987 5888999998754322 245788999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 79 EYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
||+++++|.+++...+. +++..++.++.|++.||.+||+.| ++||||||+||+++.++. ++|+|||++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLKAS 191 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC-------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCCccccc
Confidence 99999999999976553 899999999999999999999999 999999999999998887 99999999864322
Q ss_pred CC-CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCH
Q 024336 154 HS-QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232 (269)
Q Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
.. ......+++.|+|||.+.+..++.+ +||||||+++|+|+||..||......... ..+............+++
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 192 TFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVV----AAVGFKCKRLEIPRNLNP 266 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHH----HHHHHSCCCCCCCTTSCH
T ss_pred cccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcCCCCCCCccCCH
Confidence 22 2334568999999999987777555 99999999999999999999876543322 222222222222337899
Q ss_pred HHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 233 DCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+.++|.+||+.||.+|||+.++++.+
T Consensus 267 ~l~~li~~~l~~dP~~Rps~~~ll~~L 293 (309)
T 3p86_A 267 QVAAIIEGCWTNEPWKRPSFATIMDLL 293 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 999999999999999999999999843
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=341.86 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=209.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeC------CeEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTP------THLAI 76 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~~ 76 (269)
.+|++.+.||+|+||.||++.+..+|+.||+|.+..... ...+|+.+++.++||||+++++++... ..+++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 479999999999999999999999999999999875432 234799999999999999999998542 24789
Q ss_pred EEeecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 77 VMEYAAGGELFARIC----SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 77 v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
|+||+++ ++...+. ....+++..++.++.||+.||.|||+.||+||||||+||+++.++. .+||+|||++....
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLV 208 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECC
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhhcc
Confidence 9999986 5655543 3567999999999999999999999999999999999999986543 38999999997654
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh--------c----
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN--------V---- 220 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~--------~---- 220 (269)
.........+++.|+|||.+.+....+.++|||||||++|+|++|..||.+......+......... .
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~ 288 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 4445556678999999999977654566699999999999999999999887665555544432211 0
Q ss_pred -cccCCC----------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 221 -QYFLPD----------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 221 -~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.+.++. ...+++++.+||.+||..||.+|||+.|+++|+|+..+.
T Consensus 289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 111111 124688999999999999999999999999999998764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=325.63 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=211.8
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|+||.||++.+..+|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 468999999999999999999999999999999987653 4577889999999999999999999999999999999999
Q ss_pred CCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCc
Q 024336 82 AGGELFARIC-SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKS 159 (269)
Q Consensus 82 ~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~ 159 (269)
++++|.+++. ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... .....
T Consensus 107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~ 184 (314)
T 3com_A 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKRNT 184 (314)
T ss_dssp TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCBCC
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhccccCc
Confidence 9999999986 4567999999999999999999999999999999999999998887 999999998643222 22334
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
..+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||........... ........+.....+++.+.++|.
T Consensus 185 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~ 260 (314)
T 3com_A 185 VIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFM---IPTNPPPTFRKPELWSDNFTDFVK 260 (314)
T ss_dssp CCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred cCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HhcCCCcccCCcccCCHHHHHHHH
Confidence 568899999999987776555 9999999999999999999986554322221 111122223333467899999999
Q ss_pred HHhhhCCCCCCCcHHHhhccChhhh
Q 024336 240 QIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+||..||.+|||+.++++|+|+...
T Consensus 261 ~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 261 QCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHccCChhhCcCHHHHHhCHHHhcC
Confidence 9999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=334.30 Aligned_cols=263 Identities=26% Similarity=0.344 Sum_probs=212.8
Q ss_pred CcccccccceecccCceEEEEEEE-ecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCC------CcceeeEEEEeCCe
Q 024336 1 MEERYEPVKELGSGNFGVARLVRD-KRTKELVAVKYIERGKKIDENVQREIINHRSLRHP------NIIRFKEVLLTPTH 73 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~ 73 (269)
+.++|++.+.||+|+||.||++.+ ..+++.||+|++.......+.+.+|+.+++.++|+ +++++++++...+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 357999999999999999999998 56789999999976655566788899999888654 59999999999999
Q ss_pred EEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC---------------
Q 024336 74 LAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP--------------- 136 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~--------------- 136 (269)
.++|||++ +++|.+++...+ ++++..++.++.|++.||.+||+.|++|+||||+||+++.++
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99999999 779999997765 689999999999999999999999999999999999998743
Q ss_pred --CCcEEEeecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHH
Q 024336 137 --QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214 (269)
Q Consensus 137 --~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~ 214 (269)
.+.++|+|||++... ........+++.|+|||.+.+..++.+ +||||||+++|+|++|..||.............
T Consensus 171 ~~~~~~kl~Dfg~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 247 (339)
T 1z57_A 171 LINPDIKVVDFGSATYD--DEHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247 (339)
T ss_dssp ESCCCEEECCCSSCEET--TSCCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHH
T ss_pred ccCCCceEeeCcccccC--ccccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 334999999998742 333445678999999999987776554 999999999999999999998766544333222
Q ss_pred HHHhhccc--------------------------------------cCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHh
Q 024336 215 DRIRNVQY--------------------------------------FLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQK 256 (269)
Q Consensus 215 ~~~~~~~~--------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 256 (269)
........ ........++++.+||.+||+.||.+|||+.|++
T Consensus 248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 327 (339)
T 1z57_A 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL 327 (339)
T ss_dssp HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHh
Confidence 21110000 0000112356789999999999999999999999
Q ss_pred hccChhhhhhc
Q 024336 257 ASLVPEEFAER 267 (269)
Q Consensus 257 ~~~~~~~~~~~ 267 (269)
+|+|++.+.++
T Consensus 328 ~hp~f~~~~~~ 338 (339)
T 1z57_A 328 KHPFFDLLKKS 338 (339)
T ss_dssp TSGGGGGGGC-
T ss_pred cCHHHHHHhcc
Confidence 99999987653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=340.53 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=207.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCC------eEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT------HLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~ 75 (269)
..+|++.+.||+|+||+||++.+..++. +|+|.+...... ..+|+.+++.++||||+++++++.... .++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3579999999999999999999987666 888877654322 236999999999999999999986543 388
Q ss_pred EEEeecCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec-CCCCCcEEEeecCCcccC
Q 024336 76 IVMEYAAGGELFARI---CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLD-GSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~-~~~~~~~~l~df~~~~~~ 151 (269)
+||||++++.+.... .....+++..++.++.|++.||.|||+.|++||||||+||+++ .++. ++|+|||++...
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~--~kL~DFG~a~~~ 192 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV--LKLIDFGSAKIL 192 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE--EEECCCTTCEEC
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc--EEEeeCCCcccc
Confidence 999999875433322 2356799999999999999999999999999999999999998 5665 999999999765
Q ss_pred CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc-----------
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV----------- 220 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----------- 220 (269)
..........+++.|+|||.+.+....+.++|||||||++|+|++|..||.+......+..........
T Consensus 193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 272 (394)
T 4e7w_A 193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272 (394)
T ss_dssp CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 555555667789999999999776655666999999999999999999999877655555444322110
Q ss_pred --cccCCC----------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 221 --QYFLPD----------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 221 --~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
...++. ...+++++.+||.+||..||.+|||+.|+++|+|+..+.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 011111 124788999999999999999999999999999998764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=337.29 Aligned_cols=261 Identities=21% Similarity=0.303 Sum_probs=203.8
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc------------cHHHHHHHHHHHhCCCCCcceeeEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI------------DENVQREIINHRSLRHPNIIRFKEVL 68 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~~~~~~ 68 (269)
+.++|++.+.||+|+||.||++.+.. |..||+|.+...... .+.+.+|+.++++++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 46899999999999999999999865 889999998643211 15688999999999999999999998
Q ss_pred Ee-----CCeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEE
Q 024336 69 LT-----PTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKI 142 (269)
Q Consensus 69 ~~-----~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l 142 (269)
.. ...+++|||++++ +|.+.+... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl 175 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITI 175 (362)
T ss_dssp EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEE
T ss_pred EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEE
Confidence 54 3468999999985 777777554 36999999999999999999999999999999999999998887 999
Q ss_pred eecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-
Q 024336 143 CDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ- 221 (269)
Q Consensus 143 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~- 221 (269)
+|||++.............+++.|+|||.+.+....+.++||||||+++|+|++|..||....................
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 9999997544444455567889999999998755456669999999999999999999988765554444433221110
Q ss_pred -------------------ccCC------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 222 -------------------YFLP------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 222 -------------------~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
...+ .....++.+.+||.+||+.||.+|||+.|+++|+|++.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 0000 0124678899999999999999999999999999998763
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=338.12 Aligned_cols=257 Identities=26% Similarity=0.387 Sum_probs=208.3
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE----
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHL---- 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---- 74 (269)
.++|++.+.||+|+||.||++.+..+|+.||+|++...... ...+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 57899999999999999999999999999999998754322 35677899999999999999999999877654
Q ss_pred --EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 75 --AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 75 --~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
++|+|++. ++|.+.+. ..+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++...
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~- 194 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHA- 194 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC----
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCccccc-
Confidence 99999997 47877763 34899999999999999999999999999999999999998887 999999998743
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-----------
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ----------- 221 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~----------- 221 (269)
........+++.|+|||.+.+....+.++||||||+++|+|++|..||....................
T Consensus 195 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 195 -DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred -ccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 23334556899999999998744455669999999999999999999987665444444332211100
Q ss_pred --------ccCC------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 222 --------YFLP------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 222 --------~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
...+ ....+++.+.+||.+||+.||.+|||+.|+++|+|+..+.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 0000 0125789999999999999999999999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=329.95 Aligned_cols=247 Identities=28% Similarity=0.429 Sum_probs=206.2
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecC-ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG-KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++|++.+.||+|+||+||++.+..+++.||+|.+... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 36899999999999999999999999999999987543 33445688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC--
Q 024336 81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-- 157 (269)
Q Consensus 81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~-- 157 (269)
+++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC-------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceeccccccccc
Confidence 999999999977 567999999999999999999999999999999999999998887 999999998643222211
Q ss_pred -------------CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChh-----hHHHHHHHHhh
Q 024336 158 -------------KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR-----NFRKTIDRIRN 219 (269)
Q Consensus 158 -------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~-----~~~~~~~~~~~ 219 (269)
....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||....... ........
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~--- 242 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR--- 242 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH---
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc---
Confidence 14468999999999987776554 999999999999999999986533221 11111111
Q ss_pred ccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 220 VQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 220 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
..+ ..+|+.+.++|.+||+.||++|||+.++++.+
T Consensus 243 ---~~~--~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L 277 (310)
T 3s95_A 243 ---YCP--PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277 (310)
T ss_dssp ---TCC--TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---cCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 112 26888999999999999999999999998843
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=340.49 Aligned_cols=257 Identities=26% Similarity=0.379 Sum_probs=199.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCC------
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPT------ 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 72 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4689999999999999999999999999999999875432 2345778999999999999999999998765
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++....
T Consensus 104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 178 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC-----
T ss_pred ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeecccccc
Confidence 78999999976 7878775 35899999999999999999999999999999999999998887 9999999997544
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh-------------
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN------------- 219 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~------------- 219 (269)
.........+++.|+|||.+.+..++.+ +||||||+++|+|++|..||.+.+..............
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred cccccCCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 4334445678999999999988776554 99999999999999999999876654433332211100
Q ss_pred -----ccccC--------------CCc----CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 220 -----VQYFL--------------PDY----VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 220 -----~~~~~--------------~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
....+ +.. ...++++.+||.+||..||.+|||++|+++|+|+..+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 00000 000 0114678999999999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=330.69 Aligned_cols=254 Identities=25% Similarity=0.318 Sum_probs=204.2
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCC--CCcceeeEEEEeCCeEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRH--PNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~ 76 (269)
.++|++.+.||+|+||.||++.+. +++.||+|++...... .+.+.+|+.+++.++| +||+++++++.++..+++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 468999999999999999999985 6888999998754332 2467889999999976 999999999999999999
Q ss_pred EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
||| +.+++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||+++ ++. ++|+|||++........
T Consensus 87 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~--~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM--LKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTE--EEECCCSSSCCC-----
T ss_pred EEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCc--EEEeecccccccCcccc
Confidence 999 55779999999988999999999999999999999999999999999999997 444 99999999974332221
Q ss_pred ---CCcccCCCcccCchhhcc----------ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcccc
Q 024336 157 ---PKSTVGTPAYIAPEVLAR----------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF 223 (269)
Q Consensus 157 ---~~~~~~~~~~~aPE~~~~----------~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (269)
.....+++.|+|||.+.+ ....+.++||||||+++|+|++|..||........ . ...+......
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~-~~~~~~~~~~ 239 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--K-LHAIIDPNHE 239 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--H-HHHHHCTTSC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH--H-HHHHhcCCcc
Confidence 234568999999999864 13345569999999999999999999976544221 1 1222222222
Q ss_pred CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 224 LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.......+.++.+||.+||+.||.+|||+.|+++|+|++.
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 2222367789999999999999999999999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=327.29 Aligned_cols=255 Identities=31% Similarity=0.469 Sum_probs=210.1
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecC-----ccccHHHHHHHHHHHhCCCCCcceeeEEEE--eCCe
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG-----KKIDENVQREIINHRSLRHPNIIRFKEVLL--TPTH 73 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 73 (269)
+.++|++.+.||+|+||.||++.+..++..||+|++... ....+.+.+|+.+++.++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 357999999999999999999999999999999998653 233467889999999999999999999984 4457
Q ss_pred EEEEEeecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 74 LAIVMEYAAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
.++||||++++ +.+.+.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++...
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~ 159 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEAL 159 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEEC
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeecccccccc
Confidence 89999999876 7677655 456899999999999999999999999999999999999998887 999999998643
Q ss_pred CCC---CCCCcccCCCcccCchhhcccc-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCc
Q 024336 152 LLH---SQPKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227 (269)
Q Consensus 152 ~~~---~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (269)
... .......+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||..... ......+.......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~i~~~~~~~~~- 234 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI----YKLFENIGKGSYAIPG- 234 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHCCCCCCS-
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH----HHHHHHHhcCCCCCCC-
Confidence 221 1223456889999999987543 235569999999999999999999987543 3334444455544444
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 228 VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
.+++.+.++|.+||..||.+|||+.|+++|+|+...
T Consensus 235 -~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 235 -DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp -SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred -ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 789999999999999999999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=332.24 Aligned_cols=263 Identities=25% Similarity=0.356 Sum_probs=193.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.++|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+..+++++||||+++++++..++..++|+|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 478999999999999999999999899999999886432 334567889999999999999999999999999999999
Q ss_pred ecCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 80 YAAGGELFARICS--------AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 80 ~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
|+++++|.+++.. .+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~ 171 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFL 171 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCHHHHHC
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEeccchhee
Confidence 9999999999864 456899999999999999999999999999999999999998887 999999987633
Q ss_pred CCC------CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc----
Q 024336 152 LLH------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ---- 221 (269)
Q Consensus 152 ~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~---- 221 (269)
... .......+++.|+|||.+.+....+.++|+||||+++|+|++|..||....................
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccc
Confidence 221 1123446889999999987644445569999999999999999999987665443332221110000
Q ss_pred ccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 222 YFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 222 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
........+++++.++|.+||+.||.+|||+.++++|+|+.....
T Consensus 252 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp ---CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 001112367899999999999999999999999999999987654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=335.34 Aligned_cols=255 Identities=21% Similarity=0.361 Sum_probs=215.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcccc------------------HHHHHHHHHHHhCCCCCccee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID------------------ENVQREIINHRSLRHPNIIRF 64 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------------------~~~~~e~~~l~~l~h~~i~~~ 64 (269)
++|++.+.||+|+||.||++.+ +|+.||+|.+....... +.+.+|+.++++++||||+++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 6899999999999999999999 89999999987532111 788999999999999999999
Q ss_pred eEEEEeCCeEEEEEeecCCCchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCC
Q 024336 65 KEVLLTPTHLAIVMEYAAGGELFAR------ICS--AGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGS 135 (269)
Q Consensus 65 ~~~~~~~~~~~~v~e~~~~~~l~~~------~~~--~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~ 135 (269)
++++.+.+..++||||+++++|.++ +.. ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++.+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence 9999999999999999999999998 655 5679999999999999999999999 999999999999999988
Q ss_pred CCCcEEEeecCCcccCCCCCCCCcccCCCcccCchhhccc-cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHH
Q 024336 136 PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK-EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214 (269)
Q Consensus 136 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~ 214 (269)
+. ++|+|||++...... ......+++.|+|||.+.+. .+...++|+||||+++|+|++|..||....... ...
T Consensus 189 ~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~ 262 (348)
T 2pml_X 189 GR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV---ELF 262 (348)
T ss_dssp SC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH---HHH
T ss_pred Cc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHH
Confidence 87 999999998743222 33455688999999999877 444436999999999999999999998766532 233
Q ss_pred HHHhhccccCCCc-----------------CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 215 DRIRNVQYFLPDY-----------------VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 215 ~~~~~~~~~~~~~-----------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
..+......++.. ..+++++.+||.+||+.||.+|||+.|+++|+|+....
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 3344444333321 46899999999999999999999999999999998643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=327.93 Aligned_cols=259 Identities=27% Similarity=0.377 Sum_probs=210.2
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 578999999999999999999999999999999986543 3456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC-CCCCCC
Q 024336 81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQPK 158 (269)
Q Consensus 81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~-~~~~~~ 158 (269)
+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.... ......
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 175 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQKRD 175 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC--
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCccccccccccc
Confidence 999999998865 456999999999999999999999999999999999999998887 9999999864211 111223
Q ss_pred cccCCCcccCchhhc----cccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHH
Q 024336 159 STVGTPAYIAPEVLA----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
...+++.|+|||.+. .....+.++|+||||+++|+|++|..||............ .............++..+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l 252 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---AKSDPPTLLTPSKWSVEF 252 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCCCCSSGGGSCHHH
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH---hccCCcccCCccccCHHH
Confidence 456889999999984 2333355699999999999999999999876543322221 111222223334788999
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.++|.+||+.||.+|||+.++++|+|+..+.
T Consensus 253 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 253 RDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 9999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=321.42 Aligned_cols=250 Identities=24% Similarity=0.392 Sum_probs=210.3
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|+||.||++.+. ++..||+|.+.......+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 368999999999999999999987 4677999999877767788999999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--CCC
Q 024336 82 AGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPK 158 (269)
Q Consensus 82 ~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~~ 158 (269)
++++|.+++... +.+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++....... ...
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHSTT
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEecccccccccccccccccc
Confidence 999999999654 45899999999999999999999999999999999999988877 9999999986432211 223
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
...+++.|+|||.+.+..++. ++|+||||+++|+|++ |..||........ ...+... .........++.+.++
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~ll~~g~~p~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~l 239 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEV----VEDISTG-FRLYKPRLASTHVYQI 239 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHHTT-CCCCCCTTSCHHHHHH
T ss_pred CcccccccCCHHHhcCCCCCc-hhhhHHHHHHHHHHhcCCCCCCCCCCHHHH----HHHHhcC-ccCCCCCcCCHHHHHH
Confidence 344577899999998777644 5999999999999999 9999987654332 2222222 1222233689999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccC
Q 024336 238 LSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
|.+||+.||.+|||+.++++++.
T Consensus 240 i~~~l~~~p~~Rps~~~ll~~l~ 262 (269)
T 4hcu_A 240 MNHCWRERPEDRPAFSRLLRQLA 262 (269)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHccCCcccCcCHHHHHHHHH
Confidence 99999999999999999999853
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=324.95 Aligned_cols=254 Identities=27% Similarity=0.429 Sum_probs=215.2
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467999999999999999999999999999999987543 334678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK 158 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 158 (269)
|+++++|.+++.. +++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 177 (303)
T 3a7i_A 101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRN 177 (303)
T ss_dssp CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECBTTBCCBC
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccceecCccccccC
Confidence 9999999998854 57899999999999999999999999999999999999998887 9999999986433222 223
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-ccCCCcCCCCHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRVSADCRHL 237 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 237 (269)
...+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||......... ..+.... ...+ ..++..+.++
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~--~~~~~~l~~l 250 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVL----FLIPKNNPPTLE--GNYSKPLKEF 250 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHSCCCCCC--SSCCHHHHHH
T ss_pred ccCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcCHHHHH----HHhhcCCCCCCc--cccCHHHHHH
Confidence 4568899999999987776554 99999999999999999999865443222 2222221 1222 3789999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
|.+||+.||.+|||+.++++|+|+..-.
T Consensus 251 i~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 251 VEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 9999999999999999999999996543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=334.02 Aligned_cols=253 Identities=24% Similarity=0.310 Sum_probs=205.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCC--CCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLR--HPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++.+.||+|+||.||++.+.. ++.||+|++..... ..+.+.+|+.+++.+. ||||+++++++..++.+++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 469999999999999999999875 88999999875432 2356789999999996 59999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-- 155 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-- 155 (269)
|| +.+++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+||+++ ++. ++|+|||++.......
T Consensus 135 ~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~--~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM--LKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSC--EEECCCSSSCCC------
T ss_pred Ee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCe--EEEEecCccccccCCCcc
Confidence 99 56789999999888899999999999999999999999999999999999996 455 9999999997533222
Q ss_pred -CCCcccCCCcccCchhhccc----------cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC
Q 024336 156 -QPKSTVGTPAYIAPEVLARK----------EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 224 (269)
Q Consensus 156 -~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (269)
......+++.|+|||.+.+. ...+.++||||||+++|+|++|..||....... .....+.......
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEI 287 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHCTTSCC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH---HHHHHHhCccccC
Confidence 12345789999999998652 234556999999999999999999998654422 1222223222222
Q ss_pred CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 225 PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+.....+.++.+||.+||..||.+|||+.|+++|+|++.
T Consensus 288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 222356889999999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=321.15 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=210.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|+||.||++.+. ++..||+|.+.......+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 478999999999999999999876 5677999999877767788999999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--CCC
Q 024336 82 AGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPK 158 (269)
Q Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~~ 158 (269)
++++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++....... ...
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEEECC
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhhccc
Confidence 9999999997654 4999999999999999999999999999999999999998887 9999999986432222 122
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
...+++.|+|||.+.+..++.+ +|+||||+++|+|+| |..||......... ..+.... ........++.+.++
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~l~~l 237 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVV----LKVSQGH-RLYRPHLASDTIYQI 237 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----HHHHTTC-CCCCCTTSCHHHHHH
T ss_pred CCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHH----HHHHcCC-CCCCCCcChHHHHHH
Confidence 3345677999999987776555 999999999999999 99999876543322 2222222 122223678999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccC
Q 024336 238 LSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
|.+||+.||.+|||+.++++++-
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~L~ 260 (268)
T 3sxs_A 238 MYSCWHELPEKRPTFQQLLSSIE 260 (268)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHG
T ss_pred HHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=330.71 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=210.5
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeC-----Ce
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTP-----TH 73 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 73 (269)
+.++|++.+.||+|+||.||++.+..+|+.||+|.+..... ....+.+|+.+++.++||||+++++++..+ ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 46799999999999999999999999999999999864332 234577899999999999999999987764 67
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
.++|+|++++ +|.+.+.. +.+++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++.....
T Consensus 89 ~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 89 VYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDE 164 (353)
T ss_dssp EEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC-
T ss_pred EEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEeccccccccc
Confidence 9999999974 88888865 56899999999999999999999999999999999999998887 99999999864322
Q ss_pred CCC-----------CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-
Q 024336 154 HSQ-----------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ- 221 (269)
Q Consensus 154 ~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~- 221 (269)
... .....+++.|+|||.+.+....+.++|+||||+++|+|++|..||....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 111 12345789999999987655556679999999999999999999987665443333222111100
Q ss_pred -------------------ccCC------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 222 -------------------YFLP------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 222 -------------------~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
...+ ....+++++.+||.+||+.||.+|||+.|+++|+|++.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 0000 0126789999999999999999999999999999998754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=330.05 Aligned_cols=250 Identities=30% Similarity=0.482 Sum_probs=213.4
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-------ccHHHHHHHHHHHhCC--CCCcceeeEEEEeC
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSLR--HPNIIRFKEVLLTP 71 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~ 71 (269)
+.++|++.+.||+|+||.||++.+..+++.||+|.+..... ..+.+.+|+.+++++. |+|++++++++..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 46789999999999999999999999999999999875432 2245667999999996 59999999999999
Q ss_pred CeEEEEEeecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec-CCCCCcEEEeecCCcc
Q 024336 72 THLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLD-GSPQPRLKICDFGYSK 149 (269)
Q Consensus 72 ~~~~~v~e~~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~-~~~~~~~~l~df~~~~ 149 (269)
+..++|+|++.+ ++|.+++...+.+++..++.++.|++.||.+||+.|++|+||||+||+++ .++. ++|+|||++.
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~--~kL~Dfg~~~ 198 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGA 198 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE--EEECCCTTCE
T ss_pred CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC--EEEeeCcccc
Confidence 999999999976 89999998888999999999999999999999999999999999999998 5555 9999999987
Q ss_pred cCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCC
Q 024336 150 SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229 (269)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (269)
.... .......+++.|+|||.+.+....+.++||||||+++|+|++|..||.... .+......++. .
T Consensus 199 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------~~~~~~~~~~~--~ 265 (320)
T 3a99_A 199 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQ--R 265 (320)
T ss_dssp ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCCCCCSS--C
T ss_pred cccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------hhhcccccccc--c
Confidence 4332 223345689999999999877776677999999999999999999996521 11222233333 7
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 230 VSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
+++++.++|.+||+.||.+|||+.++++|+|++...
T Consensus 266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 899999999999999999999999999999998653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=343.77 Aligned_cols=248 Identities=14% Similarity=0.126 Sum_probs=198.8
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHH---HHHhCCCCCcceee-------EE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREII---NHRSLRHPNIIRFK-------EV 67 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~---~l~~l~h~~i~~~~-------~~ 67 (269)
.++|++.+.||+|+||.||++.+..+|+.||+|++.... ...+.+.+|+. .++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 367999999999999999999999899999999987432 23466889994 55556899999998 66
Q ss_pred EEeCC-----------------eEEEEEeecCCCchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCceee
Q 024336 68 LLTPT-----------------HLAIVMEYAAGGELFARICSAGRFSE-------DEARFFFQQLISGVSYCHSMEICHR 123 (269)
Q Consensus 68 ~~~~~-----------------~~~~v~e~~~~~~l~~~~~~~~~~~~-------~~~~~~~~~i~~~l~~lh~~~i~H~ 123 (269)
+.+++ ..++||||+ +|+|.+++...+.+++ ..++.++.|++.||+|||+.|++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 66553 288999999 5799999987555555 8888999999999999999999999
Q ss_pred cCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccCCCcccCchhhccc-----------cCCCccchhhhHHHHHH
Q 024336 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK-----------EYDGKISDVWSCGVTLY 192 (269)
Q Consensus 124 di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~~Di~slG~~l~ 192 (269)
||||+||+++.++. ++|+|||++... ........+ +.|+|||.+.+. .+ +.++||||||+++|
T Consensus 231 Dikp~NIll~~~~~--~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il~ 304 (377)
T 3byv_A 231 YLRPVDIVLDQRGG--VFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVIY 304 (377)
T ss_dssp CCCGGGEEECTTCC--EEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCC--EEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHHH
Confidence 99999999998887 999999998742 222334456 999999999877 45 55699999999999
Q ss_pred HHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 193 VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 193 ~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
+|+||..||......... .........+++++.+||.+||..||.+|||+.|+++|+|+..+.+
T Consensus 305 elltg~~Pf~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 305 WIWCADLPITKDAALGGS----------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp HHHHSSCCC------CCS----------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred HHHHCCCCCcccccccch----------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence 999999999764432111 1111222478999999999999999999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=328.86 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=205.5
Q ss_pred cccccccceecccCceEEEEEEEecCCe---EEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKE---LVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
.++|++.+.||+|+||.||++.+..++. .||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 4689999999999999999999975544 59999987542 233568899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 77 VMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
||||+++++|.+++... +.+++..++.++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEECC---
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCcccccccCc
Confidence 99999999999999654 57999999999999999999999999999999999999998887 9999999987432222
Q ss_pred C----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 156 Q----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 156 ~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
. .....+++.|+|||.+.+..++. ++||||||+++|+|++ |..||......... ..+... ...+....+
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~ 279 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSS-ASDVWSFGVVMWEVLAYGERPYWNMTNRDVI----SSVEEG-YRLPAPMGC 279 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH----HHHHTT-CCCCCCTTC
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCc-HHHHHHHHHHHHHHHcCCCCCcccCCHHHHH----HHHHcC-CCCCCCCCc
Confidence 1 12233567899999998777654 4999999999999999 99999876553322 222222 223334478
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
++.+.++|.+||..||.+|||+.++++.+
T Consensus 280 ~~~l~~li~~~l~~dp~~Rps~~eil~~L 308 (325)
T 3kul_A 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVL 308 (325)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 99999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=324.29 Aligned_cols=260 Identities=27% Similarity=0.373 Sum_probs=212.0
Q ss_pred cccccccceecccCceEEEEEEEe-cCCeEEEEEEeecCc---cccHHHHHHHHHHHhC---CCCCcceeeEEEE-----
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK-RTKELVAVKYIERGK---KIDENVQREIINHRSL---RHPNIIRFKEVLL----- 69 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~----- 69 (269)
.++|++.+.||+|+||.||++.+. .+|+.||+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 478999999999999999999995 678999999986432 2234566777777666 8999999999987
Q ss_pred eCCeEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCC
Q 024336 70 TPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY 147 (269)
Q Consensus 70 ~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~ 147 (269)
.....++|+|+++ ++|.+++.... .+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg~ 166 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGL 166 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCS
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCcc
Confidence 4567999999998 59999987654 4899999999999999999999999999999999999998887 99999999
Q ss_pred cccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-ccCC-
Q 024336 148 SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLP- 225 (269)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~- 225 (269)
+.............+++.|+|||.+.+..++.+ +||||||+++|+|++|..||.................... ..++
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred cccccCCCCccccccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 875443333445678999999999987776554 9999999999999999999988766555444443322110 0000
Q ss_pred -------------------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 226 -------------------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 226 -------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
....+++.+.+||.+||..||.+|||+.|+++|+|+..+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 1135788999999999999999999999999999998764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=339.66 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=204.1
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC--------CCCcceeeEEEE----
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR--------HPNIIRFKEVLL---- 69 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~---- 69 (269)
.++|++.+.||+|+||+||++.+..+++.||+|++.......+.+.+|+.+++.+. |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 47899999999999999999999999999999999866555667889999998885 788999999988
Q ss_pred eCCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCC---------
Q 024336 70 TPTHLAIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQ--------- 137 (269)
Q Consensus 70 ~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~p~ni~i~~~~~--------- 137 (269)
....+++|||++.+ ++.+.+... +.+++..++.++.||+.||.|||++ |++||||||+||+++.++.
T Consensus 116 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 116 NGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 45679999999954 666666443 4699999999999999999999998 9999999999999987641
Q ss_pred --------------------------------------CcEEEeecCCcccCCCCCCCCcccCCCcccCchhhccccCCC
Q 024336 138 --------------------------------------PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179 (269)
Q Consensus 138 --------------------------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 179 (269)
..++|+|||++.... .......+|+.|+|||.+.+..++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ 272 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH--KHFTEDIQTRQYRSLEVLIGSGYNT 272 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT--BCSCSCCSCGGGCCHHHHHTSCCCT
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc--ccCccCCCCCcccCChhhcCCCCCc
Confidence 249999999987432 2344557899999999998877655
Q ss_pred ccchhhhHHHHHHHHHhCCCCCCCCCChh------hHHHHHHHHhhc--------ccc---C------------------
Q 024336 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPR------NFRKTIDRIRNV--------QYF---L------------------ 224 (269)
Q Consensus 180 ~~~Di~slG~~l~~l~tg~~pf~~~~~~~------~~~~~~~~~~~~--------~~~---~------------------ 224 (269)
++||||||+++|+|+||..||....... ............ ... +
T Consensus 273 -~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (397)
T 1wak_A 273 -PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351 (397)
T ss_dssp -HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred -HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence 4999999999999999999997655321 111111111100 000 0
Q ss_pred -------CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChh
Q 024336 225 -------PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 225 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
......++.+.+||.+||+.||++|||++|+++|+|+.
T Consensus 352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 00012345788999999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=321.39 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=208.1
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++++.||+|+||.||++.+. ++..||+|++.......+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 368999999999999999999886 5778999999877667788999999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--CCC
Q 024336 82 AGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPK 158 (269)
Q Consensus 82 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~~ 158 (269)
++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++....... ...
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~ 179 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSV 179 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCHHHHSTT
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEcccccccccccccccccc
Confidence 99999999976 457999999999999999999999999999999999999998887 9999999986432211 222
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
...+++.|+|||.+.+..+ +.++|+||||+++|+|+| |..||.......... .+.... ........++.+.++
T Consensus 180 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~l~~l 253 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQGL-RLYRPHLASEKVYTI 253 (283)
T ss_dssp STTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH----HHHTTC-CCCCCTTCCHHHHHH
T ss_pred CCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHH----HHhccc-CCCCCCcCCHHHHHH
Confidence 3445778999999987766 445999999999999998 999998765533322 222221 122223678999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccC
Q 024336 238 LSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
|.+||+.||.+|||+.++++++.
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~L~ 276 (283)
T 3gen_A 254 MYSCWHEKADERPTFKILLSNIL 276 (283)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHHHH
Confidence 99999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=334.16 Aligned_cols=260 Identities=26% Similarity=0.328 Sum_probs=208.9
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC-CC-----CcceeeEEEEeCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HP-----NIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~ 75 (269)
.++|++.+.||+|+||+||++.+..+++.||+|++.........+..|+.+++.+. |+ +++++++++...+..+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 46899999999999999999999999999999999765544566778888888774 44 4999999999999999
Q ss_pred EEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 76 IVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCH--SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh--~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
+|||++++ +|.+++... +.+++..+..++.|++.||.+|| +.||+||||||+||+++.+..+.++|+|||++...
T Consensus 133 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 99999975 999998765 45899999999999999999999 57999999999999997544445999999999743
Q ss_pred CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc---------
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--------- 222 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~--------- 222 (269)
........+++.|+|||.+.+..++. ++||||||+++|+|+||..||........+............
T Consensus 212 --~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (382)
T 2vx3_A 212 --GQRIYQYIQSRFYRSPEVLLGMPYDL-AIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288 (382)
T ss_dssp --TCCCCSSCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred --ccccccccCCccccChHHHcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence 23344567899999999998877654 499999999999999999999987665554444332211000
Q ss_pred -----cCCC-------------------cCC-------------------------CCHHHHHHHHHHhhhCCCCCCCcH
Q 024336 223 -----FLPD-------------------YVR-------------------------VSADCRHLLSQIFVADPSKDPHSR 253 (269)
Q Consensus 223 -----~~~~-------------------~~~-------------------------~~~~~~~li~~~l~~~p~~Rps~~ 253 (269)
.+++ ... .++++.+||.+||+.||++|||++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~ 368 (382)
T 2vx3_A 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY 368 (382)
T ss_dssp HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence 0000 000 013789999999999999999999
Q ss_pred HHhhccChhhhh
Q 024336 254 DQKASLVPEEFA 265 (269)
Q Consensus 254 ~~l~~~~~~~~~ 265 (269)
|+|+|+|++...
T Consensus 369 e~L~hp~f~~~~ 380 (382)
T 2vx3_A 369 YALQHSFFKKTA 380 (382)
T ss_dssp HHTTSGGGCC--
T ss_pred HHhcCcccccCC
Confidence 999999998653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=329.33 Aligned_cols=257 Identities=25% Similarity=0.377 Sum_probs=207.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCCe-----
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTH----- 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 73 (269)
.++|++.+.||+|+||.||++.+..+|+.||+|.+...... .+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 47899999999999999999999999999999998754322 3457789999999999999999999987654
Q ss_pred -EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 74 -LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 74 -~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
+++|||++++ +|.+.+. ..+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++....
T Consensus 103 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 103 DFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD 177 (353)
T ss_dssp CCEEEEECCSE-EGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC--
T ss_pred eEEEEeccccC-CHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCC
Confidence 5999999974 8887764 34899999999999999999999999999999999999998887 9999999987432
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc------------
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV------------ 220 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~------------ 220 (269)
.......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+....+..........
T Consensus 178 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 178 --AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred --CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 223445678999999999874445566999999999999999999998766544433332211100
Q ss_pred ------------cccC-CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 221 ------------QYFL-PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 221 ------------~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
...+ .....+++++.+||.+||..||.+|||+.|+++|+|+..+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0000 11235789999999999999999999999999999998764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=331.60 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=206.3
Q ss_pred ccccccceecccCceEEEEEEEe-------cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeCC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDK-------RTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPT 72 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 72 (269)
++|++.+.||+|+||.||++.+. .++..||+|++..... ..+.+.+|+.+++.+ +||||+++++++.+++
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 68999999999999999999975 3456799999875432 234688999999999 8999999999999999
Q ss_pred eEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC
Q 024336 73 HLAIVMEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP 136 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~ 136 (269)
.+++||||+++++|.+++...+ .++...++.++.|++.||.|||+.|++||||||+||+++.++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 240 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence 9999999999999999997653 478999999999999999999999999999999999999888
Q ss_pred CCcEEEeecCCcccCCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 024336 137 QPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRK 212 (269)
Q Consensus 137 ~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~ 212 (269)
. ++|+|||++....... ......+++.|+|||.+.+..++ .++||||||+++|+|+| |..||..........
T Consensus 241 ~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~- 316 (370)
T 2psq_A 241 V--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 316 (370)
T ss_dssp C--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-
T ss_pred C--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-
Confidence 7 9999999987432221 22334467889999999877664 45999999999999999 999998765433322
Q ss_pred HHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
.+.... ....+..+++.+.++|.+||+.||.+||++.|+++++-
T Consensus 317 ---~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 360 (370)
T 2psq_A 317 ---LLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360 (370)
T ss_dssp ---HHHTTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---HHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 222221 12223378999999999999999999999999998753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=331.65 Aligned_cols=262 Identities=22% Similarity=0.322 Sum_probs=208.7
Q ss_pred CcccccccceecccCceEEEEEEEecCC-eEEEEEEeecCccccHHHHHHHHHHHhCCCCC------cceeeEEEEeCCe
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTK-ELVAVKYIERGKKIDENVQREIINHRSLRHPN------IIRFKEVLLTPTH 73 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~ 73 (269)
+.++|++.+.||+|+||.||++.+..++ ..||+|++.......+.+.+|+.+++.+.|++ ++.+.+++...+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 3589999999999999999999998766 78999999766555667888999999886654 8999999999999
Q ss_pred EEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC----------------
Q 024336 74 LAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS---------------- 135 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~---------------- 135 (269)
.++|||+++ +++.+.+.... ++++..++.++.|++.||.+||+.|++|+||||+||+++.+
T Consensus 97 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 97 MCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 999999995 56767665543 69999999999999999999999999999999999999432
Q ss_pred -CCCcEEEeecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHH
Q 024336 136 -PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214 (269)
Q Consensus 136 -~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~ 214 (269)
....++|+|||++... ........+++.|+|||.+.+..++.+ +||||||+++|+|++|..||.............
T Consensus 176 ~~~~~~kl~Dfg~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFD--HEHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252 (355)
T ss_dssp ESCCCEEECCCTTCEET--TSCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cCCCcEEEeecCccccc--cccccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 1234999999998742 333445678999999999987776554 999999999999999999998766544333322
Q ss_pred HHHhhcc--------------------------------------ccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHh
Q 024336 215 DRIRNVQ--------------------------------------YFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQK 256 (269)
Q Consensus 215 ~~~~~~~--------------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 256 (269)
....... .........+.++.+||.+||+.||.+|||+.|++
T Consensus 253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL 332 (355)
T ss_dssp HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 2211100 00001112245788999999999999999999999
Q ss_pred hccChhhhhh
Q 024336 257 ASLVPEEFAE 266 (269)
Q Consensus 257 ~~~~~~~~~~ 266 (269)
+|+|+..+..
T Consensus 333 ~hp~f~~~~~ 342 (355)
T 2eu9_A 333 LHPFFAGLTP 342 (355)
T ss_dssp TSGGGGGCCH
T ss_pred cChhhcCCCh
Confidence 9999998653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=325.88 Aligned_cols=254 Identities=28% Similarity=0.407 Sum_probs=204.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEe-----------
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT----------- 70 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------- 70 (269)
.++|++.+.||+|+||.||++.+..+++.||+|.+.......+.+.+|+.+++.++|||++++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 468999999999999999999999999999999997665556678899999999999999999998865
Q ss_pred --CCeEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCC
Q 024336 71 --PTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY 147 (269)
Q Consensus 71 --~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~ 147 (269)
....++|+||+++++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~ 162 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGL 162 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcc
Confidence 356899999999999999997544 5788999999999999999999999999999999999998887 99999998
Q ss_pred cccCCCC---------------CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHH
Q 024336 148 SKSGLLH---------------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK 212 (269)
Q Consensus 148 ~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~ 212 (269)
+...... .......+++.|+|||.+.+....+.++|+||||+++|+|++ ||... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---~~~~~ 236 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---MERVN 236 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---HHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---hhHHH
Confidence 8643211 122344578899999999866445666999999999999998 55432 12223
Q ss_pred HHHHHhhccccCCC--cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 213 TIDRIRNVQYFLPD--YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 213 ~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
....+......++. ....++.+.++|.+||+.||.+|||+.++++|+|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 33444433333332 2356778999999999999999999999999999965
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=323.18 Aligned_cols=255 Identities=29% Similarity=0.489 Sum_probs=210.2
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEe--CCeEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLT--PTHLAI 76 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 76 (269)
.++|++.+.||+|+||.||++.+..+++.||+|.+..... ..+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4789999999999999999999999999999999975432 33467889999999999999999998854 568999
Q ss_pred EEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeecCCCCcEEecCCCCCcEEEeecCC
Q 024336 77 VMEYAAGGELFARICSA----GRFSEDEARFFFQQLISGVSYCHSME-----ICHRDLKLENTLLDGSPQPRLKICDFGY 147 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~~-----i~H~di~p~ni~i~~~~~~~~~l~df~~ 147 (269)
||||+++++|.+++... ..+++..++.++.|++.||.+||+.| ++|+||+|+||+++.++. ++|+|||+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg~ 162 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGL 162 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCCH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCch
Confidence 99999999999998653 34899999999999999999999999 999999999999998887 99999998
Q ss_pred cccCCCCC-CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cCC
Q 024336 148 SKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLP 225 (269)
Q Consensus 148 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~ 225 (269)
+....... ......+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...... .....+..... ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~i~~~~~~~~~ 237 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQK----ELAGKIREGKFRRIP 237 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCCC
T ss_pred heeeccccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHH----HHHHHHhhcccccCC
Confidence 86432211 11234578999999999877664 5599999999999999999999876532 22333333332 223
Q ss_pred CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 226 DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
. .+++++.++|.+||+.||.+|||+.|+++++|+.+=.
T Consensus 238 ~--~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 238 Y--RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp T--TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred c--ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 3 7899999999999999999999999999999987643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=336.34 Aligned_cols=257 Identities=24% Similarity=0.338 Sum_probs=191.1
Q ss_pred ccccc-cceecccCceEEEEEEEe--cCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEe--CCeEEEE
Q 024336 3 ERYEP-VKELGSGNFGVARLVRDK--RTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT--PTHLAIV 77 (269)
Q Consensus 3 ~~y~~-~~~l~~g~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (269)
+.|++ .++||+|+||+||++.+. .+++.||+|.+... .....+.+|+.+++.++||||+++++++.. +..+++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 56777 458999999999999965 56889999998754 334678899999999999999999999965 6789999
Q ss_pred EeecCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe----cCCCCCcEEEee
Q 024336 78 MEYAAGGELFARICSA---------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL----DGSPQPRLKICD 144 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i----~~~~~~~~~l~d 144 (269)
|||+++ +|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||++ +.++. ++|+|
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~--~kl~D 175 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR--VKIAD 175 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC--EEECC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc--EEEEE
Confidence 999975 787777532 248999999999999999999999999999999999999 44444 99999
Q ss_pred cCCcccCCCC----CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh---------hhHH
Q 024336 145 FGYSKSGLLH----SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---------RNFR 211 (269)
Q Consensus 145 f~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~---------~~~~ 211 (269)
||++...... .......+++.|+|||.+.+....+.++|||||||++|+|++|.+||...... ..+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 9999743222 22234568999999999987665667799999999999999999999765432 2222
Q ss_pred HHHHHHhhccc-cCC-------------------------------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 212 KTIDRIRNVQY-FLP-------------------------------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 212 ~~~~~~~~~~~-~~~-------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
........... .++ .....++.+.+||.+||..||.+|||++|+|+|+
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 22222111000 000 0012267899999999999999999999999999
Q ss_pred Chhh
Q 024336 260 VPEE 263 (269)
Q Consensus 260 ~~~~ 263 (269)
||..
T Consensus 336 ~f~~ 339 (405)
T 3rgf_A 336 YFLE 339 (405)
T ss_dssp GGTS
T ss_pred hhcc
Confidence 9975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=327.34 Aligned_cols=261 Identities=27% Similarity=0.369 Sum_probs=204.7
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEE----------
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLL---------- 69 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---------- 69 (269)
+.++|++++.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 4679999999999999999999999999999999987543 23456789999999999999999999873
Q ss_pred ----eCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCCcEEEee
Q 024336 70 ----TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-SPQPRLKICD 144 (269)
Q Consensus 70 ----~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~-~~~~~~~l~d 144 (269)
+....++|+||++ ++|.+.+. .+++++..++.++.|++.||.+||+.|++|+||||+||+++. ++. ++|+|
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~--~kl~D 164 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV--LKIGD 164 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE--EEECC
T ss_pred ccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe--EEEcc
Confidence 3467899999998 58998885 467899999999999999999999999999999999999974 444 99999
Q ss_pred cCCcccCCCC----CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh-
Q 024336 145 FGYSKSGLLH----SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN- 219 (269)
Q Consensus 145 f~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~- 219 (269)
||++...... .......+++.|+|||.+.+....+.++|+||||+++|+|++|..||..................
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998743221 12234456889999999876555566799999999999999999999877654444333222100
Q ss_pred -----------------ccccCC------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 220 -----------------VQYFLP------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 220 -----------------~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.....+ ....+++++.++|.+||+.||.+|||+.|+++|+|+..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 000000 0125789999999999999999999999999999998653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=316.26 Aligned_cols=248 Identities=30% Similarity=0.403 Sum_probs=196.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-----ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++.+.||+|+||.||++.+. ++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 68999999999999999999985 88899999865322 235688999999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeecCCCCcEEecCCC------CCcEEEeecCCc
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME---ICHRDLKLENTLLDGSP------QPRLKICDFGYS 148 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~H~di~p~ni~i~~~~------~~~~~l~df~~~ 148 (269)
|||+++++|.+++. .+++++..++.++.|++.||.+||+.| ++|+||||+||+++.+. .+.++|+|||++
T Consensus 85 ~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 85 MEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 99999999988884 567899999999999999999999999 89999999999998521 234999999998
Q ss_pred ccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcC
Q 024336 149 KSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228 (269)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (269)
..... .......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||........ ...........+...
T Consensus 164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~ 237 (271)
T 3dtc_A 164 REWHR-TTKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAV----AYGVAMNKLALPIPS 237 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH----HHHHHTSCCCCCCCT
T ss_pred ccccc-ccccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHhhhcCCCCCCCCc
Confidence 74322 22234568999999999987766 4459999999999999999999987654322 222233333333344
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 229 RVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+++.+.++|.+||+.||.+|||+.|+++++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 7899999999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=326.93 Aligned_cols=250 Identities=29% Similarity=0.449 Sum_probs=204.5
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-------ccHHHHHHHHHHHhC----CCCCcceeeEEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSL----RHPNIIRFKEVLL 69 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l----~h~~i~~~~~~~~ 69 (269)
+.++|++.+.||+|+||.||++.+..+++.||+|++..... ....+.+|+..++++ +|+||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 35789999999999999999999999999999999875432 122355688888888 8999999999999
Q ss_pred eCCeEEEEEee-cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec-CCCCCcEEEeecCC
Q 024336 70 TPTHLAIVMEY-AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLD-GSPQPRLKICDFGY 147 (269)
Q Consensus 70 ~~~~~~~v~e~-~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~-~~~~~~~~l~df~~ 147 (269)
..+..++|+|+ +.+++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++ .++. ++|+|||+
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~--~kl~dfg~ 186 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--AKLIDFGS 186 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE--EEECCCSS
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe--EEEEEcch
Confidence 99999999999 78899999998888899999999999999999999999999999999999998 5665 99999999
Q ss_pred cccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCc
Q 024336 148 SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227 (269)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (269)
+..... .......+++.|+|||.+.+....+.++||||||+++|+|++|..||.... .+......++.
T Consensus 187 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------~~~~~~~~~~~- 254 (312)
T 2iwi_A 187 GALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------EILEAELHFPA- 254 (312)
T ss_dssp CEECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHTCCCCCT-
T ss_pred hhhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------HHhhhccCCcc-
Confidence 874332 233445688999999999877776656999999999999999999996521 11222333343
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 228 VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.++..+.++|.+||+.||++|||+.|+++|+|++...
T Consensus 255 -~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 255 -HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp -TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred -cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 7899999999999999999999999999999998754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=316.67 Aligned_cols=258 Identities=28% Similarity=0.426 Sum_probs=207.0
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
+|.....||+|+||.||++.+..++..||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++|+|+++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3444559999999999999999999999999987543 335678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCCcEEEeecCCcccCCCCC-CC
Q 024336 83 GGELFARICSAG---RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHS-QP 157 (269)
Q Consensus 83 ~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~-~~~~~~~l~df~~~~~~~~~~-~~ 157 (269)
+++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++. ++. ++|+|||++....... ..
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--~kl~Dfg~~~~~~~~~~~~ 180 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGINPCT 180 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC--EEECCTTTCEESCC-----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC--EEEeecccccccCCCCCcc
Confidence 999999997652 4678999999999999999999999999999999999986 665 9999999987433222 23
Q ss_pred CcccCCCcccCchhhcccc-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
....+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||............ ..........+ ..+++++.+
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~ 257 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-VGMFKVHPEIP--ESMSAEAKA 257 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH-HHHHCCCCCCC--TTSCHHHHH
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh-hcccccccccc--ccCCHHHHH
Confidence 3456889999999987653 2355699999999999999999999765443222111 11112222333 378999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
+|.+||+.||.+|||+.++++|+|+.....
T Consensus 258 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 258 FILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp HHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred HHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 999999999999999999999999986543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=320.04 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=194.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcccc---HHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|++.+.||+|+||.||++.+..+|+.||+|++....... ..+.++..+++.++||||+++++++.+++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 57999999999999999999999999999999997653322 223344556788899999999999999999999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCC
Q 024336 80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
++ ++.+..+... ...+++..++.++.|++.||.+||+. |++|+||+|+||+++.++. ++|+|||++.........
T Consensus 105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 181 (318)
T 2dyl_A 105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDDKAK 181 (318)
T ss_dssp CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC---------
T ss_pred cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccCCccc
Confidence 99 4455555543 56799999999999999999999995 9999999999999998887 999999998754444444
Q ss_pred CcccCCCcccCchhhcc----ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 158 KSTVGTPAYIAPEVLAR----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
....+++.|+|||.+.. ....+.++||||||+++|+|++|..||.......... ...........+....++++
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL--TKVLQEEPPLLPGHMGFSGD 259 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH--HHHHHSCCCCCCSSSCCCHH
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHH--HHHhccCCCCCCccCCCCHH
Confidence 45578999999999852 2233456999999999999999999998755432222 12222223334444568999
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
+.++|.+||+.||.+||+++++++|+|++.+..
T Consensus 260 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 260 FQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence 999999999999999999999999999987653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=327.60 Aligned_cols=259 Identities=30% Similarity=0.449 Sum_probs=184.0
Q ss_pred Ccccccccc-eecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEe----CCeEE
Q 024336 1 MEERYEPVK-ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT----PTHLA 75 (269)
Q Consensus 1 i~~~y~~~~-~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 75 (269)
+.++|++.+ .||+|+||.||++.+..+|+.||+|++.... .........++.+.|||++++++++.. +..++
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 357899965 5999999999999999999999999986542 222223344567799999999999876 45689
Q ss_pred EEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CCcEEEeecCCcccCC
Q 024336 76 IVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGL 152 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~~ 152 (269)
+||||+++++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||||+||+++.++ ...++|+|||++....
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999999999997654 699999999999999999999999999999999999998643 2459999999987432
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc--cCCCcCCC
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRV 230 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 230 (269)
........+++.|+|||.+.+..++. ++||||||+++|+|++|..||...............+..... ..+.+..+
T Consensus 183 -~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (336)
T 3fhr_A 183 -QNALQTPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260 (336)
T ss_dssp ----------------------CHHHH-HHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTC
T ss_pred -ccccccCCCCcCccChhhhCCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccC
Confidence 22334456789999999987666644 499999999999999999999776554333333333333222 23334578
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
++++.+||.+||+.||.+|||+.|+++|+|+...
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 9999999999999999999999999999999764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=315.62 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=205.0
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc--------cHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI--------DENVQREIINHRSLRHPNIIRFKEVLLTPTH 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (269)
.++|++.+.||+|+||.||++.+..+++.||+|.+...... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 57899999999999999999999999999999998643322 156889999999999999999999987766
Q ss_pred EEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecCCCC---CcEEEeecCC
Q 024336 74 LAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQ---PRLKICDFGY 147 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~p~ni~i~~~~~---~~~~l~df~~ 147 (269)
++||||+++++|.+.+... .++++..++.++.|++.||.+||+.| ++|+||||+||+++.++. ..++|+|||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 6999999999998887554 46999999999999999999999999 999999999999976553 2489999999
Q ss_pred cccCCCCCCCCcccCCCcccCchhhcc-ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC
Q 024336 148 SKSGLLHSQPKSTVGTPAYIAPEVLAR-KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226 (269)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (269)
+... ........+++.|+|||.+.. ....+.++||||||+++|+|++|..||......... ..............
T Consensus 176 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~ 251 (287)
T 4f0f_A 176 SQQS--VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMIREEGLRPTI 251 (287)
T ss_dssp CBCC--SSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--HHHHHHHSCCCCCC
T ss_pred cccc--cccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH--HHHHHhccCCCCCC
Confidence 8732 233345678999999999843 222355699999999999999999999876553322 12222222222223
Q ss_pred cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 227 YVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
...+++.+.++|.+||+.||.+|||+.++++.+
T Consensus 252 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 347899999999999999999999999999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=332.35 Aligned_cols=255 Identities=19% Similarity=0.266 Sum_probs=207.6
Q ss_pred cccccccceecccCceEEEEEE-----EecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVR-----DKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~-----~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
.++|++.+.||+|+||.||++. +..++..||+|.+.... .....+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4689999999999999999999 45578899999986432 2234578899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC-CcEEEeecC
Q 024336 75 AIVMEYAAGGELFARICSAG-------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFG 146 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~-~~~~l~df~ 146 (269)
++||||+++++|.+++...+ .+++..++.++.|++.||.|||++|++||||||+||+++.++. ..++|+|||
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 99999999999999997653 4899999999999999999999999999999999999985542 349999999
Q ss_pred CcccC---CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccc
Q 024336 147 YSKSG---LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQY 222 (269)
Q Consensus 147 ~~~~~---~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 222 (269)
++... ..........+++.|+|||.+.+..++. ++||||||+++|+|+| |..||....... ....+....
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DvwslG~il~ellt~g~~pf~~~~~~~----~~~~i~~~~- 303 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEFVTSGG- 303 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHHHHTTC-
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHcCC-
Confidence 98632 1122333456788999999998777644 5999999999999998 999998765432 223333322
Q ss_pred cCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChh
Q 024336 223 FLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 223 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
.......+++.+.++|.+||+.||.+|||+.+++++++..
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1222337899999999999999999999999999988654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=321.20 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=202.7
Q ss_pred cccccccceecccCceEEEEEE----EecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeE
Q 024336 2 EERYEPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTP--THL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~ 74 (269)
.++|++++.||+|+||+||++. +..+++.||+|++.... ...+.+.+|+.++++++||||+++++++... ..+
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 5789999999999999999998 56789999999987543 2235688999999999999999999998654 458
Q ss_pred EEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 75 AIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
++||||+++++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC----
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCcccccccC
Confidence 99999999999999997754 4999999999999999999999999999999999999998877 99999999874322
Q ss_pred CC----CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh------------hhHHHHHHHH
Q 024336 154 HS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP------------RNFRKTIDRI 217 (269)
Q Consensus 154 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~------------~~~~~~~~~~ 217 (269)
.. ......++..|+|||.+.+..++ .++||||||+++|+|+||..|+...... .........+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 21 12233456679999999877764 4599999999999999999998653211 1111222222
Q ss_pred hhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
. .....+....+++++.++|.+||+.||.+|||+.|+++.+
T Consensus 246 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L 286 (295)
T 3ugc_A 246 K-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286 (295)
T ss_dssp H-TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred h-ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 2 2223334447899999999999999999999999998865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=331.46 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=206.9
Q ss_pred cccccccceecccCceEEEEEE-----EecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeCC-
Q 024336 2 EERYEPVKELGSGNFGVARLVR-----DKRTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPT- 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~-----~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~- 72 (269)
.++|++.+.||+|+||.||++. +..+++.||+|++..... ..+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 4789999999999999999999 445678999999975432 234688999999999 7899999999988765
Q ss_pred eEEEEEeecCCCchHHHHHhcCC---------------------------------------------------------
Q 024336 73 HLAIVMEYAAGGELFARICSAGR--------------------------------------------------------- 95 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~--------------------------------------------------------- 95 (269)
.+++||||+++++|.+++.....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 48999999999999999976543
Q ss_pred ---------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC---CCCcccCC
Q 024336 96 ---------FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGT 163 (269)
Q Consensus 96 ---------~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~ 163 (269)
+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++....... ......++
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhccccCCC
Confidence 899999999999999999999999999999999999998887 9999999987432222 12234567
Q ss_pred CcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHh
Q 024336 164 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242 (269)
Q Consensus 164 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (269)
+.|+|||.+.+..++ .++||||||+++|+|+| |..||............... ....+....+++++.++|.+||
T Consensus 259 ~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l 333 (359)
T 3vhe_A 259 LKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTMLDCW 333 (359)
T ss_dssp GGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHT
T ss_pred ceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc----CCCCCCCCCCCHHHHHHHHHHc
Confidence 889999999877765 45999999999999998 99999876654444333322 1122223368999999999999
Q ss_pred hhCCCCCCCcHHHhhccC
Q 024336 243 VADPSKDPHSRDQKASLV 260 (269)
Q Consensus 243 ~~~p~~Rps~~~~l~~~~ 260 (269)
+.||.+|||+.|+++|+-
T Consensus 334 ~~dP~~Rps~~ell~~L~ 351 (359)
T 3vhe_A 334 HGEPSQRPTFSELVEHLG 351 (359)
T ss_dssp CSSGGGSCCHHHHHHHHH
T ss_pred cCChhhCCCHHHHHHHHH
Confidence 999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=338.65 Aligned_cols=258 Identities=14% Similarity=0.131 Sum_probs=191.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc----ccHHHHHHHHHHHhC--CCCCcceee-------EEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSL--RHPNIIRFK-------EVLL 69 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~~ 69 (269)
.+|++.+.||+|+||.||++.+..+|+.||+|++..... ..+.+.+|+.+++.+ +|||+++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 359999999999999999999999999999999987542 234566775444444 699987755 4444
Q ss_pred eC-----------------CeEEEEEeecCCCchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCceeecC
Q 024336 70 TP-----------------THLAIVMEYAAGGELFARICSA-GRFSEDEA------RFFFQQLISGVSYCHSMEICHRDL 125 (269)
Q Consensus 70 ~~-----------------~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~------~~~~~~i~~~l~~lh~~~i~H~di 125 (269)
.+ ..+++||||++ ++|.+++... ..++...+ ..++.|++.||+|||++|++||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 33 34899999998 7999999763 34455555 677899999999999999999999
Q ss_pred CCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccCCCcccCchhhcc--ccCCCccchhhhHHHHHHHHHhCCCCCCC
Q 024336 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFED 203 (269)
Q Consensus 126 ~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~pf~~ 203 (269)
||+||+++.++. ++|+|||++.... .......+++.|+|||.+.+ ..+ +.++||||||+++|+|+||..||..
T Consensus 221 kp~NIll~~~~~--~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 221 TPDNLFIMPDGR--LMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp SGGGEEECTTSC--EEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CHHHEEECCCCC--EEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCC
Confidence 999999998887 9999999987432 22224556799999999976 444 5569999999999999999999986
Q ss_pred CCChhhHHH---HHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 204 PEDPRNFRK---TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 204 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
......... ...........++....+++.+.+||.+||+.||++|||+.++++|+|+..+..
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 533211000 000011123334444578999999999999999999999999999999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=322.44 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=206.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEE--EEEEeecC--ccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELV--AVKYIERG--KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~v--aiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++.+.||+|+||.||++.+..++..+ |+|.+... ....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999999888865 89988642 23345688999999999 899999999999999999999
Q ss_pred EeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEE
Q 024336 78 MEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLK 141 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~ 141 (269)
|||+++++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~k 182 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AK 182 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe--EE
Confidence 99999999999997654 6899999999999999999999999999999999999998877 99
Q ss_pred EeecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhc
Q 024336 142 ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV 220 (269)
Q Consensus 142 l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 220 (269)
|+|||++.............+++.|+|||.+.+..++ .++||||||+++|+|+| |..||....... ....+...
T Consensus 183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~----~~~~~~~~ 257 (327)
T 1fvr_A 183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLPQG 257 (327)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHGGGT
T ss_pred EcccCcCccccccccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHH----HHHHhhcC
Confidence 9999998744333334445567899999999776664 45999999999999998 999998765422 22333322
Q ss_pred cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 221 QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 221 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
........+++.+.++|.+||..||.+|||+.++++++.
T Consensus 258 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 296 (327)
T 1fvr_A 258 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296 (327)
T ss_dssp -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 222333478999999999999999999999999998764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=320.82 Aligned_cols=249 Identities=21% Similarity=0.276 Sum_probs=198.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc----cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+++.||+|++...... .+.+.+|+..++.++||||+++++++..++..++|+
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 6899999999999999999999999999999998754332 256788999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--C
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--Q 156 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~ 156 (269)
|++++++|.+++...+++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 114 RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC-----------
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999998887 9999999886433222 2
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cCCCcCCCCHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSADCR 235 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (269)
.....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...... .....+..... .......+|+.+.
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLS----VMGAHINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp -----CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHH----HHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred ccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHH----HHHHHhccCCCCccccCCCCCHHHH
Confidence 234468899999999987766554 99999999999999999999864332 11122221111 1112236889999
Q ss_pred HHHHHHhhhCCCCCC-CcHHHhhc
Q 024336 236 HLLSQIFVADPSKDP-HSRDQKAS 258 (269)
Q Consensus 236 ~li~~~l~~~p~~Rp-s~~~~l~~ 258 (269)
++|.+||+.||.+|| +++++++.
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~~ 290 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSAA 290 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred HHHHHhccCCHHHHHHhHHHHHHH
Confidence 999999999999999 66666653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=321.02 Aligned_cols=250 Identities=21% Similarity=0.309 Sum_probs=211.8
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|+||.||++.+..++..||+|.+.......+.+.+|+.++++++||||+++++++.+++..++|+|++
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 91 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence 46899999999999999999999999999999999877666678999999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC--C
Q 024336 82 AGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--P 157 (269)
Q Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~--~ 157 (269)
++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++........ .
T Consensus 92 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~ 169 (288)
T 3kfa_A 92 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAH 169 (288)
T ss_dssp TTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSSSSEEE
T ss_pred CCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCCccccc
Confidence 999999999764 34899999999999999999999999999999999999988887 99999999874332221 1
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
....+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||............ .. ....+....+++.+.+
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~l~~ 243 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EK-DYRMERPEGCPEKVYE 243 (288)
T ss_dssp TTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----HT-TCCCCCCTTCCHHHHH
T ss_pred cCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----hc-cCCCCCCCCCCHHHHH
Confidence 223456789999999877664 45999999999999999 99999876553332221 11 2222333478999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhcc
Q 024336 237 LLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+|.+||..||.+|||+.++++.+
T Consensus 244 li~~~l~~dp~~Rps~~~~~~~l 266 (288)
T 3kfa_A 244 LMRACWQWNPSDRPSFAEIHQAF 266 (288)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhCCChhhCcCHHHHHHHH
Confidence 99999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=327.32 Aligned_cols=259 Identities=24% Similarity=0.339 Sum_probs=189.1
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHH-HHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREII-NHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.++|++.+.||+|+||.||++.+..+|+.||+|++..... ....+..|+. +++.++||||+++++++..++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 3689999999999999999999999999999999876432 2234445555 667789999999999999999999999
Q ss_pred eecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 79 EYAAGGELFARICS-----AGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 79 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
||+++ +|.+++.. ...+++..+..++.|++.||.+||+. |++|+||||+||+++.++. ++|+|||++....
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCCceecc
Confidence 99986 78777753 56789999999999999999999999 9999999999999998877 9999999987544
Q ss_pred CCCCCCcccCCCcccCchhhc----cccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-ccC--C
Q 024336 153 LHSQPKSTVGTPAYIAPEVLA----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFL--P 225 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~--~ 225 (269)
.........+++.|+|||.+. +..+ +.++||||||+++|+|++|..||....... .....+.... ..+ .
T Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 253 (327)
T 3aln_A 178 DSIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVF---DQLTQVVKGDPPQLSNS 253 (327)
T ss_dssp ----------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCCCCC
T ss_pred cccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHH---HHHHHHhcCCCCCCCCc
Confidence 333334457889999999984 3334 455999999999999999999997643211 1111111111 111 1
Q ss_pred CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhhc
Q 024336 226 DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAER 267 (269)
Q Consensus 226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~~ 267 (269)
....+++.+.++|.+||..||.+|||+.++++|+|+....++
T Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 295 (327)
T 3aln_A 254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER 295 (327)
T ss_dssp SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence 123588999999999999999999999999999999887654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=323.92 Aligned_cols=254 Identities=22% Similarity=0.238 Sum_probs=206.9
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEe
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
+.++|++.+.||+|+||.||++.+..+|+.||+|++.... ..+.+.+|+.+++.+ +||||+++++++..++..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 3578999999999999999999999999999999987543 345688999999999 89999999999999999999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC---CcEEEeecCCcccCCCCC
Q 024336 80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ---PRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 80 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~---~~~~l~df~~~~~~~~~~ 155 (269)
++ +++|.+++.. .+.+++..++.++.|++.||.|||+.|++||||||+||+++.++. ..++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99 8899999976 467999999999999999999999999999999999999987653 239999999987432222
Q ss_pred C--------CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC-
Q 024336 156 Q--------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD- 226 (269)
Q Consensus 156 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 226 (269)
. .....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||........ ......+.......+.
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIGDTKRATPIE 242 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHHHHHHHSCHH
T ss_pred CCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHHhhhccCCHH
Confidence 1 235578999999999988776 4459999999999999999999987654322 2222222222111111
Q ss_pred --cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 227 --YVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 227 --~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
...+| ++.++|.+||+.||.+||++.++++.+
T Consensus 243 ~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l 276 (330)
T 2izr_A 243 VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLF 276 (330)
T ss_dssp HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHH
Confidence 11344 999999999999999999999998743
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=326.87 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=207.5
Q ss_pred cccccccceecccCceEEEEEEEecC-------CeEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeC
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRT-------KELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTP 71 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~-------~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 71 (269)
.++|++.+.||+|+||.||++.+..+ +..||+|++..... ....+.+|+.+++++ +||||+++++++.++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 47899999999999999999998643 35799999875432 235678999999999 899999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC
Q 024336 72 THLAIVMEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS 135 (269)
Q Consensus 72 ~~~~~v~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~ 135 (269)
+..++||||+++++|.+++.... .+++..++.++.|++.||.+||+.|++||||||+||+++.+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 227 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCC
Confidence 99999999999999999997654 48999999999999999999999999999999999999988
Q ss_pred CCCcEEEeecCCcccCCCC---CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHH
Q 024336 136 PQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFR 211 (269)
Q Consensus 136 ~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~ 211 (269)
+. ++|+|||++...... .......+++.|+|||.+.+..++ .++||||||+++|+|++ |..||......
T Consensus 228 ~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~---- 300 (382)
T 3tt0_A 228 NV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 300 (382)
T ss_dssp CC--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred Cc--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 87 999999998743322 122334467789999999876664 45999999999999999 99999875542
Q ss_pred HHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 212 KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
.....+.... .......+++++.++|.+||+.||.+|||+.|+++++.
T Consensus 301 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 348 (382)
T 3tt0_A 301 ELFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348 (382)
T ss_dssp HHHHHHHTTC-CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHcCC-CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 2223333221 22223478999999999999999999999999999763
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=315.20 Aligned_cols=254 Identities=19% Similarity=0.217 Sum_probs=207.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ..+.+.+|+..++.+ +|++++++++++......++|+|+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 578999999999999999999999999999999886543 345688899999999 799999999999999999999999
Q ss_pred cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC---CcEEEeecCCcccCCCCC-
Q 024336 81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ---PRLKICDFGYSKSGLLHS- 155 (269)
Q Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~---~~~~l~df~~~~~~~~~~- 155 (269)
+ +++|.+++...+ ++++..++.++.|++.||.+||+.|++||||||+||+++.++. .+++|+|||++.......
T Consensus 88 ~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 88 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 9 889999997654 5999999999999999999999999999999999999976543 349999999987433222
Q ss_pred -------CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC---
Q 024336 156 -------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--- 225 (269)
Q Consensus 156 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 225 (269)
......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.......... ....+.......+
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~ 244 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYERIGEKKQSTPLRE 244 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHHHHHHHHHSCHHH
T ss_pred cccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHH-HHHHHHhhccCccHHH
Confidence 2234568999999999987766 455999999999999999999998754332221 1111111111111
Q ss_pred CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 226 DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
....+|+++.++|.+||+.||.+||++.++++.+
T Consensus 245 ~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l 278 (298)
T 1csn_A 245 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 278 (298)
T ss_dssp HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 1126899999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=334.39 Aligned_cols=249 Identities=26% Similarity=0.350 Sum_probs=206.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++|++.+.||+|+||.||++.+..+++.||+|.+..... ..+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 689999999999999999999998999999999875422 223577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC---
Q 024336 81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--- 156 (269)
Q Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~--- 156 (269)
+++++|.+++...+ .+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++........
T Consensus 194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~~~~~~~ 271 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVYAAS 271 (377)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTTSEEECC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCCCceeec
Confidence 99999999997654 5899999999999999999999999999999999999998887 99999999864222111
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
.....+++.|+|||.+.+..++. ++||||||+++|+|+| |..||........ ...+.. ....+.+..+|+.+.
T Consensus 272 ~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~el~t~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~l~ 345 (377)
T 3cbl_A 272 GGLRQVPVKWTAPEALNYGRYSS-ESDVWSFGILLWETFSLGASPYPNLSNQQT----REFVEK-GGRLPCPELCPDAVF 345 (377)
T ss_dssp SSCCEEEGGGSCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTSCCSSTTSCHHHH----HHHHHT-TCCCCCCTTCCHHHH
T ss_pred CCCCCCCcCcCCHhHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHc-CCCCCCCCCCCHHHH
Confidence 11223456799999998777644 4999999999999998 9999987654322 222222 222333347899999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
++|.+||+.||.+|||+.++++.+
T Consensus 346 ~li~~cl~~dP~~Rps~~~i~~~L 369 (377)
T 3cbl_A 346 RLMEQCWAYEPGQRPSFSTIYQEL 369 (377)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcCCCchhCcCHHHHHHHH
Confidence 999999999999999999998865
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=324.25 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=190.9
Q ss_pred cccccccceecccCceEEEEEEEecCCe---EEEEEEeecC---ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE-
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKE---LVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHL- 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~---~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~- 74 (269)
.++|++.+.||+|+||.||++.+..++. .||+|.+... ....+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4689999999999999999999887664 7999998753 23345688999999999999999999999887655
Q ss_pred -----EEEEeecCCCchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEe
Q 024336 75 -----AIVMEYAAGGELFARICSAG------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKIC 143 (269)
Q Consensus 75 -----~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~ 143 (269)
++|+||+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~--~kl~ 179 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVA 179 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEEC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC--EEEe
Confidence 99999999999999986533 5899999999999999999999999999999999999998877 9999
Q ss_pred ecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhh
Q 024336 144 DFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRN 219 (269)
Q Consensus 144 df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~ 219 (269)
|||++........ .....+++.|+|||.+.+..++ .++||||||+++|+|++ |..||............ ..
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----~~ 254 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL----IG 254 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HT
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHH----hc
Confidence 9999874322221 2233456789999999877664 45999999999999999 99999876654433322 22
Q ss_pred ccccCCCcCCCCHHHHHHHHHHhhhCCCCCCC-------cHHHhhccChhhhh
Q 024336 220 VQYFLPDYVRVSADCRHLLSQIFVADPSKDPH-------SRDQKASLVPEEFA 265 (269)
Q Consensus 220 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-------~~~~l~~~~~~~~~ 265 (269)
.. ..+....+++++.++|.+||+.||.+||| +++++.|+|+..-.
T Consensus 255 ~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 255 GN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp TC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred CC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 11 22233478999999999999999999999 77778888876543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=319.10 Aligned_cols=249 Identities=18% Similarity=0.175 Sum_probs=204.2
Q ss_pred cccccccceecccCceEEEEEEEecCC-------eEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTK-------ELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTH 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~-------~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (269)
.++|++.+.||+|+||+||++.+..++ ..||+|.+.... ...+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 478999999999999999999998777 469999986543 344678899999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCC------cEEEeecC
Q 024336 74 LAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP------RLKICDFG 146 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~------~~~l~df~ 146 (269)
.++||||+++++|.+++...+. +++..++.++.|++.||.+||++|++||||||+||+++.++.. .++|+|||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg 166 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence 9999999999999999977654 9999999999999999999999999999999999999876642 28999999
Q ss_pred CcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC
Q 024336 147 YSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226 (269)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (269)
++.... ......+++.|+|||.+.+....+.++||||||+++|+|++|..|+............ .......+.
T Consensus 167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~----~~~~~~~~~ 239 (289)
T 4fvq_A 167 ISITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF----YEDRHQLPA 239 (289)
T ss_dssp SCTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHTTCCCCC
T ss_pred cccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH----hhccCCCCC
Confidence 886322 1223457888999999987555566699999999999999965554443332222222 122223333
Q ss_pred cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 227 YVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
..++++.++|.+||+.||.+|||+.++++++
T Consensus 240 --~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 240 --PKAAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp --CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred --CCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 5688999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=321.87 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=206.8
Q ss_pred cccccccceecccCceEEEEEEEe-----cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
.++|++.+.||+|+||.||++.+. .++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 468999999999999999999984 3458899999875432 235678899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcE
Q 024336 75 AIVMEYAAGGELFARICSAGR------------------------FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENT 130 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~------------------------~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni 130 (269)
++|+||+++++|.+++..... +++..++.++.|++.||.+||+.|++|+||||+||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NI 181 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI 181 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheE
Confidence 999999999999999976543 89999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCcccCCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCC
Q 024336 131 LLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPED 206 (269)
Q Consensus 131 ~i~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~ 206 (269)
+++.++. ++|+|||++....... ......+++.|+|||.+.+..++ .++||||||+++|+|+| |..||.....
T Consensus 182 li~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 182 LVAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp EEETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EEcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9998877 9999999986432222 12334467789999999876664 45999999999999999 9999987655
Q ss_pred hhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
..... .+.... ..+....+++.+.++|.+||+.||.+|||+.++++++
T Consensus 259 ~~~~~----~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l 306 (314)
T 2ivs_A 259 ERLFN----LLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306 (314)
T ss_dssp GGHHH----HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHH----HhhcCC-cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 33222 222221 2222347899999999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=335.09 Aligned_cols=257 Identities=25% Similarity=0.337 Sum_probs=208.0
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCC--eEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPT--HLAI 76 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 76 (269)
+.++|++.+.||+|+||+||++.+..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.... ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 3578999999999999999999999999999999987533 33466789999999999999999999998765 7899
Q ss_pred EEeecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe----cCCCCCcEEEeecCCcc
Q 024336 77 VMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL----DGSPQPRLKICDFGYSK 149 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i----~~~~~~~~~l~df~~~~ 149 (269)
||||+++++|.+++..... +++..++.++.|++.||.|||+.|++||||||+||++ +.++ .++|+|||++.
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~DFG~a~ 164 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAAR 164 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE--EEEECCGGGCE
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce--eEEEecCCCce
Confidence 9999999999999965433 8999999999999999999999999999999999998 4444 49999999997
Q ss_pred cCCCCCCCCcccCCCcccCchhhccc-------cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc
Q 024336 150 SGLLHSQPKSTVGTPAYIAPEVLARK-------EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY 222 (269)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 222 (269)
............+++.|+|||.+.+. ...+.++||||||+++|+|+||..||............+..+.....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 55444444556789999999998652 22345599999999999999999999765544433444444433321
Q ss_pred c-------------------CCCc----CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 223 F-------------------LPDY----VRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 223 ~-------------------~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
. .+.. ..++..+.++|.+||+.||++||++.|+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l 304 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHH
Confidence 1 1111 12345788999999999999999999998765
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=312.89 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=209.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|+||.||++.+. ++..||+|.+.......+.+.+|+.++++++||||+++++++.+++..++|+|++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 368999999999999999999986 5778999999877666778999999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC--CCCC
Q 024336 82 AGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--SQPK 158 (269)
Q Consensus 82 ~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~--~~~~ 158 (269)
++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHSTT
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEcccccccccccccccccc
Confidence 999999999765 46899999999999999999999999999999999999988877 999999998643221 1222
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
...+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||........ ...+.... .......+++.+.++
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~i~~~~-~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----VEDISTGF-RLYKPRLASTHVYQI 237 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHHTTC-CCCCCTTSCHHHHHH
T ss_pred cccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHH----HHHHhcCC-cCCCCccCcHHHHHH
Confidence 34567789999999876664 55999999999999999 8999987554322 22333221 122233688999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhcc
Q 024336 238 LSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~ 259 (269)
|.+||+.||.+|||+.++++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~L 259 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQL 259 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHHH
Confidence 9999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=325.44 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=208.1
Q ss_pred ccccccceecccCceEEEEEEEe-----cCCeEEEEEEeecC--ccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERG--KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 74 (269)
++|++.+.||+|+||.||++.+. .++..||+|.+... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 68999999999999999999973 35678999998743 23456788999999999 899999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEE
Q 024336 75 AIVMEYAAGGELFARICSAG-----------------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTL 131 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~-----------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~ 131 (269)
++||||+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||||+||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 204 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence 99999999999999997643 2789999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCCh
Q 024336 132 LDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDP 207 (269)
Q Consensus 132 i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~ 207 (269)
++.++. ++|+|||++........ .....+++.|+|||.+.+..++ .++||||||+++|+|+| |..||......
T Consensus 205 l~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 205 VTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp EETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred EcCCCc--EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 998877 99999999874332222 1233457789999999877664 45999999999999998 99999877654
Q ss_pred hhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChh
Q 024336 208 RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
......... ....+....+++++.++|.+||..||.+|||+.++++++...
T Consensus 282 ~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 282 ANFYKLIQN----GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp HHHHHHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhc----CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 444333322 222233347899999999999999999999999999987543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=321.25 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=209.4
Q ss_pred cccccccceecccCceEEEEEEE-----ecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCe
Q 024336 2 EERYEPVKELGSGNFGVARLVRD-----KRTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPTH 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 73 (269)
.++|++.+.||+|+||.||++.+ ..++..||+|.+..... ..+.+.+|+.+++++ +||||+++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46899999999999999999985 35678999999875432 235688999999999 89999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC
Q 024336 74 LAIVMEYAAGGELFARICSAG------------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS 135 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~ 135 (269)
.++|+||+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||||+||+++.+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCC
Confidence 999999999999999997654 48999999999999999999999999999999999999988
Q ss_pred CCCcEEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHH
Q 024336 136 PQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFR 211 (269)
Q Consensus 136 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~ 211 (269)
+. ++|+|||++........ .....+++.|+|||.+.+..++ .++||||||+++|+|+| |..||..........
T Consensus 182 ~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 182 RI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp TE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CC--EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 77 99999999874333222 2233456789999999876664 55999999999999999 999998766544443
Q ss_pred HHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 212 KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
..... .........+++.+.++|.+||+.||.+|||+.++++++
T Consensus 259 ~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 302 (313)
T 1t46_A 259 KMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (313)
T ss_dssp HHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhcc----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 33322 222223347899999999999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=331.27 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=205.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC-----------CCCcceeeEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-----------HPNIIRFKEVLLT 70 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~ 70 (269)
.++|++.+.||+|+||+||++.+..+++.||+|++.......+.+.+|+.+++++. |+||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 46899999999999999999999999999999999866555667888999988875 8899999999986
Q ss_pred CC----eEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEecCCC----CCc
Q 024336 71 PT----HLAIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSP----QPR 139 (269)
Q Consensus 71 ~~----~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~di~p~ni~i~~~~----~~~ 139 (269)
.+ .+++++|++ +++|.+++... ..+++..++.++.||+.||.+||++ |++|+||||+||+++.++ ...
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence 54 789999999 78999999763 4599999999999999999999998 999999999999995432 225
Q ss_pred EEEeecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh------hhHHHH
Q 024336 140 LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP------RNFRKT 213 (269)
Q Consensus 140 ~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~------~~~~~~ 213 (269)
++|+|||++... ........+++.|+|||.+.+..++. ++||||||+++|+|+||..||...... ..+...
T Consensus 177 ~kl~Dfg~a~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (373)
T 1q8y_A 177 IKIADLGNACWY--DEHYTNSIQTREYRSPEVLLGAPWGC-GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253 (373)
T ss_dssp EEECCCTTCEET--TBCCCSCCSCGGGCCHHHHHTCCCCT-HHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred EEEccccccccc--CCCCCCCCCCccccCcHHHhCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence 999999998743 23334557899999999998777654 499999999999999999999865421 112222
Q ss_pred HHHHhh--------------------------------------ccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHH
Q 024336 214 IDRIRN--------------------------------------VQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQ 255 (269)
Q Consensus 214 ~~~~~~--------------------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 255 (269)
...... ....++ ...++++.+||.+||+.||.+|||++|+
T Consensus 254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~el 331 (373)
T 1q8y_A 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS--KDEAKEISDFLSPMLQLDPRKRADAGGL 331 (373)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC--HHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCC--cchHHHHHHHHHHHhccCccccCCHHHH
Confidence 111110 000111 1345688999999999999999999999
Q ss_pred hhccChhhhh
Q 024336 256 KASLVPEEFA 265 (269)
Q Consensus 256 l~~~~~~~~~ 265 (269)
++|+|+....
T Consensus 332 l~hp~f~~~~ 341 (373)
T 1q8y_A 332 VNHPWLKDTL 341 (373)
T ss_dssp HTCGGGTTCT
T ss_pred hhChhhhccc
Confidence 9999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=324.13 Aligned_cols=253 Identities=21% Similarity=0.233 Sum_probs=200.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCC----eEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT----HLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v~ 78 (269)
++|++.+.||+|+||+||++++. ++.||+|++............|+..+++++||||+++++++.... .+++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 68999999999999999999875 789999999766555556777999999999999999999998743 479999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeecCCCCcEEecCCCCCcEEEeecCCc
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM----------EICHRDLKLENTLLDGSPQPRLKICDFGYS 148 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~----------~i~H~di~p~ni~i~~~~~~~~~l~df~~~ 148 (269)
||+++++|.+++.. ..+++..++.++.|++.||.|||+. |++|+||||+||+++.++. ++|+|||++
T Consensus 102 e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~DFg~a 178 (322)
T 3soc_A 102 AFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIADFGLA 178 (322)
T ss_dssp ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC--EEECCCTTC
T ss_pred ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe--EEEccCCcc
Confidence 99999999999965 4589999999999999999999999 9999999999999998887 999999998
Q ss_pred ccCCCCC---CCCcccCCCcccCchhhcccc----CCCccchhhhHHHHHHHHHhCCCCCCCCCChh------------h
Q 024336 149 KSGLLHS---QPKSTVGTPAYIAPEVLARKE----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR------------N 209 (269)
Q Consensus 149 ~~~~~~~---~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~------------~ 209 (269)
....... ......+++.|+|||.+.+.. ..+.++||||||+++|+|+||..||....... .
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 6432222 223356899999999987632 22345899999999999999999997644321 1
Q ss_pred HHHHHHHHhhcccc--CCC---cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 210 FRKTIDRIRNVQYF--LPD---YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 210 ~~~~~~~~~~~~~~--~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
.............. .+. ....++.+.++|.+||+.||++|||+.++++.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 314 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314 (322)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11222222211111 111 0112345999999999999999999999998754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=325.82 Aligned_cols=260 Identities=20% Similarity=0.216 Sum_probs=201.9
Q ss_pred cccccccceecccCceEEEEEEEec---CCeEEEEEEeecCcc------------ccHHHHHHHHHHHhCCCCCcceeeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKR---TKELVAVKYIERGKK------------IDENVQREIINHRSLRHPNIIRFKE 66 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~------------~~~~~~~e~~~l~~l~h~~i~~~~~ 66 (269)
.++|++.+.||+|+||.||++.+.. ++..+|+|....... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999986 788999999875432 1234567888889999999999999
Q ss_pred EEEe----CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEE
Q 024336 67 VLLT----PTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKI 142 (269)
Q Consensus 67 ~~~~----~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l 142 (269)
++.. ....++|||++ +++|.+++...+.+++..++.++.|++.||.|||+.|++||||||+||+++.++.+.++|
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9988 77899999999 889999998877899999999999999999999999999999999999999877445999
Q ss_pred eecCCcccCCCCCC--------CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCC-CChhhHHHH
Q 024336 143 CDFGYSKSGLLHSQ--------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDP-EDPRNFRKT 213 (269)
Q Consensus 143 ~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~-~~~~~~~~~ 213 (269)
+|||++........ .....+++.|+|||.+.+..+ +.++||||||+++|+|+||..||... .........
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 99999864322111 134468999999999987765 45599999999999999999999643 232222222
Q ss_pred HHHHhhccc----cCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 214 IDRIRNVQY----FLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 214 ~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
......... .......+++++.++|.+||+.||.+|||++++++.+....
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 222221110 00111268899999999999999999999999998776543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=325.30 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=206.8
Q ss_pred cccccccceecccCceEEEEEEEe-----cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
.++|++.+.||+|+||.||++.+. .+++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+++..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 478999999999999999999997 3458999999875432 235688999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcE
Q 024336 75 AIVMEYAAGGELFARICSA------------------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENT 130 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni 130 (269)
++||||+++++|.+++... .++++..++.++.|++.||.+||+.|++|+||||+||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 205 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 205 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceE
Confidence 9999999999999999763 5689999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCcccCCCC---CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCC
Q 024336 131 LLDGSPQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPED 206 (269)
Q Consensus 131 ~i~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~ 206 (269)
+++.++. ++|+|||++...... .......+++.|+|||.+.+..++ .++|+||||+++|+|+| |..||.....
T Consensus 206 l~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 206 LVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp EECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred EECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 9998887 999999998632221 222344578889999999877664 45999999999999999 9999987554
Q ss_pred hhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.. ....+..... .+....+++.+.++|.+||+.||.+|||+.++++++
T Consensus 283 ~~----~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L 330 (343)
T 1luf_A 283 EE----VIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330 (343)
T ss_dssp HH----HHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HH----HHHHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 32 2233333322 122237899999999999999999999999998865
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=315.84 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=207.9
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEe-----------
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT----------- 70 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------- 70 (269)
.++|++.+.||+|+||.||++.+..+++.||+|.+.... +.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 468999999999999999999999899999999987543 457789999999999999999998864
Q ss_pred -----CCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEe
Q 024336 71 -----PTHLAIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKIC 143 (269)
Q Consensus 71 -----~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~ 143 (269)
...+++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~ 164 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIG 164 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEEC
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEEC
Confidence 44589999999999999999654 57999999999999999999999999999999999999998877 9999
Q ss_pred ecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcccc
Q 024336 144 DFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF 223 (269)
Q Consensus 144 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (269)
|||++.............+++.|+|||.+.+..++. ++|+||||+++|+|++|..|+... .......... .
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~~--~ 235 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGK-EVDLYALGLILAELLHVCDTAFET------SKFFTDLRDG--I 235 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCT-HHHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHHTT--C
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcc-hhhhHHHHHHHHHHHhcCCcchhH------HHHHHHhhcc--c
Confidence 999987655444455567899999999998776654 499999999999999998887421 1222222222 1
Q ss_pred CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 224 LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.+. .++..+.++|.+||..||.+|||+.|++++++.-.
T Consensus 236 ~~~--~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 236 ISD--IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp CCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ccc--cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 222 68899999999999999999999999999987644
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=316.11 Aligned_cols=253 Identities=26% Similarity=0.358 Sum_probs=198.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||.||++.+..+|+.||+|.+.... ...+.+.+|+.++++++||||+++++++..++..++|+
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 58999999999999999999999999999999987532 22346788999999999999999999999999999999
Q ss_pred eecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 79 EYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 79 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
|++++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 189 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCC---------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC--EEEEeccceeeecCC
Confidence 99999999998864 456899999999999999999999999999999999999998887 999999988643222
Q ss_pred C-CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 155 S-QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
. ......+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...... .......+............++++
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 266 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEE 266 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CC--HHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred CccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchh--HHHHHHHhhcccCCCCcccccCHH
Confidence 2 22344688999999999877664 4599999999999999999999754322 222333333333322223478999
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
+.++|.+||+.||.+|||+.++++++-
T Consensus 267 l~~li~~~l~~dp~~Rps~~~il~~l~ 293 (310)
T 2wqm_A 267 LRQLVNMCINPDPEKRPDVTYVYDVAK 293 (310)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 999999999999999999999998653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=312.76 Aligned_cols=245 Identities=20% Similarity=0.272 Sum_probs=204.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeC--CeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTP--THLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v 77 (269)
++|++.+.||+|+||.||++.+. ++.||+|++..... ..+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 68999999999999999999985 88899999875432 234688899999999999999999999887 788999
Q ss_pred EeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 78 MEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
+||+++++|.+++.... .+++..++.++.|++.||.+||+.| ++|+||||+||+++.++. ++++||+.+..
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~--- 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFS--- 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCT---
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccceee---
Confidence 99999999999998765 4899999999999999999999999 999999999999998887 88888887653
Q ss_pred CCCCCcccCCCcccCchhhccccCCC--ccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 154 HSQPKSTVGTPAYIAPEVLARKEYDG--KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~--~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
.......+++.|+|||.+.+..... .++||||||+++|+|++|..||.......... ...........+..++
T Consensus 163 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 237 (271)
T 3kmu_A 163 -FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM----KVALEGLRPTIPPGIS 237 (271)
T ss_dssp -TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH----HHHHSCCCCCCCTTCC
T ss_pred -ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH----HHHhcCCCCCCCCCCC
Confidence 2223456789999999998765543 25999999999999999999998765433322 2222222222334789
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+++.++|.+||+.||.+|||+.++++.+
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~~L 265 (271)
T 3kmu_A 238 PHVSKLMKICMNEDPAKRPKFDMIVPIL 265 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999999999999999999999999764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=316.66 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=204.9
Q ss_pred cccccccceecccCceEEEEEE----EecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeC--Ce
Q 024336 2 EERYEPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTP--TH 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~ 73 (269)
.++|++.+.||+|+||.||++. +..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 3579999999999999999999 56789999999987543 3346788999999999999999999999877 66
Q ss_pred EEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 74 LAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
+++||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++....
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECccccccccc
Confidence 8999999999999999954 456999999999999999999999999999999999999988876 9999999987433
Q ss_pred CCC----CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCC-----------CChhhHHHHHHHH
Q 024336 153 LHS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDP-----------EDPRNFRKTIDRI 217 (269)
Q Consensus 153 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~-----------~~~~~~~~~~~~~ 217 (269)
... ......++..|+|||.+.+..++. ++|+||||+++|+|+||..|+... ............+
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYI-ASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCc-chhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 322 223445777899999998777654 499999999999999999886432 1111222222322
Q ss_pred hhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.. ....+....+++.+.++|.+||+.||.+|||+.++++.+
T Consensus 257 ~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 257 KE-GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp HT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred hc-cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 22 223333447899999999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=331.47 Aligned_cols=244 Identities=25% Similarity=0.369 Sum_probs=204.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCC-eEEEEEeec
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT-HLAIVMEYA 81 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e~~ 81 (269)
++|++.+.||+|+||.||++.+. |+.||+|++.... ..+.+.+|+.++++++||||+++++++.... .+++||||+
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 67999999999999999999885 7799999987653 5678999999999999999999999987765 799999999
Q ss_pred CCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCc
Q 024336 82 AGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159 (269)
Q Consensus 82 ~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 159 (269)
++++|.+++...+. +++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++.... .....
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~--~~~~~ 345 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS--STQDT 345 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCccccc--ccccC
Confidence 99999999987654 799999999999999999999999999999999999998887 9999999987432 22223
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
..+++.|+|||.+.+..++. ++||||||+++|+|+| |..||........... +..+ ...+.+..+|+.+.++|
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~-~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i~~~-~~~~~p~~~~~~l~~li 419 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VEKG-YKMDAPDGCPPAVYDVM 419 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCH-HHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH----HHTT-CCCCCCTTCCHHHHHHH
T ss_pred CCCCcceeCHHHhcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcC-CCCCCCCcCCHHHHHHH
Confidence 35678899999998777654 4999999999999998 9999987665443322 2222 22333347899999999
Q ss_pred HHHhhhCCCCCCCcHHHhhcc
Q 024336 239 SQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+||+.||.+|||+.++++.+
T Consensus 420 ~~cl~~dp~~Rpt~~~l~~~L 440 (450)
T 1k9a_A 420 KNCWHLDAATRPTFLQLREQL 440 (450)
T ss_dssp HHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHHH
Confidence 999999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=337.97 Aligned_cols=249 Identities=21% Similarity=0.311 Sum_probs=211.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
++|++.+.||+|+||.||++.+..++..||+|.+.......+.+.+|+.++++++||||+++++++..+..+++||||++
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~ 299 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 299 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence 57889999999999999999999989999999998776667889999999999999999999999999999999999999
Q ss_pred CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--CCC
Q 024336 83 GGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPK 158 (269)
Q Consensus 83 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~~ 158 (269)
+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||++....... ...
T Consensus 300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~ 377 (495)
T 1opk_A 300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHA 377 (495)
T ss_dssp TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCCEECCT
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCceeecC
Confidence 99999999764 35899999999999999999999999999999999999988877 9999999987432221 122
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
...++..|+|||.+....++. ++||||||+++|+|+| |..||.......... . +.. ....+.+..+++.+.+|
T Consensus 378 ~~~~~~~y~aPE~~~~~~~~~-~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~-~---~~~-~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-L---LEK-DYRMERPEGCPEKVYEL 451 (495)
T ss_dssp TCCCCGGGCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-H---HHT-TCCCCCCTTCCHHHHHH
T ss_pred CCcCCcceeCHhHHhcCCCCc-HHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-H---HHc-CCCCCCCCCCCHHHHHH
Confidence 334567899999998777654 4999999999999999 999998766543322 1 221 22333344789999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhcc
Q 024336 238 LSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~ 259 (269)
|.+||+.||.+|||+.++++.+
T Consensus 452 i~~cl~~dP~~RPs~~el~~~L 473 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQAF 473 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHHHH
Confidence 9999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=321.51 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=198.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeE----EEEEEeecC--ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKEL----VAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~----vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
.++|++.+.||+|+||+||++.+..+++. ||+|.+... ....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 47899999999999999999999877765 477776532 234467889999999999999999999998765 78
Q ss_pred EEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 76 IVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
++++++.+++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTHHHHHTTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcceeEccCC
Confidence 89999999999999976 456999999999999999999999999999999999999998887 999999998643222
Q ss_pred CC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 155 SQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 155 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
.. .....+++.|+|||.+.+..++ .++||||||+++|+|+| |..||......... ... .. ....+....+
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~---~~-~~~~~~~~~~ 244 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL---EK-GERLPQPPIC 244 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHH---HT-TCCCCCCTTB
T ss_pred cccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HHH---Hc-CCCCCCCccC
Confidence 21 2233457789999999877765 45999999999999999 99999876553322 222 21 2223333478
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+.++.+++.+||+.||.+||++.++++++
T Consensus 245 ~~~~~~li~~~l~~~p~~Rps~~ell~~l 273 (327)
T 3poz_A 245 TIDVYMIMVKCWMIDADSRPKFRELIIEF 273 (327)
T ss_dssp CHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 99999999999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=318.73 Aligned_cols=252 Identities=24% Similarity=0.307 Sum_probs=195.8
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHh--CCCCCcceeeEEEEeC----CeE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS--LRHPNIIRFKEVLLTP----THL 74 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~~ 74 (269)
+.++|++.+.||+|+||+||++.+ +++.||+|++.... ...+..|.+++.. ++||||+++++++... ..+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 468999999999999999999988 58899999986543 3445556666555 7999999999986643 468
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeecCCCCcEEecCCCCCcEEEeecC
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH--------SMEICHRDLKLENTLLDGSPQPRLKICDFG 146 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--------~~~i~H~di~p~ni~i~~~~~~~~~l~df~ 146 (269)
++||||+++++|.++++ ...+++..++.++.|++.||.||| +.|++||||||+||+++.++. ++|+|||
T Consensus 82 ~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg 158 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLG 158 (301)
T ss_dssp EEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCT
T ss_pred EEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCC
Confidence 99999999999999994 457899999999999999999999 999999999999999998887 9999999
Q ss_pred CcccCCCCCC-----CCcccCCCcccCchhhccccCC-----CccchhhhHHHHHHHHHhC----------CCCCCCCCC
Q 024336 147 YSKSGLLHSQ-----PKSTVGTPAYIAPEVLARKEYD-----GKISDVWSCGVTLYVMLVG----------AYPFEDPED 206 (269)
Q Consensus 147 ~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~-----~~~~Di~slG~~l~~l~tg----------~~pf~~~~~ 206 (269)
++........ .....+++.|+|||.+.+.... +.++||||||+++|+|+|| ..||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 9853222211 2334789999999999766322 2459999999999999999 888865433
Q ss_pred hhhHHHHHHHHhhccc---cCCC---cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 207 PRNFRKTIDRIRNVQY---FLPD---YVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 207 ~~~~~~~~~~~~~~~~---~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
................ ..+. ....++.+.++|.+||+.||.+|||+.++++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred CCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 2222222222221111 1111 012456799999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=332.32 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=207.0
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|+||.||++.+. ++..||+|.+.......+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 367999999999999999999986 4678999999877667788999999999999999999999986 56789999999
Q ss_pred CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--CC
Q 024336 82 AGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QP 157 (269)
Q Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~ 157 (269)
++++|.+++... ..++...+..++.|++.||.|||+.|++||||||+||+++.++. +||+|||++....... ..
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCCHHHHTT
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCCCceecc
Confidence 999999999754 36899999999999999999999999999999999999998887 9999999987432211 12
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
....+++.|+|||.+....++ .++||||||+++|+|+| |..||......+... .+.. ....+.+..+|+++.+
T Consensus 343 ~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~----~i~~-~~~~~~~~~~~~~l~~ 416 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR----ALER-GYRMPRPENCPEELYN 416 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----HHHH-TCCCCCCTTSCHHHHH
T ss_pred CCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHc-CCCCCCCCCCCHHHHH
Confidence 233456789999999877664 45999999999999999 999998765433322 2222 2333444579999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhcc
Q 024336 237 LLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+|.+||+.||.+|||++++++.+
T Consensus 417 li~~cl~~dp~~RPt~~~i~~~L 439 (454)
T 1qcf_A 417 IMMRCWKNRPEERPTFEYIQSVL 439 (454)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHHHH
Confidence 99999999999999999997643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=315.27 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=196.2
Q ss_pred cccccccceecccCceEEEEEEEecC---CeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
.++|++.+.||+|+||.||++.+..+ +..||+|.+.... ...+.+.+|+..+++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 57899999999999999999998643 5679999876532 22356889999999999999999999974 456899
Q ss_pred EEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 77 VMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
||||+++++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDST 170 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC-----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECccccccccCccc
Confidence 999999999999997654 6899999999999999999999999999999999999998876 9999999987433222
Q ss_pred C--CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCH
Q 024336 156 Q--PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232 (269)
Q Consensus 156 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
. .....+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||........... +.... ..+....+++
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~----i~~~~-~~~~~~~~~~ 244 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IENGE-RLPMPPNCPP 244 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH----HHTTC-CCCCCTTCCH
T ss_pred ccccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH----HHcCC-CCCCCCCCCH
Confidence 1 2233456789999999876664 45999999999999997 9999987665433322 22221 1222337899
Q ss_pred HHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 233 DCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
.+.++|.+||+.||.+|||+.++++++..
T Consensus 245 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 245 TLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 99999999999999999999999987643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=313.44 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=194.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.++|++.+.||+|+||+||++.+.. .+|+|++...... .+.+.+|+.++++++||||++++++. .....++|+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 5789999999999999999998753 4999998654322 35688999999999999999999965 556689999
Q ss_pred eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC---C
Q 024336 79 EYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---H 154 (269)
Q Consensus 79 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~---~ 154 (269)
||+++++|.+.+.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++..... .
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC-----------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEEccceecccccccccc
Confidence 99999999999854 456999999999999999999999999999999999999998876 99999999864322 1
Q ss_pred CCCCcccCCCcccCchhhcc--ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCH
Q 024336 155 SQPKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232 (269)
Q Consensus 155 ~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
.......+++.|+|||.+.. ....+.++||||||+++|+|++|..||............................+|+
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCH
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCH
Confidence 22234568999999999862 2233556999999999999999999998877655554444332211111111236889
Q ss_pred HHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 233 DCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+.++|.+||+.||.+|||+.++++.+
T Consensus 257 ~l~~li~~~l~~~p~~Rps~~ell~~L 283 (289)
T 3og7_A 257 RMKRLMAECLKKKRDERPSFPRILAEI 283 (289)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 999999999999999999999999865
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=320.06 Aligned_cols=250 Identities=23% Similarity=0.320 Sum_probs=202.1
Q ss_pred cccccccceecccCceEEEEEEEecCCeE----EEEEEeecC--ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKEL----VAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~----vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
.++|++.+.||+|+||.||++.+..++.. ||+|.+... ......+.+|+.+++.++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 46899999999999999999999888776 677766432 223355778999999999999999999886 45689
Q ss_pred EEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 76 IVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
+|+||+.+++|.+.+... +.+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPD 168 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGSCCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCcccccCcc
Confidence 999999999999999764 57899999999999999999999999999999999999998887 999999999753322
Q ss_pred C---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 155 S---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 155 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
. ......+++.|+|||.+.+..++ .++||||||+++|+|+| |..||......... ..+.... .......+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~ 242 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP----DLLEKGE-RLAQPQIC 242 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH----HHHHTTC-BCCCCTTB
T ss_pred cccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHH----HHHHcCC-CCCCCCcC
Confidence 2 12334567789999999877764 45999999999999999 99999876553322 2222221 22223368
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
+.++.++|.+||..||.+|||+.++++++.
T Consensus 243 ~~~~~~li~~~l~~dp~~Rps~~el~~~l~ 272 (325)
T 3kex_A 243 TIDVYMVMVKCWMIDENIRPTFKELANEFT 272 (325)
T ss_dssp CTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 889999999999999999999999999753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=322.52 Aligned_cols=252 Identities=14% Similarity=0.160 Sum_probs=204.5
Q ss_pred cccccccceecccCceEEEEEEEec--------CCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcce----------
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKR--------TKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR---------- 63 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------- 63 (269)
.++|++.+.||+|+||.||++.+.. .++.||+|.+... +.+.+|+.++++++|||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 4789999999999999999999987 4889999998754 46788999999999999887
Q ss_pred -----eeEEEEe-CCeEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC
Q 024336 64 -----FKEVLLT-PTHLAIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS 135 (269)
Q Consensus 64 -----~~~~~~~-~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~ 135 (269)
+++++.. +...++||||+ +++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE 195 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence 6777776 67899999999 89999999875 679999999999999999999999999999999999999987
Q ss_pred CCCcEEEeecCCcccCCCCC--------CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCC-C
Q 024336 136 PQPRLKICDFGYSKSGLLHS--------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE-D 206 (269)
Q Consensus 136 ~~~~~~l~df~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~-~ 206 (269)
+..+++|+|||++....... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.... .
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 73349999999986432221 1133468999999999987766 445999999999999999999998765 3
Q ss_pred hhhHHHHHHHHhhccccCC----CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 207 PRNFRKTIDRIRNVQYFLP----DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.................+. .+..+++.+.++|.+||+.||.+|||+.++++.+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331 (352)
T ss_dssp HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence 3344443333333222221 1235789999999999999999999999998864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=321.81 Aligned_cols=255 Identities=16% Similarity=0.214 Sum_probs=195.9
Q ss_pred cccccccceecccCceEEEEEEEecC-----CeEEEEEEeecCcc------------ccHHHHHHHHHHHhCCCCCccee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRT-----KELVAVKYIERGKK------------IDENVQREIINHRSLRHPNIIRF 64 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~-----~~~vaiK~~~~~~~------------~~~~~~~e~~~l~~l~h~~i~~~ 64 (269)
.++|++.+.||+|+||.||++.+..+ ++.||+|++..... .......|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 35899999999999999999998764 57899999875431 11123345556677789999999
Q ss_pred eEEEEeC----CeEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCc
Q 024336 65 KEVLLTP----THLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR 139 (269)
Q Consensus 65 ~~~~~~~----~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~ 139 (269)
++++... ...++||||+ +++|.+++... +.+++..++.++.|++.||.|||+.|++||||||+||+++.+..+.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9998875 4589999999 88999999775 5799999999999999999999999999999999999998333334
Q ss_pred EEEeecCCcccCCCCCC--------CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHH
Q 024336 140 LKICDFGYSKSGLLHSQ--------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFR 211 (269)
Q Consensus 140 ~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~ 211 (269)
++|+|||++........ .....+|+.|+|||.+.+..+ +.++||||||+++|+|+||..||..........
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 99999999864322211 123448999999999987776 455999999999999999999998643322222
Q ss_pred H-HHHHHhhcc-----ccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 212 K-TIDRIRNVQ-----YFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 212 ~-~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
. ......... ..+ ....+|+++.++|..||..||.+||++.++++.+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l 324 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCF-PAANAPGEIAKYMETVKLLDYTEKPLYENLRDIL 324 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHS-CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhc-ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Confidence 1 111111100 011 1136899999999999999999999999998743
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=312.24 Aligned_cols=249 Identities=23% Similarity=0.302 Sum_probs=201.4
Q ss_pred cccccccc-eecccCceEEEEEEE--ecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 2 EERYEPVK-ELGSGNFGVARLVRD--KRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~-~l~~g~~g~v~~~~~--~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
.++|++.+ .||+|+||.||++.+ ..+++.||+|++...... .+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 36788888 999999999999954 456789999998754322 45688999999999999999999998 566789
Q ss_pred EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
+|+|++++++|.+++...+.+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADE 171 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTC
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEccCCcceeeccCC
Confidence 99999999999999998888999999999999999999999999999999999999998876 9999999986432222
Q ss_pred C----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 156 Q----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 156 ~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
. .....+++.|+|||.+.+..++ .++|+||||+++|+|+| |..||....... ....+.... .......+
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~~~-~~~~~~~~ 245 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEKGE-RMGCPAGC 245 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHHHTTC-CCCCCTTC
T ss_pred CcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHHcCC-CCCCCCCC
Confidence 1 1223356789999999776664 45999999999999999 999998765432 222222221 12223378
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
++.+.++|.+||+.||.+|||+.++++.+
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~~L 274 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVELRL 274 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999999999999999999998753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=314.61 Aligned_cols=256 Identities=24% Similarity=0.302 Sum_probs=204.1
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCC--CCCcceeeEEEEeCCeEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLR--HPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~ 76 (269)
.++|++.+.||+|+||.||++.+. +++.||+|.+..... ..+.+.+|+.++++++ |+||+++++++..++..++
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 468999999999999999999986 588899999875432 2356788999999997 5999999999999999999
Q ss_pred EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-
Q 024336 77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS- 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~- 155 (269)
||| +.+++|.+++...+.+++..++.++.|++.||.+||+.|++|+||||+||++++ +. ++|+|||++.......
T Consensus 106 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~--~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GM--LKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TE--EEECCCSSSCC------
T ss_pred EEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-Ce--EEEeeccccccccCccc
Confidence 999 557899999998888999999999999999999999999999999999999964 44 9999999987432222
Q ss_pred --CCCcccCCCcccCchhhccc----------cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcccc
Q 024336 156 --QPKSTVGTPAYIAPEVLARK----------EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF 223 (269)
Q Consensus 156 --~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (269)
......+++.|+|||.+.+. ...+.++||||||+++|+|++|..||........ ...........
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~ 258 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHE 258 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHHHHHhcccc
Confidence 12344689999999998652 2345569999999999999999999976554321 12222222222
Q ss_pred CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 224 LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.......+.++.++|.+||+.||.+|||+.|+++|+|++...
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 222235688999999999999999999999999999998643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=325.37 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=196.6
Q ss_pred ccccccceecccCceEEEEEEEe---cCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++.+.||+|+||.||++.+. .++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 58999999999999999999986 457789999987542 2335688999999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 78 MEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
|||+++++|.+++...+ .+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++........
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCccccccccCCc
Confidence 99999999999997654 6999999999999999999999999999999999999998887 99999999874322211
Q ss_pred ----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 157 ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 157 ----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
.....+++.|+|||.+.+..++. ++||||||+++|++++ |..||........ ...+... ...+....++
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~SlG~il~ellt~g~~P~~~~~~~~~----~~~i~~~-~~~~~~~~~~ 276 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDV----IKAVDEG-YRLPPPMDCP 276 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTC-CTTTTCCHHHH----HHHHHTT-EECCCCTTCB
T ss_pred cceeccCCCcCCCccChhhhccCCcCc-hhcHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHcC-CCCCCCcccc
Confidence 11223467899999998777654 5999999999999998 9999987654322 2222222 2233344789
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
..+.++|.+||+.||.+||++.++++.+
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L 304 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVSIL 304 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHHHH
Confidence 9999999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=319.98 Aligned_cols=254 Identities=27% Similarity=0.411 Sum_probs=206.0
Q ss_pred cccccccceecccCceEEEEEE----EecCCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEE--eCCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLL--TPTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 74 (269)
.++|++.+.||+|+||.||++. +..+++.||+|.+..... ..+.+.+|+.++++++||||+++++++. .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 4789999999999999999999 567899999999875432 2345889999999999999999999987 45679
Q ss_pred EEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 75 AIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
++||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCGGGCEECCT
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEEcccccceeccc
Confidence 999999999999999976 446999999999999999999999999999999999999998877 99999999874322
Q ss_pred CC----CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh-----------hhHHHHHHHHh
Q 024336 154 HS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----------RNFRKTIDRIR 218 (269)
Q Consensus 154 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~-----------~~~~~~~~~~~ 218 (269)
.. ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...... .........+.
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 22 2233457778999999987766 44599999999999999999998653221 11122222222
Q ss_pred hccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 219 NVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.....+....+++.+.++|.+||+.||.+|||+.++++++
T Consensus 259 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 298 (327)
T 3lxl_A 259 -EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298 (327)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2223333447899999999999999999999999997764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=319.72 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=205.3
Q ss_pred cccccccceecccCceEEEEEEEe-------cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeC
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK-------RTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTP 71 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 71 (269)
.++|++.+.||+|+||.||++.+. .++..||+|++..... ..+.+.+|+.+++++ +||||+++++++..+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999975 4577899999875432 234678899999999 899999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC
Q 024336 72 THLAIVMEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS 135 (269)
Q Consensus 72 ~~~~~v~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~ 135 (269)
+..++|+||+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||||+||+++.+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 193 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCC
Confidence 99999999999999999997654 38999999999999999999999999999999999999988
Q ss_pred CCCcEEEeecCCcccCCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHH
Q 024336 136 PQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFR 211 (269)
Q Consensus 136 ~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~ 211 (269)
+. ++|+|||++....... ......+++.|+|||.+.+..++ .++||||||+++|+|+| |..||.......
T Consensus 194 ~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 267 (334)
T 2pvf_A 194 NV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267 (334)
T ss_dssp CC--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred CC--EEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence 87 9999999986433221 22334467789999999877664 45999999999999999 999998754432
Q ss_pred HHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 212 KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
....+.... ..+....++..+.++|.+||+.||.+|||+.++++++-
T Consensus 268 -~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 314 (334)
T 2pvf_A 268 -LFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314 (334)
T ss_dssp -HHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHHhcCC-CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 222222222 12223478999999999999999999999999998753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=308.99 Aligned_cols=252 Identities=21% Similarity=0.221 Sum_probs=202.3
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEE-EeCCeEEEEEe
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVL-LTPTHLAIVME 79 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e 79 (269)
+.++|++.+.||+|+||.||++.+..+++.||+|++.... ..+.+.+|+.+++.++|+++++.+..+ ......++|+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 3579999999999999999999999999999999887553 345688999999999988766655554 56778899999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEec---CCCCCcEEEeecCCcccCCCCC
Q 024336 80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLD---GSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 80 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~---~~~~~~~~l~df~~~~~~~~~~ 155 (269)
|+ +++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++ .++. ++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCe--EEEeeCCCcccccccc
Confidence 99 8899999974 45799999999999999999999999999999999999994 5555 9999999987433322
Q ss_pred C--------CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh---hhHHHHHHHHhhcc-cc
Q 024336 156 Q--------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---RNFRKTIDRIRNVQ-YF 223 (269)
Q Consensus 156 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~-~~ 223 (269)
. .....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...... .............. ..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred cccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 1 234568999999999987776 44599999999999999999999864432 22222222111111 01
Q ss_pred CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 224 LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
. ...+|+++.++|.+||+.||.+|||+.++++.+
T Consensus 242 ~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 275 (296)
T 3uzp_A 242 L--CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp H--TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred H--HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHH
Confidence 1 126889999999999999999999999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=309.89 Aligned_cols=248 Identities=21% Similarity=0.344 Sum_probs=205.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|+||.||++.+. ++..||+|.+.......+.+.+|+.+++.++||||+++++++.. +..++|+|++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 478999999999999999999976 56789999998776667789999999999999999999998764 4589999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--CC
Q 024336 82 AGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QP 157 (269)
Q Consensus 82 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~ 157 (269)
++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++....... ..
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEECC
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccccCcccccc
Confidence 9999999986543 6899999999999999999999999999999999999998877 9999999987433222 22
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
....+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||......... ..+... ........+++.+.+
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~l~~ 241 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI----QNLERG-YRMVRPDNCPEELYQ 241 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHHHTT-CCCCCCTTCCHHHHH
T ss_pred cCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHH----HHHhcc-cCCCCcccccHHHHH
Confidence 233467789999999876664 45999999999999999 89999876543322 222222 122223478999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhcc
Q 024336 237 LLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+|.+||+.||++|||+.++++.+
T Consensus 242 li~~~l~~~p~~Rps~~~l~~~l 264 (279)
T 1qpc_A 242 LMRLCWKERPEDRPTFDYLRSVL 264 (279)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhccChhhCCCHHHHHHHH
Confidence 99999999999999999998753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=321.18 Aligned_cols=256 Identities=23% Similarity=0.247 Sum_probs=204.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++|++.+.||+|+||.||++.+. +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 116 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY 116 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEEC
T ss_pred HhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEc
Confidence 478999999999999999999965 68899999887543 3346788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-
Q 024336 81 AAGGELFARICSAG----RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS- 155 (269)
Q Consensus 81 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~- 155 (269)
+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 194 (321)
T 2qkw_B 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGTELDQ 194 (321)
T ss_dssp CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECSSSSC
T ss_pred CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeecccccccccccc
Confidence 99999999986543 4899999999999999999999999999999999999998887 9999999986432221
Q ss_pred --CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhH---HHHHHHHhhcccc------C
Q 024336 156 --QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF---RKTIDRIRNVQYF------L 224 (269)
Q Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~------~ 224 (269)
......+++.|+|||.+.+..++.+ +||||||+++|+|+||..||......... ............. .
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T 2qkw_B 195 THLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273 (321)
T ss_dssp CCCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred cccccccCCCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh
Confidence 1223457899999999987776554 99999999999999999999764432211 1111111111110 0
Q ss_pred C--CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 225 P--DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 225 ~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
. .....+..+.+++.+||+.||++|||+.|+++++..
T Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 0 011234678999999999999999999999988753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=319.40 Aligned_cols=261 Identities=23% Similarity=0.274 Sum_probs=205.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.++|++.+.||+|+||.||++.+. +|+.||+|++.... .....+.+|+.+++.++||||+++++++.++...++|+|
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 107 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 107 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEE
T ss_pred hhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEE
Confidence 578999999999999999999864 68899999987543 223468899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 80 YAAGGELFARICSAG----RFSEDEARFFFQQLISGVSYCHSM---EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~---~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
|+++++|.+++.... ++++..+..++.|++.||.+||+. |++|+||||+||+++.++. ++|+|||++....
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~ 185 (326)
T 3uim_A 108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLMD 185 (326)
T ss_dssp CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCEECC
T ss_pred eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCccccccC
Confidence 999999999997643 489999999999999999999999 9999999999999998887 9999999987433
Q ss_pred CCCC--CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCC----CCChhhHHHHHHHHhhcc-ccC-
Q 024336 153 LHSQ--PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFED----PEDPRNFRKTIDRIRNVQ-YFL- 224 (269)
Q Consensus 153 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~----~~~~~~~~~~~~~~~~~~-~~~- 224 (269)
.... .....+++.|+|||.+.+..++ .++||||||+++|+|+||..||.. .................. ...
T Consensus 186 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (326)
T 3uim_A 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL 264 (326)
T ss_dssp SSSSCEECCCCSCGGGCCHHHHHHSEEC-HHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTS
T ss_pred cccccccccccCCcCccCHHHhccCCCC-ccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhh
Confidence 2222 2234589999999999877764 459999999999999999999952 111111111111111100 000
Q ss_pred -------CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 225 -------PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 225 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
......++.+.+++.+||+.||.+|||+.++++++....+.+
T Consensus 265 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 265 VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp SCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred cChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 000122367999999999999999999999999987666543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=319.47 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=195.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHh--CCCCCcceeeEEEEeC----CeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS--LRHPNIIRFKEVLLTP----THLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~~~ 75 (269)
.++|++.+.||+|+||.||++.+. ++.||+|++..... .....|.+++.. ++||||+++++++... ...+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 468999999999999999999885 88999999875433 334445554444 4899999999999887 7899
Q ss_pred EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeecCCCCcEEecCCCCCcEEEeecCC
Q 024336 76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM--------EICHRDLKLENTLLDGSPQPRLKICDFGY 147 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------~i~H~di~p~ni~i~~~~~~~~~l~df~~ 147 (269)
+||||+++++|.+++.. ..+++..++.++.|++.||.+||+. |++||||||+||+++.++. ++|+|||+
T Consensus 112 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~ 188 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL 188 (337)
T ss_dssp EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTT
T ss_pred EEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCC
Confidence 99999999999999965 4689999999999999999999998 9999999999999998887 99999999
Q ss_pred cccCCCCCC-----CCcccCCCcccCchhhccccCCCc-----cchhhhHHHHHHHHHhC----------CCCCCCCCCh
Q 024336 148 SKSGLLHSQ-----PKSTVGTPAYIAPEVLARKEYDGK-----ISDVWSCGVTLYVMLVG----------AYPFEDPEDP 207 (269)
Q Consensus 148 ~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~-----~~Di~slG~~l~~l~tg----------~~pf~~~~~~ 207 (269)
+........ .....+++.|+|||.+.+...... ++||||||+++|+|+|| ..||......
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 864322221 124568999999999976655433 48999999999999999 6777654332
Q ss_pred hhH-HHHHHHHhhc--cccCCC---cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 208 RNF-RKTIDRIRNV--QYFLPD---YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 208 ~~~-~~~~~~~~~~--~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
... .......... ....+. ...+++++.++|.+||+.||.+|||+.++++++-
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence 222 2222222111 111111 1145667999999999999999999999999863
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=312.25 Aligned_cols=253 Identities=21% Similarity=0.207 Sum_probs=197.7
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEE-EeCCeEEEEEe
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVL-LTPTHLAIVME 79 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e 79 (269)
+.++|++.+.||+|+||.||++.+..+++.||+|++.... ....+.+|+.+++.++|++++..+..+ ...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 4689999999999999999999999999999999876543 334578899999999887766655554 66778999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe---cCCCCCcEEEeecCCcccCCCCC
Q 024336 80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 80 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i---~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
++ +++|.+++.. .+++++..++.++.|++.||.+||+.|++|+||||+||++ +.++. ++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~--~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe--EEEecCccceeccCcc
Confidence 99 8899999874 4579999999999999999999999999999999999999 55665 9999999987433222
Q ss_pred --------CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChh---hHHHHHHHHhhccccC
Q 024336 156 --------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR---NFRKTIDRIRNVQYFL 224 (269)
Q Consensus 156 --------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 224 (269)
......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||....... .............. .
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~ 240 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-E 240 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-H
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-h
Confidence 2234568999999999987776 455999999999999999999998654432 12211111111110 0
Q ss_pred CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 225 PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.....+|+++.++|.+||+.||++|||+.++++.+
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 275 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHH
Confidence 01126789999999999999999999999998743
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=319.82 Aligned_cols=253 Identities=22% Similarity=0.317 Sum_probs=208.5
Q ss_pred cccccccceecccCceEEEEEEEecCCe-----EEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKE-----LVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPTH 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~-----~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 73 (269)
.++|++.+.||+|+||.||++.+..++. .||+|.+..... ..+.+.+|+.+++.+ +||||+++++++..++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 3679999999999999999999976654 799999875432 335688999999999 89999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCc
Q 024336 74 LAIVMEYAAGGELFARICSA--------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR 139 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~ 139 (269)
.++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-- 202 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV-- 202 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE--
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe--
Confidence 99999999999999998653 35799999999999999999999999999999999999998876
Q ss_pred EEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHH
Q 024336 140 LKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTID 215 (269)
Q Consensus 140 ~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~ 215 (269)
++|+|||++........ .....+++.|+|||.+.+..++ .++||||||+++|+|+| |..||..............
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 281 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence 99999999874322221 2233456789999999877664 55999999999999998 9999987665444433332
Q ss_pred HHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 216 RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
. ....+.....++.+.++|.+||+.||.+|||+.++++++..
T Consensus 282 ~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 282 D----GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp H----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c----CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 2 22233334688999999999999999999999999987643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=317.35 Aligned_cols=251 Identities=20% Similarity=0.280 Sum_probs=206.5
Q ss_pred cccccccceecccCceEEEEEEEe-----cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
.++|++.+.||+|+||.||++.+. .+++.||+|.+..... ....+.+|+.+++.++||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 478999999999999999999887 4578899999875432 234578999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEee
Q 024336 75 AIVMEYAAGGELFARICSA----------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICD 144 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~d 144 (269)
++|||++++++|.+++... .++++..++.++.|++.||.+||+.|++||||||+||+++.++. ++|+|
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~kl~D 181 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGD 181 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--EEECc
Confidence 9999999999999998653 35789999999999999999999999999999999999998887 99999
Q ss_pred cCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhc
Q 024336 145 FGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV 220 (269)
Q Consensus 145 f~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 220 (269)
||++........ .....+++.|+|||.+.+..++ .++||||||+++|+|+| |..||....... ....+...
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~~~~~ 256 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQ----VLRFVMEG 256 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHH----HHHHHHTT
T ss_pred CccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHH----HHHHHHcC
Confidence 999864322211 1233457889999999877664 45999999999999999 899998755432 22222222
Q ss_pred cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 221 QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 221 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
.. .+....+++.+.++|.+||+.||.+|||+.|+++++.
T Consensus 257 ~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~ 295 (322)
T 1p4o_A 257 GL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295 (322)
T ss_dssp CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred Cc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 22 2223378999999999999999999999999999753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=317.17 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=206.4
Q ss_pred cccccccceecccCceEEEEEEEe-----cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeCC-
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPT- 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~- 72 (269)
.++|++.+.||+|+||.||++.+. .+++.||+|++..... ....+.+|+.+++++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 478999999999999999999853 4678999999875432 234678899999999 7899999999988754
Q ss_pred eEEEEEeecCCCchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGR----------------FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP 136 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~----------------~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~ 136 (269)
.+++|+||+++++|.+++..... +++..++.++.|++.||.+||+.|++|+||||+||+++.++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC
Confidence 58999999999999999977554 89999999999999999999999999999999999999887
Q ss_pred CCcEEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHH
Q 024336 137 QPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRK 212 (269)
Q Consensus 137 ~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~ 212 (269)
. ++|+|||++........ .....+++.|+|||.+.+..++ .++||||||+++|+|+| |..||...........
T Consensus 186 ~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 262 (316)
T 2xir_A 186 V--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262 (316)
T ss_dssp C--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred C--EEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence 7 99999999874332221 1233467889999999877664 45999999999999998 9999987665443333
Q ss_pred HHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
..... .....+ ..+++.+.++|.+||+.||.+|||+.++++++-
T Consensus 263 ~~~~~--~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 306 (316)
T 2xir_A 263 RLKEG--TRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306 (316)
T ss_dssp HHHHT--CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HhccC--ccCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 22221 112222 368999999999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=315.00 Aligned_cols=254 Identities=29% Similarity=0.406 Sum_probs=202.7
Q ss_pred Ccccc-cccceecccCceEEEEEEE----ecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeC--
Q 024336 1 MEERY-EPVKELGSGNFGVARLVRD----KRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTP-- 71 (269)
Q Consensus 1 i~~~y-~~~~~l~~g~~g~v~~~~~----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 71 (269)
+.++| ++++.||+|+||+||++.. ..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 34566 9999999999999987753 4578999999987643 2235688999999999999999999999884
Q ss_pred CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 72 THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 72 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
..+++||||+++++|.+++... .+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++...
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAV 184 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEEC
T ss_pred ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--EEECCccccccc
Confidence 6789999999999999999654 4899999999999999999999999999999999999998887 999999998743
Q ss_pred CCCC----CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCCh-----------hhHHHHHHH
Q 024336 152 LLHS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----------RNFRKTIDR 216 (269)
Q Consensus 152 ~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~-----------~~~~~~~~~ 216 (269)
.... ......+++.|+|||.+.+..++ .++||||||+++|+|+||..||...... .........
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 3222 12334567789999999877765 4599999999999999999998753211 111112222
Q ss_pred HhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+ ......+....+++.+.++|.+||+.||.+|||+.++++.+
T Consensus 264 ~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 305 (318)
T 3lxp_A 264 L-ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305 (318)
T ss_dssp H-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred H-hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 2 22223334457899999999999999999999999999754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=309.74 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=205.6
Q ss_pred cccccccc-eecccCceEEEEEEEe--cCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 2 EERYEPVK-ELGSGNFGVARLVRDK--RTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 2 ~~~y~~~~-~l~~g~~g~v~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
.++|.+.+ .||+|+||.||++.+. .++..||+|.+.... ...+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 46788887 9999999999999864 568889999987643 2345688999999999999999999998 4566899
Q ss_pred EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 77 VMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
|+|++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADD 164 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCS
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC--EEECcccceeeeccCc
Confidence 99999999999998643 45999999999999999999999999999999999999998776 9999999987432221
Q ss_pred ----CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 156 ----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 156 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
......+++.|+|||.+.+..++. ++|+||||+++|+|+| |..||......... ..+.... ..+....+
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~----~~i~~~~-~~~~~~~~ 238 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSS-RSDVWSYGVTMWEALSYGQKPYKKMKGPEVM----AFIEQGK-RMECPPEC 238 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH----HHHHTTC-CCCCCTTC
T ss_pred ceeeccccccccccccCHHHhccCCCCc-hhhHHHHHHHHHHHHcCCCCCcccCCHHHHH----HHHhcCC-cCCCCCCc
Confidence 122334578899999997766644 5999999999999998 99999876654332 2222222 11222378
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
++.+.++|.+||..||.+||++.+++++++..-
T Consensus 239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 239 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999999999876543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=315.96 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=199.7
Q ss_pred cccccccceecccCceEEEEEEEecCCeEE----EEEEeecC--ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELV----AVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~v----aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
.++|++.+.||+|+||.||++.+..+++.+ ++|.+... ....+.+.+|+.+++.++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 478999999999999999999998887765 66655432 234567889999999999999999999998765 78
Q ss_pred EEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 76 IVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
++++++.+++|.+++.. ...+++..++.++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTC-------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCcceeEccCc
Confidence 99999999999999976 456999999999999999999999999999999999999988877 999999998743222
Q ss_pred CC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 155 SQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 155 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
.. .....+++.|+|||.+.+..++ .++||||||+++|+|++ |..||.......... .. .. ....+....+
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-~~---~~-~~~~~~~~~~ 244 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-IL---EK-GERLPQPPIC 244 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-HH---HT-TCCCCCCTTB
T ss_pred cccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-HH---Hc-CCCCCCCccC
Confidence 21 2233456789999999877764 45999999999999999 999998765543222 21 11 2223334478
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
+.++.++|.+||+.||.+|||+.|+++.+-
T Consensus 245 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 274 (327)
T 3lzb_A 245 TIDVYMIMRKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 999999999999999999999999998643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=318.29 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=201.7
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEe----CCeEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLT----PTHLAI 76 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 76 (269)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 468999999999999999999999999999999886532 334568899999999999999999999873 347899
Q ss_pred EEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 77 VMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
|+||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~~~~ 185 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQAC 185 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCEESC
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcchhcc
Confidence 9999999999999875 467999999999999999999999999999999999999998887 9999999876422
Q ss_pred CCCCC----------CcccCCCcccCchhhccccC--CCccchhhhHHHHHHHHHhCCCCCCCCCCh-hhHHHHHHHHhh
Q 024336 153 LHSQP----------KSTVGTPAYIAPEVLARKEY--DGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRN 219 (269)
Q Consensus 153 ~~~~~----------~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~~l~~l~tg~~pf~~~~~~-~~~~~~~~~~~~ 219 (269)
..... ....+++.|+|||.+.+... .+.++||||||+++|+|++|..||...... ...... ..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~ 261 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA----VQ 261 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH----HH
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH----hh
Confidence 11111 12346889999999875431 245599999999999999999999531100 011111 11
Q ss_pred ccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 220 VQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 220 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
.....+....+++.+.++|.+||+.||.+|||+.++++++.
T Consensus 262 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 302 (317)
T 2buj_A 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302 (317)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence 12334444578999999999999999999999999999764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=318.04 Aligned_cols=256 Identities=19% Similarity=0.268 Sum_probs=204.0
Q ss_pred cccccccceecccCceEEEEEE-----EecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVR-----DKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~-----~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
.++|++.+.||+|+||.||++. +..++..||+|.+.... .....+.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 5789999999999999999999 55678899999986432 2334678899999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CCcEEEeecC
Q 024336 75 AIVMEYAAGGELFARICSAG-------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFG 146 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~~~~~l~df~ 146 (269)
++||||+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||||+||+++.++ ...++|+|||
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccc
Confidence 99999999999999997653 489999999999999999999999999999999999998543 2349999999
Q ss_pred CcccCCC---CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccc
Q 024336 147 YSKSGLL---HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQY 222 (269)
Q Consensus 147 ~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 222 (269)
++..... ........+++.|+|||.+.+..++ .++||||||+++|+|+| |..||....... ....+....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~~~- 262 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEFVTSGG- 262 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHHHHTTC-
T ss_pred cccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHH----HHHHHhcCC-
Confidence 8863211 1223344578899999999877664 45999999999999998 999998754422 222222222
Q ss_pred cCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 223 FLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 223 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.......+++.+.++|.+||+.||.+||++.+++++++...
T Consensus 263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 12223378999999999999999999999999999987643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=310.23 Aligned_cols=244 Identities=25% Similarity=0.370 Sum_probs=196.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeC-CeEEEEEeec
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTP-THLAIVMEYA 81 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~ 81 (269)
++|++.+.||+|++|.||++.+. |+.||+|.+.... ..+.+.+|+.++++++|||++++++++.+. +..++|+|++
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 68999999999999999999874 8899999987543 457788999999999999999999987654 4789999999
Q ss_pred CCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCc
Q 024336 82 AGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159 (269)
Q Consensus 82 ~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 159 (269)
++++|.+++...+. +++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.... .....
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~--~~~~~ 173 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS--STQDT 173 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC------------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeecccccccc--ccccC
Confidence 99999999976543 899999999999999999999999999999999999998887 9999999887432 22234
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
..+++.|+|||.+.+..++ .++|+||||+++|+|+| |..||.......... .+... ........+++.+.++|
T Consensus 174 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~l~~li 247 (278)
T 1byg_A 174 GKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP----RVEKG-YKMDAPDGCPPAVYEVM 247 (278)
T ss_dssp --CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH----HHTTT-CCCCCCTTCCHHHHHHH
T ss_pred CCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHhcC-CCCCCcccCCHHHHHHH
Confidence 4567889999999876664 45999999999999998 999998765433322 22222 12223347899999999
Q ss_pred HHHhhhCCCCCCCcHHHhhcc
Q 024336 239 SQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+||+.||.+|||+.++++.+
T Consensus 248 ~~~l~~~p~~Rps~~~l~~~L 268 (278)
T 1byg_A 248 KNCWHLDAAMRPSFLQLREQL 268 (278)
T ss_dssp HHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcCChhhCCCHHHHHHHH
Confidence 999999999999999998754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=314.96 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=200.2
Q ss_pred cccccccceecccCceEEEEEEEecCC----eEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTK----ELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
.++|++.+.||+|+||.||++.+..++ ..||+|.+..... ....+.+|+.+++.++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 367899999999999999999987543 4599999875432 2345788999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 76 IVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
+|||++++++|.+++... +.+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++......
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc--EEECCCCcchhhccc
Confidence 999999999999999764 57999999999999999999999999999999999999998877 999999998743222
Q ss_pred CC----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCC
Q 024336 155 SQ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229 (269)
Q Consensus 155 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (269)
.. .....+++.|+|||.+.+..++. ++||||||+++|+|++ |..||....... ....+... ...+....
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~pf~~~~~~~----~~~~~~~~-~~~~~~~~ 274 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHE----VMKAINDG-FRLPTPMD 274 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTT-CCCCCCTT
T ss_pred cccccccCCCCccccccCchhcccCCCCc-hhhhHHHHHHHHHHHcCCCCCcccCCHHH----HHHHHHCC-CcCCCccc
Confidence 11 12233567899999998766644 5999999999999999 999997755432 22222222 22333447
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 230 VSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+++.+.++|.+||+.||.+||++.++++++
T Consensus 275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 304 (333)
T 1mqb_A 275 CPSAIYQLMMQCWQQERARRPKFADIVSIL 304 (333)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 899999999999999999999999999865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=313.24 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=196.3
Q ss_pred cccccccceecccCceEEEEEEEec---CCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeCC---
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKR---TKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPT--- 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 72 (269)
.++|++.+.||+|+||.||++.+.. ++..||+|.+...... .+.+.+|+..+++++||||+++++++.+..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 4689999999999999999998865 4568999998754322 345788999999999999999999998765
Q ss_pred --eEEEEEeecCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEee
Q 024336 73 --HLAIVMEYAAGGELFARICS------AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICD 144 (269)
Q Consensus 73 --~~~~v~e~~~~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~d 144 (269)
..++|+||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kl~D 190 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVAD 190 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--EEECS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEEee
Confidence 35999999999999999843 356999999999999999999999999999999999999998887 99999
Q ss_pred cCCcccCCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhc
Q 024336 145 FGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV 220 (269)
Q Consensus 145 f~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~ 220 (269)
||++....... ......+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||............ ...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~----~~~ 265 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL----LHG 265 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----HTT
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH----HcC
Confidence 99986432221 22234467789999999876664 45999999999999999 88999876654333222 221
Q ss_pred cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 221 QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 221 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
. ..+....+++.+.++|.+||..||.+|||+.++++++-
T Consensus 266 ~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 304 (313)
T 3brb_A 266 H-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304 (313)
T ss_dssp C-CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred C-CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1 12223478999999999999999999999999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=328.66 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=202.2
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|+||.||++.+.. +..||+|++.......+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 3679999999999999999999875 4669999998766666789999999999999999999999876 6789999999
Q ss_pred CCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--CC
Q 024336 82 AGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QP 157 (269)
Q Consensus 82 ~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~ 157 (269)
++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++....... ..
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC----------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCCceecc
Confidence 99999999964 356899999999999999999999999999999999999998877 9999999987432221 12
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
....++..|+|||.+....++ .++||||||+++|+|+| |..||......+. ...+... ...+.+..+|+.+.+
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~----~~~i~~~-~~~~~~~~~~~~l~~ 412 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREV----LDQVERG-YRMPCPPECPESLHD 412 (452)
T ss_dssp ----CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----HHHHHTT-CCCCCCTTSCHHHHH
T ss_pred cCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHcC-CCCCCCCCCCHHHHH
Confidence 233456789999999877664 45999999999999999 9999987654332 2222222 223334478999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhc
Q 024336 237 LLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~ 258 (269)
+|.+||+.||++|||++++++.
T Consensus 413 li~~cl~~dP~~Rpt~~~l~~~ 434 (452)
T 1fmk_A 413 LMCQCWRKEPEERPTFEYLQAF 434 (452)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=307.26 Aligned_cols=250 Identities=23% Similarity=0.275 Sum_probs=202.1
Q ss_pred cccccccceecccCceEEEEEEEec---CCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKR---TKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
.++|++.+.||+|+||.||++.+.. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4789999999999999999999764 34569999987642 2345688899999999999999999998754 5689
Q ss_pred EEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 77 VMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
|+|++++++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIEDED 167 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC----
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCccccccc
Confidence 999999999999997654 5999999999999999999999999999999999999998876 9999999987433222
Q ss_pred --CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCH
Q 024336 156 --QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232 (269)
Q Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
......+++.|+|||.+.+..++ .++|+||||+++|+|+| |..||............ ... ...+....+++
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~----~~~-~~~~~~~~~~~ 241 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL----EKG-DRLPKPDLCPP 241 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH----HHT-CCCCCCTTCCH
T ss_pred ccccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH----hcC-CCCCCCCCCCH
Confidence 12234467789999999776664 45999999999999998 99999866554333222 111 12233347899
Q ss_pred HHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 233 DCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
.+.++|.+||..||.+|||+.++++++-
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~ell~~L~ 269 (281)
T 3cc6_A 242 VLYTLMTRCWDYDPSDRPRFTELVCSLS 269 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence 9999999999999999999999998763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=309.52 Aligned_cols=245 Identities=29% Similarity=0.452 Sum_probs=195.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
++|++.+.||+|+||.||++.+. ++.||+|.+... ...+.+.+|+..+++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 68999999999999999999885 788999998643 345678899999999999999999998774 4789999999
Q ss_pred CCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 83 GGELFARICSAG---RFSEDEARFFFQQLISGVSYCHS---MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 83 ~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~---~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
+++|.+++.... .++...++.++.|++.||.+||+ .|++|+||||+||+++.++. .++|+|||++.... ..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~--~~ 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQ--TH 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC---------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEcccccccccc--cc
Confidence 999999997655 37899999999999999999999 89999999999999987664 36999999986432 22
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....+++.|+|||.+.+..++.+ +||||||+++|+|+||..||........ ......... ...+....+++.+.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~l~~ 235 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNG-TRPPLIKNLPKPIES 235 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHHTT-CCCCCBTTCCHHHHH
T ss_pred cccCCCCCceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHhcC-CCCCcccccCHHHHH
Confidence 334568999999999987766544 9999999999999999999986544221 111111211 122223478999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhcc
Q 024336 237 LLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+|.+||+.||.+|||+.++++++
T Consensus 236 li~~~l~~dp~~Rps~~ell~~L 258 (307)
T 2eva_A 236 LMTRCWSKDPSQRPSMEEIVKIM 258 (307)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhcCChhhCcCHHHHHHHH
Confidence 99999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=307.29 Aligned_cols=249 Identities=26% Similarity=0.352 Sum_probs=199.7
Q ss_pred cccccceecccCceEEEEEEEecCCe---EEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE-EEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKE---LVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL-AIV 77 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~---~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~~v 77 (269)
.|++.+.||+|+||+||++.+..++. .+|+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+.. +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46677999999999999999765544 799998865332 235678999999999999999999999876655 999
Q ss_pred EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC---
Q 024336 78 MEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL--- 153 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~--- 153 (269)
+|++.+++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREY 179 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTTTGGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCcccccCCcc
Confidence 999999999999976 456899999999999999999999999999999999999998887 99999999863222
Q ss_pred --CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 154 --HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 154 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
........+++.|+|||.+.+..++ .++||||||+++|+|++|..|+............... . ...+....++
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~ 254 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ---G-RRLPQPEYCP 254 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT---T-CCCCCCTTCC
T ss_pred cccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc---C-CCCCCCccch
Confidence 1222344567889999999877664 4599999999999999965555444443333332222 1 1223334789
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+.+.++|.+||+.||.+|||+.++++.+
T Consensus 255 ~~l~~li~~~l~~~p~~Rps~~~ll~~l 282 (298)
T 3pls_A 255 DSLYQVMQQCWEADPAVRPTFRVLVGEV 282 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9999999999999999999999998864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=311.66 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=203.3
Q ss_pred cccccccceecccCceEEEEEE----EecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCC--eE
Q 024336 2 EERYEPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPT--HL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 74 (269)
.++|++++.||+|+||.||++. +..+++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+ .+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 4679999999999999999998 45689999999987543 23456889999999999999999999987654 68
Q ss_pred EEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 75 AIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
++|+|++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCS
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcchhhccc
Confidence 9999999999999999775 45899999999999999999999999999999999999998876 99999999874332
Q ss_pred CCC----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCC------------hhhHHHHHHHH
Q 024336 154 HSQ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED------------PRNFRKTIDRI 217 (269)
Q Consensus 154 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~------------~~~~~~~~~~~ 217 (269)
... .....++..|+|||.+.+..++ .++||||||+++|+|+||..||..... ..........+
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 221 2233466779999999877664 459999999999999999998864211 01111122222
Q ss_pred hhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.. ....+....+++++.++|.+||+.||.+|||+.++++.+
T Consensus 277 ~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L 317 (326)
T 2w1i_A 277 KN-NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317 (326)
T ss_dssp HT-TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hc-CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 22 222333447899999999999999999999999999764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=309.81 Aligned_cols=250 Identities=28% Similarity=0.412 Sum_probs=197.1
Q ss_pred cccccccceecccCceEEEEEEEec-CC--eEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKR-TK--ELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~-~~--~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
.++|++.+.||+|+||+||++.+.. ++ ..||+|++.... ...+.+.+|+..+++++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4789999999999999999998753 33 368999886532 23456789999999999999999999988765 8
Q ss_pred EEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 75 AIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
++|+|++++++|.+.+... +.+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQ 173 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEEccccccccccc
Confidence 8999999999999998764 56899999999999999999999999999999999999988876 99999999864322
Q ss_pred CCC----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcC
Q 024336 154 HSQ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228 (269)
Q Consensus 154 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (269)
... .....+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||...... .....+.......+...
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~ 248 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKIDKEGERLPRPE 248 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHTSCCCCCCCT
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHH----HHHHHHHccCCCCCCCc
Confidence 221 2233467789999999876664 45999999999999999 99999876543 33334444444444455
Q ss_pred CCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 229 RVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+++.+.++|.+||..||.+|||+.++++++
T Consensus 249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 279 (291)
T 1u46_A 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279 (291)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 7899999999999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=314.30 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=186.7
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCC-CCCcceeeEEEE--------eC
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLR-HPNIIRFKEVLL--------TP 71 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--------~~ 71 (269)
..+|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+..++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 358999999999999999999999999999999886543 23456788999999995 999999999984 34
Q ss_pred CeEEEEEeecCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecCCCCCcEEEeecC
Q 024336 72 THLAIVMEYAAGGELFARICS---AGRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICDFG 146 (269)
Q Consensus 72 ~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~p~ni~i~~~~~~~~~l~df~ 146 (269)
..+++++||++ ++|.+++.. .+++++..++.++.|++.||.+||+.| ++|+||||+||+++.++. ++|+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFG 183 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCCT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEecCc
Confidence 46899999996 588888754 456999999999999999999999999 999999999999998887 9999999
Q ss_pred CcccCCCCCC-------------CCcccCCCcccCchhhc--cccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHH
Q 024336 147 YSKSGLLHSQ-------------PKSTVGTPAYIAPEVLA--RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFR 211 (269)
Q Consensus 147 ~~~~~~~~~~-------------~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~ 211 (269)
++........ .....+++.|+|||.+. .....+.++||||||+++|+|+||..||.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--- 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--- 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence 9874332211 11345788999999984 22333556999999999999999999997643321
Q ss_pred HHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 212 KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+.......+.....+..+.++|.+||+.||.+|||+.|+++++....
T Consensus 261 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 261 -----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11222233344467889999999999999999999999999876443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=308.13 Aligned_cols=238 Identities=32% Similarity=0.491 Sum_probs=189.3
Q ss_pred ccccccc-ceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHH-HhCCCCCcceeeEEEEe----CCeEE
Q 024336 2 EERYEPV-KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH-RSLRHPNIIRFKEVLLT----PTHLA 75 (269)
Q Consensus 2 ~~~y~~~-~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~ 75 (269)
-++|.+. +.||+|+||.||++.+..+++.||+|++.. .....+|+..+ +.++||||+++++++.. ...++
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 3678887 789999999999999999999999999864 35677888887 66699999999999887 67899
Q ss_pred EEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CCcEEEeecCCcccCC
Q 024336 76 IVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGL 152 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~~ 152 (269)
+||||+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||||+||+++.++ .+.++|+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 9999999999999997754 699999999999999999999999999999999999998732 2349999999886321
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC--cCCC
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRV 230 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 230 (269)
+..+ +.++|+||||+++|+|+||..||...............+......++. +..+
T Consensus 172 ---------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (299)
T 3m2w_A 172 ---------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229 (299)
T ss_dssp ---------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTS
T ss_pred ---------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccC
Confidence 1122 445999999999999999999997654322111111111111222221 1468
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
++++.++|.+||+.||.+|||+.|+++|+|+..-.
T Consensus 230 ~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 99999999999999999999999999999998654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=306.70 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=199.9
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCc-----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
|...+.||+|+||.||++.+ ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 45569999999999999987 57889999986432 224568899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 80 YAAGGELFARICS---AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 80 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
++++++|.+++.. ..++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT--AKISDFGLARASEKFAQ 188 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSCSS
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc--EEEeecccccccccccc
Confidence 9999999999864 346899999999999999999999999999999999999998877 99999999864322221
Q ss_pred ---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcccc--------C-
Q 024336 157 ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--------L- 224 (269)
Q Consensus 157 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~--------~- 224 (269)
.....+++.|+|||.+.+. + +.++|+||||+++|+|++|..||...............+...... .
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN 266 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred cccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence 2334689999999998653 4 445999999999999999999998765543333333322221110 0
Q ss_pred CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 225 PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
......++.+.++|.+||+.||.+|||+.++++++
T Consensus 267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L 301 (307)
T 2nru_A 267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301 (307)
T ss_dssp CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 01113456789999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=306.15 Aligned_cols=249 Identities=21% Similarity=0.251 Sum_probs=197.5
Q ss_pred ccccccceecccCceEEEEEEEecC---CeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEE-eCCeEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLL-TPTHLAI 76 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~ 76 (269)
.+|++.+.||+|+||.||++.+..+ +..+|+|.+..... ..+.+.+|+.++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4689999999999999999997533 34689998865332 2356789999999999999999999864 4567899
Q ss_pred EEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 77 VMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKE 182 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSCGGGCCCSCGG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC--EEECcccccccccccc
Confidence 9999999999999975 345899999999999999999999999999999999999998887 9999999986432221
Q ss_pred -----CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCC
Q 024336 156 -----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229 (269)
Q Consensus 156 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (269)
......+++.|+|||.+.+..++ .++|+||||+++|+|++ |.+||............ .... .......
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~ 256 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGR-RLLQPEY 256 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH----HTTC-CCCCCTT
T ss_pred hhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH----hcCC-CCCCCcc
Confidence 12234467789999999877664 45999999999999999 66677665543332222 2211 1222236
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 230 VSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+++.+.++|.+||+.||.+|||+.++++.+
T Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L 286 (298)
T 3f66_A 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 899999999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=319.54 Aligned_cols=252 Identities=21% Similarity=0.225 Sum_probs=202.6
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCC-CCcceeeEEEEeCCeEEEEEe
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH-PNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (269)
+.++|++.+.||+|+||.||++.+..+++.||||++.... ....+..|+.+++.+.| +++..+..++...+..++|||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 3689999999999999999999999999999999876543 33457889999999987 566667777778889999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEe---cCCCCCcEEEeecCCcccCCCCC
Q 024336 80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 80 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i---~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
|+ +++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+||++ +.++. ++|+|||++.......
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~--vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKKYRDTS 160 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe--EEEEeCCcceeccCCc
Confidence 99 8899999975 5679999999999999999999999999999999999999 45555 9999999987433222
Q ss_pred C--------CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC---
Q 024336 156 Q--------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--- 224 (269)
Q Consensus 156 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 224 (269)
. .....+++.|+|||.+.+..++ .++||||||+++|+|++|..||............ ..+.......
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVATSIE 238 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHH-HHHHHHHHHSCHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHH-HHHhhccccccHH
Confidence 1 2255689999999999877764 4599999999999999999999876553222211 1111111100
Q ss_pred CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 225 PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
.....+++++.++|.+||+.||.+||++.++++.
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~ 272 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRL 272 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0113688999999999999999999999998874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=328.93 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=205.9
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|+||.||++.+.. +..||+|++.......+.+.+|+.++++++|+||+++++++.+ +.+++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 3678999999999999999999875 4669999998766666789999999999999999999999876 6789999999
Q ss_pred CCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--CC
Q 024336 82 AGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QP 157 (269)
Q Consensus 82 ~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~ 157 (269)
++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++. ++|+|||++....... ..
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCHHHHTT
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCCceecc
Confidence 99999999964 356899999999999999999999999999999999999988877 9999999987432211 12
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
....++..|+|||.+....++ .++||||||+++|+|+| |..||......+. ...+... ...+....+++.+.+
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~----~~~i~~~-~~~~~~~~~~~~l~~ 495 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREV----LDQVERG-YRMPCPPECPESLHD 495 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH----HHHHHTT-CCCCCCTTCCHHHHH
T ss_pred cCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHcC-CCCCCCCCCCHHHHH
Confidence 233456789999999877664 45999999999999999 9999987654332 2222222 223333478999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhcc
Q 024336 237 LLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
||.+||+.||++|||++++++.+
T Consensus 496 li~~cl~~dP~~RPt~~~l~~~L 518 (535)
T 2h8h_A 496 LMCQCWRKEPEERPTFEYLQAFL 518 (535)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHH
Confidence 99999999999999999998753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=321.16 Aligned_cols=255 Identities=26% Similarity=0.301 Sum_probs=194.5
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEeec
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.+|.+.+.||+|+||+|+. ....+|+.||||.+..... ..+.+|+.+++.+ +||||+++++++.+....++|||++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 4689999999999999763 4455789999999865432 3456899999999 7999999999999999999999999
Q ss_pred CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC---CCCCcEEEeecCCcccCCCC---
Q 024336 82 AGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG---SPQPRLKICDFGYSKSGLLH--- 154 (269)
Q Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~---~~~~~~~l~df~~~~~~~~~--- 154 (269)
++ +|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++. ++..+++|+|||++......
T Consensus 101 ~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 101 AA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp SE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred CC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 75 9999987654 3566677899999999999999999999999999999953 33445889999998753322
Q ss_pred -CCCCcccCCCcccCchhhccc--cCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhcccc-CCCcCC
Q 024336 155 -SQPKSTVGTPAYIAPEVLARK--EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYF-LPDYVR 229 (269)
Q Consensus 155 -~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 229 (269)
.......+|+.|+|||.+.+. ...+.++|||||||++|+|+| |..||........ .......... ......
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~ 255 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA----NILLGACSLDCLHPEKH 255 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH----HHHTTCCCCTTSCTTCH
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH----HHHhccCCccccCcccc
Confidence 122345689999999998742 223445999999999999999 9999965443211 1111111111 111123
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 230 VSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.+..+.+||.+||+.||.+|||+.++++|+|+..+.
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 355688999999999999999999999999997654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=323.37 Aligned_cols=253 Identities=28% Similarity=0.297 Sum_probs=193.0
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEEe
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
+.+.|.+.+.||+|+||+||.+ ...+|+.||+|.+.... .+.+.+|+.+++++ +||||+++++++.+++.+++|||
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 3567788899999999999875 44578999999987542 35678899999876 89999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-----------CCcEE
Q 024336 80 YAAGGELFARICSAGRF-------SEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-----------QPRLK 141 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-----------~~~~~ 141 (269)
+++ ++|.+++...... ++..++.++.|++.||+|||+.|++||||||+||+++.++ ...++
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 996 5999999765432 2234577999999999999999999999999999997542 33599
Q ss_pred EeecCCcccCCCCCC-----CCcccCCCcccCchhhcc------ccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhh
Q 024336 142 ICDFGYSKSGLLHSQ-----PKSTVGTPAYIAPEVLAR------KEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRN 209 (269)
Q Consensus 142 l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~ 209 (269)
|+|||++........ .....+++.|+|||.+.+ ....+.++||||||+++|+|+| |..||.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 999999875333221 223468999999999875 2334566999999999999999 999997654422
Q ss_pred HHHHHHHHhhccccCCC-----cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 210 FRKTIDRIRNVQYFLPD-----YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 210 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
. .+.......+. ...+++++.++|.+||+.||.+|||+.++++|+|+..
T Consensus 248 -~----~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 248 -S----NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp -H----HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred -H----HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 1 12222222221 1134578999999999999999999999999999964
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=310.13 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=200.5
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHh--CCCCCcceeeEEEEeCC----eEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS--LRHPNIIRFKEVLLTPT----HLA 75 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~ 75 (269)
.++|++.+.||+|+||.||++.+ +|+.||+|++... ....+.+|..+++. ++||||+++++++.... ..+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 46899999999999999999998 4899999998653 34567788888877 78999999999998876 799
Q ss_pred EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeecCCCCcEEecCCCCCcEEEeecCC
Q 024336 76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH--------SMEICHRDLKLENTLLDGSPQPRLKICDFGY 147 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--------~~~i~H~di~p~ni~i~~~~~~~~~l~df~~ 147 (269)
+|+||+++++|.+++.+ ..+++..++.++.|++.||.+|| +.|++|+||||+||+++.++. ++|+|||+
T Consensus 117 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~ 193 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL 193 (342)
T ss_dssp EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTT
T ss_pred EEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCC
Confidence 99999999999999965 46899999999999999999999 899999999999999998887 99999999
Q ss_pred cccCCCCC-----CCCcccCCCcccCchhhccccCC-----CccchhhhHHHHHHHHHhC----------CCCCCCCCCh
Q 024336 148 SKSGLLHS-----QPKSTVGTPAYIAPEVLARKEYD-----GKISDVWSCGVTLYVMLVG----------AYPFEDPEDP 207 (269)
Q Consensus 148 ~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~-----~~~~Di~slG~~l~~l~tg----------~~pf~~~~~~ 207 (269)
+....... ......+++.|+|||.+.+.... +.++||||||+++|+|+|| ..||......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 86433222 23445689999999998765322 2459999999999999999 7888764332
Q ss_pred h-hHHHHHHHHhhccc--cCCC---cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 208 R-NFRKTIDRIRNVQY--FLPD---YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 208 ~-~~~~~~~~~~~~~~--~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
. ........+..... ..+. ....++.+.++|.+||+.||++|||+.++++++-
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 2 22222222222211 1111 0123457999999999999999999999999854
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=312.31 Aligned_cols=249 Identities=18% Similarity=0.168 Sum_probs=199.9
Q ss_pred cccccccceecccCceEEEEE-----EEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC---CCCcceeeEEEEeCCe
Q 024336 2 EERYEPVKELGSGNFGVARLV-----RDKRTKELVAVKYIERGKKIDENVQREIINHRSLR---HPNIIRFKEVLLTPTH 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~ 73 (269)
.++|++.+.||+|+||+||++ .+..+++.||+|++... ....+..|+..++.+. |+|++++++++..++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 367999999999999999999 46678999999998654 3456788888888886 8999999999999999
Q ss_pred EEEEEeecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-----------CCC
Q 024336 74 LAIVMEYAAGGELFARICS-----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-----------SPQ 137 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~-----------~~~ 137 (269)
.++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.||+||||||+||+++. ++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCC
Confidence 9999999999999999974 456999999999999999999999999999999999999987 555
Q ss_pred CcEEEeecCCcccCC---CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHH
Q 024336 138 PRLKICDFGYSKSGL---LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214 (269)
Q Consensus 138 ~~~~l~df~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~ 214 (269)
++|+|||++.... .........+|+.|+|||.+.+..++. ++||||||+++|+|+||..||........
T Consensus 222 --~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~----- 293 (365)
T 3e7e_A 222 --LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNY-QIDYFGVAATVYCMLFGTYMKVKNEGGEC----- 293 (365)
T ss_dssp --EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBST-HHHHHHHHHHHHHHHHSSCCCEEEETTEE-----
T ss_pred --EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCc-cccHHHHHHHHHHHHhCCCccccCCCCce-----
Confidence 9999999995322 222334556899999999998877655 49999999999999999999965332110
Q ss_pred HHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 215 DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.....+.. ...++.+.+++..||..+|.+|++..+.+.+.+...+.
T Consensus 294 ----~~~~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 294 ----KPEGLFRR-LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ----EECSCCTT-CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ----eechhccc-cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 00111111 13467789999999999999998887777766555443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=315.01 Aligned_cols=249 Identities=21% Similarity=0.251 Sum_probs=193.1
Q ss_pred cccccceecccCceEEEEEEEecC---CeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEe-CCeEEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLT-PTHLAIV 77 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v 77 (269)
+|++.+.||+|+||.||++.+..+ +..||+|.+.... ...+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 477889999999999999998643 2468999886432 233568899999999999999999998654 5578999
Q ss_pred EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-
Q 024336 78 MEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS- 155 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~- 155 (269)
|||+++++|.+++.+.. .+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEF 247 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeecccccccccccc
Confidence 99999999999997643 5899999999999999999999999999999999999998887 9999999987432221
Q ss_pred ----CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 156 ----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 156 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
......+++.|+|||.+.+..++ .++||||||+++|+|+| |.+||........... +.... ....+..+
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~----~~~~~-~~~~p~~~ 321 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY----LLQGR-RLLQPEYC 321 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH----HHTTC-CCCCCTTC
T ss_pred ccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH----HHcCC-CCCCCCCC
Confidence 11233466789999999877664 45999999999999999 7788876655433222 22222 12223378
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
++.+.++|.+||+.||.+|||+.++++++-
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 351 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 999999999999999999999999998753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=338.29 Aligned_cols=262 Identities=27% Similarity=0.344 Sum_probs=206.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEe------CCeE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLT------PTHL 74 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~ 74 (269)
++|++.+.||+|+||.||++.+..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 68999999999999999999999999999999886532 224567889999999999999999998765 6678
Q ss_pred EEEEeecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC-CcEEEeecCCccc
Q 024336 75 AIVMEYAAGGELFARICSAG---RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKS 150 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~-~~~~l~df~~~~~ 150 (269)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ..++|+|||++..
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 99999999999999997654 5899999999999999999999999999999999999987654 3489999999986
Q ss_pred CCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHH-----HHHHH-----hhc
Q 024336 151 GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK-----TIDRI-----RNV 220 (269)
Q Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~-----~~~~~-----~~~ 220 (269)
...........+++.|+|||.+.+..++.+ +||||||+++|+|++|..||........... ..... ...
T Consensus 174 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g 252 (676)
T 3qa8_A 174 LDQGELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252 (676)
T ss_dssp TTSCCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSS
T ss_pred cccccccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcc
Confidence 555555556678999999999987777555 9999999999999999999976432111000 00000 000
Q ss_pred cccC----CC----cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 221 QYFL----PD----YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 221 ~~~~----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
...+ +. ...+++.+.++|.+||..||++|||+.++++|+||..+.
T Consensus 253 ~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 1111 11 123567899999999999999999999999999998865
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=308.18 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=200.1
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.++|++.+.||+|+||.||++.+.. .+|+|.+.... ...+.+.+|+.++++++||||+++++++.+....++|+
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 3689999999999999999999853 38999886432 23345778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC----
Q 024336 79 EYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---- 153 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~---- 153 (269)
||+++++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||||+||+++ ++. ++|+|||++.....
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~--~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGK--VVITDFGLFSISGVLQAG 185 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---C--CEECCCSCCC--------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCC--EEEeecCCcccccccccc
Confidence 9999999999997655 689999999999999999999999999999999999998 455 99999998753211
Q ss_pred --CCCCCcccCCCcccCchhhccc--------cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcccc
Q 024336 154 --HSQPKSTVGTPAYIAPEVLARK--------EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF 223 (269)
Q Consensus 154 --~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (269)
........+++.|+|||.+... ...+.++||||||+++|+|++|..||........ ...+......
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~ 261 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI----IWQMGTGMKP 261 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH----HHHHHTTCCC
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHhccCCCC
Confidence 1122334578899999998752 2335669999999999999999999987554322 2233333222
Q ss_pred CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 224 LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
......++.++.++|.+||..||.+|||+.++++.+-
T Consensus 262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 298 (319)
T 2y4i_B 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298 (319)
T ss_dssp CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 2223368899999999999999999999999998654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=329.66 Aligned_cols=242 Identities=24% Similarity=0.326 Sum_probs=196.7
Q ss_pred ceecccCceEEEEEEE--ecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRD--KRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~--~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||.||++.+ ..+++.||+|++..... ..+.+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999965 45678899999875432 24678999999999999999999999865 458899999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC----CCCc
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QPKS 159 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~----~~~~ 159 (269)
++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++....... ....
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC----------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCccccccccC
Confidence 999999998888999999999999999999999999999999999999998876 9999999986432222 1222
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
..+++.|+|||.+.+..++. ++||||||+++|+|++ |..||....... ....+.... ..+....+++++.++|
T Consensus 532 ~~~t~~y~APE~~~~~~~~~-~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~~~~i~~~~-~~~~p~~~~~~l~~li 605 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFSS-KSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEKGE-RMGCPAGCPREMYDLM 605 (635)
T ss_dssp ---CGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHHHTTC-CCCCCTTCCHHHHHHH
T ss_pred CCCceeeeChhhhcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHcCC-CCCCCCCCCHHHHHHH
Confidence 34567899999998777654 5999999999999998 999998765533 222222222 2222337899999999
Q ss_pred HHHhhhCCCCCCCcHHHhhcc
Q 024336 239 SQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+||+.||++||++.++++.+
T Consensus 606 ~~cl~~dP~~RPs~~~l~~~L 626 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAVELRL 626 (635)
T ss_dssp HHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHH
Confidence 999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=326.55 Aligned_cols=246 Identities=26% Similarity=0.360 Sum_probs=197.5
Q ss_pred ccccc-eecccCceEEEEEEEe--cCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 5 YEPVK-ELGSGNFGVARLVRDK--RTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 5 y~~~~-~l~~g~~g~v~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
+.+.+ .||+|+||.||++.+. .++..||+|++.... ...+.+.+|+.++++++||||+++++++.. +.+++|||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 34444 7999999999999876 356679999987542 345678999999999999999999999876 56899999
Q ss_pred ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC--
Q 024336 80 YAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-- 156 (269)
Q Consensus 80 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~-- 156 (269)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++. +||+|||++........
T Consensus 416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALGADDSYY 493 (613)
T ss_dssp CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC------
T ss_pred eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCcccccCCCcee
Confidence 99999999998654 45999999999999999999999999999999999999998876 99999999974322221
Q ss_pred --CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 157 --PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 157 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
.....+++.|+|||.+.+..++. ++||||||+++|+|+| |..||......+.. ..+..+. ..+.+..++++
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~-~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~----~~i~~~~-~~~~p~~~~~~ 567 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSS-RSDVWSYGVTMWEALSYGQKPYKKMKGPEVM----AFIEQGK-RMECPPECPPE 567 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH----HHHHTTC-CCCCCTTCCHH
T ss_pred eeccCCCCccceeCHhhhcCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH----HHHHcCC-CCCCCCcCCHH
Confidence 11223457899999998777654 5999999999999998 99999887664332 2333222 22233378999
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+.++|.+||..||.+||++.++++.+
T Consensus 568 l~~li~~cl~~dP~~RPs~~~l~~~L 593 (613)
T 2ozo_A 568 LYALMSDCWIYKWEDRPDFLTVEQRM 593 (613)
T ss_dssp HHHHHHHTTCSSTTTSCCHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 99999999999999999999987644
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=309.38 Aligned_cols=252 Identities=21% Similarity=0.256 Sum_probs=187.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEe-----CCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT-----PTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~v 77 (269)
++|++.+.||+|+||.||++.+ +++.||+|++............++..++.++||||+++++.+.. ...+++|
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 6899999999999999999976 68999999997654333333344445556899999999986542 3367999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeecCCCCcEEecCCCCCcEEEeecCCc
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM---------EICHRDLKLENTLLDGSPQPRLKICDFGYS 148 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---------~i~H~di~p~ni~i~~~~~~~~~l~df~~~ 148 (269)
|||+++++|.+++.... .++..++.++.|++.||.|||+. |++||||||+||+++.++. ++|+|||++
T Consensus 91 ~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kL~DFG~a 167 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISDFGLS 167 (336)
T ss_dssp ECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC--EEECCCTTC
T ss_pred EecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc--EEEeeccce
Confidence 99999999999996554 58999999999999999999999 9999999999999998887 999999998
Q ss_pred ccCCCC---------CCCCcccCCCcccCchhhccc------cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhh----
Q 024336 149 KSGLLH---------SQPKSTVGTPAYIAPEVLARK------EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN---- 209 (269)
Q Consensus 149 ~~~~~~---------~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~---- 209 (269)
...... .......+++.|+|||.+.+. ...+.++||||||+++|+|++|..||........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 643221 112244689999999998762 2224459999999999999999766543222100
Q ss_pred ----------HHHHHHHHhhc--cccCCC----cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 210 ----------FRKTIDRIRNV--QYFLPD----YVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 210 ----------~~~~~~~~~~~--~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
........... ...++. ...+++.+.++|.+||+.||++|||+.|+++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 11111111111 111111 112445799999999999999999999997753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=323.39 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=200.7
Q ss_pred cccccccceecccCceEEEEEEEecC---CeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
.++|++.+.||+|+||.||++.+..+ +..||+|.+..... ..+.+.+|+.++++++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 36799999999999999999998643 56799998765322 2356889999999999999999999985 456899
Q ss_pred EEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 77 VMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
||||+++++|.+++...+ .+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDST 545 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCCC--
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecCCCc
Confidence 999999999999997654 6899999999999999999999999999999999999998877 9999999987533222
Q ss_pred C--CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCH
Q 024336 156 Q--PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232 (269)
Q Consensus 156 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
. .....+++.|+|||.+.+..++ .++||||||+++|+|++ |..||......... ..+.... ..+.+..+++
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~----~~i~~~~-~~~~~~~~~~ 619 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----GRIENGE-RLPMPPNCPP 619 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHHTC-CCCCCTTCCH
T ss_pred ceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHHcCC-CCCCCccccH
Confidence 1 1233456789999999877664 45999999999999997 99999876543322 2222222 1222337899
Q ss_pred HHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 233 DCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
.+.++|.+||..||.+|||+.++++.+-
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el~~~L~ 647 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTELKAQLS 647 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9999999999999999999999998653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=295.63 Aligned_cols=227 Identities=13% Similarity=0.093 Sum_probs=184.8
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCcccc----HHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
+.++|++.+.||+|+||.||++.+..+++.||+|++....... +.+.+|+..++.++||||+++++++.+++..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 4578999999999999999999999999999999998654433 568899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
||||++|++|.+++.+. ....++..++.|++.||.|||+.|++||||||+||+++.++. ++|++++
T Consensus 109 v~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~---------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA---------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCC----------
T ss_pred EEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEecc----------
Confidence 99999999999998543 366788999999999999999999999999999999998887 8888543
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC--CCcCCCCHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADC 234 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 234 (269)
|++| .+.++||||||+++|+|+||..||................ ...... .....+++++
T Consensus 175 ---------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 ---------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp ---------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT-TSCBCCHHHHCTTSCHHH
T ss_pred ---------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh-ccCCCChhhcccCCCHHH
Confidence 2222 3556999999999999999999998755422110000000 000000 0113688999
Q ss_pred HHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 235 RHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 235 ~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
.++|.+||+.||.+| |+.|+++.+.
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~L~ 261 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNLMQ 261 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHHHH
T ss_pred HHHHHHHcccCCccC-CHHHHHHHHH
Confidence 999999999999999 9999998653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=309.45 Aligned_cols=246 Identities=15% Similarity=0.107 Sum_probs=190.0
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCC-CCc---------ceeeEE--
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRH-PNI---------IRFKEV-- 67 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h-~~i---------~~~~~~-- 67 (269)
+|+..+.||+|+||+||++.+..+|+.||||++... ....+.+.+|+..++.+.| ++. +...+.
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 477889999999999999999999999999998732 2235678899999999977 321 111111
Q ss_pred ----------EEe-----CCeEEEEEeecCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecC
Q 024336 68 ----------LLT-----PTHLAIVMEYAAGGELFARICS-------AGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125 (269)
Q Consensus 68 ----------~~~-----~~~~~~v~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di 125 (269)
+.. ...++++++.+ +++|.+++.. ...+++..+..++.|++.||.|||+.||+||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 111 12367777776 5689888841 234778899999999999999999999999999
Q ss_pred CCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccCCCcccCchhhc----------cccCCCccchhhhHHHHHHHHH
Q 024336 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA----------RKEYDGKISDVWSCGVTLYVML 195 (269)
Q Consensus 126 ~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~----------~~~~~~~~~Di~slG~~l~~l~ 195 (269)
||+||+++.++. +||+|||++...... .....+ +.|+|||.+. +..+ +.++||||||+++|+|+
T Consensus 238 Kp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 238 RPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHHH
Confidence 999999998888 999999998743222 334456 9999999983 3333 45599999999999999
Q ss_pred hCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhhh
Q 024336 196 VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFAE 266 (269)
Q Consensus 196 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~~ 266 (269)
||..||........ ....+.....+|+++.+||.+||+.||.+||++.++++|+|++.+.+
T Consensus 312 tg~~Pf~~~~~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~ 372 (413)
T 3dzo_A 312 CADLPNTDDAALGG----------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372 (413)
T ss_dssp HSSCCCCTTGGGSC----------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HCCCCCCCcchhhh----------HHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence 99999976543211 11123333478999999999999999999999999999999988754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=328.83 Aligned_cols=241 Identities=21% Similarity=0.249 Sum_probs=196.5
Q ss_pred cccccccceecccCceEEEEEEEec-CCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCe-----
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKR-TKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTH----- 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 73 (269)
.++|++.+.||+|+||.||++.+.. +|+.||+|.+.... .....+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4789999999999999999999976 78999999886532 223457889999999999999999999987655
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
.|+||||++|++|.+.+.. ++++..++.++.||+.||.|||+.||+||||||+||+++.+ . ++|+|||++.....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~--~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-Q--LKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-C--EEECCCTTCEETTC
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-c--EEEEecccchhccc
Confidence 7999999999999987754 68999999999999999999999999999999999999865 4 99999999874322
Q ss_pred CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHH
Q 024336 154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233 (269)
Q Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
.....+|+.|+|||++.+.. +.++||||||+++|+|++|.+||........ .........++.
T Consensus 234 ---~~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------~~~~~~~~~~~~ 296 (681)
T 2pzi_A 234 ---FGYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------PEDDPVLKTYDS 296 (681)
T ss_dssp ---CSCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------CTTCHHHHHCHH
T ss_pred ---CCccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccc------------cccccccccCHH
Confidence 24556899999999987654 5669999999999999999988864221100 000001124678
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+.++|.+||+.||.+||++.+.+.+.|...+
T Consensus 297 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 9999999999999999999999998887654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=305.27 Aligned_cols=243 Identities=17% Similarity=0.192 Sum_probs=187.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---------ccHHHHHHHHHHHhCC---------CCCccee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---------IDENVQREIINHRSLR---------HPNIIRF 64 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~---------h~~i~~~ 64 (269)
++|++.+.||+|+||+||++++ +|+.||+|++..... ..+.+.+|+.+++.++ |||++++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 6899999999999999999998 689999999976432 1267889999988885 6666666
Q ss_pred eEEE-----------------Ee-------------CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 024336 65 KEVL-----------------LT-------------PTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114 (269)
Q Consensus 65 ~~~~-----------------~~-------------~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 114 (269)
.+.+ .+ .+.+++||||+++|++.+.+.+ +.+++..++.++.||+.||.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence 6553 32 6789999999999987777744 568999999999999999999
Q ss_pred HH-hCCceeecCCCCcEEecCCCC------------------CcEEEeecCCcccCCCCCCCCcccCCCcccCchhhccc
Q 024336 115 CH-SMEICHRDLKLENTLLDGSPQ------------------PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175 (269)
Q Consensus 115 lh-~~~i~H~di~p~ni~i~~~~~------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 175 (269)
|| +.||+||||||+||+++.++. ..+||+|||++..... ....+|+.|+|||.+.+.
T Consensus 177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGCCC
T ss_pred HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhcCC
Confidence 99 999999999999999997761 1499999999974322 245789999999999866
Q ss_pred cCCCccchhhhHHHH-HHHHHhCCCCCCCCCChhhHHHHHHHHhh-ccccCC----CcCCCCHHHHHHHHHHhhhCCCCC
Q 024336 176 EYDGKISDVWSCGVT-LYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQYFLP----DYVRVSADCRHLLSQIFVADPSKD 249 (269)
Q Consensus 176 ~~~~~~~Di~slG~~-l~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~li~~~l~~~p~~R 249 (269)
. +.++||||||++ .+++++|..||.... ........+.. ...... .+..+++++.+||.+||+.|
T Consensus 253 ~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 253 G--DYQFDIYRLMKKENNNRWGEYHPYSNVL---WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp S--SHHHHHHHHHHHHHTTCTTSCCTHHHHH---HHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred C--ccceehhhhhCCCCcccccccCCCcchh---hhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 5 556999998777 667888988884310 00111122211 111111 12246788999999999976
Q ss_pred CCcHHHh-hccChh
Q 024336 250 PHSRDQK-ASLVPE 262 (269)
Q Consensus 250 ps~~~~l-~~~~~~ 262 (269)
|++|+| +|||++
T Consensus 324 -sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 -SATDLLCQHSLFK 336 (336)
T ss_dssp -SHHHHHHHCGGGC
T ss_pred -CHHHHHhcCCCcC
Confidence 999999 999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=257.76 Aligned_cols=180 Identities=14% Similarity=0.054 Sum_probs=131.0
Q ss_pred ecccCceEEEEEEEecCCeEEEEEEeecCc-----------cccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEEE
Q 024336 11 LGSGNFGVARLVRDKRTKELVAVKYIERGK-----------KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 11 l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.+.|+.|.+..++..-.|+.+++|++.... ...+.+.+|+++|+++ .|+||+++++++++++.+|+||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 456777777777777789999999987542 1224588999999999 6999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~ 157 (269)
||++|++|.+.+.+.+++++. .++.||+.||+|+|++||+||||||+|||++.++. +||+|||+++..... ...
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CCS
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCccc
Confidence 999999999999998888875 47889999999999999999999999999998887 999999998753322 223
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhC
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVG 197 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg 197 (269)
....+|+.|+|||++.+.. ..++|+||+|++++.+.++
T Consensus 397 ~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp HHHHHHHHHHHHHHC-------------------CCCCTT
T ss_pred cCceechhhccHHHhCCCC--CCcccccccccchhhhccc
Confidence 4457899999999997643 3348999999988766554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=219.65 Aligned_cols=181 Identities=19% Similarity=0.130 Sum_probs=137.5
Q ss_pred cccceecccCceEEEEEEEecCCeEEEEEEeecCccc---------cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---------DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 6 ~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
...+.||+|+||.||++.. .+..+++|........ .+.+.+|+.++++++||||+++..++...+..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 3456899999999999944 4677898876432211 2346899999999999999976666667777899
Q ss_pred EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
||||+++++|.+++.. +..++.|++.+|.|||++||+||||||+||+++. . ++|+|||+++.......
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~--~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--D--LYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--S--EEECCCTTCEECCCHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--e--EEEEECccCEECCCccc
Confidence 9999999999999865 6789999999999999999999999999999997 4 99999999975432211
Q ss_pred --------CCcccCCCcccCchhhcc--ccCCCccchhhhHHHHHHHHHhCCCCC
Q 024336 157 --------PKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPF 201 (269)
Q Consensus 157 --------~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~tg~~pf 201 (269)
.....+|+.|+|||.+.. ..+... +|+||..+-..+-+.+..+|
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhcccc
Confidence 124468999999999976 444334 89999988887777666555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-27 Score=185.83 Aligned_cols=143 Identities=19% Similarity=0.160 Sum_probs=115.4
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-------------------ccHHHHHHHHHHHhCCCCCccee
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------------------IDENVQREIINHRSLRHPNIIRF 64 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~e~~~l~~l~h~~i~~~ 64 (269)
.|.+.+.||+|+||.||++.+ .+|+.||+|.+..... ....+.+|+.++++++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 345669999999999999999 7899999999864321 2345789999999998 5 666
Q ss_pred eEEEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEee
Q 024336 65 KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICD 144 (269)
Q Consensus 65 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~d 144 (269)
.+++.. +..++||||++|++|.+ +. ......++.|++.||.+||+.|++||||||+||+++ ++. ++|+|
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~--vkl~D 235 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG--IWIID 235 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE--EEECC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc--EEEEE
Confidence 665544 45699999999999988 42 133557999999999999999999999999999999 666 99999
Q ss_pred cCCcccCCCCCCCCcccCCCcccCchhhc
Q 024336 145 FGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173 (269)
Q Consensus 145 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 173 (269)
||++.. +..+.|||.+.
T Consensus 236 FG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE------------TTSTTHHHHHH
T ss_pred CCCCeE------------CCCCCHHHHHH
Confidence 998862 33568898874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.2e-23 Score=161.81 Aligned_cols=135 Identities=14% Similarity=0.091 Sum_probs=105.8
Q ss_pred ccccceecccCceEEEEEEEecCCeE--EEEEEeecCccc-------------------------cHHHHHHHHHHHhCC
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKEL--VAVKYIERGKKI-------------------------DENVQREIINHRSLR 57 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~--vaiK~~~~~~~~-------------------------~~~~~~e~~~l~~l~ 57 (269)
|++.+.||+|+||.||++.+..+|+. ||+|++...... ...+.+|+.+++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999999778999 999987543111 125778999999998
Q ss_pred CCCc--ceeeEEEEeCCeEEEEEeecCC-C----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeecCCCCc
Q 024336 58 HPNI--IRFKEVLLTPTHLAIVMEYAAG-G----ELFARICSAGRFSEDEARFFFQQLISGVSYCH-SMEICHRDLKLEN 129 (269)
Q Consensus 58 h~~i--~~~~~~~~~~~~~~~v~e~~~~-~----~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~di~p~n 129 (269)
|+++ ..+++. +..++||||+++ | +|.+.... .++..+..++.|++.+|.+|| +.|++||||||.|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 8764 333332 346899999942 3 56655432 235678899999999999999 9999999999999
Q ss_pred EEecCCCCCcEEEeecCCccc
Q 024336 130 TLLDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 130 i~i~~~~~~~~~l~df~~~~~ 150 (269)
|+++. . ++|+|||++..
T Consensus 202 ILl~~--~--~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--K--VYFIDMGQAVT 218 (258)
T ss_dssp EEESS--S--EEECCCTTCEE
T ss_pred EEEcC--c--EEEEECccccc
Confidence 99986 4 99999999863
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=9.4e-20 Score=149.40 Aligned_cols=136 Identities=15% Similarity=0.129 Sum_probs=98.7
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---------------cHH--------HHHHHHHHHhCCCCCc
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---------------DEN--------VQREIINHRSLRHPNI 61 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------------~~~--------~~~e~~~l~~l~h~~i 61 (269)
|++...||.|++|.||+|.+. +|+.||+|++...... ... ...|...+.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 889999999999999999985 6899999987532110 011 2346667777754443
Q ss_pred ceeeEEEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCC---
Q 024336 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP--- 138 (269)
Q Consensus 62 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~--- 138 (269)
....-+... ..++||||++|.+|..+. .......++.|++.+|.+||+.|++||||||.|||++.++.+
T Consensus 176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 176 PVPEPIAQS--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp SCCCEEEEE--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred CCCeeeecc--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence 222211122 237999999998876543 123456788999999999999999999999999999877632
Q ss_pred -----cEEEeecCCcc
Q 024336 139 -----RLKICDFGYSK 149 (269)
Q Consensus 139 -----~~~l~df~~~~ 149 (269)
.+.++||+-+.
T Consensus 248 ~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMV 263 (397)
T ss_dssp TSEEEEEEECCCTTCE
T ss_pred cccccceEEEEeCCcc
Confidence 37899999665
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=1.9e-14 Score=113.47 Aligned_cols=138 Identities=17% Similarity=0.105 Sum_probs=109.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
+.|++...++.|+.+.||++... +..+++|...... .....+.+|+..++.+. +..+.++++++...+..|+|||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 35888888898999999999864 5779999886522 22346889999999884 56788899999888899999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS------------------------------------------- 117 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~------------------------------------------- 117 (269)
++|.++.+.+. +......++.+++.++..||+
T Consensus 92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 99998876531 223345788899999999998
Q ss_pred ----------------CCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 118 ----------------MEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 118 ----------------~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
..++|+|++|.||++++++. +.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV--SGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEE--EEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcE--EEEEEchhcc
Confidence 44899999999999975432 5699998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.43 E-value=3.9e-13 Score=105.73 Aligned_cols=132 Identities=13% Similarity=0.119 Sum_probs=95.6
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCC--cceeeEEEEeCCeEEEEEeecC
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN--IIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
|.+....+.|..+.||++.. .+|..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++|||+++
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 44433334566699999965 45677999987643 2355788999988885434 4558888887788999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 024336 83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME------------------------------------------- 119 (269)
Q Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~------------------------------------------- 119 (269)
|.++. .. ..+ ...++.+++.+|..||+..
T Consensus 99 G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 99 GQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp SEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred CcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 98874 21 112 2356677777888888643
Q ss_pred ---------------ceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 120 ---------------ICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 120 ---------------i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
++|+|++|.||++++++. +.|+||+.+.
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~liD~~~a~ 213 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRF--SGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEE--EEECCCTTCE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcE--EEEEcchhcc
Confidence 999999999999976543 5699999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.37 E-value=2.7e-12 Score=105.81 Aligned_cols=139 Identities=15% Similarity=0.226 Sum_probs=104.7
Q ss_pred ccceecccCceEEEEEEEecCCeEEEEEEee--cCc--cccHHHHHHHHHHHhCCC--CCcceeeEEEEeC---CeEEEE
Q 024336 7 PVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGK--KIDENVQREIINHRSLRH--PNIIRFKEVLLTP---THLAIV 77 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~--~~~--~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~~v 77 (269)
..+.|+.|.++.||++... +..+++|+.. ... .....+.+|+.+++.+.. ..+.+++.++.+. +..++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4678899999999999875 3568888776 432 223567889999998864 4577888887766 457899
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS---------------------------------------- 117 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---------------------------------------- 117 (269)
||+++|.++.+.. ...++......++.+++.+|..||+
T Consensus 120 me~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 120 MEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp EECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 9999998775421 2236788889999999999999997
Q ss_pred ------------------CCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 118 ------------------MEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 118 ------------------~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
.+++|+|++|.||+++.++...+.|+||+.+.
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 35899999999999987654335899999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.18 E-value=2.6e-11 Score=97.62 Aligned_cols=183 Identities=15% Similarity=0.111 Sum_probs=117.9
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhC-CCCC--cceeeEEEEeCC---eEEEEEeec
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPN--IIRFKEVLLTPT---HLAIVMEYA 81 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~--i~~~~~~~~~~~---~~~~v~e~~ 81 (269)
.+.++.|..+.||++. ..+++|+.... .....+.+|...++.+ .+.. +.+++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568899999999874 34889975432 3346788899999887 3333 334444333332 347899999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 024336 82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------- 117 (269)
Q Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-------------------------------------------- 117 (269)
+|.++.+... ..++..+...++.+++..+..||+
T Consensus 99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9988865432 236788888888899888888886
Q ss_pred --------------CCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcccCCCcc---cCchhhc----ccc
Q 024336 118 --------------MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY---IAPEVLA----RKE 176 (269)
Q Consensus 118 --------------~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~---~aPE~~~----~~~ 176 (269)
..++|+|++|.||+++.+....+.++||+.+....... ........ ..|+... ...
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHHHHHhhccccCHHHHHHHHHHcC
Confidence 13699999999999987422237899999875321110 00000011 2222211 000
Q ss_pred CCC---------ccchhhhHHHHHHHHHhCCCCC
Q 024336 177 YDG---------KISDVWSCGVTLYVMLVGAYPF 201 (269)
Q Consensus 177 ~~~---------~~~Di~slG~~l~~l~tg~~pf 201 (269)
... .-.+.|++|.+++.+.+|..+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000 1158999999999999998665
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=4.2e-09 Score=83.12 Aligned_cols=132 Identities=17% Similarity=0.190 Sum_probs=97.7
Q ss_pred eecccCce-EEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEEeecCCCchH
Q 024336 10 ELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVMEYAAGGELF 87 (269)
Q Consensus 10 ~l~~g~~g-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 87 (269)
.+..|..+ .||++.....+..+++|..+.. ....+.+|...++.+. +--+.+++.++.+++..++||++++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34445555 6899988877888999986643 2456788999888874 334667888888889999999999998887
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------------
Q 024336 88 ARICSAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------------- 117 (269)
Q Consensus 88 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-------------------------------------------------- 117 (269)
+..... ......+..++...|..||+
T Consensus 109 ~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 184 (272)
T 4gkh_A 109 QVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH 184 (272)
T ss_dssp HHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred ccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence 765432 23344566777777777774
Q ss_pred --------CCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 118 --------MEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 118 --------~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
..++|+|+.+.||++++++. +-|+||+.+.
T Consensus 185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~~--~~viDwe~a~ 222 (272)
T 4gkh_A 185 KLLPFSPDSVVTHGDFSLDNLIFDEGKL--IGCIDVGRVG 222 (272)
T ss_dssp TTCCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred hcccccCCcEEEcCCCCCCeEEEECCeE--EEEEECcccc
Confidence 12789999999999986553 6799999775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.88 E-value=3.5e-08 Score=79.29 Aligned_cols=133 Identities=19% Similarity=0.137 Sum_probs=91.2
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCC---CcceeeEEEE-eCCeEEEEEeecCC
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP---NIIRFKEVLL-TPTHLAIVMEYAAG 83 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~~v~e~~~~ 83 (269)
.+.++.|....||++ |..+++|+.. .......+..|..+++.+.+. .+.+++.+.. ..+..+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888999988 4568889743 222345788999999998642 3455666554 34567899999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSM--------------------------------------------- 118 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--------------------------------------------- 118 (269)
.++.+..- ..++......++.++...|..||+.
T Consensus 98 ~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 98 QILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp EECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred eECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 88866321 1234555555555555555555532
Q ss_pred ---------------CceeecCCCCcEEecC---CCCCcEEEeecCCcc
Q 024336 119 ---------------EICHRDLKLENTLLDG---SPQPRLKICDFGYSK 149 (269)
Q Consensus 119 ---------------~i~H~di~p~ni~i~~---~~~~~~~l~df~~~~ 149 (269)
.++|+|++|.||+++. ++. .+.|+||+.+.
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~-~~~~iD~~~a~ 223 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTP-LTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCC-EEEECCCTTCE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCc-eEEEEehhhcC
Confidence 3599999999999986 233 24799999775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=1.9e-07 Score=77.79 Aligned_cols=75 Identities=16% Similarity=0.124 Sum_probs=48.9
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCc--------cccHHHHHHHHHHHhCCC--CCcc-eeeEEEEeCCeEEE
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGK--------KIDENVQREIINHRSLRH--PNII-RFKEVLLTPTHLAI 76 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~e~~~l~~l~h--~~i~-~~~~~~~~~~~~~~ 76 (269)
.+.||.|..+.||++....++..+++|...... ...+.+..|..+++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568899999999999876567789999765321 123456778888887732 3433 45443 3445689
Q ss_pred EEeecCCC
Q 024336 77 VMEYAAGG 84 (269)
Q Consensus 77 v~e~~~~~ 84 (269)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=2.7e-07 Score=75.73 Aligned_cols=81 Identities=9% Similarity=0.049 Sum_probs=55.4
Q ss_pred cccee-cccCceEEEEEEEe--c----CCeEEEEEEeecCc---c-ccHHHHHHHHHHHhCC-C--CCcceeeEEEEeC-
Q 024336 7 PVKEL-GSGNFGVARLVRDK--R----TKELVAVKYIERGK---K-IDENVQREIINHRSLR-H--PNIIRFKEVLLTP- 71 (269)
Q Consensus 7 ~~~~l-~~g~~g~v~~~~~~--~----~~~~vaiK~~~~~~---~-~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~- 71 (269)
..+.| +.|..+.+|++... . ++..+++|+..... . ....+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34667 88989999998764 1 25678999865432 1 2356778888888774 2 3466677776554
Q ss_pred --CeEEEEEeecCCCchH
Q 024336 72 --THLAIVMEYAAGGELF 87 (269)
Q Consensus 72 --~~~~~v~e~~~~~~l~ 87 (269)
+..++|||+++|.++.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3468999999986653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.38 E-value=5.4e-06 Score=67.38 Aligned_cols=74 Identities=15% Similarity=0.196 Sum_probs=42.0
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC--CCCcceeeE------EEEeCCeEEEEEe
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR--HPNIIRFKE------VLLTPTHLAIVME 79 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~------~~~~~~~~~~v~e 79 (269)
.+.|+.|..+.||++... +..+++|+.... ...+..|..+++.+. .-.+.+++. +....+..+++++
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 345666778899999764 334899988753 234445555555442 112333332 1234667899999
Q ss_pred ecCCCch
Q 024336 80 YAAGGEL 86 (269)
Q Consensus 80 ~~~~~~l 86 (269)
|++|.++
T Consensus 112 ~i~G~~~ 118 (346)
T 2q83_A 112 WIEGRPF 118 (346)
T ss_dssp CCCCBCC
T ss_pred eecCccC
Confidence 9998643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.35 E-value=2e-06 Score=68.75 Aligned_cols=74 Identities=15% Similarity=0.142 Sum_probs=46.9
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCc-ceeeEEEEeCCeEEEEEeec-C
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI-IRFKEVLLTPTHLAIVMEYA-A 82 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~~-~ 82 (269)
+.-.+.|+.|....+|++ ..+++|+............+|..+++.+...++ .+++.. +.+.-+++++|+ +
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence 444788999999999999 348999876542222234568877777643333 345543 333446899999 6
Q ss_pred CCch
Q 024336 83 GGEL 86 (269)
Q Consensus 83 ~~~l 86 (269)
|.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6554
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.32 E-value=1.1e-05 Score=60.31 Aligned_cols=135 Identities=13% Similarity=0.035 Sum_probs=88.2
Q ss_pred CchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCccc
Q 024336 84 GELFARICS-AGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 161 (269)
Q Consensus 84 ~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 161 (269)
-+|.+.++. +.+++++++|.++.|.+.+|..+-. ..-...=+.|..|++..+|+ |-+.+ ..+. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s~-----------~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AADD-----------A 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-cccc-----------c
Confidence 478888865 5689999999999999999887632 22223445668999999988 66553 1110 1
Q ss_pred CCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHH
Q 024336 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241 (269)
Q Consensus 162 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 241 (269)
....+.|||... ...+.+.=|||||+++|..+--..|= + ....+|+.+.+||..|
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e----~-------------------eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE----N-------------------EERELSPPLEQLIDHM 153 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT----T-------------------EEECCCHHHHHHHHHH
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc----c-------------------cchhhCHHHHHHHHHH
Confidence 122466787653 22244578999999999988533321 1 1126889999999999
Q ss_pred hhh-------------------------CCCCCCCcHHHhh
Q 024336 242 FVA-------------------------DPSKDPHSRDQKA 257 (269)
Q Consensus 242 l~~-------------------------~p~~Rps~~~~l~ 257 (269)
..- .+..|++.+++++
T Consensus 154 t~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 154 ANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp TTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred HhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 865 3468889988886
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.23 E-value=1.5e-05 Score=63.89 Aligned_cols=76 Identities=20% Similarity=0.116 Sum_probs=59.4
Q ss_pred ccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC---CCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR---HPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
-.+.|+.|....+|++.. ++..+++|+.... ....+..|...++.|. ...+.+++.+....+..++|||+++|
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356789999999999986 3567889987653 2456788988888873 35677888888878889999999998
Q ss_pred Cch
Q 024336 84 GEL 86 (269)
Q Consensus 84 ~~l 86 (269)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=8.3e-06 Score=67.20 Aligned_cols=138 Identities=16% Similarity=0.147 Sum_probs=81.6
Q ss_pred cceecccCceEEEEEEEec-------CCeEEEEEEeecCccccHHHHHHHHHHHhCCCCC-cceeeEEEEeCCeEEEEEe
Q 024336 8 VKELGSGNFGVARLVRDKR-------TKELVAVKYIERGKKIDENVQREIINHRSLRHPN-IIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~v~e 79 (269)
++.|..|-...+|++.... ++..+++|+............+|..+++.+...+ ..++++.+.+ .+|+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 4567778888999998742 3567999986443334566778999988874323 3556655443 29999
Q ss_pred ecCCCchHHH-----------------HHhc-----CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 024336 80 YAAGGELFAR-----------------ICSA-----GRFS--EDEARFFFQQLIS-------------------GVSYCH 116 (269)
Q Consensus 80 ~~~~~~l~~~-----------------~~~~-----~~~~--~~~~~~~~~~i~~-------------------~l~~lh 116 (269)
|++|.++... ++.. ++.. ...+..+..++-. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998554210 1111 1111 3556666554422 122332
Q ss_pred ----h----CCceeecCCCCcEEecCCC--CCcEEEeecCCcc
Q 024336 117 ----S----MEICHRDLKLENTLLDGSP--QPRLKICDFGYSK 149 (269)
Q Consensus 117 ----~----~~i~H~di~p~ni~i~~~~--~~~~~l~df~~~~ 149 (269)
+ ..++|+|+.+.||+++.+. ...+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 2489999999999998761 1238999999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.07 E-value=3e-05 Score=65.03 Aligned_cols=73 Identities=16% Similarity=0.174 Sum_probs=44.1
Q ss_pred ccceecccCceEEEEEEEecCCeEEEEEEeecC-----cc-----ccHHHHHHHHHHH-hCCCCCcceeeEEEEeCCeEE
Q 024336 7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERG-----KK-----IDENVQREIINHR-SLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~-----~~-----~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~ 75 (269)
..+.||.|..+.||++.. ++..+++|...+. .. ....++.|+..+. ......+.+++.+. ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 356789999999999964 4667999943221 11 1223344443332 12223455666654 45678
Q ss_pred EEEeec-CC
Q 024336 76 IVMEYA-AG 83 (269)
Q Consensus 76 ~v~e~~-~~ 83 (269)
+|||++ ++
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.02 E-value=4.8e-05 Score=60.31 Aligned_cols=78 Identities=14% Similarity=0.058 Sum_probs=53.9
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCC---CcceeeEEEEeCCeEEEEEe
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHP---NIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~~v~e 79 (269)
+..-++.+|.|..+.||++... +|+.|++|+.+... .....+..|...|+.|... -+.+++.. .+ -++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEE
Confidence 4456778999999999999865 67889999876443 2335678899999888422 23344443 23 268899
Q ss_pred ecCCCch
Q 024336 80 YAAGGEL 86 (269)
Q Consensus 80 ~~~~~~l 86 (269)
+++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9876543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.90 E-value=0.00012 Score=59.02 Aligned_cols=76 Identities=12% Similarity=0.074 Sum_probs=49.0
Q ss_pred ceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCC--CcceeeEE-----EEeCCeEEEEEeec
Q 024336 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP--NIIRFKEV-----LLTPTHLAIVMEYA 81 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~-----~~~~~~~~~v~e~~ 81 (269)
..++ |....||++... +|+.+++|.........+.+..|..+++.+... .+.+++.. ...++..+.+++++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 788899988654 466799998875433456677788877776321 23333332 22345678899999
Q ss_pred CCCch
Q 024336 82 AGGEL 86 (269)
Q Consensus 82 ~~~~l 86 (269)
+|.++
T Consensus 110 ~G~~~ 114 (328)
T 1zyl_A 110 GGRQF 114 (328)
T ss_dssp CCEEC
T ss_pred CCCCC
Confidence 88543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=5.4e-05 Score=62.28 Aligned_cols=75 Identities=16% Similarity=0.068 Sum_probs=45.2
Q ss_pred cceecccCceEEEEEEEecC--------CeEEEEEEeecCccccHHHHHHHHHHHhCCCCC-cceeeEEEEeCCeEEEEE
Q 024336 8 VKELGSGNFGVARLVRDKRT--------KELVAVKYIERGKKIDENVQREIINHRSLRHPN-IIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~v~ 78 (269)
.+.|+.|....+|++..... +..+++|+.............|..+++.+...+ ..++++.. .+ ++|+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 55678888899999987541 367899987653322223467888887774333 34555543 22 6899
Q ss_pred eecCCCch
Q 024336 79 EYAAGGEL 86 (269)
Q Consensus 79 e~~~~~~l 86 (269)
+|++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.86 E-value=4.6e-05 Score=63.99 Aligned_cols=74 Identities=12% Similarity=0.147 Sum_probs=49.7
Q ss_pred cceecccCceEEEEEEEec-------CCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCc-ceeeEEEEeCCeEEEEEe
Q 024336 8 VKELGSGNFGVARLVRDKR-------TKELVAVKYIERGKKIDENVQREIINHRSLRHPNI-IRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e 79 (269)
++.|+.|....+|++.... ++..+++|+.... ...+.+.+|..+++.+...++ .++++.+. + .+|++
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 5678889999999998753 2567999987432 111556689888888743333 55666543 2 28999
Q ss_pred ecCCCch
Q 024336 80 YAAGGEL 86 (269)
Q Consensus 80 ~~~~~~l 86 (269)
|++|.++
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.81 E-value=8.8e-05 Score=59.69 Aligned_cols=137 Identities=14% Similarity=0.091 Sum_probs=75.0
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCC--cceeeEE------EEeCCeEEEEEe
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN--IIRFKEV------LLTPTHLAIVME 79 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~~v~e 79 (269)
.+.|+.|....+|++... +| .+++|..... ...+.+..|..+++.+...+ +.+++.. ....+..+++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 456777888999999764 33 5889987653 22345666777776663211 2223211 123456789999
Q ss_pred ecCCCchHH--------------HHHhc-CC--------CCHHHHHHH---------------HHHHHHHHHHHHh----
Q 024336 80 YAAGGELFA--------------RICSA-GR--------FSEDEARFF---------------FQQLISGVSYCHS---- 117 (269)
Q Consensus 80 ~~~~~~l~~--------------~~~~~-~~--------~~~~~~~~~---------------~~~i~~~l~~lh~---- 117 (269)
+++|..+.. .++.. .. ......... ...+...++.+.+
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 998854311 11111 00 011100000 0113334455542
Q ss_pred ---CCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 118 ---MEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 118 ---~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
.+++|+|+.+.||+++.++. +.++||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~--~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCce--EEEecchhcc
Confidence 46899999999999986542 5799998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00039 Score=56.18 Aligned_cols=137 Identities=14% Similarity=0.088 Sum_probs=68.9
Q ss_pred cceecccCceE-EEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCC--CCcceeeEEEEeCCeEEEEEeecCCC
Q 024336 8 VKELGSGNFGV-ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--PNIIRFKEVLLTPTHLAIVMEYAAGG 84 (269)
Q Consensus 8 ~~~l~~g~~g~-v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (269)
.+.|+.|+... +|++... ++..+++|...... ...+..|+.+++.+.. -.+.+++.+....+ ++++|++++.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECT-TCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcC-CCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34566665555 5677542 25567788655432 1334456666666532 23455665533333 6899999776
Q ss_pred chHHHHHhc--------------------------CCCCHHHHHH-------HH-------------HHHHHHHHHH---
Q 024336 85 ELFARICSA--------------------------GRFSEDEARF-------FF-------------QQLISGVSYC--- 115 (269)
Q Consensus 85 ~l~~~~~~~--------------------------~~~~~~~~~~-------~~-------------~~i~~~l~~l--- 115 (269)
++.+.+... ..++...... +. ..+..++..+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 664433210 0122211110 00 0111122222
Q ss_pred ---HhCCceeecCCCCcEEecCCC--CCcEEEeecCCcc
Q 024336 116 ---HSMEICHRDLKLENTLLDGSP--QPRLKICDFGYSK 149 (269)
Q Consensus 116 ---h~~~i~H~di~p~ni~i~~~~--~~~~~l~df~~~~ 149 (269)
+...++|||+.+.||+++.+. ...+.++||+.+.
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 234699999999999998641 1248999999775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.0003 Score=59.43 Aligned_cols=75 Identities=16% Similarity=0.116 Sum_probs=49.1
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCc-ceeeEEEEeCCeEEEEEeecCCCch
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI-IRFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
++.|+.|-...+|++.....+..+++|+........-...+|..+++.+...++ .++++.+. + ..|++|++|.++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 567888999999999876445789999875432222223678888888865444 45666652 2 259999987444
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0033 Score=50.93 Aligned_cols=30 Identities=23% Similarity=0.472 Sum_probs=25.7
Q ss_pred CCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 118 ~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
..++|+|+.+.||+++.++. +.++||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~--~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEES--IYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGC--EEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCe--EEEEECCCCe
Confidence 45899999999999986665 8999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0013 Score=54.98 Aligned_cols=76 Identities=17% Similarity=0.096 Sum_probs=49.8
Q ss_pred ccceecccCceEEEEEEEecC-------CeEEEEEEeecCccccHHHHHHHHHHHhCCCCC-cceeeEEEEeCCeEEEEE
Q 024336 7 PVKELGSGNFGVARLVRDKRT-------KELVAVKYIERGKKIDENVQREIINHRSLRHPN-IIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~v~ 78 (269)
-++.+..|-...+|++..... +..+++|+........-...+|..+++.+...+ ..++++.+ .+ +.|+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 356777888899999987521 577999987554323333567888888774333 34455433 22 6899
Q ss_pred eecCCCch
Q 024336 79 EYAAGGEL 86 (269)
Q Consensus 79 e~~~~~~l 86 (269)
+|++|.++
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0058 Score=50.74 Aligned_cols=30 Identities=37% Similarity=0.617 Sum_probs=23.7
Q ss_pred ceeecCCCCcEEecCC----CCCcEEEeecCCcc
Q 024336 120 ICHRDLKLENTLLDGS----PQPRLKICDFGYSK 149 (269)
Q Consensus 120 i~H~di~p~ni~i~~~----~~~~~~l~df~~~~ 149 (269)
++|+|+.+.||++..+ ....+.++||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999431 22349999999875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=94.86 E-value=0.083 Score=39.40 Aligned_cols=91 Identities=12% Similarity=0.055 Sum_probs=66.3
Q ss_pred HHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCC
Q 024336 49 EIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128 (269)
Q Consensus 49 e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ 128 (269)
|+..+. ..||++++. .+-.+++.+.+.++.-+.+.-+..+.+ .+....++++.+|+....+++++ +|--++|+
T Consensus 36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~---~~~~eKlr~l~ni~~l~~~~~~r--~tf~L~P~ 108 (215)
T 4ann_A 36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS---FTKNEKLRYLLNIKNLEEVNRTR--YTFVLAPD 108 (215)
T ss_dssp GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG---SCHHHHHHHHHHGGGGGGGGGSS--EECCCSGG
T ss_pred HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh---cCHHHHHHHHHHHHHHHHHhcCc--eEEEEecc
Confidence 444433 368999987 566777787777777654333343433 68899999999999977555444 88899999
Q ss_pred cEEecCCCCCcEEEeecCCc
Q 024336 129 NTLLDGSPQPRLKICDFGYS 148 (269)
Q Consensus 129 ni~i~~~~~~~~~l~df~~~ 148 (269)
|++++.++. +++.-.|+-
T Consensus 109 NL~f~~~~~--p~i~~RGik 126 (215)
T 4ann_A 109 ELFFTRDGL--PIAKTRGLQ 126 (215)
T ss_dssp GEEECTTSC--EEESCCEET
T ss_pred eEEEcCCCC--EEEEEccCc
Confidence 999999988 888876653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=94.57 E-value=0.25 Score=37.01 Aligned_cols=83 Identities=14% Similarity=0.070 Sum_probs=63.2
Q ss_pred CCCCcceeeEEEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCceeecCCCCcEEecCC
Q 024336 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS-YCHSMEICHRDLKLENTLLDGS 135 (269)
Q Consensus 57 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~-~lh~~~i~H~di~p~ni~i~~~ 135 (269)
.||++ -..+-.+++.+.+.++.-+++.-...+. ..+....++++.+|+.... ++ ..-+|--++|+|++++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence 67888 4555577888888888775555455553 3689999999999998665 44 344888999999999988
Q ss_pred CCCcEEEeecCCc
Q 024336 136 PQPRLKICDFGYS 148 (269)
Q Consensus 136 ~~~~~~l~df~~~ 148 (269)
+. +++.-.|+-
T Consensus 121 ~~--p~i~hRGi~ 131 (219)
T 4ano_A 121 LE--PFFLHVGVK 131 (219)
T ss_dssp CC--EEESCCEET
T ss_pred Cc--EEEEEcCCc
Confidence 88 898877754
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.88 E-value=0.12 Score=43.57 Aligned_cols=60 Identities=8% Similarity=0.037 Sum_probs=17.2
Q ss_pred ccceecccCceEEEEEEEecCCeEEEE------EEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEE
Q 024336 7 PVKELGSGNFGVARLVRDKRTKELVAV------KYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLL 69 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~~~~~vai------K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 69 (269)
+.+.|| ||.||++....+..+||+ |...... .....+.+|..+.+.++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 345565 999999998765567888 6544321 22234667778888889999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 269 | ||||
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-73 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-72 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-71 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-69 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-69 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-68 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-68 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-67 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-67 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-66 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-66 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-64 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-63 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-62 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-61 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-60 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-60 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-59 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-57 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-56 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-53 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-53 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-51 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-51 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-50 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-50 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-50 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-50 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-50 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-50 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-49 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-49 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-45 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-42 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-38 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-35 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-15 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 7e-73
Identities = 86/253 (33%), Positives = 138/253 (54%), Gaps = 10/253 (3%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
E ++ V+ LG G +G +L ++ T+E VAVK ++ + +D EN+++EI ++ L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+++F + +EY +GGELF RI E +A+ FF QL++GV Y H + I
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST---VGTPAYIAPEVLARKEY 177
HRD+K EN LLD + LKI DFG + +++ + GT Y+APE+L R+E+
Sbjct: 125 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
+ DVWSCG+ L ML G P++ P D + + +L + ++ + L
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLAL 239
Query: 238 LSQIFVADPSKDP 250
L +I V +PS
Sbjct: 240 LHKILVENPSARI 252
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 1e-72
Identities = 85/256 (33%), Positives = 135/256 (52%), Gaps = 14/256 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSLRH 58
E +E + LG G FG L R+K++K ++A+K + + + V +RE+ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
PNI+R T + +++EYA G ++ + +F E + +L + +SYCHS
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
+ HRD+K EN LL LKI DFG+S S+ + GT Y+ PE++ + +D
Sbjct: 126 RVIHRDIKPENLLLG--SAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
K D+WS GV Y LVG PFE +++T RI V++ PD+ V+ R L+
Sbjct: 183 EK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPDF--VTEGARDLI 235
Query: 239 SQIFVADPSKDPHSRD 254
S++ +PS+ P R+
Sbjct: 236 SRLLKHNPSQRPMLRE 251
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 219 bits (560), Expect = 5e-71
Identities = 70/258 (27%), Positives = 120/258 (46%), Gaps = 9/258 (3%)
Query: 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHP 59
+ + Y+ ++ELGSG FGV +K T + K+I +D V+ EI L HP
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 86
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSM 118
+I + + +++E+ +GGELF RI + + SE E + +Q G+ + H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
I H D+K EN + + +KI DFG + K T T + APE++ R+
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRH 236
+D+W+ GV YV+L G PF +D +T+ ++ + + + VS + +
Sbjct: 207 -FYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKRCDWEFDEDAFSSVSPEAKD 261
Query: 237 LLSQIFVADPSKDPHSRD 254
+ + +P K D
Sbjct: 262 FIKNLLQKEPRKRLTVHD 279
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 216 bits (551), Expect = 1e-69
Identities = 73/252 (28%), Positives = 123/252 (48%), Gaps = 9/252 (3%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPNI 61
+ Y+ +ELG+G FGV V ++ T A K++ + D E V++EI LRHP +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 62 IRFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEI 120
+ + + ++ E+ +GGELF ++ + SEDEA + +Q+ G+ + H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 145
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
H DLK EN + LK+ DFG + K T GT + APEV K
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 205
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLL 238
+D+WS GV Y++L G PF N +T+ +++ + + D + +S D + +
Sbjct: 206 -TDMWSVGVLSYILLSGLSPFGGE----NDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260
Query: 239 SQIFVADPSKDP 250
++ +ADP+
Sbjct: 261 RKLLLADPNTRM 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 3e-69
Identities = 59/251 (23%), Positives = 110/251 (43%), Gaps = 8/251 (3%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
E+Y ++LG G FG+ + +K+ K+++ V++EI RH NI+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEIC 121
E + L ++ E+ +G ++F RI ++ +E E + Q+ + + HS I
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
H D++ EN + +KI +FG ++ + P Y APEV
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA- 183
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLS 239
+D+WS G +YV+L G PF ++ I+ I N +Y + + +S + +
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLA----ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 240 QIFVADPSKDP 250
++ V +
Sbjct: 240 RLLVKERKSRM 250
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 3e-68
Identities = 75/290 (25%), Positives = 120/290 (41%), Gaps = 45/290 (15%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHP 59
++ +E + ELG+GN GV V K + ++A K I E I + RE+ P
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
I+ F + ++I ME+ GG L + AGR E +I G++Y
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 120 -ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
I HRD+K N L++ + +K+CDFG S L+ S S VGT +Y++PE L Y
Sbjct: 125 KIMHRDVKPSNILVN--SRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPED-------------------------------- 206
+ SD+WS G++L M VG YP P+
Sbjct: 182 VQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240
Query: 207 ------PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDP 250
P + +D I N S + + +++ + +P++
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 211 bits (538), Expect = 3e-68
Identities = 86/258 (33%), Positives = 129/258 (50%), Gaps = 10/258 (3%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHP 59
+ Y+ LG+G F L DKRT++LVA+K I + + +++ EI ++HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
NI+ ++ + HL ++M+ +GGELF RI G ++E +A Q++ V Y H +
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 120 ICHRDLKLENTLLDGSPQP-RLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
I HRDLK EN L + ++ I DFG SK S + GTP Y+APEVLA+K Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRH 236
D WS GV Y++L G PF D N K ++I +Y P + +S +
Sbjct: 188 KA-VDCWSIGVIAYILLCGYPPFYD----ENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242
Query: 237 LLSQIFVADPSKDPHSRD 254
+ + DP K
Sbjct: 243 FIRHLMEKDPEKRFTCEQ 260
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 4e-68
Identities = 69/251 (27%), Positives = 118/251 (47%), Gaps = 9/251 (3%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
+++Y +++G G G D T + VA++ + ++ E + EI+ R ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
I+ + + L L +VMEY AGG L + + E + ++ + + + HS ++
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDG 179
HRD+K +N LL +K+ DFG+ +ST VGTP ++APEV+ RK Y
Sbjct: 138 IHRDIKSDNILLG--MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
K D+WS G+ M+ G P+ + R N L + ++SA R L+
Sbjct: 196 K-VDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFLN 251
Query: 240 QIFVADPSKDP 250
+ D K
Sbjct: 252 RCLDMDVEKRG 262
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 1e-67
Identities = 70/260 (26%), Positives = 117/260 (45%), Gaps = 12/260 (4%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
E+ +E + ELG G FG ++K T L A K I+ + + E+ EI S HPN
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
I++ + +L I++E+ AGG + A + R +E + + +Q + ++Y H +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 178
I HRDLK N L +K+ DFG S Q + + +GTP ++APEV+ +
Sbjct: 131 IIHRDLKAGNILFT--LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 179 GKI----SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
+ +DVWS G+TL M P + R K ++ L R S++
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI---AKSEPPTLAQPSRWSSNF 245
Query: 235 RHLLSQIFVADPSKDPHSRD 254
+ L + + +
Sbjct: 246 KDFLKKCLEKNVDARWTTSQ 265
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 3e-67
Identities = 74/255 (29%), Positives = 112/255 (43%), Gaps = 16/255 (6%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRH 58
E ++ K LG G+F L R+ T A+K +E+ I EN + L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
P ++ L + YA GEL I G F E RF+ +++S + Y H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST---VGTPAYIAPEVLARK 175
I HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L K
Sbjct: 128 GIIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
SD+W+ G +Y ++ G PF N +I ++Y P+ + R
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEYDFPE--KFFPKAR 238
Query: 236 HLLSQIFVADPSKDP 250
L+ ++ V D +K
Sbjct: 239 DLVEKLLVLDATKRL 253
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (528), Expect = 1e-66
Identities = 70/256 (27%), Positives = 110/256 (42%), Gaps = 17/256 (6%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLR 57
E+ + ++E+G G+FG RD R E+VA+K + K +++ +E+ + LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
HPN I+++ L +VMEY G E E + G++Y HS
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA---R 174
+ HRD+K N LL +K+ DFG + + + S VGTP ++APEV+
Sbjct: 134 HNMIHRDVKAGNILLS--EPGLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDE 188
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
+YDGK DVWS G+T + P + N + I + S
Sbjct: 189 GQYDGK-VDVWSLGITCIELAERKPPLFN----MNAMSALYHIAQNESPALQSGHWSEYF 243
Query: 235 RHLLSQIFVADPSKDP 250
R+ + P P
Sbjct: 244 RNFVDSCLQKIPQDRP 259
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 204 bits (520), Expect = 8e-66
Identities = 84/268 (31%), Positives = 124/268 (46%), Gaps = 20/268 (7%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI----------ERGKKIDENVQREIIN 52
E YEP + LG G V R K T + AVK I E +++ E +E+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 53 HRSLR-HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
R + HPNII+ K+ T T +V + GELF + SE E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
+ H + I HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 172 LARKEYD-----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
+ D GK D+WS GV +Y +L G+ PF + R + N Q+ P+
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS--GNYQFGSPE 238
Query: 227 YVRVSADCRHLLSQIFVADPSKDPHSRD 254
+ S + L+S+ V P K + +
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEE 266
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-64
Identities = 85/260 (32%), Positives = 141/260 (54%), Gaps = 16/260 (6%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINHR 54
++ Y+ +ELGSG F V + R+K T A K+I++ + E+++RE+ +
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 55 SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
++HPN+I EV T + +++E AGGELF + +E+EA F +Q+++GV Y
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 115 CHSMEICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
HS++I H DLK EN +L P+PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRV 230
+ +D+WS GV Y++L GA PF ++T+ + V Y D +
Sbjct: 189 NYEPLG-LEADMWSIGVITYILLSGASPFLG----DTKQETLANVSAVNYEFEDEYFSNT 243
Query: 231 SADCRHLLSQIFVADPSKDP 250
SA + + ++ V DP K
Sbjct: 244 SALAKDFIRRLLVKDPKKRM 263
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-63
Identities = 85/259 (32%), Positives = 131/259 (50%), Gaps = 16/259 (6%)
Query: 3 ERYEPVKE-LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHPN 60
+ Y+ + LG G G + +KRT+E A+K ++ K +RE+ ++ R+ + P+
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRASQCPH 66
Query: 61 IIRFKEVLLTP----THLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSY 114
I+R +V L IVME GGELF+RI G F+E EA + + + Y
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 115 CHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
HS+ I HRD+K EN L P LK+ DFG++K H+ + TP Y+APEVL
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVS 231
++YD D+WS GV +Y++L G PF RIR QY P+ + VS
Sbjct: 187 PEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245
Query: 232 ADCRHLLSQIFVADPSKDP 250
+ + L+ + +P++
Sbjct: 246 EEVKMLIRNLLKTEPTQRM 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 9e-63
Identities = 83/259 (32%), Positives = 127/259 (49%), Gaps = 15/259 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-----VQREIINHRSLR 57
E + K LG G+FG L K+T + A+K +++ + ++ + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
HP + T +L VMEY GG+L I S +F A F+ ++I G+ + HS
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKE 176
I +RDLKL+N LLD +KI DFG K +L +T GTP YIAPE+L ++
Sbjct: 122 KGIVYRDLKLDNILLD--KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
Y+ D WS GV LY ML+G PF ++ + IR F P + + + +
Sbjct: 180 YNHS-VDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMDNPFYPRW--LEKEAKD 232
Query: 237 LLSQIFVADPSKDPHSRDQ 255
LL ++FV +P K R
Sbjct: 233 LLVKLFVREPEKRLGVRGD 251
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 8e-62
Identities = 72/263 (27%), Positives = 121/263 (46%), Gaps = 23/263 (8%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHP 59
E YE + +G+G++G + +R K +++ K ++ G + Q E+ R L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 60 NIIRFKEVLL--TPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVS 113
NI+R+ + ++ T T L IVMEY GG+L + I + E+ QL +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 114 YCH-----SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG-TPAYI 167
CH + HRDLK N LDG +K+ DFG ++ + TP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 168 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227
+PE + R Y+ K SD+WS G LY + PF + ++ +IR ++ Y
Sbjct: 182 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY 236
Query: 228 VRVSADCRHLLSQIFVADPSKDP 250
R S + +++++ P
Sbjct: 237 -RYSDELNEIITRMLNLKDYHRP 258
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 193 bits (491), Expect = 2e-61
Identities = 63/260 (24%), Positives = 102/260 (39%), Gaps = 13/260 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRH 58
+RYE + LG G L RD R VAVK + D + +RE N +L H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 59 PNIIRFKEVLLTPTH----LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
P I+ + T IVMEY G L + + G + A +++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFG--YSKSGLLHSQPKSTVGTPAYIAPEVL 172
H I HRD+K N ++ + ++ + SG +Q + +GT Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
D + SDV+S G LY +L G PF + + + + +SA
Sbjct: 187 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLSA 243
Query: 233 DCRHLLSQIFVADPSKDPHS 252
D ++ + +P +
Sbjct: 244 DLDAVVLKALAKNPENRYQT 263
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-60
Identities = 82/281 (29%), Positives = 125/281 (44%), Gaps = 30/281 (10%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-------VQREIINHR 54
E +Y+ LGSG FG VA+K++E+ + D V E++ +
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 55 SLR--HPNIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISG 111
+ +IR + P +++E +LF I G E+ AR FF Q++
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
V +CH+ + HRD+K EN L+D + + LK+ DFG L + GT Y PE
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEW 180
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
+ Y G+ + VWS G+ LY M+ G PFE E+ I Q F RVS
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVS 228
Query: 232 ADCRHLLSQIFVADPSKDPHSRDQKAS------LVPEEFAE 266
++C+HL+ PS P + + L+P+E AE
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 192 bits (488), Expect = 5e-60
Identities = 65/263 (24%), Positives = 116/263 (44%), Gaps = 13/263 (4%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR-------S 55
+ + +G G FG R T ++ A+K +++ + + + +N R +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
P I+ TP L+ +++ GG+L + G FSE + RF+ ++I G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
H+ + +RDLK N LLD ++I D G + +P ++VGT Y+APEVL +
Sbjct: 124 HNRFVVYRDLKPANILLD--EHGHVRISDLGLACD-FSKKKPHASVGTHGYMAPEVLQKG 180
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
+D +S G L+ +L G PF ++ + + LPD S + R
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPDS--FSPELR 237
Query: 236 HLLSQIFVADPSKDPHSRDQKAS 258
LL + D ++ + A
Sbjct: 238 SLLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 7e-60
Identities = 56/259 (21%), Positives = 107/259 (41%), Gaps = 16/259 (6%)
Query: 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHPNI 61
+ E+G G+F D T VA ++ K + + E + L+HPNI
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 62 IRFKEVLLTPT----HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
+RF + + + +V E G L + R + +Q++ G+ + H+
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 118 M--EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
I HRDLK +N + G P +KI D G + S K+ +GTP ++APE+ +
Sbjct: 131 RTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMY-EE 187
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
+YD DV++ G+ + M YP+ + ++ + R+ + + +
Sbjct: 188 KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPEVK 243
Query: 236 HLLSQIFVADPSKDPHSRD 254
++ + + +D
Sbjct: 244 EIIEGCIRQNKDERYSIKD 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 188 bits (479), Expect = 3e-59
Identities = 80/260 (30%), Positives = 132/260 (50%), Gaps = 15/260 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRH 58
+ ++ ++ LG+G+FG L+R + A+K +++ + E+ E + + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
P IIR + ++M+Y GGELF+ + + RF A+F+ ++ + Y HS
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
+I +RDLK EN LLD + +KI DFG++K + + GTP YIAPEV++ K Y+
Sbjct: 124 DIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
D WS G+ +Y ML G PF D N KT ++I N + P + + D + LL
Sbjct: 180 KS-IDWWSFGILIYEMLAGYTPFYDS----NTMKTYEKILNAELRFPPF--FNEDVKDLL 232
Query: 239 SQIFVADPSKDPHSRDQKAS 258
S++ D S+ +
Sbjct: 233 SRLITRDLSQRLGNLQNGTE 252
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 8e-57
Identities = 59/257 (22%), Positives = 101/257 (39%), Gaps = 15/257 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHP 59
+ + +GSG+FG + VAVK + + +Q E+ R RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSM 118
NI+ F T LAIV ++ G L+ + +F + +Q G+ Y H+
Sbjct: 65 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARK 175
I HRDLK N L KI DFG + Q + G+ ++APEV+ +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTV--KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 176 EYD--GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
+ + SDV++ G+ LY ++ G P+ + + + R
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 234 CRHLLSQIFVADPSKDP 250
+ L+++ + P
Sbjct: 242 MKRLMAECLKKKRDERP 258
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-56
Identities = 83/261 (31%), Positives = 127/261 (48%), Gaps = 14/261 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRH 58
++ +K LG G FG LVR+K T A+K + + I ++ E ++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
P + K T L VMEYA GGELF + F+E+ ARF+ +++S + Y HS
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLARKEY 177
++ +RD+KLEN +LD +KI DFG K G+ K+ GTP Y+APEVL +Y
Sbjct: 125 DVVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
D W GV +Y M+ G PF + ++ + + I + P +S + + L
Sbjct: 183 GRA-VDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEEIRFPRT--LSPEAKSL 235
Query: 238 LSQIFVADPSKDPHSRDQKAS 258
L+ + DP + A
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAK 256
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 179 bits (455), Expect = 3e-55
Identities = 75/260 (28%), Positives = 136/260 (52%), Gaps = 15/260 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRH 58
++++ +K LG+G+FG LV+ K + A+K +++ K + E+ E +++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59 PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
P +++ + ++L +VMEY AGGE+F+ + GRFSE ARF+ Q++ Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
++ +RDLK EN L+D Q +++ DFG++K + + GTP +APE++ K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
D W+ GV +Y M G PF + ++I + + P + S+D + LL
Sbjct: 217 KA-VDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGKVRFPSH--FSSDLKDLL 269
Query: 239 SQIFVADPSKDPHSRDQKAS 258
+ D +K + +
Sbjct: 270 RNLLQVDLTKRFGNLKNGVN 289
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 7e-54
Identities = 61/251 (24%), Positives = 95/251 (37%), Gaps = 15/251 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
+ + ++ +G G FG L + K VAVK I + + E LRH N++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSNLV 63
Query: 63 RFKEVLL-TPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSME 119
+ V++ L IV EY A G L + S GR D F + + Y
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
HRDL N L+ K+ DFG +K S + + APE L K++
Sbjct: 124 FVHRDLAARNVLVSE--DNVAKVSDFGLTK--EASSTQDTGKLPVKWTAPEALREKKFST 179
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
K SDVWS G+ L+ + P + + R+ Y + ++
Sbjct: 180 K-SDVWSFGILLWEIYSFGRV---PYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYEVMK 234
Query: 240 QIFVADPSKDP 250
+ D + P
Sbjct: 235 NCWHLDAAMRP 245
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-53
Identities = 59/252 (23%), Positives = 102/252 (40%), Gaps = 13/252 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
+ +KELG+G FGV + + R + VA+K I+ G ++ E +L H ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
+ V + I+ EY A G L + RF + + + + Y S +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEYDG 179
HRDL N L++ Q +K+ DFG S+ L S + PEVL ++
Sbjct: 123 HRDLAARNCLVND--QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 180 KISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
K SD+W+ GV ++ + +G P+E + +R L S ++
Sbjct: 181 K-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-----LYRPHLASEKVYTIM 234
Query: 239 SQIFVADPSKDP 250
+ + P
Sbjct: 235 YSCWHEKADERP 246
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 3e-53
Identities = 69/274 (25%), Positives = 107/274 (39%), Gaps = 31/274 (11%)
Query: 6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK------IDENVQREIINHRSLRHP 59
E + LG G F RDK T ++VA+K I+ G + I+ REI + L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
NII + +++++V ++ ++ + + + + G+ Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEYD 178
I HRDLK N LLD LK+ DFG +KS G + V T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLD--ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-------QYFLPDYV--- 228
G D+W+ G L +L+ D + + + LPDYV
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 229 ------------RVSADCRHLLSQIFVADPSKDP 250
D L+ +F+ +P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 272
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-53
Identities = 67/279 (24%), Positives = 109/279 (39%), Gaps = 36/279 (12%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
E Y K +G+G+FGV + + ELVA+K + + K+ RE+ R L H NI
Sbjct: 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNI 75
Query: 62 IRFKEVLLTP------THLAIVMEYAAGG---ELFARICSAGRFSEDEARFFFQQLISGV 112
+R + + +L +V++Y + + + QL +
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
+Y HS ICHRD+K +N LLD K+CDFG +K + S + + Y APE++
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-----RNVQYFLPDY 227
DVWS G L +L+G F + I + ++ P+Y
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 228 V------------------RVSADCRHLLSQIFVADPSK 248
R + L S++ P+
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (433), Expect = 1e-52
Identities = 55/252 (21%), Positives = 94/252 (37%), Gaps = 11/252 (4%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
+LG G +G K+ VAVK ++ E +E + ++HPN++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEI 120
+ V I+ E+ G L + R S + Q+ S + Y
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 136
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
HRDL N L+ + K+ DFG S+ +G ++ + APE LA ++
Sbjct: 137 IHRDLAARNCLVGENHLV--KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
K SDVW+ GV L+ + D + +++ Y + L+
Sbjct: 195 IK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----DYRMERPEGCPEKVYELM 249
Query: 239 SQIFVADPSKDP 250
+ +PS P
Sbjct: 250 RACWQWNPSDRP 261
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 7e-52
Identities = 59/251 (23%), Positives = 103/251 (41%), Gaps = 11/251 (4%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
V+E+GSG FG+ L K+ VA+K I G +E+ E L HP ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 63 RFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEIC 121
+ V L + +V E+ G L + + G F+ + + G++Y +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
HRDL N L+ + K+ DFG ++ ++ T + +PEV + Y
Sbjct: 124 HRDLAARNCLVGENQVI--KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
K SDVWS GV ++ + P + R+ + ++ I + L S +++
Sbjct: 182 K-SDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDIST-GFRLYKPRLASTHVYQIMN 236
Query: 240 QIFVADPSKDP 250
+ P P
Sbjct: 237 HCWKERPEDRP 247
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-51
Identities = 70/262 (26%), Positives = 106/262 (40%), Gaps = 21/262 (8%)
Query: 2 EERYEPVKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHR 54
E+ +++LG G+FGV VAVK ++ ++ RE+
Sbjct: 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 55 SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVS 113
SL H N+IR V+LTP + +V E A G L R+ G F + Q+ G+
Sbjct: 67 SLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIAP 169
Y S HRDL N LL + +KI DFG + + + + A+ AP
Sbjct: 126 YLESKRFIHRDLAARNLLLA--TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 170 EVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228
E L + + SD W GVTL+ M G P+ N + + +I LP
Sbjct: 184 ESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG----LNGSQILHKIDKEGERLPRPE 238
Query: 229 RVSADCRHLLSQIFVADPSKDP 250
D +++ Q + P P
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDRP 260
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 169 bits (428), Expect = 2e-51
Identities = 57/253 (22%), Positives = 107/253 (42%), Gaps = 9/253 (3%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNI 61
+ Y+ V++LG G + + E V VK ++ KK + ++REI +LR PNI
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNI 92
Query: 62 IRFKEVLLTPTH--LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
I +++ P A+V E+ + ++ + RF+ +++ + YCHSM
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
I HRD+K N ++D +L++ D+G ++ + V + + PE+L +
Sbjct: 150 IMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
D+WS G L M+ PF D + I ++ + + + + +
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 240 QIFVADPSKDPHS 252
I K
Sbjct: 269 DILGRHSRKRWER 281
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 7e-51
Identities = 71/280 (25%), Positives = 124/280 (44%), Gaps = 30/280 (10%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHP 59
E ++ V+++G G +GV R+K T E+VA+K I + + REI + L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 60 NIIRFKEVLLTPTHLAIVMEYAA-GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
NI++ +V+ T L +V E+ + F + + + QL+ G+++CHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEY 177
+ HRDLK +N L++ + +K+ DFG +++ + + + V T Y APE+L +Y
Sbjct: 122 RVLHRDLKPQNLLIN--TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-------DRIRNVQYFLPDYV-- 228
D+WS G M+ F + + + + +PDY
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 229 --------------RVSADCRHLLSQIFVADPSKDPHSRD 254
+ D R LLSQ+ DP+K ++
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 279
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 7e-51
Identities = 58/252 (23%), Positives = 98/252 (38%), Gaps = 13/252 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
E +LG G FG + T VA+K ++ G E +E + LRH ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 63 RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
+ V+ + + IV EY + G L F + + + Q+ SG++Y M
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
HRDL+ N L+ + K+ DFG ++ ++ + + APE +
Sbjct: 135 VHRDLRAANILVGENLVC--KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
K SDVWS G+ L + R ++R Y +P L+
Sbjct: 193 IK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPESLHDLM 247
Query: 239 SQIFVADPSKDP 250
Q + +P + P
Sbjct: 248 CQCWRKEPEERP 259
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 3e-50
Identities = 54/259 (20%), Positives = 95/259 (36%), Gaps = 14/259 (5%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR 63
RY +++GSG+FG L D E VA+K +E K + E ++ ++ I
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 64 -FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
+ + +VME + +FS Q+IS + Y HS H
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126
Query: 123 RDLKLENTLL-DGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPEVLA 173
RD+K +N L+ G + I DFG +K + + + K+ GT Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR--VS 231
E + D+ S G L +G+ P++ + +K + +
Sbjct: 187 GIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 232 ADCRHLLSQIFVADPSKDP 250
++ L+ P
Sbjct: 246 SEFATYLNFCRSLRFDDKP 264
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 3e-50
Identities = 54/252 (21%), Positives = 97/252 (38%), Gaps = 13/252 (5%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
E + V+ LG+G FG + + VAVK +++G + E + L+H ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 63 RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
R V+ T + I+ EY G L F + S + + ++ Q+ G+++
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEYD 178
HRDL+ N L+ KI DFG ++ + + APE + +
Sbjct: 131 IHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
K SDVWS G+ L ++ + ++R Y + + L+
Sbjct: 189 IK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPEELYQLM 243
Query: 239 SQIFVADPSKDP 250
+ P P
Sbjct: 244 RLCWKERPEDRP 255
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 3e-50
Identities = 67/276 (24%), Positives = 119/276 (43%), Gaps = 30/276 (10%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHP 59
++YE ++++G G +G +++ T E+VA+K + + + + + REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
NI+R +VL + L +V E+ G + + F QL+ G+ +CHS
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYIAPEVLARKEYD 178
+ HRDLK +N L++ LK+ +FG +++ + + S V T Y P+VL +
Sbjct: 122 VLHRDLKPQNLLIN--RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------QYFLPDYV-- 228
D+WS G + P D + K I R+ LPDY
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 229 --------------RVSADCRHLLSQIFVADPSKDP 250
+++A R LL + +P +
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-50
Identities = 57/278 (20%), Positives = 106/278 (38%), Gaps = 22/278 (7%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHP 59
+YE + ++G G FG R ++T + VA+K + + REI + L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 60 NIIRFKEVLLTPT--------HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
N++ E+ T + +V ++ +F+ E + Q L++G
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAY 166
+ Y H +I HRD+K N L+ LK+ DFG ++ ++ + V T Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLIT--RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
PE+L + G D+W G + M + + + + I + +
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG----NTEQHQLALISQLCGSITP 243
Query: 227 YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264
V + D L ++ + K KA +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 7e-50
Identities = 68/287 (23%), Positives = 115/287 (40%), Gaps = 40/287 (13%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRH 58
Y ++ +GSG +G D RT VA+K + R + + RE+ + +RH
Sbjct: 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 76
Query: 59 PNIIRFKEV------LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
N+I +V L T +VM + G ++ + ED +F Q++ G+
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
Y H+ I HRDLK N ++ LKI DFG ++ S+ V T Y APEV+
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVN--EDCELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVI 190
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI----------------DR 216
+ D+WS G + M+ G F+ + ++ + D
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 217 IRNVQYFLPDYVR---------VSADCRHLLSQIFVADPSKDPHSRD 254
+N LP+ + S +LL ++ V D + + +
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 8e-50
Identities = 69/266 (25%), Positives = 120/266 (45%), Gaps = 12/266 (4%)
Query: 3 ERYEPVKELGSGNFGV---ARLVRDKRTKELVAVKYIERGK-----KIDENVQREIINHR 54
E +E +K LG+G +G R + T +L A+K +++ K E+ + E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 55 SLRH-PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
+R P ++ T T L ++++Y GGELF + RF+E E + + +++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
+ H + I +RD+KLEN LLD + L + GT Y+AP+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 174 RKEY-DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
+ K D WS GV +Y +L GA PF + + + RI + P +SA
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSA 261
Query: 233 DCRHLLSQIFVADPSKDPHSRDQKAS 258
+ L+ ++ + DP K + A
Sbjct: 262 LAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-49
Identities = 66/281 (23%), Positives = 104/281 (37%), Gaps = 38/281 (13%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPN 60
RY + +G G +G+ D K VA+K I + + REI RH N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 61 IIRFKEVLLTPTH----LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
II +++ PT ++ + G +L+ ++ S D +F Q++ G+ Y H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIAPEVL 172
S + HRDLK N LL+ LKICDFG ++ V T Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI--------------- 217
+ K D+WS G L ML F + +
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 218 ----------RNVQYFLPDYVRVSADCRHLLSQIFVADPSK 248
+N + + + LL ++ +P K
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 285
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 162 bits (410), Expect = 2e-49
Identities = 66/275 (24%), Positives = 115/275 (41%), Gaps = 30/275 (10%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHP 59
E+Y ++++G G +GV ++ E A+K I K I REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
NI++ +V+ T L +V E+ G A+ F QL++G++YCH
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEYD 178
+ HRDLK +N L++ + LKI DFG +++ G+ + + T Y AP+VL +
Sbjct: 121 VLHRDLKPQNLLIN--REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK-----------TIDRIRNVQYFLPDY 227
D+WS G M+ G F + + + + + P++
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 228 VR------------VSADCRHLLSQIFVADPSKDP 250
+ LLS++ DP++
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-49
Identities = 60/261 (22%), Positives = 98/261 (37%), Gaps = 19/261 (7%)
Query: 9 KELGSGNFGVARLV--RDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIR 63
KELGSGNFG + + K+ + VAVK ++ + + + E + L +P I+R
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 64 FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
+ + + +VME A G L + + Q+ G+ Y HR
Sbjct: 73 MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKS----GLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
DL N LL Q KI DFG SK+ + + APE + ++
Sbjct: 132 DLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 180 KISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
K SDVWS GV ++ G P+ + + + + + L+
Sbjct: 190 K-SDVWSFGVLMWEAFSYGQKPYRG----MKGSEVTAMLEKGER-MGCPAGCPREMYDLM 243
Query: 239 SQIFVADPSKDPHSRDQKASL 259
+ + D P + L
Sbjct: 244 NLCWTYDVENRPGFAAVELRL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (410), Expect = 3e-49
Identities = 58/261 (22%), Positives = 108/261 (41%), Gaps = 21/261 (8%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKE---LVAVKYIERG--KKIDENVQREIINHRSLR 57
+ + +G+G FG K + VA+K ++ G +K + E
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFA-RICSAGRFSEDEARFFFQQLISGVSYCH 116
HPN+I + V+ T + I+ E+ G L + + G+F+ + + + +G+ Y
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSK------SGLLHSQPKSTVGTPAYIAPE 170
M HRDL N L++ + K+ DFG S+ S ++ + APE
Sbjct: 146 DMNYVHRDLAARNILVNSNLVC--KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203
Query: 171 VLARKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
+ +++ SDVWS G+ ++ ++ G P+ D + I+ I Y LP +
Sbjct: 204 AIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD----MTNQDVINAIEQ-DYRLPPPMD 257
Query: 230 VSADCRHLLSQIFVADPSKDP 250
+ L+ + D + P
Sbjct: 258 CPSALHQLMLDCWQKDRNHRP 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (409), Expect = 4e-49
Identities = 43/263 (16%), Positives = 91/263 (34%), Gaps = 16/263 (6%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
Y+ + +G G+FGV + + VA+K+ R + ++ E ++ L I
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63
Query: 63 -RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
H +V++ +FS +Q+++ V H +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 122 HRDLKLENTLLDGSPQP---RLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
+RD+K +N L+ + + DFG K + + + K+ GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
+E + D+ + G L G+ P+ ++ +RI + P +
Sbjct: 184 THLGREQSRR-DDLEALGHVFMYFLRGSLPW-QGLKAATNKQKYERIGEKKQSTP-LREL 240
Query: 231 SADCRHLLSQIFVADPSKDPHSR 253
A + + +
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 5e-49
Identities = 64/252 (25%), Positives = 98/252 (38%), Gaps = 19/252 (7%)
Query: 9 KELGSGNFGVARLVRDKRTKE--LVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRF 64
ELG GNFG R + K+ VA+K +++G K E + RE L +P I+R
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 65 KEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHR 123
V L +VME A GG L + Q+ G+ Y HR
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
DL N LL + I DFG SK ++ + + APE + +++
Sbjct: 134 DLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 180 KISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
+ SDVWS GVT++ L G P++ + + I + + L+
Sbjct: 192 R-SDVWSYGVTMWEALSYGQKPYKK----MKGPEVMAFIEQ-GKRMECPPECPPELYALM 245
Query: 239 SQIFVADPSKDP 250
S ++ P
Sbjct: 246 SDCWIYKWEDRP 257
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-48
Identities = 68/287 (23%), Positives = 108/287 (37%), Gaps = 37/287 (12%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRT-KELVAVKYI---ERGKKIDENVQREIINHRSL- 56
+++YE V E+G G +G RD + VA+K + + + + RE+ R L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 57 --RHPNIIRFKEVLLTP-----THLAIVMEYAAGGEL-FARICSAGRFSEDEARFFFQQL 108
HPN++R +V T L +V E+ + + + QL
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIA 168
+ G+ + HS + HRDLK +N L+ S Q K+ DFG ++ S V T Y A
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQI--KLADFGLARIYSFQMALTSVVVTLWYRA 183
Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI----------- 217
PEVL + Y D+WS G M F D K +D I
Sbjct: 184 PEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 218 ----------RNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRD 254
++ Q + + LL + +P+K +
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-48
Identities = 61/256 (23%), Positives = 105/256 (41%), Gaps = 16/256 (6%)
Query: 3 ERYEPVKELGSGNFGV---ARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLR 57
ER E + +G G FG + + VA+K + + E +E + R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCH 116
HP+I++ V +T + I+ME GEL + + + QL + ++Y
Sbjct: 67 HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLAR 174
S HRD+ N L+ +K+ DFG S+ + K++ ++APE +
Sbjct: 126 SKRFVHRDIAARNVLVSS--NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
+ + SDVW GV ++ +L+ P I RI N + LP
Sbjct: 184 RRFTSA-SDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRIENGER-LPMPPNCPPTL 238
Query: 235 RHLLSQIFVADPSKDP 250
L+++ + DPS+ P
Sbjct: 239 YSLMTKCWAYDPSRRP 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-48
Identities = 54/262 (20%), Positives = 94/262 (35%), Gaps = 16/262 (6%)
Query: 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI------ERGKKIDENVQREIINHRS 55
E ++ +K LGSG FG E V + K ++ + E S
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
+ +P++ R + LT T I G L + Q+ G++Y
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST---VGTPAYIAPEVL 172
+ HRDL N L+ +KI DFG +K + ++A E +
Sbjct: 128 EDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
+ Y + SDVWS GVT++ ++ D +++ LP +
Sbjct: 186 LHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----GERLPQPPICTI 240
Query: 233 DCRHLLSQIFVADPSKDPHSRD 254
D ++ + ++ D P R+
Sbjct: 241 DVYMIMVKCWMIDADSRPKFRE 262
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 7e-48
Identities = 61/283 (21%), Positives = 98/283 (34%), Gaps = 42/283 (14%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKEL-----VAVKYIERGKKIDE--NVQREIINHRS 55
E E K LGSG FG + VAVK ++ E + E+
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 56 L-RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS---------------------- 92
L H NI+ + ++ EY G+L + S
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 93 -AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK-- 149
+ ++ F Q+ G+ + HRDL N L+ + ICDFG ++
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVK--ICDFGLARDI 214
Query: 150 -SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDP 207
S + + ++APE L Y K SDVWS G+ L+ + +G P+
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 208 RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDP 250
NF K I + + + + ++ + D K P
Sbjct: 274 ANFYKLIQN----GFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-47
Identities = 59/269 (21%), Positives = 95/269 (35%), Gaps = 28/269 (10%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKEL--VAVKYIERGKKID--ENVQREIINHRSL-R 57
+ +G GNFG R K+ A+K ++ D + E+ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 58 HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARI----------------CSAGRFSEDEA 101
HPNII +L + +EYA G L + +A S +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 102 RFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 161
F + G+ Y + HRDL N L+ KI DFG S+ ++ +
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGE--NYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ 221
++A E L Y SDVWS GV L+ ++ P + +++
Sbjct: 188 LPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGT---PYCGMTCAELYEKLPQ-G 242
Query: 222 YFLPDYVRVSADCRHLLSQIFVADPSKDP 250
Y L + + L+ Q + P + P
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERP 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 1e-46
Identities = 60/282 (21%), Positives = 101/282 (35%), Gaps = 41/282 (14%)
Query: 3 ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYI--ERGKKIDENVQREIINHRS 55
E V+++G G FG R +VAVK + E + + QRE
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-------------------- 95
+PNI++ V + ++ EY A G+L + S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 96 ----FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK-- 149
S E +Q+ +G++Y + HRDL N L+ + KI DFG S+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV--KIADFGLSRNI 190
Query: 150 -SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR 208
S + + ++ PE + Y + SDVW+ GV L+ + P
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQ---PYYGM 246
Query: 209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDP 250
+ I +R+ L + +L+ + P+ P
Sbjct: 247 AHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRP 287
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 7e-45
Identities = 53/254 (20%), Positives = 96/254 (37%), Gaps = 19/254 (7%)
Query: 9 KELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDE--NVQREIINHRSLRHPNIIR 63
+ +G G+FG L+ + K AVK + R I E E I + HPN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 64 FKEVLL-TPTHLAIVMEYAAGGELFA-RICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
+ L + +V+ Y G+L + + F Q+ G+ + S +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPEVLARKE 176
HRDL N +LD K+ DFG ++ ++A E L ++
Sbjct: 153 HRDLAARNCMLDEKFTV--KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
+ K SDVWS GV L+ ++ P + + + ++ + P+Y
Sbjct: 211 FTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--LQGRRLLQPEY--CPDPLYE 265
Query: 237 LLSQIFVADPSKDP 250
++ + + P
Sbjct: 266 VMLKCWHPKAEMRP 279
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-44
Identities = 66/280 (23%), Positives = 116/280 (41%), Gaps = 40/280 (14%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHP 59
ERY+ + +GSG +G D +T VAVK + R + + RE+ + ++H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 60 NIIRFKEVLLTPTHLA-----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
N+I +V L ++ + G +L I + ++D +F Q++ G+ Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN-NIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
HS +I HRDLK N ++ LKI DFG ++ + V T Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLN 192
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFED--------------------------PEDPR 208
+ + D+WS G + +L G F E R
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK 248
N+ +++ ++ + F ++ + LL ++ V D K
Sbjct: 253 NYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDK 291
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-44
Identities = 57/263 (21%), Positives = 101/263 (38%), Gaps = 18/263 (6%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKE----LVAVKYIERG--KKIDENVQREIINHRSL 56
K +G+G FG K + VA+K ++ G +K + E
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYC 115
H NIIR + V+ + I+ EY G L + G FS + + + +G+ Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIAPEV 171
+M HRDL N L++ + K+ DFG S+ + APE
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVC--KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
++ +++ SDVWS G+ ++ ++ K I+ + LP +
Sbjct: 185 ISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----GFRLPTPMDCP 239
Query: 232 ADCRHLLSQIFVADPSKDPHSRD 254
+ L+ Q + + ++ P D
Sbjct: 240 SAIYQLMMQCWQQERARRPKFAD 262
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-43
Identities = 56/277 (20%), Positives = 90/277 (32%), Gaps = 35/277 (12%)
Query: 3 ERYEPVKELGSGNFGVARLVRD-----KRTKELVAVKYIERGKKID--ENVQREIINHRS 55
R K LG+G FG VAVK ++ + E + E+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 56 L-RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS------------------AGRF 96
L H NI+ ++ EY G+L +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 97 SEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
++ F Q+ G+++ S HRDL N LL KICDFG ++ S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT--KICDFGLARDIKNDSN 200
Query: 157 PKST---VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT 213
++APE + Y + SDVWS G+ L+ +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP---YPGMPVDSK 256
Query: 214 IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDP 250
++ + + A+ ++ + ADP K P
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 5e-42
Identities = 53/275 (19%), Positives = 97/275 (35%), Gaps = 32/275 (11%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKE-------LVAVKYI--ERGKKIDENVQREIINH 53
+R K LG G FG L + VAVK + + +K ++ E+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 54 RSL-RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARI----------------CSAGRF 96
+ + +H NII L +++EYA+ G L + +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 97 SEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHS 155
S + Q+ G+ Y S + HRDL N L+ ++ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID 215
+ + ++APE L + Y + SDVWS GV L+ + P +
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGS---PYPGVPVEELFK 248
Query: 216 RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDP 250
++ + + + + ++ + A PS+ P
Sbjct: 249 LLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRP 282
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 4e-41
Identities = 66/291 (22%), Positives = 105/291 (36%), Gaps = 51/291 (17%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHP 59
+RY+ +K +GSG G+ D VA+K + R + + RE++ + + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 60 NIIRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
NII V + +VME + + Q++ G+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
+ HS I HRDLK N ++ KI DFG +++ V T Y APEV+
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTL--KILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED---------------PRNFRKTIDRIR 218
Y + D+WS G + M+ F + P +K +R
Sbjct: 192 GMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 219 NVQYFLPDYVR---------------------VSADCRHLLSQIFVADPSK 248
N P Y ++ R LLS++ V DP+K
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 5e-41
Identities = 54/229 (23%), Positives = 83/229 (36%), Gaps = 27/229 (11%)
Query: 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
+ +G G FG + E VAVK ++ + EI LRH NI+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60
Query: 63 RFKEVL----LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
F T T L +V +Y G LF + + + + SG+++ H
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHME 119
Query: 119 E--------ICHRDLKLENTLLDGSPQPRLKICDFG-----YSKSGLLHSQPKSTVGTPA 165
I HRDLK +N L+ I D G S + + P VGT
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKK--NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 166 YIAPEVLARKEYDGKI-----SDVWSCGVTLYVMLVGAYPFEDPEDPRN 209
Y+APEVL +D+++ G+ + + ED +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-39
Identities = 49/268 (18%), Positives = 96/268 (35%), Gaps = 27/268 (10%)
Query: 3 ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKKIDE--NVQREIINHRS 55
E+ +ELG G+FG+ K + VA+K + + E E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRF----------SEDEARFFF 105
+++R V+ ++ME G+L + + S S +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 106 QQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVG 162
++ G++Y ++ + HRDL N ++ +KI DFG ++ + + +
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVA--EDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY 222
+++PE L + DVWS GV L+ + A P + + + +
Sbjct: 198 PVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQ---PYQGLSNEQVLRFVME-GG 252
Query: 223 FLPDYVRVSADCRHLLSQIFVADPSKDP 250
L L+ + +P P
Sbjct: 253 LLDKPDNCPDMLFELMRMCWQYNPKMRP 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-38
Identities = 57/276 (20%), Positives = 99/276 (35%), Gaps = 34/276 (12%)
Query: 3 ERYEPVKELGSGNFGV-----ARLVRDKRTKELVAVKYIERGKKIDEN---VQREIINHR 54
+R + K LG G FG A + T VAVK ++ G E+ + I
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 55 SLRHPNIIRFKEVLLTP-THLAIVMEYAAGGELFARICSAGR----------------FS 97
H N++ P L +++E+ G L + S +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 98 EDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLH 154
+ + Q+ G+ + S + HRDL N LL + +KICDFG ++ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS--EKNVVKICDFGLARDIYKDPDY 190
Query: 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
+ ++APE + + Y + SDVWS GV L+ + P +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGAS---PYPGVKIDEEF 246
Query: 215 DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDP 250
R + + + + + +PS+ P
Sbjct: 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 282
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 126 bits (317), Expect = 7e-35
Identities = 54/275 (19%), Positives = 101/275 (36%), Gaps = 21/275 (7%)
Query: 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR 63
RY V++LG G+F L +D VA+K + K E + EI + + + +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 64 ---------------FKEVLLTPTHLAIVMEYAAGGEL-FARICSAGRFSEDEARFFFQQ 107
F H+ +V E L + + +Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 108 LISGVSYC-HSMEICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTP 164
L+ G+ Y I H D+K EN L++ SP+ ++I + +++ T
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 165 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 224
Y +PEVL + +D+WS ++ ++ G + F +P++ ++ K D I + L
Sbjct: 194 EYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLF-EPDEGHSYTKDDDHIAQIIELL 251
Query: 225 PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259
+ F + S+ + L
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 286
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.0 bits (173), Expect = 1e-15
Identities = 31/203 (15%), Positives = 55/203 (27%), Gaps = 49/203 (24%)
Query: 9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK-----------KIDENVQREIINHRSLR 57
K +G G ++ E VK+ + G D + I
Sbjct: 6 KLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 58 HPNIIRFKEVLLTPTH----LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
+ + + + + + A++ME R + ++ V+
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELI-------DAKELYRVRVENPDEVLDMILEEVA 117
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
+ I H DL N L+ + I DF S V E+L
Sbjct: 118 KFYHRGIVHGDLSQYNVLVSE---EGIWIIDFPQS------------VEVGEEGWREILE 162
Query: 174 R----------KEYDGKISDVWS 186
R + Y D+ S
Sbjct: 163 RDVRNIITYFSRTY-RTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 269 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.93 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.55 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.46 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.97 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.83 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.16 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-65 Score=401.47 Aligned_cols=251 Identities=33% Similarity=0.587 Sum_probs=222.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++.+.||+|+||+||+|++..+++.||+|++.+. ....+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 6799999999999999999999999999999998642 234467889999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||+++|+|.+++.+.+++++..+..++.||+.||+|||++|++||||||+||+++.++. +||+|||++.... .....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~-~~~~~ 162 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SSRRT 162 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCC-CCCCE
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecC-CCccc
Confidence 99999999999999889999999999999999999999999999999999999998887 9999999997533 23344
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...||+.|+|||++.+..++. ++|||||||++|+|+||..||...+. ......+......+|. .+|+++.+||
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~-~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~li 235 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEFLVGKPPFEANTY----QETYKRISRVEFTFPD--FVTEGARDLI 235 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTTCCCCCT--TSCHHHHHHH
T ss_pred ccCCCCcccCHHHHcCCCCCc-hhhhhhHhHHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCCCCc--cCCHHHHHHH
Confidence 567899999999998877654 49999999999999999999976543 3445556666666665 7999999999
Q ss_pred HHHhhhCCCCCCCcHHHhhccChhh
Q 024336 239 SQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.+||++||.+|||++|+++|||+.+
T Consensus 236 ~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 236 SRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHccCCHhHCcCHHHHHcCcCcCC
Confidence 9999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-65 Score=404.97 Aligned_cols=261 Identities=33% Similarity=0.554 Sum_probs=222.3
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.++|++++.||+|+||+||+|++..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 478999999999999999999999999999999987543 233468899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC---CC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQ 156 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~---~~ 156 (269)
|+++|+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+|...... ..
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCcccc
Confidence 9999999999988888999999999999999999999999999999999999998887 999999999743222 22
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....||+.|+|||++.+..+.++++||||||+++|+|+||.+||.......... ..........+.+..+|+++.+
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---SDWKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH---HHHHTTCTTSTTGGGSCHHHHH
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH---HHHhcCCCCCCccccCCHHHHH
Confidence 3455799999999999888877777999999999999999999997655433222 2222333334445578999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccChhhhhhc
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVPEEFAER 267 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~~~~~~~ 267 (269)
||.+||+.||++|||++|+++|||++.-.++
T Consensus 239 li~~~L~~dP~~R~t~~eil~hpwf~~~l~k 269 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKKDRWYNKPLKK 269 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhCcCCCC
Confidence 9999999999999999999999999864444
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-63 Score=396.80 Aligned_cols=255 Identities=26% Similarity=0.401 Sum_probs=219.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 468999999999999999999999999999999987543 3446789999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 159 (269)
++||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++....... ....
T Consensus 99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCC
T ss_pred cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--Eeeccchhheeeccccccccc
Confidence 999999988755 56999999999999999999999999999999999999998887 9999999997543332 3345
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (269)
..||+.|+|||.+.+..++. ++|||||||++|+|+||..||.+........ ..........+.+..+|+++.+||.
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALY---LIATNGTPELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred cccCCCccChhhhcCCCCCc-hhceehHhHHHHHHhhCCCCCCCCCHHHHHH---HHHhCCCCCCCCcccCCHHHHHHHH
Confidence 57999999999998877755 5999999999999999999998755433322 2222333334444578999999999
Q ss_pred HHhhhCCCCCCCcHHHhhccChhh
Q 024336 240 QIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 240 ~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+||++||.+|||+.|+++|+|++.
T Consensus 252 ~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 252 RCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHccCChhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999964
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-64 Score=403.41 Aligned_cols=258 Identities=33% Similarity=0.567 Sum_probs=206.2
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
|.++|++.+.||+|+||+||+|++..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4578999999999999999999999999999999987543 22345778999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecC-CCCCcEEEeecCCcccCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~-~~~~~~~l~df~~~~~~~~~~~~ 157 (269)
||++|++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||++.. +..+.+||+|||++.........
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~ 166 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence 99999999999998889999999999999999999999999999999999999964 22234999999999765545555
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC--CCcCCCCHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCR 235 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (269)
....||+.|+|||++.+..++. ++|||||||++|+|+||..||.+.... .....+....... +.+..+|+++.
T Consensus 167 ~~~~GT~~y~APE~~~~~~~~~-~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQKPYSK-AVDCWSIGVIAYILLCGYPPFYDENDA----KLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp ------CTTSCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred eeeeeCccccCcHHHcCCCCCc-HHHhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHhccCCCCCCccccCCCHHHH
Confidence 5677999999999998877755 499999999999999999999875543 3334444444333 33457899999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+||.+||++||.+|||++|+++|||+..
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 9999999999999999999999999964
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-63 Score=396.76 Aligned_cols=253 Identities=31% Similarity=0.480 Sum_probs=220.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++++.||+|+||+||+|++..+|+.||+|++.+. ....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 6799999999999999999999999999999998743 234467889999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC---
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--- 155 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--- 155 (269)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++. ++|+|||++.......
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCccc
Confidence 99999999999999999999999999999999999999999999999999999998887 9999999997533222
Q ss_pred CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
......||+.|+|||++.+..++ .++|||||||++|+|+||..||...+. ......+....+.++. .+++++.
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~ 238 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPE--KFFPKAR 238 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHTTCCCCCT--TCCHHHH
T ss_pred ccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCH----HHHHHHHHcCCCCCCc--cCCHHHH
Confidence 23345799999999999877764 459999999999999999999987543 3344555666666665 7999999
Q ss_pred HHHHHHhhhCCCCCCCcHH------HhhccChhhh
Q 024336 236 HLLSQIFVADPSKDPHSRD------QKASLVPEEF 264 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~------~l~~~~~~~~ 264 (269)
+||.+||++||++|||++| +++||||+.+
T Consensus 239 ~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 9999999999999999998 5789998765
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-63 Score=396.99 Aligned_cols=259 Identities=33% Similarity=0.572 Sum_probs=224.7
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-------cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCe
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-------KIDENVQREIINHRSLRHPNIIRFKEVLLTPTH 73 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (269)
|.++|++.+.||+|+||+||+|++..+|+.||+|++.+.. ...+.+.+|+.++++++||||+++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4578999999999999999999999999999999986532 124678999999999999999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCC--CcEEEeecCCcccC
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ--PRLKICDFGYSKSG 151 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~--~~~~l~df~~~~~~ 151 (269)
+|+||||+++|+|.+++.+.+.+++..++.++.|++.||.|||+.|++||||||+||+++.++. ..+|++|||++...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999999998889999999999999999999999999999999999999987663 34999999999865
Q ss_pred CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC--cCC
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 229 (269)
..........+++.|+|||.+.+..++.+ +|||||||++|+|+||..||.+.+.. +....+......++. +..
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~ 242 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQ----ETLANVSAVNYEFEDEYFSN 242 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHTTCCCCCHHHHTT
T ss_pred CCCccccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCCHH----HHHHHHHhcCCCCCchhcCC
Confidence 55555666788999999999987777555 99999999999999999999875543 334444444443332 246
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 230 VSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
+|+++.+||.+||+.||++|||++|+++|+|++..
T Consensus 243 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 89999999999999999999999999999999764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-63 Score=400.11 Aligned_cols=260 Identities=28% Similarity=0.419 Sum_probs=216.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
.++|++++.||+|+||+||+|++..+|+.||+|++..... ..+.+.+|+.++++++||||++++++|.+++.+|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5789999999999999999999999999999999875432 24568899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
|++||+|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++. +||+|||+|.... .....
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~-~~~~~ 161 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI-DSMAN 161 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHH-HHTC-
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccC-CCccc
Confidence 99999999999988899999999999999999999997 59999999999999998887 9999999987432 22334
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHH--------------------------
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK-------------------------- 212 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~-------------------------- 212 (269)
...||+.|+|||++.+..++.+ +||||+||++|+|++|+.||...+.......
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred cccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence 5689999999999998877655 9999999999999999999976554321110
Q ss_pred ------------HHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 213 ------------TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 213 ------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
....+............+|.++.+||.+||..||.+|||++|+|+|||++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 01111111111111124688999999999999999999999999999998754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.9e-63 Score=403.72 Aligned_cols=257 Identities=28% Similarity=0.496 Sum_probs=221.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
++|++++.||+|+||.||+|++..+|+.||+|++..... ..+.+.+|+.++++++||||+++++++.+++.+|+||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 689999999999999999999999999999999875432 3456889999999999999999999999999999999999
Q ss_pred CCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcc
Q 024336 82 AGGELFARIC-SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST 160 (269)
Q Consensus 82 ~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (269)
+||+|.+++. ..+++++..+..++.||+.||.|||++|++||||||+||+++.+..+.+||+|||++............
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~ 185 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT 185 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEE
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccccee
Confidence 9999999985 455799999999999999999999999999999999999997654455999999999865555555567
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC--CcCCCCHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLL 238 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li 238 (269)
.+|+.|+|||++.+..++ .++|||||||++|+|+||..||.+.+.. +....+.......+ ....+|+++.+||
T Consensus 186 ~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li 260 (350)
T d1koaa2 186 TGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDD----ETLRNVKSCDWNMDDSAFSGISEDGKDFI 260 (350)
T ss_dssp CSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCSCCGGGGGCCHHHHHHH
T ss_pred cCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 899999999999887775 4599999999999999999999875443 33444444444333 2346899999999
Q ss_pred HHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 239 SQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
.+||..||++|||++|+|+|+|+...
T Consensus 261 ~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 261 RKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred HHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-62 Score=391.12 Aligned_cols=256 Identities=27% Similarity=0.369 Sum_probs=216.9
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecC-ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG-KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.+.|++++.||+|+||+||+|++..+|..||+|++... ....+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 35699999999999999999999999999999998754 34456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCC
Q 024336 81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPK 158 (269)
Q Consensus 81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~ 158 (269)
+++|+|.+++.+ .+++++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++...... ....
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHT
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCccccc
Confidence 999999998765 457999999999999999999999999999999999999998887 999999998642221 1223
Q ss_pred cccCCCcccCchhhcc----ccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc-ccCCCcCCCCHH
Q 024336 159 STVGTPAYIAPEVLAR----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRVSAD 233 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (269)
...||+.|+|||++.. ....+.++|||||||++|+|+||..||...+..+.+.. +.... .....+..+|++
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~s~~ 244 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK----IAKSEPPTLAQPSRWSSN 244 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH----HHHSCCCCCSSGGGSCHH
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH----HHcCCCCCCCccccCCHH
Confidence 5678999999999853 22335569999999999999999999987665443332 22222 233444578999
Q ss_pred HHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 234 CRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 234 ~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
+.+||.+||+.||.+|||++|+++|+|++.
T Consensus 245 ~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999999964
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-61 Score=393.46 Aligned_cols=253 Identities=32% Similarity=0.555 Sum_probs=224.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++++.||+|+||.||+|++..+|+.||+|++.+. ....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 6899999999999999999999999999999999753 234466889999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQP 157 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~ 157 (269)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+++.... ....
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~~~ 162 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATM 162 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCCB
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCCccc
Confidence 99999999999999999999999999999999999999999999999999999998887 99999999985433 2334
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....||+.|+|||++.+..++.+ +|+|||||++|+|++|.+||.+.+. ......+......+|. .+|+++.+|
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~dl 235 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFPR--TLSPEAKSL 235 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred ccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcCH----HHHHHHHhcCCCCCCc--cCCHHHHHH
Confidence 45679999999999998888554 9999999999999999999987554 3344555666666665 799999999
Q ss_pred HHHHhhhCCCCCCC-----cHHHhhccChhhh
Q 024336 238 LSQIFVADPSKDPH-----SRDQKASLVPEEF 264 (269)
Q Consensus 238 i~~~l~~~p~~Rps-----~~~~l~~~~~~~~ 264 (269)
|.+||++||.+|++ ++|+++|+||..+
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 99999999999995 8999999999764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-62 Score=392.87 Aligned_cols=252 Identities=26% Similarity=0.340 Sum_probs=215.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc----cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
+.|+.++.||+|+||+||+|++..+|+.||||++...... .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3599999999999999999999999999999998765432 235788999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||+.+|++..++...+++++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++.... ...
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~---~~~ 169 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMA---PAN 169 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSS---SBC
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccC---CCC
Confidence 99999999888878888999999999999999999999999999999999999998887 9999999997432 234
Q ss_pred cccCCCcccCchhhccc--cCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 159 STVGTPAYIAPEVLARK--EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
...||+.|+|||++.+. ...+.++|||||||++|+|++|..||.+..... ....+............+|+++.+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~s~~~~~ 245 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIAQNESPALQSGHWSEYFRN 245 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhCCCCCCCCCCCCHHHHH
Confidence 56799999999998643 223455999999999999999999998755432 233333333333344578999999
Q ss_pred HHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 237 LLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
||.+||+.||.+|||++|+++|+|+..
T Consensus 246 li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 999999999999999999999999853
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-62 Score=401.50 Aligned_cols=256 Identities=27% Similarity=0.472 Sum_probs=221.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
++|++++.||+|+||+||+|.+..+|+.||+|++.... .....+.+|+.++++++||||++++++|.+++.+|+||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999999999999999987643 23356788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCcc
Q 024336 82 AGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST 160 (269)
Q Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (269)
+||+|.+.+...+ ++++.+++.++.||+.||.|||++||+||||||+||+++....+++||+|||++............
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~ 188 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 188 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeec
Confidence 9999998876544 699999999999999999999999999999999999998544445999999999865555555667
Q ss_pred cCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCC--CcCCCCHHHHHHH
Q 024336 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLL 238 (269)
Q Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li 238 (269)
.+++.|+|||.+.+..++. ++|||||||++|+|+||..||.+.+.. .....+......++ .+..+|+++.+||
T Consensus 189 ~gt~~y~aPE~~~~~~~~~-~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 189 TATAEFAAPEIVDREPVGF-YTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp CSSGGGCCHHHHTTCCBCH-HHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred cCcccccCHHHHcCCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 8999999999998877754 499999999999999999999876543 33344444444333 2347899999999
Q ss_pred HHHhhhCCCCCCCcHHHhhccChhh
Q 024336 239 SQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.+||+.||.+|||++|+|+|+|++.
T Consensus 264 ~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 264 KNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp HTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHHccCChhHCcCHHHHhcCHhhCC
Confidence 9999999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-61 Score=383.07 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=211.0
Q ss_pred cccc-cccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEe----CCe
Q 024336 2 EERY-EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLT----PTH 73 (269)
Q Consensus 2 ~~~y-~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 73 (269)
..+| ++.+.||+|+||+||+|.+..++..||+|.+.... ...+.+.+|++++++++||||+++++++.+ +..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 3455 67788999999999999999999999999987543 223467899999999999999999999875 456
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEecC-CCCCcEEEeecCCccc
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDG-SPQPRLKICDFGYSKS 150 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~H~di~p~ni~i~~-~~~~~~~l~df~~~~~ 150 (269)
+++||||+++|+|.+++.+.+.+++..+..++.||+.||+|||++| |+||||||+||+++. ++. +||+|||++..
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~~ 164 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATL 164 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGG
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC--EEEeecCccee
Confidence 8999999999999999999889999999999999999999999999 999999999999964 566 99999999974
Q ss_pred CCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 151 GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
. .........||+.|+|||.+.+ .+ +.++|||||||++|+|+||..||....+...+ ...+.............
T Consensus 165 ~-~~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~---~~~i~~~~~~~~~~~~~ 238 (270)
T d1t4ha_ 165 K-RASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQI---YRRVTSGVKPASFDKVA 238 (270)
T ss_dssp C-CTTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH---HHHHTTTCCCGGGGGCC
T ss_pred c-cCCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHH---HHHHHcCCCCcccCccC
Confidence 2 2223345679999999999865 45 55599999999999999999999876554333 33333332222223367
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccChh
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPE 262 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~ 262 (269)
++++.+||.+||++||++|||++|+++|||++
T Consensus 239 ~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 89999999999999999999999999999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.8e-62 Score=384.73 Aligned_cols=257 Identities=32% Similarity=0.461 Sum_probs=222.2
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc----------cHHHHHHHHHHHhCC-CCCcceeeEEEEe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----------DENVQREIINHRSLR-HPNIIRFKEVLLT 70 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 70 (269)
.++|++.+.||+|+||+||+|++..+|+.||+|++.+.... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 58999999999999999999999999999999998764321 134778999999996 9999999999999
Q ss_pred CCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCccc
Q 024336 71 PTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 71 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~ 150 (269)
++.+|+||||+++++|.+++...+++++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||++..
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeE
Confidence 9999999999999999999999999999999999999999999999999999999999999998887 99999999986
Q ss_pred CCCCCCCCcccCCCcccCchhhcccc-----CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc--c
Q 024336 151 GLLHSQPKSTVGTPAYIAPEVLARKE-----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--F 223 (269)
Q Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~ 223 (269)
...........+|+.|.|||.+.+.. ..+.++||||+|+++|+|+||+.||...+... ....+..... .
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~----~~~~i~~~~~~~~ 235 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----MLRMIMSGNYQFG 235 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCC
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH----HHHHHHhCCCCCC
Confidence 55554555667899999999987432 23556999999999999999999998765433 2333333333 3
Q ss_pred CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 224 LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
.+....+|+++.+||.+||++||.+|||++|+++|+|++.+
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 33445799999999999999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-61 Score=389.60 Aligned_cols=251 Identities=33% Similarity=0.549 Sum_probs=222.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++++.||+|+||+||+|++..+|+.||+|++.+. ....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999999999999999998743 234467889999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||++|+++...+.....+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++... .....
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~--~~~~~ 159 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYV--PDVTY 159 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEEC--SSCBC
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEe--ccccc
Confidence 99999999999999999999999999999999999999999999999999999998887 999999999753 23344
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...||+.|+|||++.+..++. ++|||||||++|+|+||..||...+. ......+......++. .+|+++.++|
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~-~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~li 232 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNK-SIDWWSFGILIYEMLAGYTPFYDSNT----MKTYEKILNAELRFPP--FFNEDVKDLL 232 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCT-THHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHCCCCCCT--TSCHHHHHHH
T ss_pred cccCcccccCHHHHcCCCCCc-hhhccccchhHHHHHhCCCCCCCcCH----HHHHHHHHcCCCCCCC--CCCHHHHHHH
Confidence 567999999999998877765 49999999999999999999987544 3444555556665555 7999999999
Q ss_pred HHHhhhCCCCCC-----CcHHHhhccChhhh
Q 024336 239 SQIFVADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 239 ~~~l~~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
.+||.+||.+|+ |++++++|||++.+
T Consensus 233 ~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 233 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 999999999996 99999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-62 Score=398.08 Aligned_cols=258 Identities=23% Similarity=0.422 Sum_probs=225.7
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
|-++|++++.||+|+||+||+|.+..+|+.||+|++.........+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 45899999999999999999999999999999999987665556788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCc
Q 024336 81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 159 (269)
++|++|.+++.+.+ ++++.+++.++.||+.||.|||+.||+||||||+||+++.++..+++|+|||++...........
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~ 162 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccc
Confidence 99999999997665 79999999999999999999999999999999999999877666699999999976544444555
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC--cCCCCHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHL 237 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 237 (269)
..+++.|+|||.+.+..++. ++|||||||++|+|++|..||...... .....+......++. +..+|+++.+|
T Consensus 163 ~~~t~~y~ape~~~~~~~~~-~~DiWSlGvily~ll~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 163 LFTAPEYYAPEVHQHDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQ----QIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp EESCGGGSCHHHHTTCEECH-HHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred cccccccccchhccCCCCCc-hhhcccHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCChhhccCCCHHHHHH
Confidence 67899999999998777754 599999999999999999999876543 344445554444432 34689999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 238 LSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
|.+||.+||.+|||++|+++|+|+..
T Consensus 238 i~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHHccCChhHCcCHHHHhcCHhhcc
Confidence 99999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-62 Score=385.32 Aligned_cols=252 Identities=28% Similarity=0.474 Sum_probs=203.3
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEe--CCeEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLT--PTHLAI 76 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 76 (269)
.++|++++.||+|+||+||++++..+|+.||+|.+...... .+.+.+|+.++++++||||+++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 47899999999999999999999999999999998765332 3457889999999999999999999865 456899
Q ss_pred EEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeecCCCCcEEecCCCCCcEEEeecCC
Q 024336 77 VMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSME-----ICHRDLKLENTLLDGSPQPRLKICDFGY 147 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lh~~~-----i~H~di~p~ni~i~~~~~~~~~l~df~~ 147 (269)
||||+++|+|.+++.+ .+.+++..++.++.|++.||.|||++| |+||||||+||+++.++. +||+|||+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~ 160 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGL 160 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccc
Confidence 9999999999998854 457999999999999999999999976 999999999999998887 99999999
Q ss_pred cccCCCCC-CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC
Q 024336 148 SKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226 (269)
Q Consensus 148 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (269)
+....... ......+|+.|+|||++.+..++ +++||||||+++|+|+||..||...+.. .....+...... +.
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~----~~~~~i~~~~~~-~~ 234 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQK----ELAGKIREGKFR-RI 234 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHTCCC-CC
T ss_pred eeecccCCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHH----HHHHHHHcCCCC-CC
Confidence 87533322 23456789999999999877765 4599999999999999999999875442 333444444332 12
Q ss_pred cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 227 YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
+..+|+++.+||.+||+.||.+|||++|+++|||.
T Consensus 235 ~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 235 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 23789999999999999999999999999999994
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-60 Score=390.74 Aligned_cols=251 Identities=30% Similarity=0.506 Sum_probs=222.2
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
++|++++.||+|+||.||+|++..+|+.||+|++.+. ....+.+.+|+.+++.++||||+++++++.+...+++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 6899999999999999999999999999999998642 233456889999999999999999999999999999999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
|++.+|+|...+.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++.... ....
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~--~~~~ 196 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVK--GRTW 196 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECS--SCBC
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC--EEeeeceeeeecc--cccc
Confidence 99999999999999899999999999999999999999999999999999999998887 9999999997532 3344
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...||+.|+|||++.+..++. ++|||||||++|+|+||..||.+.+. ......+.......+. .+++++.+||
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~-~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~li 269 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNK-AVDWWALGVLIYEMAAGYPPFFADQP----IQIYEKIVSGKVRFPS--HFSSDLKDLL 269 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TCCHHHHHHH
T ss_pred cccCccccCCHHHHcCCCCCc-cccccchhHHHHHHHhCCCCCCCcCH----HHHHHHHhcCCCCCCc--cCCHHHHHHH
Confidence 567999999999998877755 49999999999999999999986543 3444555555555555 7999999999
Q ss_pred HHHhhhCCCCCC-----CcHHHhhccChhhh
Q 024336 239 SQIFVADPSKDP-----HSRDQKASLVPEEF 264 (269)
Q Consensus 239 ~~~l~~~p~~Rp-----s~~~~l~~~~~~~~ 264 (269)
.+||..||.+|+ |++++++|+||+.+
T Consensus 270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 999999999995 99999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-60 Score=391.31 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=216.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc----cccHHHHH---HHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQR---EIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
++|++.+.||+|+||.||+|++..+|+.||+|++.+.. .....+.+ ++.+++.++||||+++++++.+++.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999999999999999986432 12223334 466777788999999999999999999
Q ss_pred EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
+||||++||+|.+++.+...+++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||++..... .
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~-~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-K 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSS-S
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCC-C
Confidence 99999999999999999999999999999999999999999999999999999999998887 99999999975332 3
Q ss_pred CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
......||+.|+|||.+..+...+.++|||||||++|+|+||..||....... ...............+. .+|+++.
T Consensus 161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~--~~s~~~~ 237 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPD--SFSPELR 237 (364)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-HHHHHHHSSSCCCCCCS--SSCHHHH
T ss_pred cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccCCCCCCC--CCCHHHH
Confidence 34456799999999999766555666999999999999999999998755432 22333333344444444 7999999
Q ss_pred HHHHHHhhhCCCCCCC-----cHHHhhccChhhh
Q 024336 236 HLLSQIFVADPSKDPH-----SRDQKASLVPEEF 264 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps-----~~~~l~~~~~~~~ 264 (269)
+||.+||++||++||| ++|+++|+|++.+
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 9999999999999999 6999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-60 Score=383.81 Aligned_cols=253 Identities=34% Similarity=0.546 Sum_probs=219.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC----ccccHHHHHHHHHH-HhCCCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINH-RSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++++.||+|+||+||+|.+..+|+.||+|++.+. ....+.+..|...+ +.++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999999999999999999753 22334556666655 468999999999999999999999
Q ss_pred EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-C
Q 024336 78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-Q 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~ 156 (269)
|||+++|+|.+++...+.+++.+++.++.||+.||+|||++|++||||||+||+++.++. ++|+|||++....... .
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhccccccc
Confidence 999999999999999999999999999999999999999999999999999999998887 9999999997543322 3
Q ss_pred CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHH
Q 024336 157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236 (269)
Q Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.....||+.|+|||.+.+..++. ++|||||||++|+|+||..||.+.+. ..+...+....+.+|. .+|+++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvilyemltG~~PF~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~d 232 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNH-SVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIRMDNPFYPR--WLEKEAKD 232 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHHH
T ss_pred ccccCCCCCcCCHHHHcCCCCCc-hhhhhhhhHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCc--cCCHHHHH
Confidence 34457899999999999888765 59999999999999999999987544 3444555566666655 78999999
Q ss_pred HHHHHhhhCCCCCCCcH-HHhhccChhhh
Q 024336 237 LLSQIFVADPSKDPHSR-DQKASLVPEEF 264 (269)
Q Consensus 237 li~~~l~~~p~~Rps~~-~~l~~~~~~~~ 264 (269)
||.+||..||.+|||+. ++++|||++.+
T Consensus 233 li~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 99999999999999996 89999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-60 Score=378.39 Aligned_cols=250 Identities=30% Similarity=0.481 Sum_probs=215.0
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc-------ccHHHHHHHHHHHhCC--CCCcceeeEEEEeC
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSLR--HPNIIRFKEVLLTP 71 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~ 71 (269)
|+++|++.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+|+.++++++ ||||+++++++.++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 57899999999999999999999999999999999875321 1233668999999986 89999999999999
Q ss_pred CeEEEEEeecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCccc
Q 024336 72 THLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 150 (269)
Q Consensus 72 ~~~~~v~e~~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~ 150 (269)
+..++|||++.+ +++.+++.+...+++..++.++.|++.||+|||++|++||||||+||+++.+.. .++|+|||++..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~-~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGAL 160 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-EEEECCCTTCEE
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCC-eEEECcccccee
Confidence 999999999976 678888888889999999999999999999999999999999999999985532 399999999974
Q ss_pred CCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 151 GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
.. ........||+.|+|||.+.+..+.++++|||||||++|+|+||..||... ..+......++. .+
T Consensus 161 ~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----------~~i~~~~~~~~~--~~ 227 (273)
T d1xwsa_ 161 LK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----------EEIIRGQVFFRQ--RV 227 (273)
T ss_dssp CC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----------HHHHHCCCCCSS--CC
T ss_pred cc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----------hHHhhcccCCCC--CC
Confidence 32 233345679999999999988877777799999999999999999999752 123344445555 79
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
|+++.+||.+||+.||++|||++|+++|||++..
T Consensus 228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-60 Score=385.89 Aligned_cols=257 Identities=32% Similarity=0.490 Sum_probs=214.3
Q ss_pred cccccccc-eecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHh-CCCCCcceeeEEEEe----CCeEE
Q 024336 2 EERYEPVK-ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS-LRHPNIIRFKEVLLT----PTHLA 75 (269)
Q Consensus 2 ~~~y~~~~-~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~~~ 75 (269)
-++|++++ .||+|+||+||+|.+..+++.||||++.. ...+.+|+.++.+ ++||||++++++|.+ +..+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 46899875 59999999999999999999999999864 3567789988654 589999999999876 45799
Q ss_pred EEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CCcEEEeecCCcccCC
Q 024336 76 IVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGL 152 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~~ 152 (269)
+|||||+||+|.+++.+. .++++.+++.++.||+.||+|||+.|++||||||+||+++.+. .+.+||+|||++....
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence 999999999999999764 3699999999999999999999999999999999999998643 3459999999998655
Q ss_pred CCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCC--cCCC
Q 024336 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRV 230 (269)
Q Consensus 153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 230 (269)
.........||+.|+|||.+.+..++. ++|||||||++|+|+||.+||.+.............+......++. +..+
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~y~~-~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 244 (335)
T d2ozaa1 166 SHNSLTTPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244 (335)
T ss_dssp CCCCCCCCSCCCSSCCCCCCCGGGGSH-HHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred CCCccccccCCcccCCcHHHcCCCCCH-HHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence 556666778999999999998777755 4999999999999999999998776655555555555555554443 2468
Q ss_pred CHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 231 SADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
|+++.+||.+||+.||++|||+.|+++|+|+..
T Consensus 245 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 999999999999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-59 Score=373.87 Aligned_cols=261 Identities=27% Similarity=0.398 Sum_probs=214.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|++++.||+|+||+||+|.+..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999999999999999986432 235678899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC-CCCC
Q 024336 80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQP 157 (269)
Q Consensus 80 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~ 157 (269)
|+.++.+...... .+.+++..++.++.|++.||+|||++||+||||||+||+++.++. ++|+|||.+..... ....
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBCT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCcccc
Confidence 9987544443333 456999999999999999999999999999999999999998887 99999999864332 3344
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cC------------
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FL------------ 224 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~------------ 224 (269)
....+++.|+|||.+......+.++|+||||+++|+|++|..||...+................. .+
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 45678999999999888877777799999999999999999999876655444443332221110 00
Q ss_pred -CC---------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 225 -PD---------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 225 -~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
+. ...+++++.+||.+||..||++|||+.|+++|+|++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 00 124678899999999999999999999999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-59 Score=376.99 Aligned_cols=256 Identities=25% Similarity=0.338 Sum_probs=212.4
Q ss_pred ccceecccCceEEEEEEEecCCeEEEEEEeecCcc------ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEee
Q 024336 7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 7 ~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
.++.||+|+||+||+|.+..+|+.||||++..... ....+.+|+.++++++||||+++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46899999999999999999999999999865322 134688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCCc
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKS 159 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~ 159 (269)
+.++++..+......+++..+..++.||+.||+|||++|++||||||+||+++.++. +||+|||++...... .....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCcccccc
Confidence 999888877777778999999999999999999999999999999999999998887 999999999753332 23345
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cCC-------------
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLP------------- 225 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~------------- 225 (269)
..+|+.|+|||.+......+.++|||||||++|+|+||.+||......+.+....+....... .++
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 578999999999987766677799999999999999999999887665555444433221110 000
Q ss_pred --C------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 226 --D------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 226 --~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
. ...+++++.+||.+||..||++|||++|+|+|+|++..
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0 12467899999999999999999999999999999753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-59 Score=371.79 Aligned_cols=249 Identities=21% Similarity=0.273 Sum_probs=211.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
++|++.+.||+|+||+||+|.+..+|+.||||++..+....+.+.+|+.++++++||||+++++++.+++.+++||||++
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence 57899999999999999999999999999999998877777889999999999999999999999999999999999999
Q ss_pred CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC--CC
Q 024336 83 GGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PK 158 (269)
Q Consensus 83 ~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~--~~ 158 (269)
+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++........ ..
T Consensus 97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~~~~ 174 (287)
T d1opja_ 97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHA 174 (287)
T ss_dssp TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSEEET
T ss_pred CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCceeec
Confidence 99999998654 46899999999999999999999999999999999999998887 99999999975332222 12
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...+++.|+|||.+.+..++ .++||||||+++|+|++|..||....+........ .. ....+.+..+|+++.+||
T Consensus 175 ~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i---~~-~~~~~~~~~~~~~l~~li 249 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---EK-DYRMERPEGCPEKVYELM 249 (287)
T ss_dssp TEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---HT-TCCCCCCTTCCHHHHHHH
T ss_pred cccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH---hc-CCCCCCCccchHHHHHHH
Confidence 33478899999999887775 45999999999999999777765554443333322 22 223333347999999999
Q ss_pred HHHhhhCCCCCCCcHHHhhc
Q 024336 239 SQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~ 258 (269)
.+||+.||++|||++|+++.
T Consensus 250 ~~cl~~dP~~Rps~~ei~~~ 269 (287)
T d1opja_ 250 RACWQWNPSDRPSFAEIHQA 269 (287)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-58 Score=360.67 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=213.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
++|++.+.||+|+||+||++++. ++..||||.+..+....+.+.+|+.++++++||||+++++++.+++.+++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 68999999999999999999985 77889999999887778899999999999999999999999999999999999999
Q ss_pred CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC--CCc
Q 024336 83 GGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKS 159 (269)
Q Consensus 83 ~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~--~~~ 159 (269)
+|+|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++. +||+|||++........ ...
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceeecc
Confidence 9999888654 456899999999999999999999999999999999999998887 99999999974333222 223
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
..+++.|+|||.+.+..++. ++||||||+++|+|+| |..||...+..+ ....+.... ..+.+...++++.+||
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~-ksDiwS~G~~l~el~t~g~~Pf~~~~~~~----~~~~i~~~~-~~~~p~~~~~~l~~li 234 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSS-KSDIWAFGVLMWEIYSLGKMPYERFTNSE----TAEHIAQGL-RLYRPHLASEKVYTIM 234 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTSCHHH----HHHHHHTTC-CCCCCTTCCHHHHHHH
T ss_pred cCCCCCcCCcHHhcCCCCCc-ceeecccchhhHhHHhcCCCCCCCCCHHH----HHHHHHhCC-CCCCcccccHHHHHHH
Confidence 56788999999998887755 5999999999999998 899998776533 333333332 2334447899999999
Q ss_pred HHHhhhCCCCCCCcHHHhhcc
Q 024336 239 SQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+||+.||++|||++++++|+
T Consensus 235 ~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHh
Confidence 999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-58 Score=368.48 Aligned_cols=254 Identities=25% Similarity=0.334 Sum_probs=203.5
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc----cHHHHHHHHHHHhCCCCCcceeeEEEEeCC----
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPT---- 72 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 72 (269)
|.++|++.+.||+|+||+||+|.+..+|+.||+|++...... .+.+.+|+.+++.++||||+++++++..++
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 468999999999999999999999999999999999764332 235789999999999999999999988653
Q ss_pred eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCC
Q 024336 73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~ 152 (269)
.+|+||||++|++|...+...+++++.++..++.||+.||+|||++|++||||||+||+++.++. ++++|||.+....
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhc
Confidence 48999999999999999999999999999999999999999999999999999999999998888 9999999875332
Q ss_pred CCC----CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC--CC
Q 024336 153 LHS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PD 226 (269)
Q Consensus 153 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~ 226 (269)
... ......||+.|+|||++.+..++ .++||||||+++|+|+||.+||...+..+... ......... ..
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~----~~~~~~~~~~~~~ 237 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY----QHVREDPIPPSAR 237 (277)
T ss_dssp ----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHCCCCCGGGT
T ss_pred cccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHH----HHHhcCCCCCchh
Confidence 222 23345689999999999877664 45999999999999999999998755433222 222222211 22
Q ss_pred cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 227 YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
...+|+++.++|.+||++||.+||++.+.+.+.|.
T Consensus 238 ~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 34789999999999999999999955555555444
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-58 Score=365.40 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=202.9
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
.++|++.+.||+|+||+||+++.. ..||||++.... ...+.+.+|+.++++++||||+++++++.+ ..+++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 368999999999999999999764 349999986432 334578899999999999999999998654 5689999
Q ss_pred eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC---
Q 024336 79 EYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--- 154 (269)
Q Consensus 79 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~--- 154 (269)
||+++|+|.+++... .++++..+..++.|++.||+|||++||+||||||+||+++.++. +||+|||++......
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC-------
T ss_pred ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccCCc
Confidence 999999999999654 56999999999999999999999999999999999999998887 999999998643322
Q ss_pred CCCCcccCCCcccCchhhcccc--CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCH
Q 024336 155 SQPKSTVGTPAYIAPEVLARKE--YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232 (269)
Q Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
.......+|+.|+|||++.+.. ..+.++||||||+++|+|+||..||.+..........................+|+
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 240 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchH
Confidence 1223456899999999987532 23566999999999999999999998877655444433322111111112336889
Q ss_pred HHHHHHHHHhhhCCCCCCCcHHHhhccC
Q 024336 233 DCRHLLSQIFVADPSKDPHSRDQKASLV 260 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps~~~~l~~~~ 260 (269)
++.+||.+||+.||.+|||++|+++++.
T Consensus 241 ~l~~li~~cl~~dp~~RPt~~~il~~Le 268 (276)
T d1uwha_ 241 AMKRLMAECLKKKRDERPLFPQILASIE 268 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 9999999999999999999999999863
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-58 Score=362.27 Aligned_cols=248 Identities=24% Similarity=0.386 Sum_probs=201.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
++|++.+.||+|+||+||++.+. +++.||||.+.......+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 68999999999999999999986 56789999998877777889999999999999999999999999999999999999
Q ss_pred CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC--CCc
Q 024336 83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKS 159 (269)
Q Consensus 83 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~--~~~ 159 (269)
+|+|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++. +||+|||++........ ...
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC---------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCceeecc
Confidence 99999988654 46899999999999999999999999999999999999998887 99999999874333222 223
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhC-CCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVG-AYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
..+++.|+|||.+.+..++. ++||||||+++|+|+|+ .+||..... .. ....+... ...+.+..+++++.++|
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~-k~DVwS~Gvil~el~t~~~~~~~~~~~-~~---~~~~i~~~-~~~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSN-SE---VVEDISTG-FRLYKPRLASTHVYQIM 235 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCH-HHHHHHHHHHHHHHHTTSCCTTCSCCH-HH---HHHHHHHT-CCCCCCTTSCHHHHHHH
T ss_pred eecCcccCChHHhcCCCCCc-hhhhcchHHHHHHHHHCCCCCCCCCCH-HH---HHHHHHhc-CCCCCccccCHHHHHHH
Confidence 46789999999998887754 59999999999999995 555554332 22 22333332 22223347899999999
Q ss_pred HHHhhhCCCCCCCcHHHhhcc
Q 024336 239 SQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+||+.||++|||++|+++++
T Consensus 236 ~~cl~~~p~~Rps~~~il~~L 256 (263)
T d1sm2a_ 236 NHCWKERPEDRPAFSRLLRQL 256 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHHH
Confidence 999999999999999999984
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.3e-58 Score=366.03 Aligned_cols=258 Identities=25% Similarity=0.377 Sum_probs=213.1
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc---cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|++++.||+|+||+||+|++. +|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..+++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 69999999999999999999986 78999999986532 335678999999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC-CCCC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPK 158 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~ 158 (269)
++.++.+..+....+.+++..+..++.||+.||+|||+.||+||||||+||+++.++. +|++|||.+...... ....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCccccc
Confidence 9998777777777888999999999999999999999999999999999999998887 999999998643222 2234
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cC-------------
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FL------------- 224 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~------------- 224 (269)
...+++.|.|||.+.+....+.++|+||||+++|+|++|..||...+..+.............. .+
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 4568899999999988777777799999999999999999999876654444443322211100 00
Q ss_pred ---------CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 225 ---------PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 225 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.....+++++.+||++||..||++|||++|+++|||++.
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 001356789999999999999999999999999999973
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=366.61 Aligned_cols=261 Identities=26% Similarity=0.341 Sum_probs=211.9
Q ss_pred cccccccceecccCceEEEEEEEecC-CeEEEEEEeecCc---cccHHHHHHHHHHHhC---CCCCcceeeEEEEe----
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRT-KELVAVKYIERGK---KIDENVQREIINHRSL---RHPNIIRFKEVLLT---- 70 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~-~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~---- 70 (269)
.++|++++.||+|+||+||+|++..+ ++.||+|++.... .....+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47999999999999999999999655 6789999986432 2234566777776665 79999999999863
Q ss_pred -CCeEEEEEeecCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCc
Q 024336 71 -PTHLAIVMEYAAGGELFARIC-SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS 148 (269)
Q Consensus 71 -~~~~~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~ 148 (269)
...+++++|+++++++..... ....+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~ 163 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA 163 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhhh
Confidence 346899999999877654443 3456899999999999999999999999999999999999998887 999999998
Q ss_pred ccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc-cC---
Q 024336 149 KSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FL--- 224 (269)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~~--- 224 (269)
.............||+.|+|||.+.+..++.+ +|||||||++|+|+||.+||...+..+.+............ .+
T Consensus 164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 164 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hhhcccccCCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 76555555667789999999999988877555 99999999999999999999887665555444433221100 00
Q ss_pred -----------------CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 225 -----------------PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 225 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.-...+++.+.+||.+||+.||++|||++|+|+|||++.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 01235788999999999999999999999999999998874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-57 Score=360.08 Aligned_cols=252 Identities=20% Similarity=0.269 Sum_probs=206.6
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeec
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA 81 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
.++|++.+.||+|+||+||++.+. ++..||||.+.......+.+.+|+.++++++||||+++++++.+ +.+++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 368899999999999999999976 57889999998777777889999999999999999999998754 5679999999
Q ss_pred CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--CC
Q 024336 82 AGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QP 157 (269)
Q Consensus 82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~ 157 (269)
++|+|.+.+... .++++..+..++.||+.||.|||+.|++||||||+||+++.++. +||+|||+++...... ..
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEECC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCCccccc
Confidence 999999877443 35899999999999999999999999999999999999998887 9999999997543222 23
Q ss_pred CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHH
Q 024336 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (269)
....+++.|+|||.+.+..++ .++||||||+++|+|+||..|+........ ....+... ...+.+..+|+++.+|
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~---~~~~i~~~-~~~~~p~~~~~~l~~l 242 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLERG-YRMVRPDNCPEELYQL 242 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTT-CCCCCCTTCCHHHHHH
T ss_pred cccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHH---HHHHHHhc-CCCCCcccChHHHHHH
Confidence 345678899999999877775 459999999999999996555443333222 23333332 2223334799999999
Q ss_pred HHHHhhhCCCCCCCcHHHhh--ccChh
Q 024336 238 LSQIFVADPSKDPHSRDQKA--SLVPE 262 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~--~~~~~ 262 (269)
|.+||+.||++|||++++++ +.|+.
T Consensus 243 i~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 243 MRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999999988 45554
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-57 Score=365.30 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=197.8
Q ss_pred ccccccceecccCceEEEEEEEecCCe---EEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKE---LVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++.+.||+|+||+||++.+..+++ .||+|.+.... ...+.+.+|+.++++++|||||++++++.+++.+++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 578899999999999999999876554 58888876432 2335688999999999999999999999999999999
Q ss_pred EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCC
Q 024336 78 MEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 156 (269)
|||+++|+|.+++... +.+++.++..++.|++.||.|||+.|++||||||+||+++.++. +||+|||+++.......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccCCCC
Confidence 9999999999988764 46999999999999999999999999999999999999998887 99999999874332221
Q ss_pred C------CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCC
Q 024336 157 P------KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229 (269)
Q Consensus 157 ~------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (269)
. ....+++.|+|||.+.+..++. ++||||||+++|+|+| |..||......+ ....+... ...+.+..
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~----~~~~i~~~-~~~~~~~~ 257 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQD----VINAIEQD-YRLPPPMD 257 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTT-CCCCCCTT
T ss_pred cceeeecccccCCccccCHHHHhcCCCCc-ccccccchHHHHHHHhCCCCCCCCCCHHH----HHHHHHcC-CCCCCCcc
Confidence 1 1234688999999998777655 4999999999999998 899998765432 23333332 23334447
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 230 VSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+|+.+.+||.+||+.||++|||+.|+++.+
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~L 287 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 999999999999999999999999998864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-57 Score=369.25 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=207.7
Q ss_pred ccccccceecccCceEEEEEEEecCCe-----EEEEEEeecC--ccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKE-----LVAVKYIERG--KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~-----~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 74 (269)
++|++.+.||+|+||+||+|.+..+++ .||+|.+... ......+.+|+.+++++ +|||||++++++.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 678999999999999999999875543 6899988543 33456788999999988 899999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEE
Q 024336 75 AIVMEYAAGGELFARICSAG-----------------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTL 131 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~-----------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~ 131 (269)
++||||+++|+|.+++.+.. .+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence 99999999999999996542 4899999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCCcccCCCCCCC---CcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCCh
Q 024336 132 LDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDP 207 (269)
Q Consensus 132 i~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~ 207 (269)
++.++. +||+|||+|+........ ....+|+.|+|||.+.+..++. ++|||||||++|+|+| |.+||.+....
T Consensus 197 l~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~-~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 197 VTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI-KSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCc-ceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 998887 999999999753333221 2345689999999998777754 5999999999999998 89999876665
Q ss_pred hhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 208 RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
..+..... ....++.+..+|+++.+||.+||+.||++|||++|+++++
T Consensus 274 ~~~~~~~~----~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 274 ANFYKLIQ----NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp HHHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHh----cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 44443332 2333344447899999999999999999999999999886
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=367.80 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=211.0
Q ss_pred cccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeC------CeEEEE
Q 024336 4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTP------THLAIV 77 (269)
Q Consensus 4 ~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~~v 77 (269)
+|+.++.||+|+||+||+|++..+|+.||||++...... ..+|+.++++++||||++++++|... ..+++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 699999999999999999999999999999999765432 34799999999999999999998643 358999
Q ss_pred EeecCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 78 MEYAAGGELFAR---ICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 78 ~e~~~~~~l~~~---~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
|||++++++..+ ......+++..++.++.||+.||+|||++||+||||||+||+++.++. .+||+|||++......
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECCTT
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhccCC
Confidence 999987643333 234567999999999999999999999999999999999999987652 3899999999866556
Q ss_pred CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh-------------cc
Q 024336 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-------------VQ 221 (269)
Q Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~-------------~~ 221 (269)
.......+++.|+|||.+.+....+.++|||||||++|+|++|..||...+..+.+......... ..
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 256 (350)
T d1q5ka_ 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256 (350)
T ss_dssp SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence 66667789999999999887665566699999999999999999999877655444443322111 00
Q ss_pred ccCC----------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 222 YFLP----------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 222 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
..++ .....++++.+||.+||..||.+|||+.|+|+|+|++.+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 1111 1235788999999999999999999999999999998874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-57 Score=358.76 Aligned_cols=249 Identities=23% Similarity=0.312 Sum_probs=200.8
Q ss_pred ceecccCceEEEEEEEe--cCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecCC
Q 024336 9 KELGSGNFGVARLVRDK--RTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG 83 (269)
Q Consensus 9 ~~l~~g~~g~v~~~~~~--~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (269)
+.||+|+||+||++.+. .+++.||||++..... ..+.+.+|+.++++++||||+++++++.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 36999999999999865 3567899999864332 235688999999999999999999998654 57899999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC----CCCc
Q 024336 84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QPKS 159 (269)
Q Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~----~~~~ 159 (269)
|+|.+++.+..++++..+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||+++...... ....
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC---
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhccccccccccccc
Confidence 999999999899999999999999999999999999999999999999998887 9999999987432222 1223
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
..+|+.|+|||.+.+..++. ++||||||+++|+|+| |..||.+.... +....+..+. ..+.+..+|+++.+||
T Consensus 170 ~~gt~~y~APE~l~~~~~~~-~sDiwS~Gv~l~ellt~g~~Pf~~~~~~----~~~~~i~~~~-~~~~p~~~~~~~~~li 243 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYKFSS-KSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAMLEKGE-RMGCPAGCPREMYDLM 243 (277)
T ss_dssp -CCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHHHHTTC-CCCCCTTCCHHHHHHH
T ss_pred cCCCceecCchhhcCCCCCc-hhhhccchhhhhHHhhCCCCCCCCCCHH----HHHHHHHcCC-CCCCCcccCHHHHHHH
Confidence 45788999999998877755 4999999999999998 89999876543 2333333322 2233347999999999
Q ss_pred HHHhhhCCCCCCCcHHHh---hccChhhhhh
Q 024336 239 SQIFVADPSKDPHSRDQK---ASLVPEEFAE 266 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l---~~~~~~~~~~ 266 (269)
.+||+.||++|||+++++ +++|++...+
T Consensus 244 ~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~e 274 (277)
T d1xbba_ 244 NLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274 (277)
T ss_dssp HHHTCSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhCHHhhcCCC
Confidence 999999999999999984 5666555443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-57 Score=368.72 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=207.9
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCC-----
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPT----- 72 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 72 (269)
+.++|++++.||+|+||+||+|.+..+|+.||||++..... ..+.+.+|+.+++.++||||++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 46899999999999999999999999999999999975432 2346788999999999999999999998764
Q ss_pred -eEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 73 -HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 73 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
.+|+||||+ +.+|.... +.+++++..++.++.||+.||.|||++||+||||||+||+++.++. ++++|||++...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceecc
Confidence 479999999 45666665 5567999999999999999999999999999999999999998888 999999999743
Q ss_pred CCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc-----------
Q 024336 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV----------- 220 (269)
Q Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~----------- 220 (269)
........+++.|+|||.+.+....+.++|||||||++|+|++|.+||...+....+..........
T Consensus 172 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 172 --DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp --CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred --CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 3344566789999999999877666777999999999999999999998766544433322211100
Q ss_pred ----------cccC----CCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 221 ----------QYFL----PDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 221 ----------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.... .....+++++.+||.+||..||.+|||++|+|+|||++.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000 01135788999999999999999999999999999998754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-56 Score=355.88 Aligned_cols=261 Identities=24% Similarity=0.405 Sum_probs=217.9
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc---ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
++|++++.||+|+||+||+|++..+|+.||+|++..... ....+.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 589999999999999999999999999999999865432 23568899999999999999999999999999999999
Q ss_pred ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-CCC
Q 024336 80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK 158 (269)
Q Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 158 (269)
++.++++..++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++. ++|+|||.+....... ...
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCCC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccce
Confidence 9999999998888889999999999999999999999999999999999999998887 9999999997543333 333
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccc----------------
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY---------------- 222 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~---------------- 222 (269)
...+++.|.|||.+......+.++|||||||++|+|++|..||....+.......+........
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 4457788999999987776677799999999999999999997655544333322222211100
Q ss_pred --------cCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 223 --------FLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 223 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
.......+++.+.+||.+||+.||++|||++|+|+|||++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 0001235678999999999999999999999999999998753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-56 Score=362.89 Aligned_cols=258 Identities=22% Similarity=0.362 Sum_probs=214.1
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC-CCCcceeeEEEEeC--CeEEEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEVLLTP--THLAIVM 78 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~~v~ 78 (269)
.++|++++.||+|+||+||+|++..+|+.||+|++... ..+.+.+|+.+++.++ ||||++++++|... ..+++||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 46899999999999999999999999999999998754 3467889999999995 99999999999854 5699999
Q ss_pred eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCC
Q 024336 79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158 (269)
Q Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 158 (269)
||+++++|.... +.+++..++.++.||+.||.|||++||+||||||+||+++.++. .++|+|||++..........
T Consensus 112 e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~~ 187 (328)
T d3bqca1 112 EHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYN 187 (328)
T ss_dssp ECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCCC
T ss_pred eecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCccc
Confidence 999999987754 46899999999999999999999999999999999999986553 38999999998655555666
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh----------cc-------
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN----------VQ------- 221 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~----------~~------- 221 (269)
...+|+.|+|||.+.+....+.++|+||+|+++++|++|..||....+.......+..... ..
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 267 (328)
T d3bqca1 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267 (328)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGG
T ss_pred ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCccc
Confidence 7788999999999987776667799999999999999999999876654332222211110 00
Q ss_pred ---------------ccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 222 ---------------YFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 222 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
...+....+++++.+||++||..||++|||++|+|+||||+.+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp GGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred chhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 01111234688999999999999999999999999999998753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-56 Score=354.90 Aligned_cols=246 Identities=26% Similarity=0.358 Sum_probs=201.7
Q ss_pred ccccccce-ecccCceEEEEEEEe--cCCeEEEEEEeecCc--cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKE-LGSGNFGVARLVRDK--RTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~-l~~g~~g~v~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|.+.+. ||+|+||+||++.+. .++..||||.+.... ...+.+.+|+.++++++||||+++++++.+ +.+++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 57888885 999999999999875 345689999987543 234568899999999999999999999875 458999
Q ss_pred EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-
Q 024336 78 MEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS- 155 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~- 155 (269)
|||+++|+|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++. +||+|||+++......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDS 164 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSC
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhccccccc
Confidence 999999999998755 457999999999999999999999999999999999999998887 9999999997432222
Q ss_pred ---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 156 ---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 156 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
......+++.|+|||.+.+..++. ++||||||+++|+|+| |..||......+. ...+..+.. .+.+..+|
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~----~~~i~~~~~-~~~p~~~~ 238 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSS-RSDVWSYGVTMWEALSYGQKPYKKMKGPEV----MAFIEQGKR-MECPPECP 238 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTCCTHHH----HHHHHTTCC-CCCCTTCC
T ss_pred ccccccccccCccccChHHHhCCCCCc-cchhhcchHHHHHHHhCCCCCCCCCCHHHH----HHHHHcCCC-CCCCCcCC
Confidence 222345788999999998777655 4999999999999998 8999987765432 333333321 22234799
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhh
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKA 257 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~ 257 (269)
+++.+||.+||+.||++|||+.++++
T Consensus 239 ~~l~~li~~cl~~~p~~RPs~~~i~~ 264 (285)
T d1u59a_ 239 PELYALMSDCWIYKWEDRPDFLTVEQ 264 (285)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999999999854
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-56 Score=358.81 Aligned_cols=259 Identities=22% Similarity=0.306 Sum_probs=208.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecC---ccccHHHHHHHHHHHhCCCCCcceeeEEEEe--------C
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLT--------P 71 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~ 71 (269)
++|++++.||+|+||+||+|++..+|+.||||++... ......+.+|+.++++++|||++++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6899999999999999999999999999999998643 2344678899999999999999999999865 3
Q ss_pred CeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccC
Q 024336 72 THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151 (269)
Q Consensus 72 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~ 151 (269)
+.++++||++.++++.........+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||++...
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~~ 167 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAF 167 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEEC
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeecceeeec
Confidence 458999999988777766666778999999999999999999999999999999999999998887 999999998632
Q ss_pred CC-----CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccC-C
Q 024336 152 LL-----HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL-P 225 (269)
Q Consensus 152 ~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~ 225 (269)
.. ........+|+.|+|||.+.+....+.++||||||+++|+|++|..||.+..................... .
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 21 12223456899999999998776556679999999999999999999987665444443333222111100 0
Q ss_pred Cc-------------------------CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhh
Q 024336 226 DY-------------------------VRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEE 263 (269)
Q Consensus 226 ~~-------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~ 263 (269)
.. ...++++.+||.+||..||++|||++|+|+||||..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 00 012567889999999999999999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=361.97 Aligned_cols=258 Identities=29% Similarity=0.503 Sum_probs=220.4
Q ss_pred ccccccceecccCceEEEEEEEe---cCCeEEEEEEeecCc-----cccHHHHHHHHHHHhCCC-CCcceeeEEEEeCCe
Q 024336 3 ERYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK-----KIDENVQREIINHRSLRH-PNIIRFKEVLLTPTH 73 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 73 (269)
++|++++.||+|+||+||+|.+. .+|+.||+|++.+.. ...+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 57999999999999999999974 468999999986432 234567889999999976 899999999999999
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
+++++||+.+++|.+.+...+.+++..+..++.||+.||.|+|++|++||||||+||+++.++. ++|+|||++.....
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCG
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhcc
Confidence 9999999999999999999999999999999999999999999999999999999999998887 99999999864322
Q ss_pred --CCCCCcccCCCcccCchhhcccc-CCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCC
Q 024336 154 --HSQPKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230 (269)
Q Consensus 154 --~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
........+++.|+|||.+.+.. ..+.++|||||||++|+|+||..||.......................+. .+
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~--~~ 259 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EM 259 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--TS
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc--cC
Confidence 22334567899999999997654 34556999999999999999999998877666666665555555554444 79
Q ss_pred CHHHHHHHHHHhhhCCCCCCC-----cHHHhhccChhhh
Q 024336 231 SADCRHLLSQIFVADPSKDPH-----SRDQKASLVPEEF 264 (269)
Q Consensus 231 ~~~~~~li~~~l~~~p~~Rps-----~~~~l~~~~~~~~ 264 (269)
|+++.+||.+||.+||.+||| ++|+++|||++.+
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 999999999999999999995 7999999999764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-56 Score=352.89 Aligned_cols=252 Identities=23% Similarity=0.272 Sum_probs=203.8
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEEEEeecC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA 82 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
++|++.+.||+|+||.||++.+..+ ..||||++.......+.+.+|+.++++++|||||++++++.+ +.+++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 6899999999999999999998754 569999998777677889999999999999999999999854 56789999999
Q ss_pred CCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC--CCC
Q 024336 83 GGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPK 158 (269)
Q Consensus 83 ~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~~ 158 (269)
+|+|...+.. .+.+++.+++.++.||+.||+|||++|++||||||+||+++.++. +||+|||++....... ...
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC-----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCceeec
Confidence 9999888754 456999999999999999999999999999999999999998887 9999999997432222 223
Q ss_pred cccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHHHHH
Q 024336 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238 (269)
Q Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (269)
...+++.|+|||.+.+..++. ++||||||+++|+|+||..|+.......... ..+... ...+....+|+++.++|
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~-ksDI~S~Giil~el~t~~~p~~~~~~~~~~~---~~i~~~-~~~~~~~~~~~~l~~li 247 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQVERG-YRMPCPPECPESLHDLM 247 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHHTT-CCCCCCTTSCHHHHHHH
T ss_pred cccccccccChHHHhCCCCCc-HHhhhcchHHHHHHHhCCCCCCCCCCHHHHH---HHHHhc-CCCCCCcccCHHHHHHH
Confidence 356889999999998887755 5999999999999999766665544433332 223322 22233347899999999
Q ss_pred HHHhhhCCCCCCCcHHHhh--ccChhh
Q 024336 239 SQIFVADPSKDPHSRDQKA--SLVPEE 263 (269)
Q Consensus 239 ~~~l~~~p~~Rps~~~~l~--~~~~~~ 263 (269)
.+||+.||++|||+.++++ +.|+..
T Consensus 248 ~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 248 CQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 9999999999999999987 555543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-56 Score=362.59 Aligned_cols=262 Identities=26% Similarity=0.391 Sum_probs=207.1
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCC----eE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPT----HL 74 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~ 74 (269)
|.++|++++.||+|+||+||+|.+..+|+.||||++.+... ..+.+.+|+.++++++|||++++++++..+. ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 46899999999999999999999999999999999875432 2346788999999999999999999987653 23
Q ss_pred EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
+++++++.+++|.+++.. +++++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||++......
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPD 162 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGG
T ss_pred EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCC
Confidence 344455668899999965 46999999999999999999999999999999999999998887 999999998643222
Q ss_pred C----CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhc----------
Q 024336 155 S----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------- 220 (269)
Q Consensus 155 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~---------- 220 (269)
. ......+++.|+|||.+......+.++||||+|+++|+|++|..||...+...............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 2 23445689999999998777666777999999999999999999998765443332222111100
Q ss_pred ------cccCC---------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 221 ------QYFLP---------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 221 ------~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
....+ ....+++++.+||.+||..||.+|||+.|+|+|+|+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 00000 0135678999999999999999999999999999998654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=349.40 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=198.6
Q ss_pred ccccccceecccCceEEEEEEEecCC----eEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTK----ELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
+.|++.+.||+|+||.||+|.+..++ ..||||.+..... ....+.+|+.++++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 46899999999999999999987554 4799999865432 23467899999999999999999999999999999
Q ss_pred EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 77 VMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
|+||+.++++.+.+... +.+++..+..++.|++.||.|||+.+|+||||||+||+++.++. +||+|||+++......
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDP 164 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC--------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhcccCCC
Confidence 99999999998887654 57999999999999999999999999999999999999998887 9999999997432222
Q ss_pred ----CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 156 ----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 156 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
......+|+.|+|||.+.+..++. ++||||||+++|+|+||..|+......... ...+... ...+.+..+|
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~-~sDI~S~Gvil~el~t~~~~~~~~~~~~~~---~~~i~~~-~~~~~~~~~~ 239 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEV---MKAINDG-FRLPTPMDCP 239 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHTT-CCCCCCTTCB
T ss_pred ccceEeccCCCCccccCHHHHccCCCCC-cccccccHHHHHHHHhCCCCccccCCHHHH---HHHHhcc-CCCCCchhhH
Confidence 122345788999999998777655 499999999999999966655444333332 2333322 2333444789
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+.+.+||.+||+.||++|||+.|+++.+
T Consensus 240 ~~l~~li~~cl~~~p~~RPt~~eil~~L 267 (283)
T d1mqba_ 240 SAIYQLMMQCWQQERARRPKFADIVSIL 267 (283)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence 9999999999999999999999998854
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=345.15 Aligned_cols=243 Identities=25% Similarity=0.378 Sum_probs=197.0
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEe-CCeEEEEEeec
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT-PTHLAIVMEYA 81 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~ 81 (269)
++|++.+.||+|+||.||++.+. |+.||+|.+..+ ...+.+.+|+.++++++||||+++++++.+ ++.+++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 57999999999999999999984 788999998654 345779999999999999999999999865 45689999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCCCCCc
Q 024336 82 AGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159 (269)
Q Consensus 82 ~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 159 (269)
++|+|.+++.+.+ .+++..+..++.||+.||.|||+.+++||||||+||+++.++. ++|+|||++... ......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~--~~~~~~ 159 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEA--SSTQDT 159 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC------------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--Eeecccccceec--CCCCcc
Confidence 9999999986543 4899999999999999999999999999999999999999888 999999999743 233344
Q ss_pred ccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhh-ccccCCCcCCCCHHHHHH
Q 024336 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRN-VQYFLPDYVRVSADCRHL 237 (269)
Q Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 237 (269)
..+++.|+|||.+.+..++ .++||||||+++|+|+| |.+||......+.. ..+.. .....+. .+++.+.+|
T Consensus 160 ~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~----~~i~~~~~~~~~~--~~~~~~~~l 232 (262)
T d1byga_ 160 GKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV----PRVEKGYKMDAPD--GCPPAVYEV 232 (262)
T ss_dssp --CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH----HHHTTTCCCCCCT--TCCHHHHHH
T ss_pred ccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH----HHHHcCCCCCCCc--cCCHHHHHH
Confidence 5678899999999887764 55999999999999998 68888766543332 22222 2223333 789999999
Q ss_pred HHHHhhhCCCCCCCcHHHhhcc
Q 024336 238 LSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 238 i~~~l~~~p~~Rps~~~~l~~~ 259 (269)
|.+||+.||.+|||+.++++++
T Consensus 233 i~~cl~~dP~~Rps~~~l~~~L 254 (262)
T d1byga_ 233 MKNCWHLDAAMRPSFLQLREQL 254 (262)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHcccCHhHCcCHHHHHHHH
Confidence 9999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-55 Score=348.37 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=196.6
Q ss_pred cccccccceecccCceEEEEEEEecC---CeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+..... ..+.+.+|+.++++++||||+++++++. ++.+++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 37899999999999999999998644 45688888764322 2356889999999999999999999986 467899
Q ss_pred EEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 77 VMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
||||+++|++.+++.. ..++++..++.++.||+.||.|||++|++||||||+||+++.++. +||+|||++.......
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC-----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCCc
Confidence 9999999999988755 446899999999999999999999999999999999999998887 9999999987533222
Q ss_pred --CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCH
Q 024336 156 --QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232 (269)
Q Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
......+++.|+|||.+.+..++. ++||||||+++|+|+| |.+||......+... .+.... ..+.+..+|+
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~-~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~----~i~~~~-~~~~~~~~~~ 236 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG----RIENGE-RLPMPPNCPP 236 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----HHHTTC-CCCCCTTCCH
T ss_pred ceeccceecCcccchhhHhccCCCCC-ccccccchHHHHHHHhcCCCCCCCCCHHHHHH----HHHcCC-CCCCCCCCCH
Confidence 223445788999999998777654 5999999999999998 899998766543332 233322 2233448999
Q ss_pred HHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 233 DCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 233 ~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
++.+||.+||+.||.+|||+.|+++++
T Consensus 237 ~~~~li~~cl~~dp~~Rps~~ei~~~L 263 (273)
T d1mp8a_ 237 TLYSLMTKCWAYDPSRRPRFTELKAQL 263 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 999999999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=362.31 Aligned_cols=259 Identities=24% Similarity=0.384 Sum_probs=209.4
Q ss_pred cccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeC-----Ce
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTP-----TH 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 73 (269)
.++|++++.||+|+||+||+|++..+|+.||||++...... .+.+.+|+.++++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 47899999999999999999999999999999999754332 34577899999999999999999998643 33
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
.+++++++.+++|.+++. .+++++..++.++.||+.||+|||++||+||||||+||+++.++. ++++|||.+...
T Consensus 97 ~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~-- 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT-- 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CC--
T ss_pred eEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhccc--
Confidence 466667778899999884 457999999999999999999999999999999999999998887 999999998642
Q ss_pred CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhcc------------
Q 024336 154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ------------ 221 (269)
Q Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~------------ 221 (269)
........+++.|+|||.+.+....+.++||||||+++|+|++|.+||.+.+................
T Consensus 172 ~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 33344566888999999988877767779999999999999999999987765444433332211110
Q ss_pred -------ccCC------CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhhh
Q 024336 222 -------YFLP------DYVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEFA 265 (269)
Q Consensus 222 -------~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~~ 265 (269)
...+ ....+++++.+||.+||..||++|||++|+|+|+|++.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0000 0135788999999999999999999999999999998754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-55 Score=360.23 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=197.6
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccc---cHHHHHHHHHHHhCCCCCcceeeEEEEeC------Ce
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTP------TH 73 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~ 73 (269)
++|++++.||+|+||+||+|.+..+|+.||||++...... ...+.+|+.++++++||||++++++|... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6899999999999999999999999999999999754322 34577999999999999999999999643 67
Q ss_pred EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCC
Q 024336 74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL 153 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~ 153 (269)
+|+||||+.++++ +.+ ...+++..++.++.|++.||.|||++||+||||||+||+++.++. ++++|||++.....
T Consensus 97 ~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT 171 (355)
T ss_dssp EEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC------
T ss_pred eEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhcccc
Confidence 9999999977544 444 346899999999999999999999999999999999999998888 99999999886665
Q ss_pred CCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh--------------
Q 024336 154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-------------- 219 (269)
Q Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~-------------- 219 (269)
........+|+.|+|||.+.+..++.+ +||||+||++++|++|++||.+.+..............
T Consensus 172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 172 SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ---------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred ccccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 566666778999999999988776555 99999999999999999999876654443333222111
Q ss_pred ----ccccCCC------------------cCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhccChhhh
Q 024336 220 ----VQYFLPD------------------YVRVSADCRHLLSQIFVADPSKDPHSRDQKASLVPEEF 264 (269)
Q Consensus 220 ----~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~~~~~ 264 (269)
....... ....++++.+||++||..||++|||++|+|+|||++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0000000 01235678999999999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=349.75 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=205.3
Q ss_pred ccccccceecccCceEEEEEEEecCCeE--EEEEEeecC--ccccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCeEEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKEL--VAVKYIERG--KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV 77 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~--vaiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
++|++.+.||+|+||+||+|.+..+|.. ||||.+... ....+.+.+|+.+++++ +||||+++++++.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 5899999999999999999999988774 667776532 23445789999999998 799999999999999999999
Q ss_pred EeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEE
Q 024336 78 MEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLK 141 (269)
Q Consensus 78 ~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~ 141 (269)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++. +|
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~--~k 167 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AK 167 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--eE
Confidence 9999999999998654 46899999999999999999999999999999999999998887 99
Q ss_pred EeecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCC-CCCCCCCChhhHHHHHHHHhhc
Q 024336 142 ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA-YPFEDPEDPRNFRKTIDRIRNV 220 (269)
Q Consensus 142 l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~-~pf~~~~~~~~~~~~~~~~~~~ 220 (269)
|+|||++.............++..|+|||.+.+..++.+ +||||||+++|+|++|. +||...+. ......+...
T Consensus 168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~~----~~~~~~i~~~ 242 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEKLPQG 242 (309)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHGGGT
T ss_pred EccccccccccccccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCCH----HHHHHHHHhc
Confidence 999999976554444555678999999999988877544 99999999999999975 56765433 2333333332
Q ss_pred cccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 221 QYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 221 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
...+.+..+++++.+||.+||+.||++|||+.++++++
T Consensus 243 -~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 243 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 22333447999999999999999999999999999984
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=349.95 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=200.3
Q ss_pred ccccccceecccCceEEEEEEEecCCe----EEEEEEeecC--ccccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKE----LVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI 76 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~----~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
++|++++.||+|+||+||++.+..+|+ .||+|.+... ....+.+.+|+.++++++||||+++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 579999999999999999999987775 5888877543 33456789999999999999999999999875 4677
Q ss_pred EEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC
Q 024336 77 VMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS 155 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~ 155 (269)
+++++.+++|.+.+.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++. +||+|||++.......
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTTTC
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceeccccc
Confidence 8888888899887765 457999999999999999999999999999999999999998887 9999999987433222
Q ss_pred C---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCC
Q 024336 156 Q---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231 (269)
Q Consensus 156 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
. .....+|+.|+|||.+.+..++ .++||||||+++|+|+| |.+||........ .. .+..+ ...+.+..+|
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-~~---~i~~~-~~~~~p~~~~ 239 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SS---ILEKG-ERLPQPPICT 239 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-HH---HHHHT-CCCCCCTTBC
T ss_pred ccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-HH---HHHcC-CCCCCCcccC
Confidence 2 2233578999999999887765 45999999999999998 7889887654332 22 22222 2223334789
Q ss_pred HHHHHHHHHHhhhCCCCCCCcHHHhhccCh
Q 024336 232 ADCRHLLSQIFVADPSKDPHSRDQKASLVP 261 (269)
Q Consensus 232 ~~~~~li~~~l~~~p~~Rps~~~~l~~~~~ 261 (269)
+++.+||.+||..||.+|||+.|+++++..
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 999999999999999999999999998543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-55 Score=345.40 Aligned_cols=248 Identities=28% Similarity=0.402 Sum_probs=196.1
Q ss_pred ccccccceecccCceEEEEEEEecC---CeEEEEEEeecCc----cccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~---~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
++|++++.||+|+||.||++....+ ...||||++.+.. ...+.+.+|+.++++++||||+++++++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 6799999999999999999987533 2468999886532 2235688999999999999999999999764 678
Q ss_pred EEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCC
Q 024336 76 IVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~ 154 (269)
+|+||++++++.+.+.. .+++++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||++......
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQN 164 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhhcccC
Confidence 99999999999887754 456999999999999999999999999999999999999998876 999999998753322
Q ss_pred CC----CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHHHHHHHHhhccccCCCcCC
Q 024336 155 SQ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229 (269)
Q Consensus 155 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (269)
.. .....++..|+|||.+.+..++. ++||||||+++|+|+| |..||...+.. .....+.......+.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~-~~Di~S~Gvil~emlt~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~ 239 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSH-ASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKIDKEGERLPRPED 239 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHTSCCCCCCCTT
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCc-chhhhhhHHHHHHHHhCCCCCCCCcCHH----HHHHHHHhCCCCCCCccc
Confidence 22 22334677899999998877654 4999999999999998 89999876543 333444445555555568
Q ss_pred CCHHHHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 230 VSADCRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
+|+++.+||.+||..||++|||+.++++.
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~~ 268 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDF 268 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999999753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-54 Score=345.87 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=205.5
Q ss_pred cccccccceecccCceEEEEEEEec-----CCeEEEEEEeecCcc--ccHHHHHHHHHHHhCCCCCcceeeEEEEeCCeE
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL 74 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (269)
+++|++.+.||+|+||+||+|+... +++.||||++..... ..+.+.+|+.++++++|||++++++++.+.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 4789999999999999999999753 567899999875432 235688999999999999999999999999999
Q ss_pred EEEEeecCCCchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcE
Q 024336 75 AIVMEYAAGGELFARICSAG------------------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENT 130 (269)
Q Consensus 75 ~~v~e~~~~~~l~~~~~~~~------------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni 130 (269)
++++|++++++|.+++.... .++...+..++.|++.||+|||+.|++||||||+||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence 99999999999999986432 378999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEeecCCcccCCCC---CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCC-CCCCCCCC
Q 024336 131 LLDGSPQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA-YPFEDPED 206 (269)
Q Consensus 131 ~i~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~-~pf~~~~~ 206 (269)
+++.++. +||+|||++...... .......+++.|+|||.+.+..++ .++||||||+++|+|++|. +||.....
T Consensus 172 Lld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 172 LVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp EECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred EECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 9998887 999999998633222 222345678899999999887775 4599999999999999985 67776544
Q ss_pred hhhHHHHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.+ ....+..... .+.+..+|+++.+||.+||+.||++|||+.|+++.+
T Consensus 249 ~e----~~~~v~~~~~-~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L 296 (301)
T d1lufa_ 249 EE----VIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296 (301)
T ss_dssp HH----HHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HH----HHHHHHcCCC-CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 33 3333444332 223347899999999999999999999999997643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-54 Score=343.26 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=202.1
Q ss_pred cccccccceecccCceEEEEEEEecCC-------eEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeC
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKRTK-------ELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTP 71 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~~~-------~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 71 (269)
.++|++.+.||+|+||.||+|++..++ ..||+|.+..... ....+.+|...+.++ +||||+++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 478999999999999999999986543 4799999876543 335677888888887 799999999999999
Q ss_pred CeEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC
Q 024336 72 THLAIVMEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS 135 (269)
Q Consensus 72 ~~~~~v~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~ 135 (269)
+.+++||||+++|+|.+++.... .+++..++.++.|++.||+|||+.|++||||||+||+++.+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 171 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCC
Confidence 99999999999999999996543 48999999999999999999999999999999999999988
Q ss_pred CCCcEEEeecCCcccCCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHH
Q 024336 136 PQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFR 211 (269)
Q Consensus 136 ~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~ 211 (269)
+. +||+|||++....... ......+++.|+|||.+.++.++ +++||||||+++|+|+| |.+||......
T Consensus 172 ~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---- 244 (299)
T d1fgka_ 172 NV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 244 (299)
T ss_dssp CC--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred CC--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHH----
Confidence 87 9999999987443332 23345678899999999887775 45999999999999998 78888765442
Q ss_pred HHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 212 KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.....+... ...+.+..+++++.+||.+||+.||++|||+.|+++.+
T Consensus 245 ~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 245 ELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp HHHHHHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcC-CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 233333332 22333447999999999999999999999999999865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-54 Score=343.96 Aligned_cols=251 Identities=23% Similarity=0.331 Sum_probs=194.7
Q ss_pred cccccccceecccCceEEEEEEEec-----CCeEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeC-C
Q 024336 2 EERYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTP-T 72 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~ 72 (269)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+..... ....+.+|...+.++ +|+||+.+++++..+ .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 3689999999999999999999764 346899999865332 234566777777766 689999999987765 4
Q ss_pred eEEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC
Q 024336 73 HLAIVMEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP 136 (269)
Q Consensus 73 ~~~~v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~ 136 (269)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence 689999999999999998653 2488999999999999999999999999999999999999888
Q ss_pred CCcEEEeecCCcccCCCCC---CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhC-CCCCCCCCChhhHHH
Q 024336 137 QPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVG-AYPFEDPEDPRNFRK 212 (269)
Q Consensus 137 ~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg-~~pf~~~~~~~~~~~ 212 (269)
. +||+|||+++...... ......+|+.|+|||.+.+..++ .++||||||+++|+|+|| .+||........+..
T Consensus 172 ~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 172 V--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp C--EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred c--EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 7 9999999997432222 22345688999999999887765 459999999999999986 567876655444333
Q ss_pred HHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
.... . ...+.+..+++++.++|.+||+.||.+|||++|+++|+
T Consensus 249 ~~~~---~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L 291 (299)
T d1ywna1 249 RLKE---G-TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291 (299)
T ss_dssp HHHH---T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhc---C-CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 3322 1 12222337899999999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-53 Score=340.66 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=206.6
Q ss_pred cccccccceecccCceEEEEEEEe-----cCCeEEEEEEeecCcc--ccHHHHHHHHHHHhC-CCCCcceeeEEEEeCCe
Q 024336 2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPTH 73 (269)
Q Consensus 2 ~~~y~~~~~l~~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 73 (269)
.++|++.+.||+|+||.||+|++. .+++.||||++..... ....+.+|+.+++.+ +||||+++++++.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 378889999999999999999863 4577899999975433 234578899999998 69999999999999999
Q ss_pred EEEEEeecCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCC
Q 024336 74 LAIVMEYAAGGELFARICSAG------------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS 135 (269)
Q Consensus 74 ~~~v~e~~~~~~l~~~~~~~~------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~ 135 (269)
++++|||+++++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccccc
Confidence 999999999999999986543 48999999999999999999999999999999999999988
Q ss_pred CCCcEEEeecCCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHh-CCCCCCCCCChhhHH
Q 024336 136 PQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFR 211 (269)
Q Consensus 136 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~pf~~~~~~~~~~ 211 (269)
+. ++++|||.+........ .....+++.|+|||.+.+..++. ++||||||+++|+|+| |.+||........+.
T Consensus 182 ~~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 182 RI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred Cc--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCC-cccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 77 99999999975433222 23346789999999998777655 4999999999999999 566666655544444
Q ss_pred HHHHHHhhccccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 212 KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
..... ......+..+|+++.+||.+||+.||.+|||+.|+++.+
T Consensus 259 ~~i~~----~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L 302 (311)
T d1t46a_ 259 KMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (311)
T ss_dssp HHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhc----CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 33322 222333347899999999999999999999999999744
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=335.34 Aligned_cols=245 Identities=20% Similarity=0.244 Sum_probs=195.5
Q ss_pred cceecccCceEEEEEEEecC---CeEEEEEEeecC--ccccHHHHHHHHHHHhCCCCCcceeeEEEEe-CCeEEEEEeec
Q 024336 8 VKELGSGNFGVARLVRDKRT---KELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLT-PTHLAIVMEYA 81 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~---~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~ 81 (269)
.+.||+|+||+||++.+..+ ...||||.+... ....+.+.+|+.++++++||||+++++++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999998654 346899998643 2234568999999999999999999999876 56899999999
Q ss_pred CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeecCCcccCCCCC-----
Q 024336 82 AGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----- 155 (269)
Q Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~~~~~~~----- 155 (269)
++++|.+++.... .+++..+..++.|++.||.|||+.+++||||||+||+++.++. +||+|||++.......
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~~~ 189 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVH 189 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCCTT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhccccccccce
Confidence 9999999887544 5778899999999999999999999999999999999998877 9999999997433222
Q ss_pred CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhhccccCCCcCCCCHHHH
Q 024336 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235 (269)
Q Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
......+++.|+|||.+.+..++.+ +||||||+++|+|+||..||........ ....+..+. ..+.+..+++++.
T Consensus 190 ~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~~---~~~~i~~g~-~~~~p~~~~~~l~ 264 (311)
T d1r0pa_ 190 NKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLLQGR-RLLQPEYCPDPLY 264 (311)
T ss_dssp CTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC---------CHHHHHTTC-CCCCCTTCCHHHH
T ss_pred ecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcCC-CCCCcccCcHHHH
Confidence 1223457889999999988777554 9999999999999998877765433222 222222222 2223347899999
Q ss_pred HHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 236 HLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 236 ~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
+||.+||+.||++|||+.|+++++
T Consensus 265 ~li~~cl~~dP~~RPs~~ei~~~L 288 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMRPSFSELVSRI 288 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHH
Confidence 999999999999999999999984
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=335.76 Aligned_cols=248 Identities=20% Similarity=0.281 Sum_probs=204.3
Q ss_pred ccccccceecccCceEEEEEEEec-----CCeEEEEEEeecCccc--cHHHHHHHHHHHhCCCCCcceeeEEEEeCCeEE
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKKI--DENVQREIINHRSLRHPNIIRFKEVLLTPTHLA 75 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (269)
++|++.+.||+|+||+||+|.+.. ++..||||++...... ...+.+|+.++++++||||+++++++..+...+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 688999999999999999999863 3578999998754322 235789999999999999999999999999999
Q ss_pred EEEeecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeec
Q 024336 76 IVMEYAAGGELFARICSA----------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDF 145 (269)
Q Consensus 76 ~v~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df 145 (269)
+||||+++|+|.+++... ..++...+..++.|++.||.|||+++++||||||+||+++.++. +||+||
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~Kl~DF 177 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDF 177 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCT
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EEEeec
Confidence 999999999999988542 24789999999999999999999999999999999999998887 999999
Q ss_pred CCcccCCCCCC---CCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCC-CCCCCCCChhhHHHHHHHHhhcc
Q 024336 146 GYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA-YPFEDPEDPRNFRKTIDRIRNVQ 221 (269)
Q Consensus 146 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~-~pf~~~~~~~~~~~~~~~~~~~~ 221 (269)
|++........ .....+++.|+|||.+.+..++. ++|+||||+++|+|+||. +||...+... ....+....
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~-~~Dv~S~G~il~El~t~~~~p~~~~~~~~----~~~~i~~~~ 252 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQ----VLRFVMEGG 252 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHHTSCCTTTTSCHHH----HHHHHHTTC
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCc-ccccccHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHhCC
Confidence 99874332222 23345789999999998877754 499999999999999984 7776654432 233333332
Q ss_pred ccCCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhc
Q 024336 222 YFLPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKAS 258 (269)
Q Consensus 222 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 258 (269)
. .+.+..+|+.+.++|.+||+.||.+|||+++++++
T Consensus 253 ~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 253 L-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2 22334789999999999999999999999999984
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.9e-52 Score=332.02 Aligned_cols=257 Identities=21% Similarity=0.185 Sum_probs=197.0
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCC-cceeeEEEEeCCeEEEEEe
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN-IIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~v~e 79 (269)
++++|++.+.||+|+||.||+|++..+|+.||||++.... ..+.+..|+.+++.++|++ |+.+..++.+.+..++|||
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 3679999999999999999999999999999999887543 3456788999999998765 5555666778889999999
Q ss_pred ecCCCchHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC-CCcEEEeecCCcccCCCCC--
Q 024336 80 YAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHS-- 155 (269)
Q Consensus 80 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~-~~~~~l~df~~~~~~~~~~-- 155 (269)
++++ ++...+ ...+.+++..+..++.|++.||+|||++||+||||||+||+++..+ ...++|+|||++.......
T Consensus 84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 84 LLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp CCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred EcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 9965 555544 4466799999999999999999999999999999999999986433 2359999999997432221
Q ss_pred ------CCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHHHHHHhh-ccccCC-Cc
Q 024336 156 ------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQYFLP-DY 227 (269)
Q Consensus 156 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~-~~ 227 (269)
......||+.|+|||.+.+..++ +++||||||+++|+|+||..||.................. .....+ ..
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence 22345689999999999877764 5599999999999999999999876554333222211111 000000 12
Q ss_pred CCCCHHHHHHHHHHhhhCCCCCCCcHHH---hhccC
Q 024336 228 VRVSADCRHLLSQIFVADPSKDPHSRDQ---KASLV 260 (269)
Q Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~~~---l~~~~ 260 (269)
..+|+++.++|.+||+.||.+||++.++ |++++
T Consensus 242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 3689999999999999999999998755 55544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=333.87 Aligned_cols=254 Identities=22% Similarity=0.247 Sum_probs=194.5
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCcceeeEEEEeCC----eEEE
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT----HLAI 76 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~ 76 (269)
|+++|.+.+.||+|+||+||+++. +|+.||||.+..........+.|+..++.++||||+++++++.+++ .+++
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 578999999999999999999986 5889999998765433333445666667889999999999998654 6899
Q ss_pred EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeecCCCCcEEecCCCCCcEEEeecCCc
Q 024336 77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS--------MEICHRDLKLENTLLDGSPQPRLKICDFGYS 148 (269)
Q Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~--------~~i~H~di~p~ni~i~~~~~~~~~l~df~~~ 148 (269)
||||+++|+|.+++++. ++++..+..++.|++.||++||+ +||+||||||+||+++.++. +||+|||++
T Consensus 79 v~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~ 155 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLA 155 (303)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTC
T ss_pred EEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCcc
Confidence 99999999999999764 68999999999999999999996 59999999999999998887 999999988
Q ss_pred ccCCCCC-----CCCcccCCCcccCchhhccccC-----CCccchhhhHHHHHHHHHhCCCCCCCCCCh-----------
Q 024336 149 KSGLLHS-----QPKSTVGTPAYIAPEVLARKEY-----DGKISDVWSCGVTLYVMLVGAYPFEDPEDP----------- 207 (269)
Q Consensus 149 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~~l~~l~tg~~pf~~~~~~----------- 207 (269)
....... ......+|+.|+|||.+.+... .+.++||||||+++|+|+||..||......
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 6432222 2234568999999999875432 244599999999999999998877532211
Q ss_pred hhHHHHHHHHhhccc--cCCCc---CCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 208 RNFRKTIDRIRNVQY--FLPDY---VRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 208 ~~~~~~~~~~~~~~~--~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
............... ..+.. ...+..+.+|+.+||+.||++|||+.|+++++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L 292 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 111222222222111 11110 11234588999999999999999999998875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.5e-51 Score=325.06 Aligned_cols=254 Identities=18% Similarity=0.197 Sum_probs=202.6
Q ss_pred CcccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCC-CCcceeeEEEEeCCeEEEEEe
Q 024336 1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH-PNIIRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 1 i~~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (269)
|+++|++.+.||+|+||+||+|++..+|+.||+|++.... ....+.+|++.++.+.| +|++.+++++.++...++|||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 4689999999999999999999999999999999876543 34557889999999975 899999999999999999999
Q ss_pred ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCC---CCcEEEeecCCcccCCCC-
Q 024336 80 YAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP---QPRLKICDFGYSKSGLLH- 154 (269)
Q Consensus 80 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~---~~~~~l~df~~~~~~~~~- 154 (269)
++ +++|.+.+... ..++...+..++.|++.||.+||++|++||||||+||+++.+. .+.++|+|||++......
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 99 56888888664 4699999999999999999999999999999999999997521 234999999999743221
Q ss_pred -------CCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChhhHHHH--HHHHhhccccCC
Q 024336 155 -------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT--IDRIRNVQYFLP 225 (269)
Q Consensus 155 -------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~~~~~~--~~~~~~~~~~~~ 225 (269)
.......||+.|+|||++.+..++ .++||||||+++|+|+||..||............ +...+.......
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence 122345689999999999877664 5599999999999999999999865543332221 111111111000
Q ss_pred CcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhh
Q 024336 226 DYVRVSADCRHLLSQIFVADPSKDPHSRDQKA 257 (269)
Q Consensus 226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 257 (269)
-..++|+++.+++..|++.+|.+||+.+.+.+
T Consensus 240 l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11368999999999999999999999776544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.2e-48 Score=320.70 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=195.7
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCC-----------CCCcceeeEEEEeC
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-----------HPNIIRFKEVLLTP 71 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~~ 71 (269)
+||++++.||+|+||+||+|++..+|+.||||++.......+.+.+|+.+++.+. |+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4799999999999999999999999999999999876555567788998888774 57899999887653
Q ss_pred --CeEEEEEeecCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEecCCCC----CcEE
Q 024336 72 --THLAIVMEYAAGGELFARI---CSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQ----PRLK 141 (269)
Q Consensus 72 --~~~~~v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~di~p~ni~i~~~~~----~~~~ 141 (269)
...++++.++..+...... .....+++..++.++.|++.||++||+ .||+||||||+||+++.++. ..++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence 4566666666544332222 234568999999999999999999998 89999999999999976553 2489
Q ss_pred EeecCCcccCCCCCCCCcccCCCcccCchhhccccCCCccchhhhHHHHHHHHHhCCCCCCCCCChh------hHHHHHH
Q 024336 142 ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR------NFRKTID 215 (269)
Q Consensus 142 l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~pf~~~~~~~------~~~~~~~ 215 (269)
++|||.+.. .........+++.|+|||.+....++.+ +|+||+|+++++|++|..||....... .......
T Consensus 173 l~dfg~s~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 173 IADLGNACW--YDEHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp ECCCTTCEE--TTBCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred Eeecccccc--cccccccccccccccChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 999999873 2334456679999999999988877654 999999999999999999997543321 1111111
Q ss_pred HHhhc-----------------c---cc----------------CCCcCCCCHHHHHHHHHHhhhCCCCCCCcHHHhhcc
Q 024336 216 RIRNV-----------------Q---YF----------------LPDYVRVSADCRHLLSQIFVADPSKDPHSRDQKASL 259 (269)
Q Consensus 216 ~~~~~-----------------~---~~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~ 259 (269)
..... . .. .......++++.+||.+||+.||.+|||++|+|+||
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp 329 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 329 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 10000 0 00 000112356799999999999999999999999999
Q ss_pred Chhhhh
Q 024336 260 VPEEFA 265 (269)
Q Consensus 260 ~~~~~~ 265 (269)
||+...
T Consensus 330 ~f~~~~ 335 (362)
T d1q8ya_ 330 WLKDTL 335 (362)
T ss_dssp GGTTCT
T ss_pred ccCCCC
Confidence 998543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=3.5e-27 Score=176.09 Aligned_cols=131 Identities=18% Similarity=0.155 Sum_probs=104.3
Q ss_pred ccccceecccCceEEEEEEEecCCeEEEEEEeecCccc-------------------cHHHHHHHHHHHhCCCCCcceee
Q 024336 5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-------------------DENVQREIINHRSLRHPNIIRFK 65 (269)
Q Consensus 5 y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------------------~~~~~~e~~~l~~l~h~~i~~~~ 65 (269)
+.+.+.||+|+||+||+|.+. +|+.||+|++..+... ......|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 457899999999999999985 6899999986532110 12244678888999999998887
Q ss_pred EEEEeCCeEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEecCCCCCcEEEeec
Q 024336 66 EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDF 145 (269)
Q Consensus 66 ~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~di~p~ni~i~~~~~~~~~l~df 145 (269)
++. . .+++||++++..+.. ++...+..++.|++.++.+||+.|++||||||+||++++++ ++|+||
T Consensus 81 ~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDF 146 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDF 146 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCC
T ss_pred Eec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEEC
Confidence 653 2 269999998865533 45566778999999999999999999999999999998544 899999
Q ss_pred CCccc
Q 024336 146 GYSKS 150 (269)
Q Consensus 146 ~~~~~ 150 (269)
|.+..
T Consensus 147 G~a~~ 151 (191)
T d1zara2 147 PQSVE 151 (191)
T ss_dssp TTCEE
T ss_pred CCccc
Confidence 98863
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.93 E-value=4e-09 Score=80.92 Aligned_cols=138 Identities=17% Similarity=0.102 Sum_probs=93.4
Q ss_pred ccccccceecccCceEEEEEEEecCCeEEEEEEeecCc-cccHHHHHHHHHHHhCC-CCCcceeeEEEEeCCeEEEEEee
Q 024336 3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVMEY 80 (269)
Q Consensus 3 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
++|+..+..+.++.+.||++.. ++..+++|+..... .....+.+|...++.+. +--+.+++.+...++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 4566666655555678998864 35557888776433 23445778888887764 33356778888888899999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 024336 81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS------------------------------------------- 117 (269)
Q Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~------------------------------------------- 117 (269)
++|.++.+.... ......++.+++..+..||+
T Consensus 92 l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 92 ADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred cccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 999877654321 12223344555555555653
Q ss_pred ----------------CCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 118 ----------------MEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 118 ----------------~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
..++|+|+.|.||++++++. +.|.||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~--~~lIDwe~a~ 212 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV--SGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCce--EEEeechhcc
Confidence 12789999999999986543 5699998775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.55 E-value=3.3e-07 Score=74.19 Aligned_cols=77 Identities=17% Similarity=0.133 Sum_probs=48.6
Q ss_pred cceecccCceEEEEEEEecCCeEEEEEEeecC--------ccccHHHHHHHHHHHhCC-C-CC-cceeeEEEEeCCeEEE
Q 024336 8 VKELGSGNFGVARLVRDKRTKELVAVKYIERG--------KKIDENVQREIINHRSLR-H-PN-IIRFKEVLLTPTHLAI 76 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~e~~~l~~l~-h-~~-i~~~~~~~~~~~~~~~ 76 (269)
.+.||.|....||++.+..+++.+++|.-.+. ....+....|...++.+. + |. +.+++. .+++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEE
Confidence 45789999999999998877888999975431 112234556887777662 2 33 444444 34555678
Q ss_pred EEeecCCCch
Q 024336 77 VMEYAAGGEL 86 (269)
Q Consensus 77 v~e~~~~~~l 86 (269)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.46 E-value=6.1e-07 Score=67.99 Aligned_cols=74 Identities=14% Similarity=0.065 Sum_probs=52.0
Q ss_pred eecccCc-eEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCC--CCcceeeEEEEeCCeEEEEEeecCCCch
Q 024336 10 ELGSGNF-GVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--PNIIRFKEVLLTPTHLAIVMEYAAGGEL 86 (269)
Q Consensus 10 ~l~~g~~-g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~v~e~~~~~~l 86 (269)
.+..|.. +.||++... ++..+++|...... ...+..|...++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4445554 578988864 46668889765443 3456778888877643 3356678877888889999999998665
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.97 E-value=3.1e-05 Score=60.61 Aligned_cols=70 Identities=11% Similarity=0.060 Sum_probs=47.4
Q ss_pred cCceEEEEEEEecCCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCc--ceee-----EEEEeCCeEEEEEeecCCC
Q 024336 14 GNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI--IRFK-----EVLLTPTHLAIVMEYAAGG 84 (269)
Q Consensus 14 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~-----~~~~~~~~~~~v~e~~~~~ 84 (269)
+....||++... +|+.|++|+..+.....+.+..|...+..|...++ +... ..+..++..+.++++++|.
T Consensus 33 s~EN~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 33 SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cccceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 334589999874 67889999988776667788889888877632211 1111 1234466788999999873
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.83 E-value=4.3e-05 Score=61.54 Aligned_cols=74 Identities=12% Similarity=0.151 Sum_probs=51.5
Q ss_pred cceecccCceEEEEEEEec-------CCeEEEEEEeecCccccHHHHHHHHHHHhCCCCCc-ceeeEEEEeCCeEEEEEe
Q 024336 8 VKELGSGNFGVARLVRDKR-------TKELVAVKYIERGKKIDENVQREIINHRSLRHPNI-IRFKEVLLTPTHLAIVME 79 (269)
Q Consensus 8 ~~~l~~g~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~v~e 79 (269)
++.|+.|-.-.+|++.... .++.|++++... ........+|..+++.+.-.++ .++++++.. ..|++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5678889999999998753 245688887663 3344567789988888853344 467776542 58899
Q ss_pred ecCCCch
Q 024336 80 YAAGGEL 86 (269)
Q Consensus 80 ~~~~~~l 86 (269)
|++|.++
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.16 E-value=0.0025 Score=49.09 Aligned_cols=30 Identities=23% Similarity=0.344 Sum_probs=25.6
Q ss_pred CCceeecCCCCcEEecCCCCCcEEEeecCCcc
Q 024336 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149 (269)
Q Consensus 118 ~~i~H~di~p~ni~i~~~~~~~~~l~df~~~~ 149 (269)
.|++|+|+.++||+++.+.. .-+.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v--~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred cccccCCcchhhhhcccccc--eeEecccccc
Confidence 57999999999999986654 6899999775
|